{"title": "vacuna anti-haemophilus influenzae: Topics by WorldWideScience.org", "author": null, "url": null, "hostname": null, "description": null, "sitename": null, "date": "2015-11-17", "id": null, "license": null, "body": null, "comments": "", "commentsbody": null, "raw_text": null, "text": "[Impact of Haemophilus influenzae type b conjugate vaccine on bacterial meningitis in the Dominican Republic Impacto de la vacuna conjugada contra Haemophilus influenzae tipo b sobre la meningitis bacteriana en la Rep\u00fablica Dominicana](http://www.scielosp.org/scielo.php?script=sci_arttext&pid=S1020-49892008000900002) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nEllen H. Lee\n2008-09-01\nFull Text Available OBJECTIVES: Widespread use of Haemophilus influenzae type b (Hib vaccines has dramatically reduced the burden of Hib disease throughout the Americas. Few studies have evaluated the impact of Hib vaccination on non-culture-confirmed disease. This study analyzed trends in probable bacterial meningitis before and after the introduction of Hib vaccine in the Dominican Republic and estimated vaccine effectiveness against Hib meningitis. METHODS: Meningitis cases among children OBJETIVOS: El uso generalizado de la vacuna contra Haemophilus influenzae tipo b (Hib ha permitido reducir radicalmente la carga de enfermedad por Hib en las Am\u00e9ricas. Pocos estudios han evaluado el impacto de la vacunaci\u00f3n contra Hib sobre los casos no confirmados mediante cultivo. En este estudio se analizaron las tendencias en el n\u00famero de casos probables de meningitis bacteriana antes y despu\u00e9s de la introducci\u00f3n de la vacuna contra Hib en la Rep\u00fablica Dominicana y se estim\u00f3 la eficacia de la vacuna contra la meningitis. M\u00c9TODOS: Se identificaron los casos de meningitis en ni\u00f1os menores de 5 a\u00f1os a partir de los registros de ingreso del principal hospital pedi\u00e1trico de Santo Domingo entre 1998 y 2004. Los casos de meningitis con probable etiolog\u00eda bacteriana se clasificaron seg\u00fan criterios de laboratorio; los casos confirmados contaban con cultivo bacteriano positivo o detecci\u00f3n de ant\u00edgenos espec\u00edficos en el l\u00edquido cefalorraqu\u00eddeo. Se calcularon las tasas de incidencia acumulada de casos confirmados y probables de meningitis en los ni\u00f1os que viv\u00edan en el Distrito Nacional. Los casos confirmados de meningitis por Hib se incorporaron a un estudio de casos y controles -pareados seg\u00fan la edad y el barrio de residencia- para calcular la eficacia de la vacuna. RESULTADOS: Antes de la introducci\u00f3n de la vacuna, la tasa anual de meningitis de posible etiolog\u00eda bacteriana era de 49 casos por 100 000 ni\u00f1os menores de 5 a\u00f1os; de los casos confirmados de\n[Vigilancia de serotipos en infecciones invasivas por Haemophilus influenzae en la Argentina en la era de la vacuna conjugada contra el serotipo b durante el per\u00edodo 2005-2010](https://www.openaire.eu/search/publication?articleId=dedup_wf_001::0594a940d911cdbd3278b867bfb39dec)\nEfron, Adriana M.; Moscoloni, Mar\u00eda A.; Reijtman, Vanesa R.; Regueira, Mabel\n2013-01-01\nLa introducci\u00f3n de la vacuna contra Haemophilus influenzae tipo b en los programas de inmunizaci\u00f3n de muchos pa\u00edses produjo una reducci\u00f3n marcada en la incidencia de enfermedad invasiva causada por este serotipo y en su portaci\u00f3n y un incremento de otros tipos capsulares y de aislamientos no capsulados. Se estudiaron 313 aislamientos de H. influenzae recuperados de sitio est\u00e9ril, provenientes de pacientes pedi\u00e1tricos y adultos con enfermedad invasiva atendidos en 90 hospitales de la Red Nacio...\n[Fallos vacunales a vacunas conjugadas de Streptococcus pneumoniae y Haemophilus influenzae tipo b](http://www.anfamed.edu.uy/index.php/rev/article/view/185) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nGonzalo Angulo\n2016-11-01\nFull Text Available Haemophilus influenzae type b and Streptococcus pneumoniae are the main cause agents of otitis, pneumonia, sepsis and meningitis, affecting mainly children under 5 years. Conjugate vaccines for encapsulated germs have dramatically decreased, the various diseases caused by these germs. Despite the decrease in morbidity and mortality, vaccine failures were observed. Children who experienced vaccine failures to Haemophilus influenzae type b had associated comorbidities more frequently than the general population (prematurity, HIV, Down syndrome, tumors, etc.. Nevertheless, most of these children have no medical history or immunological disorders. There is no consensus on whether all patients with vaccine failures should be assessed immunologically and how. There are recommendations to indicate a booster dose to patients with certain comorbidities and patients experiencing vaccine failure even in the absence of theses. Of the vaccine preparations available for Haemophilus influenzae type b association with acellular Bordetella pertussis proved to be less immunogenic and is currently being discouraged. Streptococcus pneumoniae serotypes 6B and 19F are less immunogenics and explain most of the vaccine failures in some series.\n[ENFERMEDAD INVASORA POR HAEMOPHILUS INFLUENZAE ANTES Y DESPU\u00c9S DE LA CAMPA\u00d1A DE VACUNACI\u00d3N EN LA POBLACI\u00d3N INFANTIL DE LA COMUNIDAD VALENCIANA (1996-2000](http://www.redalyc.org/articulo.oa?id=17076304) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nMercedes Goicoechea S\u00e1ez\n2002-01-01\nFull Text Available Fundamento: La introducci\u00f3n de la vacuna conjugada anti Haemophilus influenzae tipo b (Hib en ni\u00f1os ha provocado un llamativo descenso de la incidencia de la enfermedad por H. influenzae. El objetivo de este estudio es analizar las caracter\u00edsticas m\u00e1s relevantes de la enfermedad invasora por H. influenzae en cuanto a la epidemiolog\u00eda, cl\u00ednica, evoluci\u00f3n y estado de vacunaci\u00f3n de la poblaci\u00f3n infantil de la Comunidad Valenciana en el periodo 1996-2000. M\u00e9todo: Los datos se recogen de las historias cl\u00ednicas de los ni\u00f1os menores de 15 a\u00f1os que hayan presentado s\u00edntomas y signos cl\u00ednicos sugestivos de enfermedad invasora con aislamiento de Haemophilus influenzae y/o que cumple con los criterios de definici\u00f3n de caso establecidos, atendidos en todos los hospitales p\u00fablicos de la Comunidad Valenciana entre 1996 y 2000. La evoluci\u00f3n de la incidencia se valor\u00f3 mediante tasas de incidencia. La cl\u00ednica y su evoluci\u00f3n (secuelas y letalidad mediante la frecuencia y distribuci\u00f3n por edad. Resultados: Se registraron un total de 36 casos de enfermedad invasora por Haemophilus influenzae. La tasa de incidencia en ni\u00f1os menores de 15 a\u00f1os pas\u00f3 de 3,56/105 en 1996 a 1,07/105 en 1997 (coincidiendo con la campa\u00f1a de vacunaci\u00f3n y la posterior inclusi\u00f3n de la vacuna conjugada anti Hib en el Calendario de Vacunaciones Sistem\u00e1ticas de la Comunidad Valenciana y 0,30/105 en 1998, situaci\u00f3n que se sigue manteniendo en los a\u00f1os posteriores. El 53% de los casos se dan en menores de 18 meses. Tanto las secuelas como los fallecimientos se producen en la \u00e9poca anterior a la aplicaci\u00f3n rutinaria de la vacuna conjugada. Ning\u00fan ni\u00f1o vacunado correctamente falleci\u00f3. Se registraron 2 casos de H. influenzae tipo no b en ni\u00f1os vacunados. Conclusiones: La incidencia de la infecci\u00f3n por Haemophilus influenzae tipo b disminuy\u00f3 dr\u00e1sticamente desde el inicio de la vacunaci\u00f3n sistem\u00e1tica de la poblaci\u00f3n infantil.\n[Enfermedad invasora por Haemophilus Influenzae antes y despu\u00e9s de la campa\u00f1a de vacunaci\u00f3n en la poblaci\u00f3n infantil de la Comunidad Valenciana (1996-2000](http://www.scielosp.org/scielo.php?script=sci_arttext&pid=S1135-57272002000300004) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nGoicoechea S\u00e1ez Mercedes\n2002-01-01\nFull Text Available Fundamento: La introducci\u00f3n de la vacuna conjugada anti Haemophilus influenzae tipo b (Hib en ni\u00f1os ha provocado un llamativo descenso de la incidencia de la enfermedad por H. influenzae. El objetivo de este estudio es analizar las caracter\u00edsticas m\u00e1s relevantes de la enfermedad invasora por H. influenzae en cuanto a la epidemiolog\u00eda, cl\u00ednica, evoluci\u00f3n y estado de vacunaci\u00f3n de la poblaci\u00f3n infantil de la Comunidad Valenciana en el periodo 1996-2000. M\u00e9todo: Los datos se recogen de las historias cl\u00ednicas de los ni\u00f1os menores de 15 a\u00f1os que hayan presentado s\u00edntomas y signos cl\u00ednicos sugestivos de enfermedad invasora con aislamiento de Haemophilus influenzae y/o que cumple con los criterios de definici\u00f3n de caso establecidos, atendidos en todos los hospitales p\u00fablicos de la Comunidad Valenciana entre 1996 y 2000. La evoluci\u00f3n de la incidencia se valor\u00f3 mediante tasas de incidencia. La cl\u00ednica y su evoluci\u00f3n (secuelas y letalidad mediante la frecuencia y distribuci\u00f3n por edad. Resultados: Se registraron un total de 36 casos de enfermedad invasora por Haemophilus influenzae. La tasa de incidencia en ni\u00f1os menores de 15 a\u00f1os pas\u00f3 de 3,56/10(5 en 1996 a 1,07/10(5 en 1997 (coincidiendo con la campa\u00f1a de vacunaci\u00f3n y la posterior inclusi\u00f3n de la vacuna conjugada anti Hib en el Calendario de Vacunaciones Sistem\u00e1ticas de la Comunidad Valenciana y 0,30/10(5 en 1998, situaci\u00f3n que se sigue manteniendo en los a\u00f1os posteriores. El 53% de los casos se dan en menores de 18 meses. Tanto las secuelas como los fallecimientos se producen en la \u00e9poca anterior a la aplicaci\u00f3n rutinaria de la vacuna conjugada. Ning\u00fan ni\u00f1o vacunado correctamente falleci\u00f3. Se registraron 2 casos de H. influenzae tipo no b en ni\u00f1os vacunados. Conclusiones: La incidencia de la infecci\u00f3n por Haemophilus influenzae tipo b disminuy\u00f3 dr\u00e1sticamente desde el inicio de la vacunaci\u00f3n sistem\u00e1tica de la poblaci\u00f3n infantil.\n[Impacto de la vacuna conjugada en la incidencia de meningitis por Haemophilus influenzae en el Distrito Federal de Brasil: resultados de tres a\u00f1os de seguimiento Impact of anti-Hib conjugate vaccine on the incidence of Haemophilus influenzae meningitis in Brazil's Federal District: results of a three-year follow-up](http://www.scielosp.org/scielo.php?script=sci_arttext&pid=S1020-49892006000100005) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nHelen Selma de Abreu Freitas\n2006-01-01\nFull Text Available INTRODUCCI\u00d3N: Haemophilus influenzae del serotipo b (Hib es todav\u00eda un importante agente causal de procesos infecciosos. Su variante encapsulada es la causa de formas invasoras de enfermedad. En algunas poblaciones abor\u00edgenes, la incidencia de enfermedades causadas por Hib es mayor de 400 por 100 000 ni\u00f1os menores de 5 a\u00f1os. En los decenios de 1970 y 1980, tras la identificaci\u00f3n de anticuerpos protectores contra la c\u00e1psula de Hib, se desarrollaron vacunas contra este microorganismo. OBJETIVO: Estimar el impacto que ha tenido desde su introducci\u00f3n, en marzo de 1998, la vacunaci\u00f3n contra Hib en el Distrito Federal de Brasil. M\u00c9TODO: Con los datos de base poblacional del Sistema de Vigilancia de la Secretar\u00eda de Salud del Distrito Federal de Brasil, se compararon las tasas de incidencia de meningitis correspondientes a los tres a\u00f1os anteriores y posteriores a la introducci\u00f3n de la vacuna. Se compararon tambi\u00e9n los cambios en su tendencia. RESULTADOS: Al comparar los dos per\u00edodos se advierte una reducci\u00f3n de aproximadamente 90% en la incidencia de meningitis por Hib, cambio que no ocurre en el caso de las meningitis ocasionadas por otros agentes bacterianos. Se registr\u00f3 un aumento proporcional de los casos entre los ni\u00f1os de 6 meses de edad y menores, debido a la reducci\u00f3n de la incidencia entre los mayores de esa edad. CONCLUSI\u00d3N: La introducci\u00f3n de la vacuna conjugada en el Distrito Federal de Brasil redujo de 168 por 100 000 (1995-1997 a 15 por 100 000 (1999-2001 la incidencia de meningitis por Hib entre ni\u00f1os de 7 a 35 meses. Esto representa una reducci\u00f3n de 91,1%.INTRODUCTION: Type b Haemophilus influenzae (Hib continues to be an important causative agent of various infectious processes, and its encapsulated strains cause invasive disease. In some aboriginal populations, the incidence of Hib infections in children under five is greater than 400 per 100 000. In the seventies and eighties, vaccines against Hib were\n[Hib Disease (Haemophilus Influenzae Type b)](https://kidshealth.org/en/teens/hib.html)\n... Fitness Diseases & Conditions Infections Drugs & Alcohol School & Jobs Sports Expert Answers (Q&A) Staying Safe Videos for Educators Search English Espa\u00f1ol Hib Disease (Haemophilus Influenzae Type b) KidsHealth / For Teens / Hib Disease (Haemophilus Influenzae ...\n[Tipificaci\u00f3n capsular mediante PCR de aislamientos de Haemophilus influenzae no tipificables por aglutinaci\u00f3n PCR-based capsular typing of Haemophilus influenzae isolates non-typeable by agglutination](http://www.scielo.org.ar/scielo.php?script=sci_arttext&pid=S0325-75412005000400007) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nG. Weltman\n2005-12-01\nFull Text Available Haemophilus influenzae es reconocido como un agente pat\u00f3geno responsable de infecciones localizadas y sist\u00e9micas. Se han descrito 6 tipos de polisac\u00e1ridos capsulares antig\u00e9nicamente distintos (a, b, c, d, e, y f que se pueden identificar por aglutinaci\u00f3n en l\u00e1mina con antisueros espec\u00edficos. Tambi\u00e9n existen cepas no capsuladas (NC fenot\u00edpicamente no tipificables (NT. La introducci\u00f3n de la vacuna conjugada produjo una marcada disminuci\u00f3n de las enfermedades invasivas causadas por H. influenzae tipo b. En este contexto, la tipificaci\u00f3n capsular mediante PCR es el m\u00e9todo m\u00e1s apropiado para distinguir las cepas no capsuladas de las mutantes b deficientes en c\u00e1psula (b- y detectar la presencia de cepas pertenecientes a otros serotipos que no puedan ser tipificables por aglutinaci\u00f3n. Se determin\u00f3 el genotipo capsular a 38 aislamientos de Haemophilus influenzae no tipificables por aglutinaci\u00f3n, derivados al servicio de Bacteriolog\u00eda Cl\u00ednica del INEI-ANLIS \"Dr. Carlos G. Malbr\u00e1n\" en el per\u00edodo 2002-2004. El 78,9% de los aislamientos proven\u00edan de hemocultivos y la mayor parte de ellos estaban asociados a foco respiratorio. El 100% de los aislamientos fueron identificados como H. influenzae no capsulados mediante la t\u00e9cnica de PCR.Haemophilus influenzae is recognized as a pathogenic agent responsible of localized and systemic infections. Six antigenically different capsular polysaccharide types have been described (a, b, c, d, e, and f which can be identified by slide agglutination with specific antisera. Besides there are non capsulated strains that cannot be typed by slide agglutination. The introduction of the conjugated vaccine produced an important reduction of invasive diseases caused by H. influenzae type b. Capsular typing by PCR is the most appropriated method for distinguishing non capsulated strains from capsule deficient type b mutants (b- and for detecting strains of other serotypes that cannot be detected by slide\n[Molecular basis of antimicrobial resistance in non-typable Haemophilus influenzae.](https://www.ncbi.nlm.nih.gov/pubmed/9353749)\nS\u00e1nchez, L; Leranoz, S; Puig, M; Lor\u00e9n, J G; Nikaido, H; Vi\u00f1as, M\n1997-09-01\nStrains of the facultative anaerobe Haemophilus influenzae, both type b and non typable strains, are frequently multiresistant. The measurement of the antibiotic permeability of Haemophilus influenzae outer membrane (OM) shows that antibiotics can cross through the OM easily. Thus, enzymatic activity or efflux pumps could be responsible for multiresistance. An efflux system closely related to AcrAB of Escherichia coli is present in Haemophilus influenzae. However, their role in multiresistance seems irrelevant. Classical mechanisms such as plasmid exchange seems to be playing a major role in the multidrug resistance in Haemophilus influenzae.\n[The role of cytomegalovirus, Haemophilus influenzae and Epstein Barr virus in Guillain Barre syndrome.](http://acta.tums.ac.ir/index.php/acta/article/view/4428) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nShahriar Nafissi\n2013-06-01\nFull Text Available Guillain Barre Syndrome (GBS is an inflammatory, usually demyelinating, polyneuropathy; clinically characterized by acute onset of symmetric progressive muscle weakness with loss of myotatic reflexes. Thirty five patients with GBS, defined clinically according to the criteria of Asbury and Cornblath, were recruited from three hospital affiliated to Tehran University of Medical Sciences.As a control group 35 age and sex matched patients with other neurological diseases admitted to the same hospital at the same time, were included in our study. Serum samples were collected before treatment from each patient (within 4 weeks after the disease onset and controls, and stored frozen at -80\u00baC until serologic assays were done. Serologic testing of pretreatment serum was performed in all patients. Positive titer of virus specific IgM antibody against cytomegalovirus (CMV was found in 6 cases and 2 controls. 34 patients and 31 controls had high titer of anti Haemophilus influenzae IgG and one patient had serologic evidence of a recent Epstein Barr virus (EBV infection. The mean titer of IgG antibody against Haemophilus influenzae in cases and controls was 5.21 and 2.97 respectively. Although serologic evidence of all these infections were more frequent in cases than in controls, only Haemophilus influenzae infection appeared to be significantly related to GBS (P=0.002. Eleven cases and 3 controls had high titers of IgG antibody against Haemophilus influenzae type B (titer >8. There is significant association between high titer of IgG antibody against Haemophilus influenzae and GBS (P=0.017. Our results provide further evidence that Haemophilus influenzae and probably CMV, can be associated with GBS.\n[Haemophilus haemolyticus: A Human Respiratory Tract Commensal to Be Distinguished from Haemophilus influenzae](http://www.forskningsdatabasen.dk/en/catalog/2389196035) [DEFF Research Database (Denmark)](http://forskningsbasen.deff.dk/?lang=eng)\nMurphy, T.F.; Brauer, A.L.; Sethi, S.\n2007-01-01\nBackground. Haemophilus influenzae is a common pathogen in adults with chronic obstructive pulmonary disease (COPD). In a prospective study, selected isolates of apparent H. influenzae had an altered phenotype. We tested the hypothesis that these variant strains were genetically different from...... typical H. influenzae.Methods. A prospective study of adults with COPD was conducted. Strains of apparent H. influenzae obtained from a range of clinical sources were evaluated by ribosomal DNA sequence analysis, multilocus sequence analysis, DNA-DNA hybridization, and sequencing of the conserved P6 gene.......Results. Variant strains were determined to be Haemophilus haemolyticus by means of 4 independent methods. Analysis of 490 apparent H. influenzae strains, identified by standard methods, revealed that 39.5% of sputum isolates and 27.3% of nasopharyngeal isolates were H. haemolyticus. Isolates obtained from...\n[Administraci\u00f3n de vacunas y casos de muerte s\u00fabita del lactante en el Per\u00fa, 2001. \u00bfAsociaci\u00f3n o coincidencia temporal?](https://www.openaire.eu/search/publication?articleId=dedup_wf_001::e53e6396d7036924ac4edb136005a9b2)\nVargas H, Javier; Centro Nacional de Salud P\u00fablica, Instituto Nacional de Salud. Lima, Per\u00fa.; Su\u00e1rez J, Magna; Centro Nacional de Salud P\u00fablica, Instituto Nacional de Salud. Lima, Per\u00fa.; Llamoga S, Alejandro; Centro Nacional de Salud P\u00fablica, Instituto Nacional de Salud. Lima, Per\u00fa.; Quispe T, Neyda; Centro Nacional de Salud P\u00fablica, Instituto Nacional de Salud. Lima, Per\u00fa.; Alva R, Fernando; Chu C, Julia; Centro Nacional de Producci\u00f3n de Biol\u00f3gicos, Instituto Nacional de Salud. Lima Per\u00fa.; Pereyra S, H\u00e9ctor; Oficina General de Epidemiolog\u00eda, Ministerio de Salud. Lima, Per\u00fa.; Ticona Z, Mar\u00eda; Oficina General de Epidemiolog\u00eda, Ministerio de Salud. Lima, Per\u00fa.; Medrano G, Jorge; Direcci\u00f3n General de Salud de las Personas, Ministerio de Salud. Lima, Per\u00fa.; Cerna D, Carolina; Direcci\u00f3n General de Salud de las Personas, Ministerio de Salud. Lima, Per\u00fa.\n2006-01-01\nObjetivos: Describir las caracter\u00edsticas cl\u00ednicas, socioecon\u00f3micas, y patol\u00f3gicas de nueve casos de lactantes que fallecieron horas despu\u00e9s de administr\u00e1rseles vacunas antipolio y DPT junto con anti Haemophilus influenzae b o asociada con antihepatitis B o BCG. Materiales y m\u00e9todos: Revisi\u00f3n de la historia cl\u00ednica, entrevista con el equipo de salud a cargo de la vacunaci\u00f3n y con los padres del lactante fallecido. Revisi\u00f3n de los informes del protocolo de autopsia e informes de anatom\u00eda patol\u00f3...\n[Evaluation of new biomarker genes for differentiating Haemophilus influenzae from Haemophilus haemolyticus.](https://www.ncbi.nlm.nih.gov/pubmed/22301020)\nTheodore, M Jordan; Anderson, Raydel D; Wang, Xin; Katz, Lee S; Vuong, Jeni T; Bell, Melissa E; Juni, Billie A; Lowther, Sara A; Lynfield, Ruth; MacNeil, Jessica R; Mayer, Leonard W\n2012-04-01\nPCR detecting the protein D (hpd) and fuculose kinase (fucK) genes showed high sensitivity and specificity for identifying Haemophilus influenzae and differentiating it from H. haemolyticus. Phylogenetic analysis using the 16S rRNA gene demonstrated two distinct groups for H. influenzae and H. haemolyticus.\n[Epidemiology of Haemophilus influenzae bacteremia: A multi-national population-based assessment](http://www.forskningsdatabasen.dk/en/catalog/163541806) [DEFF Research Database (Denmark)](http://forskningsbasen.deff.dk/?lang=eng)\nLaupland, Kevin B; Sch\u00f8nheyder, Henrik C; \u00d8stergaard, Christian\n2011-01-01\nOBJECTIVES: Haemophilus influenzae is an important cause of invasive infection but contemporary data in non-selected populations is limited. METHODS: Population-based surveillance for Haemophilus influenzae bacteremia was conducted in seven regions in Australia, Canada, and Denmark during 2000-20...\n[Vigilancia de los serotipos y susceptibilidad antimicrobiana de Haemophilus influenzae en Colombia, 1994-2002.](http://www.revistabiomedica.org/index.php/biomedica/article/view/1211) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nMar\u00eda Victoria Ovalle\n2003-06-01\nFull Text Available La enfermedad invasora causada por Haemophilus influenzae, serotipo b, ha sido una de las mayores causas de morbilidad y mortalidad en la poblaci\u00f3n infantil; afortunadamente, en algunos pa\u00edses con amplia cobertura de la vacuna conjugada esta situaci\u00f3n ha cambiado. En 1994 se inici\u00f3 en el Grupo de Microbiolog\u00eda un programa de vigilancia de la susceptibilidad antimicrobiana y de los serotipos de aislamientos invasores de H. influenzae, remitidos por los hospitales y Laboratorios de Salud P\u00fablica del pa\u00eds como componente de los programas de vigilancia en red de infecci\u00f3n respiratoria aguda y meningitis bacteriana aguda. El objetivo de este trabajo fue determinar la evoluci\u00f3n de los serotipos y los patrones de susceptibilidad antimicrobiana de los aislamientos invasores de H. influenzae obtenidos de 1994 al 2002 y realizar un nuevo an\u00e1lisis sobre el impacto de la vacuna conjugada de H. influenzae, serotipo b, en Colombia. De 1994 a 2002 se han estudiado 683 aislamientos; 379 (55,5% de pacientes del g\u00e9nero masculino; 370 (54,2% de menores de 1 a\u00f1o; 227 (33,2% de 1 a 5 a\u00f1os; 19 (2,8% de 6 a 14 a\u00f1os; 38 (5,6% de mayores de 14 a\u00f1os, y de 29 (4,2% no se ten\u00eda el dato de la edad; 493 (72,2% fueron recuperados de pacientes con meningitis, 181 (26,5% de neumon\u00eda y 9 (0,9% de otras enfermedades. El 85,1% de los aislamientos fueron H. influenzae, serotipo b, 12,9% no capsulares y 2,0% de otros serotipos (10 a, 1 d, 1 e y 2 f. Del total de aislamientos, 12% fueron productores de beta-lactamasa; 13,9%, resistentes a ampicilina; 12,7%, a trimetoprim sulfametoxazol (SXT; 5,4%, a cloranfenicol, y 1% a cefuroxima; todos fueron sensibles a ceftriaxona. Durante este per\u00edodo se observ\u00f3 un incremento en la resistencia de los aislamientos a SXT (5% al 13%, pero la diferencia no fue estad\u00edsticamente significativa (p=0,1. Con la vigilancia se pudo determinar una disminuci\u00f3n significativa de los casos de meningitis en los menores de 1 a\u00f1o y en el\n[Meningitis y artritis por Haemophilus influenzae en un adulto](http://www.iatreia.udea.edu.co/index.php/iatreia/article/view/664) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nJavier Molina\n1988-02-01\nFull Text Available Tradicionalmente el Haemophilus influenzae ha sido considerado un germen causante de infecciones en ni\u00f1os; en adultos se lo ha relacionado con Infecciones respiratorias, pero en los \u00faltimos tiempos se han descrito en ellos infecciones severas cuando hay algunos factores predisponentes. Se describe un paciente drogadicto de 30 a\u00f1os con cuadro de meningitis y artritis y prueba de l\u00e1tex y cultivo de LCR positivos para HaemophiIus influenzae, quien recibi\u00f3 tratamiento con ampicilina, 2 gramos Intravenosos cada 4 horas y evolucion\u00f3 a la mejor\u00eda sin secuelas. Se plantea la necesidad de tener en cuenta al Haemophilus influenzae como pat\u00f3geno del adulto y m\u00e1s en aquellas personas con factores predisponentes.\nHaemophilus influenzae has traditionally been considered as an infectious agent that predominantly affects children; instead, in adults It has been Linked either to respiratory infections or to gevere infections occurring when predisposing factors are present. We describe a 30 year-old drug adict patient that presented with meningitis and arthritis; both latex test and cerebrospinal fluid culture were positive for Haemophilus influenzae. He was treated with ampicilin 2 gm, I. V. every four hours and improved without sequelae. This microorganism must be considered among those affecting adult patients specially when predisposing factors for infection are present.\n[Low occurrence of 'non-haemolytic Haemophilus haemolyticus' misidentified as Haemophilus influenzae in cystic fibrosis respiratory specimens, and frequent recurrence of persistent H. influenzae clones despite antimicrobial treatment.](https://www.ncbi.nlm.nih.gov/pubmed/23177564)\nFenger, Mette G; Ridderberg, Winnie; Olesen, Hanne V; N\u00f8rskov-Lauritsen, Niels\n2012-12-01\nNon-influenzae commensal Haemophilus species of low pathogenicity may be difficult to discriminate from Haemophilus influenzae. We investigated the level of misidentifications in respiratory specimens from cystic fibrosis patients and evaluated the colonisation dynamics of genuine H. influenzae isolates. One hundred and ninety-two presumptive H. influenzae isolates were re-examined by assessment of marker genes sodC and fucK, and isolates with aberrant genotypes were subjected to multilocus sequence typing. Misidentifications (3%) were mainly caused by failure to identify porphyrin-synthesising strains, and only a single strain (0.5%) could be classified as 'non-haemolytic Haemophilus haemolyticus'. Sequential isolates of confirmed H. influenzae isolates from individual patients were typed by pulsed-field gel electrophoresis. Despite the routine prescription of antimicrobial therapy, the majority of H. influenzae isolates were identical with at least one of the strains cultured from the two preceding positive samples from the same patient. Copyright \u00a9 2012 Elsevier GmbH. All rights reserved.\n[Delineation of the species Haemophilus influenzae by phenotype, multilocus sequence phylogeny, and detection of marker genes](http://www.forskningsdatabasen.dk/en/catalog/2389207629) [DEFF Research Database (Denmark)](http://forskningsbasen.deff.dk/?lang=eng)\nN\u00f8rskov-Lauritsen, Niels; Overballe, MD; Kilian, Mogens\n2009-01-01\nTo obtain more information on the much-debated definition of prokaryotic species, we investigated the borders of Haemophilus influenzae by comparative analysis of H. influenzae reference strains with closely related bacteria including strains assigned to Haemophilus haemolyticus, cryptic genospec......To obtain more information on the much-debated definition of prokaryotic species, we investigated the borders of Haemophilus influenzae by comparative analysis of H. influenzae reference strains with closely related bacteria including strains assigned to Haemophilus haemolyticus, cryptic...... genospecies biotype IV, and the never formally validated species \"Haemophilus intermedius\". Multilocus sequence phylogeny based on six housekeeping genes separated a cluster encompassing the type and the reference strains of H. influenzae from 31 more distantly related strains. Comparison of 16S rRNA gene...\n[Vigilancia de serotipos en infecciones invasivas por Haemophilus influenzae en la Argentina en la era de la vacuna conjugada contra el serotipo b durante el per\u00edodo 2005-2010](http://www.scielo.org.ar/scielo.php?script=sci_arttext&pid=S0325-75412013000400004&lng=en&tlng=en) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nAdriana M. Efron\nFull Text Available La introducci\u00f3n de la vacuna contra Haemophilus influenzae tipo b en los programas de inmunizaci\u00f3n de muchos pa\u00edses produjo una reducci\u00f3n marcada en la incidencia de enfermedad invasiva causada por este serotipo y en su portaci\u00f3n y un incremento de otros tipos capsulares y de aislamientos no capsulados. Se estudiaron 313 aislamientos de H. influenzae recuperados de sitio est\u00e9ril, provenientes de pacientes pedi\u00e1tricos y adultos con enfermedad invasiva atendidos en 90 hospitales de la Red Nacional de Laboratorios para Meningitis e Infecciones Respiratorias Agudas Bacterianas durante el per\u00edodo 2005-2010. Las patolog\u00edas m\u00e1s frecuentes fueron neumon\u00eda, 40,3 % (n = 126, meningitis, 30,0 % (n = 94 y bacteriemia, 26,5 % (n = 83. En los pacientes pedi\u00e1tricos (n = 279, la mayor frecuencia de aislamientos correspondi\u00f3 a menores de 2 a\u00f1os, 74,5 % (n = 208. Con respecto a la distribuci\u00f3n de tipos, el 61,3 %, correspondi\u00f3 a H. influenzae no capsulados (n = 192; el 20,1 % al b (n = 63; 11,2 % al a (n = 35; 4,8 % al f y 2,6 % a otros. En meningitis predominaron H. influenzae capsulados mientras que en neumon\u00eda y bacteriemia resultaron dominantes los tipos no capsulados. Se determin\u00f3 el biotipo en 306 aislamientos. Todos los aislamientos de tipo a correspondieron al biotipo II; el 66,7 % de los tipo b pertenecieron al biotipo I. Mediante las t\u00e9cnicas de aglutinaci\u00f3n en l\u00e1mina y PCR se estudiaron 220 aislamientos; la concordancia entre ambas fue de 0,982 (IC: 0,92-1,00. En el \u00faltimo a\u00f1o se encontr\u00f3 un aumento significativo del tipo b, lo cual indica la importancia de mantener la vigilancia cl\u00ednica y laboratorial de la enfermedad invasiva por H. influenzae.\n[Identifying Haemophilus haemolyticus and Haemophilus influenzae by SYBR Green real-time PCR.](https://www.ncbi.nlm.nih.gov/pubmed/25753676)\nLatham, Roger; Zhang, Bowen; Tristram, Stephen\n2015-05-01\nSYBR Green real time PCR assays for protein D (hpd), fuculose kinase (fucK) and [Cu, Zn]-superoxide dismutase (sodC) were designed for use in an algorithm for the identification of Haemophilus influenzae and H. haemolyticus. When tested on 127 H. influenzae and 60 H. haemolyticus all isolates were identified correctly. Crown Copyright \u00a9 2015. Published by Elsevier B.V. All rights reserved.\n[NNDSS - Table II. Giardiasis to Haemophilus influenza](https://catalog.data.gov/dataset/nndss-table-ii-giardiasis-to-haemophilus-influenza-ad506)\nU.S. Department of Health & Human Services \u2014 NNDSS - Table II. Giardiasis to Haemophilus influenza - 2017. In this Table, provisional cases of selected notifiable diseases (\u22651,000 cases reported during the...\n[NNDSS - Table II. Giardiasis to Haemophilus influenza](https://catalog.data.gov/dataset/nndss-table-ii-giardiasis-to-haemophilus-influenza-718ed)\nU.S. Department of Health & Human Services \u2014 NNDSS - Table II. Giardiasis to Haemophilus influenza - 2018. In this Table, provisional cases of selected notifiable diseases (\u22651,000 cases reported during the...\n[NNDSS - Table II. Giardiasis to Haemophilus influenza](https://catalog.data.gov/dataset/nndss-table-ii-giardiasis-to-haemophilus-influenza-5cf59)\nU.S. Department of Health & Human Services \u2014 NNDSS - Table II. Giardiasis to Haemophilus influenza - 2015.In this Table, provisional cases of selected notifiable diseases (\u22651,000 cases reported during the...\n[NNDSS - Table II. Giardiasis to Haemophilus influenza](https://catalog.data.gov/dataset/nndss-table-ii-giardiasis-to-haemophilus-influenza)\nU.S. Department of Health & Human Services \u2014 NNDSS - Table II. Giardiasis to Haemophilus influenza - 2016. In this Table, provisional* cases of selected\u2020 notifiable diseases (\u22651,000 cases reported during the...\n[Efectividad de la vacuna contra influenza: metan\u00e1lisis de literatura](http://www.revistabiomedica.org/index.php/biomedica/article/view/44) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nJos\u00e9 Moreno\n2009-03-01\nConclusiones. Los an\u00e1lisis sugieren la vacunaci\u00f3n como medida masiva de control para influenza en adultos mayores de 65 a\u00f1os. Existe un importante vac\u00edo de conocimiento en la efectividad de la vacuna en ni\u00f1os menores de dos a\u00f1os y madres gestantes.\n[NNDSS - Table II. Giardiasis to Haemophilus influenza](https://catalog.data.gov/dataset/nndss-table-ii-giardiasis-to-haemophilus-influenza-73c8e)\nU.S. Department of Health & Human Services \u2014 NNDSS - Table II. Giardiasis to Haemophilus influenza - 2014. In this Table, all conditions with a 5-year average annual national total of more than or equals 1,000...\n[Evaluaci\u00f3n r\u00e1pida del impacto de la vacuna contra Haemophilus influenzae serotipo b en Colombia](http://www.scielosp.org/scielo.php?script=sci_arttext&pid=S1020-49892000000800005&lng=en&tlng=en) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nClara In\u00e9s Agudelo\n2000-09-01\nFull Text Available En 1998, el Ministerio de Salud de Colombia inici\u00f3 la vacunaci\u00f3n contra Haemophilus influenzae b (Hib en menores de 1 a\u00f1o. En 1999 se evalu\u00f3 el impacto de esta intervenci\u00f3n en la incidencia de la meningitis bacteriana aguda (MBA utilizando los datos del sistema de vigilancia por laboratorio que coordina desde 1994 el Grupo de Microbiolog\u00eda del Instituto Nacional de Salud. En el an\u00e1lisis se compar\u00f3 el n\u00famero anual de casos de meningitis por Hib en ni\u00f1os menores de 1 a\u00f1o que se diagnosticaron en el sistema de vigilancia, antes de introducirse la vacuna, con el n\u00famero de casos registrados durante el primer a\u00f1o despu\u00e9s de iniciada la vacunaci\u00f3n. El n\u00famero de casos esperado, seg\u00fan el promedio anual de los diagnosticados entre junio de 1994 y mayo de 1998, se compar\u00f3 con el n\u00famero de casos observado despu\u00e9s de la vacunaci\u00f3n entre junio de 1998 y mayo de 1999. Para controlar la calidad del sistema de vigilancia, se realiz\u00f3 un estudio similar de los casos de meningitis por Streptococcus pneumoniae. En los an\u00e1lisis se incluyeron solamente los datos de los departamentos que hab\u00edan participado con mayor regularidad en la vigilancia. Entre 1994 y 1998 se confirmaron, respectivamente, 45, 37, 61, 64 y 31 casos de MBA por Hib, mientras que en el per\u00edodo posvacunal se esperaban 52 casos y se observaron 31 (P < 0,001. Durante los mismos per\u00edodos anuales se confirmaron tambi\u00e9n 32, 26, 43, 48 y 42 casos de MBA por S. pneumoniae en menores de 5 a\u00f1os, cifras que no representaron una disminuci\u00f3n significativa del n\u00famero de casos esperados. Sin embargo, la reducci\u00f3n observada en los casos de meningitis por Hib fue de 40%, porci\u00f3n no atribuible a cambios en el sistema de vigilancia. Concluimos, por lo tanto, que esta disminuci\u00f3n se debi\u00f3 en su mayor parte a los efectos de la vacunaci\u00f3n.\n[Evaluaci\u00f3n r\u00e1pida del impacto de la vacuna contra Haemophilus influenzae serotipo b en Colombia](http://www.scielosp.org/scielo.php?script=sci_arttext&pid=S1020-49892000000800005) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nAgudelo Clara In\u00e9s\n2000-01-01\nFull Text Available En 1998, el Ministerio de Salud de Colombia inici\u00f3 la vacunaci\u00f3n contra Haemophilus influenzae b (Hib en menores de 1 a\u00f1o. En 1999 se evalu\u00f3 el impacto de esta intervenci\u00f3n en la incidencia de la meningitis bacteriana aguda (MBA utilizando los datos del sistema de vigilancia por laboratorio que coordina desde 1994 el Grupo de Microbiolog\u00eda del Instituto Nacional de Salud. En el an\u00e1lisis se compar\u00f3 el n\u00famero anual de casos de meningitis por Hib en ni\u00f1os menores de 1 a\u00f1o que se diagnosticaron en el sistema de vigilancia, antes de introducirse la vacuna, con el n\u00famero de casos registrados durante el primer a\u00f1o despu\u00e9s de iniciada la vacunaci\u00f3n. El n\u00famero de casos esperado, seg\u00fan el promedio anual de los diagnosticados entre junio de 1994 y mayo de 1998, se compar\u00f3 con el n\u00famero de casos observado despu\u00e9s de la vacunaci\u00f3n entre junio de 1998 y mayo de 1999. Para controlar la calidad del sistema de vigilancia, se realiz\u00f3 un estudio similar de los casos de meningitis por Streptococcus pneumoniae. En los an\u00e1lisis se incluyeron solamente los datos de los departamentos que hab\u00edan participado con mayor regularidad en la vigilancia. Entre 1994 y 1998 se confirmaron, respectivamente, 45, 37, 61, 64 y 31 casos de MBA por Hib, mientras que en el per\u00edodo posvacunal se esperaban 52 casos y se observaron 31 (P < 0,001. Durante los mismos per\u00edodos anuales se confirmaron tambi\u00e9n 32, 26, 43, 48 y 42 casos de MBA por S. pneumoniae en menores de 5 a\u00f1os, cifras que no representaron una disminuci\u00f3n significativa del n\u00famero de casos esperados. Sin embargo, la reducci\u00f3n observada en los casos de meningitis por Hib fue de 40%, porci\u00f3n no atribuible a cambios en el sistema de vigilancia. Concluimos, por lo tanto, que esta disminuci\u00f3n se debi\u00f3 en su mayor parte a los efectos de la vacunaci\u00f3n.\n[Invasive Disease Caused by Nontypeable Haemophilus Influenzae](https://www2c.cdc.gov/podcasts/player.asp?f=8639125) [Centers for Disease Control (CDC) Podcasts](http://www2c.cdc.gov/podcasts/search.asp)\n2015-11-12\nDr. Elizabeth Briere discusses Nontypeable Haemophilus influenzae which causes a variety of infections in children and adults. Created: 11/12/2015 by National Center for Emerging and Zoonotic Infectious Diseases (NCEZID). Date Released: 11/17/2015.\n[Haemophilus influenzae Type a Meningitis in Immunocompetent Child, Oman, 2015.](https://www.ncbi.nlm.nih.gov/pubmed/28628438)\nSawardekar, Kiran P\n2017-07-01\nMeningitis caused by Haemophilus influenzae type b (Hib) was eliminated in Oman after the introduction of Hib vaccine in 2001. However, a case of H. influenzae type a meningitis was diagnosed in a child from Oman in 2015, which highlights the need to monitor the incidence of invasive non-Hib H. influenzae disease.\n[Clinical and microbiological features of Haemophilus influenzae vulvovaginitis in young girls](https://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=1769841)\nCox, R A; Slack, M P E\n2002-01-01\nAims: To define the clinical and microbiological features of vulvovaginitis in prepubertal girls whose genital swabs yielded Haemophilus influenzae. Methods: Laboratory based study and retrospective collection of clinical data from the requesting doctors. Results: Thirty eight isolates of non-capsulate Haemophilus influenzae and one of H parainfluenzae were isolated from 32 girls aged 18 months to 11 years. No other pathogens, such as \u03b2 haemolytic streptococci or yeasts, were present with H influenzae. The most common biotype was biotype II, comprising 57% of the 26 isolates biotyped. Six children had more than one episode of vulvovaginitis caused by H influenzae and a total of 14 children had recurrent vaginal symptoms. Conclusion: Children who have H influenzae vulvovaginitis are at risk of recurrent symptoms. Biotype II is the one most commonly associated with this condition. PMID:12461068\n[Vaccine-Induced Waning of Haemophilus influenzae Empyema and Meningitis, Angola](https://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=4214300)\nPeltola, Heikki; Bernardino, Luis; Monteiro, Lurdes; Silvestre, Silvia da Concei\u00e7\u00e3o; Anjos, Elizabete; Cruzeiro, Manuel Leite; Pitk\u00e4ranta, Anne; Roine, Irmeli\n2014-01-01\nIn Angola during 2003\u20132012, we detected Haemophilus influenzae in 18% of 2,634 and 26% of 2,996 bacteriologically positive pleural or cerebrospinal fluid samples, respectively, from children. After vaccination launch in 2006, H. influenzae empyema declined by 83% and meningitis by 86%. Severe H. influenzae pneumonia and meningitis are preventable by vaccination. PMID:25340259\n[Haemophilus influenzae type b pneumonia in Egyptian children ...](https://www.ajol.info/index.php/ejhg/article/view/77700) [African Journals Online (AJOL)](http://www.ajol.info/index.php)\nHaemophilus influenzae (Hi) causes more than 3 million cases of serious disease, mainly meningitis and ... One hundred patients with community-acquired pneumonia were investigated for Hib by both real-time PCR and bacterial culture.\n[Quorum signaling and sensing by nontypeable Haemophilus influenzae](http://journal.frontiersin.org/Journal/10.3389/fcimb.2012.00100/full) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nW Edward Swords\n2012-07-01\nFull Text Available Quorum signals are diffusible factors produced by bacteria that coordinate communal responses. For Haemophilus influenzae, a series of recent papers indicate that production and sensing of quorum signals are determinants of biofilm formation/maturation and persistence in vivo. In this mini-review I will summarize the current knowledge about quorum signaling/sensing by H. influenzae, and identify specific topics for additional study.\n[[Two cases of invasive Haemophilus influenzae type f infection](http://www.forskningsdatabasen.dk/en/catalog/2434078580) [DEFF Research Database (Denmark)](http://forskningsbasen.deff.dk/?lang=eng)\nNielsen, J.D.; Lind, J.W.; Bruun, B.\n2009-01-01\nTwo cases of invasive Haemophilus influenzae type f infection are presented: a three-week-old boy with meningitis and a 62-year-old woman with arthritis and bacteremia. Since 1993 vaccination against H. influenzae type b (Hib) has been offered to Danish children. The result has been a remarkable...... decrease in invasive Hib disease. However, physicians need to be aware of the existence of non-type b invasive H. influenzae disease Udgivelsesdato: 2009/1/19...\n[Plasmid containing a DNA ligase gene from Haemophilus influenzae](https://inis.iaea.orgsearchsinglerecord.aspx?recordsFor=SingleRecord&RN=17068041) [International Nuclear Information System (INIS) ](http://inis.iaea.org/search/)\nMcCarthy, D.; Griffin, K.; Setlow, J.K.\n1984-01-01\nA ligase gene from Haemophilus influenzae was cloned into the shuttle vector pDM2. Although the plasmid did not affect X-ray sensitivity, it caused an increase in UV sensitivity of the wild-type but not excision-defective H. influenzae and a decrease in UV sensitivity of the rec-1 mutant. 14 references, 2 figures\n[Haemophilus influenzae type f meningitis in a previously healthy boy](http://www.forskningsdatabasen.dk/en/catalog/241237321) [DEFF Research Database (Denmark)](http://forskningsbasen.deff.dk/?lang=eng)\nRonit, Andreas; Berg, Ronan M G; Bruunsgaard, Helle\n2013-01-01\nNon-serotype b strains of Haemophilus influenzae are extremely rare causes of acute bacterial meningitis in immunocompetent individuals. We report a case of acute bacterial meningitis in a 14-year-old boy, who was previously healthy and had been immunised against H influenzae serotype b (Hib...\n[To tilfaelde af invasive infektioner med Haemophilus influenzae type f](http://www.forskningsdatabasen.dk/en/catalog/2398336027) [DEFF Research Database (Denmark)](http://forskningsbasen.deff.dk/?lang=eng)\nNielsen, Jette Dettmann; Lind, Jens Wentzel; Bruun, Britta\n2009-01-01\nTwo cases of invasive Haemophilus influenzae type f infection are presented: a three-week-old boy with meningitis and a 62-year-old woman with arthritis and bacteremia. Since 1993 vaccination against H. influenzae type b (Hib) has been offered to Danish children. The result has been a remarkable...... decrease in invasive Hib disease. However, physicians need to be aware of the existence of non-type b invasive H. influenzae disease. Udgivelsesdato: 2009-Jan...\n[To tilfaelde af invasive infektioner med Haemophilus influenzae type f](http://www.forskningsdatabasen.dk/en/catalog/2397929331) [DEFF Research Database (Denmark)](http://forskningsbasen.deff.dk/?lang=eng)\nNielsen, Jette Dettmann; Lind, Jens; Bruun, Brita\n2009-01-01\nTwo cases of invasive Haemophilus influenzae type f infection are presented: a three-week-old boy with meningitis and a 62-year-old woman with arthritis and bacteremia. Since 1993 vaccination against H. influenzae type b (Hib) has been offered to Danish children. The result has been a remarkable...... decrease in invasive Hib disease. However, physicians need to be aware of the existence of non-type b invasive H. influenzae disease. Udgivelsesdato: 2009-Jan-19...\n[Invasive Haemophilus Influenzae Disease, Europe, 1996\u00e22006](https://tools.cdc.gov/medialibrary/index.aspx#/media/id/302614) [Centers for Disease Control (CDC) Podcasts](http://www2c.cdc.gov/podcasts/search.asp)\nThis podcast describes monitoring of Haemophilus influenzae disease in Europe from 1996 through 2006. CDC epidemiologist Stacey Martin discusses what researchers learned about the effect of vaccination on disease prevalence.\n[Inhibitory effect of 1,2,4-triazole-ciprofloxacin hybrids on Haemophilus parainfluenzae and Haemophilus influenzae biofilm formation in vitro under stationary conditions.](https://www.ncbi.nlm.nih.gov/pubmed/27292570)\nKosikowska, Urszula; Andrzejczuk, Sylwia; Plech, Tomasz; Malm, Anna\n2016-10-01\nHaemophilus parainfluenzae and Haemophilus influenzae, upper respiratory tract microbiota representatives, are able to colonize natural and artificial surfaces as biofilm. The aim of the present study was to assay the effect of ten 1,2,4-triazole-ciprofloxacin hybrids on planktonic or biofilm-forming haemophili cells in vitro under stationary conditions on the basis of MICs (minimal inhibitory concentrations) and MBICs (minimal biofilm inhibitory concentrations). In addition, anti-adhesive properties of these compounds were examined. The reference strains of H. parainfluenzae and H. influenzae were included. The broth microdilution microtiter plate (MTP) method with twofold dilution of the compounds, or ciprofloxacin (reference agent) in 96-well polystyrene microplates, was used. The optical density (OD) reading was made spectrophotometrically at a wavelength of 570 nm (OD570) both to measure bacterial growth and to detect biofilm-forming cells under the same conditions with 0.1% crystal violet. The following values of parameters were estimated for 1,2,4-triazole-ciprofloxacin hybrids - MIC = 0.03-15.63 mg/L, MBIC = 0.03-15.63 mg/L, MBIC/MIC = 0.125-8, depending on the compound, and for ciprofloxacin - MIC = 0.03-0.06 mg/L, MBIC = 0.03-0.12 mg/L, MBIC/MIC = 1-2. The observed strong anti-adhesive properties (95-100% inhibition) of the tested compounds were reversible during long-term incubation at subinhibitory concentrations. Thus, 1,2,4-triazole-ciprofloxacin hybrids may be considered as starting compounds for designing improved agents not only against planktonic but also against biofilm-forming Haemophilus spp. cells. Copyright \u00a9 2016 Institut Pasteur. Published by Elsevier Masson SAS. All rights reserved.\n[Prevenci\u00f3n de las neumon\u00edas mediante vacunas](http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S0034-75312014000200012&lng=en&tlng=en) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nRoberto Raz\u00f3n Behar\nFull Text Available La neumon\u00eda es una infecci\u00f3n respiratoria aguda que afecta a los pulmones. La neumon\u00eda adquirida en la comunidad, es la principal causa individual de mortalidad infantil en todo el mundo. Se calcula que cada a\u00f1o mueren por su causa m\u00e1s de 1,5 millones de ni\u00f1os menores de 5 a\u00f1os, lo que supone el 18 % de todas las defunciones de este grupo etario en todo el mundo. Diversos agentes infecciosos, particularmente los virus y bacterias, causan neumon\u00eda, y son los m\u00e1s comunes el Streptococcus pneumoniae -la causa m\u00e1s com\u00fan de neumon\u00eda bacteriana en ni\u00f1os-; el Haemophilus influenzae de tipo b -la segunda causa m\u00e1s com\u00fan de neumon\u00eda bacteriana-; as\u00ed como el virus sincitial respiratorio. La prevenci\u00f3n de la neumon\u00eda infantil es un componente fundamental de toda estrategia para reducir la mortalidad infantil. La inmunizaci\u00f3n, particularmente contra el Haemophilus influenzae de tipo b, los neumococos, el sarampi\u00f3n y la tos ferina, es la forma m\u00e1s eficaz de prevenirla. Por tal motivo se considera importante una revisi\u00f3n y actualizaci\u00f3n de las principales vacunas existentes hoy en d\u00eda.\n[Aislamiento de distintos serotipos de Haemophilus influenzae en muestras profundas de pacientes pedi\u00e1tricos Isolation of Haemophilus influenzae serotypes from sterile sites in sick children](http://www.scielo.org.ar/scielo.php?script=sci_arttext&pid=S0325-75412004000100004) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nB.M. Gatti\n2004-03-01\nFull Text Available Haemophilus influenzae (Hi es responsable de diversas enfermedades humanas como sepsis, meningitis, celulitis y osteoartritis. En este trabajo se investig\u00f3 la recuperaci\u00f3n de distintos serotipos de Hi en muestras profundas de pacientes pedi\u00e1tricos. Se estudiaron 179 aislamientos de 146 ni\u00f1os durante el periodo 1996-2002 en el Laboratorio de Microbiolog\u00eda del Hospital de Ni\u00f1os Superiora Sor Mar\u00eda Ludovica, Argentina. La distribuci\u00f3n de los serotipos fue la siguiente: 1 a, 112 b, 1 c,1 d, 4 e, 3 f y 24 no tipificables. A partir del establecimiento de la estrategia de vacunaci\u00f3n universal anti Hi b en 1998 se observa una disminuci\u00f3n notable del serotipo b y un aumento relativo de otros y no tipificables.Haemophilus influenzae (Hi is the causative agent of several human diseases such as sepsis, meningitis, celulitis, and osteoarthritis. We investigated the isolation of Hi serotypes from sterile sites in sick children. One hundred and seventy nine strains from 146 patients were studied, period 1996-2002, at the Microbiology Laboratory, Hospital de Ni\u00f1os Superiora Sor Mar\u00eda Ludovica, Argentina. The serotype distribution was:1 a, 112 b,1 c,1 d, 4 e, 3 f y 24 no typable. Since the beginning of universal Hi b vaccination in 1998, we have observed the fast decrease of serotype b and a relative increase of other serotypes.\n[Impacto del neumococo y de los virus influenza en ni\u00f1os y adultos : su prevenci\u00f3n con vacunas](http://www.anfamed.edu.uy/index.php/rev/article/view/123) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nMar\u00eda Hortal\n2015-07-01\nFull Text Available Durante siglos las enfermedades infecciosas han diezmado a poblaciones enteras, por lo que se ha procurado descubrir su causa y as\u00ed lograr su prevenci\u00f3n. Actualmente, la vacunaci\u00f3n es una de las intervenciones en salud m\u00e1s costo-efectivas para reducir la morbilidad y mortalidad por enfermedades infecciosas. La historia as\u00ed lo confirma con la erradicaci\u00f3n de la viruela, y el control de la poliomielitis y del sarampi\u00f3n a nivel mundial. En Uruguay, el inicio de la vacunaci\u00f3n obligatoria contra la viruela se remonta a 1911, en tanto que la vacunaci\u00f3n contra la poliomielitis y el sarampi\u00f3n, se implementaron en 1957 y 1966 respectivamente. Dentro de las enfermedades inmunoprevenibles, las infecciones respiratorias agudas son notoriamente las m\u00e1s frecuentes. Su impacto urgi\u00f3 la necesidad de contar con medidas de control. La neumon\u00eda, aunque se observa en todas las edades, predomina en los extremos de la vida. En la infancia, en menores de cinco a\u00f1os, es una de las causas m\u00e1s frecuentes de hospitalizaci\u00f3n y en las poblaciones m\u00e1s desfavorecidas provoca elevada mortalidad. En los adultos con comorbilidades ocurre en todas las edades, pero es m\u00e1s frecuente en los mayores de 65 a\u00f1os, en los que patolog\u00edas asociadas aumentan el riesgo vital, que es mayor cuanto mayor es la persona. Una vez controladas las neumon\u00edas por la vacuna conjugada de Haemophilus influenzae tipo b, el agente bacteriano de mayor frecuencia es Streptococcus pneumoniae y, entre los virus respiratorios, los brotes anuales y las pandemias por virus influenza contribuyen al aumento de hospitalizaciones y decesos por neumon\u00eda. Cuando ambos agentes se asocian en un paciente, sus efectos se potencian mutuamente y sus resultados pueden ser fatales. En consecuencia, la prevenci\u00f3n de esas infecciones con las vacunas disponibles, neumoc\u00f3ccica y de influenza, es una prioridad de Salud P\u00fablica para asegurar la supervivencia infantil y disminuir costos sociales y econ\u00f3micos.\n[Lower airway colonization and inflammatory response in COPD: a focus on Haemophilus influenzae](http://www.dovepress.com/lower-airway-colonization-and-inflammatory-response-in-copd-a-focus-on-peer-reviewed-article-COPD) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nFinney LJ\n2014-10-01\nFull Text Available Lydia J Finney,1 Andrew Ritchie,1 Elizabeth Pollard,2 Sebastian L Johnston,1 Patrick Mallia1 1Airway Disease Infection Section, National Heart and Lung Institute, Imperial College, London, United Kingdom; 2King's College London, London, United Kingdom Abstract: Bacterial infection of the lower respiratory tract in chronic obstructive pulmonary disease (COPD patients is common both in stable patients and during acute exacerbations. The most frequent bacteria detected in COPD patients is Haemophilus influenzae, and it appears this organism is uniquely adapted to exploit immune deficiencies associated with COPD and to establish persistent infection in the lower respiratory tract. The presence of bacteria in the lower respiratory tract in stable COPD is termed colonization; however, there is increasing evidence that this is not an innocuous phenomenon but is associated with airway inflammation, increased symptoms, and increased risk for exacerbations. In this review, we discuss host immunity that offers protection against H. influenzae and how disturbance of these mechanisms, combined with pathogen mechanisms of immune evasion, promote persistence of H. influenzae in the lower airways in COPD. In addition, we examine the role of H. influenzae in COPD exacerbations, as well as interactions between H. influenzae and respiratory virus infections, and review the role of treatments and their effect on COPD outcomes. This review focuses predominantly on data derived from human studies but will refer to animal studies where they contribute to understanding the disease in humans. Keywords: chronic obstructive pulmonary disease, Haemophilus influenzae, nontypeable Haemophilus influenzae, respiratory viruses, vaccination\n[Safety and immunogenicity of two Haemophilus influenzae type b ...](https://www.ajol.info/index.php/samj/article/view/134279) [African Journals Online (AJOL)](http://www.ajol.info/index.php)\nObjectives. Haemophilus influenzae type b (Hib) infection remains a major public health problem inthe developing world. We evaluated the safety and immunogenicity of a new PRP-CRM197 conjugate Hib vaccine (Vaxem Hib, Chiron Vacdnes), compared with theHibTITER vaccine (WyethLederle Vaccines), following the ...\n[Relaci\u00f3n costo-efectividad de la vacuna contra Haemophilus influenzae tipo b en ni\u00f1os menores de dos a\u00f1os de edad en Colombia The cost-effectiveness of Haemophilus influenzae type b vaccine for children under 2 years of age in Colombia](http://www.scielosp.org/scielo.php?script=sci_arttext&pid=S1020-49892006000900005) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nNelson Alvis Guzm\u00e1n\n2006-10-01\nFull Text Available OBJETIVOS: Las vacunas conjugadas contra Haemophilus influenzae tipo b (Hib son la herramienta m\u00e1s importante para prevenir la mayor\u00eda de las enfermedades invasoras producidas por dicho pat\u00f3geno, pero debido a su costo, a\u00fan no se han introducido mundialmente de manera masiva. En el presente estudio se determin\u00f3 la relaci\u00f3n costo-efectividad de una vacuna contra Hib para prevenir la neumon\u00eda y la meningitis bacterianas en ni\u00f1os menores de 2 a\u00f1os en Colombia. M\u00c9TODOS: Se estimaron los costos directos e indirectos de la neumon\u00eda y la meningitis hospitalaria y siguiendo las recomendaciones de la Organizaci\u00f3n Mundial de la Salud (OMS, la relaci\u00f3n costo-efectividad de los programas de vacunaci\u00f3n contra Hib. Se estimaron tambi\u00e9n las razones de costos por caso evitado de enfermedad invasora por Hib y el costo por a\u00f1o de vida salvado en dos situaciones hipot\u00e9ticas: con vacunaci\u00f3n contra Hib (cobertura vacunal: 90% y sin vacunaci\u00f3n. RESULTADOS: El costo medio del tratamiento hospitalario de un caso de neumon\u00eda fue de 611,5 d\u00f3lares estadounidenses (US$ (intervalo de confianza del 95% [IC95%]: 532,2 - 690,8, el costo medio del tratamiento hospitalario de un caso de meningitis fue de US$ 848,9 (IC95%: 716,8 - 981,0 y el costo por caso evitado de enfermedad invasora por Hib, de US$ 316,7 (IC95%: 294,2 - 339,2. La relaci\u00f3n costo-efectividad en la hip\u00f3tesis con vacunaci\u00f3n fue de 2,38, frente a 3,81 en la hip\u00f3tesis sin vacunaci\u00f3n. CONCLUSI\u00d3N: La aplicaci\u00f3n de un programa adecuado de vacunaci\u00f3n contra Hib en Colombia puede prevenir cerca de 25 000 casos de enfermedad invasora por a\u00f1o, lo que representa un ahorro de por lo menos US$ 15 millones anuales. Adem\u00e1s, puede evitar cerca de 700 defunciones y salvar anualmente 44 054 a\u00f1os de vida.OBJECTIVE: Conjugate vaccines are the best public health tools available for preventing most invasive diseases caused by Haemophilus influenzae type b (Hib, but the high cost of the vaccines has so\n[[Severe Haemophilus influenzae b infection in healthy male adult](http://www.forskningsdatabasen.dk/en/catalog/2434078496) [DEFF Research Database (Denmark)](http://forskningsbasen.deff.dk/?lang=eng)\nVilmar, A.C.; Gjorup, I.; David, Kim Peter\n2008-01-01\nHaemophilus influenzae b (Hib) can be the cause of serious infections, and is mainly observed affecting children and immuno-compromised patients. We report a case of a healthy 49-year old male with a severe Hib infection complicated by septicaemia, meningitis and anuria. The risk of invasive Hib...\n[A new DTPw-HB/Hib combination vaccine for primary and booster vaccination of infants in Latin America Nueva vacuna combinada DTPw-HB/Hib para la vacunaci\u00f3n primaria y de refuerzo de menores de un a\u00f1o en Am\u00e9rica Latina](http://www.scielosp.org/scielo.php?script=sci_arttext&pid=S1020-49892006000300006) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nMiguel Tregnaghi\n2006-03-01\n, la Organizaci\u00f3n Mundial de la Salud (OMS recomend\u00f3 que se incluyeran vacunas conjugadas contra Haemophilus influenzae tipo B (Hib en los programas de vacunaci\u00f3n de ni\u00f1os menores de un a\u00f1o, siempre que ello estuviera en consonancia con las prioridades nacionales. La compa\u00f1\u00eda GlaxoSmithKline Biologicals ha creado una nueva vacuna pentavalente que es una combinaci\u00f3n de la vacuna contra la difteria (D, el t\u00e9tanos (T y la tos ferina (P (con ant\u00edgeno tosfer\u00ednico a base de c\u00e9lulas completas y las vacunas contra la hepatitis B (HB y contra Haemophilus influenzae tipo B (Hib (DTPw-HB/Hib, con un total de 5 \u00b5g de fosfato de polirribosilrribitol (FPR. Hemos evaluado la inmunogenia y reactogenia observadas al aplicarse las dosis primaria y de refuerzo de esta nueva vacuna a ni\u00f1os sanos y las hemos comparado con las observadas al aplicar un r\u00e9gimen de referencia a base de las vacunas autorizadas DTPw-HB (Tritanrix y antiHib (Hiberix en forma de inyecciones simult\u00e1neas. M\u00c9TODOS: Llevamos a cabo un estudio aleatorizado y con doble enmascaramiento de septiembre de 1998 a agosto de 1999 para establecer la inmunogenia y reactogenia observadas al administrarles a ni\u00f1os sanos la nueva vacuna combinada pentavalente (DTPw-HB/Hib en una sola inyecci\u00f3n, y compararlas con las observadas con el r\u00e9gimen de referencia. RESULTADOS: Se obtuvieron excelentes respuestas inmunitarias con ambos reg\u00edmenes. Todos los ni\u00f1os vacunados en ambos grupos alcanzaron concentraciones s\u00e9ricas protectoras de anticuerpos antiFPR > 0,15 \u00b5g un mes despu\u00e9s de recibir la dosis primaria. La vacuna combinada DTPw-HB/Hib no dio resultados inferiores a los obtenidos con las vacunas autorizadas en t\u00e9rminos de los porcentajes de seroprotecci\u00f3n, seropositividad y respuesta frente a todos los componentes antig\u00e9nicos de la vacuna. La persistencia de anticuerpos contra todos los ant\u00edgenos contenidos en ella hasta el momento en que se administr\u00f3 la dosis de refuerzo fue parecida en ambos grupos, y\n[Quorum signaling and sensing by nontypeable Haemophilus influenzae.](https://www.ncbi.nlm.nih.gov/pubmed/22919689)\nSwords, W Edward\n2012-01-01\nQuorum signals are diffusible factors produced by bacteria that coordinate communal responses. For nontypeable Haemophilus influenzae (NTHi), a series of recent papers indicate that production and sensing of quorum signals are determinants of biofilm formation/maturation and persistence in vivo. In this mini-review I will summarize the current knowledge about quorum signaling/sensing by this organism, and identify specific topics for additional study.\n[Paracytosis of Haemophilus influenzae through cell layers of NCI-H292 lung epithelial cells](https://www.narcis.nl/publication/RecordID/oai%3Apure.amc.nl%3Apublications%2F065c92c6-0b76-450f-a36c-5d01eab161b8/uquery/presence%20AND%20capsule%20AND%20bacteria/id/6/Language/EN)\nvan Schilfgaarde, M.; van Alphen, L.; Eijk, P.; Everts, V.; Dankert, J.\n1995-01-01\nHaemophilus influenzae penetrates the respiratory epithelium during carriage and invasive disease, including respiratory tract infections. We developed an in vitro model system consisting of lung epithelial NCI-H292 cells on permeable supports to study the passage of H. influenzae through lung\n[Oropharyngeal colonization by Haemophilus influenzae in healthy children from Taubat\u00e9 (S\u00e3o Paulo, prior to the Haemophilus influenzae type b vaccination program in Brazil Coloniza\u00e7\u00e3o da orofaringe de crian\u00e7as saud\u00e1veis de Taubat\u00e9 (S\u00e3o Paulo por Haemophilus influenzae, antes da introdu\u00e7\u00e3o da vacina contra Haemophilus influenzae do tipo b no Brasil](http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0041-87812004000500003) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nLucia Ferro Bricks\n2004-01-01\nFull Text Available Haemophilus influenzae is one of the most important bacterial agents of otitis and sinusitis. H. influenzae type b (Hib is one of the main causes of meningitis, pneumonia, and septicemia in nonvaccinated children under 6 years of age. The aims of this study were to determine the prevalence of H. influenzae and Hib oropharyngeal colonization prior to the onset of the Hib vaccination program in Brazil in previously healthy children and to assess the susceptibility profile of this microorganism to a selected group of antimicrobials that are used to treat acute respiratory infections. METHOD: Cultures of Haemophilus influenzae were made from oropharynx swabs from 987 children under 6 years of age who were enrolled in 29 day-care centers in Taubat\u00e9 (a city of S\u00e3o Paulo state, Brazil between July and December 1998. RESULTS: The prevalence of H. influenzae carriers was 17.4%, and only 5.5% of the strains were beta-lactamase producers. The prevalence of Hib carriers was high, 7.3% on average (range, 0.0 - 33.3%. CONCLUSIONS: The low prevalence of colonization by penicillin-resistant strains indicates that it is not necessary to substitute ampicilin or amoxicilin to effectively treat otitis and sinusitis caused by H. influenzae in Taubat\u00e9.Haemophilus influenzae \u00e9 um dos mais importantes agentes bacterianos de otites e sinusites. Em crian\u00e7as menores de seis anos de idade n\u00e3o vacinadas contra o H. influenzae do tipo b (Hib, essa bact\u00e9ria \u00e9 uma das principais causadoras de meningite, pneumonia e sepse. O objetivo deste estudo foi determinar a preval\u00eancia da coloniza\u00e7\u00e3o da orofaringe de crian\u00e7as previamente saud\u00e1veis por H. influenzae e Hib e avaliar o perfil de suscetibilidade desses microorganismos a um grupo seleto de antimicrobianos, que habitualmente s\u00e3o utilizados para tratar as infec\u00e7\u00f5es respirat\u00f3rias agudas. M\u00c9TODO: Foram colhidos swabs da orofaringe de 987 crian\u00e7as menores de seis anos de idade que freq\u00fcentavam 29 creches da\n[A review of the role of Haemophilus influenzae in community-acquired pneumonia](https://pneumonia.org.au/index.php/pneumonia/article/view/520/626) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nMary PE Slack\n2015-06-01\nFull Text Available In an era when Haemophilus influenzae type b (Hib conjugate vaccine is widely used, the incidence of Hib as a cause of community-acquired pneumonia (CAP has dramatically declined. Non-typeable H. influenzae (NTHi strains and, occasionally, other encapsulated serotypes of H. influenzae are now the cause of the majority of invasive H. influenzae infections, including bacteraemic CAP. NTHi have long been recognised as an important cause of lower respiratory tract infection, including pneumonia, in adults, especially those with underlying diseases. The role of NTHi as a cause of non-bacteraemic CAP in children is less clear. In this review the evidence for the role of NTHi and capsulated strains of H. influenzae will be examined.\n[Impacto da vacina\u00e7\u00e3o contra o Haemophilus influenzae b na redu\u00e7\u00e3o de meningites, Goi\u00e1s](http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0034-89102004000500008) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nSim\u00f5es Luciana Leite Pineli\n2004-01-01\nFull Text Available OBJETIVO: Avaliar o impacto da vacina\u00e7\u00e3o contra o Haemophilus influenzae b na incid\u00eancia de meningites em crian\u00e7as menores de cinco anos de idade. M\u00c9TODOS: Utilizou-se o delineamento tipo \"antes-depois\" para comparar as taxas de incid\u00eancia de meningites por Haemophilus influenzae b nos per\u00edodos pr\u00e9-vacina\u00e7\u00e3o (julho/95-junho/99 e p\u00f3s-vacina\u00e7\u00e3o (julho/99-junho/2001 no Estado de Goi\u00e1s. A defini\u00e7\u00e3o de caso de meningite bacteriana seguiu os crit\u00e9rios da Organiza\u00e7\u00e3o Mundial de Sa\u00fade. As taxas de meningite por Streptococcus pneumoniae e Neisseria. meningitidis foram utilizadas para efeito de compara\u00e7\u00e3o. Para an\u00e1lise estat\u00edstica foram utilizados o teste de chi2 e o t de Student. Valores de p<0,05 foram considerados estatisticamente significantes. RESULTADOS: Foi detectada meningite bacteriana aguda em 979 crian\u00e7as no per\u00edodo de estudo. A incid\u00eancia de meningite por Haemophilus influenzae b diminuiu de 10,8x10(5 no per\u00edodo pr\u00e9-vacinal para 2,3x10(5 no segundo ano p\u00f3s-vacina, significando 78% de redu\u00e7\u00e3o no risco, principalmente na faixa et\u00e1ria de 7-23 meses (p<0,05. Foram prevenidos 65 casos de meningite por Haemophilus influenzae b. Observou-se aumento na incid\u00eancia de meningite por S. pneumoniae. Foi observada falha vacinal em um caso. CONCLUS\u00d5ES: Expressivo decl\u00ednio da incid\u00eancia de meningite por Haemophilus influenzae b foi detectado, precocemente, logo ap\u00f3s o primeiro ano de introdu\u00e7\u00e3o da vacina contra o Haemophilus influenzae b. Assim, se faz necess\u00e1ria a vigil\u00e2ncia cont\u00ednua com instrumental de alta acur\u00e1cia para: (i detectar re-emerg\u00eancia do Haemophilus influenzae b; (ii avaliar possibilidade de falha vacinal; (iii identificar mudan\u00e7as no padr\u00e3o dos sorotipos do H. influenzae.\n[An isolate of Haemophilus haemolyticus produces a bacteriocin-like substance that inhibits the growth of nontypeable Haemophilus influenzae.](https://www.ncbi.nlm.nih.gov/pubmed/28242259)\nLatham, Roger D; Gell, David A; Fairbairn, Rory L; Lyons, A Bruce; Shukla, Shakti D; Cho, Kum Yin; Jones, David A; Harkness, Nick M; Tristram, Stephen G\n2017-04-01\nNontypeable Haemophilus influenzae (NTHi) frequently colonises the upper respiratory tract and is an important cause of respiratory infections. Resistance to antibiotics is an emerging trend in NTHi and alternative prevention or treatment strategies are required. Haemophilus haemolyticus is a common commensal occupying the same niche as NTHi and, if able to produce substances that inhibit NTHi growth, may have a role as a probiotic. In this study, ammonium sulphate extracts from broth culture of 100 H. haemolyticus isolates were tested for the presence of substances inhibitory to NTHi using a well diffusion assay. One isolate produced a substance that consistently inhibited the growth of NTHi. The substance was inactivated by protease enzymes and had a molecular size of ca. 30 kDa as determined by size exclusion chromatography. When the substance was tested against bacteria from eight Gram-negative and three Gram-positive genera, only Haemophilus spp. were inhibited. Quantitative PCR testing showed the substance to be different to 'haemocin', the previously described bacteriocin of H. influenzae type b. These molecular characteristics, together with narrow-spectrum activity, suggest the substance may be a novel bacteriocin, and there is potential for this H. haemolyticus isolate to function as a probiotic for reduction of colonisation and subsequent infection with NTHi. Copyright \u00a9 2017 Elsevier B.V. and International Society of Chemotherapy. All rights reserved.\n[Quantitation of antibody-secreting cells in the blood after vaccination with Haemophilus influenzae type b conjugate vaccine](http://www.forskningsdatabasen.dk/en/catalog/2389066466) [DEFF Research Database (Denmark)](http://forskningsbasen.deff.dk/?lang=eng)\nBarington, T; Heilmann, C; Andersen, V\n1990-01-01\nThe human B-lymphocyte response to protein-conjugated polysaccharide antigens has not previously been studied at the cellular level. In order to do so, we developed and evaluated haemolytic plaque-forming cell assays detecting Haemophilus influenzae type b (Hib) capsular polysaccharide-specific a......The human B-lymphocyte response to protein-conjugated polysaccharide antigens has not previously been studied at the cellular level. In order to do so, we developed and evaluated haemolytic plaque-forming cell assays detecting Haemophilus influenzae type b (Hib) capsular polysaccharide...\n[Invasive Haemophilus Influenzae Disease, Europe, 1996\u00e22006](https://www2c.cdc.gov/podcasts/player.asp?f=1135366) [Centers for Disease Control (CDC) Podcasts](http://www2c.cdc.gov/podcasts/search.asp)\n2010-03-15\nThis podcast describes monitoring of Haemophilus influenzae disease in Europe from 1996 through 2006. CDC epidemiologist Stacey Martin discusses what researchers learned about the effect of vaccination on disease prevalence. Created: 3/15/2010 by National Center for Emerging and Zoonotic Infectious Diseases (NCEZID); National Center for Immunization and Respiratory Diseases (NCIRD). Date Released: 4/5/2010.\n[Immunological characterization of conjugated Haemophilus influenzae type b vaccine failure in infants](https://www.narcis.nl/publication/RecordID/oai%3Apure.amc.nl%3Apublications%2F657d9a36-232a-4f16-882f-b4644bb978c2/uquery/immunological%20AND%20response/id/18/Language/EN)\nBreukels, M. A.; Spanjaard, L.; Sanders, L. A.; Rijkers, G. T.\n2001-01-01\nInfant vaccination with conjugated Haemophilus influenzae type b (Hib) vaccine is highly effective in protecting against invasive Hib infections, but vaccine failures do occur. Twenty-one vaccine failures are reported since the introduction of the Hib conjugate vaccine in The Netherlands. Of the 14\n[The Lung Immune Response to Nontypeable Haemophilus influenzae (Lung Immunity to NTHi](http://dx.doi.org/10.1155/2015/706376) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nPaul T. King\n2015-01-01\nFull Text Available Haemophilus influenzae is divided into typeable or nontypeable strains based on the presence or absence of a polysaccharide capsule. The typeable strains (such as type b are an important cause of systemic infection, whilst the nontypeable strains (designated as NTHi are predominantly respiratory mucosal pathogens. NTHi is present as part of the normal microbiome in the nasopharynx, from where it may spread down to the lower respiratory tract. In this context it is no longer a commensal and becomes an important respiratory pathogen associated with a range of common conditions including bronchitis, bronchiectasis, pneumonia, and particularly chronic obstructive pulmonary disease. NTHi induces a strong inflammatory response in the respiratory tract with activation of immune responses, which often fail to clear the bacteria from the lung. This results in recurrent/persistent infection and chronic inflammation with consequent lung pathology. This review will summarise the current literature about the lung immune response to nontypeable Haemophilus influenzae, a topic that has important implications for patient management.\n[A comparative study of preservation and storage of Haemophilus influenzae](http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0074-02762001000400022) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nOlga C Aulet de Saab\n2001-05-01\nFull Text Available The aim of this study was to compare the efficacy of conservation by freezing the strains of Haemophilus influenzae at -20\u00baC and -70\u00baC. Skim milk supplemented with glucose, yeast extract and glycerol allowed highest viability of H. influenzae both at -20\u00baC and -70\u00baC from the media analyzed. Trypticase soy broth and brain heart infusion broth supplemented with glycerol, allowed excellent recovery. Use of cotton swaps as supporting material, with or without addition of cryoprotective agents, did not modify H. influenzae viability after six months of storage. Concentration of the initial inoculum positively affected viability when stored at -20\u00baC. Initial concentration did not influence survival after storage at -70\u00baC. Thawing at room temperature should not exceed 3 h as to get highest survival percentage.\n[Immunogenicity and tolerability of inactivated flu vaccine In high risk and healthy children Inmunogenicidad y tolerancia de la vacuna inactivada anti-influenza en ni\u00f1os en alto riesgo y en controles sanos](http://www.scielo.org.ar/scielo.php?script=sci_arttext&pid=S0025-76802007000400005) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nMaria Luisa Avila Aguero\n2007-08-01\nFull Text Available We conducted this open study to evaluate the immunogenicity and safety of the inactivated influenza vaccine, Imovax Gripe\u00ae in 154 children between 6 and 36 months of age at high risk of influenza- related complications, and in a reference group of 64 healthy children. The study was conducted over two flu seasons, in which the vaccine contained the same A strains but different B strains. The results for the A/H3N2 and A/H1N1 strains from the two flu seasons were pooled, but those for the B strains were not. Anti-hemagglutinin (HA antibody titers were determined before, and one month after each vaccination, and safety was evaluated based on diary card reporting any adverse event observed, either included or not in the list of \"solicited events\". Within each group of vaccines, the seroconversion rates, seroprotection rates, and ratio of post- to prevaccination geometric mean titers (GMTR for the A/H3N2 and the A/H1N1 strains fulfilled all requirements of the criteria of the European Union Committee for Proprietary Medicinal Products (CPMP. The immune responses in high-risk and in healthy children were similar, and consistent with those observed in previous studies conducted in healthy children. The vaccine was equally well tolerated by all study groups. Reactogenicity was low and similar in both high-risk and healthy children. Overall from 9.5% to 15.4% of at-risk children and 12% of healthy children reported a solicited local reaction; 23.0 to 28.8% of high-risk and 25.3% of healthy children reported a solicited systemic reaction. The study results provide support for vaccination of children at high-risk of influenza related complications.Se realiz\u00f3 un estudio cl\u00ednico abierto para evaluar la inmunogen\u00edcidad y la seguridad de la vacuna inactivada anti-influenza, Imovax Gripe\u00ae, en 154 ni\u00f1os entre 6 y 36 meses de edad con alto riesgo de complicaciones ligadas a la influenza, y en un grupo de referencia de 64 ni\u00f1os sanos. El estudio fue\n[First Necrotizing Fasciitis Caused by Haemophilus influenza Serotype a](https://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=5661755)\nQuach, Giang T.; Frisby, Jared; Kralovich, Kurt; Bohra, Mustafa\n2017-01-01\nNecrotizing fasciitis (NF) is an infrequently encountered skin infection that has high morbidity and mortality, even with prompt medical and surgical intervention. We describe the case of a 67-year-old male presenting with significant NF in his left lower extremity, despite aggressive surgical intervention, and included multiple surgical debridements, ACell Matrix, split-thickness, and negative wound VAC therapy. Ultimately, this patient required a below the knee amputation. This is the first documented case of Haemophilus influenza type a causing NF. PMID:29124073\n[Detection of cryptic genospecies misidentified as Haemophilus influenzae in routine clinical samples by assessment of marker genes fucK, hap, and sodC.](https://www.ncbi.nlm.nih.gov/pubmed/19535530)\nN\u00f8rskov-Lauritsen, Niels\n2009-08-01\nClinical isolates of Haemophilus influenzae were assessed for the presence of fucK, hap, and sodC by hybridization with gene-specific probes, and isolates diverging from the expected H. influenzae genotype were characterized by phenotype and 16S rRNA gene sequencing. Two of 480 isolates were finally classified as variant strains (\"nonhemolytic Haemophilus haemolyticus\").\n[Detection of Cryptic Genospecies Misidentified as Haemophilus influenzae in Routine Clinical Samples by Assessment of Marker Genes fucK, hap, and sodC\u25bf](https://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=2725679)\nN\u00f8rskov-Lauritsen, Niels\n2009-01-01\nClinical isolates of Haemophilus influenzae were assessed for the presence of fucK, hap, and sodC by hybridization with gene-specific probes, and isolates diverging from the expected H. influenzae genotype were characterized by phenotype and 16S rRNA gene sequencing. Two of 480 isolates were finally classified as variant strains (\u201cnonhemolytic Haemophilus haemolyticus\u201d). PMID:19535530\n[Vacina\u00e7\u00e3o contra Haemophilus influenzae tipo b: prote\u00e7\u00e3o a longo prazo Haemophilus influenzae type b vaccination: long term protection](http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0021-75572006000400013) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nCristiana M. Nascimento-Carvalho\n2006-07-01\nFull Text Available OBJETIVO: Identificar as evid\u00eancias sobre o impacto da vacina conjugada para Haemophilus influenzae tipo b (Hib na epidemiologia da doen\u00e7a invasiva por Hib. FONTE DOS DADOS: Pesquisa nas bases de dados do MEDLINE, LILACS, publica\u00e7\u00f5es t\u00e9cnicas de organiza\u00e7\u00f5es internacionais, diretrizes nacionais e internacionais, nos \u00faltimos 15 anos (1991-2005, utilizando os seguintes unitermos: Haemophilus influenzae type b, immunization, impact, effectiveness. Foram inclu\u00eddas as publica\u00e7\u00f5es que apresentaram informa\u00e7\u00e3o para atender o objetivo deste artigo. Artigos publicados em per\u00edodo anterior ao da pesquisa e citados em refer\u00eancias dos artigos inclu\u00eddos foram analisados quanto \u00e0 apresenta\u00e7\u00e3o de informa\u00e7\u00e3o de interesse. S\u00cdNTESE DOS DADOS: A introdu\u00e7\u00e3o da vacina conjugada para Hib produziu grande decl\u00ednio na incid\u00eancia de casos de doen\u00e7a invasiva por Hib nos diversos pa\u00edses em que seu uso foi incorporado \u00e0 rotina de vacina\u00e7\u00e3o das crian\u00e7as. No entanto, o ressurgimento de casos com doen\u00e7a invasiva por Hib tem mobilizado v\u00e1rios investigadores na busca das poss\u00edveis explica\u00e7\u00f5es para esses eventos, bem como a identifica\u00e7\u00e3o das medidas a serem implementadas para evitar o reaparecimento da doen\u00e7a. CONCLUS\u00d5ES: O uso da vacina conjugada para Hib em escala populacional tem sido extremamente efetivo. No entanto, mudan\u00e7as no esquema vacinal poder\u00e3o ser necess\u00e1rias para a manuten\u00e7\u00e3o do controle da doen\u00e7a invasiva por Hib, frente ao atual cen\u00e1rio epidemiol\u00f3gico das infec\u00e7\u00f5es pelo Hib.OBJECTIVE: To identify evidence of the impact of Haemophilus influenzae type b (Hib conjugate vaccine on the epidemiology of invasive Hib disease. SOURCES OF DATA: This review was based on a search of MEDLINE, LILACS, technical reports, national and international guidelines (publications from 1991 to 2005. The keywords Haemophilus influenzae type b, immunization, impact and effectiveness, alone or in combination, were used to retrieve the\nH. influenzae meningitis; H. flu meningitis; Haemophilus influenzae type b meningitis ... H. influenzae meningitis is caused by Haemophilus influenzae type b bacteria. This illness is not the same ...\n[Mielitis transversa relacionada con vacunaci\u00f3n anti-influenza A(H1N1](http://www.scielo.org.ar/scielo.php?script=sci_arttext&pid=S0025-76802011000200009&lng=en&tlng=en) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nMar\u00eda Florencia Arcondo\n2011-04-01\nFull Text Available La mielitis transversa es una enfermedad inflamatoria que se caracteriza por disfunci\u00f3n de la m\u00e9dula espinal. Las causas reconocidas de mielitis transversa son autoinmunes, enfermedades desmielinizantes, post infecciosas y post vacunales, aunque hasta el 50% de los casos son idiop\u00e1ticas. Las vacunas contra la rub\u00e9ola, paperas, rabia y gripe estacional han sido asociadas a diversos trastornos neurol\u00f3gicos, como el S\u00edndrome de Guillain Barr\u00e9, la encefalomielitis diseminada aguda (ADEM y la mielitis transversa. Como mecanismo preventivo luego de la pandemia de 2009, en febrero del a\u00f1o 2010 se inici\u00f3 en nuestro pa\u00eds la campa\u00f1a de vacunaci\u00f3n contra la Influenza A (H1N1. Se presenta el caso de una paciente con hipoestesias que aparecieron cuatro d\u00edas despu\u00e9s de haber recibido la vacuna monovalente anti-influenza A (H1N1 y progresaron con evidente nivel sensitivo. La paciente cumpl\u00eda criterios diagn\u00f3sticos de mielitis transversa, seg\u00fan el Transverse Myelitis Consortium Working Group. Tuvo remisi\u00f3n de las im\u00e1genes de la resonancia magn\u00e9tica y estabilidad cl\u00ednica sin tratamiento con corticoides. Se discuten aspectos diagn\u00f3sticos, pron\u00f3sticos y terap\u00e9uticos de esta entidad cl\u00ednica.\n[Structure-based functional annotation of putative conserved proteins having lyase activity from Haemophilus influenzae.](https://www.ncbi.nlm.nih.gov/pubmed/28324295)\nShahbaaz, Mohd; Ahmad, Faizan; Imtaiyaz Hassan, Md\n2015-06-01\nHaemophilus influenzae is a small pleomorphic Gram-negative bacteria which causes several chronic diseases, including bacteremia, meningitis, cellulitis, epiglottitis, septic arthritis, pneumonia, and empyema. Here we extensively analyzed the sequenced genome of H. influenzae strain Rd KW20 using protein family databases, protein structure prediction, pathways and genome context methods to assign a precise function to proteins whose functions are unknown. These proteins are termed as hypothetical proteins (HPs), for which no experimental information is available. Function prediction of these proteins would surely be supportive to precisely understand the biochemical pathways and mechanism of pathogenesis of Haemophilus influenzae. During the extensive analysis of H. influenzae genome, we found the presence of eight HPs showing lyase activity. Subsequently, we modeled and analyzed three-dimensional structure of all these HPs to determine their functions more precisely. We found these HPs possess cystathionine-\u03b2-synthase, cyclase, carboxymuconolactone decarboxylase, pseudouridine synthase A and C, D-tagatose-1,6-bisphosphate aldolase and aminodeoxychorismate lyase-like features, indicating their corresponding functions in the H. influenzae. Lyases are actively involved in the regulation of biosynthesis of various hormones, metabolic pathways, signal transduction, and DNA repair. Lyases are also considered as a key player for various biological processes. These enzymes are critically essential for the survival and pathogenesis of H. influenzae and, therefore, these enzymes may be considered as a potential target for structure-based rational drug design. Our structure-function relationship analysis will be useful to search and design potential lead molecules based on the structure of these lyases, for drug design and discovery.\n[Isolation of Haemophilus influenzae and Haemophilus parainfluenzae in urethral exudates from men with acute urethritis: a descriptive study of 52 cases.](https://www.ncbi.nlm.nih.gov/pubmed/26139207)\nDeza, Gustavo; Martin-Ezquerra, Gemma; G\u00f3mez, Juli\u00e0; Villar-Garc\u00eda, Judit; Supervia, August; Pujol, Ramon M\n2016-02-01\nTo describe the clinical characteristics and therapeutic outcomes from male patients diagnosed of Haemophilus spp urethritis. A chart review of patients who presented to our hospital from January 2013 to December 2014 with symptoms of acute urethritis in which Haemophilus spp was isolated in their urethral samples was performed. Haemophilus spp was isolated in 52 out of 413 urethral samples (12.6%) received in our laboratory from patients with symptoms of acute urethritis during the study period. Seven cases corresponded to Haemophilus influenzae and 45 cases to Haemophilus parainfluenzae. The most common clinical presentation was mucopurulent urethral discharge (71%). Eight per cent were HIV-infected patients, and 60% were men who have sex with men. Haemophilus spp was isolated as a single pathogen in 6.8% (28 of 413) of cases. Seventeen per cent of Haemophilus spp were \u03b2-lactamase producers. All patients reported having practiced unprotected insertive oral sex the month before consultation, and five of them denied having had another sexual contact apart from this exposure. In all cases in which follow-up was available, empirical treatment achieved a complete clinical resolution. Haemophilus spp was considered a pathogen in at least 6.8% of the patients from the evaluated area. It affected men regardless their sexual orientation or HIV status. Unprotected oral sex could play a role in its transmission. The limitations of the study (small sample size and lack of a representative control group) do not allow to prove the true pathogenic role of Haemophilus spp in acute urethritis. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/\n[Inflammatory response of Haemophilus influenzae biotype aegyptius causing Brazilian Purpuric Fever](http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1517-83822014000400040&lng=en&tlng=en) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nGisele Cristiane Gentile Cury\n2014-12-01\nFull Text Available The Brazilian Purpuric Fever (BPF is a systemic disease with many clinical features of meningococcal sepsis and is usually preceded by purulent conjunctivitis. The illness is caused by Haemophilus influenza biogroup aegyptius, which was associated exclusively with conjunctivitis. In this work construction of the las gene, hypothetically responsible for this virulence, were fusioned with ermAM cassette in Neisseria meningitidis virulent strains and had its DNA transfer to non BPF H. influenzae strains. The effect of the las transfer was capable to increase the cytokines TNF\u03b1 and IL10 expression in Hec-1B cells line infected with these transformed mutants (in eight log scale of folding change RNA expression. This is the first molecular study involving the las transfer to search an elucidation of the pathogenic factors by horizontal intergeneric transfer from meningococci to H. influenzae.\n[Influenza. Vacunas cl\u00e1sicas y novedosas a las puertas de otra pandemia](http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1025-028X2006000200005&lng=es&nrm=iso&tlng=es) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nRaiza Mart\u00ednez\n2006-08-01\nFull Text Available Los virus de la influenza A, adem\u00e1s del hombre, infectan otros mam\u00edferos y una gran variedad de especies de aves. Desde 1997 se sabe que cepas aviares son capaces de infectar al hombre provocando una enfermedad generalmente leve. El brote actual de gripe aviar H5N1 en humanos ha puesto en alerta a la comunidad cient\u00edfica internacional, no solo por su elevada mortalidad sino por su potencialidad en la generaci\u00f3n de una nueva pandemia. Las autoridades sanitarias han puesto en marcha un amplio programa para la preparaci\u00f3n ante esta contingencia, que abarca diferentes campos, desde el diagn\u00f3stico y la detecci\u00f3n precoz de los brotes tanto en animales como en humanos, la caracterizaci\u00f3n sistem\u00e1tica de las cepas circulantes, el sacrificio de aves infectadas, la producci\u00f3n masiva de antivirales y por supuesto el desarrollo y producci\u00f3n a gran escala de vacunas eficaces. En este \u00faltimo tema se trabaja intensamente tanto en el mejoramiento de las vacunas ya existentes como en la b\u00fasqueda de alternativas basadas en tecnolog\u00edas de nueva generaci\u00f3n.\n[Detection of Haemophilus influenzae in respiratory secretions from pneumonia patients by quantitative real-time polymerase chain reaction.](https://www.ncbi.nlm.nih.gov/pubmed/19446978)\nAbdeldaim, Guma M K; Str\u00e5lin, Kristoffer; Kirsebom, Leif A; Olc\u00e9n, Per; Blomberg, Jonas; Herrmann, Bj\u00f6rn\n2009-08-01\nA quantitative real-time polymerase chain reaction (PCR) based on the omp P6 gene was developed to detect Haemophilus influenzae. Its specificity was determined by analysis of 29 strains of 11 different Haemophilus spp. and was compared with PCR assays having other target genes: rnpB, 16S rRNA, and bexA. The method was evaluated on nasopharyngeal aspirates from 166 adult patients with community-acquired pneumonia. When 10(4) DNA copies/mL was used as cutoff limit for the method, P6 PCR had a sensitivity of 97.5% and a specificity of 96.0% compared with the culture. Of 20 culture-negative but P6 PCR-positive cases, 18 were confirmed by fucK PCR as H. influenzae. Five (5.9%) of 84 nasopharyngeal aspirates from adult controls tested PCR positive. We conclude that the P6 real-time PCR is both sensitive and specific for identification of H. influenzae in respiratory secretions. Quantification facilitates discrimination between disease-causing H. influenzae strains and commensal colonization.\n[Clinical characteristics of Haemophilus influenzae meningitis in Denmark in the post-vaccination era](http://www.forskningsdatabasen.dk/en/catalog/2398113216) [DEFF Research Database (Denmark)](http://forskningsbasen.deff.dk/?lang=eng)\nPedersen, T.I.; Howitz, M.; Andersen, Christian \u00d8stergaard\n2010-01-01\nP>The introduction of Haemophilus influenzae type b (Hib) vaccine into the Danish childhood vaccination programme in 1993 may have influenced the epidemiology of H. influenzae meningitis (i.e. increasing frequency of other non-vaccine types; presentation in other age groups). Based on nationwide...... registration, clinical information and laboratory findings were collected from all 65 confirmed cases of H. influenzae meningitis during the period 1994-2005. Twenty-nine patients (45%) were 24 years old [median 62 years (range 25...... infected with Hib, two cases (13%) were identified as true vaccine failures. Six patients (9%) died; one premature infant infected with serotype f and five adults (age 83-96 years) with non-typeable H. influenzae. Hearing loss was reported in 16% of the surviving children and in 10% of the surviving adults...\n[Administraci\u00f3n de vacunas y casos de muerte s\u00fabita del lactante en el Per\u00fa, 2001: \u00bfasociaci\u00f3n o coincidencia temporal?](http://www.scielo.org.pe/scielo.php?script=sci_arttext&pid=S1726-46342006000100007&lng=en&tlng=en) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nJavier Vargas H\nFull Text Available Objetivos: Describir las caracter\u00edsticas cl\u00ednicas, socioecon\u00f3micas, y patol\u00f3gicas de nueve casos de lactantes que fallecieron horas despu\u00e9s de administr\u00e1rseles vacunas antipolio y DPT junto con anti Haemophilus influenzae b o asociada con antihepatitis B o BCG. Materiales y m\u00e9todos: Revisi\u00f3n de la historia cl\u00ednica, entrevista con el equipo de salud a cargo de la vacunaci\u00f3n y con los padres del lactante fallecido. Revisi\u00f3n de los informes del protocolo de autopsia e informes de anatom\u00eda patol\u00f3gica y entrevista con los m\u00e9dicos legistas y pat\u00f3logos. Evaluaci\u00f3n de control de calidad de las vacunas administradas. Realizaci\u00f3n de ex\u00e1menes de inmunohistoqu\u00edmica de tejidos pulmonares para el diagn\u00f3stico de virus. Resultados: Entre agosto y diciembre de 2001 se notificaron en el Per\u00fa, nueve casos de fallecimiento de lactantes entre ocho horas y tres d\u00edas despu\u00e9s de la aplicaci\u00f3n de vacunas DPT y antipolio. Despu\u00e9s de la vacunaci\u00f3n, los s\u00edntomas iniciaron entre 30 minutos a tres horas y la muerte se produjo entre ocho a 78 horas. Los s\u00edntomas m\u00e1s frecuentes fueron irritabilidad 8/9, llanto persistente 6/9, somnolencia 5/9, sangrado por nariz y boca 5/9. Todos los casos procedieron de familias pobres o muy pobres. El control de calidad se corrobor\u00f3 que las vacunas cumplieron con los est\u00e1ndares establecidos por la OMS. Las causas de la muerte reportadas en las necropsias fueron neumon\u00eda en dos casos y edema pulmonar en cinco casos, los informes de anatom\u00eda patol\u00f3gica mostraron una neumonitis intersticial y meningitis linfocitaria. No se observaron efectos citop\u00e1ticos virales en los tejidos pulmonares y los estudios toxicol\u00f3gicos fueron negativos. Conclusiones: No existe evidencia de una asociaci\u00f3n causal entre los eventos fatales y la administraci\u00f3n de las vacunas.\n[The capsule biosynthesis locus of Haemophilus influenzae show conspicuous similarity to the corresponding locus in Haemophilus sputorum and may have been recruited from this species by horizontal gene transfer](http://www.forskningsdatabasen.dk/en/catalog/2264317803) [DEFF Research Database (Denmark)](http://forskningsbasen.deff.dk/?lang=eng)\nNielsen, Signe Maria; de Gier, Camilla; Dimopoulou, Chrysoula\n2015-01-01\nin export and processing of the capsular material, show high similarity to the corresponding genes in capsulate lineages of the pathogenic species Haemophilus influenzae; indeed, standard bexA and bexB PCRs for detection of capsulated strains of H. influenzae give positive results with strains of H....... sputorum was only distantly related to H. influenzae. In contrast to H. influenzae, the capsule locus in H. sputorum is not associated with transposases or other transposable elements. Our data suggest that the capsule locus of capsulate lineages of H. influenzae may relatively recently have been recruited...\n[The Seroepidemiology of Haemophilus Influenzae Type b in Children Under 6 Years Old in Khorramabad, Iran](http://aums.abzums.ac.ir/browse.php?a_code=A-10-1-103&slc_lang=en&sid=1) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nN. Ansari\n2015-05-01\nFull Text Available Background and Objective: Haemophilus influenzae type b (Hib is now recognized as an agent of bacterial meningitis in Asia. Polyribosil Ribitol Phosphate (PRP capsule are in all of the strains and IgG antibodies can be target. Due to limited studies on H. influenzae type b in the country and the lack of sufficient information on the status of carriers, achieve a comprehensive model of the spread of the bacteria in the carrier's most vulnerable children is the aim of this study. Material and Methods: In this study, 194 (49% female and 51% male serum samples were collected from children under 6 years old referred to medical centers in Korram Abad. The serological study of H. influenzae type b was carried using anti-H. influenzae PRP IgG antibodies kit by indirect enzyme linked immunosorbent assay (ELISA. Results: Of 194 children under 6 years-old screened for H. influenzae-specific IgG antibodies with ELISA, 6 (3 percent were IgG seropositive. Prevalence of bacteria in children under 2 years was 67% that demonstrated no significant association between seropositivity in subjects and place of residence of children with the prevalence of bacteria. Conclusion: The prevalence of H. influenzae type b seropositivity in our study was 3% of the total sample. In current study, a higher percentage of males than females were seropositive and frequency of predominant bacteria in patients younger than 2 years. The age factor is a variable that positively affects serum. Regarding to non-Hib vaccination in children, the presence of the bacteria in children can be important.\n[Serious systemic infection caused by non-encapsulated Haemophilus influenzae biotype III in an adult](http://www.forskningsdatabasen.dk/en/catalog/2379269297) [DEFF Research Database (Denmark)](http://forskningsbasen.deff.dk/?lang=eng)\nLester, Anne; Pedersen, P B\n1991-01-01\nHaemophilus influenzae is the aetiological agent in less than 1% of septic arthritis cases in adults and most often serotype b is involved. We report here a case of severe systemic infection due to non-encapsulated H. influenzae biotype III in a 40-year-old man, previously healthy although alcohol...... abuser. Cholangitis and acute alcoholic hepatitis were diagnosed simultaneously. The organism was grown from blood and from synovial fluid of the left knee, but several other joints were also affected. The close relationship between H. influenzae biotype III and H. aegyptius is mentioned in view...... of recent reports of fatal childhood illness caused by a special clone of H. aegyptius and the importance of reporting both serotype and biotype in severe H. influenzae induced disease is emphasized....\n[Clonal relationship of recent invasive Haemophilus influenzae serotype f isolates from Denmark and the United States](http://www.forskningsdatabasen.dk/en/catalog/38019662) [DEFF Research Database (Denmark)](http://forskningsbasen.deff.dk/?lang=eng)\nBruun, B; Gahrn-Hansen, B; Westh, H\n2004-01-01\nSurveillance performed after the introduction of general Haemophilus influenzae serotype b (Hib) vaccination in Denmark identified 13 cases of invasive bacteraemic H. influenzae serotype f (Hif) disease in adults over a period of 7 years. Bacteraemic respiratory tract infections accounted for 61...... sequences. Multilocus enzyme electrophoresis typing revealed that recent Danish and American isolates belonged to a single Hif clone, which may be undergoing expansion. The need for accurate serotyping of H. influenzae to enable reliable monitoring for Hib replacement by other capsular types is emphasized....\n[Recurrent Posttraumatic Meningitis due to Nontypable Haemophilus influenzae: Case Report and Review of the Literature](http://www.forskningsdatabasen.dk/en/catalog/2389199692) [DEFF Research Database (Denmark)](http://forskningsbasen.deff.dk/?lang=eng)\nKunze, W; M\u00fcller, L; Kilian, Mogens\n2007-01-01\nWe report a case of relapsing Haemophilus influenzae meningitis in a boy at the age of nearly 3 years and 4.2 years who had been successfully vaccinated against H. influenzae serotype b (Hib). The pathogen was a nonencapsulated (nontypable) H. influenzae strain of biotypes III and VI, respectively....... A rhinobasal impalement injury with development of a posttraumatic encephalocele is considered to be the predisposing condition. Review of the literature reveals that in patients systemically infected by nonencapsulated H. influenzae strains predisposing factors such as cerebrospinal fluid-shunts, implants...... and traumas are often found. To obtain further information on potential new disease patterns H. influenzae isolates from cerebrospinal fluid should be examined for capsule production and, if relevant, further characterized by capsular typing....\n[Haemophilus influenzae type B genital infection and septicemia in pregnant woman: a case report](http://oaji.net/articles/2016/3556-1469437061.pdf) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nHosuru Subramanya Supram\n2014-06-01\nFull Text Available Haemophilus influenzae (H. influenzae type B a non-motile, aerobic, gram negative cocobacillus is a commensal of upper respiratory tract. Genitourinary infection due to H. influenzae has been reported but bacteremia associated with such infection appears to be rare. We report a case of 19 years young primigravida with complaints of amenorrhea of 32 weeks and 5 days, pyrexia, abdominal pain and blood stained discharge per vaginum. H. influenzae type B was recovered from the genital tract as well as blood of the mother indicating maternal septicemia. Septicemia caused by H. influenzae type B in pregnant women following vaginal colonization and infection is rare. It has been reported in many parts of world over the years; to the best of our knowledge this is the first reported case from Nepal. H. influenzae should be considered as a potential maternal, fetal, and neonatal pathogen.\n[Impacto de la vacunaci\u00f3n contra Haemophilus influenzae tipo b en Cuba](http://www.scielosp.org/scielo.php?script=sci_arttext&pid=S1020-49892001000900004) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nDickinson F\u00e9lix O.\n2001-01-01\nFull Text Available Objetivo. Determinar el impacto de la vacunaci\u00f3n de menores de 2 a\u00f1os en Cuba contra Haemophilus influenzae tipo b (Hib, principal agente causal de la meningitis bacteriana en ese pa\u00eds. M\u00e9todos. La disponibilidad de vacunas conjugadas eficaces contra Hib motiv\u00f3 la vacunaci\u00f3n nacional en 1999 de ni\u00f1os menores de 2 a\u00f1os, que alcanz\u00f3 una cobertura de 97%. El impacto se evalu\u00f3 mediante el Sistema Nacional de Vigilancia de Meningoencefalitis Bacterianas (SNVMEB. Resultados. La eficacia global de la vacunaci\u00f3n se estim\u00f3 en 99% y la incidencia general de la meningoencefalitis por Hib disminuy\u00f3 de 1,3 a 0,6 por 100 000 habitantes (46,1%, observ\u00e1ndose la mayor reducci\u00f3n en ni\u00f1os menores de 5 a\u00f1os (56,1%. En los menores de 1 a\u00f1o se redujo 70,5% y en el resto de los grupos de menores de 5 a\u00f1os disminuy\u00f3 entre 25,9 y 49,6%. En el grupo diana para la vacunaci\u00f3n, la incidencia se redujo 61,1%; entre los ni\u00f1os de este grupo que contrajeron la meningoencefalitis por Hib, solamente 8 (24,2% estaban vacunados, 7 de ellos con una sola dosis, aplicada 1 mes antes de enfermar. Conclusiones. Se ha demostrado que la vacunaci\u00f3n a gran escala de los ni\u00f1os menores de 2 a\u00f1os contra Hib en Cuba a trav\u00e9s del SNVMEB ha logrado disminuir notablemente la incidencia de meningoencefalitis por Hib.\n[Difficult identification of Haemophilus influenzae, a typical cause of upper respiratory tract infections, in the microbiological diagnostic routine.](https://www.ncbi.nlm.nih.gov/pubmed/25883794)\nHinz, Rebecca; Zautner, Andreas Erich; Hagen, Ralf Matthias; Frickmann, Hagen\n2015-03-01\nHaemophilus influenzae is a key pathogen of upper respiratory tract infections. Its reliable discrimination from nonpathogenic Haemophilus spp. is necessary because merely colonizing bacteria are frequent at primarily unsterile sites. Due to close phylogenetic relationship, it is not easy to discriminate H. influenzae from the colonizer Haemophilus haemolyticus. The frequency of H. haemolyticus isolations depends on factors like sampling site, patient condition, and geographic region. Biochemical discrimination has been shown to be nonreliable. Multiplex PCR including marker genes like sodC, fucK, and hpd or sequencing of the 16S rRNA gene, the P6 gene, or multilocus-sequence-typing is more promising. For the diagnostic routine, such techniques are too expensive and laborious. If available, matrix-assisted laser-desorption-ionization time-of-flight mass spectrometry is a routine-compatible option and should be used in the first line. However, the used database should contain well-defined reference spectra, and the spectral difference between H. influenzae and H. haemolyticus is small. Fluorescence in-situ hybridization is an option for less well-equipped laboratories, but the available protocol will not lead to conclusive results in all instances. It can be used as a second line approach. Occasional ambiguous results have to be resolved by alternative molecular methods like 16S rRNA gene sequencing.\n[The Comparison of Haemophilus Influenza in the Throat of Healthy Infants with Different Feeding Methods](http://journals.mui.ac.ir/jrms/article/view/903) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nA Kazemi\n2004-06-01\nFull Text Available Background: Haemophilus influenza (HI is the most commonly found pathogenic bacteria in pediatric otitis media and lower respiratory tract infections. Bacterial attachment to pharyngeal cells and proliferation may be necessary for infection. In the presence of human milk, attachment of HI to pharyngeal cells and colonization may be inhibited. To evaluate the protecting role of breast milk, we investigated the incidence of HI isolated from the throat of healthy infants with different feeding methods. Methods: Between August 2002 and March 2003, 210 healthy infants (70 purely breast-fed, 70 purely formula-fed, 70 mixed-fed, aged 1-6 months were enrolled into the study and a throat culture was taken in all of them. The incidence of HI was evaluated using Haemophilus Test Agar Bose (HTAB plates. Results: The incidence of HI in purely breast-fed, mixed-fed and purely formula-fed infants was 2.9%, 42.9% and 75.7% respectively (P = 0.000. The mean age and weight of cases in the three groups were not statistically different. Conclusion: These data suggest that human milk protects the throat of healthy infants from HI colonization especially in purely breast-fed cases. Keywords: Breast milk, Haemophilus influenza, Throat culture\n[Immunogenicity and effectiveness of Haemophilus influenzae type b conjugate vaccine in HIV infected and uninfected African children.](https://www.ncbi.nlm.nih.gov/pubmed/16107294)\nMadhi, Shabir A; Kuwanda, Locadiah; Saarinen, Leena; Cutland, Clare; Mothupi, Rosalia; K\u00e4yhty, Helena; Klugman, Keith P\n2005-12-01\nThe quantitative (anti-Hib capsular polysaccharide antibody concentrations; anti-HibPS) and qualitative (bactericidal activity and avidity) aspects in immune responses to Haemophilus influenzae type b polyribosyl ribitol phospshate-CRM(197) conjugate vaccine (HibCV; HibTiter) were evaluated in 66 HIV infected children not receiving anti-retroviral therapy and 127 HIV uninfected children. Surveillance was conducted for invasive Hib disease in a cohort of 39,865 (approximately 6.4% of whom were HIV infected) children from March 1998 to June 2004. HIV infected children had lower anti-HibPS geometric mean antibody concentrations 1 month post-immunisation than HIV uninfected children (Por=1.0 microg/ml (RR 0.54; 95% CI 0.43-0.69). A lower proportion of HIV infected children than HIV uninfected children (RR 0.78; 95% CI 0.66-0.93) had measurable anti-Hib serum bactericidal activity (SBA) and the HibPS antibody concentration required for 50% killing of Hib bacteria was greater among HIV infected than HIV uninfected children (P=0.001). The estimated risk of HibCV failure was 35.1-fold greater (95% CI 14.6-84.6) amongst HIV infected than HIV uninfected children.\n[Endogenous and exogenous reinfections by Haemophilus influenzae in patients with chronic obstructive pulmonary disease: the effect of antibiotic treatment on persistence](https://www.narcis.nl/publication/RecordID/oai%3Apure.amc.nl%3Apublications%2F8549a934-cda3-4b3e-bd69-1627081f32f6/uquery/endogenous%20AND%20exogenous/id/18/Language/EN)\nGroeneveld, K.; van Alphen, L.; Eijk, P. P.; Visschers, G.; Jansen, H. M.; Zanen, H. C.\n1990-01-01\nTo analyze whether exacerbations in chronic obstructive pulmonary disease (COPD) coincide with reinfection by Haemophilus influenzae, 16 COPD patients were studied longitudinally for 3 years. Exacerbations coincided with reinfection by H. influenzae, either endogenous, by a strain with a DNA\n[Contribution of the major and minor subunits to fimbria-mediated adherence of Haemophilus influenzae to human epithelial cells and erythrocytes](https://www.narcis.nl/publication/RecordID/oai%3Apure.amc.nl%3Apublications%2F501e04c0-6937-4667-b806-571e5904d625/uquery/Human%2C%20AND%20H/id/14/Language/EN)\nvan Ham, S. M.; van Alphen, L.; Mooi, F. R.; van Putten, J. P.\n1995-01-01\nFimbriae are colonization factors of the human pathogen Haemophilus influenzae in that they mediate bacterial adherence to human eukaryotic cells. The contribution of the major (HifA) and putative minor (HifD and HifE) subunits of H. influenzae fimbriae to fimbria-specific adherence was studied by\n[Complete Deletion of the Fucose Operon in Haemophilus influenzae Is Associated with a Cluster in Multilocus Sequence Analysis-Based Phylogenetic Group II Related to Haemophilus haemolyticus: Implications for Identification and Typing.](https://www.ncbi.nlm.nih.gov/pubmed/26378279)\nde Gier, Camilla; Kirkham, Lea-Ann S; N\u00f8rskov-Lauritsen, Niels\n2015-12-01\nNonhemolytic variants of Haemophilus haemolyticus are difficult to differentiate from Haemophilus influenzae despite a wide difference in pathogenic potential. A previous investigation characterized a challenging set of 60 clinical strains using multiple PCRs for marker genes and described strains that could not be unequivocally identified as either species. We have analyzed the same set of strains by multilocus sequence analysis (MLSA) and near-full-length 16S rRNA gene sequencing. MLSA unambiguously allocated all study strains to either of the two species, while identification by 16S rRNA sequence was inconclusive for three strains. Notably, the two methods yielded conflicting identifications for two strains. Most of the \"fuzzy species\" strains were identified as H. influenzae that had undergone complete deletion of the fucose operon. Such strains, which are untypeable by the H. influenzae multilocus sequence type (MLST) scheme, have sporadically been reported and predominantly belong to a single branch of H. influenzae MLSA phylogenetic group II. We also found evidence of interspecies recombination between H. influenzae and H. haemolyticus within the 16S rRNA genes. Establishing an accurate method for rapid and inexpensive identification of H. influenzae is important for disease surveillance and treatment. Copyright \u00a9 2015, American Society for Microbiology. All Rights Reserved.\n[Changes in outer membrane proteins of nontypable Haemophilus influenzae in patients with chronic obstructive pulmonary disease](https://www.narcis.nl/publication/RecordID/oai%3Apure.amc.nl%3Apublications%2Faf573f94-7642-4280-9dce-64d4ee26c938/uquery/fingerprints%20AND%20identical/id/1/Language/EN)\nGroeneveld, K.; van Alphen, L.; Eijk, P. P.; Jansen, H. M.; Zanen, H. C.\n1988-01-01\nFive individual colonies of Haemophilus influenzae were isolated from each of one to three cultures of sputum collected from 18 patients with chronic obstructive pulmonary disease (COPD). The isolates were studied to investigate whether the major outer membrane proteins (MOMPs) changed during\n[Molecular surveillance of true nontypeable Haemophilus influenzae: an evaluation of PCR screening assays.](https://www.ncbi.nlm.nih.gov/pubmed/22470516)\nBinks, Michael J; Temple, Beth; Kirkham, Lea-Ann; Wiertsema, Selma P; Dunne, Eileen M; Richmond, Peter C; Marsh, Robyn L; Leach, Amanda J; Smith-Vaughan, Heidi C\n2012-01-01\nUnambiguous identification of nontypeable Haemophilus influenzae (NTHi) is not possible by conventional microbiology. Molecular characterisation of phenotypically defined NTHi isolates suggests that up to 40% are Haemophilus haemolyticus (Hh); however, the genetic similarity of NTHi and Hh limits the power of simple molecular techniques such as PCR for species discrimination. Here we assess the ability of previously published and novel PCR-based assays to identify true NTHi. Sixty phenotypic NTHi isolates, classified by a dual 16S rRNA gene PCR algorithm as NTHi (n = 22), Hh (n = 27) or equivocal (n = 11), were further characterised by sequencing of the 16S rRNA and recA genes then interrogated by PCR-based assays targeting the omp P2, omp P6, lgtC, hpd, 16S rRNA, fucK and iga genes. The sequencing data and PCR results were used to define NTHi for this study. Two hpd real time PCR assays (hpd#1 and hpd#3) and the conventional iga PCR assay were equally efficient at differentiating study-defined NTHi from Hh, each with a receiver operator characteristic curve area of 0.90 [0.83; 0.98]. The hpd#1 and hpd#3 assays were completely specific against a panel of common respiratory bacteria, unlike the iga PCR, and the hpd#3 assay was able to detect below 10 copies per reaction. Our data suggest an evolutionary continuum between NTHi and Hh and therefore no single gene target could completely differentiate NTHi from Hh. The hpd#3 real time PCR assay proved to be the superior method for discrimination of NTHi from closely related Haemophilus species with the added potential for quantification of H. influenzae directly from specimens. We suggest the hpd#3 assay would be suitable for routine NTHi surveillance and to assess the impact of antibiotics and vaccines, on H. influenzae carriage rates, carriage density, and disease.\n[Molecular surveillance of true nontypeable Haemophilus influenzae: an evaluation of PCR screening assays.](http://europepmc.org/articles/PMC3314702?pdf=render) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nMichael J Binks\nFull Text Available BACKGROUND: Unambiguous identification of nontypeable Haemophilus influenzae (NTHi is not possible by conventional microbiology. Molecular characterisation of phenotypically defined NTHi isolates suggests that up to 40% are Haemophilus haemolyticus (Hh; however, the genetic similarity of NTHi and Hh limits the power of simple molecular techniques such as PCR for species discrimination. METHODOLOGY/PRINCIPAL FINDINGS: Here we assess the ability of previously published and novel PCR-based assays to identify true NTHi. Sixty phenotypic NTHi isolates, classified by a dual 16S rRNA gene PCR algorithm as NTHi (n = 22, Hh (n = 27 or equivocal (n = 11, were further characterised by sequencing of the 16S rRNA and recA genes then interrogated by PCR-based assays targeting the omp P2, omp P6, lgtC, hpd, 16S rRNA, fucK and iga genes. The sequencing data and PCR results were used to define NTHi for this study. Two hpd real time PCR assays (hpd#1 and hpd#3 and the conventional iga PCR assay were equally efficient at differentiating study-defined NTHi from Hh, each with a receiver operator characteristic curve area of 0.90 [0.83; 0.98]. The hpd#1 and hpd#3 assays were completely specific against a panel of common respiratory bacteria, unlike the iga PCR, and the hpd#3 assay was able to detect below 10 copies per reaction. CONCLUSIONS/SIGNIFICANCE: Our data suggest an evolutionary continuum between NTHi and Hh and therefore no single gene target could completely differentiate NTHi from Hh. The hpd#3 real time PCR assay proved to be the superior method for discrimination of NTHi from closely related Haemophilus species with the added potential for quantification of H. influenzae directly from specimens. We suggest the hpd#3 assay would be suitable for routine NTHi surveillance and to assess the impact of antibiotics and vaccines, on H. influenzae carriage rates, carriage density, and disease.\n[Prevenci\u00f3n de las infecciones respiratorias agudas: Presente y futuro](http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S0034-75312003000400006) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nRoberto Raz\u00f3n Behar\n2003-12-01\nFull Text Available Las infecciones respiratorias agudas (IRA, son las causas m\u00e1s frecuentes de morbilidad en el mundo y de elevada mortalidad particularmente en los pa\u00edses en desarrollo. Los virus son los agentes etiol\u00f3gicos m\u00e1s frecuentes. Los virus influenza a y b, y el virus sincitial respiratorio (VSR son los m\u00e1s importantes por la severidad de la enfermedad y por la alta transmisibilidad. Las bacterias, principalmente el Streptococcus pneumoniae (neumococo, y el Haemophilus influenzae tipo B (Hib, son las causas m\u00e1s frecuentes de neumon\u00edas adquiridas en la comunidad. Las estrategias generales en la prevenci\u00f3n y en el tratamiento se basan en: evaluar sistem\u00e1ticamente los conocimientos existentes acerca de las IRA, divulgarlos y aplicarlos, desarrollar una gu\u00eda nacional para las indicaciones de los antibi\u00f3ticos, aplicar las vacunas existentes: DPT, triple viral (SRP, anti-Hi, incrementar la inmunizaci\u00f3n contra el neumococo y los virus influenza, particularmente en grupos de riesgo y desarrollar y evaluar nuevas vacunas contra el VSR, Haemophilus influenzae no serotipificables, Bordetella pertussis y otros agentes infecciosos que afectan el aparato respiratorio. Se realiza una revisi\u00f3n de nuevos agentes y drogas antivirales, as\u00ed como del desarrollo presente y futuro de las inmunizaciones contra los principales virus y bacterias, que causan infecciones respiratorias agudas.Acute respiratory infections (ARI are the most frequent cause of morbidity and of the high mortality in the world, particularly in the developing countries. The viruses are the most common etiological agents.The influenza a and b viruses and the syncytial respiratory virus (SRV are the most important due to the severity of the disease and to their high transmissibility. The bacteria, mainly Streptococcus pneumoniae (Pneumococcus, and Haemophilus influenzae type B (Hib, are the most frequent cause of pneumonias acquired in the community. The general strategies in the prevention and\n[Reacciones adversas a la vacuna contra influenza A (H1N1 en trabajadores de salud de una instituci\u00f3n p\u00fablica peruana](http://www.scielo.org.pe/scielo.php?script=sci_arttext&pid=S1025-55832011000300003&lng=en&tlng=en) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nPedro P. \u00c1lvarez-Falcon\u00ed\n2011-07-01\nFull Text Available Introducci\u00f3n: En abril de 2009 se produjo un brote de influenza en la frontera de M\u00e9xico y EE UU por el nuevo virus A(H1N1 2009. La pandemia no fue severa y la vacuna aplicada en diversos pa\u00edses produjo diversas reacciones adversas a medicamentos (RAM. Objetivos: Evaluar la posible relaci\u00f3n entre las RAM notificadas espont\u00e1neamente y la vacunaci\u00f3n en trabajadores de salud de un instituto. As\u00ed mismo, identificar t\u00f3picos afines a las RAM por dicha vacuna. Dise\u00f1o: Estudio prospectivo y descriptivo basado en la notificaci\u00f3n espont\u00e1nea. Instituci\u00f3n: Local central del Instituto Nacional de Salud en Lima. Participantes: Trabajadores de salud. Metodolog\u00eda: Las RAM notificadas espont\u00e1neamente fueron registradas en Hojas RAM. Se aplic\u00f3 un algoritmo para buscar una relaci\u00f3n causa-efecto. Principales medidas de resultados: Reacciones adversas a la vacuna influenza A(H1N1. Resultados: Hubo tres notificaciones espont\u00e1neas entre 148 trabajadores de salud vacunados (2% contra la influenza A(H1N1 2009. La relaci\u00f3n causa-efecto fue \u2018cierta\u2019 para fiebre y fatiga y \u2018posible\u2019 para afecciones respiratorias en tres mujeres (faringitis aguda, catarro nasal agudo, bronquitis catarral. Conclusiones: Entre los pocos trabajadores de salud que presentaron RAM, las afecciones respiratorias con una relaci\u00f3n considerada \u2018posible\u2019 podr\u00eda interpretarse que las mujeres ser\u00edan m\u00e1s sensibles para esa RAM comparadas con los varones. Las RAM fiebre y fatiga alcanzaron una relaci\u00f3n considerada \u2018cierta\u2019. La menor cantidad de infectados en personas de tercera edad en el pa\u00eds y en otros podr\u00eda explicarse por la presencia de \u2018anticuerpos protectores\u2019 en ellos.\n[Antibody response to Haemophilus influenzae type b capsular polysaccharide conjugated to tetanus toxoid in preterm infants](http://www.forskningsdatabasen.dk/en/catalog/2389066514) [DEFF Research Database (Denmark)](http://forskningsbasen.deff.dk/?lang=eng)\nKristensen, Kim; Gyhrs, A; Lausen, B\n1996-01-01\nOBJECTIVE: To evaluate the antibody response to a Haemophilus influenzae type b capsular polysaccharide (HibCP) tetanus toxoid (TT) conjugate vaccine (HibCP-TT) in preterm infants. SUBJECTS: Thirty-five healthy preterm infants with gestational ages (GA) from 27 to 36 weeks and birth weights from...\n[Radioimmunoassay of capsular polysaccaride antigens of groups A and C meningococci and Haemophilus influenza type b in cerebrospinal fluid](https://inis.iaea.orgsearchsinglerecord.aspx?recordsFor=SingleRecord&RN=9349844) [International Nuclear Information System (INIS) ](http://inis.iaea.org/search/)\nKaeyhty, H.; Maekelae, P.H.; Ruoslahti, E.\n1977-01-01\nSensitive radioimmunoassays capable of measuring 0.5 ng/ml of the Haemophilus influenza type b polysaccharide and 2 ng/ml of the groups A and C meningococcal polysaccharides were developed and used to detect these substances in cerebrospinal fluid (CSF). Polysaccharide of the causative agent was detected in the CSF of 14 out of 15 patients with Haemophilus influenza type b meningitis, in 18 out of 23 patients with group A, and in two out of four patients with group C meningococcal meningitis. In some cases the antigen could be detected even after three days of antibacterial treatment. No false positive reactions were seen. The assay procedure could be shortened to approximately three hours. These assays could be useful in routine diagnostic work and epidemiological investigations. (author)\n[Meningite por Haemophilus influenzae tipo b em cidades do estado do Paran\u00e1, Brasil Haemophilus influenzae type b meningitis in the state of Paran\u00e1, Brazil](http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0021-75572001000500009) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nN\u00e1dia S. Takemura\n2001-10-01\nFull Text Available OBJETIVO: no segundo semestre de 1996, os munic\u00edpios de Londrina e Curitiba (Paran\u00e1 iniciaram a vacina\u00e7\u00e3o contra Haemophilus influenzae b (Hib, aproximadamente trinta meses antes de sua introdu\u00e7\u00e3o no Programa Nacional de Imuniza\u00e7\u00e3o. O presente trabalho objetivou avaliar a incid\u00eancia da meningite por Hib, entre crian\u00e7as, em Londrina, Curitiba e nos demais munic\u00edpios do estado do Paran\u00e1, antes e ap\u00f3s a introdu\u00e7\u00e3o da vacina nessas duas cidades. M\u00c9TODOS: foi realizado um estudo observacional retrospectivo de todos os casos de meningite por Hib, entre menores de 5 anos, diagnosticados pelo sistema de vigil\u00e2ncia epidemiol\u00f3gica de Londrina e pela Secretaria de Estado da Sa\u00fade do Paran\u00e1, de 1992 a 1999. Taxas de incid\u00eancia da meningite por Hib foram calculadas por 100.000 menores de cinco anos. RESULTADOS: comparando com o per\u00edodo anterior \u00e0 vacina\u00e7\u00e3o, houve redu\u00e7\u00e3o importante do coeficiente de incid\u00eancia da meningite por Hib em Londrina, passando de 23,91, em 1996, para 2,79 por 100.000 menores de cinco anos, em 1999. Redu\u00e7\u00e3o semelhante foi observada em Curitiba, enquanto nos demais munic\u00edpios do Paran\u00e1, que n\u00e3o dispunham da vacina at\u00e9 meados de 1999, o coeficiente se manteve praticamente inalterado. CONCLUS\u00c3O: a vacina\u00e7\u00e3o contra Hib foi efetiva na redu\u00e7\u00e3o da incid\u00eancia da meningite entre menores de cinco anos em Londrina e Curitiba. Para a manuten\u00e7\u00e3o dessa baixa incid\u00eancia devem ser garantidas adequada cobertura vacinal e boa qualidade do servi\u00e7o de vigil\u00e2ncia epidemiol\u00f3gica.OBJECTIVE: during the second half of 1996, the municipalities of Londrina and Curitiba (State of Paran\u00e1, Brazil included Haemophilus influenzae type b (Hib vaccine into their routine vaccination regimen, approximately 30 months before its introduction into the National Immunization Program. The present study aimed at verifying the incidence of meningitis caused by Hib among children in Londrina, Curitiba, and in the remaining\n[Recombinant C-terminal 311 amino acids of HapS adhesin as a vaccine candidate for nontypeable Haemophilus influenzae: A study on immunoreactivity in Balb/C mouse.](https://www.ncbi.nlm.nih.gov/pubmed/27377430)\nTabatabaee Bafroee, Akram Sadat; Siadat, Seyed Davar; Mousavi, Seyed Fazlollah; Aghasadeghi, Mohammad Reza; Khorsand, Hashem; Nejati, Mehdi; Sadat, Seyed Mehdi; Mahdavi, Mehdi\n2016-09-01\nHap, an auto-transporter protein, is an antigenically conserved adhesion protein which is present on both typeable and nontypeable Haemophilus influenzae. This protein has central role in bacterial attachment to respiratory tract epithelial cells. A 1000bp C-terminal fragment of Hap passenger domain (HapS) from nontypeable Haemophilus influenzae was cloned into a prokaryotic expression vector, pET-24a. BALB/c mice were immunized subcutaneously with purified rC-HapS. Serum IgG responses to purified rC-HapS, serum IgG subclasses were determined by ELISA and functional activity of antibodies was examined by Serum Bactericidal Assay. The output of rC-HapS was approximately 62% of the total bacterial proteins. Serum IgG responses were significantly increased in immunized group with rC-HapS mixed with Freund's adjuvant in comparison with control groups. Analysis of the serum IgG subclasses showed that the IgG1 subclass was predominant after subcutaneous immunization in BALB/c mice (IgG2a/IgG1 HapS immunized animals were strongly bactericidal against nontypeable Haemophilus influenzae. These results suggest that rC-HapS may be a potential vaccine candidate for nontypeable Haemophilus influenzae. Copyright \u00a9 2016 Elsevier Ltd. All rights reserved.\n[Airway inflammation in nonobstructive and obstructive chronic bronchitis with chronic haemophilus influenzae airway infection. Comparison with noninfected patients with chronic obstructive pulmonary disease](https://www.narcis.nl/publication/RecordID/oai%3Apure.amc.nl%3Apublications%2Fb7ecd503-9a86-4bd2-b4b3-b5034921455b/uquery/chronic%20AND%20obstructive%20AND%20pulmonary%20AND%20disease%20and%20copd/id/16/Language/EN)\nBresser, P.; Out, T. A.; van Alphen, L.; Jansen, H. M.; Lutter, R.\n2000-01-01\nNonencapsulated Haemophilus influenzae often causes chronic infections of the lower respiratory tract in both nonobstructive and obstructive chronic bronchitis. We assessed airway inflammation in clinically stable, chronically H. influenzae-infected patients with nonobstructive (CB-HI, n = 10) and\n[Correlaci\u00f3n entre la tipificaci\u00f3n capsular de aislamientos colombianos de Haemophilus influenzae por el m\u00e9todo de aglutinaci\u00f3n en l\u00e1mina y la t\u00e9cnica de PCR.](http://www.revistabiomedica.org/index.php/biomedica/article/view/1213) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nMarylin Hidalgo\n2003-06-01\nFull Text Available En 1998 se inici\u00f3 en Colombia la inmunizaci\u00f3n de ni\u00f1os menores de un a\u00f1o de edad con la vacuna conjugada contra Haemophilus influenzae, serotipo b. En el 2000, el programa de vigilancia del Grupo de Microbiolog\u00eda del Instituto Nacional de Salud inform\u00f3 una disminuci\u00f3n de 40% de los casos de meningitis por este microorganismo, la cual se atribuy\u00f3 a la vacunaci\u00f3n. En este programa de vigilancia se utiliza de rutina la t\u00e9cnica estandarizada de aglutinaci\u00f3n en l\u00e1mina para la tipificaci\u00f3n capsular de H. influenzae. El objetivo de este trabajo fue establecer la concordancia entre la prueba de aglutinaci\u00f3n en l\u00e1mina y la t\u00e9cnica de PCR. Se estudiaron con ambas t\u00e9cnicas 146 aislamientos cl\u00ednicos invasores de H. influenzae, obtenidos de ni\u00f1os menores de 5 a\u00f1os, recolectados a partir de 1999 hasta 2002, identificados y serotipificados por el laboratorio de referencia como parte de la vigilancia de la meningitis bacteriana aguda y la infecci\u00f3n respiratoria aguda. Nuestros resultados mostraron una correlaci\u00f3n de 93% en la tipificaci\u00f3n capsular de H. influenzae, serotipo b, y de 92% con respecto al resto de serotipos. La t\u00e9cnica de aglutinaci\u00f3n en l\u00e1mina realizada con un estricto control de calidad contin\u00faa siendo una herramienta sensible y espec\u00edfica para la serotipificaci\u00f3n de H. influenzae.\n[Haemophilus influenzae: an underrated cause of vulvovaginitis in young girls.](https://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=500174)\nCox, R A\n1997-01-01\nAIMS: To establish the common pathogens associated with infective vulvovaginitis in young girls in the local population and to determine current management of this condition. METHODS: A prospective laboratory based survey was carried out over 19 months. A questionnaire was then sent to local general practitioners and hospital doctors. RESULTS: One hundred and six swabs were received during the study period of which 43 (40.5%) yielded organisms recognised as causes of vulvovaginitis. The most common pathogen was group A beta haemolytic streptococcus (19), with Haemophilus influenzae the second most common (11). Candida was isolated on nine occasions. The users' questionnaire had an overall response rate of 52%. Forty one per cent of respondents nominated candida as the most common cause of this condition. Forty six per cent were aware that beta haemolytic streptococci caused juvenile vulvovaginitis, but only four (3.6%) knew that H influenzae was a possible pathogen. The most popular agent for empirical treatment of vulvovaginitis was topical clotrimazole cream, although 24 respondents (22%) prescribed antibiotics that are active against both group A beta haemolytic streptococci and H influenzae. CONCLUSIONS: Although H influenzae is the second most common infective cause of juvenile vulvovaginitis in the local population, most doctors managing these patients were unaware of its importance and may not be prescribing appropriate empirical treatment. Images PMID:9389978\n[Rapid Differentiation of Haemophilus influenzae and Haemophilus haemolyticus by Use of Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry with ClinProTools Mass Spectrum Analysis.](https://www.ncbi.nlm.nih.gov/pubmed/28637909)\nChen, Jonathan H K; Cheng, Vincent C C; Wong, Chun-Pong; Wong, Sally C Y; Yam, Wing-Cheong; Yuen, Kwok-Yung\n2017-09-01\nHaemophilus influenzae is associated with severe invasive disease, while Haemophilus haemolyticus is considered part of the commensal flora in the human respiratory tract. Although the addition of a custom mass spectrum library into the matrix-assisted laser desorption ionization-time of flight mass spectrometry (MALDI-TOF MS) system could improve identification of these two species, the establishment of such a custom database is technically complicated and requires a large amount of resources, which most clinical laboratories cannot afford. In this study, we developed a mass spectrum analysis model with 7 mass peak biomarkers for the identification of H. influenzae and H. haemolyticus using the ClinProTools software. We evaluated the diagnostic performance of this model using 408 H. influenzae and H. haemolyticus isolates from clinical respiratory specimens from 363 hospitalized patients and compared the identification results with those obtained with the Bruker IVD MALDI Biotyper. The IVD MALDI Biotyper identified only 86.9% of H. influenzae (311/358) and 98.0% of H. haemolyticus (49/50) clinical isolates to the species level. In comparison, the ClinProTools mass spectrum model could identify 100% of H. influenzae (358/358) and H. haemolyticus (50/50) clinical strains to the species level and significantly improved the species identification rate (McNemar's test, P mass spectrometry to handle closely related bacterial species when the proprietary spectrum library failed. This approach should be useful for the differentiation of other closely related bacterial species. Copyright \u00a9 2017 American Society for Microbiology.\n[Nontypeable Haemophilus influenzae biofilms: role in chronic airway infections](http://journal.frontiersin.org/Journal/10.3389/fcimb.2012.00097/full) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nW Edward Swords\n2012-07-01\nFull Text Available Like many pathogens inhabiting mucosal surfaces, nontypeable Haemophilus influenzae (NTHi forms multicellular biofilm communities both in vitro and in various infection models. In the past 15 years much has been learned about determinants of biofilm formation by this organism and potential roles in bacterial virulence, especially in the context of chronic and recurrent infections. However, this concept has not been without some degree of controversy, and in the past some have expressed doubts about the relevance of NTHi biofilms to disease. In this review, I will summarize the present information on the composition and potential role(s of NTHi biofilms in different clinical contexts, as well as highlight potential areas for future work.\n[Nontypeable Haemophilus influenzae biofilms: role in chronic airway infections.](https://www.ncbi.nlm.nih.gov/pubmed/22919686)\nSwords, W Edward\n2012-01-01\nLike many pathogens inhabiting mucosal surfaces, nontypeable Haemophilus influenzae (NTHi) forms multicellular biofilm communities both in vitro and in various infection models. In the past 15 years much has been learned about determinants of biofilm formation by this organism and potential roles in bacterial virulence, especially in the context of chronic and recurrent infections. However, this concept has not been without some degree of controversy, and in the past some have expressed doubts about the relevance of NTHi biofilms to disease. In this review, I will summarize the present information on the composition and potential role(s) of NTHi biofilms in different clinical contexts, as well as highlight potential areas for future work.\n[A simplification of the enzyme-linked immunospot technique. Increased sensitivity for cells secreting IgG antibodies to Haemophilus influenzae type b capsular polysaccharide](http://www.forskningsdatabasen.dk/en/catalog/2270513896) [DEFF Research Database (Denmark)](http://forskningsbasen.deff.dk/?lang=eng)\nBarington, T; Sparholt, S; Juul, L\n1992-01-01\nA simplified enzyme-linked immunospot (ELISPOT) technique is described for the detection of cells secreting antibodies to tetanus toxoid (TT), diphtheria toxoid (DT) or Haemophilus influenzae type b capsular polysaccharide (PRP). By combining the cell suspension with the enzyme-linked secondary...... antibodies in one incubation, the second incubation and washing procedure could be omitted from the original technique. The simplified assay had the same sensitivity for anti-TT and anti-DT spot-forming cells as the ordinary ELISPOT assay. The IgG anti-PRP spots were, however, improved both in quality...... and in quantity (median: 40% more spots), while the detection of IgM and IgA anti-PRP spot-forming cells was the same in the two techniques. This simplified technique can probably also be used to save time in other antigen systems and should be considered when designing ELISPOT assays for the detection...\n[Structure of the N-terminal region of Haemophilus Influenzae HI0017: Implications for function](http://dx.doi.org/10.1023/A:1011264300726) [International Nuclear Information System (INIS) ](http://inis.iaea.org/search/)\nYu Liping; Mack, Jamey; Hajduk, Phil; Fesik, Stephen W.\n2001-01-01\nHaemophilus influenzae is a gram-negative pathogen that causes infections ranging from asymptomatic colonization of the human upper respiratory tract to serious invasive diseases such as meningitis. Although the genome of Haemophilus influenzae has been completely sequenced, the structure and function of many of these proteins are unknown. HI0017 is one of these uncharacterized proteins. Here we describe the three-dimensional solution structure of the N-terminal portion of HI0017 as determined by NMR spectroscopy. The structure consists of a five-stranded antiparallel \u03b2-sheet and two short \u03b1-helices. It is similar to the C-terminal domain of Diphtheria toxin repressor (DtxR). The C-terminal portion of HI0017 has an amino acid sequence that closely resembles pyruvate formate-lyase - an enzyme that converts pyruvate and CoA into acetyl-CoA and formate by a radical mechanism. Based on structural and sequence comparisons, we propose that the C-terminus of HI0017 functions as an enzyme with a glycyl radical mechanism, while the N-terminus participates in protein/protein interactions involving an activase (iron-sulfur protein) and/or the substrate\n[Structure of the N-terminal region of Haemophilus Influenzae HI0017: Implications for function](http://www.etde.org/etdeweb/details.jsp?query_id=1&page=0&osti_id=21099618) [Energy Technology Data Exchange (ETDEWEB)](https://www.etde.org/etdeweb/fieldedsearch.jsp)\nYu Liping; Mack, Jamey; Hajduk, Phil; Fesik, Stephen W. [Abbott Laboratories, Pharmaceutical Discovery Division, D46Y, AP10/LL (United States)\n2001-06-15\nHaemophilus influenzae is a gram-negative pathogen that causes infections ranging from asymptomatic colonization of the human upper respiratory tract to serious invasive diseases such as meningitis. Although the genome of Haemophilus influenzae has been completely sequenced, the structure and function of many of these proteins are unknown. HI0017 is one of these uncharacterized proteins. Here we describe the three-dimensional solution structure of the N-terminal portion of HI0017 as determined by NMR spectroscopy. The structure consists of a five-stranded antiparallel {beta}-sheet and two short {alpha}-helices. It is similar to the C-terminal domain of Diphtheria toxin repressor (DtxR). The C-terminal portion of HI0017 has an amino acid sequence that closely resembles pyruvate formate-lyase - an enzyme that converts pyruvate and CoA into acetyl-CoA and formate by a radical mechanism. Based on structural and sequence comparisons, we propose that the C-terminus of HI0017 functions as an enzyme with a glycyl radical mechanism, while the N-terminus participates in protein/protein interactions involving an activase (iron-sulfur protein) and/or the substrate.\n[Clinical characteristics of Haemophilus influenzae meningitis in Denmark in the post-vaccination era](http://www.forskningsdatabasen.dk/en/catalog/112791499) [DEFF Research Database (Denmark)](http://forskningsbasen.deff.dk/?lang=eng)\nPedersen, T.I.; Howitz, Michael Frantz; Andersen, Christian \u00d8stergaard\n2010-01-01\nP>The introduction of Haemophilus influenzae type b (Hib) vaccine into the Danish childhood vaccination programme in 1993 may have influenced the epidemiology of H. influenzae meningitis (i.e. increasing frequency of other non-vaccine types; presentation in other age groups). Based on nationwide...... infected with Hib, two cases (13%) were identified as true vaccine failures. Six patients (9%) died; one premature infant infected with serotype f and five adults (age 83-96 years) with non-typeable H. influenzae. Hearing loss was reported in 16% of the surviving children and in 10% of the surviving adults....... The presence of a lung focus was an independent prognostic factor for an unfavourable outcome (p 0.03). In conclusion, meningitis caused by Hib has been infrequent in Denmark after introduction of the Hib vaccine in the childhood vaccination programme, and no increase in meningitis cases due to non-b type H...\n[Non-Type b Haemophilus influenzae Invasive Infections in North Dakota and South Dakota, 2013-2015.](https://www.ncbi.nlm.nih.gov/pubmed/27656134)\nAntony, Stephanie; Kaushik, Ashlesha; Mauriello, Clifford; Chatterjee, Archana\n2017-09-01\nReports of children with non-type b Haemophilus influenzae infection in the United States in recent years have been limited. Here, we report the spectrum and severity of disease associated with invasive non-type b H influenzae infection in 17 patients at 2 tertiary-care children's hospitals over a 2-year period. Meningitis was the most common diagnosis. The majority of the patients had neurologic sequelae, and 1 patient died. The high proportions of hospitalization, intensive care utilization, and neurologic complications reveal that non-type b H influenzae infection was associated with significant morbidity in this pediatric population. \u00a9 The Author 2016. Published by Oxford University Press on behalf of the Pediatric Infectious Diseases Society. All rights reserved. For Permissions, please e-mail: journals.permissions@oup.com.\n[Towards a sustainable, quality and affordable Haemophilus influenzae type b vaccine for every child in the world](https://www.narcis.nl/publication/RecordID/oai%3Atudelft.nl%3Auuid%3A734f1261-0065-4572-b414-cdaa0b923689/uquery/cogs/id/16/Language/EN)\nHamidi, A.\n2016-01-01\nHaemophilus influenzae type b (Hib) conjugate vaccine is a safe and effective vaccine that can prevent meningitis and pneumonia caused by Hib disease. Hib vaccine is recommended for all children under 5 years. Despite the availability of safe and effective Hib vaccines since early 1987, Gambia was\n[Metabolic versatility in Haemophilus influenzae: a metabolomic and genomic analysis](http://journal.frontiersin.org/Journal/10.3389/fmicb.2014.00069/full) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nDk Seti Maimonah Pg eOthman\n2014-03-01\nFull Text Available Haemophilus influenzae is a host adapted human pathogen known to contribute to a variety of acute and chronic diseases of the upper and lower respiratory tract as well as the middle ear. At the sites of infection as well as during growth as a commensal the environmental conditions encountered by H. influenzae will vary significantly, especially in terms of oxygen availability, however, the mechanisms by which the bacteria can adapt their metabolism to cope with such changes have not been studied in detail. Using targeted metabolomics the spectrum of metabolites produced during growth of H. influenzae on glucose in RPMI-based medium was found to change from acetate as the main product during aerobic growth to formate as the major product during anaerobic growth. This is likely caused by a switch in the major pyruvate degrading route. Neither lactate nor succinate or fumarate were major products of H. influenzae growth under any condition studied Gene expression studies and enzyme activity data revealed that despite an identical genetic makeup and very similar metabolite production profiles, H. influenzae strain Rd appeared to favour glucose degradation via the PPP, while strain 2019, a clinical isolate, showed higher expression of enzymes involved in glycolysis. Components of the respiratory chain were most highly expressed during microaerophilic and anaerobic growth in both strains, but again clear differences existed in the expression of genes associated e.g. with NADH oxidation, nitrate and nitrite reduction in the two strains studied.Together our results indicate that H. influenzae uses a specialized type of metabolism that could be termed \u2018respiration assisted fermentation\u2019 where the respiratory chain likely serves to alleviate redox imbalances caused by incomplete glucose oxidation, and at the same time provides a means of converting a variety of compounds including nitrite and nitrate that arise as part of the host defence mechanisms.\n[Frequent carriage of resistance mechanisms to beta-lactams and biofilm formation in Haemophilus influenzae causing treatment failure and recurrent otitis media in young children](https://www.narcis.nl/publication/RecordID/oai%3Apure.rug.nl%3Apublications%2F50dc1830-d899-4e6d-af1d-d02ebe79446f/uquery/jesus%20AND%20campos%20AND%20garc%C3%ADa/id/1/Language/EN)\nGarcia-Cobos, Silvia; Moscoso, Miriam; Pumarola, Felix; Arroyo, Margarita; Lara, Noelia; Perez-Vazquez, Maria; Aracil, Belen; Oteo, Jesus; Garcia, Ernesto; Campos, Jose\nObjectives: Non-typeable Haemophilus influenzae are a major cause of acute otitis media (AOM), including chronic and recurrent otitis in young children. The objective of this study was to determine whether non-typeable H. influenzae isolates causing these infections produce biofilms and carry\n[Aspectos epidemiol\u00f3gicos da infec\u00e7\u00e3o por Haemophilus influenzae tipo b Epidemiologic aspects of Haemophilus influenzae type b infection](http://www.scielosp.org/scielo.php?script=sci_arttext&pid=S1020-49892000000500007) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nMaria Angela Loguercio Bouskela\n2000-05-01\nFull Text Available O objetivo do presente trabalho foi revisar o papel do Haemophilus influenzae tipo b (Hib como um dos pat\u00f3genos mais importantes implicados em doen\u00e7as infecciosas invasivas, especialmente nos 2 primeiros anos de vida. Nos pa\u00edses em desenvolvimento, o H. Influenzae chega a causar 30% dos casos de pneumonia com cultura positiva e de 20 a 60% dos casos de meningite bacteriana. No presente estudo, dados epidemiol\u00f3gicos do Brasil foram comparados com dados internacionais obtidos em bancos de dados (Medline, 1966 a 1995; LILACS, 1982 a 1995; Thesis databank, 1980 a 1995; e Dissertation abstracts, 1988 a 1994. Analis\u00e1mos o coeficiente de incid\u00eancia do Hib no Brasil por estado e por faixa et\u00e1ria, com estratifica\u00e7\u00e3o inclusive para o 1\u00b0 ano de vida. A meningite foi utilizada como marcador do coeficiente de incid\u00eancia devido \u00e0s dificuldades para obter material adequado para a identifica\u00e7\u00e3o do microrganismo nos outros quadros, como pneumonia, osteomielite, epiglotite ou endocardite. Nossa an\u00e1lise revelou que os dados nacionais mascaram a incid\u00eancia e a letalidade regionais do H. influenzae: por exemplo, em 1991, a incid\u00eancia no Brasil foi de 18,4 em 100 000 crian\u00e7as menores de 1 ano; no mesmo per\u00edodo, a incid\u00eancia no Distrito Federal foi de 175 em 100 000 crian\u00e7as entre 4 e 6 meses. Al\u00e9m disso, a letalidade na regi\u00e3o Norte foi de 35% em 1987, contra 22% para o Brasil como um todo. Nosso estudo abre a discuss\u00e3o sobre aspectos epidemiol\u00f3gicos relevantes das infec\u00e7\u00f5es por Hib e sobre o custo-benef\u00edcio da profilaxia e vacina\u00e7\u00e3o nas faixas et\u00e1rias de maior risco.This paper reviews the role of Haemophilus influenzae type b (Hib as one of the most important pathogens causing invasive infectious diseases, especially in the first 2 years of life. In developing countries H. influenzae is responsible for 30% of all pneumonia cases with positive cultures and for 20% to 60% of all bacterial meningitis cases. In this study we compared\n[Haemophilus influenzae vulvovaginitis associated with rhinitis caused by the same clone in a prepubertal girl.](https://www.ncbi.nlm.nih.gov/pubmed/28621044)\nChen, Xiao; Chen, Lifeng; Zeng, Wenjie; Zhao, Xiaofeng\n2017-06-01\nVulvovaginitis caused by upper respiratory flora is generally considered to be the most common gynecological problem in prepubertal girls. To date, however, no direct evidence has been obtained for the underlying mechanism of transmission. This report describes a case of non-capsulate Haemophilus influenzae vulvovaginitis in a 6-year-old girl with a history of foreign bodies (cotton wool) in her vagina. Moreover, this girl had recurrent rhinitis for approximately 3 years. On Pulsed Field Gel Electrophoresis (PFGE) analysis the H. influenzae strain isolated from vaginal secretions and the H. influenzae strain isolated from nasal secretions were derived from the same clone. The patient was successfully treated with appropriate antibiotics. The present case might provide the first direct evidence of the nose-hand-vagina method of transmission. \u00a9 2017 Japan Society of Obstetrics and Gynecology.\n[Haemophilus influenzae pneumonia in human immunodeficiency virus-infected patients. The Grupo Andaluz para el Estudio de las Enfermedades Infecciosas.](https://www.ncbi.nlm.nih.gov/pubmed/10722428)\nCordero, E; Pach\u00f3n, J; Rivero, A; Gir\u00f3n, J A; G\u00f3mez-Mateos, J; Merino, M D; Torres-Tortosa, M; Gonz\u00e1lez-Serrano, M; Aliaga, L; Collado, A; Hern\u00e1ndez-Quero, J; Barrera, A; Nu\u00f1o, E\n2000-03-01\nAlthough Haemophilus influenzae is a common etiologic agent of pneumonia in patients infected with human immunodeficiency virus (HIV), the characteristics of this pneumonia have not been adequately assessed. We have prospectively studied features of H. influenzae pneumonia in 26 consecutive HIV-infected inpatients. Most of these patients were severely immunosuppressed; 73.1% had a CD4+ cell count caused by H. influenzae affects mainly patients with advanced HIV disease, and since its clinical and radiological features may be diverse, this etiology should be considered when pneumonia occurs in patients with advanced HIV infection. The mortality rate associated with H. influenzae pneumonia is not higher than that occurring in the general population.\n[In vitro capability of faropenem to select for resistant mutants of Streptococcus pneumoniae and Haemophilus influenzae.](https://www.ncbi.nlm.nih.gov/pubmed/18086853)\nKosowska-Shick, Klaudia; Clark, Catherine; Credito, Kim; Dewasse, Bonifacio; Beachel, Linda; Ednie, Lois; Appelbaum, Peter C\n2008-02-01\nWhen tested against nine strains of pneumococci and six of Haemophilus influenzae of various resistotypes, faropenem failed to select for resistant mutants after 50 days of consecutive subculture in subinhibitory concentrations. Faropenem also yielded low rates of spontaneous mutations against all organisms of both species. By comparison, resistant clones were obtained with macrolides, ketolides, and quinolones.\n[Identification of a group of Haemophilus influenzae penicillin-binding proteins that may have complementary physiological roles](https://inis.iaea.orgsearchsinglerecord.aspx?recordsFor=SingleRecord&RN=21067336) [International Nuclear Information System (INIS) ](http://inis.iaea.org/search/)\nMalouin, F.; Parr, T.R. Jr.; Bryan, L.E.\n1990-01-01\n[35S]penicillin bound to different Haemophilus influenzae proteins in assays performed at 20, 37, or 42 degrees C. Penicillin-binding proteins 3a, 3b, 4, and 4' formed a group characterized by their affinity for moxalactam, cefotaxime, and piperacillin. Penicillin-binding protein 4' showed specific properties that may reflect its complementary role in septation\nBradbury, Andrew M [Santa Fe, NM\n2011-12-20\nHumanized recombinant and monoclonal antibodies specific for the ectodomain of the influenza virus M2 ion channel protein are disclosed. The antibodies of the invention have anti-viral activity and may be useful as anti-viral therapeutics and/or prophylactic/vaccine agents for inhibiting influenza virus replication and for treating individuals infected with influenza.\n[Characterization of the rec-1 gene of Haemophilus influenzae and behavior of the gene in Escherichia coli](http://www.etde.org/etdeweb/details.jsp?query_id=1&page=0&osti_id=6745089) [Energy Technology Data Exchange (ETDEWEB)](https://www.etde.org/etdeweb/fieldedsearch.jsp)\nSetlow, J.K.; Spikes, D.; Griffin, K.\n1988-09-01\nThe rec-1 gene of Haemophilus influenzae was cloned into a shuttle vector that replicates in Escherichia coli as well as in H. influenzae. The plasmid, called pRec1, complemented the defects of a rec-1 mutant in repair of UV damage, transformation, and ability of prophage to be induced by UV radiation. Although UV resistance and recombination were caused by pRec1 in E. coli recA mutants, UV induction of lambda and UV mutagenesis were not. We suggest that the ability of the H. influenzae Rec-1 protein to cause cleavage of repressors but not the recombinase function differs from that of the E. coli RecA protein.\n[Characterization of the rec-1 gene of Haemophilus influenzae and behavior of the gene in Escherichia coli](https://inis.iaea.orgsearchsinglerecord.aspx?recordsFor=SingleRecord&RN=20015433) [International Nuclear Information System (INIS) ](http://inis.iaea.org/search/)\nSetlow, J.K.; Spikes, D.; Griffin, K.\n1988-01-01\nThe rec-1 gene of Haemophilus influenzae was cloned into a shuttle vector that replicates in Escherichia coli as well as in H. influenzae. The plasmid, called pRec1, complemented the defects of a rec-1 mutant in repair of UV damage, transformation, and ability of prophage to be induced by UV radiation. Although UV resistance and recombination were caused by pRec1 in E. coli recA mutants, UV induction of lambda and UV mutagenesis were not. We suggest that the ability of the H. influenzae Rec-1 protein to cause cleavage of repressors but not the recombinase function differs from that of the E. coli RecA protein\n[Structural Determinants of Autoproteolysis of the Haemophilus influenzae Hap Autotransporter\u25bf](https://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=2772505)\nKenjale, Roma; Meng, Guoyu; Fink, Doran L.; Juehne, Twyla; Ohashi, Tomoo; Erickson, Harold P.; Waksman, Gabriel; St. Geme, Joseph W.\n2009-01-01\nHaemophilus influenzae is a gram-negative bacterium that initiates infection by colonizing the upper respiratory tract. The H. influenzae Hap autotransporter protein mediates adherence, invasion, and microcolony formation in assays with respiratory epithelial cells and presumably facilitates colonization. The serine protease activity of Hap is associated with autoproteolytic cleavage and extracellular release of the HapS passenger domain, leaving the Hap\u03b2 C-terminal domain embedded in the outer membrane. Cleavage occurs most efficiently at the LN1036-37 peptide bond and to a lesser extent at three other sites. In this study, we utilized site-directed mutagenesis, homology modeling, and assays with a peptide library to characterize the structural determinants of Hap proteolytic activity and cleavage specificity. In addition, we used homology modeling to predict the S1, S2, and S4 subsite residues of the Hap substrate groove. Our results indicate that the P1 and P2 positions at the Hap cleavage sites are critical for cleavage, with leucine preferred over larger hydrophobic residues or other amino acids in these positions. The substrate groove is formed by L263 and N274 at the S1 subsite, R264 at the S2 subsite, and E265 at the S4 subsite. This information may facilitate design of approaches to block Hap activity and interfere with H. influenzae colonization. PMID:19687208\n[Influence of prevaccination immunity on the human B-lymphocyte response to a Haemophilus influenzae type b conjugate vaccine](http://www.forskningsdatabasen.dk/en/catalog/2389066515) [DEFF Research Database (Denmark)](http://forskningsbasen.deff.dk/?lang=eng)\nBarington, T; Kristensen, K; Henrichsen, J\n1991-01-01\nof Haemophilus influenzae type b capsular polysaccharide (PRP) and diphtheria toxoid (DT), and the response was related to the prevaccination levels of PRP and DT antibodies. Positive correlations were found between increases in plasma PRP (median, 32.0 micrograms/ml) and DT (1.14 IU/ml) antibodies and numbers...\n[[Isolation of Haemophilus influenzae serotypes from deep sites in sick children].](https://www.ncbi.nlm.nih.gov/pubmed/15174745)\nGatti, B M; Ramirez Gronda, G A; Etchevarr\u00eda, M; Vescina, C M; Varea, A M; Gonz\u00e1lez Ayala, S E\n2004-01-01\nHaemophilus influenzae (Hi) is the causative agent of several human diseases such as sepsis, meningitis, celulitis, and osteoarthritis. We investigated the isolation of Hi serotypes from sterile sites in sick children. One hundred and seventy nine strains from 146 patients were studied, period 1996-2002, at the Microbiology Laboratory, Hospital de Ni\u00f1os Superiora Sor Mar\u00eda Ludovica, Argentina. The serotype distribution was:1 a, 112 b,1 c,1 d, 4 e, 3 f y 24 no typable. Since the beginning of universal Hi b vaccination in 1998, we have observed the fast decrease of serotype b and a relative increase of other serotypes.\n[Mutation induction in Haemophilus influenzae by ICR-191. Pt. 1](https://inis.iaea.orgsearchsinglerecord.aspx?recordsFor=SingleRecord&RN=12613223) [International Nuclear Information System (INIS) ](http://inis.iaea.org/search/)\nPerdue, S.W.; Kimball, R.F.; McGray, P.C.; Tennessee Univ., Oak Ridge\n1981-01-01\nThe investigation of mutagenic mechanisms in Haemophilus influenzae has been confined until now to mutagens that normally produce mainly base pair substitutions. This paper describes the development of a system suitable for detecting frameshift mutations induced by ICR-191. The system involves reversions from thymidine dependence to thymidine independence. Evidence is presented from a comparison of the responses to ICR-191 and to N-methyl-N'-nitro-N-nitrosoguanidine that the system is specific for frameshift mutations. The genetic recombination involved in transformation leads to a marked increase in spontaneous reversion of the frameshift mutations but not of the base substitution mutations. Presumably, this is a consequence of mispairing, with consequent change in the number of bases, during the recombination. (orig.)\n[An up date on influenza Influenza: actualizaci\u00f3n de conceptos](http://www.iatreia.udea.edu.co/index.php/iatreia/article/view/284) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nHel\u00ed Salgado V\u00e9lez\n2002-04-01\nFull Text Available A review is presented on present-day concepts on influenza with emphasis on vaccination; included are considerations about the etiologic agent, pathogenesis, clinical picture, laboratory diagnosis, epidemiology and vaccines; concerning the latter, the following aspects are included: administration, secondary reactions, indications and contraindications. Se presenta una actualizaci\u00f3n de conceptos sobre la influenza con \u00e9nfasis en la vacuna; se incluyen consideraciones sobre el virus, la patog\u00e9nesis, la cl\u00ednica, el diagn\u00f3stico de laboratorio, la epidemiolog\u00eda y las vacunas; acerca de \u00e9stas se detallan sus caracter\u00edsticas, esquemas de aplicaci\u00f3n, reacciones secundarias, indicaciones y contraindicaciones.\n[Human milk lactoferrin inactivates two putative colonization factors expressed by Haemophilus influenzae.](https://www.ncbi.nlm.nih.gov/pubmed/9770539)\nQiu, J; Hendrixson, D R; Baker, E N; Murphy, T F; St Geme, J W; Plaut, A G\n1998-10-13\nHaemophilus influenzae is a major cause of otitis media and other respiratory tract disease in children. The pathogenesis of disease begins with colonization of the upper respiratory mucosa, a process that involves evasion of local immune mechanisms and adherence to epithelial cells. Several studies have demonstrated that human milk is protective against H. influenzae colonization and disease. In the present study, we examined the effect of human milk on the H. influenzae IgA1 protease and Hap adhesin, two autotransported proteins that are presumed to facilitate colonization. Our results demonstrated that human milk lactoferrin efficiently extracted the IgA1 protease preprotein from the bacterial outer membrane. In addition, lactoferrin specifically degraded the Hap adhesin and abolished Hap-mediated adherence. Extraction of IgA1 protease and degradation of Hap were localized to the N-lobe of the bilobed lactoferrin molecule and were inhibited by serine protease inhibitors, suggesting that the lactoferrin N-lobe may contain serine protease activity. Additional experiments revealed no effect of lactoferrin on the H. influenzae P2, P5, and P6 outer-membrane proteins, which are distinguished from IgA1 protease and Hap by the lack of an N-terminal passenger domain or an extracellular linker region. These results suggest that human milk lactoferrin may attenuate the pathogenic potential of H. influenzae by selectively inactivating IgA1 protease and Hap, thereby interfering with colonization. Future studies should examine the therapeutic potential of lactoferrin, perhaps as a supplement in infant formulas.\n[Relationship between secretion of the Anton blood group antigen in saliva and adherence of Haemophilus influenzae to oropharynx epithelial cells](https://www.narcis.nl/publication/RecordID/oai%3Apure.amc.nl%3Apublications%2F585b8f9a-5784-4831-af53-5e40899d6a72/uquery/H%20Anton/id/4/Language/EN)\nvan Alphen, L.; van Ham, M.; Geelen-van den Broek, L.; Pieters, T.\n1989-01-01\nInhibition of adherence of bacteria to epithelial cells contributes to a reduction of infections by these bacteria. We have shown that the Anton blood group antigen, the erythrocyte receptor for Haemophilus influenzae (van Alphen et al. 1986, FEMS Microbiol. Lett. 37, 69-71), occurs in saliva, that\n[Multicentre in-vitro evaluation of the susceptibility of Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis to ciprofloxacin, clarithromycin, co-amoxiclav and sparfloxacin](https://www.narcis.nl/publication/RecordID/oai%3Apure.rug.nl%3Apublications%2F2d1e8efd-5bce-4195-a3d7-b4def9bbd272/uquery/R.w.%20AND%20Davies/id/8/Language/EN)\nHoogkampKorstanje, JAA; DirksGo, SIS; Kabel, P; Manson, WL; Stobberingh, EE; Vreede, RW; Davies, BI\nSeven laboratories, including a reference laboratory, tested the susceptibility of Moraxella catarrhalis, Streptococcus pneumoniae and Haemophilus influenzae strains to ciprofloxacin, clarithromycin, co-amoxiclav and sparfloxacin with the Etest. A total of 976 strains were collected. The results\n[Identification of immunogenic outer membrane proteins of Haemophilus influenzae type b in the infant rat model system](https://inis.iaea.orgsearchsinglerecord.aspx?recordsFor=SingleRecord&RN=13692082) [International Nuclear Information System (INIS) ](http://inis.iaea.org/search/)\nHansen, E.J.; Frisch, C.F.; McDade, R.L. Jr.; Johnston, K.H.\n1981-01-01\nOuter membrane proteins of Haemophilus influenzae type b which are immunogenic in infant rats were identified by a radioimmunoprecipitation method. Intact cells of H. influenzae type b were radioiodinated by a lactoperoxidase-catalyzed procedure, and an outer membrane-containing fraction was prepared from these cells. These radioiodinated outer membranes were mixed with sera obtained from rats convalescing from systemic H. influenzae type b disease induced at 6 days of age, and the resultant (antibody-outer membrane protein antigen) complexes were extracted from these membranes by treatment with nonionic detergent and ethylenediaminetetraacetic acid. These soluble antibody-antigen complexes were isolated by means of adsorption to protein A-bearing staphylococci, and the radioiodinated protein antigens were identified by gel electrophoresis followed by autoradiography. Infant rats were shown to mount a readily detectable antibody response to several different proteins present in the outer membrane of H. influenzae type b. Individual infant rats were found to vary both qualitatively and quantitatively in their immune response to these immunogenic outer membrane proteins\n[DNA repair in Haemophilus influenzae: isolation and characterization of an ultraviolet sensitive mutator mutant](https://inis.iaea.orgsearchsinglerecord.aspx?recordsFor=SingleRecord&RN=17072304) [International Nuclear Information System (INIS) ](http://inis.iaea.org/search/)\nWalter, R.B.\n1985-01-01\nDNA repair in Haemophilus influenzae appears to be quite different from that seen in Escherichia coli in that H. influenzae shows neither SOS nor adaptation phenomena. Repair of DNA lesions in H. influenzae has been seen to occur via recombinational, excision, and mismatch repair pathways acting independently of one another. The author has isolated an ultraviolet (UV)-sensitive mutator mutant (mutB1) of H. influenzae Rd which shows deficiencies in both recombinational and mismatch repair pathways. This mutant is sensitive to a variety of DNA damaging agents as well as being hypermutable by alkylating agents and base analogues. MutB1 cells do not show post-UV DNA breakdown but do begin excision after UV irradiation. Genetic transformation with UV-irradiated DNA on mut B1 recipients shows that high (HE) and low (LE) efficiency markers are transformed at a ratio of 1.0 as in the mismatch repair deficient hex 1 mutant; however, kinetics of UV-inactivation experiments indicate that HE markers are sensitized and act as LE markers do on wild type recipients. Thus, the mutB gene product appears to play a role in both DNA repair and genetic transformation. A model is outlined which presents a role for a DNA helicase in both DNA repair and genetic transformation of H. influenzae\n[Estudio de inmunogenicidad para dos vacunas recombinantes contra hepatitis B](http://www.revistabiomedica.org/index.php/biomedica/article/view/2011) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nO. Juliao\n1991-12-01\nFull Text Available Este estudio compara la inmunogenicidad (seroconversi\u00f3n, seroprotecci\u00f3n e Hiperrespuesta, producida por dos vacunas recombinantes contra la hepatitis B (Engerix-B de B\u00e9lgica y Cubana, en dos esquemas (012 y 016 meses, empleando los m\u00e9todos de cuantificaci\u00f3n para Anti-HBsAg (Abbott y Organ\u00f3n, los cuales fueron tambi\u00e9n comparados. En el estudio participaron 257 voluntarios, divididos al azar en 4 grupos (dos vacunas, dos esquemas. Resultados: los dos m\u00e9todos de Abbon y Organon, no presentan diferencias estad\u00edsticas significativas. La vacuna cubana muestra una mayor respuesta inmunog\u00e9nica para dos dosis de vacuna y para el esquema 012. No hay diferencia entre los esquemas 012 y 016 y en el esquema 016 no se ven diferencias estad\u00edsticamente significativas con la vacuna Engerix-B. En esta \u00daltima el esquema 016 muestra mejores resultados que el 012.\n[Polyarticular Septic Arthritis Caused by Haemophilus influenzae Serotype f in an 8-Month-Old Immunocompetent Infant: A Case Report and Review of the Literature](http://dx.doi.org/10.1155/2015/163812) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nRaheel Ahmed Ali\n2015-01-01\nFull Text Available Background. The standard use of vaccinations against pathogens has resulted in a decreased incidence of musculoskeletal infections caused by these previously common bacterial pathogens. Consequently, the incidence of infections caused by atypical bacteria is rising. This report presents a case of septic arthritis caused by non-type b H. influenzae in a pediatric patient. Methods. We report a case of an infant with polyarticular septic arthritis caused by H. influenzae serotype f. A literature review was conducted with the inclusion criteria of case reports and studies published between 2004 and 2013 addressing musculoskeletal H. influenzae infections. Results. An 8-month-old female presented with pain and swelling in her right ankle and left elbow. The patient was diagnosed with septic arthritis and underwent incision and drainage. Wound and blood cultures were positive for Haemophilus influenzae serotype f. In addition to treatment with IV antibiotics, the patient underwent immunocompetency studies, which were normal. Subsequent follow-up revealed eradication of the infection. Conclusions. Haemophilus influenzae non-type b may cause serious invasive infections such as sepsis or septic arthritis in children with or without predisposing factors such as immunodeficiency or asplenia. Optimal treatment includes surgical management, culture driven IV antibiotics, and an immunologic workup.\n[Risk of Febrile Seizures and Epilepsy After Vaccination With Diphtheria, Tetanus, Acellular Pertussis, Inactivated Poliovirus, and Haemophilus Influenzae Type b](http://www.forskningsdatabasen.dk/en/catalog/194413653) [DEFF Research Database (Denmark)](http://forskningsbasen.deff.dk/?lang=eng)\nSun, Yuelian; Christensen, Jakob Christensen; Hviid, Anders\n2012-01-01\n-acellular pertussis\u2013inactivated poliovirus\u2013 Haemophilus influenzae type b (DTaP-IPV-Hib) vaccine since September 2002. Objective To estimate the risk of febrile seizures and epilepsy after DTaP-IPV-Hib vaccination given at 3, 5, and 12 months. Design, Setting, and Participants A population-based cohort study of 378...\n[Impact of the Haemophilus influenzae type b vaccination program on HIB meningitis in Brazil Impacto do programa de vacina\u00e7\u00e3o contra meningites causadas por Haemophilus influenzae tipo b no Brasil](http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0102-311X2007000700021) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nSybelle de Souza Castro Miranzi\n2007-07-01\nFull Text Available This study aimed to evaluate the impact of vaccination against Haemophilus influenzae type b (HIB in Brazil on the morbidity, mortality, and case fatality of HIB meningitis, using the Ministry of Health database and population data from the Brazilian Institute of Geography and Statistics (Instituto Brasileiro de Geografia e Estat\u00edstica - IBGE. Impact was evaluated through a time series analysis (1983-2002, using regression forecasting (RF by dividing the time series into two periods: (a historical (1983-1998 and (b validation (1999-2002. Impact of the vaccination was positive, although more significant for incidence and mortality than for case fatality rates.A proposta deste trabalho foi avaliar o impacto da vacina\u00e7\u00e3o contra Haemophilus influenzae tipo b (HIB no Brasil sobre a morbi-mortalidade e a letalidade das meningites por HIB, a partir de base de dados fornecida pelo Minist\u00e9rio da Sa\u00fade e as estimativas populacionais provenientes do Instituto Brasileiro de Geografia e Estat\u00edstica (IBGE. Para a avalia\u00e7\u00e3o do impacto utilizou-se an\u00e1lise de tend\u00eancia temporal (1983-2002, aplicando-se a t\u00e9cnica RF (regression forecasting, dividindo-se a s\u00e9rie em dois per\u00edodos: (a per\u00edodo hist\u00f3rico (1983-1998 e (b per\u00edodo de estima\u00e7\u00e3o (1999-2002. O impacto da vacina\u00e7\u00e3o foi positivo, embora tenha se revelado mais expressivo sobre a morbi-mortalidade que sobre a letalidade.\n[Development of a diagnostic real-time polymerase chain reaction assay for the detection of invasive Haemophilus influenzae in clinical samples.](http://www.lenus.ie/hse/handle/10147/296026) [LENUS (Irish Health Repository)](http://www.lenus.ie/hse/)\nMeyler, Kenneth L\n2012-12-01\nSince the introduction of the Haemophilus influenzae serotype b vaccine, invasive H. influenzae disease has become dominated by nontypeable (NT) strains. Several widely used molecular diagnostic methods have been shown to lack sensitivity or specificity in the detection of some of these strains. Novel real-time assays targeting the fucK, licA, and ompP2 genes were developed and evaluated. The fucK assay detected all strains of H. influenzae tested (n = 116) and had an analytical sensitivity of 10 genome copies\\\\/polymerase chain reaction (PCR). This assay detected both serotype b and NT H. influenzae in 12 previously positive specimens (culture and\\\\/or bexA PCR) and also detected H. influenzae in a further 5 of 883 culture-negative blood and cerebrospinal fluid (CSF) samples. The fucK assay has excellent potential as a diagnostic test for detection of typeable and nontypeable strains of invasive H. influenzae in clinical samples of blood and CSF.\n[Development of a diagnostic real-time polymerase chain reaction assay for the detection of invasive Haemophilus influenzae in clinical samples.](https://www.ncbi.nlm.nih.gov/pubmed/23017260)\nMeyler, Kenneth L; Meehan, Mary; Bennett, Desiree; Cunney, Robert; Cafferkey, Mary\n2012-12-01\nSince the introduction of the Haemophilus influenzae serotype b vaccine, invasive H. influenzae disease has become dominated by nontypeable (NT) strains. Several widely used molecular diagnostic methods have been shown to lack sensitivity or specificity in the detection of some of these strains. Novel real-time assays targeting the fucK, licA, and ompP2 genes were developed and evaluated. The fucK assay detected all strains of H. influenzae tested (n = 116) and had an analytical sensitivity of 10 genome copies/polymerase chain reaction (PCR). This assay detected both serotype b and NT H. influenzae in 12 previously positive specimens (culture and/or bexA PCR) and also detected H. influenzae in a further 5 of 883 culture-negative blood and cerebrospinal fluid (CSF) samples. The fucK assay has excellent potential as a diagnostic test for detection of typeable and nontypeable strains of invasive H. influenzae in clinical samples of blood and CSF. Copyright \u00a9 2012 Elsevier Inc. All rights reserved.\n[A plasmid carrying mucA and mucB genes from pKM101 in Haemophilus influenzae and Escherichia coli](https://inis.iaea.orgsearchsinglerecord.aspx?recordsFor=SingleRecord&RN=21027372) [International Nuclear Information System (INIS) ](http://inis.iaea.org/search/)\nSpikes, D.; Setlow, J.K.\n1989-01-01\nThe plasmid pMucAMucB, constructed from the Haemophilus influenzae vector pDM2, and a similar plasmid, constructed from pBR322, increased the survival after UV irradiation of Escherichia coli AB1157 with the umu-36 mutation and also caused UV-induced mutation in the E. coli strain. In H. influenzae, pMucAMucB caused a small but reproducible increase in survival after UV irradiation in wild-type cells and in a rec-1 mutant, but there was no increase in spontaneous mutation in the wild type or in the rec-1 mutant and no UV-induced mutation\n[Ampicillin resistance in Haemophilus influenzae from COPD patients in the UK](https://www.dovepress.com/ampicillin-resistance-in-haemophilus-influenzae-from-copd-patients-in--peer-reviewed-article-COPD) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nMaddi S\n2017-05-01\nFull Text Available Satyanarayana Maddi,1 Umme Kolsum,1 Sarah Jackson,1 Richard Barraclough,2 Barbara Maschera,3 Karen D Simpson,3 Thierry G Pascal,4 Serge Durviaux,4 Edith M Hessel,3 Dave Singh1 1Division of Infection, Immunity and Respiratory Medicine, Medicines Evaluation Unit, University Hospital of South Manchester Foundation Trust, University of Manchester, 2Department of Respiratory Medicine, University Hospital of South Manchester Foundation Trust, Manchester, 3Refractory Respiratory Inflammation DPU, GlaxoSmithKline Medicines Research Centre, Stevenage, Hertfordshire, UK; 4Clinical Laboratory Sciences, GlaxoSmithKline Vaccines, Wavre, Belgium Background: Haemophilus influenzae is commonly isolated from the airways of COPD patients. Antibiotic treatment may cause the emergence of resistant H. influenzae strains, particularly ampicillin-resistant strains, including \u03b2-lactamase-negative ampicillin resistance (BLNAR strains. Genetic identification using ftsI sequencing is the optimum method for identifying mutations within BLNAR strains. The prevalence of BLNAR in COPD patients during the stable state has not been reported. We investigated the antibiotic resistance patterns of H. influenzae present in the sputum of stable COPD patients, focusing on ampicillin resistance; the prevalence of enzyme and non-enzyme-mediated ampicillin resistance was determined. A subset of patients was followed up longitudinally to study H. influenzae strain switching and antibiotic sensitivity changes.Patients and methods: Sputum sampling was performed in 61 COPD patients, with 42 samples obtained at baseline; H. influenzae was detected by polymerase chain reaction in 28 samples. In all, 45 patients completed the follow-up for 2 years; 24 H. influenzae isolates were obtained.Results: Disk diffusion showed the highest antibiotic resistance in the penicillin antibiotic group (eg, 67% for ampicillin and macrolides (eg, 46% for erythromycin, whereas all isolates were susceptible to\n[Costo-efectividad de la vacunaci\u00f3n contra Haemophilus influenzae tipo b : un an\u00e1lisis de decisi\u00f3n para Cuba](https://www.narcis.nl/publication/RecordID/oai%3Apure.rug.nl%3Apublications%2Ff18144fd-7d94-4c15-8d6d-28b48195c69a/uquery/costo/id/11/Language/EN)\nCarc\u00eda, A; Postma, Maarten; G\u00e1lvez, AM; Sierra, G\n2002-01-01\nThe objective of the present study was to estimate the cost-effectiveness ratio of the therapeutic and prophylactic alternatives for treatment of meningitis caused by Haemophilus influenzae type b in less than one year old infants applying a mathematical model. A hypothetical setting with two\n[Structural determinants of the interaction between the Haemophilus influenzae Hap autotransporter and fibronectin.](https://www.ncbi.nlm.nih.gov/pubmed/24687948)\nSpahich, Nicole A; Kenjale, Roma; McCann, Jessica; Meng, Guoyu; Ohashi, Tomoo; Erickson, Harold P; St Geme, Joseph W\n2014-06-01\nHaemophilus influenzae is a Gram-negative cocco-bacillus that initiates infection by colonizing the upper respiratory tract. Hap is an H. influenzae serine protease autotransporter protein that mediates adherence, invasion and microcolony formation in assays with human epithelial cells and is presumed to facilitate the process of colonization. Additionally, Hap mediates adherence to fibronectin, laminin and collagen IV, extracellular matrix (ECM) proteins that are present in the respiratory tract and are probably important targets for H. influenzae colonization. The region of Hap responsible for adherence to ECM proteins has been localized to the C-terminal 511 aa of the Hap passenger domain (HapS). In this study, we characterized the structural determinants of the interaction between HapS and fibronectin. Using defined fibronectin fragments, we established that Hap interacts with the fibronectin repeat fragment called FNIII(1-2). Using site-directed mutagenesis, we found a series of motifs in the C-terminal region of HapS that contribute to the interaction with fibronectin. Most of these motifs are located on the F1 and F3 faces of the HapS structure, suggesting that the F1 and F3 faces may be responsible for the HapS-fibronectin interaction. \u00a9 2014 The Authors.\n[Conocimientos, actitudes y pr\u00e1cticas sobre la influenza A(H1N1 2009 y la vacunaci\u00f3n contra influenza pand\u00e9mica: resultados de una encuesta poblacional Knowledge, attitudes and practices about influenza A(H1N1 2009, and influenza vaccine in Mexico: results of a population survey](http://www.scielo.org.mx/scielo.php?script=sci_arttext&pid=S0036-36342012000600009) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nMar\u00eda Eugenia Jim\u00e9nez-Corona\n2012-12-01\nFull Text Available OBJETIVO: Evaluar conocimientos, actitudes y pr\u00e1cticas respecto a la pandemia de influenza, con especial \u00e9nfasis en la vacuna contra influenza estacional y pand\u00e9mica. MATERIAL Y M\u00c9TODOS: Estudio transversal con muestreo poliet\u00e1pico probabil\u00edstico, realizado durante diciembre de 2009 en residentes mayores de 18 a\u00f1os de la Ciudad de M\u00e9xico (y \u00e1rea metropolitana, Monterrey, Guadalajara y M\u00e9rida. RESULTADOS: Se incluyeron 1 600 sujetos (48.9% masculino; 34% hab\u00eda recibido vacuna contra influenza estacional en a\u00f1os pasados, 90.6% estaba dispuesto a recibir la vacuna contra A(H1N1. La principal causa de rechazo a la vacunaci\u00f3n fue no confiar en la vacuna (46.5%. Principales medidas preventivas identificadas por los encuestados: lavado de manos (47.5%, vacuna contra A(H1N1 (28% y etiqueta respiratoria (19.4%. El nivel escolar (1.7, p=0.006 y edad (1.02, pOBJECTIVE: To assess knowledge, attitudes and practices regarding influenza pandemic, with special emphasis on issues related to influenza vaccine, seasonal and pandemic. MATERIALS AND METHODS: Cross-sectional study, probabilistic multistage sampling in patients over 18 years, residents of Mexico City (and metropolitan area, Monterrey, Guadalajara and Merida in December 2009. RESULTS: A total of 1.600 subjects (48.9% male were interviewed, 34% had previously received seasonal flu vaccine, 90.6% were willing to be vaccinated against A(H1N1, 46.5% of those who would not receive the vaccine was because they did not trust A (H1N1, 68% considered influenza A (H1N1 as a risk for their family. Hand washing was the preventive measure most commonly reported (47.5%, secondly influenza vaccine (28%. Schooling (1.7, p=0.006 and age (1.02, p<0.001 influence rejection to get vaccine. 82.9% of respondents rate the federal government's management as good or very good. CONCLUSIONS: There was a high acceptance rate for the pandemic influenza vaccine in Mexico when compared to similar studies in other\n[Quantitative fucK gene polymerase chain reaction on sputum and nasopharyngeal secretions to detect Haemophilus influenzae pneumonia.](https://www.ncbi.nlm.nih.gov/pubmed/23541117)\nAbdeldaim, Guma M K; Str\u00e5lin, Kristoffer; Olc\u00e9n, Per; Blomberg, Jonas; M\u00f6lling, Paula; Herrmann, Bj\u00f6rn\n2013-06-01\nA quantitative polymerase chain reaction (PCR) for the fucK gene was developed for specific detection of Haemophilus influenzae. The method was tested on sputum and nasopharyngeal aspirate (NPA) from 78 patients with community-acquired pneumonia (CAP). With a reference standard of sputum culture and/or serology against the patient's own nasopharyngeal isolate, H. influenzae etiology was detected in 20 patients. Compared with the reference standard, fucK PCR (using the detection limit 10(5) DNA copies/mL) on sputum and NPA showed a sensitivity of 95.0% (19/20) in both cases, and specificities of 87.9% (51/58) and 89.5% (52/58), respectively. In a receiver operating characteristic curve analysis, sputum fucK PCR was found to be significantly superior to sputum P6 PCR for detection of H. influenzae CAP. NPA fucK PCR was positive in 3 of 54 adult controls without respiratory symptoms. In conclusion, quantitative fucK real-time PCR provides a sensitive and specific identification of H. influenzae in respiratory secretions. Copyright \u00a9 2013 Elsevier Inc. All rights reserved.\n[Variabilidad de las meningoencefalitis bacterianas en el Hospital Pedi\u00e1trico \"Pepe Portilla\" Variability of the bacterial meningoencephalitis at \"Pepe Portilla\" Paediatric Hospital](http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1561-31942009000100003) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nMaydelin Fern\u00e1ndez Gonz\u00e1lez\n2009-03-01\nFull Text Available Se realiz\u00f3 un estudio retrospectivo y prospectivo longitudinal de las Meningoencefalitis Bacterianas diagnosticadas en el Hospital Pedi\u00e1trico \"Pepe Portilla\" en el a\u00f1o 2006 y 2007, con el objetivo de determinar los g\u00e9rmenes que han aislado en dicha patolog\u00eda, compar\u00e1ndose con a\u00f1os anteriores desde 1992, analizando el impacto de la vacunaci\u00f3n contra Neisseria meningitidis y Haemophilus influenzae. Los estudios de l\u00edquido cefalorraqu\u00eddeo se realizaron como indican las normativas para estos casos. Se encontr\u00f3 que en el 2006 solo hubo un caso de meningitis a Neisseria meningitidis y en el 2007 dos casos de meningitis por Streptocuccus pneumoneae, y adem\u00e1s que la incidencia de Neisseria meningitidis y Haemophilus influenzae disminuy\u00f3 despu\u00e9s de la aplicaci\u00f3n de las vacunas VAMENGO BC y Hib de manera ostensible como lo hizo en el pa\u00eds en general, demostr\u00e1ndose la efectividad de dicha vacuna en nuestro medio.A retrospective-prospective and longitudinal study about Bacterial Meningoencephalitis diagnosed at \"Pepe Portilla\" Paediatric Hopital was carried out during 2006-2007 aimed at determining the isolated germs of this pathology comparing them with previous years (since 1992 and analyzing the impact of vaccination against Neisseria meningitidis y Haemophilus influenzae. The studies about cerebrospinal fluid were conducted as indicated by the rules towards these cases. Results showed that in 2006 only one case of meningitis a Neisseria meningitidis occurred and two cases of meningitis by Streptocuccus pneumoneae in 2007; besides the incidence of Neisseria meningitidis y Haemophilus influenza diminished after the vaccination with VAMENGON BC and Hib observed in all the country, showing the effectiveness of the vaccine in our environment.\n[Carrier state of Haemophilus influenzae type b (Hib, Streptococcus pneumoniae, Streptococcus pyogenes, Neisseria meningitidis and Corynebacterium diphtheriae among school children in Pokhara, Nepal](http://oaji.net/articles/2016/3556-1469433557.pdf) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nDharm Raj Bhatta\n2014-02-01\nFull Text Available Objective: To determine the incidence of carrier state of Haemophilus influenzae type b, Streptococcus pneumoniae (S. pneumoniae, Streptococcus pyogenes, Neisseria meningitidis and Corynebacterium diphtheriae among school children. Methods: Specimen from posterior pharyngeal wall and tonsils were collected on calcium alginate coated swabs from 1 02 participants. Processing of specimen and antimicrobial susceptibility testing was done by standard procedures. Results: Potential pathogens isolated in our study were S. pneumoniae (14.7%, Staphylococcus aureus (12.7%, Corynebacterium diphtheriae (3.9%, Streptococcus pyogenes (3.9% and Haemophilus influenzae (1.9%. Important findings in antibiogram include high resistance of S. pneumoniae to penicillin (73% and resistance of Staphylococcus aureus to oxacillin (23%. Conclusions: Pharyngeal colonization by S. pneumoniae among school children was found high and there is need of introduction of pneumococcal vaccines among children. Despite expected universal vaccination, pharyngeal colonization by Corynebacterium diphtheriae is possible and there is possibility of transmission.\n[Antibody responses to tetanus toxoid and Haemophilus influenzae type b conjugate vaccines following autologous peripheral blood stem cell transplantation (PBSCT).](https://www.ncbi.nlm.nih.gov/pubmed/9232253)\nChan, C Y; Molrine, D C; Antin, J H; Wheeler, C; Guinan, E C; Weinstein, H J; Phillips, N R; McGarigle, C; Harvey, S; Schnipper, C; Ambrosino, D M\n1997-07-01\nAccelerated granulocyte and platelet recovery following peripheral blood stem cell transplantation (PBSCT) are well documented. We hypothesize that functional immunity may also be enhanced in PBSCT and performed a phase II trial of immunizations in patients with lymphoma undergoing autologous transplantation with peripheral blood stem cells or bone marrow. Seventeen BMT and 10 PBSCT recipients were immunized at 3, 6, 12, and 24-months post-transplantation with Haemophilus influenzae type b (HIB)-conjugate and tetanus toxoid (TT) vaccines. IgG anti-HIB and anti-TT antibody concentrations were measured and compared between the two groups. Geometric mean IgG anti-HIB antibody concentrations were significantly higher for PBSCT recipients compared to BMT recipients at 24 months post-transplantation (11.3 micrograms/ml vs 0.93 microgram/ml, P = 0.051) and following the 24 month immunization (66.2 micrograms/ml vs 1.30 micrograms/ml, P = 0.006). Similar results were noted for IgG anti-TT antibody with significantly higher geometric mean antibody concentrations in the PBSCT group at 24 months post-transplantation (182 micrograms/ml vs 21.6 micrograms/ml, P = 0.039). Protective levels of total anti-HIB antibody were achieved earlier in PBSCT recipients compared with those of BMT recipients. PBSCT recipients had higher antigen-specific antibody concentrations following HIB and TT immunizations. These results suggest enhanced recovery of humoral immunity in PBSCT recipients and earlier protection against HIB with immunization.\n[Anti-influenza drugs: the development of sialidase inhibitors.](https://www.ncbi.nlm.nih.gov/pubmed/19048199)\nvon Itzstein, Mark; Thomson, Robin\n2009-01-01\nViruses, particularly those that are harmful to humans, are the 'silent terrorists' of the twenty-first century. Well over four million humans die per annum as a result of viral infections alone. The scourge of influenza virus has plagued mankind throughout the ages. The fact that new viral strains emerge on a regular basis, particularly out of Asia, establishes a continual socio-economic threat to mankind. The arrival of the highly pathogenic avian influenza H5N1 heightened the threat of a potential human pandemic to the point where many countries have put in place 'preparedness plans' to defend against such an outcome. The discovery of the first designer influenza virus sialidase inhibitor and anti-influenza drug Relenza, and subsequently Tamiflu, has now inspired a number of continuing efforts towards the discovery of next generation anti-influenza drugs. Such drugs may act as 'first-line-of-defence' against the spread of influenza infection and buy time for necessary vaccine development particularly in a human pandemic setting. Furthermore, the fact that influenza virus can develop resistance to therapeutics makes these continuing efforts extremely important. An overview of the role of the virus-associated glycoprotein sialidase (neuraminidase) and some of the most recent developments towards the discovery of anti-influenza drugs based on the inhibition of influenza virus sialidase is provided in this chapter.\n[Incid\u00eancia de meningite por Haemophilus influenzae no RS 1999-2010: impacto da cobertura vacinal Incidence of meningitis caused by Haemophilus influenzae in the state of Rio Grande do Sul 1999-2010: impact of vaccination campaign](http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1413-81232013001100030) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nMarli Matiko Anraku de Campos\n2013-05-01\nFull Text Available O objetivo deste artigo \u00e9 analisar e verificar a situa\u00e7\u00e3o epidemiol\u00f3gica das meningites causadas pelo agente Haemophilus influenzae tipo b nos \u00faltimos 10 anos no Rio Grande do Sul. Estudo retrospectivo, descritivo, utilizando o sistema de dados de notifica\u00e7\u00e3o de meningites, e cobertura vacinal, armazenados em base on line Tabnet - Tabula\u00e7\u00e3o de dados Epidemiol\u00f3gicos - CEVS/SES/RS, abrangendo o per\u00edodo de 1999 a 2010. Foram utilizados casos notificados e confirmados, tendo como crit\u00e9rio de sele\u00e7\u00e3o o ano de inicio dos sintomas, idade, diagnostico e evolu\u00e7\u00e3o. Foi analisado o Estado do Rio Grande do Sul, representado por 19 coordenadorias de sa\u00fade. Compara\u00e7\u00f5es entre propor\u00e7\u00f5es foram avaliadas pelo teste de z. No RS foram notificados 3043 casos confirmados de meningite bacteriana, sendo 6,77% dos casos causados por H. influenzae. O coeficiente de incid\u00eancia da meningite por H. influenzae, sem considerar faixa et\u00e1ria, caiu significativamente (95,6% ap\u00f3s 1999, assim como a mortalidade. Crian\u00e7as menores de um ano continuam sendo as mais acometidas (52%, n\u00e3o havendo altera\u00e7\u00e3o na letalidade. Os resultados apresentados revelaram um impacto positivo das estrat\u00e9gias de vacina\u00e7\u00e3o contra Hib no Estado do Rio Grande do Sul nos \u00faltimos dez anos.This article seeks to analyze and update the epidemiological situation of meningitis caused by Haemophilus influenzae type b in the past 10 years in the state of Rio Grande do Sul (RS. It is a retrospective, descriptive study, which used the data notification system of meningitis and vaccination campaign coverage, stored in the Epidemiological TABNET online database, for the period from 1999 to 2010. Cases notified and confirmed were used and the selection criteria were the year when the symptoms were detected, age, diagnosis, and evolution. Nineteen health centers in the state of Rio Grande do Sul were analyzed. The z-test was used to evaluate comparisons between the proportions. In the\n[Effect of Multiple Mutations in the Hemoglobin- and Hemoglobin-Haptoglobin-Binding Proteins, HgpA, HgpB, and HgpC, of Haemophilus influenzae Type b](https://www.openaire.eu/search/publication?articleId=od_______908::25e783a27073de234a1219b7d164ad2b)\nMorton, Daniel J.; Whitby, Paul W.; Jin, Hongfan; Ren, Zhen; Stull, Terrence L.\n1999-01-01\nHaemophilus influenzae requires heme for growth and can utilize hemoglobin and hemoglobin-haptoglobin as heme sources. We previously identified two hemoglobin- and hemoglobin-haptoglobin-binding proteins, HgpA and HgpB, in H. influenzae HI689. Insertional mutation of hgpA and hgpB, either singly or together, did not abrogate the ability to utilize or bind either hemoglobin or the hemoglobin-haptoglobin complex. A hemoglobin affinity purification method was used to isolate a protein of approxi...\n[Development and validation of an Haemophilus influenzae supragenome hybridization (SGH array for transcriptomic analyses.](http://europepmc.org/articles/PMC4188559?pdf=render) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nBenjamin A Janto\nFull Text Available We previously carried out the design and testing of a custom-built Haemophilus influenzae supragenome hybridization (SGH array that contains probe sequences to 2,890 gene clusters identified by whole genome sequencing of 24 strains of H. influenzae. The array was originally designed as a tool to interrogate the gene content of large numbers of clinical isolates without the need for sequencing, however, the data obtained is quantitative and is thus suitable for transcriptomic analyses. In the current study RNA was extracted from H. influenzae strain CZ4126/02 (which was not included in the design of the array converted to cDNA, and labelled and hybridized to the SGH arrays to assess the quality and reproducibility of data obtained from these custom-designed chips to serve as a tool for transcriptomics. Three types of experimental replicates were analyzed with all showing very high degrees of correlation, thus validating both the array and the methods used for RNA profiling. A custom filtering pipeline for two-condition unpaired data using five metrics was developed to minimize variability within replicates and to maximize the identification of the most significant true transcriptional differences between two samples. These methods can be extended to transcriptional analysis of other bacterial species utilizing supragenome-based arrays.\n[Comparison of Established Diagnostic Methodologies and a Novel Bacterial smpB Real-Time PCR Assay for Specific Detection of Haemophilus influenzae Isolates Associated with Respiratory Tract Infections.](https://www.ncbi.nlm.nih.gov/pubmed/26109443)\nReddington, Kate; Schwenk, Stefan; Tuite, Nina; Platt, Gareth; Davar, Danesh; Coughlan, Helena; Personne, Yoann; Gant, Vanya; Enne, Virve I; Zumla, Alimuddin; Barry, Thomas\n2015-09-01\nHaemophilus influenzae is a significant causative agent of respiratory tract infections (RTI) worldwide. The development of a rapid H. influenzae diagnostic assay that would allow for the implementation of infection control measures and also improve antimicrobial stewardship for patients is required. A number of nucleic acid diagnostics approaches that detect H. influenzae in RTIs have been described in the literature; however, there are reported specificity and sensitivity limitations for these assays. In this study, a novel real-time PCR diagnostic assay targeting the smpB gene was designed to detect all serogroups of H. influenzae. The assay was validated using a panel of well-characterized Haemophilus spp. Subsequently, 44 Haemophilus clinical isolates were collected, and 36 isolates were identified as H. influenzae using a gold standard methodology that combined the results of matrix-assisted laser desorption ionization-time of flight mass spectrometry (MALDI-TOF MS) and a fucK diagnostic assay. Using the novel smpB diagnostic assay, 100% concordance was observed with the gold standard, demonstrating a sensitivity of 100% (95% confidence interval [CI], 90.26% to 100.00%) and a specificity of 100% (95% CI, 63.06% to 100.00%) when used on clinical isolates. To demonstrate the clinical utility of the diagnostic assay presented, a panel of lower RTI samples (n = 98) were blindly tested with the gold standard and smpB diagnostic assays. The results generated were concordant for 94/98 samples tested, demonstrating a sensitivity of 90.91% (95% CI, 78.33% to 97.47%) and a specificity of 100% (95% CI, 93.40% to 100.00%) for the novel smpB assay when used directly on respiratory specimens. Copyright \u00a9 2015, American Society for Microbiology. All Rights Reserved.\n[Genomic Variability of Haemophilus influenzae Isolated from Mexican Children Determined by Using Enterobacterial Repetitive Intergenic Consensus Sequences and PCR](https://www.openaire.eu/search/publication?articleId=od_______908::2f8826a972d0c02fd2b0670c47a6e126)\nGomez-De-Leon, Patricia; Santos, Jose I.; Caballero, Javier; Gomez, Demostenes; Espinosa, Luz E.; Moreno, Isabel; Pi\u00f1ero, Daniel; Cravioto, Alejandro\n2000-01-01\nGenomic fingerprints from 92 capsulated and noncapsulated strains of Haemophilus influenzae from Mexican children with different diseases and healthy carriers were generated by PCR using the enterobacterial repetitive intergenic consensus (ERIC) sequences. A cluster analysis by the unweighted pair-group method with arithmetic averages based on the overall similarity as estimated from the characteristics of the genomic fingerprints, was conducted to group the strains. A total of 69 fingerprint...\n[Genomic DNA fingerprinting of clinical Haemophilus influenzae isolates by polymerase chain reaction amplification: comparison with major outer-membrane protein and restriction fragment length polymorphism analysis](https://www.narcis.nl/publication/RecordID/oai%3Apure.amc.nl%3Apublications%2Fe68da8b2-3a31-4720-835a-33b212a423e1/uquery/fingerprints%20AND%20identical/id/3/Language/EN)\nvan Belkum, A.; Duim, B.; Regelink, A.; M\u00f6ller, L.; Quint, W.; van Alphen, L.\n1994-01-01\nNon-capsulate strains of Haemophilus influenzae were genotyped by analysis of variable DNA segments obtained by amplification of genomic DNA with the polymerase chain reaction (PCR fingerprinting). Discrete fragments of 100-2000 bp were obtained. The reproducibility of the procedure was assessed by\n[GENOMIC DNA-FINGERPRINTING OF CLINICAL HAEMOPHILUS-INFLUENZAE ISOLATES BY POLYMERASE CHAIN-REACTION AMPLIFICATION - COMPARISON WITH MAJOR OUTER-MEMBRANE PROTEIN AND RESTRICTION-FRAGMENT-LENGTH-POLYMORPHISM ANALYSIS](https://www.narcis.nl/publication/RecordID/oai%3Apure.rug.nl%3Apublications%2F83496784-5e96-4d21-81d7-3702af53846d/uquery/fingerprints%20AND%20identical/id/2/Language/EN)\nVANBELKUM, A; DUIM, B; REGELINK, A; MOLLER, L; QUINT, W; VANALPHEN, L\nNon-capsulate strains of Haemophilus influenzae were genotyped by analysis of variable DNA segments obtained by amplification of genomic DNA with the polymerase chain reaction (PCR fingerprinting). Discrete fragments of 100-2000 bp were obtained. The reproducibility of the procedure was assessed by\n[The C-Terminal Fragment of the Internal 110-Kilodalton Passenger Domain of the Hap Protein of Nontypeable Haemophilus influenzae Is a Potential Vaccine Candidate](https://www.openaire.eu/search/publication?articleId=od_______908::e9861174eb459cdec76f7c971f45dcdd)\nLiu, Dai-Fang; Mason, Kathryn W.; Mastri, Maria; Pazirandeh, Mehran; Cutter, David; Fink, Doran L.; St. Geme, Joseph W.; Zhu, Duzhang; Green, Bruce A.\n2004-01-01\nNontypeable Haemophilus influenzae is a major causative agent of bacterial otitis media in children. H. influenzae Hap autotransporter protein is an adhesin composed of an outer membrane Hap\u03b2 region and a moiety of an extracellular internal 110-kDa passenger domain called HapS. The HapS moiety promotes adherence to human epithelial cells and extracellular matrix proteins, and it also mediates bacterial aggregation and microcolony formation. A recent work (D. L. Fink, A. Z. Buscher, B. A. Gree...\n[Haemophilus influenzae from Patients with Chronic Obstructive Pulmonary Disease Exacerbation Induce More Inflammation than Colonizers](https://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=2718449)\nChin, Cecilia L.; Manzel, Lori J.; Lehman, Erin E.; Humlicek, Alicia L.; Shi, Lei; Starner, Timothy D.; Denning, Gerene M.; Murphy, Timothy F.; Sethi, Sanjay; Look, Dwight C.\n2005-01-01\nRationale: Airway infection with Haemophilus influenzae causes airway inflammation, and isolation of new strains of this bacteria is associated with increased risk of exacerbations in patients with chronic obstructive pulmonary disease (COPD). Objective: To determine whether strains of H. influenzae associated with exacerbations cause more inflammation than strains that colonize the airways of patients with COPD. Methods: Exacerbation strains of H. influenzae were isolated from patients during exacerbation of clinical symptoms with subsequent development of a homologous serum antibody response and were compared with colonization strains that were not associated with symptom worsening or an antibody response. Bacterial strains were compared using an in vivo mouse model of airway infection and in vitro cell culture model of bacterial adherence and defense gene and signaling pathway activation in primary human airway epithelial cells. Results: H. influenzae associated with exacerbations caused more airway neutrophil recruitment compared with colonization strains in the mouse model of airway bacterial infection. Furthermore, exacerbation strains adhered to epithelial cells in significantly higher numbers and induced more interleukin-8 release after interaction with airway epithelial cells. This effect was likely mediated by increased activation of the nuclear factor-\u03baB and p38 mitogen-activated protein kinase signaling pathways. Conclusions: The results indicate that H. influenzae strains isolated from patients during COPD exacerbations often induce more airway inflammation and likely have differences in virulence compared with colonizing strains. These findings support the concept that bacteria infecting the airway during COPD exacerbations mediate increased airway inflammation and contribute to decreased airway function. PMID:15805181\n[Haemophilus influenzae tipo b: situa\u00e7\u00e3o epidemiol\u00f3gica no Estado de Minas Gerais, Brasil, 1993 a 1997 Haemophilus influenzae type b: epidemiological situation in the State of Minas Gerais, Brazil, 1993-1997](http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0102-311X2003000500005) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nSybelle de Souza Castro Miranzi\n2003-10-01\nFull Text Available Entre as doen\u00e7as invasivas causadas pelo Haemophilus influenzae tipo b (Hib, destacam-se, pela freq\u00fc\u00eancia e gravidade, as pneumonias e as meningites. No per\u00edodo de 1993 a 1997, foram notificados, em Minas Gerais, 720 casos de meningites por Hib, sendo a causa mais freq\u00fcente de meningite bacteriana em menores de um ano e a segunda causa no total de meningites. Entretanto, estimou-se uma ocorr\u00eancia total de 1.160 casos considerando as meningites bacterianas n\u00e3o especificadas. O total de casos estimados de doen\u00e7a invasiva por Hib parece justificar a recente inclus\u00e3o da vacina no esquema b\u00e1sico de imuniza\u00e7\u00f5es. O alto custo da vacina refor\u00e7a a necessidade de melhorar a vigil\u00e2ncia epidemiol\u00f3gica da meningite, que constitui uma das fragilidades das a\u00e7\u00f5es de controle desta doen\u00e7a.Among Haemophilus influenzae type b (Hib invasive diseases, pneumonia and meningitis are the most relevant in public health due to their frequency and severity. From 1993 to 1997, there were 720 cases of Hib meningitis in Minas Gerais State, Brazil, representing the most frequent cause of bacterial meningitis in infants (< 1 year and the second most frequent among all causes of meningitis. The total estimated cases of invasive Hib diseases thus appear to justify the recent inclusion of the vaccine in the basic immunization protocol. The vaccine's high cost reinforces the need for more precise monitoring of the etiological diagnosis of meningitis cases, representing one of the weaknesses in the prevailing epidemiological surveillance system.\n[Methodology optimization and diversification for the investigation of virulence potential in Haemophilus influenzae clinical strains.](https://www.ncbi.nlm.nih.gov/pubmed/22568263)\nGiuc\u0103, Mihaela Cristina; Str\u0103u\u0163, Monica; Surdeanu, Maria; Nica, Maria; Ungureanu, Vasilica; Mih\u0103escu, Grigore\n2011-01-01\nTen Haemophilus influenzae strains were isolated from patients aged between 1.6 - 24 years, with various diagnoses (acute meningitis, acute upper respiratory infection, otitis media and acute sinusitis). Identification was based on phenotypic and molecular characteristics; antibiotic susceptibility testing was performed by diffusion method according to CLSI standards 2011 for seven antibiotics. The results of molecular testing showed that all the studied strains produced an amplicon of 1000 bp with ompP2 primers indicating that all strains were H. influenzae. For six strains, the PCR amplicon obtained with bexA specific primers, proving that the strains were capsulated. The results of phenotypic testing showed that four strains were ampicillin nonsusceptible and (beta-lactamase-positive. The virulence potential of H. influenzae clinical strains was investigated by phenotypic methods, including the assessment of the soluble virulence factors on specific media containing the biochemical substratum for the investigated enzymatic factor, as well as the adherence and invasion capacity to HeLa cells monolayer using Cravioto modified method. The studied strains exhibited mainly a diffuse adherence pattern and different adherence indexes. Interestingly, two strains isolated from the same pacient (blood and CSF) showed a different degree of invasiveness, the strain isolated from blood being 20 times more invasive than the one isolated from CSF.\n[Incidence of invasive Haemophilus influenzae type b disease in Italian children](http://dx.doi.org/10.1023/A:1007320124502) [International Nuclear Information System (INIS) ](http://inis.iaea.org/search/)\nTozzi, Alberto E.; Salmaso, Stefania; Atti, Marta L. Ciofi degli; Panei, Pietro; Anemona, Alessandra; Scuderi, Gabriella; Wassilak, Steven G.F.\n1997-01-01\nTo estimate the incidence of Haemophilus influenzae type b (Hib) invasive disease in Italian infants we performed a prospective study in a cohort of newborns enrolled for a randomized trial on safety and efficacy of three pertussis vaccines and followed for onset of serious disease or pertussis. The overall cumulative incidence observed in 15,601 children was 51.3/100,000 for all invasive Hib infections and 38.4/100,000 for Hib meningitis, over 27 months of observation. The incidence density of all invasive Hib diseases was 28.7/100,000 person-years, while meningitis occurred with an incidence of 21.5/100,000 person-years. Among the eight cases detected, six were meningitis, one sepsis, and one cellulitis. The child with sepsis died. The incidence and epidemiology of invasive Hib disease in Italy are comparable to those reported from other European countries. Cost-benefit analyses are needed for planning Italian vaccination policy\n[Capsule Typing of Haemophilus influenzae by Matrix-Assisted Laser Desorption/Ionization Time-of-Flight Mass Spectrometry.](https://www.ncbi.nlm.nih.gov/pubmed/29460728)\nM\u00e5nsson, Viktor; Gilsdorf, Janet R; Kahlmeter, Gunnar; Kilian, Mogens; Kroll, J Simon; Riesbeck, Kristian; Resman, Fredrik\n2018-03-01\nEncapsulated Haemophilus influenzae strains belong to type-specific genetic lineages. Reliable capsule typing requires PCR, but a more efficient method would be useful. We evaluated capsule typing by using matrix-assisted laser desorption/ionization time-of-flight (MALDI-TOF) mass spectrometry. Isolates of all capsule types (a-f and nontypeable; n = 258) and isogenic capsule transformants (types a-d) were investigated. Principal component and biomarker analyses of mass spectra showed clustering, and mass peaks correlated with capsule type-specific genetic lineages. We used 31 selected isolates to construct a capsule typing database. Validation with the remaining isolates (n = 227) showed 100% sensitivity and 92.2% specificity for encapsulated strains (a-f; n = 61). Blinded validation of a supplemented database (n = 50) using clinical isolates (n = 126) showed 100% sensitivity and 100% specificity for encapsulated strains (b, e, and f; n = 28). MALDI-TOF mass spectrometry is an accurate method for capsule typing of H. influenzae.\n[[Exploration on mechanism of anti-influenza virus activity of genus Paeonia based on network pharmacology].](https://www.ncbi.nlm.nih.gov/pubmed/29728040)\nCai, Ya-Qi; Bao, Ya-Ting; Wang, Hong-Jin; Ren, Xiao-Dong; Huang, Lin-Fang; He, Jie; Liu, Tian-Tian; Zeng, Rui\n2018-04-01\nThis paper aimed to investigate the anti-influenza virus activity of the genus Paeonia, screen potential anti-influenza virus compounds and predict targets of anti-influenza virus to explore the mechanism of anti-influenza virus activity. First of all, a total of 301 compounds of the genus Paeonia were summarized from the literatures in recent ten years. The candidate active ingredients from the genus Paeonia were identified by database such as PubChem and Chemical Book. The ligands were constructed by ChemDraw, Avogadro and Discovery Studio Visualizer. Secondly, 23 potential anti-influenza virus targets were developed by combining the target database and the literatures. Uniprot database was used to find the anti-influenza virus targets, and RCSB was used to identify targets associated with anti-influenza virus activity as docked receptor proteins. QuickVina 2.0 software was used for molecular docking. Finally, the Cytoscape 3.5.1 software was used to map the potential activity compounds of the genus Paeonia against influenza virus and the anti-influenza virus target network. Uniprot online database was used to analyze the target GO enrichment and KEGG metabolic pathways. The results showed that 74 compounds of the genus Paeonia had anti-influenza virus effect and 18 potential anti-influenza virus targets were screened. GO analysis concluded that the mechanism of the genus Paeonia anti-influenza virus is consistent with the mechanism of NA anti-influenza virus in order to stop the sprouting, dispersion and diffusion of virus and reduce the ability of virus to infect, so that the infection can be restricted so as to achieve the anti-influenza virus effect. Copyright\u00a9 by the Chinese Pharmaceutical Association.\n[Haemophilus influenzae Isolated From Men With Acute Urethritis: Its Pathogenic Roles, Responses to Antimicrobial Chemotherapies, and Antimicrobial Susceptibilities.](https://www.ncbi.nlm.nih.gov/pubmed/28282645)\nIto, Shin; Hatazaki, Kyoko; Shimuta, Ken; Kondo, Hiromi; Mizutani, Kosuke; Yasuda, Mitsuru; Nakane, Keita; Tsuchiya, Tomohiro; Yokoi, Shigeaki; Nakano, Masahiro; Ohinishi, Makoto; Deguchi, Takashi\n2017-04-01\nThere have been few comprehensive studies on Haemophilus influenza-positive urethritis. In this retrospective study, we enrolled 68 men with H. influenzae-positive urethritis, including coinfections with Neisseria gonorrhoeae, Chlamydia trachomatis, and/or genital mycoplasmas: 2, 3, 20, and 43 treated with ceftriaxone, levofloxacin, sitafloxacin, and extended-release azithromycin (azithromycin-SR), respectively. We assessed microbiological outcomes in 54 men and clinical outcomes in 46 with H. influenzae-positive monomicrobial nongonococcal urethritis. We determined minimum inhibitory concentrations (MICs) of 6 antimicrobial agents for 59 pretreatment isolates. H. influenzae was eradicated from the men treated with ceftriaxone, levofloxacin, or sitafloxacin. The eradication rate with azithromycin-SR was 85.3%. The disappearance or alleviation of urethritis symptoms and the decreases in leukocyte counts in first-voided urine were significantly associated with the eradication of H. influenzae after treatment. For the isolates, ceftriaxone, levofloxacin, sitafloxacin, azithromycin, tetracycline, and doxycycline MICs were \u22640.008-0.25, 0.008-0.5, 0.001-0.008, 0.12-1, 0.25-16, and 0.25-2 \u03bcg/mL, respectively. The azithromycin MICs for 3 of 4 strains persisting after azithromycin-SR administration were 1 \u03bcg/mL. H. influenzae with an azithromycin MIC of 1 \u03bcg/mL increased chronologically. H. influenzae showed good responses to the chemotherapies for urethritis. The significant associations of the clinical outcomes of the chemotherapies with their microbiological outcomes suggested that H. influenzae could play pathogenic roles in urethritis. All isolates, except for one with decreased susceptibility to tetracyclines, were susceptible to the examined agents. However, the increase in H. influenzae with an azithromycin MIC of 1 \u03bcg/mL might threaten efficacies of azithromycin regimens on H. influenzae-positive urethritis.\n[Indirect pathogenicity of Haemophilus influenzae and Moraxella catarrhalis in polymicrobial otitis media occurs via interspecies quorum signaling.](https://www.ncbi.nlm.nih.gov/pubmed/20802829)\nArmbruster, Chelsie E; Hong, Wenzhou; Pang, Bing; Weimer, Kristin E D; Juneau, Richard A; Turner, James; Swords, W Edward\n2010-07-06\nOtitis media (OM) is among the leading diseases of childhood and is caused by opportunists that reside within the nasopharynx, such as Haemophilus influenzae and Moraxella catarrhalis. As with most airway infections, it is now clear that OM infections involve multiple organisms. This study addresses the hypothesis that polymicrobial infection alters the course, severity, and/or treatability of OM disease. The results clearly show that coinfection with H. influenzae and M. catarrhalis promotes the increased resistance of biofilms to antibiotics and host clearance. Using H. influenzae mutants with known biofilm defects, these phenotypes were shown to relate to biofilm maturation and autoinducer-2 (AI-2) quorum signaling. In support of the latter mechanism, chemically synthesized AI-2 (dihydroxypentanedione [DPD]) promoted increased M. catarrhalis biofilm formation and resistance to antibiotics. In the chinchilla infection model of OM, polymicrobial infection promoted M. catarrhalis persistence beyond the levels seen in animals infected with M. catarrhalis alone. Notably, no such enhancement of M. catarrhalis persistence was observed in animals infected with M. catarrhalis and a quorum signaling-deficient H. influenzae luxS mutant strain. We thus conclude that H. influenzae promotes M. catarrhalis persistence within polymicrobial biofilms via interspecies quorum signaling. AI-2 may therefore represent an ideal target for disruption of chronic polymicrobial infections. Moreover, these results strongly imply that successful vaccination against the unencapsulated H. influenzae strains that cause airway infections may also significantly impact chronic M. catarrhalis disease by removing a reservoir of the AI-2 signal that promotes M. catarrhalis persistence within biofilm.\n[Efectividad de una vacuna antigripal en una poblaci\u00f3n laboral colombiana Effectiveness of an influenza vaccine in a working population in Colombia](http://www.scielosp.org/scielo.php?script=sci_arttext&pid=S1020-49892001001000003) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nStella Sof\u00eda Mesa Duque\n2001-10-01\nFull Text Available Objetivos. Determinar si una vacuna contra la influenza disminuye significativamente los episodios de infecci\u00f3n respiratoria superior aguda (IRSA y la incapacidad laboral por esta causa, en trabajadores adultos sanos de una entidad bancaria en la ciudad de Medell\u00edn. M\u00e9todos. Se realiz\u00f3 un estudio aleatorizado con doble enmascaramiento y placebo en 493 voluntarios. Mediante asignaci\u00f3n aleatoria se conformaron dos grupos, uno de estudio y otro de control, con 247 y 246 empleados, respectivamente. Se utilizaron por participante dosis de 0,5 mL de una vacuna contra la influenza que contiene ant\u00edgenos de superficie de las cepas recomendadas por la OMS para el per\u00edodo 1996-1997 con los subtipos A/Wahan/359/95 (H3N2, A/Texas/36/91 (H1N1 y B/Beijing/184/93. Se consider\u00f3 episodio de IRSA cuando alg\u00fan participante refer\u00eda dolor de garganta, fiebre y tos con m\u00e1s de 24 horas de duraci\u00f3n. La evaluaci\u00f3n se realiz\u00f3 quincenalmente durante seis meses; la gravedad de los episodios se estudi\u00f3 por el ausentismo laboral debido a IRSA, seg\u00fan la novena Clasificaci\u00f3n Internacional de Enfermedades (CIE-9, mediante la evaluaci\u00f3n mensual de las ausencias laborales por incapacidad certificada por la Seguridad Social en Salud, a lo largo de un a\u00f1o. Resultados. La descripci\u00f3n de los efectos colaterales asociados con la vacuna fueron el eritema (riesgo relativo (RR = 8,0; P = 0,02 y el edema local (RR = 4,5; P = 0,03. La incidencia acumulada anual de los episodios de IRSA fue 78,5% para los vacunados y 91,5% para el grupo placebo, con una reducci\u00f3n de 14%, observ\u00e1ndose valores entre 7 y 20% (RR = 0,86; IC95%: 0,80-0,93. La incidencia acumulada anual de IRSA con discapacidad fue de 15,8% en el grupo de vacunados, con una reducci\u00f3n de 31% respecto al grupo placebo (22,8%, con valores entre 0 y 52% (RR = 0,69; IC95%: 0,48-1,0. Estos niveles de protecci\u00f3n, tanto contra las formas menos sintom\u00e1ticas de IRSA como contra las causantes de incapacidad laboral\n[Tend\u00eancia das meningites por Haemophilus influenzae tipo b no Brasil, em menores de 5 anos, no per\u00edodo de 1983 a 2002 Trends in Haemophilus influenzae type b meningitis in Brazil in children under five years of age from 1983 through 2002](http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0037-86822006000500010) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nSybelle de Souza Castro Miranzi\n2006-10-01\nFull Text Available Trata-se de um estudo ecol\u00f3gico, tipo s\u00e9rie hist\u00f3rica (1983-2002, onde foram calculados os coeficientes de incid\u00eancia, mortalidade e letalidade de meningites por Haemophilus influenzae , tipo b, no Brasil, e avaliou-se a tend\u00eancia da morbi-mortalidade em menores de 5 anos. Para a an\u00e1lise de tend\u00eancia dos coeficientes constru\u00edram-se modelos de regress\u00e3o polinomial para as faixas et\u00e1rias de The study was based on an ecological design using a historical time series (1983-2002, related to Haemophilus influenzae type b meningitis in Brazil. Incidence, mortality and case-fatality rates, as well as trends in incidence and morbidity-mortality were estimated in children less than 5 years of age. Polynomial regression analysis was used to analyze trends, adopting a significance level of 0.05. 43.9% of confirmed cases occurred in infants less than 1 year old and 38.7% in children 1-4 years old. The observed rates were also highest in these two age strata. The incidence and mortality rates showed an increasing trend, until approximately 1999, when a quick decline was observed. The study results reinforce the effectiveness of the Vaccination Program against HIB in Brazil, which benefited age ranges that did not receive the vaccine (Herd Immunity.\n[Transformation of natural genetic variation into Haemophilus influenzae genomes.](http://europepmc.org/articles/PMC3145789?pdf=render) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nJoshua Chang Mell\n2011-07-01\nFull Text Available Many bacteria are able to efficiently bind and take up double-stranded DNA fragments, and the resulting natural transformation shapes bacterial genomes, transmits antibiotic resistance, and allows escape from immune surveillance. The genomes of many competent pathogens show evidence of extensive historical recombination between lineages, but the actual recombination events have not been well characterized. We used DNA from a clinical isolate of Haemophilus influenzae to transform competent cells of a laboratory strain. To identify which of the ~40,000 polymorphic differences had recombined into the genomes of four transformed clones, their genomes and their donor and recipient parents were deep sequenced to high coverage. Each clone was found to contain ~1000 donor polymorphisms in 3-6 contiguous runs (8.1\u00b14.5 kb in length that collectively comprised ~1-3% of each transformed chromosome. Seven donor-specific insertions and deletions were also acquired as parts of larger donor segments, but the presence of other structural variation flanking 12 of 32 recombination breakpoints suggested that these often disrupt the progress of recombination events. This is the first genome-wide analysis of chromosomes directly transformed with DNA from a divergent genotype, connecting experimental studies of transformation with the high levels of natural genetic variation found in isolates of the same species.\n[Identification, distribution, and expression of novel genes in 10 clinical isolates of nontypeable Haemophilus influenzae.](https://www.ncbi.nlm.nih.gov/pubmed/15908377)\nShen, Kai; Antalis, Patricia; Gladitz, John; Sayeed, Sameera; Ahmed, Azad; Yu, Shujun; Hayes, Jay; Johnson, Sandra; Dice, Bethany; Dopico, Richard; Keefe, Randy; Janto, Benjamin; Chong, William; Goodwin, Joseph; Wadowsky, Robert M; Erdos, Geza; Post, J Christopher; Ehrlich, Garth D; Hu, Fen Z\n2005-06-01\nWe hypothesize that Haemophilus influenzae, as a species, possesses a much greater number of genes than that found in any single H. influenzae genome. This supragenome is distributed throughout naturally occurring infectious populations, and new strains arise through autocompetence and autotransformation systems. The effect is that H. influenzae populations can readily adapt to environmental stressors. The supragenome hypothesis predicts that significant differences exist between and among the genomes of individual infectious strains of nontypeable H. influenzae (NTHi). To test this prediction, we obtained 10 low-passage NTHi clinical isolates from the middle ear effusions of patients with chronic otitis media. DNA sequencing was performed with 771 clones chosen at random from a pooled genomic library. Homology searching demonstrated that approximately 10% of these clones were novel compared to the H. influenzae Rd KW20 genome, and most of them did not match any DNA sequence in GenBank. Amino acid homology searches using hypothetical translations of the open reading frames revealed homologies to a variety of proteins, including bacterial virulence factors not previously identified in the NTHi isolates. The distribution and expression of 53 of these genes among the 10 strains were determined by PCR- and reverse transcription PCR-based analyses. These unique genes were nonuniformly distributed among the 10 isolates, and transcription of these genes in planktonic cultures was detected in 50% (177 of 352) of the occurrences. All of the novel sequences were transcribed in one or more of the NTHi isolates. Seventeen percent (9 of 53) of the novel genes were identified in all 10 NTHi strains, with each of the remaining 44 being present in only a subset of the strains. These genic distribution analyses were more effective as a strain discrimination tool than either multilocus sequence typing or 23S ribosomal gene typing methods.\n[Centers for Disease Control (CDC) Podcasts](http://www2c.cdc.gov/podcasts/search.asp)\n2010-12-08\nEn la charla, un m\u00c3\u00a9dico responde a las preguntas frecuentes sobre la vacuna contra la influenza (gripe). Created: 12/8/2010 by Centro Nacional para la Inmunizaci\u00c3\u00b3n y Enfermedades Respiratorias (NCIRD). Date Released: 12/8/2010.\n[Phylogeny of the genus Haemophilus as determined by comparison of partial infB sequences](http://www.forskningsdatabasen.dk/en/catalog/2389184320) [DEFF Research Database (Denmark)](http://forskningsbasen.deff.dk/?lang=eng)\nHedegaard, J; Okkels, H; Bruun, B\n2001-01-01\nA 453 bp fragment of infB, the gene encoding translation initiation factor 2, was sequenced and compared from 66 clinical isolates and type strains of Haemophilus species and related bacteria. Analysis of the partial infB sequences obtained suggested that the human isolates dependent on X and V...... factor, H. influenzae, H. haemolyticus, H. aegyptius and some cryptic genospecies of H. influenzae, were closely related to each other. H. parainfluenzae constituted a heterogeneous group within the boundaries of the genus, whereas H. aphrophilus/paraphrophilus and Actinobacillus actinomycetemcomitans...... were only remotely related to the type species of the genus Haemophilus H. parahaemolyticus and H. paraphrohaemolyticus took up an intermediary position and may not belong in the genus Haemophilus sensu stricto. Ambiguous results were obtained with seven isolates tentatively identified as H. segnis...\n[Antimicrobial susceptibility of Haemophilus influenzae strains isolated from the urethra of men with acute urethritis and/or epididymitis.](https://www.ncbi.nlm.nih.gov/pubmed/28619239)\nDeguchi, Takashi; Ito, Shin; Hatazaki, Kyoko; Horie, Kengo; Yasuda, Mitsuru; Nakane, Keita; Mizutani, Kosuke; Tsuchiya, Tomohiro; Yokoi, Shigeaki; Hanaoka, Nozomu; Shimuta, Ken; Ohnishi, Makoto; Muratani, Tetsuro; Nakano, Masahiro\n2017-11-01\nWe determined minimum inhibitory concentrations (MICs) of 41 antimicrobial agents for 73 clinical strains of Haemophilus influenzae isolated from the urethra of men with acute urethritis and/or epididymitis and examined the strains for the production of \u03b2-lactamase. We also compared their antimicrobial susceptibilities with those of H. influenzae strains from respiratory tract or otorhinolaryngological infections that were reported in Japan. The proportion of \u03b2-lactamase-nonproducing ampicillin-resistant strains from acute urethritis and/or epididymitis appeared to be lower, but that of \u03b2-lactamase-producing ampicillin-resistant strains appeared to be higher, compared with those from respiratory tract or otorhinolaryngological infections. However, their antimicrobial susceptibilities to a variety of other antimicrobial agents would be similar to those from respiratory tract or otorhinolaryngological infections. Almost all of the strains of H. influenzae from acute urethritis and/or epididymitis were susceptible to the agents, including ceftriaxone, quinolones, macrolides, and tetracyclines, commonly prescribed for treatment of acute urethritis based on the MIC breakpoints recommended by the Clinical and Laboratory Standards Institute. Ceftriaxone and quinolones could be effective on H. influenzae-induced urethritis. However, azithromycin treatment failures were reported in acute urethritis caused by H. influenzae strains considered susceptible to azithromycin. Further studies will be needed to determine MIC breakpoints of antimicrobial agents, which are recommended for treatment of urogenital infections, for H. influenzae strains causing these infections. Nevertheless, this study provides useful data regarding antimicrobial susceptibilities of H. influenzae strains isolated from the urogenital tract, which have rarely been studied. Copyright \u00a9 2017 Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases. Published by Elsevier\n[Evidence for covalent attachment of phospholipid to the capsular polysaccharide of Haemophilus influenzae type b](https://inis.iaea.orgsearchsinglerecord.aspx?recordsFor=SingleRecord&RN=17043623) [International Nuclear Information System (INIS) ](http://inis.iaea.org/search/)\nKuo, J.S.; Doelling, V.W.; Graveline, J.F.; McCoy, D.W.\n1985-01-01\nCells of Haemophilus influenzae type b were grown in a liquid medium containing [ 3 H]palmitate or [ 14 C]ribose or both for two generations of exponential growth. Radiolabeled type-specific capsular polysaccharide, polyribosyl ribitol phosphate (PRP), was purified from the culture supernatant by Cetavlon precipitation, ethanol fractionation, and hydroxylapatite and Sepharose 4B chromatography. The doubly labeled ( [ 3 H]palmitate and [ 14 C]ribose) PRP preparation was found to coelute in a single peak from a Sepharose 4B column, suggesting that both precursors were incorporated into the purified PRP. A singly labeled ( [ 3 H]palmitate) purified PRP preparation was found to be quantitatively immune precipitated by human serum containing antibody against PRP. Only after acid, alkaline, or phospholipase A2 treatment of PRP labeled with [ 3 H]palmitate or [ 3 H]palmitate and [ 14 C]ribose followed by chloroform-methanol extraction could most of the 3 H-radioactivity be recovered in the organic phase. The chloroform-soluble acid-hydrolyzed or phospholipase A2-treated product was identified as palmitic acid after thin-layer chromatography. These results strongly suggest that a phospholipid moiety is covalently associated with the H. influenzae type b polysaccharide PRP\n[Caracterizaci\u00f3n de aislamientos invasivos de S. pneumoniae, H. influenzae y N. meningitidis en Am\u00e9rica Latina y el Caribe: SIREVA II, 2000-2005 Characterization of invasive isolates of S. pneumoniae, H. influenzae, and N. meningitidis in Latin America and the Caribbean: SIREVA II, 2000-2005](http://www.scielosp.org/scielo.php?script=sci_arttext&pid=S1020-49892008000700001) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nJean-Marc Gabastou\n2008-07-01\nFull Text Available OBJETIVOS: Analizar las caracter\u00edsticas fenot\u00edpicas y la susceptibilidad a antibi\u00f3ticos de las cepas circulantes de Streptococcus pneumoniae, Haemophilus influenzae y Neisseria meningitidis en Am\u00e9rica Latina y el Caribe entre 2000 y 2005. Se evalu\u00f3 la cobertura potencial de las vacunas conjugadas. M\u00c9TODOS: Se estudi\u00f3 por m\u00e9todos convencionales la distribuci\u00f3n de los serotipos o serogrupos de 17 303 cepas de S. pneumoniae, 2 782 cepas de H. influenzae y 6 955 cepas de N. meningitidis aisladas de casos de neumon\u00eda, meningitis, sepsis, bacteriemias y otros procesos invasivos. Se evalu\u00f3 la susceptibilidad a los antibi\u00f3ticos de las cepas estudiadas. Los aislamientos proced\u00edan de 453 centros centinelas de 19 pa\u00edses de Am\u00e9rica Latina y 4 del Caribe, como parte del proyecto SIREVA II. RESULTADOS: El serotipo 14 de S. pneumoniae fue el m\u00e1s frecuentemente aislado (21,1%, especialmente en ni\u00f1os menores de 6 a\u00f1os (29,1%. Las coberturas potenciales de las vacunas conjugadas antineumoc\u00f3cicas hepta, nona, deca y tridecavalentes fueron de 59,0%, 73,4%, 76,5% y 85,9%, respectivamente. De los aislamientos, 63,3% eran sensibles a la penicilina. El serotipo b de H. influenzae estuvo presente en 72,2% de los aislamientos en ni\u00f1os menores de 2 a\u00f1os, mientras 8,6% correspondieron a los serotipos a, c, d, e y f; 19,2% resultaron no serotipables. La proporci\u00f3n de cepas de H. influenzae productoras de betalactamasa en aislamientos en ni\u00f1os menores de 2 a\u00f1os fue de 16,3%. Los serogrupos de N. meningitidis m\u00e1s frecuentes fueron el B (69,0% y el C (25,7%; 65,8% y 99,2% de las cepas fueron sensibles a la penicilina y a la rifampicina, respectivamente. CONCLUSIONES: Estos resultados resaltan la importancia de la vigilancia epidemiol\u00f3gica integral de S. pneumoniae, H. influenzae y N. meningitidis en Am\u00e9rica Latina y el Caribe. La gran heterogeneidad en la distribuci\u00f3n de los serotipos de S. pneumoniae en los pa\u00edses estudiados podr\u00eda reducir la\n[Biofilm-specific extracellular matrix proteins of non-typeable Haemophilus influenzae](https://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=4262604)\nWu, Siva; Baum, Marc M.; Kerwin, James; Guerrero-Given, Debbie; Webster, Simon; Schaudinn, Christoph; VanderVelde, David; Webster, Paul\n2014-01-01\nNon-typeable Haemophilus influenzae (NTHi), a human respiratory tract pathogen can form colony biofilms in vitro. Bacterial cells and the amorphous extracellular matrix (ECM) constituting the biofilm can be separated using sonication. The ECM from 24 hr and 96 hr NTHi biofilms contained polysaccharides and proteinaceous components as detected by NMR and FTIR spectroscopy. More conventional chemical assays on the biofilm ECM confirmed the presence of these components and also DNA. Proteomics revealed eighteen proteins present in biofilm ECM that were not detected in planktonic bacteria. One ECM protein was unique to 24 hr biofilms, two were found only in 96 hr biofilms, and fifteen were present in the ECM of both 24 hr and 96 hr NTHi biofilms. All proteins identified were either associated with bacterial membranes or were cytoplasmic proteins. Immunocytochemistry showed two of the identified proteins, a DNA-directed RNA polymerase and the outer membrane protein OMP P2, associated with bacteria and biofilm ECM. Identification of biofilm-specific proteins present in immature biofilms is an important step in understanding the in vitro process of NTHi biofilm formation. The presence of a cytoplasmic protein and a membrane protein in the biofilm ECM of immature NTHi biofilms suggests that bacterial cell lysis may be a feature of early biofilm formation. PMID:24942343\n[Live Streptococcus pneumoniae, Haemophilus influenzae, and Neisseria meningitidis activate the inflammatory response trhough Toll-like receptors 2, 4, and 9 in species-specific patterns](http://www.forskningsdatabasen.dk/en/catalog/2389195185) [DEFF Research Database (Denmark)](http://forskningsbasen.deff.dk/?lang=eng)\nMogensen, T.H.; Paludan, S\u00f8ren Riis; Kilian, Mogens\n2006-01-01\nactivation by live bacteria. Here, we demonstrate that live Streptococcus pneumoniae, Haemophilus influenzae type b, and Neisseria meningitidis, the three principal causes of bacterial meningitis, use distinct sets of TLRs to trigger the inflammatory response. Using human embryonic kidney 293 cell lines......, each overexpressing one type of TLR, we found that S. pneumoniae triggered activation of the transcription factor nuclear factor-kappaB and expression of interleukin-8, only in cells expressing TLR2 or -9. The same response was evoked by H. influenzae in cells expressing TLR2 or -4 and by N...... and confirmed the essential role of these TLRs and also identified differential functions of TLRs in activation of the inflammatory response. Collectively, we here demonstrate that S. pneumoniae, H. influenzae, and N. meningitidis each activate several TLRs in species-specific patterns and show that infection...\n[Coinfection with Haemophilus influenzae promotes pneumococcal biofilm formation during experimental otitis media and impedes the progression of pneumococcal disease.](https://www.ncbi.nlm.nih.gov/pubmed/20715928)\nWeimer, Kristin E D; Armbruster, Chelsie E; Juneau, Richard A; Hong, Wenzhou; Pang, Bing; Swords, W Edward\n2010-10-01\nOtitis media is an extremely common pediatric infection and is mostly caused by bacteria that are carried within the nasopharyngeal microbiota. It is clear that most otitis media cases involve simultaneous infection with multiple agents. Chinchillas were infected with nontypeable Haemophilus influenzae, Streptococcus pneumoniae, or a combination of both organisms, and the course of disease was compared. In vitro experiments were also performed to address how coinfection impacts biofilm formation. The incidence of systemic disease was reduced in coinfected animals, compared with those infected with pneumococcus alone. Pneumococci were present within surface-attached biofilms in coinfected animals, and a greater proportion of translucent colony type was observed in the coinfected animals. Because this colony type has been associated with pneumococcal biofilms, the impact of coinfection on pneumococcal biofilm formation was investigated. The results clearly show enhanced biofilm formation in vitro by pneumococci in the presence of H. influenzae. Based on these data, we conclude that coinfection with H. influenzae facilitates pneumococcal biofilm formation and persistence on the middle ear mucosal surface. This enhanced biofilm persistence correlates with delayed emergence of opaque colony variants within the bacterial population and a resulting decrease in systemic infection.\n[Haemophilus in\ufb02uenzae Sepsis and Placental Abruption in an Unvaccinated Immigrant](http://escholarship.org/uc/item/4313m32x) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nPaul A. Calner\n2012-04-01\nFull Text Available Background: Haemophilus influenzae infections have declined dramatically in the United States sinceimplementation of the conjugate vaccine. However, in countries where widespread immunization is notroutine, H influenzae remains a significant cause of morbidity and mortality. We report a case of apreviously unvaccinated immigrant with confirmed H influenzae sepsis and placental abruption leadingto spontaneous abortion.Objectives: To alert emergency medicine practitioners that H influenzae should be recognized as amaternal, fetal, and neonatal pathogen. Clinicians should consider this diagnosis in immigrants presentingwith uncertain vaccination history, as H influenzae can cause significant morbidity and mortality.Case Presentation: A 36-year-old female was referred to our emergency department (ED with lowerabdominal pain with some vaginal spotting. The patient had an initial visit with normal laboratoryinvestigations and normal imaging results, with complete resolution of symptoms. The patient returned tothe ED with sudden onset of vaginal bleeding and abdominal pain. She presented at this time with sepsis,which progressed to septic shock, causing placental abruption and ultimately, spontaneous abortion. Thepatient was treated with pressors and antibiotics and was admitted to the medical intensive care unitwhere she received ampicillin, gentamycin, and clindamycin for suspected chorioamnionitis. The patient\u2019sblood cultures came back positive after 1 day for H influenzae. The patient did well and was dischargedfrom the hospital 4 days later.Conclusion: Haemophilus influenzae should be recognized as a neonatal and maternal pathogen.Clinicians should consider this diagnosis in immigrants presenting with uncertain vaccination history,especially in pregnant females, as H influenzae can cause significant morbidity and mortality. [West JEmerg Med. 2012;13(1:133\u2013135.\n[Crystal structure of the Haemophilus influenzae Hap adhesin reveals an intercellular oligomerization mechanism for bacterial aggregation](https://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=3173798)\nMeng, Guoyu; Spahich, Nicole; Kenjale, Roma; Waksman, Gabriel; St Geme, Joseph W\n2011-01-01\nBacterial biofilms are complex microbial communities that are common in nature and are being recognized increasingly as an important determinant of bacterial virulence. However, the structural determinants of bacterial aggregation and eventual biofilm formation have been poorly defined. In Gram-negative bacteria, a major subgroup of extracellular proteins called self-associating autotransporters (SAATs) can mediate cell\u2013cell adhesion and facilitate biofilm formation. In this study, we used the Haemophilus influenzae Hap autotransporter as a prototype SAAT to understand how bacteria associate with each other. The crystal structure of the H. influenzae HapS passenger domain (harbouring the SAAT domain) was determined to 2.2 \u00c5 by X-ray crystallography, revealing an unprecedented intercellular oligomerization mechanism for cell\u2013cell interaction. The C-terminal SAAT domain folds into a triangular-prism-like structure that can mediate Hap\u2013Hap dimerization and higher degrees of multimerization through its F1\u2013F2 edge and F2 face. The intercellular multimerization can give rise to massive buried surfaces that are required for overcoming the repulsive force between cells, leading to bacterial cell\u2013cell interaction and formation of complex microcolonies. PMID:21841773\n[Anti-influenza Hyperimmune Immunoglobulin Enhances Fc-functional Antibody Immunity during Human Influenza Infection.](https://www.ncbi.nlm.nih.gov/pubmed/29860297)\nVanderven, Hillary A; Wragg, Kathleen; Ana-Sosa-Batiz, Fernanda; Kristensen, Anne B; Jegaskanda, Sinthujan; Wheatley, Adam K; Wentworth, Deborah; Wines, Bruce D; Hogarth, P Mark; Rockman, Steve; Kent, Stephen J\n2018-05-31\nNew treatments for severe influenza are needed. Passive transfer of influenza-specific hyperimmune pooled immunoglobulin (Flu-IVIG) boosts neutralising antibody responses to past strains in influenza-infected subjects. The effect of Flu-IVIG on antibodies with Fc-mediated functions, which may target diverse influenza strains, is unclear. We studied the capacity of Flu-IVIG, relative to standard IVIG, to bind to Fc receptors and mediate antibody-dependent cellular cytotoxicity in vitro. The effect of Flu-IVIG infusion, compared to placebo infusion, was examined in serial plasma samples from 24 subjects with confirmed influenza infection in the INSIGHT FLU005 pilot study. Flu-IVIG contains higher concentrations of Fc-functional antibodies than IVIG against a diverse range of influenza hemagglutinins. Following infusion of Flu-IVIG into influenza-infected subjects, a transient increase in Fc-functional antibodies was present for 1-3 days against infecting and non-infecting strains of influenza. Flu-IVIG contains antibodies with Fc-mediated functions against influenza virus and passive transfer of Flu-IVIG increases anti-influenza Fc-functional antibodies in the plasma of influenza-infected subjects. Enhancement of Fc-functional antibodies to a diverse range of influenza strains suggests that Flu-IVIG infusion could prove useful in the context of novel influenza virus infections, when there may be minimal or no neutralising antibodies in the Flu-IVIG preparation.\n[Nonencapsulated Streptococcus pneumoniae causes otitis media during single-species infection and during polymicrobial infection with nontypeable Haemophilus influenzae.](https://www.ncbi.nlm.nih.gov/pubmed/26014114)\nMurrah, Kyle A; Pang, Bing; Richardson, Stephen; Perez, Antonia; Reimche, Jennifer; King, Lauren; Wren, John; Swords, W Edward\n2015-07-01\nStreptococcus pneumoniae strains lacking capsular polysaccharide have been increasingly reported in carriage and disease contexts. Since most cases of otitis media involve more than one bacterial species, we aimed to determine the capacity of a nonencapsulated S. pneumoniae clinical isolate to induce disease in the context of a single-species infection and as a polymicrobial infection with nontypeable Haemophilus influenzae. Using the chinchilla model of otitis media, we found that nonencapsulated S. pneumoniae colonizes the nasopharynx following intranasal inoculation, but does not readily ascend into the middle ear. However, when we inoculated nonencapsulated S. pneumoniae directly into the middle ear, the bacteria persisted for two weeks post-inoculation and induced symptoms consistent with chronic otitis media. During coinfection with nontypeable H. influenzae, both species persisted for one week and induced polymicrobial otitis media. We also observed that nontypeable H. influenzae conferred passive protection from killing by amoxicillin upon S. pneumoniae from within polymicrobial biofilms in vitro. Therefore, based on these results, we conclude that nonencapsulated pneumococci are a potential causative agent of chronic/recurrent otitis media, and can also cause mutualistic infection with other opportunists, which could complicate treatment outcomes. \u00a9 FEMS 2014. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.\n[Individual risk factors associated with nasopharyngeal colonization with Streptococcus pneumoniae and Haemophilus influenzae: a Japanese birth cohort study.](https://www.ncbi.nlm.nih.gov/pubmed/23411622)\nOtsuka, Taketo; Chang, Bin; Shirai, Takatoshi; Iwaya, Atsushi; Wada, Akihito; Yamanaka, Noboru; Okazaki, Minoru\n2013-07-01\nThe first step in a bacterial disease is the establishment of nasopharyngeal carriage. We conducted a birth cohort study to identify factors associated with colonization in healthy children and evaluate the serotype distributions and resistances of Streptococcus pneumoniae/Haemophilus influenzae. Nasopharyngeal cultures were obtained from 349 subjects at 5 time points coinciding with health checkups (4, 7, 10, 18 and 36 months). A total of 551 S. pneumoniae (penicillin resistance rate: 46.3%) and 301 H. influenzae (ampicillin resistance rate: 44.5%) isolates were obtained from 1654 samples. In this study, 47.5% and 60.9% of S. pneumoniae isolates were included in the serotypes of 7- and 13-valent pneumococcal conjugate vaccines, respectively. Analyzing by Cox proportional hazards models, cohabiting older sibling(s) attending day-care (hazard ratios: 2.064-3.518, P rates. This data indicated that introduction of appropriate antimicrobial usage in areas of overuse of antimicrobials could contribute to lower colonization of S. pneumoniae/H. influenzae, resulting in a decrease in the absolute number of resistant isolates. Strategies to control transmission at day-care centers or from older sibling(s) as well as appropriate use of antimicrobials are essential for reducing colonization and the absolute number of resistant isolates.\n[Nonencapsulated or nontypeable Haemophilus influenzae are more likely than their encapsulated or serotypeable counterparts to have mutations in their fucose operon.](https://www.ncbi.nlm.nih.gov/pubmed/22107351)\nShuel, Michelle L; Karlowsky, Kathleen E; Law, Dennis K S; Tsang, Raymond S W\n2011-12-01\nPopulation biology of Haemophilus influenzae can be studied by multilocus sequence typing (MLST), and isolates are assigned sequence types (STs) based on nucleotide sequence variations in seven housekeeping genes, including fucK. However, the ST cannot be assigned if one of the housekeeping genes is absent or cannot be detected by the current protocol. Occasionally, strains of H. influenzae have been reported to lack the fucK gene. In this study, we examined the prevalence of this mutation among our collection of H. influenzae isolates. Of the 704 isolates studied, including 282 encapsulated and 422 nonencapsulated isolates, nine were not typeable by MLST owing to failure to detect the fucK gene. All nine fucK-negative isolates were nonencapsulated and belonged to various biotypes. DNA sequencing of the fucose operon region confirmed complete deletion of genes in the operon in seven of the nine isolates, while in the remaining two isolates, some of the genes were found intact or in parts. The significance of these findings is discussed.\n[Expression of urease by Haemophilus influenzae during human respiratory tract infection and role in survival in an acid environment](https://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=3166929)\n2011-01-01\nBackground Nontypeable Haemophilus influenzae is a common cause of otitis media in children and lower respiratory tract infection in adults with chronic obstructive pulmonary disease (COPD). Prior studies have shown that H. influenzae expresses abundant urease during growth in the middle ear of the chinchilla and in pooled human sputum, suggesting that expression of urease is important for colonization and infection in the hostile environments of the middle ear and in the airways in adults. Virtually nothing else is known about the urease of H. influenzae, which was characterized in the present study. Results Analysis by reverse transcriptase PCR revealed that the ure gene cluster is expressed as a single transcript. Knockout mutants of a urease structural gene (ureC) and of the entire ure operon demonstrated no detectable urease activity indicating that this operon is the only one encoding an active urease. The ure operon is present in all strains tested, including clinical isolates from otitis media and COPD. Urease activity decreased as nitrogen availability increased. To test the hypothesis that urease is expressed during human infection, purified recombinant urease C was used in ELISA with pre acquisition and post infection serum from adults with COPD who experienced infections caused by H. influenzae. A total of 28% of patients developed new antibodies following infection indicating that H. influenzae expresses urease during airway infection. Bacterial viability assays performed at varying pH indicate that urease mediates survival of H. influenzae in an acid environment. Conclusions The H. influenzae genome contains a single urease operon that mediates urease expression and that is present in all clinical isolates tested. Nitrogen availability is a determinant of urease expression. H. influenzae expresses urease during human respiratory tract infection and urease is a target of the human antibody response. Expression of urease enhances viability in an acid\n[Immunoglobulin G avidities in infants in Mexico after primary immunization with three doses of polyribosylribitol phosphate-tetanus toxoid Haemophilus influenzae type b vaccine.](https://www.ncbi.nlm.nih.gov/pubmed/18417667)\nG\u00f3mez-de-Le\u00f3n, Patricia; D\u00edaz-Garc\u00eda, F Javier; Villase\u00f1or-Sierra, Alberto; Segura, Jorge; Carranza, Martha I; Arredondo-Garcia, Jos\u00e9 Luis; Santos, Jos\u00e9 Ignacio\n2008-06-01\nSerum immunoglobulin G concentrations and avidities specific to Haemophilus influenzae type b (Hib) were measured in 208 children living in Guadalajara and Mexico City. Protective concentrations were found in 98.9% and 100.0% of participants, respectively. Geometric mean concentrations differed between both populations and/or among age groups. Mean avidities differed only among the 7- to 12-month-old children. Diphtheria-tetanus-whole-cell pertussis-hepatitis B-Hib primary vaccination seems to induce protection in Mexican children.\n[Nontypeable Haemophilus influenzae initiates formation of neutrophil extracellular traps.](https://www.ncbi.nlm.nih.gov/pubmed/20956567)\nJuneau, Richard A; Pang, Bing; Weimer, Kristin E D; Armbruster, Chelsie E; Swords, W Edward\n2011-01-01\nNontypeable Haemophilus influenzae (NTHI) is a leading cause of otitis media infections, which are often chronic and/or recurrent in nature. NTHI and other bacterial species persist in vivo within biofilms during otitis media and other persistent infections. These biofilms have a significant host component that includes neutrophil extracellular traps (NETs). These NETs do not mediate clearance of NTHI, which survives within NET structures by means of specific subpopulations of lipooligosaccharides on the bacterial surface that are determinants of biofilm formation in vitro. In this study, the ability of NTHI and NTHI components to initiate NET formation was examined using an in vitro model system. Both viable and nonviable NTHI strains were shown to promote NET formation, as did preparations of bacterial DNA, outer membrane proteins, and lipooligosaccharide (endotoxin). However, only endotoxin from a parental strain of NTHI exhibited equivalent potency in NET formation to that of NTHI. Additional studies showed that NTHI entrapped within NET structures is resistant to both extracellular killing within NETs and phagocytic killing by incoming neutrophils, due to oligosaccharide moieties within the lipooligosaccharides. Thus, we concluded that NTHI elicits NET formation by means of multiple pathogen-associated molecular patterns (most notably endotoxin) and is highly resistant to killing within NET structures. These data support the conclusion that, for NTHI, formation of NET structures may be a persistence determinant by providing a niche within the middle-ear chamber.\n[Oxygen-independent inactivation of Haemophilus influenzae transforming DNA by monochromatic radiation: action spectrum, effect of histidine and repair](https://www.osti.gov/etdeweb/biblio/7319187) [Energy Technology Data Exchange (ETDEWEB)](https://www.etde.org/etdeweb/fieldedsearch.jsp)\nCabrera-Juarez, E; Setlow, J K; Swenson, P A; Peak, M J\n1976-01-01\nThe action spectrum for the oxygen-independent inactivation of native transforming DNA from Haemophilus influenzae with near-uv radiation revealed a shoulder beginning at 334 and extending to 460 nm. The presence of 0.2 M histidine during irradiation produced a small increase in inactivation at 254, 290 and 313 nm, a large increase at 334 nm and a decrease in inactivation at 365, 405, and 460 nm. Photoreactivation did not reverse the DNA damage produced at pH 7.0 at 334, 365, 405 and 460 nm, but did reactivate the DNA after irradiation at 254, 290 and 313 nm. The inactivation of DNA irradiated at 254, 290 and 313 nm was considerably greater when the transforming ability was assayed in an excision-defective mutant compared with the wild type, although DNA irradiated at 334, 365, 405 and 460 nm showed smaller differences. These results suggest that the oxygen-independent inactivation of H. influenzae DNA at pH 7 by irradiation at 334, 365, 405 and 460 nm is caused by lesions other than pyrimidine dimers.\n[Susceptibilities of Haemophilus influenzae and Moraxella catarrhalis to ABT-773 compared to their susceptibilities to 11 other agents.](https://www.ncbi.nlm.nih.gov/pubmed/11120946)\nCredito, K L; Lin, G; Pankuch, G A; Bajaksouzian, S; Jacobs, M R; Appelbaum, P C\n2001-01-01\nThe activity of the ketolide ABT-773 against Haemophilus and Moraxella was compared to those of 11 other agents. Against 210 Haemophilus influenzae strains (39.0% beta-lactamase positive), microbroth dilution tests showed that azithromycin and ABT-773 had the lowest MICs (0.5 to 4.0 and 1.0 to 8.0 microg/ml, respectively), followed by clarithromycin and roxithromycin (4.0 to >32.0 microg/ml). Of the beta-lactams, ceftriaxone had the lowest MICs (32.0 microg/ml). Against 50 Moraxella catarrhalis strains, all of the compounds except amoxicillin and cefprozil were active. Time-kill studies against 10 H. influenzae strains showed that ABT-773, at two times the MIC, was bactericidal against 9 of 10 strains, with 99% killing of all strains at the MIC after 24 h; at 12 h, ABT-773 gave 90% killing of all strains at two times the MIC. At 3 and 6 h, killing by ABT-773 was slower, with 99.9% killing of four strains at two times the MIC after 6 h. Similar results were found for azithromycin, with slightly slower killing by erythromycin, clarithromycin, and roxithromycin, especially at earlier times. beta-Lactams were bactericidal against 8 to 10 strains at two times the MIC after 24 h, with slower killing at earlier time periods. Most compounds gave good killing of five M. catarrhalis strains, with beta-lactams killing more rapidly than other drugs. ABT-773 and azithromycin gave the longest postantibiotic effects (PAEs) of the ketolide-macrolide-azalide group tested (4.4 to >8.0 h), followed by clarithromycin, erythromycin, and roxithromycin. beta-Lactam PAEs were similar and shorter than those of the ketolide-macrolide-azalide group for all strains tested.\n[Crystal Structure of Homoserine Transacetylase from Haemophilus Influenzae Reveals a New Family of alpha/beta-Hydrolases](http://www.etde.org/etdeweb/details.jsp?query_id=1&page=0&osti_id=913920) [Energy Technology Data Exchange (ETDEWEB)](https://www.etde.org/etdeweb/fieldedsearch.jsp)\nMirza,I.; Nazi, I.; Korczynska, M.; Wright, G.; Berghuis, A.\n2005-01-01\nHomoserine transacetylase catalyzes one of the required steps in the biosynthesis of methionine in fungi and several bacteria. We have determined the crystal structure of homoserine transacetylase from Haemophilus influenzae to a resolution of 1.65 A. The structure identifies this enzyme to be a member of the alpha/beta-hydrolase structural superfamily. The active site of the enzyme is located near the end of a deep tunnel formed by the juxtaposition of two domains and incorporates a catalytic triad involving Ser143, His337, and Asp304. A structural basis is given for the observed double displacement kinetic mechanism of homoserine transacetylase. Furthermore, the properties of the tunnel provide a rationale for how homoserine transacetylase catalyzes a transferase reaction vs. hydrolysis, despite extensive similarity in active site architecture to hydrolytic enzymes.\n[CD4+ T-cell Responses Among Adults and Young Children In Response to Streptococcus pneumoniae and Haemophilus influenzae Vaccine Candidate Protein Antigens](https://www.openaire.eu/search/publication?articleId=od_______908::3708acad29fc53abc7e0d6b74de3b7d6)\nSharma, Sharad K.; Roumanes, David; Almudevar, Anthony; Mosmann, Tim R.; Pichichero, Michael E.\n2013-01-01\nWe characterized cytokine profiles of CD4+ T-helper (h) cells in adults and young children to ascertain if responses occur to next-generation candidate vaccine antigens PspA, PcpA, PhtD, PhtE, Ply, LytB of Streptococcus pneumonia (Spn) and Protein D and OMP26 of non-typeable Haemophilus influenzae (NTHi). Adults had vaccine antigen-specific Th1 - and Th2 cells responsive to all antigens evaluated whereas young children had significant numbers of vaccine antigen-specific CD4+ T cells producing...\n[Frequency of Streptococcus pneumonia and Haemophilus influenza in acute exacerbation of chronic obstructive airway disease and their sensitivity to levofloxacin](https://inis.iaea.orgsearchsinglerecord.aspx?recordsFor=SingleRecord&RN=45060391) [International Nuclear Information System (INIS) ](http://inis.iaea.org/search/)\nFurqan, S.; Paracha, S.A.U.\n2014-01-01\nObjective: To determine the frequency of Streptococcus pneumoniae and Haemophilus influenzae in acute exacerbation of chronic obstructive pulmonary disease and their sensitivity to levofloxacin. Methods: The cross-sectional study was conducted at the Department of Medicine, AbbasiShaheed Hospital, Karachi, between July 2009 and January 2010. Patients already diagnosed with chronic obstructive pulmonary disease and admitted with symptoms of acute exacerbation were included in the study and their sputum samples were sent for microbiological evaluation. SPSS 16 was used for statistical analysis. Results: Of the total 105 patients in the study, 90 (85.17%) were males. Overall mean age at presentation was 62+-10.2 years. S. pneumoniae was isolated from sputum culture of 33 (31.4%) patients, while 13 (12.4%) patients showed growth of H. influenzae. Out of the 33 sputum specimens of S. pneumoniae, 32 (97.0%) were sensitive to levofloxacin, while 1 (3.0%) was resistant. All the 13 isolates of H. influenzae were sensitive to levofloxacin. Conclusion: S. pneumoniae and H. influenzae are still the most prevalent organisms isolated in acute exacerbation of chronic obstructive pulmonary disease in our population. Levofloxacin is still considered a highly sensitive antibiotic against these common micro-organisms in our population, but S. pneumoniae has started developing resistance against levofloxacin. Therefore, intermittent surveillance regarding development of resistance pattern of common micro-organisms against commonly prescribed antibiotics is required. (author)\n[Inmunizaciones en la adolescencia](http://www.sciencedirect.com/science/article/pii/S0716864011703881) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nDr. V. Jacob Cohen\n2011-01-01\nSe agregan vacunas especiales en caso de viaje a zonas end\u00e9micas, como es el caso de rabia, encefalitis japonesa o fiebre amarilla; tema que no se incluye en este art\u00edculo, propio de la medicina del viajero, o tampoco el de aquellos con mayor susceptibilidad a infecciones espec\u00edficas como las vacunas anti neumoc\u00f3cica 23 valente, anti meningoc\u00f3cica no conjugada o anti Hemophilus influenza b (Ej., Aspl\u00e9nicos, Hipogamaglobulinemia, S. nefr\u00f3tico etc..\n[Frequency of Haemophilus spp. in urinary and and genital tract samples](http://www.ljkzedo.com.ba/medglasnik/vol71/MGvol71_10.pdf) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nTatjana Marijan,\n2010-02-01\nFull Text Available Aim To determine the prevalence and antibiotic susceptibility of Haemophilus influenzae and H. parainfluenzae isolated from the urinary and genital tracts. Methods Identification of strains bacteria Haemophilus spp. was carried out by using API NH identifi-cation system, and antibiotic susceptibility was performed by Kirby-Bauer disk diffusion method. Results A total number of 50 (0,03% H. influenzae and 14 (0,01% H. parainfluenzae (out of 180, 415 samples were isolated from genitourinary tract. From urine samples of the girls under 15 years of age these bacteria were isolated in 13 (0,88% and two (0,13% cases, respectively, and only in one case(0,11% of the UTI in boys (H. influenzae. In persons of fertile age, it was only H. influenzae bacteria that was found in urine samples of the five women (0,04% and in three men (0,22%. As a cause of vulvovaginitis, H. influenzae was isolated in four (5,63%, and H. parainfluenzae in two (2,82% girls. In persons of fertile age, H. influenzae was isolated from 10 (0,49% smears of the cervix, and in nine (1,74% male samples. H. parainfluenzae was isolated from seven (1,36% male samples. (p<0.01. Susceptibility testing of H. influenzae and H. parainfluenzae revealed that both pathogens were signifi- cantly resistant to cotrimoxasol only (26.0% and 42.9%, respectively. Conclusion In the etiology of genitourinary infections of girls during childhood, genital infections of women in fertile age (especially in pregnant women, and men with cases of epididimytis and/or orchitis,it is important to think about this rare and demanding bacteria in terms of cultivation.\n[Streptococcus pneumoniae and Haemophilus influenzae as etiological agents of conjunctivitis outbreaks in the region of Ribeir\u00e3o Preto, SP, Brazil](http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0036-46651998000100002) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nMarta I. C. MEDEIROS\n1998-01-01\nFull Text Available In the study of conjunctivitis outbreaks occurring from September 1994 to September 1996 in the region of Ribeir\u00e3o Preto, conjunctival exudates of 92 patients were cultivated in Instituto Adolfo Lutz Laboratory I, Ribeir\u00e3o Preto. Most cases occurred in the age range 2-7 years. The etiological agents which were most frequently isolated from the analyzed cases were: Streptococcus pneumoniae and Haemophilus influenzae, in 40.22% and 21.74%, respectively. 51.35% of the S. pneumoniae isolated strains were not typable. The oxacillin-resistant S. pneumoniae strains were submitted to the minimum inhibitory concentration test (MIC and three of them presented intermediate resistance, whereas only one was highly resistant to penicillin.No estudo de surtos de conjuntivite ocorridos no per\u00edodo de setembro de 1994 a setembro de 1996, na regi\u00e3o de Ribeir\u00e3o Preto, foram semeadas no Instituto Adolfo Lutz Laborat\u00f3rio I, Ribeir\u00e3o Preto, exsudatos conjuntivais de 92 pacientes, sendo que a maioria dos casos estava na faixa et\u00e1ria de 2-7 anos. Os agentes etiol\u00f3gicos mais freq\u00fcentemente isolados dos casos analisados foram: Streptococcus pneumoniae e Haemophilus influenzae em 40,22% e 21,74% respectivamente. 51,35% das cepas de S. pneumoniae isoladas foram n\u00e3o tip\u00e1veis. As cepas de S. pneumoniae oxacilina resistente foram submetidas ao teste de concentra\u00e7\u00e3o inibit\u00f3ria m\u00ednima (CIM, sendo que tr\u00eas apresentaram resist\u00eancia intermedi\u00e1ria e apenas uma foi altamente resistente \u00e0 penicilina.\nLlor Vila, Carles\n2005-01-01\nLa vacunaci\u00f3n antigripal, con m\u00e1s de 50 a\u00f1os de existencia, tiene una eficacia, una efectividad y una seguridad contrastadas, pero la respuesta inmunitaria oscila entre el 60 y el 90%, siendo algo menor en la poblaci\u00f3n anciana. Cl\u00e1sicamente se han utilizado las vacunas inactivadas trivalentes en las campa\u00f1as de vacunaci\u00f3n antigripal pero se considera que su aceptabilidad no es \u00f3ptima. Desde hace unos a\u00f1os se est\u00e1n investigando otros tipos de vacunas antigripales con el objetivo de mejorar su ...\n[Heavy-chain isotype patterns of human antibody-secreting cells induced by Haemophilus influenzae type b conjugate vaccines in relation to age and preimmunity](http://www.forskningsdatabasen.dk/en/catalog/2389066337) [DEFF Research Database (Denmark)](http://forskningsbasen.deff.dk/?lang=eng)\nBarington, T; Juul, Lars; Gyhrs, A\n1994-01-01\nThe influence of preexisting immunity on the heavy-chain isotypes of circulating antibody-secreting cells (AbSC) induced by vaccination with Haemophilus influenzae type b (Hib) capsular polysaccharide (HibCP) coupled to tetanus toxoid (TT) or diphtheria toxoid (DT) and by vaccination with TT or D...... of natural HibCP antibodies (r = 0.59; P = 0.00002). A possible role of natural exposure for Hib or cross-reactive bacteria on the mucosal surfaces in the shaping of the isotype response to HibCP conjugate vaccines is discussed....\n[Immunoglobulin G Avidities in Infants in Mexico after Primary Immunization with Three Doses of Polyribosylribitol Phosphate-Tetanus Toxoid Haemophilus influenzae Type b Vaccine\u25bf \u2020](https://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=2446616)\nG\u00f3mez-de-Le\u00f3n, Patricia; D\u00edaz-Garc\u00eda, F. Javier; Villase\u00f1or-Sierra, Alberto; Segura, Jorge; Carranza, Martha I.; Arredondo-Garcia, Jos\u00e9 Luis; Santos, Jos\u00e9 Ignacio\n2008-01-01\nSerum immunoglobulin G concentrations and avidities specific to Haemophilus influenzae type b (Hib) were measured in 208 children living in Guadalajara and Mexico City. Protective concentrations were found in 98.9% and 100.0% of participants, respectively. Geometric mean concentrations differed between both populations and/or among age groups. Mean avidities differed only among the 7- to 12-month-old children. Diphtheria-tetanus-whole-cell pertussis-hepatitis B-Hib primary vaccination seems to induce protection in Mexican children. PMID:18417667\n[A qualitative analysis of the beliefs of Japanese anti-influenza vaccination website authors.](https://www.ncbi.nlm.nih.gov/pubmed/29862370)\nOkuhara, Tsuyoshi; Ishikawa, Hirono; Kato, Mio; Okada, Masafumi; Kiuchi, Takahiro\n2018-04-01\nInfluenza vaccine coverage among the Japanese population is less than optimal. Anti-vaccination sentiment exists worldwide, and Japan is no exception. Anti-influenza vaccination activists argue on the internet that influenza vaccine has little or no efficacy and a high risk of side effects, and they warn that people should forgo vaccination. We conducted a qualitative analysis to explore beliefs underlying the messages of anti-influenza vaccination websites, by focusing on the perceived value these beliefs provide to those who hold them. We conducted online searches in January 2017 using two major Japanese search engines (Google Japan and Yahoo! Japan). Targeted websites were classified as \"pro\", \"anti\", or \"neutral\" depending on their claims. We applied a dual analytic approach-inductive thematic analysis and deductive interpretative analysis-to textual data of the anti websites. Of the 113 anti websites, we identified two themes that correspond to beliefs: it is necessary to 1) protect others against risks and exploitation related to influenza vaccination, and 2) educate others about hidden truths and self-determination. Authors of anti websites ascribed two values (people's \"safety\" and one's own \"self-esteem\") to their beliefs. Website authors may engage in anti-vaccination activities because they want to feel they are virtuous, saving people from harm caused by vaccination, and to boost their self-esteem, thinking \"I am enlightening uninformed people.\" The anti-vaccination beliefs of website authors were considered to be strong. In promoting vaccination, it would be better not to target outright vaccine refusers, such as the authors of anti-vaccination websites; it is preferable to target vaccine-hesitant people who are more amenable to changing their attitudes toward vaccination. We discuss possible means of promoting vaccination in that target population.\n[Origin of the diversity in DNA recognition domains in phasevarion associated modA genes of pathogenic Neisseria and Haemophilus influenzae.](https://www.ncbi.nlm.nih.gov/pubmed/22457715)\nGawthorne, Jayde A; Beatson, Scott A; Srikhanta, Yogitha N; Fox, Kate L; Jennings, Michael P\n2012-01-01\nPhase variable restriction-modification (R-M) systems have been identified in a range of pathogenic bacteria. In some it has been demonstrated that the random switching of the mod (DNA methyltransferase) gene mediates the coordinated expression of multiple genes and constitutes a phasevarion (phase variable regulon). ModA of Neisseria and Haemophilus influenzae contain a highly variable, DNA recognition domain (DRD) that defines the target sequence that is modified by methylation and is used to define modA alleles. 18 distinct modA alleles have been identified in H. influenzae and the pathogenic Neisseria. To determine the origin of DRD variability, the 18 modA DRDs were used to search the available databases for similar sequences. Significant matches were identified between several modA alleles and mod gene from distinct bacterial species, indicating one source of the DRD variability was via horizontal gene transfer. Comparison of DRD sequences revealed significant mosaicism, indicating exchange between the Neisseria and H. influenzae modA alleles. Regions of high inter- and intra-allele similarity indicate that some modA alleles had undergone recombination more frequently than others, generating further diversity. Furthermore, the DRD from some modA alleles, such as modA12, have been transferred en bloc to replace the DRD from different modA alleles.\n[A qualitative analysis of the beliefs of Japanese anti-influenza vaccination website authors](http://www.sciencedirect.com/science/article/pii/S2405844018305437) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nTsuyoshi Okuhara\n2018-04-01\nFull Text Available Background: Influenza vaccine coverage among the Japanese population is less than optimal. Anti-vaccination sentiment exists worldwide, and Japan is no exception. Anti-influenza vaccination activists argue on the internet that influenza vaccine has little or no efficacy and a high risk of side effects, and they warn that people should forgo vaccination. We conducted a qualitative analysis to explore beliefs underlying the messages of anti-influenza vaccination websites, by focusing on the perceived value these beliefs provide to those who hold them. Methods: We conducted online searches in January 2017 using two major Japanese search engines (Google Japan and Yahoo! Japan. Targeted websites were classified as \u201cpro\u201d, \u201canti\u201d, or \u201cneutral\u201d depending on their claims. We applied a dual analytic approach\u2014inductive thematic analysis and deductive interpretative analysis\u2014to textual data of the anti websites. Results: Of the 113 anti websites, we identified two themes that correspond to beliefs: it is necessary to 1 protect others against risks and exploitation related to influenza vaccination, and 2 educate others about hidden truths and self-determination. Authors of anti websites ascribed two values (people's \u201csafety\u201d and one's own \u201cself-esteem\u201d to their beliefs. Discussion: Website authors may engage in anti-vaccination activities because they want to feel they are virtuous, saving people from harm caused by vaccination, and to boost their self-esteem, thinking \u201cI am enlightening uninformed people.\u201d The anti-vaccination beliefs of website authors were considered to be strong. In promoting vaccination, it would be better not to target outright vaccine refusers, such as the authors of anti-vaccination websites; it is preferable to target vaccine-hesitant people who are more amenable to changing their attitudes toward vaccination. We discuss possible means of promoting vaccination in that target population. Keywords\n[A biphasic epigenetic switch controls immunoevasion, virulence and niche adaptation in non-typeable Haemophilus influenzae.](https://www.ncbi.nlm.nih.gov/pubmed/26215614)\nAtack, John M; Srikhanta, Yogitha N; Fox, Kate L; Jurcisek, Joseph A; Brockman, Kenneth L; Clark, Tyson A; Boitano, Matthew; Power, Peter M; Jen, Freda E-C; McEwan, Alastair G; Grimmond, Sean M; Smith, Arnold L; Barenkamp, Stephen J; Korlach, Jonas; Bakaletz, Lauren O; Jennings, Michael P\n2015-07-28\nNon-typeable Haemophilus influenzae contains an N(6)-adenine DNA-methyltransferase (ModA) that is subject to phase-variable expression (random ON/OFF switching). Five modA alleles, modA2, modA4, modA5, modA9 and modA10, account for over two-thirds of clinical otitis media isolates surveyed. Here, we use single molecule, real-time (SMRT) methylome analysis to identify the DNA-recognition motifs for all five of these modA alleles. Phase variation of these alleles regulates multiple proteins including vaccine candidates, and key virulence phenotypes such as antibiotic resistance (modA2, modA5, modA10), biofilm formation (modA2) and immunoevasion (modA4). Analyses of a modA2 strain in the chinchilla model of otitis media show a clear selection for ON switching of modA2 in the middle ear. Our results indicate that a biphasic epigenetic switch can control bacterial virulence, immunoevasion and niche adaptation in an animal model system.\n[Vaccination for the control of childhood bacterial pneumonia - Haemophilus influenzae type b and pneumococcal vaccines](https://pneumonia.org.au/index.php/pneumonia/article/view/229) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nDiana C Otczyk\n2013-01-01\nFull Text Available Pneumonia in childhood is endemic in large parts of the world and in particular, in developing countries, as well as in many indigenous communities within developed nations. Haemophilus influenzae type b and Streptococcus pneumoniae conjugate vaccines are currently available against the leading bacterial causes of pneumonia. The use of the vaccines in both industrialised and developing countries have shown a dramatic reduction in the burden of pneumonia and invasive disease in children. However, the greatest threat facing pneumococcal conjugate vaccine effectiveness is serotype replacement. The current vaccines provide serotype-specific, antibody\u2013mediated protection against only a few of the 90+ capsule serotypes. Therefore, there has been a focus in recent years to rapidly advance technologies that will result in broader disease coverage and more affordable vaccines that can be used in developing countries. The next generation of pneumococcal vaccines have advanced to clinical trials.\n[Spontaneous Subconjunctival Abscess Because of Haemophilus influenzae](http://www.dtic.mil/docs/citations/ADA629393)\n2010-07-01\nany recent sexually transmitted diseases, vaginal discharge, or sores. Her past medical history included mild seasonal allergies and no history of...culture confirmed a nontypeable strain of H. influenzae. DISCUSSION H. influenzae is a small aerobic Gram-negative cocco- bacillus found mainly in the\n[Crystal Structures of Active Fully Assembled Substrate- and Product-Bound Complexes of UDP-N-Acetylmuramic Acid:l-Alanine Ligase (MurC) from Haemophilus influenzae](https://www.openaire.eu/search/publication?articleId=od_______908::aa788c15a0ee42c8e6bf39ba0bc758e5)\nMol, Clifford D.; Brooun, Alexei; Dougan, Douglas R.; Hilgers, Mark T.; Tari, Leslie W.; Wijnands, Robert A.; Knuth, Mark W.; McRee, Duncan E.; Swanson, Ronald V.\n2003-01-01\nUDP-N-acetylmuramic acid:l-alanine ligase (MurC) catalyzes the addition of the first amino acid to the cytoplasmic precursor of the bacterial cell wall peptidoglycan. The crystal structures of Haemophilus influenzae MurC in complex with its substrate UDP-N-acetylmuramic acid (UNAM) and Mg2+ and of a fully assembled MurC complex with its product UDP-N-acetylmuramoyl-l-alanine (UMA), the nonhydrolyzable ATP analogue AMPPNP, and Mn2+ have been determined to 1.85- and 1.7-\u00c5 resolution, respective...\n[Long-term persistence of immunity and B-cell memory following Haemophilus influenzae type B conjugate vaccination in early childhood and response to booster.](https://www.ncbi.nlm.nih.gov/pubmed/24403544)\nPerrett, K P; John, T M; Jin, C; Kibwana, E; Yu, L-M; Curtis, N; Pollard, A J\n2014-04-01\nProtection against Haemophilus influenzae type b (Hib), a rapidly invading encapsulated bacteria, is dependent on maintenance of an adequate level of serum antibody through early childhood. In many countries, Hib vaccine booster doses have been implemented after infant immunization to sustain immunity. We investigated the long-term persistence of antibody and immunological memory in primary-school children following infant (with or without booster) Hib vaccination. Anti-polyribosylribitol phosphate (PRP) immunoglobulin G (IgG) concentration and the frequency of circulating Hib-specific memory B cells were measured before a booster of a Hib-serogroup C meningococcal (MenC) conjugate vaccine and again 1 week, 1 month, and 1 year after the booster in 250 healthy children aged 6-12 years in an open-label phase 4 clinical study. Six to 12 years following infant priming with 3 doses of Hib conjugate vaccine, anti-PRP IgG geometric mean concentrations were 3.11 \u00b5g/mL and 0.71 \u00b5g/mL and proportions with anti-PRP IgG \u22651.0 \u00b5g/mL were 79% and 43% in children who had or had not, respectively, received a fourth Hib conjugate vaccine dose (mean age, 3.9 years). Higher baseline and post-Hib-MenC booster responses (anti-PRP IgG and memory B cells) were found in younger children and in those who had received a fourth Hib dose. Sustained Hib conjugate vaccine-induced immunity in children is dependent on time since infant priming and receipt of a booster. Understanding the relationship between humoral and cellular immunity following immunization with conjugate vaccines may direct vaccine design and boosting strategies to sustain individual and population immunity against encapsulated bacteria in early childhood. Clinical Trials Registration ISRCTN728588998.\n[Polyarteritis nodosa related with influenza vaccine = Poliarteritis nodosa relacionada con vacuna contra la influenza](http://www.iatreia.udea.edu.co/index.php/iatreia/article/view/13644/12135) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nRestrepo Escobar, Mauricio\n2013-01-01\nFull Text Available Vasculitis can be secondary to various processes, among them infections, malignancies, connective tissue diseases or medications, or primary, generally idiopathic. The reported adverse events after vaccination can be mild and transient or more serious such as autoimmune diseases. Possibly the most frequently described autoimmune phenomena after influenza vaccination are different forms of vasculitis. We report the case of a patient who presented a clinical picture of vasculitis classified as polyarteritis nodosa that began two weeks after receiving the influenza vaccine. After critically reviewing the literature, this would be the first clearly documented case of polyarteritis nodosa associated with vaccination against influenza.\n[Nontypeable Haemophilus influenzae in chronic obstructive pulmonary disease and lung cancer](http://www.dovepress.com/nontypeable-haemophilus-influenzae-in-chronic-obstructive-pulmonary-di-a6156) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nSeyed Javad Moghaddam\n2011-01-01\nFull Text Available Seyed Javad Moghaddam1, Cesar E Ochoa1,2, Sanjay Sethi3, Burton F Dickey1,41Department of Pulmonary Medicine, the University of Texas MD Anderson Cancer Center, Houston, TX, USA; 2Tecnol\u00f3gico de Monterrey School of Medicine, Monterrey, Nuevo Le\u00f3n, Mexico; 3Department of Medicine, University at Buffalo, State University of New York, Buffalo, NY, USA; 4Center for Inflammation and Infection, Institute of Biosciences and Technology, Texas A&M Health Science Center, Houston, TX, USAAbstract: Chronic obstructive pulmonary disease (COPD is predicted to become the third leading cause of death in the world by 2020. It is characterized by airflow limitation that is not fully reversible. The airflow limitation is usually progressive and associated with an abnormal inflammatory response of the lungs to noxious particles and gases, most commonly cigarette smoke. Among smokers with COPD, even following withdrawal of cigarette smoke, inflammation persists and lung function continues to deteriorate. One possible explanation is that bacterial colonization of smoke-damaged airways, most commonly with nontypeable Haemophilus influenzae (NTHi, perpetuates airway injury and inflammation. Furthermore, COPD has also been identified as an independent risk factor for lung cancer irrespective of concomitant cigarette smoke exposure. In this article, we review the role of NTHi in airway inflammation that may lead to COPD progression and lung cancer promotion.Keywords: COPD, NTHi, inflammation\n[[Optimized isolation and purification of non-typeable Haemophilus influenzae Haps protein].](https://www.ncbi.nlm.nih.gov/pubmed/18159010)\nLi, Wan-yi; Kuang, Yu; Li, Ming-yuan; Yang, Yuan; Jiang, Zhong-hua; Yao, Feng; Chen, Chang-chun\n2007-12-01\nTo optimize the isolation and purification conditions for Hap(s) protein of non-typeable Haemophilus influenzae. Hap(s) protein was purified by ammonium sulfate precipitation, dialysis desalting and Hitrap weak cation exchange columns of CM Sepharose Fast Flow. The condition of the elution was optimized for pH and ionic strength, the absorbance at 280 nm of the elution samples were detected, and the targeted protein band in the collected samples was observed by SDS-PAGE electrophoresis. The Hitrap ion exchange column was eluted with buffer 1, which resulted in a baseline distribution of absorbance at 280 nm. Buffer 2 elution of the column resulted in the presence of peak absorbance with trails, which was identified to be constituted by some low molecular weight bands by subsequent SDS-PAGE. In serial column elution with buffer 3 with different ionic strength, a peak absorbance was observed with the ionic strength of 100 mmol/L NaCl, and SDS-PAGE confirmed that the peak was generated by the target protein. No obvious peaks or bands in SDS-PAGE occurred with the other ionic strengths. The pH of the buffer only affect the elution of the irrelevant proteins rather than the Hap(s) protein, and elution with the buffer containing 100 mmol/L NaCl can be optimal for eluting the Hap(s) protein.\n[Mutation of Haemophilus influenzae transforming DNA in vitro with near-ultraviolet radiation: action spectrum](https://www.osti.gov/etdeweb/biblio/7137387) [Energy Technology Data Exchange (ETDEWEB)](https://www.etde.org/etdeweb/fieldedsearch.jsp)\nCabrera-Juarez, E; Setlow, J K [Escuela Nacional de Ciencias Biologicas, Mexico City. Dept. de Bioquimica; Oak Ridge National Lab., Tenn. (USA). Biology Div.)\n1976-05-01\nMutations were produced in purified transforming DNA from Haemophilus influenzae by near UV radiation and were assayed as mutants among cells transformed with irradiated DNA. The maximum efficiency of mutation induction was at around 334 nm, and the efficiency dropped off steeply at lower and higher wavelengths. The difference between the action spectrum for mutation and that for the oxygen-independent inactivation of transforming DNA, which had a shoulder at 365 nm, indicates that there are different lesions involved in the inactivating and mutagenic effects of near-UV. The presence of histidine during irradiation enhanced the mutagenic effect at 334 and 365 nm, although it protected against inactivation at 365 nm. The effective near-UV wavelengths for in vitro mutation are to some extent the same as the effective wavelengths for mutation in vivo reported previously. These findings indicate that mutations are produced in vivo by near-UV with DNA as the primary target molecule rather than by a secondary non-photochemical reaction between DNA and some other cell component.\n[Immunogenicity of a 2-dose priming and booster vaccination with the 10-valent pneumococcal nontypeable Haemophilus influenzae protein D conjugate vaccine](http://www.forskningsdatabasen.dk/en/catalog/18955081) [DEFF Research Database (Denmark)](http://forskningsbasen.deff.dk/?lang=eng)\nSilfverdal, Sven Arne; H\u00f8gh, Birthe; Bergsaker, Marianne Riise\n2009-01-01\nBACKGROUND: The immunogenicity of the 10-valent pneumococcal nontypeable Haemophilus influenzae protein D-conjugate vaccine (PHiD-CV) was determined following a simplified 2-dose priming and the more commonly employed 3-dose priming both followed by a booster dose. METHODS: A total of 351 healthy....... RESULTS: Depending on the serotype, the percentages of subjects reaching the ELISA antibody threshold of 0.2 microg/mL were 92.8% to 98.0% following 2 primary doses and 96.1% to 100% following 3 primary doses except for serotype 6B (55.7% and 63.1%, respectively) and serotype 23F (69.3% and 77...\n[Los laboratorios p\u00fablicos productores de vacunas: el nuevo paradigma](http://www.scielosp.org/scielo.php?script=sci_arttext&pid=S1020-49891998001000001&lng=en&tlng=en) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nAkira Homma\nFull Text Available Los laboratorios p\u00fablicos productores de vacunas de Am\u00e9rica Latina y el Caribe han contribuido en diferente grado al control y a la erradicaci\u00f3n de las enfermedades prevenibles por vacunaci\u00f3n y varios est\u00e1n produciendo las vacunas que se aplican rutinariamente en los programas nacionales de inmunizaci\u00f3n, como la vacuna antituberculosa (a base del bacilo de Calmette-Gu\u00e9rin, BCG, la vacuna contra difteria-t\u00e9tanos-pertussis (DTP, el toxoide tet\u00e1nico (TT, la vacuna antisarampionosa y la vacuna antipoliomiel\u00edtica oral. Gracias a los adelantos cient\u00edficos recientes, se prev\u00e9 un aumento importante del n\u00famero de vacunas seguras y eficaces que estar\u00e1n disponibles en un futuro cercano para uso en los programas normales de vacunaci\u00f3n. Sin embargo, los gastos asociados con el desarrollo de estas vacunas y con los derechos de propiedad intelectual que las protegen son cuantiosos. Adem\u00e1s, pocos laboratorios en Am\u00e9rica Latina poseen la capacidad t\u00e9cnica para investigar y elaborar estas vacunas. Tales factores tendr\u00e1n un impacto en la celeridad con que se incorporar\u00e1n en los esquemas de vacunaci\u00f3n de los pa\u00edses de la Regi\u00f3n. En la actualidad, los laboratorios p\u00fablicos productores de vacunas de la Regi\u00f3n no est\u00e1n capacitados para competir en este nuevo contexto y corren el riesgo de ser desplazados del mercado por completo. De ah\u00ed la necesidad de que cambien radicalmente su manejo gerencial y su capacidad cientificot\u00e9cnica, lo cual exige que los gobiernos se comprometan a mejorar y fortalecer aquellos aspectos pol\u00edticos y financieros que garanticen la participaci\u00f3n de los laboratorios nacionales en el suministro sostenible de vacunas a los programas de vacunaci\u00f3n, as\u00ed como en la investigaci\u00f3n, desarrollo y producci\u00f3n de vacunas nuevas\n[Multiplex quantitative PCR for detection of lower respiratory tract infection and meningitis caused by Streptococcus pneumoniae, Haemophilus influenzae and Neisseria meningitidis.](https://www.ncbi.nlm.nih.gov/pubmed/21129171)\nAbdeldaim, Guma M K; Str\u00e5lin, Kristoffer; Korsgaard, Jens; Blomberg, Jonas; Welinder-Olsson, Christina; Herrmann, Bj\u00f6rn\n2010-12-03\nStreptococcus pneumoniae and Haemophilus influenzae cause pneumonia and as Neisseria meningitidis they are important agents of meningitis. Although several PCR methods have been described for these bacteria the specificity is an underestimated problem. Here we present a quantitative multiplex real-time PCR (qmPCR) for detection of S. pneumoniae (9802 gene fragment), H. influenzae (omp P6 gene) and N. meningitidis (ctrA gene). The method was evaluated on bronchoalveolar lavage (BAL) samples from 156 adults with lower respiratory tract infection (LRTI) and 31 controls, and on 87 cerebrospinal fluid (CSF) samples from meningitis patients. The analytical sensitivity was not affected by using a combined mixture of reagents and a combined DNA standard (S. pneumoniae/H. influenzae/N. meningitidis) in single tubes. By blood- and BAL-culture and S. pneumoniae urinary antigen test, S. pneumoniae and H. influenzae were aetiological agents in 21 and 31 of the LTRI patients, respectively. These pathogens were identified by qmPCR in 52 and 72 of the cases, respectively, yielding sensitivities and specificities of 95% and 75% for S. pneumoniae, and 90% and 65% for H. influenzae, respectively. When using a cut-off of 10\u2075 genome copies/mL for clinical positivity the sensitivities and specificities were 90% and 80% for S. pneumoniae, and 81% and 85% for H. influenzae, respectively. Of 44 culture negative but qmPCR positive for H. influenzae, 41 were confirmed by fucK PCR as H. influenzae. Of the 103 patients who had taken antibiotics prior to sampling, S. pneumoniae and H. influenzae were identified by culture in 6% and 20% of the cases, respectively, and by the qmPCR in 36% and 53% of the cases, respectively.In 87 CSF samples S. pneumoniae and N. meningitidis were identified by culture and/or 16 S rRNA in 14 and 10 samples and by qmPCR in 14 and 10 samples, respectively, giving a sensitivity of 100% and a specificity of 100% for both bacteria. The PCR provides increased\n[Multiplex quantitative PCR for detection of lower respiratory tract infection and meningitis caused by Streptococcus pneumoniae, Haemophilus influenzae and Neisseria meningitidis](http://www.biomedcentral.com/1471-2180/10/310) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nWelinder-Olsson Christina\n2010-12-01\nFull Text Available Abstract Background Streptococcus pneumoniae and Haemophilus influenzae cause pneumonia and as Neisseria meningitidis they are important agents of meningitis. Although several PCR methods have been described for these bacteria the specificity is an underestimated problem. Here we present a quantitative multiplex real-time PCR (qmPCR for detection of S. pneumoniae (9802 gene fragment, H. influenzae (omp P6 gene and N. meningitidis (ctrA gene. The method was evaluated on bronchoalveolar lavage (BAL samples from 156 adults with lower respiratory tract infection (LRTI and 31 controls, and on 87 cerebrospinal fluid (CSF samples from meningitis patients. Results The analytical sensitivity was not affected by using a combined mixture of reagents and a combined DNA standard (S. pneumoniae/H. influenzae/N. meningitidis in single tubes. By blood- and BAL-culture and S. pneumoniae urinary antigen test, S. pneumoniae and H. influenzae were aetiological agents in 21 and 31 of the LTRI patients, respectively. These pathogens were identified by qmPCR in 52 and 72 of the cases, respectively, yielding sensitivities and specificities of 95% and 75% for S. pneumoniae, and 90% and 65% for H. influenzae, respectively. When using a cut-off of 105 genome copies/mL for clinical positivity the sensitivities and specificities were 90% and 80% for S. pneumoniae, and 81% and 85% for H. influenzae, respectively. Of 44 culture negative but qmPCR positive for H. influenzae, 41 were confirmed by fucK PCR as H. influenzae. Of the 103 patients who had taken antibiotics prior to sampling, S. pneumoniae and H. influenzae were identified by culture in 6% and 20% of the cases, respectively, and by the qmPCR in 36% and 53% of the cases, respectively. In 87 CSF samples S. pneumoniae and N. meningitidis were identified by culture and/or 16 S rRNA in 14 and 10 samples and by qmPCR in 14 and 10 samples, respectively, giving a sensitivity of 100% and a specificity of 100% for both\n[Unexpected effects of absorbed normal rabbit serum and bovine serum albumin on survival of Haemophilus influenzae type b in the infant rat.](https://www.ncbi.nlm.nih.gov/pubmed/3264378)\nLoeb, M R\n1988-01-01\nIn the course of using the infant rat model to determine the ability of various rabbit antisera to protect against challenge by Haemophilus influenzae type b we made two unexpected observations. In these experiments 4-day-old rats were inoculated s.c. on the dorsum with either rabbit serum or physiological buffers (sham serum) and then were challenged the next day with H. influenzae type b injected i.p. Bacteremia, as a marker for disease, was measured 24 h later on day 6. We observed the following. (i) Pre-immune, i.e., normal rabbit serum, containing minimal levels of antibodies to outer membrane proteins and depleted of antibodies to capsule and lipopolysaccharide, nevertheless significantly (P less than 0.01) protected the rats from challenge with H. influenzae type b when compared to a sham inoculation of buffer; (ii) In the absence of a serum inoculation on day 4 (a buffer was used as a sham serum inoculation), the levels of bacteremia obtained after inoculation with bacteria on day 5 depended upon the composition of the buffer in which the H. influenzae inoculum was suspended. Use of phosphate buffered saline (PBS) resulted in higher levels of bacteremia than PBS containing 0.5% bovine serum albumin (PBS-BSA) (P less than 0.001), i.e. the BSA apparently acted to protect the rats from H. influenzae infection. In fact the use of PBS-BSA as an inoculum buffer masked the protective effect noted above of the absorbed normal rabbit serum.\n[Antimicrobial resistance in Streptococcus pneumoniae, Haemophilus influenzae, Moraxella catarrhalis and group A beta-haemolytic streptococci in 2002-2003. Results of the multinational GRASP Surveillance Program](http://www.forskningsdatabasen.dk/en/catalog/51196562) [DEFF Research Database (Denmark)](http://forskningsbasen.deff.dk/?lang=eng)\nBeekmann, Susan E; Heilmann, Kris P; Richter, Sandra S\n2005-01-01\nA multinational surveillance study, GRASP, was conducted between November 2002 and April 2003 with the aim of assessing rates of antimicrobial resistance among 2656 isolates of Streptococcus pneumoniae, 2486 isolates of group A beta-haemolytic streptococci, 1358 isolates of Haemophilus influenzae...... and 1047 of Moraxella catarrhalis from 20 countries in Europe, eastern Asia and southern Africa. Conspicuous differences between various countries were noted in the S. pneumoniae resistance rates observed for penicillin (0-79.2%) and erythromycin (4-66%), along with other antimicrobials. The percentage...... of MDR strains was above 25% in 8 of the 20 countries studied. Group A streptococcal macrolide resistance rates ranged from 0% to 35% by country, while rates of beta-lactamase production ranged from 0% to 39% for H. influenzae and 80-100% for M. catarrhalis. Antibiotic resistance in S. pneumoniae remains...\n[H3N2 influenza infection elicits more cross-reactive and less clonally expanded anti-hemagglutinin antibodies than influenza vaccination.](http://europepmc.org/articles/PMC3198447?pdf=render) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nM Anthony Moody\nFull Text Available BACKGROUND: During the recent H1N1 influenza pandemic, excess morbidity and mortality was seen in young but not older adults suggesting that prior infection with influenza strains may have protected older subjects. In contrast, a history of recent seasonal trivalent vaccine in younger adults was not associated with protection. METHODS AND FINDINGS: To study hemagglutinin (HA antibody responses in influenza immunization and infection, we have studied the day 7 plasma cell repertoires of subjects immunized with seasonal trivalent inactivated influenza vaccine (TIV and compared them to the plasma cell repertoires of subjects experimentally infected (EI with influenza H3N2 A/Wisconsin/67/2005. The majority of circulating plasma cells after TIV produced influenza-specific antibodies, while most plasma cells after EI produced antibodies that did not react with influenza HA. While anti-HA antibodies from TIV subjects were primarily reactive with single or few HA strains, anti-HA antibodies from EI subjects were isolated that reacted with multiple HA strains. Plasma cell-derived anti-HA antibodies from TIV subjects showed more evidence of clonal expansion compared with antibodies from EI subjects. From an H3N2-infected subject, we isolated a 4-member clonal lineage of broadly cross-reactive antibodies that bound to multiple HA subtypes and neutralized both H1N1 and H3N2 viruses. This broad reactivity was not detected in post-infection plasma suggesting this broadly reactive clonal lineage was not immunodominant in this subject. CONCLUSION: The presence of broadly reactive subdominant antibody responses in some EI subjects suggests that improved vaccine designs that make broadly reactive antibody responses immunodominant could protect against novel influenza strains.\n[Recurrent meningitis due to pneumococci and non-typable Haemophilus influenzae in a child with a Mondini malformation.](https://www.ncbi.nlm.nih.gov/pubmed/3485576)\nValmari, P; Palva, A\n1986-01-01\nAn eight-year-old boy with a congenital inner ear malformation and recurrent otitis media had three episodes of bacteriologically confirmed meningitis within seven months. The first episode was caused by pneumococci, the other two by non-typable Haemophilus influenzae. All episodes were characterized by an abrupt onset. The CSF cultures were positive within 0.5 to 12 hours after the onset of symptoms. Despite misleading laboratory studies, surgical exploration revealed a CSF fistula associated to the inner ear anomaly. No further episodes occurred after the fistula was closed. Careful roentgenographic evaluation, including recently introduced special computed tomography (CT) methods, is indicated in recurrent meningitis. In addition, such evaluations should be considered even after the first episode, when special clinical features suggest a CSF fistula. Such features include an extremely rapid onset and detection of common non-invasive bacteria as causative agents, as illustrated by the present case.\n[Nontypeable Haemophilus influenzae induces sustained lung oxidative stress and protease expression.](http://europepmc.org/articles/PMC4368769?pdf=render) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nPaul T King\nFull Text Available Nontypeable Haemophilus influenzae (NTHi is a prevalent bacterium found in a variety of chronic respiratory diseases. The role of this bacterium in the pathogenesis of lung inflammation is not well defined. In this study we examined the effect of NTHi on two important lung inflammatory processes 1, oxidative stress and 2, protease expression. Bronchoalveolar macrophages were obtained from 121 human subjects, blood neutrophils from 15 subjects, and human-lung fibroblast and epithelial cell lines from 16 subjects. Cells were stimulated with NTHi to measure the effect on reactive oxygen species (ROS production and extracellular trap formation. We also measured the production of the oxidant, 3-nitrotyrosine (3-NT in the lungs of mice infected with this bacterium. NTHi induced widespread production of 3-NT in mouse lungs. This bacterium induced significantly increased ROS production in human fibroblasts, epithelial cells, macrophages and neutrophils; with the highest levels in the phagocytic cells. In human macrophages NTHi caused a sustained, extracellular production of ROS that increased over time. The production of ROS was associated with the formation of macrophage extracellular trap-like structures which co-expressed the protease metalloproteinase-12. The formation of the macrophage extracellular trap-like structures was markedly inhibited by the addition of DNase. In this study we have demonstrated that NTHi induces lung oxidative stress with macrophage extracellular trap formation and associated protease expression. DNase inhibited the formation of extracellular traps.\n[Registro de ensayos con vacunas del Programa Mundial de Vacunas e Inmunizaci\u00f3n de la OMS](http://www.scielosp.org/scielo.php?script=sci_arttext&pid=S1020-49891998001000006) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nRobertson S. E.\n1998-01-01\nFull Text Available En 1995, el Programa Mundial de Vacunas e Inmunizaci\u00f3n de la OMS estableci\u00f3 un registro para ensayos con vacunas. En septiembre de 1996, este registro conten\u00eda 50 ensayos de vacunaci\u00f3n patrocinados por la OMS, de los cuales 25 (50% eran estudios ya terminados. Las vacunas que se hab\u00edan estudiado con mayor frecuencia fueron las de sarampi\u00f3n (9 ensayos, poliovirus (8 ensayos, c\u00f3lera (8 ensayos, Escherichia coli enterotox\u00edgena (4 ensayos y neumococo (4 ensayos. Casi 80% de estos ensayos se llevaron a cabo en pa\u00edses en desarrollo, principalmente en el \u00c1frica. En los 25 ensayos ya terminados, los resultados investigados fueron la respuesta inmunitaria (24 ensayos, las reacciones adversas (13 ensayos, la morbilidad (4 ensayos y la mortalidad (1 ensayo. La OMS contribuy\u00f3 a estos ensayos con el aporte indirecto de fondos, ayuda con el dise\u00f1o metodol\u00f3gico, visitas a las localidades, el an\u00e1lisis de los datos, la adquisici\u00f3n de vacunas y la investigaci\u00f3n de su potencia.\n[Non-epitope-specific suppression of the antibody response to Haemophilus influenzae type b conjugate vaccines by preimmunization with vaccine components](http://www.forskningsdatabasen.dk/en/catalog/2389066513) [DEFF Research Database (Denmark)](http://forskningsbasen.deff.dk/?lang=eng)\nBarington, T; Skettrup, M; Juul, L\n1993-01-01\nchildren and adults. Despite its potential importance, the possible influence of preexisting immunity to the components of such conjugates on the vaccination response in humans has been addressed by few studies. To study this issue, we randomized 82 healthy adult volunteers into six groups and vaccinated......Recently, conjugate vaccines containing Haemophilus influenzae type b capsular polysaccharide (HibCP) coupled to protein carriers were introduced for use in infants and certain adult risk groups. Similar conjugate vaccines against other capsulated bacteria are currently under development for both......CP-TT, P = 0.00002; HibCP-TT and then HibCP-DT, P = 0.06) as well as to HibCP itself. Possible mechanisms behind this non-epitope-specific suppression and its relevance for vaccine development are discussed....\n[Vacuna contra el VPH (HPV Vaccine)](https://www2c.cdc.gov/podcasts/player.asp?f=8630175) [Centers for Disease Control (CDC) Podcasts](http://www2c.cdc.gov/podcasts/search.asp)\n2013-07-25\nDesde el 2006, hay una vacuna que protege contra los tipos de VPH que causan c\u00c3\u00a1ncer con mayor frecuencia. Este podcast habla sobre la importancia de que los padres hablen con los proveedores de atenci\u00c3\u00b3n m\u00c3\u00a9dica de sus hijos sobre ponerles la vacuna contra el VPH. Created: 7/25/2013 by MMWR. Date Released: 11/4/2013.\n[Epidemiology of paediatric meningitis in central C\u00f4te d'Ivoire after the implementation of Haemophilus influenzae type b vaccination.](https://www.ncbi.nlm.nih.gov/pubmed/28513815)\nTour\u00e9, Fid\u00e8le S; Kouame, Samson; Tia, Honor\u00e9; Monemo, Pac\u00f4me; Ciss\u00e9, Amadou; Dian\u00e9, Bamourou; Becker, S\u00f6ren L; Akoua-Koffi, Chantal\n2017-07-01\nInfectious meningitis accounts for enormous morbidity worldwide, but there is a paucity of data on its regional epidemiology in resource-constrained settings of sub-Saharan Africa. Here, we present a study on the aetiology of paediatric meningitis in central C\u00f4te d'Ivoire. Between June 2012 and December 2013, all cerebrospinal fluid (CSF) samples drawn at the University Teaching Hospital Bouak\u00e9 were examined for the presence of bacterial and fungal pathogens. A causative agent was detected in 31 out of 833 CSF specimens (3.7%), with the most prevalent pathogens being Streptococcus pneumoniae (n=15) and Neisseria meningitidis (n=5). With the exception of neonates, these two bacteria were the most common agents in all age groups. Of note, only a single case of Haemophilus influenzae meningitis was detected. Hence, this study reports a considerable shift in the epidemiology of paediatric meningitis in central C\u00f4te d'Ivoire. Following the implementation of a nation-wide childhood vaccination programme against H. influenzae type b, this pathogen was much less frequently reported than in previous studies. The integration of specific vaccines against S. pneumoniae and N. meningitidis into the childhood vaccination programme in C\u00f4ted'Ivoire holds promise to further reduce the burden due to infectious meningitis.\n[Safety and reactogenicity of the combined diphtheria-tetanus-acellular pertussis-inactivated poliovirus-Haemophilus influenzae type b (DTPa-IPV/Hib) vaccine in healthy Vietnamese toddlers: An open-label, phase III study.](https://www.ncbi.nlm.nih.gov/pubmed/26337197)\nAnh, Dang Duc; Van Der Meeren, Olivier; Karkada, Naveen; Assudani, Deepak; Yu, Ta-Wen; Han, Htay Htay\n2016-03-03\nThe introduction of combination vaccines plays a significant role in increasing vaccine acceptance and widening vaccine coverage. Primary vaccination against diphtheria, tetanus, pertussis, poliomyelitis and Haemophilus influenza type b (Hib) diseases has been implemented in Vietnam. In this study we evaluated the safety and reactogenicity of combined diphtheria-tetanus-pertussis-inactivated polio (DTPa-IPV)/Hib vaccine when administered as a booster dose in 300 healthy Vietnamese children Vietnamese children aged <2 years.\n[Immunogenicity and safety of two doses of catch-up immunization with Haemophilus influenzae type b conjugate vaccine in Indian children living with HIV.](https://www.ncbi.nlm.nih.gov/pubmed/26988256)\nArya, Bikas K; Bhattacharya, Sangeeta Das; Sutcliffe, Catherine G; Saha, Malay K; Bhattacharyya, Subhasish; Niyogi, Swapan Kumar; Moss, William J; Panda, Samiran; Das, Ranjan Saurav; Mallick, Mausom; Mandal, Sutapa\n2016-04-27\nChildren living with HIV are at increased risk of disease from Haemophilus influenzae type b (Hib). Data are limited on the immunogenicity of a two-dose, catch-up schedule for Hib conjugate vaccine (HibCV) among HIV-infected children accessing antiretroviral therapy (ART) late. The objectives of the study were to: (1) evaluate baseline immunity to Hib and the immunogenicity and safety of two doses of HibCV among HIV-infected Indian children; and (2) document the threshold antibody level required to prevent Hib colonization among HIV-infected children following immunization. We conducted a prospective cohort study among HIV-infected children 2-15 years of age and HIV-uninfected children 2-5 years of age. HIV-infected children received two doses of HibCV and uninfected children received one. Serum anti-Hib PRP IgG antibodies were measured at baseline and two months after immunization in the HIV-infected children. Nasopharyngeal (NP) swabs were collected at baseline and follow-up. 125 HIV-infected and 44 uninfected children participated. 40% of HIV-infected children were receiving ART and 26% had a viral load >100,000 copies/mL. The geometric mean concentration of serum anti-Hib PRP antibody increased from 0.25 \u03bcg/mL at baseline to 2.65 \u03bcg/mL after two doses of HibCV, representing a 10.6-fold increase (pchildren mounted an immune response. Moderate or severe immune suppression, trimethoprim/sulfamethoxazole prophylaxis, and lower baseline antibody levels were associated with lower post-vaccine serum anti-Hib PRP IgG antibodies. A serum anti-Hib PRP IgG antibody level \u2265 3.3 \u03bcg/mL was protective against Hib NP colonization. There were no differences in adverse events between HIV-infected and uninfected children. Including a catch-up immunization schedule for older HIV infected children in countries introducing Hib vaccines is important. Older HIV-infected children with delayed access to ART and without suppressed viral loads mounted an adequate immune response\n[Characterization of the N-Acetyl-5-neuraminic Acid-binding Site of the Extracytoplasmic Solute Receptor (SiaP) of Nontypeable Haemophilus influenzae Strain 2019](http://www.etde.org/etdeweb/details.jsp?query_id=1&page=0&osti_id=1033769) [Energy Technology Data Exchange (ETDEWEB)](https://www.etde.org/etdeweb/fieldedsearch.jsp)\nJohnston, Jason W.; Coussens, Nathan P.; Allen, Simon; Houtman, Jon C.D.; Turner, Keith H.; Zaleski, Anthony; Ramaswamy, S.; Gibson, Bradford W.; Apicella, Michael A. (Iowa); (Buck Inst.)\n2012-11-14\nNontypeable Haemophilus influenzae is an opportunistic human pathogen causing otitis media in children and chronic bronchitis and pneumonia in patients with chronic obstructive pulmonary disease. The outer membrane of nontypeable H. influenzae is dominated by lipooligosaccharides (LOS), many of which incorporate sialic acid as a terminal nonreducing sugar. Sialic acid has been demonstrated to be an important factor in the survival of the bacteria within the host environment. H. influenzae is incapable of synthesizing sialic acid and is dependent on scavenging free sialic acid from the host environment. To achieve this, H. influenzae utilizes a tripartite ATP-independent periplasmic transporter. In this study, we characterize the binding site of the extracytoplasmic solute receptor (SiaP) from nontypeable H. influenzae strain 2019. A crystal structure of N-acetyl-5-neuraminic acid (Neu5Ac)-bound SiaP was determined to 1.4 {angstrom} resolution. Thermodynamic characterization of Neu5Ac binding shows this interaction is enthalpically driven with a substantial unfavorable contribution from entropy. This is expected because the binding of SiaP to Neu5Ac is mediated by numerous hydrogen bonds and has several buried water molecules. Point mutations targeting specific amino acids were introduced in the putative binding site. Complementation with the mutated siaP constructs resulted either in full, partial, or no complementation, depending on the role of specific residues. Mass spectrometry analysis of the O-deacylated LOS of the R127K point mutation confirmed the observation of reduced incorporation of Neu5Ac into the LOS. The decreased ability of H. influenzae to import sialic acid had negative effects on resistance to complement-mediated killing and viability of biofilms in vitro, confirming the importance of sialic acid transport to the bacterium.\n[The Role of \u03b1-Defensins 1\u20133 in Antimicrobial Protection Forming in Children with Recurrent Bronchitis Caused by Bacteria of the Genus Haemophilus](http://childshealth.zaslavsky.com.ua/article/view/88021) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nG.O. Lezhenko\n2013-03-01\nFull Text Available The level of \u03b1-defensins 1\u20133 (HNP 1\u20133 has been analyzed in the blood plasma of children with recurrent bronchitis caused by bacteria of the genus Haemophilus. It is shown that the level of HNP 1\u20133 in the blood plasma depends on the form of Haemophilus. Trigger of HNP 1\u20133 outflow for neutrophils was the presence of bacterial capsule while presence of L-forms of Haemophilus influenzae wasn\u2019t associated with increase in synthesis of antimicrobial peptides that could be one of the factors of forming of Haemophilus antibiotic resistance.\n[La vacuna contra el virus del papiloma humano](https://www.openaire.eu/search/publication?articleId=od______3040::cc271e44d67bb301b8673ae704eb1321)\nTobar Ruiz, Mar\u00eda\n2015-01-01\nLa carciog\u00e9nesis est\u00e1 condicionada por factores dependientes del virus como de los h\u00e1bitos del hu\u00e9sped. En cuanto a la vacunaci\u00f3n se han descubierto vacunas seguras y eficaces, siendo las dos vacunas destacadas la tetravalente o Gardasil y la bivalente o Cervarix. E nfermer\u00eda es la profesional que administra la vacuna y conoce los efectos adversos posibl es a causa de su administraci\u00f3n, y es por esa raz\u00f3n por la que mi inter\u00e9s se centr\u00f3 en la vacunaci\u00f3n.\n[Erythromycin and azithromycin transport into Haemophilus influenzae ATCC 19418 under conditions of depressed proton motive force (delta mu H)](http://www.etde.org/etdeweb/details.jsp?query_id=1&page=0&osti_id=6007431) [Energy Technology Data Exchange (ETDEWEB)](https://www.etde.org/etdeweb/fieldedsearch.jsp)\nCapobianco, J.O.; Goldman, R.C. (Abbott Laboratories, IL (USA))\n1990-09-01\nThe effect of collapsing the electrochemical proton gradient (delta mu H) on ({sup 3}H)erythromycin and ({sup 14}C)azithromycin transport in Haemophilus influenzae ATCC 19418 was studied. The proton gradient and membrane potential were determined from the distribution of (2-{sup 14}C)dimethadione and rubidium-86, respectively. delta mu H was reduced from 124 to 3 mV in EDTA-valinomycin-treated cells at 22{degrees}C with 150 mM KCl and 0.1 mM carbonyl cyanide m-chlorophenylhydrazone. During the collapse of delta mu H, macrolide uptake increased. Erythromycin efflux studies strongly suggested that this increase was not due to an energy-dependent efflux pump but was likely due to increased outer membrane permeability. These data indicated that macrolide entry was not a delta mu H-driven active transport process but rather a passive diffusion process.\n[Trends in the epidemiology of invasive Haemophilus influenzae disease in Queensland, Australia from 2000 to 2013: what is the impact of an increase in invasive non-typable H. influenzae (NTHi)?](https://www.ncbi.nlm.nih.gov/pubmed/25762194)\nWan Sai Cheong, J; Smith, H; Heney, C; Robson, J; Schlebusch, S; Fu, J; Nourse, C\n2015-10-01\nFollowing the introduction of vaccination against Haemophilus influenzae type b (Hib), cases of invasive encapsulated Hib disease have decreased markedly. This study aimed to examine subsequent epidemiological trends in invasive H. influenzae disease in Queensland, Australia and in particular, assess the clinical impact and public health implications of invasive non-typable H. influenzae (NTHi) strains. A multicentre retrospective study was conducted from July 2000 to June 2013. Databases of major laboratories in Queensland including Queensland Forensic and Scientific Services (jurisdictional referral laboratory for isolate typing) were examined to identify cases. Demographic, infection site, Indigenous status, serotype, and mortality data were collected. In total, 737 invasive isolates were identified, of which 586 (79\u00b75%) were serotyped. Hib, NTHi and encapsulated non-b strains, respectively, constituted 12\u00b71%, 69\u00b71% and 18\u00b78% of isolates. The predominant encapsulated non-b strains were f (45\u00b75%) and a (27\u00b73%) serotypes. Of isolates causing meningitis, 48\u00b79% were NTHi, 14\u00b79% Hib, 14\u00b79% Hie, 10\u00b76% Hif, 6\u00b74% Hia and 4\u00b73% were untyped. During the study period, there was an increase in the incidence of invasive NTHi disease (P = 0\u00b7007) with seasonal peaks in winter and spring (P 0\u00b7001) and Hib (P = 0\u00b7039) than non-Indigenous patients. In Queensland, invasive H. influenzae disease is now predominantly encountered in adults and most commonly caused by NTHi strains with demonstrated pathogenicity extending to otherwise young or immunocompetent individuals. Routine public health notification of these strains is recommended and recent available immunization options should be considered.\n[Vaccines against dengue: a review of current candidate vaccines at advanced development stages Vacunas contra el dengue: una revisi\u00f3n de las vacunas candidatas en etapas avanzadas de desarrollo](http://www.scielosp.org/scielo.php?script=sci_arttext&pid=S1020-49892007000300011) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nJoachim Hombach\n2007-04-01\nFull Text Available Los esfuerzos sistem\u00e1ticos para desarrollar una vacuna contra el dengue comenzaron durante la Segunda Guerra Mundial, inspirados en el desarrollo exitoso de una vacuna contra la fiebre amarilla. Sin embargo, la falta de modelos adecuados de la enfermedad, la informaci\u00f3n incompleta acerca de los mecanismos patog\u00e9nicos y los insuficientes incentivos econ\u00f3micos han dificultado los avances. Debido al impacto actual del dengue en todo el mundo y su explosiva diseminaci\u00f3n, ha aumentado el inter\u00e9s en el desarrollo de vacunas contra el dengue y se ha avanzado considerablemente en el camino hacia la evaluaci\u00f3n cl\u00ednica de vacunas candidatas. La Iniciativa para la Investigaci\u00f3n en Vacunas, de la Organizaci\u00f3n Mundial de la Salud, est\u00e1 facilitando el desarrollo de y los ensayos con las vacunas candidatas. Las vacunas contra el dengue que se encuentran actualmente en etapas avanzadas de desarrollo son de tres tipos fundamentales: 1 vivas atenuadas; 2 vivas recombinantes; y 3 de subunidades e inactivadas. La mayor\u00eda de las vacunas en cartera son vivas atenuadas, siguiendo el camino exitoso de otras vacunas vivas contra flavivirus, especialmente de la desarrollada contra la fiebre amarilla. En general, las vacunas contra el dengue que se encuentran actualmente en desarrollo est\u00e1n bastante avanzadas y son muy diversas. Muy pronto comenzar\u00e1 la evaluaci\u00f3n de estas vacuna candidatas en ensayos de eficacia basados en poblaciones expuestas, lo que requerir\u00e1 resolver varios problemas t\u00e9cnicos, operacionales y regulatorios.\n[Vacunas de bacterias recombinantes vivas](https://www.openaire.eu/search/publication?articleId=od______3272::e04c2a8ca070b76a97f8c299cefc6434)\nBlanco Le\u00f3n, Marina\n2016-01-01\nLa vacunaci\u00f3n es uno de los logros m\u00e1s importantes en la historia de la medicina, que ha ido evolucionando a lo largo de los a\u00f1os permitiendo una reducci\u00f3n significativa de la mortalidad infantil, una disminuci\u00f3n de la incidencia de enfermedades e incluso la erradicaci\u00f3n de algunas de ellas en pa\u00edses enteros. Las vacunas de nueva generaci\u00f3n surgen para reducir o eliminar las carencias de las vacunas \u201ctradicionales\u201d. T\u00e9cnicas biotecnol\u00f3gicas basadas en el ADN recombinante han dado lugar, entre...\n[Comparison of radiometric and conventional culture systems in detecting Haemophilus influenzae type b bacteremia in rats](https://inis.iaea.orgsearchsinglerecord.aspx?recordsFor=SingleRecord&RN=17039577) [International Nuclear Information System (INIS) ](http://inis.iaea.org/search/)\nMitchell, M.J.; Zwahlen, A.; Elliott, H.L.; Ford, N.K.; Charache, F.P.; Moxon, E.R.\n1985-01-01\nTo compare the efficiency of detecting Haemophilus influenzae type b bacteremia by the BACTEC radiometric system and a conventional Trypticase soy broth blood culture system, the authors developed an in vivo model of bacteremia in rats. After intravenous injection of 50 to 200 CFU into adult rats, there was a linear logarithmic increase in CFU per milliliter of rat blood during the first 10 h (r = 0.98), allowing accurate prediction of the level of bacteremia with time. Culture bottles were inoculated with 0.5 ml of blood obtained by cardiac puncture and processed as clinical samples in the microbiology laboratory with RS and conventional protocols. They found the following. (i) The first detection of bacteremia by RS was similar to that by TSB if a Gram stain of the TSB was done on day 1 and was superior if that smear was omitted (P less than 0.01). (ii) The detection times in both systems were comparable at different magnitudes of bacteremia (10(1) to 10(4) CFU/ml). (iii) Supplementation of inoculated bottles with 2 ml of sterile rat blood interfered with Gram stain detection in TSB but resulted in increased 14 CO 2 production in RS. (iv) No difference in detection time was found between RS and TSB for four different clinical isolates. These studies show that, in a biologically relevant model, the detection of positive blood cultures for H. influenzae type b by RS was comparable to or better than detection by TSB when blood was processed analogously to clinical specimens\n[Reliability of Haemophilus influenzae biofilm measurement via static method, and determinants of in vitro biofilm production.](https://www.ncbi.nlm.nih.gov/pubmed/27763775)\nObaid, Najla A; Tristram, Stephen; Narkowicz, Christian K; Jacobson, Glenn A\n2016-12-01\nInformation is lacking regarding the precision of microtitre plate (MTP) assays used to measure biofilm. This study investigated the precision of an MTP assay to measure biofilm production by nontypeable Haemophilus influenzae (NTHi) and the effects of frozen storage and inoculation technique on biofilm production. The density of bacterial final growth was determined by absorbance after 18-20 h incubation, and biofilm production was then measured by absorbance after crystal violet staining. Biofilm formation was categorised as high and low for each strain. For the high biofilm producing strains of NTHi, interday reproducibility of NTHi biofilm formation measured using the MTP assay was excellent and met the acceptance criteria, but higher variability was observed in low biofilm producers. Method of inoculum preparation was a determinant of biofilm formation with inoculum prepared directly from solid media showing increased biofilm production for at least one of the high producing strains. In general, storage of NTHi cultures at -80 \u00b0C for up to 48 weeks did not have any major effect on their ability to produce biofilm.\n[IMMUNOGENICITY AND SAFETY OF QUINVAXEM\u00ae (DIPHTHERIA, TETANUS, WHOLE-CELL PERTUSSIS, HEPATITIS B AND HAEMOPHILUS INFLUENZAE TYPE B VACCINE) GIVEN TO VIETNAMESE INFANTS AT 2 TO 4 MONTHS OF AGE.](https://www.ncbi.nlm.nih.gov/pubmed/26867396)\nHuu, Tran Ngoc; Phuong, Nguyen Thi Minh; Toan, Nguyen Trong; Thang, Ho Vinh\n2015-07-01\nVietnam plans to replace the routine childhood diphtheria, pertussis and tetanus combination (DPT) vaccine with a pentavalent vaccine. The present study was performed to assess the immunogenicity and safety of the combined diphtheria, tetanus, whole-cell pertussis, hepatitis B (HepB), and Haemophilus influenzae type b (Hib) (DTwP-HepB-Hib) Quinvaxem\u00ae vaccine in children. A total of 131 infants received the Quinvaxem\u00ae vaccine at 2, 3 and 4 months. Antibody levels were measured at baseline, at one month after the third injection and one year after the first injection. Seroprotection rates were high for each vaccine antigen at one month after the third dose: 93.1% for diphtheria, 98.5% for tetanus, 99.2% for pertussis (seroconversion rate), 93.1% for HepB, and 100% for Hib (anti-PRP \u2265 0.15 \u00b5g/ml). The rate of children with protective antibodies persisting at one year after the first dose was 88.4% for diphtheria, 49.6% for pertussis, 82.2% for tetanus, 76.7% for HepB and 97.7% for Hib (anti-PRP \u2265 0.15 \u00b5g/ml). The Quinvaxem\u00ae vaccine was well tolerated and has a low rate of adverse events. Quinvaxem\u00ae given at 2, 3 and 4 months of age was immunogenic and safe for primary immunization among infants in Vietnam.\n[La influenza, un problema vigente de salud p\u00fablica Influenza, an existing public health problem](http://www.scielo.org.mx/scielo.php?script=sci_arttext&pid=S0036-36342006000300009) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nJuan Garc\u00eda-Garc\u00eda\n2006-06-01\nFull Text Available La influenza estacional es una enfermedad respiratoria aguda, recurrente y com\u00fan que se conoce desde la antig\u00fcedad y se presenta sobre todo durante los meses de invierno con un elevado impacto para la salud p\u00fablica mundial. La enfermedad se manifiesta con altas tasas de morbilidad en individuos de todas las edades y elevadas tasas de mortalidad en ni\u00f1os, individuos mayores de 60 a\u00f1os, pacientes con enfermedades cr\u00f3nicas y mujeres en gestaci\u00f3n. Las estrategias de prevenci\u00f3n incluyen el uso de vacunas: inactivadas, subunitarias o vacuna con virus gen\u00e9ticamente modificados. Dos subtipos de virus de influenza tipo A y un virus de influenza tipo B causan la enfermedad en humanos. Los virus de influenza A que afectan a los humanos mutan con facilidad, por lo que con frecuencia aparecen nuevas variantes antig\u00e9nicas de cada subtipo, lo que obliga a incluir dichas variantes en las vacunas anuales para brindar una adecuada protecci\u00f3n a la poblaci\u00f3n. La influenza pand\u00e9mica se refiere a la introducci\u00f3n y posterior diseminaci\u00f3n mundial de un nuevo virus de influenza en la poblaci\u00f3n humana, lo que ocurre de manera espor\u00e1dica, y que debido a que los humanos carecen de inmunidad para el nuevo virus pueden suscitarse epidemias graves con elevadas tasas de morbilidad y mortalidad. Hist\u00f3ricamente el origen de las pandemias de influenza se debe a la transmisi\u00f3n de virus de aves al hombre o la transferencia de genes de \u00e9stos a los virus de la influenza estacional. En las aves acu\u00e1ticas silvestres, tanto migratorias como costeras, se mantiene una gran diversidad de subtipos de virus de influenza, los cuales se introducen eventualmente en aves dom\u00e9sticas, donde algunos virus adquieren la capacidad de infectar a mam\u00edferos, incluido el hombre. El proceso de adaptaci\u00f3n de los virus aviarios a hospederos mam\u00edferos requiere tiempo, por lo que la presentaci\u00f3n de estos casos puede tardar varios a\u00f1os. Desde diciembre de 2003, en varios pa\u00edses del\n[La articulaci\u00f3n p\u00fablico-privada en la producci\u00f3n de vacunas en M\u00e9xico](http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0103-11042016000400009&lng=en&tlng=en) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nSilvia Tamez\nFull Text Available RESUMEN El art\u00edculo analiza el proceso de privatizaci\u00f3n de la atenci\u00f3n a la salud: la Articulaci\u00f3n P\u00fablico-Privada (APP. Espec\u00edficamente estudia la producci\u00f3n de vacunas em M\u00e9xico, tomando como caso los Laboratorios de Biol\u00f3gicos y Reactivos de M\u00e9xico, S.A. de C.V. (Birmex, empresa paraestatal, responsable de producir, distribuir e investigar biol\u00f3gicos y reactivos en M\u00e9xico. Interesa destacar el comportamiento de Birmex durante el periodo de la pandemia de influenza de 2009, producida por el virus de la influenza A subtipo H1N1. Los resultados muestran que gracias al impulso de las pol\u00edticas de liberalizaci\u00f3n y desregulaci\u00f3n, existe una apertura de los servicios p\u00fablicos a las corporaciones supranacionales.\n[A natural component from Euphorbia humifusa Willd displays novel, broad-spectrum anti-influenza activity by blocking nuclear export of viral ribonucleoprotein](http://www.etde.org/etdeweb/details.jsp?query_id=1&page=0&osti_id=22594271) [Energy Technology Data Exchange (ETDEWEB)](https://www.etde.org/etdeweb/fieldedsearch.jsp)\nChang, So Young; Park, Ji Hoon [Respiratory Viruses Research Laboratory, Discovery Biology Department, Institut Pasteur Korea, 16, Daewangpangyo-ro 712 Beon-gil, Bundang-gu, Seongnam-si, Gyeonggi-do, 463-400 (Korea, Republic of); Kim, Young Ho; Kang, Jong Seong [College of Pharmacy, Chungnam National University, Daejeon, 305-764 (Korea, Republic of); Min, Ji-Young, E-mail: jiyoung.min@ip-korea.org [Respiratory Viruses Research Laboratory, Discovery Biology Department, Institut Pasteur Korea, 16, Daewangpangyo-ro 712 Beon-gil, Bundang-gu, Seongnam-si, Gyeonggi-do, 463-400 (Korea, Republic of)\n2016-03-04\nThe need to develop anti-influenza drugs with novel antiviral mechanisms is urgent because of the rapid rate of antigenic mutation and the emergence of drug-resistant viruses. We identified a novel anti-influenza molecule by screening 861 plant-derived natural components using a high-throughput image-based assay that measures inhibition of the influenza virus infection. 1,3,4,6-tetra-O-galloyl-\u03b2-D-glucopyranoside (TGBG) from Euphorbia humifusa Willd showed broad-spectrum anti-influenza activity against two seasonal influenza A strains, A/California/07/2009 (H1N1) and A/Perth/16/2009 (H3N2), and seasonal influenza B strain B/Florida/04/2006. We investigated the mode of action of TGBG using neuraminidase activity inhibition and time-of-addition assays, which evaluate the viral release and entry steps, respectively. We found that TGBG exhibits a novel antiviral mechanism that differs from the FDA-approved anti-influenza drugs oseltamivir which inhibits viral release, and amantadine which inhibits viral entry. Immunofluorescence assay demonstrated that TGBG significantly inhibits nuclear export of influenza nucleoproteins (NP) during the early stages of infection causing NP to accumulate in the nucleus. In addition, influenza-induced activation of the Akt signaling pathway was suppressed by TGBG in a dose-dependent manner. These data suggest that a putative mode of action of TGBG involves inhibition of viral ribonucleoprotein (vRNP) export from the nucleus to the cytoplasm consequently disrupting the assembly of progeny virions. In summary, TGBG has potential as novel anti-influenza therapeutic with a novel mechanism of action. - Highlights: \u2022 The plant-derived natural product TGBG has broad-spectrum antiviral activity against seasonal influenza A and B viruses. \u2022 TGBG has a novel anti-viral mechanism of action that from differs from the currently available anti-influenza drugs. \u2022 TGBG hinders nuclear export of the influenza virus ribonucleoprotein (v\n[A natural component from Euphorbia humifusa Willd displays novel, broad-spectrum anti-influenza activity by blocking nuclear export of viral ribonucleoprotein](http://dx.doi.org/10.1016/j.bbrc.2016.01.123) [International Nuclear Information System (INIS) ](http://inis.iaea.org/search/)\nChang, So Young; Park, Ji Hoon; Kim, Young Ho; Kang, Jong Seong; Min, Ji-Young\n2016-01-01\nThe need to develop anti-influenza drugs with novel antiviral mechanisms is urgent because of the rapid rate of antigenic mutation and the emergence of drug-resistant viruses. We identified a novel anti-influenza molecule by screening 861 plant-derived natural components using a high-throughput image-based assay that measures inhibition of the influenza virus infection. 1,3,4,6-tetra-O-galloyl-\u03b2-D-glucopyranoside (TGBG) from Euphorbia humifusa Willd showed broad-spectrum anti-influenza activity against two seasonal influenza A strains, A/California/07/2009 (H1N1) and A/Perth/16/2009 (H3N2), and seasonal influenza B strain B/Florida/04/2006. We investigated the mode of action of TGBG using neuraminidase activity inhibition and time-of-addition assays, which evaluate the viral release and entry steps, respectively. We found that TGBG exhibits a novel antiviral mechanism that differs from the FDA-approved anti-influenza drugs oseltamivir which inhibits viral release, and amantadine which inhibits viral entry. Immunofluorescence assay demonstrated that TGBG significantly inhibits nuclear export of influenza nucleoproteins (NP) during the early stages of infection causing NP to accumulate in the nucleus. In addition, influenza-induced activation of the Akt signaling pathway was suppressed by TGBG in a dose-dependent manner. These data suggest that a putative mode of action of TGBG involves inhibition of viral ribonucleoprotein (vRNP) export from the nucleus to the cytoplasm consequently disrupting the assembly of progeny virions. In summary, TGBG has potential as novel anti-influenza therapeutic with a novel mechanism of action. - Highlights: \u2022 The plant-derived natural product TGBG has broad-spectrum antiviral activity against seasonal influenza A and B viruses. \u2022 TGBG has a novel anti-viral mechanism of action that from differs from the currently available anti-influenza drugs. \u2022 TGBG hinders nuclear export of the influenza virus ribonucleoprotein (v\n[Antibacterial activity of Artemisia asiatica essential oil against some common respiratory infection causing bacterial strains and its mechanism of action in Haemophilus influenzae.](https://www.ncbi.nlm.nih.gov/pubmed/29241769)\nHuang, Jiehui; Qian, Chao; Xu, Hongjie; Huang, Yanjie\n2018-01-01\nThe main objective of the current study was to investigate the chemical composition of the essential oil of Artemisia asiatica together with investigating the antibacterial effects it exerts on several common respiratory infection causing bacteria including Haemophilus influenzae. Its mechanism of action was studied using various state-of-the-art assays like scanning electron microscopy, DNA, RNA and protein leakage assays, growth curve assays etc. The essential oil was extracted from the leaves of A. asiatica by supercritical CO 2 fluid extraction technology. Chemical composition of essential oils was analyzed by gas chromatography-mass-spectrometry (GC-MS). The antibacterial activity was evaluated against 6 bacteria by the paper disc diffusion method. The minimum inhibitory concentration (MIC) and minimum bactericide concentration (MBC) values of the essential oil were estimated by agar dilution method. The antibacterial mechanism was evaluated by growth curve, the integrity of cell membrane and scanning electronmicroscope (SEM). Gas chromatographic analysis of the A. asiatica essential oil led to the identification of 16 chemical constituents accounting for 97.2% of the total oil composition. The major components were found to be Piperitone, (z)-davanone, p-cymene and 1, 8-cineole. The essential oil showed maximum growth inhibition against Haemophilus influenzae with a zone of inhibition of 24.5 mm and MIC/MBC values of 1.9/4.5 mg/mL respectively. Bacteria treated with the essential oil led to a rapid decrease in the number of viable cells. On adding the essential oil of A. asiatica to the bacterial culture, the constituents of the bacterial cell got released into the medium and this cell constituent release increased with increasing doses of the essential oil. SEM showed that the bacterial cells treated with the essential oil showed damaged cell wall, deformed cell morphology and shrunken cells. Copyright \u00a9 2017. Published by Elsevier Ltd.\n[In vitro selection of resistance in haemophilus influenzae by 4 quinolones and 5 beta-lactams.](https://www.ncbi.nlm.nih.gov/pubmed/15135497)\nClark, Catherine; Kosowska, Klaudia; Bozdogan, B\u00fclent; Credito, Kim; Dewasse, Bonifacio; McGhee, Pamela; Jacobs, Michael R; Appelbaum, Peter C\n2004-05-01\nWe tested abilities of ciprofloxacin, levofloxacin, gatifloxacin, moxifloxacin, amoxicillin, amoxicillin/clavulanate, cefixime, cefpodoxime, and cefdinir to select resistant mutants in 5 beta-lactamase positive and 5 beta-lactamase negative Haemophilus influenzae strains by single and multistep methodology. In multistep tests, amoxicillin, amoxicillin/clavulanate and cefpodoxime exposure did not cause >4-fold minimum inhibitory concentration (MIC) increase after 50 days. One mutant selected by cefdinir had one amino acid substitution (Gly490Glu) in PBP3 and became resistant to cefdinir. Cefixime exposure caused 8-fold MIC-increase in 1 strain with TEM but the mutant remained cefixime susceptible and had no alteration in PBP3 or TEM. Among 10 strains tested, ciprofloxacin, moxifloxacin, gatifloxacin, levofloxacin caused >4-fold MIC increase in 6, 6, 5, and 2 strain, respectively. Despite the increases in quinolone MICs, none of the mutants became resistant to quinolones by established criteria. Quinolone selected mutants had quindone resistance-determining region (QRDR) alterations in GyrA, GyrB, ParC, ParE. Four quinolone mutants had no QRDR alterations. Among beta-lactams cefdinir and cefixime selected one mutant each with higher MICs however amoxicillin, amoxicillin/clavulanate, and cefpodoxime exposure did not select resistant mutants.\n[Genes from plasmid pKM101 in Haemophilus influenzae: separation of functions of mucA and mucB](https://inis.iaea.orgsearchsinglerecord.aspx?recordsFor=SingleRecord&RN=17068044) [International Nuclear Information System (INIS) ](http://inis.iaea.org/search/)\nBalganesh, M.; Setlow, J.K.\n1985-01-01\nHaemophilus influenzae, normally not mutable by UV, became UV mutable with a recombinant plasmid insertion. A 7.8-kilobase-pair (kbp) fragment of the plasmid pKM101 containing the mucA and mucB genes was ligated to the shuttle vector pDM2, and a Rec- strain of H. influenzae was transformed with the ligated mixture. All of the transformants, unlike the parent Rec- strain, were resistant to UV, could carry out postreplication repair and Weigle reactivation, showed greatly increased spontaneous mutation, and contained a plasmid carrying an insert of only 1.2 rather than 7.8 kbp. This plasmid in a umuC mutant strain of Escherichia coli complemented a pKM101 derivative lacking mucA function but with an intact mucB gene, although there was no complementation with a mucA+ mucB- plasmid, suggesting that the newly constructed plasmid coded for the mucA protein; this is in accord with the restriction analysis and hybridization between the plasmid and a probe containing all of the mucA gene but only a small fraction of mucB. When one of the H. influenzae Rec- transformants lost the plasmid, the resistance to UV was retained but the high spontaneous mutation and UV mutability were not. The fact that there was hybridization between the chromosome of the cured strain and a probe containing both muc genes but none when almost no mucB was present suggested that at least part of the mucB gene had been integrated into the Rec- chromosome. Five different postreplication repair-proficient strains became UV mutable and had high spontaneous mutation rates caused by the putative mucA plasmid, indicating that these strains already possessed a chromosomal equivalent of the mucB gene\n[Combined Haemophilus Influenzae type B-Neisseria meningitidis serogroup C vaccine is immunogenic and well tolerated in preterm infants when coadministered with other routinely recommended vaccines.](https://www.ncbi.nlm.nih.gov/pubmed/21747321)\nOme\u00f1aca, F\u00e9lix; Ar\u00edstegui, Javier; Tejedor, Juan Carlos; Moreno-Perez, David; Ruiz-Contreras, J\u00e9sus; Merino, Jose Manuel; Muro Brussi, Marta; S\u00e1nchez-Tamayo, Tom\u00e1s; Castro Fernandez, Javier; Cabanillas, Lucia; Peddiraju, Kavitha; Mesaros, Narcisa; Miller, Jacqueline M\n2011-11-01\nPreterm infants are at greater risk of morbidity from vaccine-preventable diseases. Therefore, their responses to vaccination are of particular interest. In this open, controlled, Spanish multicenter study, we assessed immunogenicity and safety following primary vaccination of 163 preterm infants (n = 56, 36 weeks' gestation), with Haemophilus Influenzae type B (Hib)-MenC-TT, DTaP(diphtheria-tetanus-acellular pertussis vaccine)-HepB-IPV, and PCV7 at 2 to 4-6 months of age followed by booster vaccination at 16 to 18 months of age. Serum bactericidal activity (rabbit complement) against MenC, and antibodies to Hib and hepatitis b (anti-HBs) were determined. Local/general symptoms were assessed after each vaccination via diary cards. Serious adverse events were recorded throughout the study. There were no statistically significant differences between preterm and full-term infants in either Hib or MenC seroprotection rates or geometric mean concentrations at 1 month postdose 3, before or 1 month postbooster. Postdose 3, >99% of participants had seroprotective anti-HBs antibody concentrations. Anti-HBs geometric mean concentrations was significantly lower in the group compared with other groups and this difference persisted until 16 to 18 months of age. Hib-MenC-TT vaccine was well tolerated at all ages. There was one death caused by meningococcal serogroup-B sepsis (full term). No serious adverse events were assessed by the investigator as being vaccine related. Hib-MenC-TT vaccine had a similar immunogenicity and safety profile in preterm and full-term infants. These results demonstrate that preterm infants can be safely vaccinated with Hib-MenC-TT at the recommended chronologic age without impacting the responses to the Hib and MenC antigens.\n[Primary and booster vaccination with DTPw-HB/Hib pentavalent vaccine in Costa Rican children who had received a birth dose of hepatitis B vaccine Vacunaci\u00f3n primaria y de refuerzo con la vacuna pentavalente DTPw-HB/Hib en ni\u00f1os costarricenses vacunados al nacer contra la hepatitis B](http://www.scielosp.org/scielo.php?script=sci_arttext&pid=S1020-49892002001000005) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nIdis Faingezicht\n2002-10-01\nprotective/seropositive titers for Hib, HB, and tetanus and about 50% for diphtheria and Bordetella pertussis. At 15 months of age, virtually all the toddlers responded with a strong boost response to all the vaccine antigens, whether they received the DTPw-HB/Hib pentavalent vaccine or the DTPw/Hib vaccine as a booster. Both booster regimens were equally well tolerated, indicating that up to five doses of the HB vaccine can be given without impact on safety. Conclusions. Our study confirms that the DTPw-HB/Hib pentavalent vaccine is highly immunogenic as a primary vaccination in children who received an HB vaccine at birth, with the pentavalent combination inducing both persisting immunity and boostable memory. The pentavalent vaccine was safe both for primary and booster vaccinations. Thus, this study in Costa Rican infants supports the routine use of the pentavalent DTPw-HB/Hib vaccine as part of childhood vaccination programs in Latin America and the Caribbean.Objetivos. La vacuna combinada pentavalente DTPw-HB/Hib ha sido creada siguiendo la recomendaci\u00f3n de la Organizaci\u00f3n Mundial de la Salud de a\u00f1adir las vacunas contra la hepatitis b (HB y el Haemophilus influenzae tipo b (Hib a los programas de vacunaci\u00f3n infantil. Los objetivos del presente estudio consistieron en: 1 analizar la inmunogenicidad y reactogenicidad de la vacuna combinada pentavalente DTPw-HB/Hib en comparaci\u00f3n con las inyecciones separadas de las vacunas DTPw-HB e Hib como vacunaci\u00f3n primaria en un grupo de ni\u00f1os que hab\u00edan recibido al nacer una dosis de vacuna contra la HB, y 2 evaluar la persistencia de anticuerpos en el segundo a\u00f1o de vida, as\u00ed como la respuesta a las dosis de recuerdo de DTPw-HB/Hib o DTPw/Hib. M\u00e9todos. En la primera parte del estudio (fase de vacunaci\u00f3n primaria, realizada en 1998-1999, se analiz\u00f3 la inmunogenicidad y reactogenicidad de la vacuna combinada DTPw-HB/Hib en comparaci\u00f3n con inyecciones separadas de las vacunas DTPw-HB e Hib como vacunaci\u00f3n primaria a\n[The structure of Haemophilus influenzae prephenate dehydrogenase suggests unique features of bifunctional TyrA enzymes](http://dx.doi.org/10.1107/S1744309110021688) [International Nuclear Information System (INIS) ](http://inis.iaea.org/search/)\nChiu, Hsiu-Ju; Abdubek, Polat; Astakhova, Tamara; Axelrod, Herbert L.; Carlton, Dennis; Clayton, Thomas; Das, Debanu; Deller, Marc C.; Duan, Lian; Feuerhelm, Julie; Grant, Joanna C.; Grzechnik, Anna; Han, Gye Won; Jaroszewski, Lukasz; Jin, Kevin K.; Klock, Heath E.; Knuth, Mark W.; Kozbial, Piotr; Krishna, S. Sri; Kumar, Abhinav; Marciano, David; McMullan, Daniel; Miller, Mitchell D.; Morse, Andrew T.; Nigoghossian, Edward; Okach, Linda; Reyes, Ron; Tien, Henry J.; Trame, Christine B.; Bedem, Henry van den; Weekes, Dana; Xu, Qingping; Hodgson, Keith O.; Wooley, John; Elsliger, Marc-Andr\u00e9; Deacon, Ashley M.; Godzik, Adam; Lesley, Scott A.; Wilson, Ian A.\n2010-01-01\nThe crystal structure of the prephenate dehydrogenase component of the bifunctional H. influenzae TyrA reveals unique structural differences between bifunctional and monofunctional TyrA enzymes. Chorismate mutase/prephenate dehydrogenase from Haemophilus influenzae Rd KW20 is a bifunctional enzyme that catalyzes the rearrangement of chorismate to prephenate and the NAD(P) + -dependent oxidative decarboxylation of prephenate to 4-hydroxyphenylpyruvate in tyrosine biosynthesis. The crystal structure of the prephenate dehydrogenase component (HinfPDH) of the TyrA protein from H. influenzae Rd KW20 in complex with the inhibitor tyrosine and cofactor NAD + has been determined to 2.0 \u00c5 resolution. HinfPDH is a dimeric enzyme, with each monomer consisting of an N-terminal \u03b1/\u03b2 dinucleotide-binding domain and a C-terminal \u03b1-helical dimerization domain. The structure reveals key active-site residues at the domain interface, including His200, Arg297 and Ser179 that are involved in catalysis and/or ligand binding and are highly conserved in TyrA proteins from all three kingdoms of life. Tyrosine is bound directly at the catalytic site, suggesting that it is a competitive inhibitor of HinfPDH. Comparisons with its structural homologues reveal important differences around the active site, including the absence of an \u03b1\u2013\u03b2 motif in HinfPDH that is present in other TyrA proteins, such as Synechocystis sp. arogenate dehydrogenase. Residues from this motif are involved in discrimination between NADP + and NAD + . The loop between \u03b25 and \u03b26 in the N-terminal domain is much shorter in HinfPDH and an extra helix is present at the C-terminus. Furthermore, HinfPDH adopts a more closed conformation compared with TyrA proteins that do not have tyrosine bound. This conformational change brings the substrate, cofactor and active-site residues into close proximity for catalysis. An ionic network consisting of Arg297 (a key residue for tyrosine binding), a water molecule, Asp206 (from\n[Secondary Bacterial Infections Associated with Influenza Pandemics](https://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=5481322)\nMorris, Denise E.; Cleary, David W.; Clarke, Stuart C.\n2017-01-01\nLower and upper respiratory infections are the fourth highest cause of global mortality (Lozano et al., 2012). Epidemic and pandemic outbreaks of respiratory infection are a major medical concern, often causing considerable disease and a high death toll, typically over a relatively short period of time. Influenza is a major cause of epidemic and pandemic infection. Bacterial co/secondary infection further increases morbidity and mortality of influenza infection, with Streptococcus pneumoniae, Haemophilus influenzae, and Staphylococcus aureus reported as the most common causes. With increased antibiotic resistance and vaccine evasion it is important to monitor the epidemiology of pathogens in circulation to inform clinical treatment and development, particularly in the setting of an influenza epidemic/pandemic. PMID:28690590\n[Secondary Bacterial Infections Associated with Influenza Pandemics](http://journal.frontiersin.org/article/10.3389/fmicb.2017.01041/full) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nDenise E. Morris\n2017-06-01\nFull Text Available Lower and upper respiratory infections are the fourth highest cause of global mortality (Lozano et al., 2012. Epidemic and pandemic outbreaks of respiratory infection are a major medical concern, often causing considerable disease and a high death toll, typically over a relatively short period of time. Influenza is a major cause of epidemic and pandemic infection. Bacterial co/secondary infection further increases morbidity and mortality of influenza infection, with Streptococcus pneumoniae, Haemophilus influenzae, and Staphylococcus aureus reported as the most common causes. With increased antibiotic resistance and vaccine evasion it is important to monitor the epidemiology of pathogens in circulation to inform clinical treatment and development, particularly in the setting of an influenza epidemic/pandemic.\n[Relative Contribution of P5 and Hap Surface Proteins to Nontypable Haemophilus influenzae Interplay with the Host Upper and Lower Airways](https://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=4403991)\nViadas, Cristina; Ruiz de los Mozos, Igor; Valle, Jaione; Bengoechea, Jos\u00e9 Antonio; Garmendia, Junkal\n2015-01-01\nNontypable Haemophilus influenzae (NTHi) is a major cause of opportunistic respiratory tract disease, and initiates infection by colonizing the nasopharynx. Bacterial surface proteins play determining roles in the NTHi-airways interplay, but their specific and relative contribution to colonization and infection of the respiratory tract has not been addressed comprehensively. In this study, we focused on the ompP5 and hap genes, present in all H. influenzae genome sequenced isolates, and encoding the P5 and Hap surface proteins, respectively. We employed isogenic single and double mutants of the ompP5 and hap genes generated in the pathogenic strain NTHi375 to evaluate P5 and Hap contribution to biofilm growth under continuous flow, to NTHi adhesion, and invasion/phagocytosis on nasal, pharyngeal, bronchial, alveolar cultured epithelial cells and alveolar macrophages, and to NTHi murine pulmonary infection. We show that P5 is not required for bacterial biofilm growth, but it is involved in NTHi interplay with respiratory cells and in mouse lung infection. Mechanistically, P5NTHi375 is not a ligand for CEACAM1 or \u03b15 integrin receptors. Hap involvement in NTHi375-host interaction was shown to be limited, despite promoting bacterial cell adhesion when expressed in H. influenzae RdKW20. We also show that Hap does not contribute to bacterial biofilm growth, and that its absence partially restores the deficiency in lung infection observed for the \u0394ompP5 mutant. Altogether, this work frames the relative importance of the P5 and Hap surface proteins in NTHi virulence. PMID:25894755\n[Realidad y nuevos horizontes de la vacuna del virus del papiloma humano](https://www.openaire.eu/search/publication?articleId=od______1472::a09ac4cf255ae73a6b4363b1bbc0a6ad)\nGarc\u00eda G\u00f3mez, Nuria\n2014-01-01\nLa vacuna frente al VPH es la primera vacuna destinada a la prevenci\u00f3n del c\u00e1ncer inducido por un virus, el CCU (problema de salud p\u00fablica mundial), y de lesiones precursoras. Disponemos de 2 vacunas profil\u00e1cticas: Gardasil\u00ae (frente a VPH 6, 11, 16 y 18) y Cervarix\u00ae (frente a VPH 16 y 18). El trabajo consiste en una revisi\u00f3n bibliogr\u00e1fica que tiene como objetivo conocer la situaci\u00f3n que vive actualmente la vacuna del VPH en Espa\u00f1a, utilizando como palabras clave virus, vacun...\n[Structural Analysis of Substrate, Reaction Intermediate, and Product Binding in Haemophilus influenzae Biotin Carboxylase](https://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=4654113)\nBroussard, Tyler C.; Pakhomova, Svetlana; Neau, David B.; Bonnot, Ross; Waldrop, Grover L.\n2015-01-01\nAcetyl-CoA carboxylase catalyzes the first and regulated step in fatty acid synthesis. In most Gram-negative and Gram-positive bacteria, the enzyme is composed of three proteins: biotin carboxylase, a biotin carboxyl carrier protein (BCCP), and carboxyltransferase. The reaction mechanism involves two half-reactions with biotin carboxylase catalyzing the ATP-dependent carboxylation of biotin-BCCP in the first reaction. In the second reaction, carboxyltransferase catalyzes the transfer of the carboxyl group from biotin-BCCP to acetyl-CoA to form malonyl-CoA. In this report, high-resolution crystal structures of biotin carboxylase from Haemophilus influenzae were determined with bicarbonate, the ATP analogue AMPPCP; the carboxyphosphate intermediate analogues, phosphonoacetamide and phosphonoformate; the products ADP and phosphate; and the carboxybiotin analogue N1\u2032-methoxycarbonyl biotin methyl ester. The structures have a common theme in that bicarbonate, phosphate, and the methyl ester of the carboxyl group of N1\u2032-methoxycarbonyl biotin methyl ester all bound in the same pocket in the active site of biotin carboxylase and as such utilize the same set of amino acids for binding. This finding suggests a catalytic mechanism for biotin carboxylase in which the binding pocket that binds tetrahedral phosphate also accommodates and stabilizes a tetrahedral dianionic transition state resulting from direct transfer of CO2 from the carboxyphosphate intermediate to biotin. PMID:26020841\n[Los laboratorios p\u00fablicos productores de vacunas: el nuevo paradigma](http://www.scielosp.org/scielo.php?script=sci_arttext&pid=S1020-49891998001000001) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nAkira Homma\n1998-10-01\nFull Text Available Los laboratorios p\u00fablicos productores de vacunas de Am\u00e9rica Latina y el Caribe han contribuido en diferente grado al control y a la erradicaci\u00f3n de las enfermedades prevenibles por vacunaci\u00f3n y varios est\u00e1n produciendo las vacunas que se aplican rutinariamente en los programas nacionales de inmunizaci\u00f3n, como la vacuna antituberculosa (a base del bacilo de Calmette-Gu\u00e9rin, BCG, la vacuna contra difteria-t\u00e9tanos-pertussis (DTP, el toxoide tet\u00e1nico (TT, la vacuna antisarampionosa y la vacuna antipoliomiel\u00edtica oral. Gracias a los adelantos cient\u00edficos recientes, se prev\u00e9 un aumento importante del n\u00famero de vacunas seguras y eficaces que estar\u00e1n disponibles en un futuro cercano para uso en los programas normales de vacunaci\u00f3n. Sin embargo, los gastos asociados con el desarrollo de estas vacunas y con los derechos de propiedad intelectual que las protegen son cuantiosos. Adem\u00e1s, pocos laboratorios en Am\u00e9rica Latina poseen la capacidad t\u00e9cnica para investigar y elaborar estas vacunas. Tales factores tendr\u00e1n un impacto en la celeridad con que se incorporar\u00e1n en los esquemas de vacunaci\u00f3n de los pa\u00edses de la Regi\u00f3n. En la actualidad, los laboratorios p\u00fablicos productores de vacunas de la Regi\u00f3n no est\u00e1n capacitados para competir en este nuevo contexto y corren el riesgo de ser desplazados del mercado por completo. De ah\u00ed la necesidad de que cambien radicalmente su manejo gerencial y su capacidad cientificot\u00e9cnica, lo cual exige que los gobiernos se comprometan a mejorar y fortalecer aquellos aspectos pol\u00edticos y financieros que garanticen la participaci\u00f3n de los laboratorios nacionales en el suministro sostenible de vacunas a los programas de vacunaci\u00f3n, as\u00ed como en la investigaci\u00f3n, desarrollo y producci\u00f3n de vacunas nuevasIn Latin America and the Caribbean, public laboratories that produce vaccines have contributed in varying degrees to the control and eradication of vaccine-preventable diseases, and several of them\n[Vacunas, biotecnolog\u00eda y su relaci\u00f3n con el aborto provocado](https://www.openaire.eu/search/publication?articleId=doajarticles::4639710bd8874709386dd27339826e1d)\nJos\u00e9 Luis Redondo Calder\u00f3n\n2008-01-01\nLas vacunas de c\u00e9lulas diploides humanas (WI-38, MRC-5) tienen un origen \u00e9ticamente objetable, dado que dichas c\u00e9lulas proceden de abortos provocados. Entre ellas destacan vacunas empleadas contra rub\u00e9ola, sarampi\u00f3n, parotiditis, rabia, poliomielitis, viruela, hepatitis A, varicela y herpes z\u00f3ster. Actualmente se encuentran en desarrollo otras vacunas cultivadas en c\u00e9lulas (293, PER.C6) transformadas mediante virus, procedentes de abortos. Entre ellas hay vacunas contra la gripe, virus respi...\n[Pyrazole compound BPR1P0034 with potent and selective anti-influenza virus activity](http://www.jbiomedsci.com/content/17/1/13) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nYeh Jiann-Yih\n2010-02-01\nFull Text Available Abstract Background Influenza viruses are a major cause of morbidity and mortality around the world. More recently, a swine-origin influenza A (H1N1 virus that is spreading via human-to-human transmission has become a serious public concern. Although vaccination is the primary strategy for preventing infections, influenza antiviral drugs play an important role in a comprehensive approach to controlling illness and transmission. In addition, a search for influenza-inhibiting drugs is particularly important in the face of high rate of emergence of influenza strains resistant to several existing influenza antivirals. Methods We searched for novel anti-influenza inhibitors using a cell-based neutralization (inhibition of virus-induced cytopathic effect assay. After screening 20,800 randomly selected compounds from a library from ChemDiv, Inc., we found that BPR1P0034 has sub-micromolar antiviral activity. The compound was resynthesized in five steps by conventional chemical techniques. Lead optimization and a structure-activity analysis were used to improve potency. Time-of-addition assay was performed to target an event in the virus life cycle. Results The 50% effective inhibitory concentration (IC50 of BPR1P0034 was 0.42 \u00b1 0.11 \u03bcM, when measured with a plaque reduction assay. Viral protein and RNA synthesis of A/WSN/33 (H1N1 was inhibited by BPR1P0034 and the virus-induced cytopathic effects were thus significantly reduced. BPR1P0034 exhibited broad inhibition spectrum for influenza viruses but showed no antiviral effect for enteroviruses and echovirus 9. In a time-of-addition assay, in which the compound was added at different stages along the viral replication cycle (such as at adsorption or after adsorption, its antiviral activity was more efficient in cells treated with the test compound between 0 and 2 h, right after viral infection, implying that an early step of viral replication might be the target of the compound. These results suggest\n[Assessment of immunogenicity and safety following primary and booster immunisation with a CRM197 -conjugated Haemophilus influenzae type B vaccine in healthy Chinese infants.](https://www.ncbi.nlm.nih.gov/pubmed/23964690)\nJun, L; Yuguo, C; Zhiguo, W; Jinfeng, L; Huawei, M; Xiuhua, L; Yonggui, Z; Yanhua, X; Kong, Y; Hongtao, L; Yuliang, Z\n2013-10-01\nInvasive meningitis and pneumonia caused by Haemophilus influenzae type b (Hib) is an important cause of childhood mortality in countries where Hib vaccination is not routine. We evaluated the non-inferiority of a licensed Hib vaccine, PRP-CRM(197) compared with a second licensed Hib vaccine, PRP-T, following the recommended Chinese immunisation schedule for infants between 6 months and 1 year of age. In the first study phase, 6-12 month-old infants received two primary doses of either PRP-CRM(197) (n = 335) or PRP-T (n = 335) vaccine administered 1 month apart. In the second study phase 8 months later, the same children received a single booster dose of vaccine identical to that use for priming (PRP-CRM(197), n = 327; PRP-T, n = 333). Serum levels of anti-polyribosylribitol phosphate (PRP) antibodies were measured using enzyme-linked immunosorbent assay (ELISA). Non-inferiority of primary and booster doses was assessed in terms of percentages of subjects with anti-PRP antibody levels associated with providing short-term (\u2265 0.15 \u03bcg/ml) and long-term (\u2265 1.0 \u03bcg/ml) protection; the non-inferiority margin was set at -5%. PRP-CRM(197) was demonstrated to be non-inferior to PRP-T. Anti-PRP antibodies levels \u2265 0.15 \u03bcg/ml and \u2265 1.0 \u03bcg/ml were achieved by 97% of infants in the PRP-CRM(197) group and 98% of infants in the PRP-T group 1 month after primary immunisation, and by all subjects (100%) in both vaccine groups 1 month after booster administration. Safety profiles for both vaccines were similar; no serious adverse events, deaths or adverse events leading to withdrawal occurred during the study. PRP-CRM(197) was well-tolerated and immunologically non-inferior to a licensed comparator Hib vaccine in Chinese infants (Clinicaltrials.gov: NCT01044316 & NCT01226953). \u00a9 2013 John Wiley & Sons Ltd.\n[Vacina contra influenza: conhecimentos, atitudes e pr\u00e1ticas de idosos em Teresina Vacuna contra gripe: conocimiento, actitudes y pr\u00e1ctica de ancianos en Teresina Vaccine influenza: knowledge, attitudes and practices of elderly in Teresina](http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0034-71672007000400015) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nTelma Maria Evangelista de Ara\u00fajo\n2007-08-01\nFull Text Available Este estudo objetiva levantar os conhecimentos, atitudes e pr\u00e1ticas dos idosos de uma \u00e1rea do Programa de Sa\u00fade da Fam\u00edlia (PSF sobre a vacina contra influenza e identificar os motivos que levaram alguns a n\u00e3o se vacinarem. Consiste em um inqu\u00e9rito domiciliar, em uma \u00e1rea do PSF de Teresina, com 74 idosos a partir de 60 anos. Os resultados evidenciaram que n\u00e3o obstante 85,3% tenham conhecimento inadequado sobre a vacina, 89,1% s\u00e3o favor\u00e1veis. Os motivos mais freq\u00fcentes para a n\u00e3o vacina\u00e7\u00e3o foram doen\u00e7a e temor dos eventos adversos. Conclui-se que a atitude favor\u00e1vel a respeito da vacina\u00e7\u00e3o pode modificar a pr\u00e1tica frente a ela, instaurando comportamento de autoprote\u00e7\u00e3o e maior ades\u00e3o.Este estudio objetivo para levantar el conocimiento, pr\u00e1ctico y actitudes envejecidos de un \u00e1rea del programa de la salud de Familia (PSF en la vacuna cuenta gripe e identificar las razones que hab\u00edan tomado alguno para no ser vaccined. Consiste en una investigaci\u00f3n domiciliaria, un \u00e1rea del PSF de Teresina, con 74 envejeci\u00f3 unos a partir de 60 a\u00f1os. El resultado hab\u00eda evidenciado que sin embargo 85.3% tienen conocimiento inadecuado en la vacuna, 89.1% es favorable. Las razones m\u00e1s frecuentes para la vacunaci\u00f3n no hab\u00edan sido enfermedad y miedo de los acontecimientos adversos. Se concluye que la actitud favorable con respecto a la vacunaci\u00f3n puede modificar el frente pr\u00e1ctico \u00e9l, restaurando el comportamiento de la uno mismo-protecci\u00f3n y de la mayor adherencia.This objective study to raise the knowledge, practical and attitudes of the aged ones of an area of the Program of Health of Fam\u00edlia (PSF on the vaccine it counts influenza and to identify the reasons that had taken some not to be vaccined. It consists of a domiciliary inquiry, an area of the PSF of Teresina, with 74 aged ones from 60 years. The result had evidenced that even so 85.3% have inadequate knowledge on the vaccine, 89.1% is favorable. The reasons most frequent\n[Economic evaluations of Haemophilus influenzae type b (Hib) vaccine: a systematic review.](https://www.ncbi.nlm.nih.gov/pubmed/28737468)\nChongmelaxme, Bunchai; Hammanee, Maythika; Phooaphirak, Wariya; Kotirum, Surachai; Hutubessy, Raymond; Chaiyakunapruk, Nathorn\n2017-10-01\nThe World Health Organization (WHO) recommends the use of Haemophilus influenzae type b (Hib) conjugate vaccines, but China and Thailand have not used Hib vaccination in their national immunization programs. This systematic review aimed to update published economic evaluations of Hib vaccinations and to determine factors that potentially affected their cost-effectiveness. Searches were performed from the inception until December 2015 using 13 databases: CAB direct; CEA registry; EconLit; EMBASE; E-library; NHSEED; PAHO; POPLINE; PubMed; Redalyc project; RePEc; SciELO; and WHOLIS. Reference lists of relevant studies and grey literature were also searched. Full economic evaluations of Hib vaccination with results of costs and outcomes were included. The WHO checklist was used to evaluate the quality of the included studies. Data from eligible studies were extracted using a standardized data collection form. Out of 830 articles, 27 were included. Almost half of the studies (12/27) were conducted in high-income countries. Twelve studies (12/27) investigated the Hib vaccine as an addition to the existing vaccination program. Most studies (17/27) examined a 3-dose schedule of Hib vaccine. Nineteen studies (19/27) reported the model used, where all were decision tree models. Most of the studies (23/27) demonstrated an economic value of Hib vaccination programs, key influential parameters being incidence rates of Hib disease and vaccine price. Hib vaccination programs are mostly found to be cost-effective across geographic regions and country income levels, and Hib vaccination is recommended for inclusion into all national immunization programs. The findings are expected to support policy-makers for making decisions on allocating limited resources of the Hib vaccination program effectively.\n[Haemophilus parainfluenzae Strain ATCC 33392 Forms Biofilms In Vitro and during Experimental Otitis Media Infections.](https://www.ncbi.nlm.nih.gov/pubmed/28674033)\nPang, Bing; Swords, W Edward\n2017-09-01\nHaemophilus parainfluenzae is a nutritionally fastidious, Gram-negative bacterium with an oropharyngeal/nasopharyngeal carriage niche that is associated with a range of opportunistic infections, including infectious endocarditis and otitis media (OM). These infections are often chronic/recurrent in nature and typically involve bacterial persistence within biofilm communities that are highly resistant to host clearance. This study addresses the primary hypothesis that H. parainfluenzae forms biofilm communities that are important determinants of persistence in vivo The results from in vitro biofilm studies confirmed that H. parainfluenzae formed biofilm communities within which the polymeric matrix was mainly composed of extracellular DNA and proteins. Using a chinchilla OM infection model, we demonstrated that H. parainfluenzae formed surface-associated biofilm communities containing bacterial and host components that included neutrophil extracellular trap (NET) structures and that the bacteria mainly persisted in these biofilm communities. We also used this model to examine the possible interaction between H. parainfluenzae and its close relative Haemophilus influenzae , which is also commonly carried within the same host environments and can cause OM. The results showed that coinfection with H. influenzae promoted clearance of H. parainfluenzae from biofilm communities during OM infection. The underlying mechanisms for bacterial persistence and biofilm formation by H. parainfluenzae and knowledge about the survival defects of H. parainfluenzae during coinfection with H. influenzae are topics for future work. Copyright \u00a9 2017 American Society for Microbiology.\n['Haemophilus quentini' in the urethra of men complaining of urethritis symptoms.](https://www.ncbi.nlm.nih.gov/pubmed/28889986)\nHorie, Kengo; Ito, Shin; Hatazaki, Kyoko; Yasuda, Mitsuru; Nakano, Masahiro; Kawakami, Kyojiro; Fujita, Yasunori; Ito, Masafumi; Ezaki, Takayuki; Deguchi, Takashi\n2018-01-01\nWe isolated a cryptic genospecies of Haemophilus influenzae referred to as 'Haemophilus quentini' in the urethra of 3 men complaining of urethritis symptoms. H. influenzae strains, which had been isolated from the urethra in 77 of 1518 men complaining of urethritis symptoms, identified by the conventional test, and stored, were re-cultured for this study. Sixty-seven strains surviving storage were screened by a PCR-based assay specific for the cryptic genital Haemophilus genospecies. Three strains (HI09003, HI11006, and HI14016) were screened by PCR and identified as 'H. quentini' by 16S rRNA sequencing. The men positive for HI09003 and HI11006 were diagnosed as having non-chlamydial non-gonococcal urethritis (NGU), and their demographic and clinical features were similar to those of NGU caused by other pathogens. The man positive for HI14016 was ultimately diagnosed as having condyloma acuminatum on the glans. The 3 strains of 'H. quentini' produced no \u03b2-lactamase and were susceptible to ampicillin and other antimicrobial agents, including cephalosporins, fluoroquinolones, tetracyclines, and macrolides, recommended for treatment for urethritis. 'H. quentini' would be an uncommon pathogen in men with urogenital infections. Based on the clinical features of the two patients with 'H. quentini'-positive NGU, it would be difficult to predict the presence of 'H. quentini' in the urethra. The 3 strains of 'H. quentini' were susceptible to a variety of antimicrobial agents. Further accumulation of data regarding 'H. quentini' infections is needed to characterize the pathogenic roles of this genospecies in urogenital infections and to establish appropriate management of 'H. quentini' infections. Copyright \u00a9 2017 Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.\n[Haemophilus influenzae : Caracterizaci\u00f3n de aislamientos recuperados de enfermedades invasivas en Cuba durante el per\u00edodo 2008-2011](http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1025-028X2012000300005&lng=es&nrm=iso) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nGilda Tora\u00f1o\n2012-12-01\nFull Text Available Con el objetivo de caracterizar los aislamientos de Haemophilus influenzae, responsables de enfermedades invasivas en Cuba, en la etapa posterior a la vacunaci\u00f3n se estudi\u00f3 el total de los recuperados durante el per\u00edodo 2008-2011, remitidos al Instituto \"Pedro Kour\u00ed\" desde diferentes provincias del pa\u00eds. La confirmaci\u00f3n de especie y determinaci\u00f3n de serotipos se realiz\u00f3 atendiendo al requerimiento de los factores V y X y empleando el m\u00e9todo de aglutinaci\u00f3n en l\u00e1mina, respectivamente. Se definieron los biotipos a trav\u00e9s de las pruebas de indol, urea y ornitina; se determin\u00f3 la concentraci\u00f3n m\u00ednima inhibitoria (CMI mediante la prueba del elips\u00f3metro para la ampicilina, la ceftriaxona, el cloranfenicol y la rifampicina. Para 23 aislamientos se corrobor\u00f3 la identificaci\u00f3n como H. influenzae : 21 fueron serotipables y 2 no tipables (HNT. El 90,4% de los serotipables fueron serotipo b y se detectaron dos serotipos a. Nueve aislamientos de H. influenzae b pertenecieron al biotipo I y los aislamientos, serotipo a y HNT, al biotipo II. En una cepa se demostr\u00f3 producci\u00f3n de la enzima \u00df-lactamasa y resistencia para la ampicilina y el cloranfenicol, con valores de CMI= 8 y 12 \u00b5g/mL, respectivamente. Se puso en evidencia que a pesar de la disminuci\u00f3n de la incidencia de la enfermedad invasiva por Hib, este serotipo a\u00fan constituye el m\u00e1s frecuente y se alerta sobre la necesidad de una vigilancia sostenida que permita detectar fallos vacunales. La susceptibilidad antimicrobiana demostrada para este per\u00edodo pudiera considerarse como un beneficio adicional de la introducci\u00f3n de la vacunaci\u00f3n en Cuba.\n[Overexpression and Purification of C-terminal Fragment of the Passenger Domain of Hap Protein from Nontypeable Haemophilus influenzae in a Highly Optimized Escherichia coli Expression System](https://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=3732867)\nTabatabaee, Akram; Siadat, Seyed Davar; Moosavi, Seyed Fazllolah; Aghasadeghi, Mohammad Reza; Memarnejadian, Arash; Pouriayevali, Mohammad Hassan; Yavari, Neda\n2013-01-01\nBackground Nontypeable Haemophilus influenzae (NTHi) is a common cause of respiratory tract disease and initiates infection by colonization in nasopharynx. The Haemophilus influenzae (H. influenzae) Hap adhesin is an auto transporter protein that promotes initial interaction with human epithelial cells. Hap protein contains a 110 kDa internal passenger domain called \u201cHapS\u201d and a 45 kDa C-terminal translocator domain called \u201cHap\u03b2\u201d. Hap adhesive activity has been recently reported to be connected to its Cell Binding Domain (CBD) which resides within the 311 C-terminal residues of the internal passenger domain of the protein. Furthermore, immunization with this CBD protein has been shown to prevent bacterial nasopharynx colonization in animal models. Methods To provide enough amounts of pure HapS protein for vaccine studies, we sought to develop a highly optimized system to overexpress and purify the protein in large quantities. To this end, pET24a-cbd plasmid harboring cbd sequence from NTHi ATCC49766 was constructed and its expression was optimized by testing various expression parameters such as growth media, induction temperature, IPTG inducer concentration, induction stage and duration. SDS-PAGE and Western-blotting were used for protein analysis and confirmation and eventually the expressed protein was easily purified via immobilized metal affinity chromatography (IMAC) using Ni-NTA columns. Results The highest expression level of target protein was achieved when CBD expressing E. coli BL21 (DE3) cells were grown at 37\u00b0C in 2xTY medium with 1.0 mM IPTG at mid-log phase (OD600 nm equal to 0.6) for 5 hrs. Amino acid sequence alignment of expressed CBD protein with 3 previously published CBD amino acid sequences were more than %97 identical and antigenicity plot analysis further revealed 9 antigenic domains which appeared to be well conserved among different analyzed CBD sequences. Conclusion Due to the presence of high similarity among CBD from NTHi ATCC\n[Evidence that UV-inducible error-prone repair is absent in Haemophilus influenzae Rd, with a discussion of the relation to error-prone repair of alkylating-agent damage](https://inis.iaea.orgsearchsinglerecord.aspx?recordsFor=SingleRecord&RN=10420857) [International Nuclear Information System (INIS) ](http://inis.iaea.org/search/)\nKimball, R.F.; Boling, M.E.; Perdue, S.W.\n1977-01-01\nHaemophilus influenzae Rd and its derivatives are mutated either not at all or to only a very small extent by ultraviolet radiation, X-rays, methyl methanesulfonate, and nitrogen mustard, though they are readily mutated by such agents as N-methyl-N'-nitro-N-nitrosoguanidine, ethyl methanesulfonate, and nitrosocarbaryl (NC). In these respects H. influenzae Rd resembles the lexA mutants of Escherichia coli that lack the SOS or reclex UV-inducible error-prone repair system. This similarity is further brought out by the observation that chloramphenicol has little or no effect on post-replication repair after UV irradiation. In E. coli, chloramphenicol has been reported to considerably inhibit post-replication repair in the wild type but not in the lexA mutant. Earlier work has suggested that most or all the mutations induced in H. influenzae by NC result from error-prone repair. Combined treatment with NC and either X-rays or UV shows that the NC error-prone repair system does not produce mutations from the lesions induced by these radiations even while it is producing them from its own lesions. It is concluded that the NC error-prone repair system or systems and the reclex error-prone system are different\n[Divergent mechanisms for passive pneumococcal resistance to \u03b2-lactam antibiotics in the presence of Haemophilus influenzae.](https://www.ncbi.nlm.nih.gov/pubmed/21220774)\nWeimer, Kristin E D; Juneau, Richard A; Murrah, Kyle A; Pang, Bing; Armbruster, Chelsie E; Richardson, Stephen H; Swords, W Edward\n2011-02-15\nOtitis media, for which antibiotic treatment failure is increasingly common, is a leading pediatric public health problem. In vitro and in vivo studies using the chinchilla model of otitis media were performed using a \u03b2-lactamase-producing strain of nontypeable Haemophilus influenzae (NTHi 86-028NP) and an isogenic mutant deficient in \u03b2-lactamase production (NTHi 86-028NP bla) to define the roles of biofilm formation and \u03b2-lactamase production in antibiotic resistance. Coinfection studies were done with Streptococcus pneumoniae to determine if NTHi provides passive protection by means of \u03b2-lactamase production, biofilm formation, or both. NTHi 86-028NP bla was resistant to amoxicillin killing in biofilm studies in vitro; however, it was cleared by amoxicillin treatment in vivo, whereas NTHi 86-028NP was unaffected in either system. NTHi 86-028NP protected pneumococcus in vivo in both the effusion fluid and bullar homogenate. NTHi 86-028NP bla and pneumococcus were both recovered from the surface-associated bacteria of amoxicillin-treated animals; only NTHi 86-028NP bla was recovered from effusion. Based on these studies, we conclude that NTHi provides passive protection for S. pneumoniae in vivo through 2 distinct mechanisms: production of \u03b2-lactamase and formation of biofilm communities.\n[Safety and Immunogenicity of Coadministering a Combined Meningococcal Serogroup C and Haemophilus influenzae Type b Conjugate Vaccine with 7-Valent Pneumococcal Conjugate Vaccine and Measles, Mumps, and Rubella Vaccine at 12 Months of Age \u25bf](https://www.openaire.eu/search/publication?articleId=od_______908::7b2efba4f4ae1facffa048f5bd49f88c)\nMiller, Elizabeth; Andrews, Nick; Waight, Pauline; Findlow, Helen; Ashton, Lindsey; England, Anna; Stanford, Elaine; Matheson, Mary; Southern, Joanna; Sheasby, Elizabeth; Goldblatt, David; Borrow, Ray\n2010-01-01\nThe coadministration of the combined meningococcal serogroup C conjugate (MCC)/Haemophilus influenzae type b (Hib) vaccine with pneumococcal conjugate vaccine (PCV7) and measles, mumps, and rubella (MMR) vaccine at 12 months of age was investigated to assess the safety and immunogenicity of this regimen compared with separate administration of the conjugate vaccines. Children were randomized to receive MCC/Hib vaccine alone followed 1 month later by PCV7 with MMR vaccine or to receive all thr...\n[Evidence of functional cell-mediated immune responses to nontypeable Haemophilus influenzae in otitis-prone children](https://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=5886403)\nSeppanen, Elke; Tan, Dino; Corscadden, Karli J.; Currie, Andrew J.; Richmond, Peter C.; Thornton, Ruth B.\n2018-01-01\nOtitis media (OM) remains a common paediatric disease, despite advances in vaccinology. Susceptibility to recurrent acute OM (rAOM) has been postulated to involve defective cell-mediated immune responses to common otopathogenic bacteria. We compared the composition of peripheral blood mononuclear cells (PBMC) from 20 children with a history of rAOM (otitis-prone) and 20 healthy non-otitis-prone controls, and assessed innate and cell-mediated immune responses to the major otopathogen nontypeable Haemophilus influenzae (NTHi). NTHi was a potent stimulator of inflammatory cytokine secretion from PBMC within 4 hours, with no difference in cytokine levels produced between PBMC from cases or controls. In the absence of antigen stimulation, otitis-prone children had more circulating Natural Killer (NK) cells (potitis-prone and non-otitis-prone children (potitis-prone children are functional and respond to NTHi. CD8+ T cells and NK cells from both cases and controls produced IFN\u03b3 in response to polyclonal stimulus (Staphylococcal enterotoxin B; SEB), with more IFN\u03b3+ CD8+ T cells present in cases than controls (pOtitis-prone children had more circulating IFN\u03b3-producing NK cells (potitis-prone children mounted innate and T cell-mediated responses to NTHi challenge that were comparable to healthy children. These data provide evidence that otitis-prone children do not have impaired functional cell mediated immunity. PMID:29621281\n[Validaci\u00f3n del m\u00e9todo de Ellman para la determinaci\u00f3n de la concentraci\u00f3n de grupos sulfhidrilosa muestras de la producci\u00f3n de la vacuna sint\u00e9tica contra el Haemophilus influenzae tipo b](http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1025-028X2014000200006&lng=es&nrm=iso) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nMayra Wood-Duque\n2014-08-01\nFull Text Available e valid\u00f3 el m\u00e9todo de Ellman para la determinaci\u00f3n de grupos sulfhidrilos de la producci\u00f3n del Ingrediente Farmac\u00e9utico Activo de la vacuna contra el Haemophilusinfluenzaetipo b (Hib. Se evaluaron los par\u00e1metros: linealidad, rango de trabajo, especificidad, exactitud y precisi\u00f3n. El m\u00e9todo fue lineal en el rango de 0,25-4 mM/L. Se demostr\u00f3 que la t\u00e9cnica fue espec\u00edfica con una exactitud entre 95 y 105%. La repetibilidad y la precisi\u00f3n intermedia mostraron coeficientes de variaci\u00f3n inferiores al 5% y 10% respectivamente, por debajo de los criterios de aceptaci\u00f3n requeridos para estos par\u00e1metros. Se estableci\u00f3 el reactivo hidrocloruro de L-ciste\u00edna monohidratado como control positivo del m\u00e9todo. Este ensayo por su precisi\u00f3n, especificidad y exactitud se convierte en una eficaz herramienta para el control del proceso de obtenci\u00f3n de esta vacuna.\n[Anti-pandemic influenza A (H1N1) virus potential of catechin and gallic acid.](https://www.ncbi.nlm.nih.gov/pubmed/29287704)\nYou, Huey-Ling; Huang, Chao-Chun; Chen, Chung-Jen; Chang, Cheng-Chin; Liao, Pei-Lin; Huang, Sheng-Teng\n2018-05-01\nThe pandemic influenza A (H1N1) virus has spread worldwide and infected a large proportion of the human population. Discovery of new and effective drugs for the treatment of influenza is a crucial issue for the global medical community. According to our previous study, TSL-1, a fraction of the aqueous extract from the tender leaf of Toonasinensis, has demonstrated antiviral activities against pandemic influenza A (H1N1) through the down-regulation of adhesion molecules and chemokine to prevent viral attachment. The aim of the present study was to identify the active compounds in TSL-1 which exert anti-influenza A (H1N1) virus effects. XTT assay was used to detect the cell viability. Meanwhile, the inhibitory effect on the pandemic influenza A (H1N1) virus was analyzed by observing plaque formation, qRT-PCR, neuraminidase activity, and immunofluorescence staining of influenza A-specific glycoprotein. Both catechin and gallic acid were found to be potent inhibitors in terms of influenza virus mRNA replication and MDCK plaque formation. Additionally, both compounds inhibited neuraminidase activities and viral glycoprotein. The 50% effective inhibition concentration (EC 50 ) of catechin and gallic acid for the influenza A (H1N1) virus were 18.4 \u03bcg/mL and 2.6 \u03bcg/mL, respectively; whereas the 50% cytotoxic concentrations (CC 50 ) of catechin and gallic acid were >100 \u03bcg/mL and 22.1 \u03bcg/mL, respectively. Thus, the selectivity indexes (SI) of catechin and gallic acid were >5.6 and 22.1, respectively. The present study demonstrates that catechin might be a safe reagent for long-term use to prevent influenza A (H1N1) virus infection; whereas gallic acid might be a sensitive reagent to inhibit influenza virus infection. We conclude that these two phyto-chemicals in TSL-1 are responsible for exerting anti-pandemic influenza A (H1N1) virus effects. Copyright \u00a9 2017. Published by Elsevier Taiwan LLC.\n[Relation between enzyme-linked immunosorbent assay and radioimmunoassay for detection of antibodies to the capsular polysaccharide of Haemophilus influenzae type b](https://inis.iaea.orgsearchsinglerecord.aspx?recordsFor=SingleRecord&RN=23071324) [International Nuclear Information System (INIS) ](http://inis.iaea.org/search/)\nKristensen, K.; Weis Bentzon, M.\n1992-01-01\nThe measurement of antibodies to the capsular polysaccharide (PRP) of Haemophilus influenzae type b (Hib) is important because vaccines inducing such antibodies are now available. We developed and evaluated an enzyme-linked immunosorbent assay (ELISA) for detection of these antibodies based on direct coating of the plates with tyraminated PRP. The assay fulfilled the requirements for parallel line assays; it was sensitive, specific, and reproducible with a coefficient of variation between days of 19%. Results from the ELISA were compared with results from radioimmunoassay and a correlation coefficient of 0.93 was found. Results obtained by the two methods were proportional and the relation was indepenedent of the antibody level. The relation between them was also unaffected by the contribution of different antibody isotypes, indicating that these were measured to the same extent by both methods. ELISA employing direct coating of the plates with tyraminated PRP represents a useful alternative for detection of antibodies when studying immunogenicity of Hib vaccines. (au)\n[Identification and Characterization of msf, a Novel Virulence Factor in Haemophilus influenzae.](http://europepmc.org/articles/PMC4792463?pdf=render) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nJennifer M Kress-Bennett\nFull Text Available Haemophilus influenzae is an opportunistic pathogen. The emergence of virulent, non-typeable strains (NTHi emphasizes the importance of developing new interventional targets. We screened the NTHi supragenome for genes encoding surface-exposed proteins suggestive of immune evasion, identifying a large family containing Sel1-like repeats (SLRs. Clustering identified ten SLR-containing gene subfamilies, each with various numbers of SLRs per gene. Individual strains also had varying numbers of SLR-containing genes from one or more of the subfamilies. Statistical genetic analyses of gene possession among 210 NTHi strains typed as either disease or carriage found a significant association between possession of the SlrVA subfamily (which we have termed, macrophage survival factor, msf and the disease isolates. The PittII strain contains four chromosomally contiguous msf genes. Deleting all four of these genes (msfA1-4 (KO resulted in a highly significant decrease in phagocytosis and survival in macrophages; which was fully complemented by a single copy of the msfA1 gene. Using the chinchilla model of otitis media and invasive disease, the KO strain displayed a significant decrease in fitness compared to the WT in co-infections; and in single infections, the KO lost its ability to invade the brain. The singly complemented strain showed only a partial ability to compete with the WT suggesting gene dosage is important in vivo. The transcriptional profiles of the KO and WT in planktonic growth were compared using the NTHi supragenome array, which revealed highly significant changes in the expression of operons involved in virulence and anaerobiosis. These findings demonstrate that the msfA1-4 genes are virulence factors for phagocytosis, persistence, and trafficking to non-mucosal sites.\n[A clinical trial examining the effect of increased total CRM(197) carrier protein dose on the antibody response to Haemophilus influenzae type b CRM(197) conjugate vaccine.](https://www.ncbi.nlm.nih.gov/pubmed/18577410)\nUsonis, Vytautas; Bakasenas, Vytautas; Lockhart, Stephen; Baker, Sherryl; Gruber, William; Laudat, France\n2008-08-18\nCRM(197) is a carrier protein in certain conjugate vaccines. When multiple conjugate vaccines with the same carrier protein are administered simultaneously, reduced response to vaccines and/or antigens related to the carrier protein may occur. This study examined responses of infants who, in addition to diphtheria toxoid/tetanus toxoid/acellular pertussis vaccine (DTaP) received either diphtheria CRM(197)-based Haemophilus influenzae type b conjugate vaccine (HbOC) or HbOC and a diphtheria CRM(197)-based combination 9-valent pneumococcal conjugate vaccine/meningococcal group C conjugate vaccine. Administration of conjugate vaccines with CRM(197) carrier protein load >50 microg did not reduce response to CRM(197) conjugate vaccines or immunogenicity to immunologically cross-reactive diphtheria toxoid.\n[Vacuna Sint\u00e9tica contra la Malaria](http://revistamedicina.net/ojsanm/index.php/Revistamedicina/article/view/903) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nManuel Elkin Patarroyo\n1993-12-01\nFull Text Available\nEl doctor Manuel Elkin Patarroyo hace un recuento de lo que fueron sus primeros a\u00f1os de estudio y los primeros pasos que se dieron para fundar el Instituto de Inmunolog\u00eda, ayudado por muchos de los Acad\u00e9micos. Siempre ha querido representar al pueblo colombiano en sus valores de trabajo, disciplina, estudio, pensamiento y generosidad, en aras de un pueblo que sufre, que en definitiva es el objetivo del M\u00e9dico, el paciente.\nPosteriormente comenta qu\u00e9 es lo que se ha hecho con toda la profundidad que se merece pero con simpleza de palabras y en t\u00e9rminos sencillos, c\u00f3mo se desarroll\u00f3 la Vacuna Sint\u00e9tica contra la malaria: \u00bfPor qu\u00e9 malaria?, porque esta es una enfermedad de gran trascendencia; aclara que \u00e9l no le teme ni le molesta el cuestionamiento cient\u00edfico sobre el desarrollo de esta investigaci\u00f3n, por el contrario lo acepta y lo goza porque es el ejercicio intelectual; lo que s\u00ed le molesta es el morbo alrededor de ello, por esto pidi\u00f3 al doctor Mu\u00f1oz que al final se adelante un debate al respecto.\nDice a continuaci\u00f3n que las vacunas tradicionales son biol\u00f3gicas como todo el mundo lo sabe, es el microorganismo causal mismo que se muta ose mata, pero que descomponiendo la estructura qu\u00edmica de sus mol\u00e9culas, con el concepto de la s\u00edntesis qu\u00edmica se podr\u00edan rehacer qu\u00edmicamente y ser utilizadas como vacuna.\nDecidieron entonces atacar el problema de la vacuna a trav\u00e9s de esta metodolog\u00eda creando la vacuna contra la malaria de la cual se conoce su estructura qu\u00edmica, y aclara que las vacunas qu\u00edmicas tienen otra ventaja, que son puras, con menos reacciones adversas que las tradicionales.\nDice el doctor Patarroyo que decidieron aislar, e identificar m\u00e1s de la mitad de las prote\u00ednas del par\u00e1sito y dividiendo la muestra en dos fracciones, una de ellas se seleccion\u00f3 para averiguar su composici\u00f3n qu\u00edmica y la otra para saber cu\u00e1l podr\u00eda ser \u00fatil como vacuna. As\u00ed, fueron al Amazonas y all\n[Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nAlejandro Roque Vald\u00e9s\n2004-04-01\nFull Text Available El presente trabajo es un art\u00edculo de revisi\u00f3n que pretende abordar un tema tan controvertido como actual: la posible asociaci\u00f3n causal que se ha querido establecer entre el autismo y las vacunas infantiles. A partir de la \u00faltima d\u00e9cada del siglo XX se producen una serie de cambios en la clasificaci\u00f3n, nomenclatura y criterios diagn\u00f3sticos del autismo. Los hallazgos de estudios epidemiol\u00f3gicos llevados a cabo bajo estos nuevos ponderados han revelado que las tasas de prevalencia del autismo son en la actualidad muy superiores a las de hace 15 a\u00f1os. Entre los factores que se esgrimen para explicar este fen\u00f3meno est\u00e1n las vacunas, y entre los mecanismos que se invocan para tratar de inculpar a las vacunas en la etiolog\u00eda del autismo est\u00e1n el exceso de mercurio derivado del tiomersal que se emplea como conservante de las mismas y procesos autoinmunes que de forma directa o indirectamente act\u00faan sobre el SNC, induciendo lesiones a nivel de la mucosa intestinal, lo cual favorecer\u00e1 la absorci\u00f3n de macromol\u00e9culas, ant\u00edgenos y toxinas que una vez en el torrente sangu\u00edneo llegar\u00edan al SNC produciendo all\u00ed las lesiones responsables de la g\u00e9nesis del autismo.\n[Una vacuna contra la tuberculosi, provada en cabres](https://www.openaire.eu/search/publication?articleId=od______1404::6574285bd1662fef225103ab5f2fa6f1)\nP\u00e9rez del Val, Bernat\n2012-01-01\nInvestigadors del CReSA han dut a terme el primer estudi de vacunaci\u00f3 contra la tuberculosi utilitzant com a model experimental la cabra dom\u00e8stica, que reprodueix amb molta similitud la resposta a la tuberculosi en humans. La vacuna, anomenada AdAg85A, ha estat dissenyada per investigadors de McMaster University (Canad\u00e0) per prevenir la tuberculosi en humans, i actualment es troba en fase I d\u2019assajos cl\u00ednics. De moment, aquest estudi mostra que la inoculaci\u00f3 d\u2019aquesta nova vacuna, com a refor...\n[Assessment of Anti-Influenza Activity and Hemagglutination Inhibition of Plumbago indica and Allium sativum Extracts.](https://www.ncbi.nlm.nih.gov/pubmed/27034600)\nChavan, Rahul Dilip; Shinde, Pramod; Girkar, Kaustubh; Madage, Rajendra; Chowdhary, Abhay\n2016-01-01\nHuman influenza is a seasonal disease associated with significant morbidity and mortality. Anti-flu ayurvedic/herbal medicines have played a significant role in fighting the virus pandemic. Plumbagin and allicin are commonly used ingredients in many therapeutic remedies, either alone or in conjunction with other natural substances. Evidence suggests that these extracts are associated with a variety of pharmacological activities. To evaluate anti-influenza activity from Plumbago indica and Allium sativum extract against Influenza A (H1N1)pdm09. Different extraction procedures were used to isolate the active ingredient in the solvent system, and quantitative HPLTC confirms the presence of plumbagin and allicin. The cytotoxicity was carried out on Madin-Darby Canine kidney cells, and the 50% cytotoxic concentration (CC50) values were below 20 mg/mL for both plant extracts. To assess the anti-influenza activity, two assays were employed, simultaneous and posttreatment assay. A. sativum methanolic and ethanolic extracts showed only 14% reduction in hemagglutination in contrast to P. indica which exhibited 100% reduction in both simultaneous and posttreatment assay at concentrations of 10 mg/mL, 5 mg/mL, and 1 mg/mL. Our results suggest that P. indica extracts are good candidates for anti-influenza therapy and should be used in medical treatment after further research. The search for natural antiviral compounds from plants is a promising approach in the development of new therapeutic agents. In the past century, several scientific efforts have been directed toward identifying phytochemicals capable of inhibiting virus. Knowledge of ethnopharmacology can lead to new bioactive plant compounds suitable for drug discovery and development. Macromolecular docking studies provides most detailed possible view of drug-receptor interaction where the structure of drug is designed based on its fit to three dimensional structures of receptor site rather than by analogy to other\n[In Vitro Capability of Faropenem To Select for Resistant Mutants of Streptococcus pneumoniae and Haemophilus influenzae\u25bf \u2020](https://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=2224784)\nKosowska-Shick, Klaudia; Clark, Catherine; Credito, Kim; Dewasse, Bonifacio; Beachel, Linda; Ednie, Lois; Appelbaum, Peter C.\n2008-01-01\nWhen tested against nine strains of pneumococci and six of Haemophilus influenzae of various resistotypes, faropenem failed to select for resistant mutants after 50 days of consecutive subculture in subinhibitory concentrations. Faropenem also yielded low rates of spontaneous mutations against all organisms of both species. By comparison, resistant clones were obtained with macrolides, ketolides, and quinolones. PMID:18086853\n[NUEVO CALENDARIO DE VACUNACI\u00d3N PARA ESPA\u00d1A, 2016 (PARTE 2](http://www.redalyc.org/articulo.oa?id=17043728006) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nJos\u00e9 Antonio Navarro-Alonso\n2016-01-01\nFull Text Available En este documento se justifican los fundamentos inmunol\u00f3gicos y cl\u00ed - nicos para abordar una modificaci\u00f3n del Calendario de Vacunaci\u00f3n Infantil de Espa\u00f1a para el a\u00f1o 2016. Se revisa la inmunogenicidad y la experiencia cl\u00ednica con esquemas de vacunaci\u00f3n de dos dosis como primovacunaci\u00f3n en el primer a\u00f1o de vida y una dosis de recuerdo precoz, para los ant\u00edgenos de difteria, t\u00e9tanos, tosferina, Haemophilus influenzae tipo b, poliomielitis y hepatitis B. Por sus peculiaridades tambi\u00e9n se considera el impacto cl\u00ednico que esta pauta de vacunaci\u00f3n podr\u00eda tener en el lactante prematuro. Debido a que varias comunidades aut\u00f3nomas administran la primera dosis de vacuna de hepatitis B al nacimiento, se exponen las condiciones que se deber\u00edan cumplir para iniciar la vacunaci\u00f3n a los dos meses de vida. Se emiten las recomendaciones de calendario que incluyen como principales cambios la administraci\u00f3n de las vacunas hexavalentes a los 2, 4 y 11 meses, a\u00f1adiendo la recomendaci\u00f3n del uso de vacuna DTPa-VPI a los seis a\u00f1os de edad.\n[The dapE-encoded N-succinyl-l,l-diaminopimelic acid desuccinylase from Haemophilus influenzae is a dinuclear metallohydrolase.](https://www.ncbi.nlm.nih.gov/pubmed/14640610)\nCosper, Nathaniel J; Bienvenue, David L; Shokes, Jacob E; Gilner, Danuta M; Tsukamoto, Takashi; Scott, Robert A; Holz, Richard C\n2003-12-03\nThe Zn K-edge extended X-ray absorption fine structure (EXAFS) spectra, of the dapE-encoded N-succinyl-l,l-diaminopimelic acid desuccinylase (DapE) from Haemophilus influenzae have been recorded in the presence of one or two equivalents of Zn(II) (i.e. [Zn_(DapE)] and [ZnZn(DapE)]). The Fourier transforms of the Zn EXAFS are dominated by a peak at ca. 2.0 A, which can be fit for both [Zn_(DapE)] and [ZnZn(DapE)], assuming ca. 5 (N,O) scatterers at 1.96 and 1.98 A, respectively. A second-shell feature at ca. 3.34 A appears in the [ZnZn(DapE)] EXAFS spectrum but is significantly diminished in [Zn_(DapE)]. These data show that DapE contains a dinuclear Zn(II) active site. Since no X-ray crystallographic data are available for any DapE enzyme, these data provide the first glimpse at the active site of DapE enzymes. In addition, the EXAFS data for DapE incubated with two competitive inhibitors, 2-carboxyethylphosphonic acid and 5-mercaptopentanoic acid, are also presented.\n[VACUNAS E INFECCIONES RESPIRATORIAS](http://www.sciencedirect.com/science/article/pii/S0716864017300160) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nDr. Rodolfo Villena\n2017-01-01\nFull Text Available Las vacunas han demostrado ser una excelente estrategia para reducir la morbimortalidad en infecciones respiratorias, con un perfil de seguridad adecuado. Nuestro PNI incorpora varias de ellas con este objetivo, logrando resultados de alto impacto a nivel de salud p\u00fablica. Para que esto prosiga se requiere de nuestro compromiso y conocimiento para estimular, difundir y obtener altas tasas de cobertura, de manera de lograr efectos de protecci\u00f3n indirecta, conocidos como inmunidad comunitaria. Por otro lado, se debe mantener la vigilancia epidemiol\u00f3gica de los agentes inmunoprevenibles para conocer su oscilaci\u00f3n temporal, serogrupos, sero y/o genotipos, de manera de establecer directrices adecuadas de edad y esquemas de vacunaci\u00f3n para la poblaci\u00f3n. Debemos avanzar en estos temas y realizar estudios de efectividad de las vacunas que hemos introducido, para conocer su aporte en la prevenci\u00f3n de infecciones respiratorias, de manera de objetivar sus beneficios, conocer el impacto en poblaciones de riesgo y avanzar en la vacunaci\u00f3n de embarazadas, para otorgar mejores estrategias de prevenci\u00f3n a nuestra poblaci\u00f3n.\n[Economic evaluation of delivering Haemophilus influenzae type b vaccine in routine immunization services in Kenya.](https://www.ncbi.nlm.nih.gov/pubmed/17768499)\nAkumu, Angela Oloo; English, Mike; Scott, J Anthony G; Griffiths, Ulla K\n2007-07-01\nHaemophilus influenzae type b (Hib) vaccine was introduced into routine immunization services in Kenya in 2001. We aimed to estimate the cost-effectiveness of Hib vaccine delivery. A model was developed to follow the Kenyan 2004 birth cohort until death, with and without Hib vaccine. Incidence of invasive Hib disease was estimated at Kilifi District Hospital and in the surrounding demographic surveillance system in coastal Kenya. National Hib disease incidence was estimated by adjusting incidence observed by passive hospital surveillance using assumptions about access to care. Case fatality rates were also assumed dependent on access to care. A price of US$ 3.65 per dose of pentavalent diphtheria-tetanus-pertussis-hep B-Hib vaccine was used. Multivariate Monte Carlo simulations were performed in order to assess the impact on the cost-effectiveness ratios of uncertainty in parameter values. The introduction of Hib vaccine reduced the estimated incidence of Hib meningitis per 100,000 children aged disability adjusted life year (DALY) and per discounted death averted were US$ 38 (95% confidence interval, CI: 26-63) and US$ 1197 (95% CI: 814-2021) respectively. Most of the uncertainty in the results was due to uncertain access to care parameters. The break-even pentavalent vaccine price--where incremental Hib vaccination costs equal treatment costs averted from Hib disease--was US$ 1.82 per dose. Hib vaccine is a highly cost-effective intervention in Kenya. It would be cost-saving if the vaccine price was below half of its present level.\n[Cost-benefit analysis of a Haemophilus influenzae type b meningitis prevention programme in The Philippines.](https://www.ncbi.nlm.nih.gov/pubmed/11383755)\nLimcangco, M R; Armour, C L; Salole, E G; Taylor, S J\n2001-01-01\nHaemophilus influenzae type b (Hib) meningitis is associated with high mortality and serious sequelae in children under 5 years of age. Vaccines which can prevent this infection are available. To evaluate the costs and benefits of a 3-dose immunisation schedule in Manila, Philippines. Government and societal perspectives. A cost-benefit analysis based on a birth cohort of 100,000 children. The state of health of the cohort with and without a Hib immunisation programme was modelled over a 5-year period. A survey of medical records of patients with Hib in Manila provided data on the extent and cost of sequelae following infection. A 3-dose Hib vaccination programme given at ages 2, 3 and 4 months. The model predicted that vaccinating children against Hib meningitis would prevent 553 cases per year in a birth cohort of 100,000, at a cost of 56,200 Philippine pesos (PHP) [$US1,605; 1998 exchange rate] per case (base case assumptions of 90% vaccine efficacy rate, 95 per 100,000 Hib incidence rate, 85% vaccination coverage). Results from the cost-benefit analyses indicated that the saving to the government would be around PHP39 million ($US1.11 million), and the saving to society would be PHP255 million ($US7.28 million). There would be a positive economic benefit for the Philippine government and for the Filipino society if a Hib vaccination programme was introduced in Manila.\n[Haemophilus influenzae type b disease in Auckland children during the Hib vaccination era: 1995-2009.](https://www.ncbi.nlm.nih.gov/pubmed/23254497)\nLeung, Bonnie; Taylor, Susan; Drinkovic, Dragana; Roberts, Sally; Carter, Phil; Best, Emma\n2012-11-09\nTo characterise Haemophilus influenzae type b (Hib) invasive disease in the era of Hib vaccination, in children of the greater Auckland region of New Zealand. Identification of sterile site culture positive Hib via the Auckland hospital laboratories databases and national laboratory surveillance database in the time period; 1995 to 2009. There were a total of 26 cases in the Auckland Region. Over the 15-year period, the annual incidence of invasive Hib disease was 0.61 per 100,000 (95% CI: 0.4-0.9) for children aged under 15 years and 1.65 per 100,000 (95% CI: 1.1-2.5) for children aged under 5 years. Ninety-two percent were under 5 years and 54% were under 1 year. Sixty percent of the children were of Maori and Pacific ethnicity. The predominant diagnosis was meningitis, accounting for 15 cases (60%). There were no fatalities. Forty-eight percent of affected children were completely unimmunised with the Hib vaccine which has been fully funded on the National Immunisation Schedule since 1994. Since the introduction of the Hib vaccine, the disease rates have greatly reduced in the Auckland region. Although ethnic disparities have improved amongst the cases that occur, immunisation rates in cases are low and infants remain most at risk. Current emphasis on intensifying immunisation programmes to achieve higher vaccination rates and timeliness of delivery will help in efforts to achieve elimination of the disease in New Zealand.\n[VACCINE IMMUNIZATION FOR PREVENTION OF PNEUMOCOCCAL, HAEMOPHILUS INFLUENZAE AND FLU AMONG SICKLY CHILDREN, WHO OFTEN SUFFER FROM PERSISTENT HETEROSPECIFIC INFECTIOUS PATHOLOGY OF THE BRONCHOPULMONARY SYSTEM](http://vsp.spr-journal.ru:80/jour/article/view/752) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nL.I. Ilienko\n2006-01-01\nFull Text Available Among serious diseases of the lower respiratory tract a special place is taken by pneumonias and chronic infectious respiratory diseases caused by pneumococcus and Haemophilus influenzae type b (HIB. The research purpose is to determine the effectiveness of vaccine combined application to treat sickly children, who often suffer from persistent infectious pathology of the respiratory tract, for flu, pneumococcal and HIB disease. 110 children aged between 3 and 12 have been vaccinated. The first part of research implied children vaccination by means of Actahib and Pneumo 23 vaccines (Sanofi Pasteur, France, the second one consisted in immunization of children with the same pathology by means of Pneumo 23, Actahib and Vaxigrip vaccines (Sanofi Pasteur, France. The researches established that within a year after HIB and Pneumo 23 vaccination the frequency of upper and lower respiratory tract acerbations reduced by 2,3 times on average; likewise, the number of system antimicrobial dosage reduced by 7,4 times along with the total duration of dosage; the carrier state of S. pneumoniae reduced by 3,7 times, H. influenzae \u2014 by 3,9 times. In the course of application of three vaccines, the frequency of persistent heat erospecific infectious bronchopulmonary pathology acerbations reduced by 3,3 times. The carrier state of S. pneumoniae reduced by 2,5 times, H. influenzae \u2014 by 4,1 times. Thus, vaccine immunization to treat for flu, pneumococcal and HIB disease in various combinations may be recoma mended for wider application to reduce the frequency and severity of heat erospecific infectious respiratory diseases among sickly children, who often suffer from various illnesses.Key words: children with recurrent diseases, vaccination, prevention, flu, H. Influenzae, S. pneumoniae.\n[The dapE-encoded N-succinyl-L,L-diaminopimelic acid desuccinylase from Haemophilus influenzae contains two active-site histidine residues.](https://www.ncbi.nlm.nih.gov/pubmed/18712420)\nGillner, Danuta M; Bienvenue, David L; Nocek, Boguslaw P; Joachimiak, Andrzej; Zachary, Vincentos; Bennett, Brian; Holz, Richard C\n2009-01-01\nThe catalytic and structural properties of the H67A and H349A dapE-encoded N-succinyl-L,L-diaminopimelic acid desuccinylase (DapE) from Haemophilus influenzae were investigated. On the basis of sequence alignment with the carboxypeptidase from Pseudomonas sp. strain RS-16, both H67 and H349 were predicted to be Zn(II) ligands. The H67A DapE enzyme exhibited a decreased catalytic efficiency (180-fold) compared with wild-type (WT) DapE towards N-succinyldiaminopimelic acid. No catalytic activity was observed for H349A under the experimental conditions used. The electronic paramagnetic resonance (EPR) and electronic absorption data indicate that the Co(II) ion bound to H349A-DapE is analogous to that of WT DapE after the addition of a single Co(II) ion. The addition of 1 equiv of Co(II) to H67A DapE provides spectra that are very different from those of the first Co(II) binding site of the WT enzyme, but that are similar to those of the second binding site. The EPR and electronic absorption data, in conjunction with the kinetic data, are consistent with the assignment of H67 and H349 as active-site metal ligands for the DapE from H. influenzae. Furthermore, the data suggest that H67 is a ligand in the first metal binding site, while H349 resides in the second metal binding site. A three-dimensional homology structure of the DapE from H. influenzae was generated using the X-ray crystal structure of the DapE from Neisseria meningitidis as a template and superimposed on the structure of the aminopeptidase from Aeromonas proteolytica (AAP). This homology structure confirms the assignment of H67 and H349 as active-site ligands. The superimposition of the homology model of DapE with the dizinc(II) structure of AAP indicates that within 4.0 A of the Zn(II) binding sites of AAP all of the amino acid residues of DapE are nearly identical.\n[Fibroblast activation protein is dispensable in the anti-influenza immune response in mice.](http://europepmc.org/articles/PMC5291439?pdf=render) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nSioh-Yang Tan\nFull Text Available Fibroblast activation protein alpha (FAP is a unique dual peptidase of the S9B serine protease family, being capable of both dipeptidyl peptidase and endopeptidase activities. FAP is expressed at low level in healthy adult organs including the pancreas, cervix, uterus, submaxillary gland and the skin, and highly upregulated in embryogenesis, chronic inflammation and tissue remodelling. It is also expressed by cancer-associated stromal fibroblasts in more than 90% of epithelial tumours. FAP has enzymatic and non-enzymatic functions in the growth, immunosuppression, invasion and cell signalling of tumour cells. FAP deficient mice are fertile and viable with no gross abnormality, but little data exist on the role of FAP in the immune system. FAP is upregulated in association with microbial stimulation and chronic inflammation, but its function in infection remains unknown. We showed that major populations of immune cells including CD4+ and CD8+ T cells, B cells, dendritic cells and neutrophils are generated and maintained normally in FAP knockout mice. Upon intranasal challenge with influenza virus, FAP mRNA was increased in the lungs and lung-draining lymph nodes. Nonetheless, FAP deficient mice showed similar pathologic kinetics to wildtype controls, and were capable of supporting normal anti-influenza T and B cell responses. There was no evidence of compensatory upregulation of other DPP4 family members in influenza-infected FAP-deficient mice. FAP appears to be dispensable in anti-influenza adaptive immunity.\n[Efectividad comunitaria de las vacunas frente a la Parotiditis Infecciosa. Estudio de casos](http://www.scielosp.org/scielo.php?script=sci_arttext&pid=S1135-57271999000400003) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nLim\u00f3n Mora Juan\n1999-01-01\nFull Text Available FUNDAMENTO: En nuestro pa\u00eds existen dos tipos de vacunas disponibles frente a la parotiditis infecciosa. En los \u00faltimos tiempos se han planteado dudas sobre la eficacia global de estas vacunas y de la eficacia comparada entre ambas (cepa Rubini y cepa Jeryl Lynn. En el distrito sanitario de A.P. \"Sevilla Este\" se registraron 256 casos durante 1997 (90,1 casos por 100.000 habitantes. Con este estudio se pretende aprovechar la aparici\u00f3n de casos de parotiditis para evaluar poblaciones afectadas e incidencia comparada seg\u00fan tipo de vacuna recibida durante la infancia. M\u00c9TODOS: An\u00e1lisis descriptivo de los casos (edad, distribuci\u00f3n territorial, antecedentes vacunales,... y an\u00e1lisis evolutivo (tasas de incidencia anuales en el distrito sanitario y su entorno. Se eval\u00faa la efectividad global de las vacunas frente a la parotiditis. Igualmente se estiman las tasas de incidencia de casos entre los vacunados con cepa Rubini y Jeryl Lynn. RESULTADOS: Se observan las tasas de incidencias m\u00e1s elevadas en ni\u00f1os entre 1 y 4 a\u00f1os. Se han estimado niveles de efectividad global para estas vacunas. Adem\u00e1s se observa una incidencia de casos significativamente m\u00e1s elevada entre los ni\u00f1os vacunados con cepa Rubini que en los que lo hicieron con Jeryl Lynn (riesgo relativo de 6,5 con Intervalo de confianza 95% 3,6-11,8. CONCLUSIONES: La efectividad que se desprende de este estudio no parece ser tan buena como la eficacia te\u00f3rica preconizada para las vacunas frente a la parotiditis. Se plantea la conveniencia de realizar otros estudios de casos seg\u00fan tipos de vacunas utilizadas. Igualmente son de gran inter\u00e9s los datos a suministrar por estudios seroepidemiol\u00f3gicos.\n[Physical size of the donor locus and transmission of Haemophilus influenzae ampicillin resistance genes by deoxyribonucleic acid-mediated transformation](https://inis.iaea.orgsearchsinglerecord.aspx?recordsFor=SingleRecord&RN=7248436) [International Nuclear Information System (INIS) ](http://inis.iaea.org/search/)\nBendler, J.W. III\n1976-01-01\nThe properties of donor deoxyribonucleic acid (DNA) from three clinical isolates and its ability to mediate the transformation of competent Rd strains to ampicillin resistance were examined. A quantitative technique for determining the resistance of individual Haemophilus influenzae cells to ampicillin was developed. When this technique was used, sensitive cells failed to tolerate levels of ampicillin greater than 0.1 to 0.2 \u03bcg/ml, whereas three resistant type b \u03b2-lactamase-producing strains could form colonies 1- to 3-\u03bcg/ml levels of the antibiotic. DNA extracted from the resistant strains elicited transformation of the auxotrophic genes in a multiply auxotrophic Rd strain. For two of the donors, transformation to ampicillin resistance occurred after the uptake of a single DNA molecule approximately 10 4 -fold less frequently than transformation of auxotrophic loci and was not observed to occur at all with the third. The frequency of transformation to ampicillin resistance was two- to fivefold higher in strain BC200 (Okinaka and Barnhart, 1974), which was cured of a defective prophage. All three clinical ampicillin-resistant strains were poor recipients, but the presence of the ampicillin resistant genes in strain BC200 did not reduce its competence\n[Vacunas en situaciones especiales. Embarazo, inmunodepresi\u00f3n, transplante](https://www.openaire.eu/search/publication?articleId=od______1404::05502ca26081377cb9ac9b967d7e66d8)\nFarjas Abad\u00eda, M\u00aa Pilar\n2005-01-01\nEn las recomendaciones de vacunaci\u00f3n de grupos de poblaci\u00f3n que por su situaci\u00f3n de salud requieren medidas espec\u00edficas deben conjugarse: Las limitaciones en la aplicaci\u00f3n de determinadas vacunas por la mayor probabilidad de efectos secundarios en estos pacientes (por ejemplo la aplicaci\u00f3n de vacunas de virus vivos en pacientes inmunodeprimidos). El mayor riesgo de infecci\u00f3n frente a determinados agentes que genera la patolog\u00eda o situaci\u00f3n inmunitaria del paciente, y que determina un mayor in...\n[PRACTICAS MEDICAS, PRACTICAS POLITICAS. ROSAS Y LA \u00abVACUNA INDIGENA\u00bb](http://www.revistas.usach.cl/ojs/index.php/historiasocial/article/view/319) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nMAR\u00cdA SILVIA DI LISCIA\n2011-10-01\nFull Text Available BUENOS AIRES, 1830. Se declara una epidemia de viruela entre los indios \u00abpampas\u00bb que est\u00e1n en la ciudad para honrar al Restaurador de las Leyes. Los caciques no disimulan su admiraci\u00f3n ante la valent\u00eda de Rosas, quien los visita sin alarma ante el contagio y los estimula a vacunarse para eliminar el temible mal. Un n\u00famero estimado en m\u00e1s de cien indios acepta, entonces, inmunizarse, coloc\u00e1ndose, seg\u00fan el testimonio de Parish, la \u00abvacuna a ind\u00edgenas \u00bb. Buenos Aires, 1833. Francisco X. Mu\u00f1iz, m\u00e9dico de la campa\u00f1a bonaerense, inicia las investigaciones con las que diez a\u00f1os despu\u00e9s se logra el redescubrimiento del cow pox, es decir, la viruela vacuna, llamada por Sarmiento \u00abla vacuna ind\u00edgena\u00bb.\n[Impact of protein D-containing pneumococcal conjugate vaccines on non-typeable Haemophilus influenzae acute otitis media and carriage.](https://www.ncbi.nlm.nih.gov/pubmed/28571504)\nClarke, Christopher; Bakaletz, Lauren O; Ruiz-Gui\u00f1az\u00fa, Javier; Borys, Dorota; Mrkvan, Tomas\n2017-07-01\nProtein D-containing vaccines may decrease acute otitis media (AOM) burden and nasopharyngeal carriage of non-typeable Haemophilus influenzae (NTHi). Protein D-containing pneumococcal conjugate vaccine PHiD-CV (Synflorix, GSK Vaccines) elicits robust immune responses against protein D. However, the phase III Clinical Otitis Media and PneumoniA Study (COMPAS), assessing PHiD-CV efficacy against various pneumococcal diseases, was not powered to demonstrate efficacy against NTHi; only trends of protective efficacy against NTHi AOM in children were shown. Areas covered: This review aims to consider all evidence available to date from pre-clinical and clinical phase III studies together with further evidence emerging from post-marketing studies since PHiD-CV has been introduced into routine clinical practice worldwide, to better describe the clinical utility of protein D in preventing AOM due to NTHi and its impact on NTHi nasopharyngeal carriage. Expert commentary: Protein D is an effective carrier protein in conjugate vaccines and evidence gathered from pre-clinical, clinical and observational studies suggest that it also elicits immune response that can help to reduce the burden of AOM due to NTHi. There remains a need to develop improved vaccines for prevention of NTHi disease, which could be achieved by combining protein D with other antigens.\n[Accelerating policy decisions to adopt haemophilus influenzae type B vaccine: a global, multivariable analysis.](https://www.ncbi.nlm.nih.gov/pubmed/20305714)\nShearer, Jessica C; Stack, Meghan L; Richmond, Marcie R; Bear, Allyson P; Hajjeh, Rana A; Bishai, David M\n2010-03-16\nAdoption of new and underutilized vaccines by national immunization programs is an essential step towards reducing child mortality. Policy decisions to adopt new vaccines in high mortality countries often lag behind decisions in high-income countries. Using the case of Haemophilus influenzae type b (Hib) vaccine, this paper endeavors to explain these delays through the analysis of country-level economic, epidemiological, programmatic and policy-related factors, as well as the role of the Global Alliance for Vaccines and Immunisation (GAVI Alliance). Data for 147 countries from 1990 to 2007 were analyzed in accelerated failure time models to identify factors that are associated with the time to decision to adopt Hib vaccine. In multivariable models that control for Gross National Income, region, and burden of Hib disease, the receipt of GAVI support speeded the time to decision by a factor of 0.37 (95% CI 0.18-0.76), or 63%. The presence of two or more neighboring country adopters accelerated decisions to adopt by a factor of 0.50 (95% CI 0.33-0.75). For each 1% increase in vaccine price, decisions to adopt are delayed by a factor of 1.02 (95% CI 1.00-1.04). Global recommendations and local studies were not associated with time to decision. This study substantiates previous findings related to vaccine price and presents new evidence to suggest that GAVI eligibility is associated with accelerated decisions to adopt Hib vaccine. The influence of neighboring country decisions was also highly significant, suggesting that approaches to support the adoption of new vaccines should consider supply- and demand-side factors.\n[VACUNAS E INFECCIONES RESPIRATORIAS](https://www.openaire.eu/search/publication?articleId=dedup_wf_001::61ee14b25b56c72855596bb426219d56)\nDr. Rodolfo Villena\n2017-01-01\nLas vacunas han demostrado ser una excelente estrategia para reducir la morbimortalidad en infecciones respiratorias, con un perfil de seguridad adecuado. Nuestro PNI incorpora varias de ellas con este objetivo, logrando resultados de alto impacto a nivel de salud p\u00fablica. Para que esto prosiga se requiere de nuestro compromiso y conocimiento para estimular, difundir y obtener altas tasas de cobertura, de manera de lograr efectos de protecci\u00f3n indirecta, conocidos como inmunidad comunitaria. ...\n[Applying Central Composite Design and Response Surface Methodology to Optimize Growth and Biomass Production of Haemophilus influenzae Type b.](https://www.ncbi.nlm.nih.gov/pubmed/27630761)\nMomen, Seyed Bahman; Siadat, Seyed Davar; Akbari, Neda; Ranjbar, Bijan; Khajeh, Khosro\n2016-06-01\nHaemophilus influenzae type b (Hib) is the leading cause of bacterial meningitis, otitis media, pneumonia, cellulitis, bacteremia, and septic arthritis in infants and young children. The Hib capsule contains the major virulence factor, and is composed of polyribosyl ribitol phosphate (PRP) that can induce immune system response. Vaccines consisting of Hib capsular polysaccharide (PRP) conjugated to a carrier protein are effective in the prevention of the infections. However, due to costly processes in PRP production, these vaccines are too expensive. To enhance biomass, in this research we focused on optimizing Hib growth with respect to physical factors such as pH, temperature, and agitation by using a response surface methodology (RSM). We employed a central composite design (CCD) and a response surface methodology to determine the optimum cultivation conditions for growth and biomass production of H. influenzae type b. The treatment factors investigated were initial pH, agitation, and temperature, using shaking flasks. After Hib cultivation and determination of dry biomass, analysis of experimental data was performed by the RSM-CCD. The model showed that temperature and pH had an interactive effect on Hib biomass production. The dry biomass produced in shaking flasks was about 5470 mg/L, which was under an initial pH of 8.5, at 250 rpm and 35\u00b0 C. We found CCD and RSM very effective in optimizing Hib culture conditions, and Hib biomass production was greatly influenced by pH and incubation temperature. Therefore, optimization of the growth factors to maximize Hib production can lead to 1) an increase in bacterial biomass and PRP productions, 2) lower vaccine prices, 3) vaccination of more susceptible populations, and 4) lower risk of Hib infections.\n[Outcome of meningitis caused by Streptococcus pneumoniae and Haemophilus influenzae type b in children in The Gambia.](https://www.ncbi.nlm.nih.gov/pubmed/10747284)\nGoetghebuer, T; West, T E; Wermenbol, V; Cadbury, A L; Milligan, P; Lloyd-Evans, N; Adegbola, R A; Mulholland, E K; Greenwood, B M; Weber, M W\n2000-03-01\nIn developing countries, endemic childhood meningitis is a severe disease caused most commonly by Streptococcus pneumoniae or Haemophilus influenzae type b (Hib). Although many studies have shown that fatality rates associated with meningitis caused by these organisms are high in developing countries, little is known about the long-term outcome of survivors. The purpose of this study was to assess the importance of disabilities following pneumococcal and Hib meningitis in The Gambia. 257 children aged 0-12 years hospitalized between 1990 and 1995 with culture-proven S. pneumoniae (n = 134) or Hib (n = 123) meningitis were included retrospectively in the study. 48% of children with pneumococcal meningitis and 27% of children with Hib meningitis died whilst in hospital. Of the 160 survivors, 89 (55%) were followed up between September 1996 and October 1997. Of the children with pneumococcal meningitis that were traced, 58% had clinical sequelae; half of them had major disabilities preventing normal adaptation to social life. 38% of survivors of Hib meningitis had clinical sequelae, a quarter of whom had major disabilities. Major handicaps found were hearing loss, mental retardation, motor abnormalities and seizures. These data show that despite treatment with effective antibiotics, pneumococcal and Hib meningitis kill many Gambian children and leave many survivors with severe sequelae. Hib vaccination is now given routinely in The Gambia; an effective pneumococcal vaccine is needed.\n[Haemophilus influenzae genome evolution during persistence in the human airways in chronic obstructive pulmonary disease.](https://www.ncbi.nlm.nih.gov/pubmed/29555745)\nPettigrew, Melinda M; Ahearn, Christian P; Gent, Janneane F; Kong, Yong; Gallo, Mary C; Munro, James B; D'Mello, Adonis; Sethi, Sanjay; Tettelin, Herv\u00e9; Murphy, Timothy F\n2018-04-03\nNontypeable Haemophilus influenzae (NTHi) exclusively colonize and infect humans and are critical to the pathogenesis of chronic obstructive pulmonary disease (COPD). In vitro and animal models do not accurately capture the complex environments encountered by NTHi during human infection. We conducted whole-genome sequencing of 269 longitudinally collected cleared and persistent NTHi from a 15-y prospective study of adults with COPD. Genome sequences were used to elucidate the phylogeny of NTHi isolates, identify genomic changes that occur with persistence in the human airways, and evaluate the effect of selective pressure on 12 candidate vaccine antigens. Strains persisted in individuals with COPD for as long as 1,422 d. Slipped-strand mispairing, mediated by changes in simple sequence repeats in multiple genes during persistence, regulates expression of critical virulence functions, including adherence, nutrient uptake, and modification of surface molecules, and is a major mechanism for survival in the hostile environment of the human airways. A subset of strains underwent a large 400-kb inversion during persistence. NTHi does not undergo significant gene gain or loss during persistence, in contrast to other persistent respiratory tract pathogens. Amino acid sequence changes occurred in 8 of 12 candidate vaccine antigens during persistence, an observation with important implications for vaccine development. These results indicate that NTHi alters its genome during persistence by regulation of critical virulence functions primarily by slipped-strand mispairing, advancing our understanding of how a bacterial pathogen that plays a critical role in COPD adapts to survival in the human respiratory tract.\n[RbsB (NTHI_0632) mediates quorum signal uptake in nontypeable Haemophilus influenzae strain 86-028NP.](https://www.ncbi.nlm.nih.gov/pubmed/21923771)\nArmbruster, Chelsie E; Pang, Bing; Murrah, Kyle; Juneau, Richard A; Perez, Antonia C; Weimer, Kristin E D; Swords, W Edward\n2011-11-01\nNontypeable Haemophilus influenzae (NTHI) is a respiratory commensal and opportunistic pathogen, which persists within biofilms on airway mucosal surfaces. For many species, biofilm formation is impacted by quorum signalling. Our prior work shows that production of autoinducer-2 (AI-2) promotes biofilm development and persistence for NTHI 86-028NP. NTHI 86-028NP encodes an ABC transporter annotated as a ribose transport system that includes a protein (RbsB) with similarity to the Escherichia coli LsrB and Aggregatibacter actinomycetemcomitans RbsB proteins that bind AI-2. In this study, inactivation of rbsB significantly reduced uptake of AI-2 and the AI-2 precursor dihydroxypentanedione (DPD) by NTHI 86-028NP. Moreover, DPD uptake was not competitively inhibited by ribose or other pentose sugars. Transcript levels of rbsB increased in response to DPD and as bacteria approached stationary-phase growth. The NTHI 86-028NP rbsB mutant also formed biofilms with significantly reduced thickness and total biomass and reduced surface phosphorylcholine, similar to a luxS mutant. Infection studies revealed that loss of rbsB impaired bacterial persistence in the chinchilla middle ear, similar to our previous results with luxS mutants. Based on these data, we conclude that in NTHI 86-028NP, RbsB is a LuxS/AI-2 regulated protein that is required for uptake of and response to AI-2. \u00a9 2011 Blackwell Publishing Ltd.\n[Vaccination coverage among children aged 13 to 59 months in Buenos Aires, Argentina, 2002 La cobertura de la vacunaci\u00f3n en ni\u00f1os de 13 a 59 meses de edad en Buenos Aires, Argentina, en 2002](http://www.scielosp.org/scielo.php?script=sci_arttext&pid=S1020-49892004000900002) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nGustavo H. Dayan\n2004-09-01\nFull Text Available OBJECTIVES: To estimate antigen-specific and series-complete vaccination coverage among children aged 13 to 59 months in Buenos Aires; to compare the results of a community-based household survey with coverage rates obtained from administrative records; and to identify risk factors for incomplete vaccination. METHODS: Census tracts in Buenos Aires were surveyed systematically in March and April, 2002. Three children aged 13 to 24 months and 25 to 59 months were surveyed per block in each census tract. Written documentation of vaccination was required. Risk factors associated with incomplete vaccination were identified with univariate analysis and multivariate logistic regression. RESULTS: A total of 1391 children were surveyed. Antigen-specific coverage ranged from 69.4% (95% CI 66.7%-72% for Haemophilus influenzae type b vaccination to 99% (95% CI 98.4%-99.6% for BCG vaccination. Except for measles, coverage estimates found in the survey did not differ substantially from those obtained from city health authority records. Multivariate logistic regression analysis showed child's age (P OBJETIVOS: Calcular la cobertura con el r\u00e9gimen de vacunaci\u00f3n completo y con vacunas contra ant\u00edgenos particulares en ni\u00f1os de 13 a 59 meses de edad en Buenos Aires; comparar los resultados de una encuesta comunitaria a domicilio con los porcentajes de cobertura indicados en los registros p\u00fablicos; e identificar los factores que ponen a los ni\u00f1os en riesgo de no recibir todas las dosis de vacunas recomendadas bajo el r\u00e9gimen oficial. M\u00c9TODOS: Se encuestaron sistem\u00e1ticamente los corredores censales en Buenos Aires en marzo y abril de 2002. En cada cuadra de cada corredor censal se encuest\u00f3 a tres ni\u00f1os entre las edades de 13 a 24 meses y de 25 a 29 meses. Se solicitaba ver una constancia de vacunaci\u00f3n escrita. Se identificaron factores de riesgo asociados con la falta de vacunaci\u00f3n completa mediante un an\u00e1lisis unifactorial y regresi\u00f3n log\n[A novel anti-influenza copper oxide containing respiratory face mask.](https://www.ncbi.nlm.nih.gov/pubmed/20592763)\nBorkow, Gadi; Zhou, Steve S; Page, Tom; Gabbay, Jeffrey\n2010-06-25\nProtective respiratory face masks protect the nose and mouth of the wearer from vapor drops carrying viruses or other infectious pathogens. However, incorrect use and disposal may actually increase the risk of pathogen transmission, rather than reduce it, especially when masks are used by non-professionals such as the lay public. Copper oxide displays potent antiviral properties. A platform technology has been developed that permanently introduces copper oxide into polymeric materials, conferring them with potent biocidal properties. We demonstrate that impregnation of copper oxide into respiratory protective face masks endows them with potent biocidal properties in addition to their inherent filtration properties. Both control and copper oxide impregnated masks filtered above 99.85% of aerosolized viruses when challenged with 5.66+/-0.51 and 6.17+/-0.37 log(10)TCID(50) of human influenza A virus (H1N1) and avian influenza virus (H9N2), respectively, under simulated breathing conditions (28.3 L/min). Importantly, no infectious human influenza A viral titers were recovered from the copper oxide containing masks within 30 minutes (masks. Similarly, the infectious avian influenza titers recovered from the copper oxide containing masks were masks 5.03+/-0.54 log(10)TCID(50). The copper oxide containing masks successfully passed Bacterial Filtration Efficacy, Differential Pressure, Latex Particle Challenge, and Resistance to Penetration by Synthetic Blood tests designed to test the filtration properties of face masks in accordance with the European EN 14683:2005 and NIOSH N95 standards. Impregnation of copper oxide into respiratory protective face masks endows them with potent anti-influenza biocidal properties without altering their physical barrier properties. The use of biocidal masks may significantly reduce the risk of hand or environmental contamination, and thereby subsequent infection, due to improper handling and disposal of the masks.\n[RELATION BETWEEN BETA-LACTAMASE-PRODUCING BACTERIA AND PATIENT CHARACTERISTICS IN CHROMIC OBSTRUCTIVE PULMONARY-DISEASE (COPD)](https://www.narcis.nl/publication/RecordID/oai%3Apure.rug.nl%3Apublications%2Fd539369e-a7ca-4a4a-9d06-ae24e64f05d1/uquery/antibiotics%20AND%20anti-inflammatory/id/12/Language/EN)\nSPORTEL, JH; KOETER, GH; VANALTENA, R; LOWENBERG, A; BOERSMA, WG\nBackground - In addition to bronchodilator and anti-inflammatory therapy, exacerbations in patients with chronic obstructive pulmonary disease (COPD) are often treated with antibiotics. Haemophilus influenzae and Moraxella (Branhamella) catarrhalis, two important respiratory pathogens, may produce\n[El legado de la Real Expedici\u00f3n Filantr\u00f3pica de la Vacuna (1803-1810: las juntas de vacuna](http://asclepio.revistas.csic.es/index.php/asclepio/article/view/71/74) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nRam\u00edrez Mart\u00edn, Susana Mar\u00eda\n2004-06-01\nFull Text Available The Royal Vaccination Expedition, directed by the physicians Francisco Xavier Balmis and Jos\u00e9 Salvany, was the most important scientific and medical achievement of the Spanish colonial era. It took place at a time of political restlessness, and its achievements were thus conditioned by each of the cultures into which the vaccine was introduced. As its legacy, the philantropic expedition left the Vaccination Boards, established in the Americas as centers of medical expertise to sustain the expedition\u00b4s principal objetive: the battle against the smallpox epidemics in pursuit of public health.\nLa Expedici\u00f3n de la Vacuna, dirigida por los m\u00e9dicos Francisco Xavier Balmis y Jos\u00e9 Salvany, es la gesta cient\u00edfica y sanitaria m\u00e1s importante de \u00e9poca colonial. Su desarrollo tuvo lugar en un momento pol\u00edtico convulso y los resultados estuvieron condicionados por las sociedades donde la vacuna se estableci\u00f3. El legado de esta expedici\u00f3n filantr\u00f3pica fue la creaci\u00f3n de las Juntas de Vacuna. Estas instituciones se erigieron como centros creadores de saber m\u00e9dico en Am\u00e9rica y consolidaron el objetivo primario de la expedici\u00f3n: la b\u00fasqueda de la salud p\u00fablica luchando contra las epidemias de viruela.\n[Computational screen and experimental validation of anti-influenza effects of quercetin and chlorogenic acid from traditional Chinese medicine](http://adsabs.harvard.edu/abs/2016NatSR...619095L)\nLiu, Zekun; Zhao, Junpeng; Li, Weichen; Shen, Li; Huang, Shengbo; Tang, Jingjing; Duan, Jie; Fang, Fang; Huang, Yuelong; Chang, Haiyan; Chen, Ze; Zhang, Ran\n2016-01-01\nThe Influenza A virus is a great threat for human health, while various subtypes of the virus made it difficult to develop drugs. With the development of state-of-art computational chemistry, computational molecular docking could serve as a virtual screen of potential leading compound. In this study, we performed molecular docking for influenza A H1N1 (A/PR/8/34) with small molecules such as quercetin and chlorogenic acid, which were derived from traditional Chinese medicine. The results showed that these small molecules have strong binding abilities with neuraminidase from H1N1 (A/PR/8/34). Further details showed that the structural features of the molecules might be helpful for further drug design and development. The experiments in vitro, in vivo have validated the anti-influenza effect of quercetin and chlorogenic acid, which indicating comparable protection effects as zanamivir. Taken together, it was proposed that chlorogenic acid and quercetin could be employed as the effective lead compounds for anti-influenza A H1N1.\n[A randomized controlled trial comparing split and subunit influenza vaccines in adults in Colombia](http://www.scielo.org.ar/scielo.php?script=sci_arttext&pid=S0025-76802003000300002) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nA. Morales\n2003-06-01\nFull Text Available In a two-center, comparative trial, 344 adults were randomly assigned to receive a single dose of inactivated split-virion (Imovax Gripe\u00e2 or sub-unit (Agrippal S1\u00e2 influenza vaccine (1999-2000 formulations. For analysis, study groups were subdivided into adult (18-60 years old and elderly (over 60 years subjects. Blood was drawn immediately before and one month after vaccination, safety was evaluated using a blind-observer design based on reporting of solicited and unsolicited adverse events. Both vaccines were very well tolerated, had similar reactogenicity profiles, and elicited fewer reports of reactions in elderly individuals. Post-vaccination Imovax Gripe\u00e2 induced seroprotective antibody titers against the three vaccine strains in 94-99% of adults and 88-97% of elderly subjects, compared with 88-100% and 88-98%, respectively, of those given Agrippal S1\u00e2. In conclusion, the split-virion and sub-unit influenza vaccines had similar safety and reactogenicity profiles, and elicited satisfactory immunity in adult and elderly subjects. However, higher post-vaccination geometric mean titer (GMT values in response to the B strain were seen with the split vaccine Imovax Gripe\u00e2, giving it a better overall immunogenicity.En un ensayo comparativo realizado en dos centros, se asignaron de manera aleatoria 344 adultos para recibir una dosis de vacuna contra la gripe de virus fraccionado inactivado (Imovax Gripe\u00e2 o de vacuna de subunidades (Agrippal S1\u00e2 (formulaciones 1999-2000. Para el an\u00e1lisis, los grupos estudiados fueron subdivididos en adultos (18-60 a\u00f1os y ancianos (m\u00e1s de 60 a\u00f1os. La sangre fue extra\u00edda justo antes y un mes despu\u00e9s de la vacunaci\u00f3n. La inocuidad fue evaluada utilizando un informe sobre reacciones adversas, usando un dise\u00f1o de observador a ciegas. Ambas vacunas fueron muy bien toleradas, con perfiles de reactogenicidad similares y desarrollaron escasas reacciones adversas en los individuos ancianos. La vacunaci\u00f3n con\n[La vacuna en Cuba durante el gobierno de Someruelos](https://www.openaire.eu/search/publication?articleId=dedup_wf_001::9c7220297c636745e06628ec37f2b47e)\nV\u00e1zquez Cienfuegos, Sigfrido\n2004-01-01\nLa Real Expedici\u00f3n Filantr\u00f3pica de la Vacuna (1803-1806), dirigida por Francisco Javier de Balmis, se dirigi\u00f3 al Nuevo Mundo para paliar las epidemias de viruelas que hab\u00edan venido asolando Am\u00e9rica desde casi el mismo momento del Descubrimiento. Para entonces en la isla de Cuba ya se hab\u00eda iniciado una labor con el mismo objetivo por el m\u00e9dico cubano Tom\u00e1s Romay, apoyado en el fomento de la introducci\u00f3n y aplicaci\u00f3n de la vacuna por el marqu\u00e9s de Someruelos gobernador y capit\u00e1n general de la ...\n[Development and Validation of a Multiplex PCR-Based Assay for the Upper Respiratory Tract Bacterial Pathogens Haemophilus influenzae, Streptococcus pneumoniae, and Moraxella catarrhalis.](https://www.ncbi.nlm.nih.gov/pubmed/10330195)\nPost; White; Aul; Zavoral; Wadowsky; Zhang; Preston; Ehrlich\n1996-06-01\nBackground: Conventional simplex polymerase chain reaction (PCR)-based assays are limited in that they only provide for the detection of a single infectious agent. Many clinical diseases, however, present in a nonspecific, or syndromic, fashion, thereby necessitating the simultaneous assessment of multiple pathogens. Panel-based molecular diagnostic testing can be accomplished by the development of multiplex PCR-based assays, which can detect, individually or severally, different pathogens that are associated with syndromic illness. As part of a larger program of panel development, an assay that can simultaneously detect Haemophilus influenzae, Streptococcus pneumoniae, and Moraxella catarrhalis was developed. These organisms were chosen as they are the most common bacterial pathogens associated with both the acute and chronic forms of otitis media; they are also responsible for a high percentage of sinus infections in both children and adults. In addition, H. influenzae and S. pneumoniae are commonly associated with septic meningitits. Methods and Results: Multiple individual PCR-based assays were developed for each of the three target organisms which were then evaluated for sensitivity and specificity. Utilizing the simplex assays that met our designated performance criteria, a matrix style approach was used to develop a duplex H. influenzae-S. pneumoniae assay. The duplex assay was then used as a single component in the development of a triplex assay, wherein the various M. catarrhalis primer-probe sets were tested for compatibility with the existing assay. A single-step PCR protocol, with species-specific primers for each of the three target organisms and a liquid hybridization-gel retardation amplimer detection system, was developed, which amplifies and then discriminates among each of the amplification products according to size. This assay is able to detect all three organisms in a specific manner, either individually or severally. Dilutional experiments\n[Perfil de seguridad de la vacuna antileptospir\u00f3sica trivalente vax-SPIRAL\u00ae](http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1025-028X2010000300001&lng=es&nrm=iso&tlng=es) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nGiset Jim\u00e9nez\n2010-12-01\nFull Text Available Con el objetivo de mostrar el perfil de seguridad de la vacuna antileptospir\u00f3sica cubana, vax-SPIRAL\u00ae, se realiz\u00f3 un estudio observacional descriptivo y transversal, a partir de la base de datos de la red nacional de farmacovigilancia a medicamentos. Se estim\u00f3 la frecuencia de reportes por dosis de vacunas administradas, la valoraci\u00f3n de causalidad, severidad, localizaci\u00f3n y los eventos adversos con mayor asociaci\u00f3n estad\u00edstica, a partir del c\u00e1lculo de disproporcionalidad de las combinaciones de eventos adversos a vacunas de todos los diagn\u00f3sticos en los reportes de eventos del grupo farmacol\u00f3gico de vacunas y el c\u00e1lculo de la Raz\u00f3n de Riesgo Proporcional (PRR y la Raz\u00f3n Diferencial de Riesgo (ROR. Hubo 1,62 reportes por 100 000 dosis administradas y 1,9 diagn\u00f3sticos por reporte en personas entre 18 y 77 a\u00f1os de edad y una media \u00b1DE de 40 \u00b1 13 a\u00f1os, con predominio del sexo femenino (65,54%. No se reportaron casos graves; el 74,17% fueron con severidad leve y el 66,96% fueron manifestaciones adversas sist\u00e9micas. El 94,17% de los reportes estuvieron relacionados con la vacuna. Los eventos adversos m\u00e1s frecuentes fueron: fiebre/hipertermia (18,75%, cefalea (14,73%, dolor local (13,84%, enrojecimiento/eritema/rubor en el sitio de inyecci\u00f3n (12,05%, malestar general (8,48% y manifestaciones de hipersensibilidad m\u00ednimas, s\u00f3lo a nivel cut\u00e1neo. Entre los que mostraron mayor asociaci\u00f3n: cefalea, malestar general y rubor. Los resultados obtenidos son similares y con mejor perfil de seguridad que los de la vacuna francesa SPIROLEPT, por lo cual se recomienda para la protecci\u00f3n en grupos de riesgo de leptospirosis.\n[Haemophilus influenzae Type b disease among Amish children in Pennsylvania: reasons for persistent disease.](https://www.ncbi.nlm.nih.gov/pubmed/11581468)\nFry, A M; Lurie, P; Gidley, M; Schmink, S; Lingappa, J; Fischer, M; Rosenstein, N E\n2001-10-01\nTo identify reservoirs of Haemophilus influenzae type b (Hib) pharyngeal carriage and assess barriers to vaccination among 2 Amish communities in Pennsylvania. We investigated recent cases, performed community surveys for Hib vaccination coverage and pharyngeal carriage, and administered a questionnaire assessing vaccination knowledge and attitudes to 298 members of 2 Amish communities (A and B) in Pennsylvania and, as a comparison group, 136 non-Amish family members who participated in state immunization clinics. From December 1999 to February 2000, 8 cases of invasive Hib disease occurred among children who were 5 years of age or younger in Pennsylvania. Six of the case-patients were from Amish communities. None of the children had been vaccinated. Among children who were 5 years of age or younger, Hib vaccine coverage was low in the 2 Amish communities: A (9 [28%] of 32) and B (3 [7%] of 41) compared with the non-Amish group (19 [95%] of 20). Hib carriage prevalence was higher in both Amish communities than in the non-Amish group (A: 3%; B: 8%; non-Amish: 0%). More households in community B had 1 or more Hib carriers than in community A (8 [28%] of 29 vs 3 [9%] of 32). Among Amish parents who did not vaccinate their children, only 25% (13 of 51) identified either religious or philosophical objections as a factor; 51% (26 of 51) reported that vaccinating was not a priority compared with other activities of daily life. Seventy-three percent (36 of 49) would vaccinate their children if vaccination were offered locally. Undervaccinated communities in the United States still exist and allow circulation of Hib strains, resulting in disease among susceptible children. Identification of undervaccinated populations, such as the Amish, and targeted education and vaccination campaigns are essential to achieving elimination of Hib disease.\n[GyrA and/or ParC alterations of Haemophilus influenzae strains isolated from the urethra of men with acute urethritis.](https://www.ncbi.nlm.nih.gov/pubmed/29138021)\nKondo, Hiromi; Ito, Shin; Hatazaki, Kyoko; Horie, Kengo; Nakane, Keita; Mizutani, Kosuke; Tsuchiya, Tomohiro; Yasuda, Mitsuru; Yokoi, Shigeaki; Nakano, Masahiro; Deguchi, Takashi\n2018-03-01\nOf 73 clinical strains of Haemophilus influenzae isolated from the urethra of men with urogenital infections, we enrolled 6 strains (8.2%) with levofloxacin (LVFX) minimum inhibitory concentrations (MICs) of \u22650.03 \u03bcg/ml in this study. All the strains were isolated from non-gonococcal urethritis (NGU). We amplified the quinolone resistance-determining region of the gyrA gene and the analogous region of the parC gene from bacterial DNAs by PCR and sequenced the PCR products. Two strains with a LVFX MIC of 0.03 \u03bcg/ml had an amino acid change of Asp88 to Gly in GyrA. One with a LVFX MIC of 0.06 \u03bcg/ml had a change of Asp88 to Tyr in GyrA. Two with respective LVFX MICs of 0.12 and 0.25 \u03bcg/ml had a change of Ser84 to Leu in GyrA. One with a LVFX MIC of 1 \u03bcg/ml had changes of Ser84 to Leu in GyrA and of Ser84 to Ile in ParC. Multilocus sequence typing showed two strains with a change of Asp88 to Gly in GyrA had the same sequence type, but the others had sequence types different from each other. Single amino acid changes in GyrA alone or single changes in both GyrA and ParC could contribute to decreased susceptibility to fluoroquinolones in H. influenzae isolates from NGU. Most of the isolates with GyrA and/or ParC alterations would be multiclonal. The prevalence of such isolates would be relatively low, and they would still be susceptible to fluoroquinolones commonly prescribed for treatment of NGU. Copyright \u00a9 2017 Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.\n[Estudio de inmunogenicidad de la vacuna antitifo\u00eddica cubana de polisac\u00e1rido Vi vax-TyVi\u00ae en ratones](http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1025-028X2006000200001&lng=es&nrm=iso&tlng=es) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nJuan Carlos Ram\u00edrez\n2006-08-01\nFull Text Available Salmonella enterica serovar Typhi es un microorganismo que provoca m\u00e1s de 16 millones de casos de fiebre tifoidea con aproximadamente 600 000 muertes al a\u00f1o en todo el mundo. Dentro de las vacunas antitifo\u00eddicas la de polisac\u00e1rido capsular Vi ha encontrado, gracias a sus incuestionables ventajas, una gran aceptaci\u00f3n entre productores y consumidores. El presente trabajo aborda el estudio de inmunogenicidad de la vacuna antitifo\u00eddica cubana de polisac\u00e1rido Vi vax-TyVi\u00e2 en ratones. El estudio estuvo conformado por un grupo control no inoculado y un segundo grupo que recibi\u00f3 0,05 mL de la vacuna por v\u00eda intramuscular. Se tomaron muestras de sangre a los -3, 7, 14, 21, 28, 42, 56 y 84 d\u00edas. La actividad de anticuerpos IgG antipolisac\u00e1rido Vi de los sueros individuales fue determinada por ELISA. Los datos fueron analizados por grupo y por sexo y se calcul\u00f3 el porcentaje de seroconversi\u00f3n, consider\u00e1ndose respondedor aquel animal que al menos aumentara en cuatro veces su t\u00edtulo inicial. La respuesta de anticuerpos inducida por la vacuna mostr\u00f3 un aumento notable de los t\u00edtulos de IgG antipolisac\u00e1rido Vi en el grupo vacunado (100% de seroconversi\u00f3n, mientras que el grupo control no increment\u00f3 sus niveles m\u00ednimos iniciales (0% de respondedores. Aunque m\u00e1s dispersa, la respuesta de anticuerpos antiVi fue significativamente mayor en las hembras que en los machos.\n[A new class of synthetic anti-lipopolysaccharide peptides inhibits influenza A virus replication by blocking cellular attachment.](https://www.ncbi.nlm.nih.gov/pubmed/24486207)\nHoffmann, Julia; Schneider, Carola; Heinbockel, Lena; Brandenburg, Klaus; Reimer, Rudolph; Gabriel, G\u00fclsah\n2014-04-01\nInfluenza A viruses are a continuous threat to human health as illustrated by the 2009 H1N1 pandemic. Since circulating influenza virus strains become increasingly resistant against currently available drugs, the development of novel antivirals is urgently needed. Here, we have evaluated a recently described new class of broad-spectrum antiviral peptides (synthetic anti-lipopolysaccharide peptides; SALPs) for their potential to inhibit influenza virus replication in vitro and in vivo. We found that particularly SALP PEP 19-2.5 shows high binding affinities for the influenza virus receptor molecule, N-Acetylneuraminic acid, leading to impaired viral attachment and cellular entry. As a result, replication of several influenza virus subtypes (H7N7, H3N2 and 2009 pandemic H1N1) was strongly reduced. Furthermore, mice co-treated with PEP 19-2.5 were protected against an otherwise 100% lethal H7N7 influenza virus infection. These findings show that SALPs exhibit antiviral activity against influenza viruses by blocking virus attachment and entry into host cells. Thus, SALPs present a new class of broad-spectrum antiviral peptides for further development for influenza virus therapy. Copyright \u00a9 2014 Elsevier B.V. All rights reserved.\n[Aceptabilidad de la vacuna contra el virus papiloma humano en padres de adolescentes, en colombia](https://www.openaire.eu/search/publication?articleId=od______1326::8ba7ba7cedd44552d4d60ca52f50c9aa)\nWiesner, Carolina; Pi\u00f1eros, Marion; Cort\u00e9s, Claudia; Jaime Ardila, Jaime Ardila\n2012-01-01\nObjetivo La vacuna contra el VPH es una nueva tecnolog\u00eda disponible para el control del c\u00e1ncer de cuello uterino. Se espera, que en el menor tiempo posible esta vacuna pueda tener cobertura universal. Este art\u00edculo presenta la aceptabilidad que tiene los padres de adolescentes en Colombia hacia la vacuna contra el VPH y hace una aproximaci\u00f3n a sus determinantes. M\u00e9todos Estudio cualitativo en cuatro regiones en Colombia. Se realizaron 17 grupos focales con padres de ni\u00f1as y ni\u00f1os entre 11 a 1...\n[Basic Characterization of Natural Transformation in a Highly Transformable Haemophilus parasuis Strain SC1401](https://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=5809987)\nDai, Ke; He, Lvqin; Chang, Yung-Fu; Cao, Sanjie; Zhao, Qin; Huang, Xiaobo; Wu, Rui; Huang, Yong; Yan, Qigui; Han, Xinfeng; Ma, Xiaoping; Wen, Xintian; Wen, Yiping\n2018-01-01\nHaemophilus parasuis causes Gl\u00e4sser's disease and pneumonia, incurring serious economic losses in the porcine industry. In this study, natural competence was investigated in H. parasuis. We found competence genes in H. parasuis homologous to ones in Haemophilus influenzae and a high consensus battery of Sxy-dependent cyclic AMP (cAMP) receptor protein (CRP-S) regulons using bioinformatics. High rates of natural competence were found from the onset of stationary-phase growth condition to mid-stationary phase (OD600 from 0.29 to 1.735); this rapidly dropped off as cells reached mid-stationary phase (OD600 from 1.735 to 1.625). As a whole, bacteria cultured in liquid media were observed to have lower competence levels than those grown on solid media plates. We also revealed that natural transformation in this species is stable after 200 passages and is largely dependent on DNA concentration. Transformation competition experiments showed that heterogeneous DNA cannot outcompete intraspecific natural transformation, suggesting an endogenous uptake sequence or other molecular markers may be important in differentiating heterogeneous DNA. We performed qRT-PCR targeting multiple putative competence genes in an effort to compare bacteria pre-cultured in TSB++ vs. TSA++ and SC1401 vs. SH0165 to determine expression profiles of the homologs of competence-genes in H. influenzae. Taken together, this study is the first to investigate natural transformation in H. parasuis based on a highly naturally transformable strain SC1401. PMID:29473023\n[Economic Evaluation and Budget Impact Analysis of Vaccination against Haemophilus influenzae Type b Infection in Thailand](http://journal.frontiersin.org/article/10.3389/fpubh.2017.00289/full) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nSurachai Kotirum\n2017-11-01\nFull Text Available Current study aimed to estimate clinical and economic outcomes of providing the Haemophilus influenzae type b (Hib vaccination as a national vaccine immunization program in Thailand. A decision tree combined with Markov model was developed to simulate relevant costs and health outcomes covering lifetime horizon in societal and health care payer perspectives. This analysis considered children aged under 5 years old whom preventive vaccine of Hib infection are indicated. Two combined Hib vaccination schedules were considered: three-dose series (3 + 0 and three-dose series plus a booster does (3 + 1 compared with no vaccination. Budget impact analysis was also performed under Thai government perspective. The outcomes were reported as Hib-infected cases averted and incremental cost-effectiveness ratios (ICERs in 2014 Thai baht (THB ($ per quality-adjusted life year (QALY gained. In base-case scenario, the model estimates that 3,960 infected cases, 59 disability cases, and 97 deaths can be prevented by national Hib vaccination program. The ICER for 3 + 0 schedule was THB 1,099 ($34 per QALY gained under societal perspective. The model was sensitive to pneumonia incidence among aged under 5 years old and direct non-medical care cost per episode of Hib pneumonia. Hib vaccination is very cost-effective in the Thai context. The budget impact analysis showed that Thai government needed to invest an additional budget of 110 ($3.4 million to implement Hib vaccination program. Policy makers should consider our findings for adopting this vaccine into national immunization program.\n[No evidence of increasing Haemophilus influenzae non-b infection in Australian Aboriginal children](http://www.circumpolarhealthjournal.net/index.php/ijch/article/download/20992/pdf_1) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nRobert I. Menzies\n2013-08-01\nFull Text Available Background. High, or increasing, rates of invasive Haemophilus influenzae (Hi type a disease have been reported from North American native children from circumpolar regions, raising the question of serotype replacement being driven by vaccination against Hi type b (Hib. Indigenous Australians from remote areas had high rates of invasive Hib disease in the past, comparable to those in North American Indigenous populations. Objective. Evaluate incidence rates of invasive Hi (overall and by serotype in Indigenous Australian children over time. Design. Descriptive study of Hi incidence rates by serotype, in the Northern Territory (NT and South Australia (SA from 2001 to 2011. Comparison of NT data with a study that was conducted in the NT in 1985\u20131988, before Hib vaccine was introduced. Results. The average annual rate of invasive Hi type a (Hia disease in Indigenous children aged <5 years was 11/100,000 population. Although the incidence of Hi infection in Indigenous children in 2001\u20132003 was lower than during 2004\u20132011, this may be due to changes in surveillance. No other trend over time in individual serotypes or total invasive Hi disease, in Indigenous or non-Indigenous people, was identified. Compared to 1985\u20131988, rates in 2001\u20132011 were lower in all serotype groupings, by 98% for Hib, 75% for Hia, 79% for other serotypes and 67% for non-typeable Hi. Conclusions. There is no evidence of increases in invasive disease due to Hia, other specific non-b types, or non-typeable Hi in Australian Indigenous children. These data suggest that the increase in Hia some time after the introduction of Hib vaccine, as seen in the North American Arctic Region, is not common to all populations with high pre-vaccine rates of invasive Hib disease. However, small case numbers and the lack of molecular subtyping and PCR confirmation of pre-vaccine results complicate comparisons with North American epidemiology.\n[[Invasive infections caused by Haemophilus influenzae type b after the institution of the conjugated vaccine on the expanded programm on immunization in Chile].](https://www.ncbi.nlm.nih.gov/pubmed/16462964)\nCruces R, Pablo; Donoso F, Alejandro; Camacho A, Jorge; Llorente H, Marcela\n2006-03-01\nAfter almost a decade since the introduction of Haemophilus influenzae type b (Hib) conjugate vaccines in Chile (in a 2-4-6 month schedule), Hib invasive infections have dramatically decreased, albeit they remain to occasionally produce disease in pediatric patients. We report our experience with children whom developed Hib invasive disease in children since 2000 to 2004. Medical records of children with Hib were reviewed in order to describe the epidemiology, main clinical and laboratory findings, management and complications. Twenty three patients (17 male), between 1 and 71 months (median 30 months) were identified: pneumonia (7), meningitis (4), pleuropneumonia (2), empyema (2), sepsis (2), cellulitis (2), meningitis and pleuropneumonia (1), purpura fulminans (1), miositis (1) and epiglottitis (1). No deaths were observed and four patients presented severe sequelae at hospital discharge. Twenty patients were considered vaccine failures. Hib remains as a sporadic cause of severe disease in Chile and thus for physicians should still keep it in mind. Case analysis and active surveillance are necessary to monitor the current immunization regimen.\nPatarroyo, Manuel Elkin\n2017-01-01\nLa malaria es una enfermedad parasitaria producida por la picadura de un mosquito; una afecci\u00f3n que en el a\u00f1o 2015 registr\u00f3 212 millones de casos y 429.000 muertes. Cada dos minutos, la malaria provoc\u00f3 la muerte de un ni\u00f1o menor de cinco a\u00f1os en todo el mundo. Diferentes cient\u00edficos a lo largo de todo el mundo han hecho m\u00faltiples intentos para combatir esta enfermedad con una vacuna efectiva que pueda erradicarla de ra\u00edz.\n[A novel anti-influenza copper oxide containing respiratory face mask.](http://europepmc.org/articles/PMC2892464?pdf=render) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nGadi Borkow\nFull Text Available BACKGROUND: Protective respiratory face masks protect the nose and mouth of the wearer from vapor drops carrying viruses or other infectious pathogens. However, incorrect use and disposal may actually increase the risk of pathogen transmission, rather than reduce it, especially when masks are used by non-professionals such as the lay public. Copper oxide displays potent antiviral properties. A platform technology has been developed that permanently introduces copper oxide into polymeric materials, conferring them with potent biocidal properties. METHODOLOGY/PRINCIPAL FINDINGS: We demonstrate that impregnation of copper oxide into respiratory protective face masks endows them with potent biocidal properties in addition to their inherent filtration properties. Both control and copper oxide impregnated masks filtered above 99.85% of aerosolized viruses when challenged with 5.66+/-0.51 and 6.17+/-0.37 log(10TCID(50 of human influenza A virus (H1N1 and avian influenza virus (H9N2, respectively, under simulated breathing conditions (28.3 L/min. Importantly, no infectious human influenza A viral titers were recovered from the copper oxide containing masks within 30 minutes (< or = 0.88 log(10TCID(50, while 4.67+/-1.35 log(10TCID(50 were recovered from the control masks. Similarly, the infectious avian influenza titers recovered from the copper oxide containing masks were < or = 0.97+/-0.01 log(10TCID(50 and from the control masks 5.03+/-0.54 log(10TCID(50. The copper oxide containing masks successfully passed Bacterial Filtration Efficacy, Differential Pressure, Latex Particle Challenge, and Resistance to Penetration by Synthetic Blood tests designed to test the filtration properties of face masks in accordance with the European EN 14683:2005 and NIOSH N95 standards. CONCLUSIONS/SIGNIFICANCE: Impregnation of copper oxide into respiratory protective face masks endows them with potent anti-influenza biocidal properties without altering their physical\n[Efectividad de la vacuna VA-MENGOC-BC\u00ae contra cepas heter\u00f3logas de meningococo B](http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1025-028X2016000200003&lng=es&nrm=iso&tlng=es) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nRolando Ochoa-Azze\n2016-08-01\nFull Text Available La efectividad de las vacunas de ves\u00edculas de membrana externa de Neisseria meningitidis serogrupo B ha sido cuestionada por algunos investigadores, limit\u00e1ndola a la cepa vacunal. VA-MENGOC-BC\u00ae es una vacuna antimeningoc\u00f3cica basada en dicha tecnolog\u00eda. Presentamos un metaan\u00e1lisis de estudios realizados en diferentes contextos epidemiol\u00f3gicos, evaluando su efectividad contra cepas heter\u00f3logas de meningococo B en varios grupos de edades. Se demuestra que la vacuna es efectiva contra cepas hom\u00f3logas, heter\u00f3logas y de diferentes complejos clonales.\n[Ampicillin-Resistant Non-\u03b2-Lactamase-Producing Haemophilus influenzae in Spain: Recent Emergence of Clonal Isolates with Increased Resistance to Cefotaxime and Cefixime\u25bf](https://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=1913223)\nGarc\u00eda-Cobos, Silvia; Campos, Jos\u00e9; L\u00e1zaro, Edurne; Rom\u00e1n, Federico; Cercenado, Emilia; Garc\u00eda-Rey, C\u00e9sar; P\u00e9rez-V\u00e1zquez, Mar\u00eda; Oteo, Jes\u00fas; de Abajo, Francisco\n2007-01-01\nThe sequence of the ftsI gene encoding the transpeptidase domain of penicillin-binding protein 3 (PBP 3) was determined for 354 nonconsecutive Haemophilus influenzae isolates from Spain; 17.8% of them were ampicillin susceptible, 56% were \u03b2-lactamase nonproducing ampicillin resistant (BLNAR), 15.8% were \u03b2-lactamase producers and ampicillin resistant, and 10.4% displayed both resistance mechanisms. The ftsI gene sequences had 28 different mutation patterns and amino acid substitutions at 23 positions. Some 93.2% of the BLNAR strains had amino acid substitutions at the Lys-Thr-Gly (KTG) motif, the two most common being Asn526 to Lys (83.9%) and Arg517 to His (9.3%). Amino acid substitutions at positions 377, 385, and 389, which conferred cefotaxime and cefixime MICs 10 to 60 times higher than those of susceptible strains, were found for the first time in Europe. In 72 isolates for which the repressor acrR gene of the AcrAB efflux pump was sequenced, numerous amino acid substitutions were found. Eight isolates with ampicillin MICs of 0.25 to 2 \u03bcg/ml showed changes that predicted the early termination of the acrR reading frame. Pulsed-field gel electrophoresis analysis demonstrated that most BLNAR strains were genetically diverse, although clonal dissemination was detected in a group of isolates presenting with increased resistance to cefotaxime and cefixime. Background antibiotic use at the community level revealed a marked trend toward increased amoxicillin-clavulanic acid consumption. BLNAR H. influenzae strains have arisen by vertical and horizontal spread and have evolved to adapt rapidly to the increased selective pressures posed by the use of oral penicillins and cephalosporins. PMID:17470649\n[Inmunogenicidad y tolerancia de una vacuna contra influenza, en una poblaci\u00f3n mexicana mayor de 55 a\u00f1os de edad Immunogenicity and safety of the influenza vaccine, in a population older than 55-years in Mexico](http://www.scielo.org.mx/scielo.php?script=sci_arttext&pid=S0036-36342005000200009) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nOctavio Ayala-Montiel\n2005-04-01\nFull Text Available OBJETIVO: Verificar la inmunogenicidad y tolerancia de una vacuna purificada, inactivada y fraccionada contra influenza, en adultos mexicanos derechohabientes de Petr\u00f3leos Mexicanos (Pemex. MATERIAL Y M\u00c9TODOS: Se incluyeron 90 adultos mayores de 55 a\u00f1os de edad, derechohabientes de los servicios m\u00e9dicos del Hospital Central Sur Pemex, durante los meses de noviembre y diciembre de 2000. Los criterios evaluados en relaci\u00f3n con la inmunogenicidad incluyeron el porcentaje de sujetos protegidos, cuantificados por medio de anticuerpos antihemaglutininas superior o igual a 1:40, as\u00ed como por el porcentaje de seroconversi\u00f3n determinado por el t\u00edtulo inicial de anticuerpos multiplicado por un factor 4X. Los criterios secundarios fueron la frecuencia de reacciones adversas tanto locales como sist\u00e9micas. Se realizaron estudios de afinidad ant\u00edgeno-anticuerpo para determinar la respuesta policlonal de anticuerpos y de anticuerpos de alta afinidad prevacunaci\u00f3n y posvacunaci\u00f3n. Se calcularon frecuencias y porcentajes. RESULTADOS: Se identific\u00f3 una seroprotecci\u00f3n en 95.6% de los sujetos a la cepa H1N1, de 98.9% a la cepa H3N2 y de 100% a la cepa B/ Yamanashi. En cuanto a los porcentajes de seroconversi\u00f3n, se identific\u00f3 un incremento 4X de 74.4 para la cepa H1N1, de 88.9 para la cepa H3N2, y de 82.2 para la cepa B / Yamanashi. Un total de 18 individuos (20% presentaron reacciones locales, mientras que 17 (18.8% presentaron reacciones sist\u00e9micas a los cinco d\u00edas posvacunaci\u00f3n y nueve sujetos (10% a los 28 d\u00edas. Las reacciones locales a los cinco d\u00edas consistieron en dolor, en 10 individuos (11.1%; enrojecimiento, en ocho (8.8%, e induraci\u00f3n, en seis (6.6%. Malestar general, cefalea y fiebre se presentaron a los cinco d\u00edas en 10, 8.8, y 0% de individuos, respectivamente, y en 4.4, 6.6, y 0%, respectivamente, a los 28 d\u00edas. CONCLUSIONES: Esta vacuna contra influenza demostr\u00f3 ser altamente inmunog\u00e9nica en adultos mexicanos mayores de 55 a\n[Patterns of binding of aluminum-containing adjuvants to Haemophilus influenzae type b and meningococcal group C conjugate vaccines and components](https://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=4582044)\nOtto, Robert B.D.; Burkin, Karena; Amir, Saba Erum; Crane, Dennis T.; Bolgiano, Barbara\n2015-01-01\nThe basis of Haemophilus influenzae type b (Hib) and Neisseria meningitidis serogroup C (MenC) glycoconjugates binding to aluminum-containing adjuvants was studied. By measuring the amount of polysaccharide and protein in the non-adsorbed supernatant, the adjuvant, aluminum phosphate, AlPO4, was found to be less efficient than aluminum hydroxide, Al(OH)3 at binding to the conjugates, at concentrations relevant to licensed vaccine formulations and when equimolar. At neutral pH, binding of TT conjugates to AlPO4 was facilitated through the carrier protein, with only weak binding of AlPO4 to CRM197 being observed. There was slightly higher binding of either adjuvant to tetanus toxoid conjugates, than to CRM197 conjugates. This was verified in AlPO4 formulations containing DTwP\u2013Hib, where the adsorption of TT-conjugated Hib was higher than CRM197-conjugated Hib. At neutral pH, the anionic Hib and MenC polysaccharides did not appreciably bind to AlPO4, but did bind to Al(OH)3, due to electrostatic interactions. Phosphate ions reduced the binding of the conjugates to the adjuvants. These patterns of adjuvant adsorption can form the basis for future formulation studies with individual and combination vaccines containing saccharide-protein conjugates. PMID:26194164\n[Enfermedad meningoc\u00f3cica: epidemiolog\u00eda y vacunas, un enfoque pr\u00e1ctico](http://www.sciencedirect.com/science/article/pii/S0716864014700689) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nC. Giannina Izquierdo, Dra.\n2014-05-01\nLas principales estrategias para la prevenci\u00f3n de la enfermedad son el uso de vacunas (prevenci\u00f3n primaria y el uso de quimioprofilaxis a los contactos de un caso \u00edndice (prevenci\u00f3n secundaria. A la fecha existen numerosas vacunas contra Nmen, todas ellas con adecuados perfiles de seguridad e inmunogenicidad, por lo que la elecci\u00f3n de la vacuna a utilizar depender\u00e1 del serogrupo prevalente en cada pa\u00eds; de las caracter\u00edsticas de la poblaci\u00f3n m\u00e1s afectada y de la factibilidad de disponer de ella e insertarla dentro de los programas nacionales o campa\u00f1as respectivas de vacunaci\u00f3n.\n[Budesonide Inhibits Intracellular Infection with Non-Typeable Haemophilus influenzae Despite Its Anti-Inflammatory Effects in Respiratory Cells and Human Lung Tissue: A Role for p38 MAP Kinase.](https://www.ncbi.nlm.nih.gov/pubmed/26452008)\nWagner, Christopher; Goldmann, Torsten; Rohmann, Kristina; Rupp, Jan; Marwitz, Sebastian; Rotta Detto Loria, Johannes; Limmer, Stefan; Zabel, Peter; Dalhoff, Klaus; Dr\u00f6mann, Daniel\n2015-01-01\nInhaled corticosteroids (ICS) are widely used in the treatment of obstructive lung diseases. Recent data suggest a higher pneumonia risk in chronic obstructive pulmonary disease (COPD) patients treated with ICS. Since non-typeable Haemophilus influenzae (NTHi) is the most common pathogen associated with acute exacerbations of COPD, we investigated the effects of budesonide (BUD) on NTHi-induced inflammation and invasive infection. The alveolar epithelial cell line A549 and specimens of human lung tissue (HLT) were used in our experiments. Intracellular infection was determined by a lysis/culture assay of infected cells. Activated p38 mitogen-associated protein kinase (MAPK) was assessed using Western blotting and immunohistochemistry, expression of toll-like receptor 2 (TLR2) was determined by PCR, and CXCL-8 levels were measured using ELISA. Immunohistochemistry was used for detection of CXCL-8, platelet-activating factor receptor (PAF-R) and NTHi. BUD significantly reduced CXCL-8 secretion in A549 cells and lung tissue infected with NTHi. Furthermore, BUD decreased the expression of PAF-R in HLT and A549 cells. In A549 cells and HLT, BUD inhibited intracellular infection and - synergistically with NTHi - increased the expression of TLR2 (in A549 cells). TLR2 stimulation did not influence the intracellular infection of A549 cells, but p38 MAPK inhibition resulted in a significant reduction of infection. The present study adds new insights into the effects of glucocorticoids on pulmonary host defence after NTHi infection. Although the inflammatory response to infection is suppressed by BUD, interestingly, the intracellular infection is also inhibited. This effect seems to depend on the inhibition of p38 MAPK - a key enzyme in many pro-inflammatory pathways - as well as of PAF-R expression. \u00a9 2015 S. Karger AG, Basel.\n[Immunogenicity and safety of primary and booster vaccination with 2 investigational formulations of diphtheria, tetanus and Haemophilus influenzae type b antigens in a hexavalent DTPa-HBV-IPV/Hib combination vaccine in comparison with the licensed Infanrix hexa](https://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=5512790)\nVesikari, Timo; Rivera, Luis; Korhonen, Tiina; Ahonen, Anitta; Cheuvart, Brigitte; Hezareh, Marjan; Janssens, Winnie; Mesaros, Narcisa\n2017-01-01\nABSTRACT Safety and immunogenicity of 2 investigational formulations of diphtheria, tetanus and Haemophilus influenzae type b antigens of the combined diphtheria-tetanus-acellular pertussis-hepatitis B-inactivated poliomyelitis-Hib vaccine (DTPa-HBV-IPV/Hib) were evaluated in a Primary (NCT01248884) and a Booster vaccination (NCT01453998) study. In the Primary study, 721 healthy infants (randomized 1:1:1) received 3 doses of DTPa-HBV-IPV/Hib formulation A (DATAPa-HBV-IPV/Hib), or B (DBTBPa-HBV-IPV/Hib) or the licensed DTPa-HBV-IPV/Hib vaccine (Infanrix hexa, GSK; control group) at 2, 3, 4 months of age. Infants were planned to receive a booster dose at 12\u201315 months of age with the same formulation received in the Primary study; however, following high incidence of fever associated with the investigational formulations in the Primary study, the Booster study protocol was amended and all infants yet to receive a booster dose (N = 385) received the licensed vaccine. In the Primary study, non-inferiority of 3-dose vaccination with investigational formulations compared with the licensed vaccine was not demonstrated due to anti-pertactin failing to meet the non-inferiority criterion. Post-primary vaccination, most infants had seroprotective levels of anti-diphtheria (100% of infants), anti-tetanus antigens (100%), against hepatitis B (\u2265 97.5% across groups), polyribosyl-ribitol-phosphate (\u2265 88.0%) and poliovirus types 1\u20133 (\u2265 90.5%). Seropositivity rates for each pertussis antigen were 100% in all groups. Higher incidence of fever (> 38\u00b0C) was reported in infants receiving the investigational formulations (Primary study: 75.0% [A] and 72.1% [B] vs 58.8% [control]; Booster study, before amendment: 49.4% and 46.6% vs 37.4%, respectively). The development of the investigational formulations was not further pursued. PMID:28340322\n[Beta- Lactam Antibiotics Stimulate Biofilm Formation in Non-Typeable Haemophilus influenzae by Up-Regulating Carbohydrate Metabolism](https://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=4090067)\nWu, Siva; Li, Xiaojin; Gunawardana, Manjula; Maguire, Kathleen; Guerrero-Given, Debbie; Schaudinn, Christoph; Wang, Charles; Baum, Marc M.; Webster, Paul\n2014-01-01\nNon-typeable Haemophilus influenzae (NTHi) is a common acute otitis media pathogen, with an incidence that is increased by previous antibiotic treatment. NTHi is also an emerging causative agent of other chronic infections in humans, some linked to morbidity, and all of which impose substantial treatment costs. In this study we explore the possibility that antibiotic exposure may stimulate biofilm formation by NTHi bacteria. We discovered that sub-inhibitory concentrations of beta-lactam antibiotic (i.e., amounts that partially inhibit bacterial growth) stimulated the biofilm-forming ability of NTHi strains, an effect that was strain and antibiotic dependent. When exposed to sub-inhibitory concentrations of beta-lactam antibiotics NTHi strains produced tightly packed biofilms with decreased numbers of culturable bacteria but increased biomass. The ratio of protein per unit weight of biofilm decreased as a result of antibiotic exposure. Antibiotic-stimulated biofilms had altered ultrastructure, and genes involved in glycogen production and transporter function were up regulated in response to antibiotic exposure. Down-regulated genes were linked to multiple metabolic processes but not those involved in stress response. Antibiotic-stimulated biofilm bacteria were more resistant to a lethal dose (10 \u00b5g/mL) of cefuroxime. Our results suggest that beta-lactam antibiotic exposure may act as a signaling molecule that promotes transformation into the biofilm phenotype. Loss of viable bacteria, increase in biofilm biomass and decreased protein production coupled with a concomitant up-regulation of genes involved with glycogen production might result in a biofilm of sessile, metabolically inactive bacteria sustained by stored glycogen. These biofilms may protect surviving bacteria from subsequent antibiotic challenges, and act as a reservoir of viable bacteria once antibiotic exposure has ended. PMID:25007395\n[El estado actual de las vacunas contra las drogas](http://riiad.org/index.php/riiad/article/view/riiad.2017.2.05) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nMaura Epifan\u00eda Matus Ortega\n2017-12-01\nFull Text Available Introducci\u00f3n: por lo com\u00fan, la adicci\u00f3n a las drogas se trata con psicoterapia y farmacolog\u00eda que evita la uni\u00f3n de las sustancias psicoactivas a receptores espec\u00edficos en el cerebro. El resultado de estos tratamientos no ha sido del todo satisfactorio, por lo que el desarrollo de terapias m\u00e1s eficaces representa un reto constante para tratar las adicciones. Una alternativa a la farmacolog\u00eda antiadictiva es la vacunaci\u00f3n activa dirigida contra las sustancias de abuso. Objetivo: esta revisi\u00f3n re\u00fane la informaci\u00f3n disponible sobre los fundamentos y avances cient\u00edficos en la generaci\u00f3n de una terapia inmunol\u00f3gica, que coadyuve al tratamiento de la adicci\u00f3n a sustancias como la hero\u00edna-morfina, la coca\u00edna, la nicotina y la anfetamina. M\u00e9todo: se consideraron los reportes cient\u00edficos disponibles en PubMed \u2013de 2005 a abril de 2017\u2013, sobre los fundamentos, la metodolog\u00eda empleada, los estudios precl\u00ednicos y cl\u00ednicos, y los resultados obtenidos en dichas investigaciones para generar vacunas contra las drogas. Resultados: las vacunas lograron mitigar los efectos producidos por las sustancias en los estudios precl\u00ednicos en modelos de estudio en animales; sin embargo, con pacientes humanos los resultados no han sido del todo satisfactorios. Discusi\u00f3n y conclusiones: a pesar de los esfuerzos realizados por diferentes grupos de investigaci\u00f3n y compa\u00f1\u00edas farmac\u00e9uticas para generar vacunas terap\u00e9uticas contra el uso de diferentes drogas, ninguna ha alcanzado la fase III de estudios cl\u00ednicos. En la actualidad, se contin\u00faa con los esfuerzos para lograr que las vacunas contra las adicciones alcancen su m\u00e1xima eficiencia y eficacia, y contribuyan al tratamiento de la adicci\u00f3n a las drogas.\n[Combination Chemotherapy for Influenza](http://www.mdpi.com/1999-4915/2/8/1510/) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nRobert G. Webster\n2010-07-01\nFull Text Available The emergence of pandemic H1N1 influenza viruses in April 2009 and the continuous evolution of highly pathogenic H5N1 influenza viruses underscore the urgency of novel approaches to chemotherapy for human influenza infection. Anti-influenza drugs are currently limited to the neuraminidase inhibitors (oseltamivir and zanamivir and to M2 ion channel blockers (amantadine and rimantadine, although resistance to the latter class develops rapidly. Potential targets for the development of new anti-influenza agents include the viral polymerase (and endonuclease, the hemagglutinin, and the non-structural protein NS1. The limitations of monotherapy and the emergence of drug-resistant variants make combination chemotherapy the logical therapeutic option. Here we review the experimental data on combination chemotherapy with currently available agents and the development of new agents and therapy targets.\n[Las vacunas nos protegen (Vaccines Help Protect Us)](https://www2c.cdc.gov/podcasts/player.asp?f=8630647) [Centers for Disease Control (CDC) Podcasts](http://www2c.cdc.gov/podcasts/search.asp)\n2013-04-23\nEn este podcast, los ni\u00c3\u00b1os de Kidtastics hablan sobre la importancia de las vacunas y c\u00c3\u00b3mo funcionan. Created: 4/23/2013 by Centers for Disease Control and Prevention (CDC). Date Released: 12/11/2013.\n[The cytolethal distending toxin of Haemophilus ducreyi aggravates dermal lesions in a rabbit model of chancroid.](https://www.ncbi.nlm.nih.gov/pubmed/15876546)\nWising, Catharina; M\u00f6lne, Lena; Jonsson, Ing-Marie; Ahlman, Karin; Lagerg\u00e5rd, Teresa\n2005-05-01\nHaemophilus ducreyi, the etiologic agent of the sexually transmitted disease chancroid, produces a cytolethal distending toxin (HdCDT) that inhibits cultured cell proliferation, leading to cell death. A rabbit model of dermal infection was used to investigate the roles of H. ducreyi bacteria and HdCDT in the development, clinical appearance, and persistence of infection. A non-toxin producing H. ducreyi strain, and for comparison purposes a non-capsulated Haemophilus influenzae strain, were inoculated intradermally, with and without co-administration of purified HdCDT. Co-administration of HdCDT resulted in significant aggravation of H. ducreyi-induced inflammatory lesions, and development of ulcers in rabbit skin. Less pronounced inflammatory lesions and lack of epithelial eruption were observed after inoculation with H. influenzae. Histopathological sections of the H. ducreyi-induced lesions, in both the presence and absence of HdCDT, showed dense infiltrates of the same type inflammatory cells, with the exception of a prominent endothelial cell proliferation noted in sections from lesions caused by H. ducreyi and toxin. Signs of chronic inflammation with involvement of T cells, macrophages, eosinophils, and granuloma formation were observed after H. ducreyi inoculation both with and without toxin. In conclusion, H. ducreyi causes a pronounced, chronic inflammation with involvement of T cells and macrophages, and in combination with HdCDT production of ulcers in the rabbit model. These pathogenic mechanisms may promote the development and persistence of chancroid ulcers.\n[Mandatory vaccinations in European countries, undocumented information, false news and the impact on vaccination uptake: the position of the Italian pediatric society.](https://www.ncbi.nlm.nih.gov/pubmed/29898770)\nBozzola, Elena; Spina, Giulia; Russo, Rocco; Bozzola, Mauro; Corsello, Giovanni; Villani, Alberto\n2018-06-14\nHigh rates of vaccination coverage are important in preventing infectious diseases. Enforcing mandatory vaccinations is one of the strategies that some Countries adopted to protect the community when vaccination coverage is not satisfactory. In Italy, in 2017 vaccination against diphtheria, tetanus, pertussis, hepatitis B, poliovirus, Haemophilus influenzae type b, measles, mumps, rubella and varicella became compulsory in childhood. In order to contrast vaccination policies, anti-vaccination campaigns contribute to the spread of fake news. Among them, there is the false information that Italy is the only one country with mandatory vaccination policy. Aim of our study is confronting vaccination policies in children under 18 months against among different European countries for the following vaccines: diphtheria, tetanus, pertussis, hepatitis B, poliovirus, Haemophilus influenzae type b, measles, mumps, rubella and varicella. Information on policies of mandatory or recommended vaccinations of the European Countries were gathered by ECDC and compared to the Italian one. European Countries recommend or contemplate compulsory vaccines. Among them, eleven Countries (35.4%) have mandatory vaccinations for at least one out of diphtheria, tetanus, pertussis, hepatitis B, poliovirus, Haemophilus influenzae type b, measles, mumps, rubella and varicella vaccine. Not only in Italy, vaccination against diphtheria, tetanus, pertussis, hepatitis B, poliovirus, Haemophilus influenzae type b, measles, mumps, rubella and varicella is mandatory in children under 18 months. Other European countries adopted compulsory policies in order to prevent the spread of infectious diseases and to protect the community.\n[Eficacia de la vacuna meningoc\u00f3cica de polisac\u00e1rido capsular del grupo C](http://www.scielosp.org/scielo.php?script=sci_arttext&pid=S1135-57271997000200003) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nGonz\u00e1lez Enr\u00edquez Jes\u00fas\n1997-01-01\nFull Text Available FUNDAMENTO: Este trabajo consiste esencialmente en una revisi\u00f3n sistem\u00e1tica de la literatura cient\u00edfica sobre los efectos, intensidad y duraci\u00f3n de la respuesta serol\u00f3gica, as\u00ed como sobre la eficacia, efectividad y seguridad de la vacuna meningoc\u00f3cica de polisac\u00e1rido capsular del grupo C. M\u00c9TODOS: B\u00fasqueda en repertorio MEDLINE en el periodo 1970-1996. B\u00fasqueda espec\u00edfica de ensayos cl\u00ednicos aleatorizados y estudios de intervenci\u00f3n prospectivos en humanos con vacunas de polisac\u00e1ridos capsulares de meningococo en el mismo repertorio y periodo. An\u00e1lisis cr\u00edtico de literatura cient\u00edfica y s\u00edntesis de evidencia. RESULTADOS: La vacuna de polisac\u00e1rido capsular del serogrupo C es considerada segura y ha mostrado una eficacia superior al 85% en adultos y ni\u00f1os mayores, 70% (IC95%: 5-91% en ni\u00f1os menores de 5 a\u00f1os y 55% (IC90%: 14-76% en ni\u00f1os de 2-3 a\u00f1os. La vacuna no se ha mostrado eficaz en ni\u00f1os menores de 2 a\u00f1os. La duraci\u00f3n de niveles de anticuerpos protectores disminuye con la edad. La proporci\u00f3n de ni\u00f1os menores de 6 a\u00f1os efectivamente protegidos al a\u00f1o de la vacunaci\u00f3n es baja. La vacunaci\u00f3n no limita la respuesta serol\u00f3gica de vacunaciones ulteriores. CONCLUSIONES: La vacuna meningoc\u00f3cica de polisac\u00e1rido capsular del serogrupo C est\u00e1 indicada en adultos y ni\u00f1os mayores de 2 a\u00f1os como protecci\u00f3n contra la enfermedad meningoc\u00f3cica causada por este serogrupo en situaciones de alto riesgo de enfermedad. La escasa protecci\u00f3n que ofrece la vacuna en los menores de 2 a\u00f1os, la limitada eficacia en menores de 5 a\u00f1os y la corta duraci\u00f3n de la inmunidad que confiere a estas edades, hace que la vacunaci\u00f3n rutinaria no est\u00e9 recomendada y que la vacuna se use fundamentalmente en el control de brotes epid\u00e9micos causados por serogrupo C.\n[Properties of polysaccharides in several seaweeds from Atlantic Canada and their potential anti-influenza viral activities](http://adsabs.harvard.edu/abs/2012JOUC...11..205J)\nJiao, Guangling; Yu, Guangli; Wang, Wei; Zhao, Xiaoliang; Zhang, Junzeng; Ewart, Stephen H.\n2012-06-01\nTo explore the polysaccharides from selected seaweeds of Atlantic Canada and to evaluate their potential anti-influenza virus activities, polysaccharides were isolated from several Atlantic Canadian seaweeds, including three red algae ( Polysiphonia lanosa, Furcellaria lumbricalis, and Palmaria palmata), two brown algae ( Ascophyllum nodosum and Fucus vesiculosus), and one green alga ( Ulva lactuca) by sequential extraction with cold water, hot water, and alkali solutions. These polysaccharides were analyzed for monosaccharide composition and other general chemical properties, and they were evaluated for anti-influenza virus activities. Total sugar contents in these polysaccharides ranged from 15.4% (in U. lactuca) to 91.4% (in F. lumbricalis); sulfation level was as high as 17.6% in a polysaccharide from U. lactuca, whereas it could not be detected in an alikali-extract from P. palmaria. For polysaccharides from red seaweeds, the main sugar units were sulfated galactans (agar or carrageenan) for P. lanosa, F. lumbricalis, and xylans for P. palmata. In brown seaweeds, the polysaccharides largely contained sulfated fucans, whereas the polysaccharides in green seaweed were mainly composed of heteroglycuronans. Screening for antiviral activity against influenza A/PR/8/34 (H1N1) virus revealed that brown algal polysaccharides were particularly effective. Seaweeds from Atlantic Canada are a good source of marine polysaccharides with potential antiviral properties.\n[Estrategia y resultados de la farmacovigilancia de vacunas desde el Instituto Finlay, 2009](http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1025-028X2010000200006&lng=es&nrm=iso) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nIv\u00e1n E. Cuevas-Valdespino\n2010-08-01\nFull Text Available El objetivo de este trabajo fue mostrar la estrategia y los resultados de la farmacovigilancia desde el Instituto Finlay, como titular de registros sanitarios. Se concret\u00f3 la biograf\u00eda de los productos en la etapa de poscomercializaci\u00f3n y se examin\u00f3 el balance riesgo/beneficio. Esto fue posible gracias a convenios con instituciones que permitieron el acceso a bases de datos digitales y auditables, donde se encontr\u00f3 la notificaci\u00f3n espont\u00e1nea de eventos adversos y el cumplimiento de las buenas pr\u00e1cticas, reglamentos y regulaciones de la autoridad reguladora. La miner\u00eda de datos para la b\u00fasqueda de la agrupaci\u00f3n de eventos raros e inesperados para un mismo lote o de accidentes, la confecci\u00f3n de los informes peri\u00f3dicos de seguridad y la pr\u00e1ctica sistem\u00e1tica para completar la informaci\u00f3n de seguridad solicitada en subpoblaciones y grupos especiales permiti\u00f3 actualizar el perfil de seguridad de las vacunas. Se confirm\u00f3 que la vacuna antileptospir\u00f3sica trivalente, la antitifo\u00eddica Vi y el toxoide tet\u00e1nico, presentaron una frecuencia de eventos adversos menor de 0,1 reporte por cada 100.000 dosis administradas, mientras las dem\u00e1s vacunas tuvieron valores entre 1 y 10 por cada 10.000 vacunados. Entre el 80% y 95% de las notificaciones fueron relacionadas causalmente con la vacuna, y solo el 0,89% fueron de severidad grave, casi todas en ni\u00f1os menores de un a\u00f1o. Las manifestaciones generales fueron las que predominaron. Los resultados presentados muestran la importancia que tiene la farmacovigilancia desde la industria para obtener una valiosa informaci\u00f3n de la seguridad en la aplicaci\u00f3n de las vacunas.\n[Antibiotic Resistance in Haemophilus influenzae Decreased, except for \u03b2-Lactamase-Negative Amoxicillin-Resistant Isolates, in Parallel with Community Antibiotic Consumption in Spain from 1997 to 2007\u25bf](https://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=2493100)\nGarc\u00eda-Cobos, Silvia; Campos, Jos\u00e9; Cercenado, Emilia; Rom\u00e1n, Federico; L\u00e1zaro, Edurne; P\u00e9rez-V\u00e1zquez, Mar\u00eda; de Abajo, Francisco; Oteo, Jes\u00fas\n2008-01-01\nThe susceptibility to 14 antimicrobial agents and the mechanisms of aminopenicillin resistance were studied in 197 clinical isolates of Haemophilus influenzae\u2014109 isolated in 2007 (study group) and 88 isolated in 1997 (control group). Community antibiotic consumption trends were also examined. H. influenzae strains were consecutively isolated from the same geographic area, mostly from respiratory specimens from children and adults. Overall, amoxicillin resistance decreased by 8.4% (from 38.6 to 30.2%). \u03b2-Lactamase production decreased by 15.6% (from 33 to 17.4%, P = 0.01), but amoxicillin resistance without \u03b2-lactamase production increased by 7.1% (from 5.7 to 12.8%). All \u03b2-lactamase-positive isolates were TEM-1, but five different promoter regions were identified, with Pdel being the most prevalent in both years, and Prpt being associated with the highest amoxicillin resistance. A new promoter consisting of a double repeat of 54 bp was detected. Community consumption of most antibiotics decreased, as did the geometric means of their MICs, but amoxicillin-clavulanic acid and azithromycin consumption increased by ca. 60%. For amoxicillin-clavulanic acid, a 14.2% increase in the population with an MIC of 2 to 4 \u03bcg/ml (P = 0.02) was observed; for azithromycin, a 21.2% increase in the population with an MIC of 2 to 8 \u03bcg/ml (P = 0.0005) was observed. In both periods, the most common gBLNAR (i.e., H. influenzae isolates with mutations in the ftsI gene as previously defined) patterns were IIc and IIb. Community consumption of trimethoprim-sulfamethoxazole decreased by 54%, while resistance decreased from 50 to 34.9% (P = 0.04). Antibiotic resistance in H. influenzae decreased in Spain from 1997 to 2007, but surveillance should be maintained since new forms of resistances may be developing. PMID:18505850\n[Aislamientos invasivos de Haemophilus influenzae en menores de 5 a\u00f1os: distribuci\u00f3n de los serotipos y de la sensibilidad antimicrobiana, SIREVA II, Colombia 2002-2013](http://www.scielo.org.co/scielo.php?script=sci_arttext&pid=S0123-93922015000200004&lng=en&tlng=en) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nMabel Karina Rodr\u00edguez\nFull Text Available Objetivo: Analizar del 2002 al 2013 los datos de la vigilancia de los serotipos y sensibilidad antimicrobiana de los aislamientos invasivos de Haemophilus influenzae ( H. influenzae en ni\u00f1os menores de 60 meses. Materiales y m\u00e9todos: Se analizaron los datos demogr\u00e1ficos, fuente y enfermedad asociada de los aislamientos invasivos de H. influenzae recibidos entre 2002 y 2013. Todos los aislamientos hab\u00edan sido confirmados bacteriol\u00f3gicamente, ten\u00edan el dato del serotipo, el cual fue determinado por el m\u00e9todo de aglutinaci\u00f3n en l\u00e1mina y PCR y los patrones de sensibilidad antimicrobiana por concentraci\u00f3n inhibitoria m\u00ednima a ampicilina, SXT, cloranfenicol, cefuroxima y ceftriaxona. El an\u00e1lisis se realiz\u00f3 por periodos de 3 a\u00f1os. Resultados: Por enfermedad invasiva el 50,5% eran de pacientes con meningitis, 23,5% de neumon\u00edas, 19,5% de sepsis y bacteriemia, 2,0% de otros y 4,5% sin dato. Por procedencia se recibieron de Bogot\u00e1 y Antioquia 55 aislamientos de cada uno, de Risaralda 24, de Valle 15, de Santander 11 y 40 de 14 departamentos. El serotipo predominante fue el Hib (40,5%, seguido de HiNT (38,0%, Hia (17,5%, Hid (2,0%, Hif (1,5% y Hie (0,5%. Del total de los aislamientos, 12,0% eran resistentes a ampicilina; 16,5% a SXT; 1,0% a cloranfenicol y 0,5% a ceftriaxona. Todos los aislamientos fueron sensibles a cefuroxima y a rifampicina. Conclusiones: La vigilancia por el laboratorio es una vigilancia pasiva voluntaria pero, no obstante el n\u00famero reducido de aislamientos, permite determinar que Hib contin\u00faa circulando en esta poblaci\u00f3n y que hay otros serotipos de H. influenzae que causan enfermedad invasiva. Por tanto es necesario mantener y fortalecer la vigilancia de este pat\u00f3geno.\n[Perspectivas para nuevas vacunas antituberculosas en la era posgen\u00f3mica.](http://www.revistabiomedica.org/index.php/biomedica/article/view/1320) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nLuis F. Garc\u00eda\n2004-06-01\nFull Text Available A pesar de que la vacunaci\u00f3n con Mycobacterium bovis BCG es el procedimiento m\u00e1s utilizado a nivel mundial para prevenir la tuberculosis, su eficicacia es muy cuestionable, lo cual ha motivado la b\u00fasqueda de nuevas opciones inmunoprofil\u00e1cticas. El conocimiento generado con el secuenciamiento completo de una cepa de Mycobacterium tuberculosis H37Rv y la aplicaci\u00f3n de nuevas tecnolog\u00edas inmunol\u00f3gicas, bioqu\u00edmicas y gen\u00e9ticas han permitido realizar una disecci\u00f3n fina del transcriptoma y el proteoma de M. tuberculosis, lo cual ha generado una gran cantidad de conocimiento sobre la biolog\u00eda de este microorganismo. Dado que alrededor de una tercera parte de la poblaci\u00f3n mundial puede estar infectada con M. tuberculosis y que \u00e9ste s\u00f3lo se detecta cuando se inicia la enfermedad, la mayor parte de los esfuerzos se han dedicado al dise\u00f1o de vacunas posinfecci\u00f3n que induzcan un aumento selectivo de la inmunidad celular espec\u00edfica del hospedero a largo plazo, no generen reacciones adversas y sean de bajo costo. Dentro de las nuevas estrategias que est\u00e1n siendo utilizadas para el desarrollo de vacunas, se destaca la utilizaci\u00f3n de mezclas de prote\u00ednas con una alta inmunogenicidad, cepas de M. bovis BCG recombinantes y de M. tuberculosis gen\u00e9ticamente atenuadas o modificadas para inducir una mayor respuesta inmune, y las vacunas de ADN desnudo. Los candidatos con m\u00e1s potencial incluyen las vacunas de subunidades micobacterianas, las cuales expresan mol\u00e9culas ampliamente reconocidas por el sistema inmune y cuyo reconocimiento resulta en el incremento de la respuesta Th1 y aqu\u00e9llas que utilizan vectores virales dise\u00f1ados para expresar mol\u00e9culas micobacterianas antig\u00e9nicas. Aunque los modelos animales son de valor limitado, puesto que la patolog\u00eda observada en ellos s\u00f3lo reproduce parcialmente la observada en humanos, los resultados obtenidos con estas vacunas son muy prometedores y algunas est\u00e1n siendo actualmente evaluadas en\n[Asymtomatic carriage of Neisseria meningitidis and Neisseria lactamica in relation to Streptococcus pneumoniae and Haemophilus influenzae colonization in healthy children: Apropos of 1400 children sampled](http://dx.doi.org/10.1023/A:1020021109462) [International Nuclear Information System (INIS) ](http://inis.iaea.org/search/)\nBakir, Mustafa; Yagci, Aysegul; Ulger, Nurver; Akbenlioglu, Cengiz; Ilki, Arzu; Soyletir, Guner\n2001-01-01\nMeningococcal disease is one of the most important causes of morbidity and mortality among children in many parts of the world. Main reservoir of carriage and site of meningococcal dissemination appears to be the upper respiratory tract. Colonization of Neisseria meningitidis and lactamica and factors affecting this carriage were determined in a group of healthy children aged 0-10 years. Meningococcus and N. lactamica carriage were detected in 17 (1.23%) and 245 (17.7%) of 1382 subjects, respectively. Number (%) of serogroups for meningococci was 1 (6), 5 (29), 0 (0), 1 (6), 1 (6), and 9 (53) for A, B, C, D, W135, and Y, respectively. Having more than three household members, elementary school attendance, pharyngeal carriage of Streptococcus pneumoniae and Haemophilus influenzae were associated with carriage of meningococci, whereas age less than 24-month was associated with carriage of N. lactamica. There was a reverse carriage rate between N. meningitidis and N. lactamica by age which may suggest a possible protective role of N. lactamica against meningococcal colonization among pre-school children\n[Patterns of binding of aluminum-containing adjuvants to Haemophilus influenzae type b and meningococcal group C conjugate vaccines and components.](https://www.ncbi.nlm.nih.gov/pubmed/26194164)\nOtto, Robert B D; Burkin, Karena; Amir, Saba Erum; Crane, Dennis T; Bolgiano, Barbara\n2015-09-01\nThe basis of Haemophilus influenzae type b (Hib) and Neisseria meningitidis serogroup C (MenC) glycoconjugates binding to aluminum-containing adjuvants was studied. By measuring the amount of polysaccharide and protein in the non-adsorbed supernatant, the adjuvant, aluminum phosphate, AlPO4, was found to be less efficient than aluminum hydroxide, Al(OH)3 at binding to the conjugates, at concentrations relevant to licensed vaccine formulations and when equimolar. At neutral pH, binding of TT conjugates to AlPO4 was facilitated through the carrier protein, with only weak binding of AlPO4 to CRM197 being observed. There was slightly higher binding of either adjuvant to tetanus toxoid conjugates, than to CRM197 conjugates. This was verified in AlPO4 formulations containing DTwP-Hib, where the adsorption of TT-conjugated Hib was higher than CRM197-conjugated Hib. At neutral pH, the anionic Hib and MenC polysaccharides did not appreciably bind to AlPO4, but did bind to Al(OH)3, due to electrostatic interactions. Phosphate ions reduced the binding of the conjugates to the adjuvants. These patterns of adjuvant adsorption can form the basis for future formulation studies with individual and combination vaccines containing saccharide-protein conjugates. Crown Copyright \u00a9 2015. Published by Elsevier Ltd. All rights reserved.\n[Vaccines against dengue: a review of current candidate vaccines at advanced development stages Vacunas contra el dengue: una revisi\u00f3n de las vacunas candidatas en etapas avanzadas de desarrollo](https://www.openaire.eu/search/publication?articleId=doajarticles::d1c5d56abb3c55f6f0d140a1ec694442)\nJoachim Hombach\n2007-01-01\nLos esfuerzos sistem\u00e1ticos para desarrollar una vacuna contra el dengue comenzaron durante la Segunda Guerra Mundial, inspirados en el desarrollo exitoso de una vacuna contra la fiebre amarilla. Sin embargo, la falta de modelos adecuados de la enfermedad, la informaci\u00f3n incompleta acerca de los mecanismos patog\u00e9nicos y los insuficientes incentivos econ\u00f3micos han dificultado los avances. Debido al impacto actual del dengue en todo el mundo y su explosiva diseminaci\u00f3n, ha aumentado el inter\u00e9s e...\n[Vacuna contra la fiebre hemorr\u00e1gica argentina Candid#1 producida en la Argentina: Inmunogenicidad y seguridad](http://www.scielo.org.ar/scielo.php?script=sci_arttext&pid=S0025-76802010000300002&lng=en&tlng=en) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nDelia A. Enria\n2010-06-01\nFull Text Available Se realiz\u00f3 un estudio cl\u00ednico en 946 voluntarios humanos sanos, donde se compar\u00f3 la vacuna Candid#1 producida en Argentina con la elaborada en EE.UU., que hab\u00eda sido utilizada en estudios previos. Como objetivo primario se evalu\u00f3 la equivalencia en la eficacia utilizando como marcador subrogante a la inmunogenicidad medida por detecci\u00f3n de anticuerpos neutralizantes. Como objetivo secundario se evalu\u00f3 la equivalencia en inocuidad comparando las tasas de reacciones adversas. Ambas vacunas mostraron una tasa equivalente de inmunogenicidad ligeramente superior al 95.5%, que es la eficacia estimada para Candid #1 en estudios previos. No se observaron eventos adversos graves relacionados con la vacuna. Los eventos adversos generales considerados relacionados fueron de escasa significaci\u00f3n cl\u00ednica y de resoluci\u00f3n espont\u00e1nea o con tratamiento sintom\u00e1tico; se presentaron en los receptores de ambas vacunas en tasas equivalentes (29.9% para la vacuna fabricada en la Argentina y 35.0% para la fabricada en EE.UU., e incluyeron: cefalea, decaimiento, mialgias, plaquetopenia leve (< 150 000 plaquetas/mm\u00b3, n\u00e1useas y/o v\u00f3mitos, leucopenia leve (< 4 000 blancos/mm\u00b3, fiebre, dolor retroocular, mareos, microhematuria, lumbalgia y exantema. Estos resultados indican que la vacuna Candid #1 elaborada en la Argentina es equivalente a la elaborada en los EE.UU. Este estudio permiti\u00f3 el registro del biol\u00f3gico producido en la Argentina ante la autoridad regulatoria del pa\u00eds (ANMAT.\n[Beta- lactam antibiotics stimulate biofilm formation in non-typeable haemophilus influenzae by up-regulating carbohydrate metabolism.](http://europepmc.org/articles/PMC4090067?pdf=render) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nSiva Wu\nFull Text Available Non-typeable Haemophilus influenzae (NTHi is a common acute otitis media pathogen, with an incidence that is increased by previous antibiotic treatment. NTHi is also an emerging causative agent of other chronic infections in humans, some linked to morbidity, and all of which impose substantial treatment costs. In this study we explore the possibility that antibiotic exposure may stimulate biofilm formation by NTHi bacteria. We discovered that sub-inhibitory concentrations of beta-lactam antibiotic (i.e., amounts that partially inhibit bacterial growth stimulated the biofilm-forming ability of NTHi strains, an effect that was strain and antibiotic dependent. When exposed to sub-inhibitory concentrations of beta-lactam antibiotics NTHi strains produced tightly packed biofilms with decreased numbers of culturable bacteria but increased biomass. The ratio of protein per unit weight of biofilm decreased as a result of antibiotic exposure. Antibiotic-stimulated biofilms had altered ultrastructure, and genes involved in glycogen production and transporter function were up regulated in response to antibiotic exposure. Down-regulated genes were linked to multiple metabolic processes but not those involved in stress response. Antibiotic-stimulated biofilm bacteria were more resistant to a lethal dose (10 \u00b5g/mL of cefuroxime. Our results suggest that beta-lactam antibiotic exposure may act as a signaling molecule that promotes transformation into the biofilm phenotype. Loss of viable bacteria, increase in biofilm biomass and decreased protein production coupled with a concomitant up-regulation of genes involved with glycogen production might result in a biofilm of sessile, metabolically inactive bacteria sustained by stored glycogen. These biofilms may protect surviving bacteria from subsequent antibiotic challenges, and act as a reservoir of viable bacteria once antibiotic exposure has ended.\n[Provada amb \u00e8xit en cabres una nova vacuna contra la tuberculosi](https://www.openaire.eu/search/publication?articleId=od______1404::4dfcdb9afa501d98d59e07e37c0dec1f)\nP\u00e9rez del Val, Bernat\n2014-01-01\nInvestigadors del CReSA proven per primer cop i amb \u00e8xit una nova vacuna contra la tuberculosi que millora la protecci\u00f3 de l\u2019\u00fanica vacuna existent en l\u2019actualitat, l\u2019efic\u00e0cia de la qual \u00e9s for\u00e7a limitada. Els estudis s\u2019han realitzat emprant cabres dom\u00e8stiques, que reprodueixen amb elevada similitud les caracter\u00edstiques patol\u00f2giques i la resposta immunol\u00f2gica a la infecci\u00f3 tuberculosa activa en humans i que, pel fet de ser hostes naturals de la tuberculosi, tamb\u00e9 permeten estudiar l\u2019\u00fas potenci...\n[Dicty_cDB: Contig-U05349-1 [Dicty_cDB](http://togodb.dbcls.jp/dicty_cdb_contig/show/1698) [Lifescience Database Archive (English)](http://biosciencedbc.jp/dbsearch/index.php?lang=en)\nFull Text Available fluenzae PittGG, complete genome. 62 2e-14 3 ( DM109591 ) HAEMOPHILUS INFLUENZAE ... ) The Nucleotide Sequence of the Haemophilus influe... 62 3e-14 3 ( DM108107 ) HAEMOPHILUS INFLUENZAE TYPE\n[Conocimientos de los pediatras de Salvador, Brasil, sobre la vacuna antisarampionosa](http://www.scielosp.org/scielo.php?script=sci_arttext&pid=S1020-49891997001200001) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nMoreira Luiza A. Cabus\n1997-01-01\nFull Text Available El \u00e9xito de las iniciativas internacionales para la erradicaci\u00f3n del sarampi\u00f3n depende en gran medida del grado de conocimiento sobre la vacunaci\u00f3n. En 1992 se evaluaron mediante un estudio transversal los conocimientos sobre la vacuna antisarampionosa de los pediatras de la ciudad brasile\u00f1a de Salvador, Bahia. Del total de 506 pediatras residentes en la ciudad, 299 (59% pudieron ser localizados y respondieron a un cuestionario de 15 preguntas en las que se planteaban situaciones hipot\u00e9ticas sobre indicaciones y contraindicaciones de esta vacuna. El promedio de aciertos fue de 9,3 preguntas de las 15, lo que muestra el poco conocimiento de los pediatras sobre la vacunaci\u00f3n antisarampiososa. Situaciones comunes en la pr\u00e1ctica pedi\u00e1trica brasile\u00f1a -desnutrici\u00f3n, infecci\u00f3n de v\u00edas respiratorias altas, diarrea y estado prematuro- fueron a menudo err\u00f3neamente consideradas como contraindicaciones para la inmunizaci\u00f3n. M\u00e1s de la mitad (62% de los pediatras no conoc\u00edan la v\u00eda correcta de administraci\u00f3n de la vacuna. Los conocimientos sobre la vacuna no variaron en funci\u00f3n del tiempo transcurrido desde la formaci\u00f3n universitaria del pediatra o de su trabajo en centros sanitarios de la Secretar\u00eda Estatal de Salud. Los profesores universitarios, los pediatras con maestr\u00eda y los que cursaban estudios de posgrado tuvieron una media de aciertos ligeramente superior a la del resto. Estos resultados indican la necesidad de reforzar la ense\u00f1anza sobre la vacunaci\u00f3n antisarampionosa en las facultades de medicina y en los programas de formaci\u00f3n continuada para pediatras.\n[Conocimientos de los pediatras de Salvador, Brasil, sobre la vacuna antisarampionosa](http://www.scielosp.org/scielo.php?script=sci_arttext&pid=S1020-49891997001200001&lng=en&tlng=en) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nLuiza A. Cabus Moreira\n1997-12-01\nFull Text Available El \u00e9xito de las iniciativas internacionales para la erradicaci\u00f3n del sarampi\u00f3n depende en gran medida del grado de conocimiento sobre la vacunaci\u00f3n. En 1992 se evaluaron mediante un estudio transversal los conocimientos sobre la vacuna antisarampionosa de los pediatras de la ciudad brasile\u00f1a de Salvador, Bahia. Del total de 506 pediatras residentes en la ciudad, 299 (59% pudieron ser localizados y respondieron a un cuestionario de 15 preguntas en las que se planteaban situaciones hipot\u00e9ticas sobre indicaciones y contraindicaciones de esta vacuna. El promedio de aciertos fue de 9,3 preguntas de las 15, lo que muestra el poco conocimiento de los pediatras sobre la vacunaci\u00f3n antisarampiososa. Situaciones comunes en la pr\u00e1ctica pedi\u00e1trica brasile\u00f1a -desnutrici\u00f3n, infecci\u00f3n de v\u00edas respiratorias altas, diarrea y estado prematuro- fueron a menudo err\u00f3neamente consideradas como contraindicaciones para la inmunizaci\u00f3n. M\u00e1s de la mitad (62% de los pediatras no conoc\u00edan la v\u00eda correcta de administraci\u00f3n de la vacuna. Los conocimientos sobre la vacuna no variaron en funci\u00f3n del tiempo transcurrido desde la formaci\u00f3n universitaria del pediatra o de su trabajo en centros sanitarios de la Secretar\u00eda Estatal de Salud. Los profesores universitarios, los pediatras con maestr\u00eda y los que cursaban estudios de posgrado tuvieron una media de aciertos ligeramente superior a la del resto. Estos resultados indican la necesidad de reforzar la ense\u00f1anza sobre la vacunaci\u00f3n antisarampionosa en las facultades de medicina y en los programas de formaci\u00f3n continuada para pediatras.\n[Identidad de la vacuna contra Streptococcus pneumoniae \u201cQuimi-Vio\u201d mediante la t\u00e9cnica Dot Blot empleando los anticuerpos monoclonales contra los polisac\u00e1ridos capsulares 1,5, 6B, 14 y 19F de la bacteria](http://revistabionatura.com/2017.02.01.7.html) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nElizabeth Gonz\u00e1lez Aznar\n2017-02-01\nFull Text Available Streptococcus pneumoniae (neumococo constituye una de las principales causas de enfermedades infecciosas bacterianas, particularmente en ni\u00f1os menores de 2 a\u00f1os de edad. Basadas en el polisac\u00e1rido capsular (PsC, su principal factor de virulencia, existen dos tipos de vacunas aprobadas para uso en humanos: las vacunas polisacar\u00eddicas planas y las vacunas polisacar\u00eddicas conjugadas. Quimi-Vio, la vacuna antineumoc\u00f3cica cubana, pertenece al segundo grupo y est\u00e1 compuesta por los PsC de los siete serotipos de mayor incidencia y circulaci\u00f3n en Cuba (1, 5, 6B, 14, 18C, 19F y 23F. El objetivo de este trabajo fue realizar el ensayo de identidad de la vacuna cubana Quimi-Vio empleando los AcM contra los PsC 1, 5, 6B, 14, y 19F de Sp obtenidos recientemente en el Instituto Finlay de Vacunas, teniendo en cuenta que los Ensayos de identidad de las vacunas son requisito indispensable para la liberaci\u00f3n final de los lotes. La t\u00e9cnica empleada para la realizaci\u00f3n del ensayo de identidad de Quimi-Vio fue el Dot Blot, donde empleando membrana de Nitrocelulosa se realiz\u00f3 la captura de tres lotes de vacuna Quimi-Vio y como control positivo de la t\u00e9cnica los respectivos PsC de los serotipos 1, 5, 6B, 14, y 19F sin conjugar y una vacuna comercial Prevenar-13. Para la identidad de los PsC de neumococo se emplearon los respectivos AcM a una concentraci\u00f3n de 10\u00b5g/mL y como segundo anticuerpo anti IgG de rat\u00f3n conjugado a peroxidasa teniendo en cuenta que los AcMs empleados son murinos. Cada AcM fue capaz de identificar de forma altamente especifica al PsC homologo (mismo serotipo, tanto en su forma no conjugada y monovalente como en el contexto de las vacunas Quimi-Vio y Prevenar 13V, donde adem\u00e1s de estar conjugado al TT se encuentra mezclado con otros PsC de forma multivalente. La t\u00e9cnica Dot Blot empleando los AcMs contra los PsC serotipos 1, 5,6B, 14 y 19F permite identificar de forma espec\u00edfica cada PsC en la formulaci\u00f3n multivalente, por lo\n[VARIABILIDAD EN LA NOTIFICACI\u00d3N DE REACCIONES ADVERSAS A LAS VACUNAS DE LA GRIPE PAND\u00c9MICA Y ESTACIONAL. TEMPORADAS 2009-2010 Y 2010-2011, COMUNITAT VALENCIANA](http://www.redalyc.org/articulo.oa?id=17023106004) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nAna Mar\u00eda Alguacil Ramos\n2012-01-01\nFull Text Available Fundamentos: La p\u00e9rdida de confianza en la seguridad de las vacunas derivada de situaciones de alarma, como en el caso de la gripe pand\u00e9mica, puede afectar tanto a las coberturas vacunales como a la sensibilidad frente a la notificaci\u00f3n de las sospechas de reacciones adversas asociadas a vacunas (SRAAV. El objetivo del trabajo es describir los efectos adversos a la vacuna frente a la gripe pand\u00e9mica notificados en la temporada 2009-2010 y comparar si existen diferencias con los descritos con la vacuna de la gripe estacional en las temporadas 2009-2010 y 2010-2011 en la Comunitat Valenciana (CV. M\u00e9todos: Se realiz\u00f3 un estudio descriptivo de los individuos vacunados frente a la gripe que presentaron alguna SRAAV a la vacuna antigripal y que fue notificada a trav\u00e9s del Sistema de Informaci\u00f3n Vacunal, durante las temporadas 2009-2010 (incluyendo la vacunaci\u00f3n pand\u00e9mica y 2010-2011 en CV. se calcularon las tasas de notificaci\u00f3n de sospechas de reacciones adversas asociadas a vacunas por cada mil dosis de vacunas administradas y sus intervalos de confianza al 95%. Resultados: Durante el periodo 2009-2010 la tasa de notificaci\u00f3n de SRAAV para la vacuna de la gripe estacional fue de 0,02 por mil dosis administradas, para la vacuna pand\u00e9mica de 0,95. En el periodo 2010-2011 la tasa para la vacuna de la gripe estacional fue de 0,04 por mil. Conclusiones: Durante las temporadas analizadas se increment\u00f3 el n\u00famero de notificaciones de SRAAV para las vacunas pand\u00e9micas en comparaci\u00f3n con el resto de vacunas antigripales. La mayor tasa de notificaci\u00f3n de SRAAV correspondi\u00f3 al grupo de profesionales sociosanitarios, tanto para las vacunas frente a la gripe estacional como pand\u00e9- mica.\n[Evaluaci\u00f3n de la eficiencia de la vacunaci\u00f3n antigripal en la poblaci\u00f3n laboral espa\u00f1ola Efficiency of influenza vaccination in the working population in Spain](http://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S0213-91112006000200004) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nJos\u00e9 Ram\u00f3n de Juanes\n2006-03-01\nFull Text Available Introducci\u00f3n: La gripe es la mayor causa de morbimortalidad en el mundo. Actualmente, las vacunas contra la gripe son efectivas y seguras. Las intervenciones que reduzcan la carga de la enfermedad deben analizarse desde el punto de vista cl\u00ednico y econ\u00f3mico. Objetivos: Evaluar la eficiencia de un programa de vacunaci\u00f3n contra la gripe en la poblaci\u00f3n laboral espa\u00f1ola. M\u00e9todos: Modelo te\u00f3rico de an\u00e1lisis de costes y beneficios en t\u00e9rminos de ahorro para una cohorte de 1.000 trabajadores entre 16 y 65 a\u00f1os de edad vacunada, y otra no vacunada, a 1 a\u00f1o desde la perspectiva social. Intervenciones: vacunaci\u00f3n contra la gripe respecto a no vacunaci\u00f3n. Mediciones principales: datos epidemiol\u00f3gicos y cl\u00ednicos de incidencia de gripe y efectividad de la vacuna. Datos de uso de recursos directos (de atenci\u00f3n primaria y especializada e indirectos obtenidos por consenso de 5 expertos en medicina preventiva, microbiolog\u00eda, medicina del trabajo y econom\u00eda de la salud. Datos de costes unitarios (euros de 2003. Se realiz\u00f3 un an\u00e1lisis de sensibilidad con la incidencia de gripe, la efectividad de la vacuna y los d\u00edas de ausencia del trabajo por gripe. Resultados: En el escenario base, la vacuna permite ahorrar 35 euros netos por trabajador (el 88% corresponde al ahorro en p\u00e9rdidas de productividad evitadas. El an\u00e1lisis de sensibilidad indica que los valores umbral de incidencia de gripe y de ausencia del trabajo son del 6% y de 1,5 d\u00edas, respectivamente, a partir de los cuales la vacunaci\u00f3n se asocia con el ahorro neto. Conclusiones: Vacunar contra la gripe a la poblaci\u00f3n laboral espa\u00f1ola puede comportar un ahorro neto a la sociedad.Introduction: Influenza is a major cause of morbidity and mortality worldwide. Currently, licensed influenza vaccines are safe and effective. Any intervention aimed at reducing the burden of illness is worth analyzing from a clinical and economic perspective. Objective: To assess the costs and benefits of an\n[An\u00e1lisis econ\u00f3mico de las vacunas 10-valente y 13-valente contra neumococo: revisi\u00f3n sistem\u00e1tica](https://www.openaire.eu/search/publication?articleId=od______1325::3699ed70c8821c924c79160abcf4fcaf)\nTorres Garrido, Alba Luz; Vargas-Zambrano, Juan-Camilo\n2014-01-01\nIntroducci\u00f3n: Las vacunas cl\u00e1sicamente han representado un m\u00e9todo econ\u00f3mico y eficaz para el control y prevenci\u00f3n de m\u00faltiples enfermedades infecciosas. En los \u00faltimos a\u00f1os se han introducido nuevas vacunas contra neumococo a precios elevados, y los diferentes an\u00e1lisis econ\u00f3micos a nivel mundial de estas vacunas no muestran tendencias. El objetivo de este trabajo era resumir la evidencia existente a trav\u00e9s de los diferentes estudios econ\u00f3micos evaluando las dos vacunas de segunda generaci\u00f3n c...\n[Peroxiredoxin-glutaredoxin and catalase promote resistance of nontypeable Haemophilus influenzae 86-028NP to oxidants and survival within neutrophil extracellular traps.](https://www.ncbi.nlm.nih.gov/pubmed/25348637)\nJuneau, Richard A; Pang, Bing; Armbruster, Chelsie E; Murrah, Kyle A; Perez, Antonia C; Swords, W Edward\n2015-01-01\nNontypeable Haemophilus influenzae (NTHI) is a common commensal and opportunistic pathogen of the human airways. For example, NTHI is a leading cause of otitis media and is the most common cause of airway infections associated with chronic obstructive pulmonary disease (COPD). These infections are often chronic/recurrent in nature and involve bacterial persistence within biofilm communities that are highly resistant to host clearance. Our previous work has shown that NTHI within biofilms has increased expression of factors associated with oxidative stress responses. The goal of this study was to define the roles of catalase (encoded by hktE) and a bifunctional peroxiredoxin-glutaredoxin (encoded by pdgX) in resistance of NTHI to oxidants and persistence in vivo. Isogenic NTHI strain 86-028NP mutants lacking hktE and pdgX had increased susceptibility to peroxide. Moreover, these strains had persistence defects in the chinchilla infection model for otitis media, as well as in a murine model for COPD. Additional work showed that pdgX and hktE were important determinants of NTHI survival within neutrophil extracellular traps (NETs), which we have shown to be an integral part of NTHI biofilms in vivo. Based on these data, we conclude that catalase and peroxiredoxin-glutaredoxin are determinants of bacterial persistence during chronic/recurrent NTHI infections that promote bacterial survival within NETs. Copyright \u00a9 2015, American Society for Microbiology. All Rights Reserved.\n[Generation and testing anti-influenza human monoclonal antibodies in a new humanized mouse model (DRAGA: HLA-A2. HLA-DR4. Rag1 KO. IL-2R\u03b3c KO. NOD).](https://www.ncbi.nlm.nih.gov/pubmed/29135340)\nMendoza, Mirian; Ballesteros, Angela; Qiu, Qi; Pow Sang, Luis; Shashikumar, Soumya; Casares, Sofia; Brumeanu, Teodor-D\n2018-02-01\nPandemic outbreaks of influenza type A viruses have resulted in numerous fatalities around the globe. Since the conventional influenza vaccines (CIV) provide less than 20% protection for individuals with weak immune system, it has been considered that broadly cross-neutralizing antibodies may provide a better protection. Herein, we showed that a recently generated humanized mouse (DRAGA mouse; HLA-A2. HLA-DR4. Rag1KO. IL-2Rgc KO. NOD) that lacks the murine immune system and expresses a functional human immune system can be used to generate cross-reactive, human anti-influenza monoclonal antibodies (hu-mAb). DRAGA mouse was also found to be suitable for influenza virus infection, as it can clear a sub-lethal infection and sustain a lethal infection with PR8/A/34 influenza virus. The hu-mAbs were designed for targeting a human B-cell epitope ( 180 WGIHHPPNSKEQ QNLY 195 ) of hemagglutinin (HA) envelope protein of PR8/A/34 (H1N1) virus with high homology among seven influenza type A viruses. A single administration of HA 180-195 specific hu-mAb in PR8-infected DRAGA mice significantly delayed the lethality by reducing the lung damage. The results demonstrated that DRAGA mouse is a suitable tool to (i) generate heterotype cross-reactive, anti-influenza human monoclonal antibodies, (ii) serve as a humanized mouse model for influenza infection, and (iii) assess the efficacy of anti-influenza antibody-based therapeutics for human use.\n[Preclinical evaluation of a Haemophilus influenzae type b conjugate vaccine process intended for technology transfer.](https://www.ncbi.nlm.nih.gov/pubmed/25483504)\nHamidi, Ahd; Verdijk, Pauline; Kreeftenberg, Hans\n2014-01-01\nIntroduction of Haemophilus influenzae type b (Hib) vaccine in low- and middle-income countries has been limited by cost and availability of Hib conjugate vaccines for a long time. It was previously recognized by the Institute for Translational Vaccinology (Intravacc, originating from the former Vaccinology Unit of the National Institute of Public Health [RIVM] and the Netherlands Vaccine Institute [NVI]) that local production of a Hib conjugate vaccine would increase the affordability and sustainability of the vaccine and thereby help to speed up Hib introduction in these countries. A new affordable and a non-infringing production process for a Hib conjugate vaccine was developed, including relevant quality control tests, and the technology was transferred to a number of vaccine manufacturers in India, Indonesia, and China. As part of the Hib technology transfer project managed by Intravacc, a preclinical toxicity study was conducted in the Netherlands to test the safety and immunogenicity of this new Hib conjugate vaccine. The data generated by this study were used by the technology transfer partners to accelerate the clinical development of the new Hib conjugate vaccine. A repeated dose toxicity and local tolerance study in rats was performed to assess the reactogenicity and immunogenicity of a new Hib conjugate vaccine compared to a licensed vaccine. The results showed that the vaccine was well tolerated and immunogenic in rats, no major differences in both safety and immunogenicity in rats were found between the vaccine produced according to the production process developed by Intravacc and the licensed one. Rats may be useful to verify the immunogenicity of Hib conjugate vaccines and for preclinical evaluation. In general, nonclinical evaluation of the new Hib conjugate vaccine, including this proof of concept (safety and immunogenicity study in rats), made it possible for technology transfer partners, having implemented the original process with no changes\n[A critical role of T follicular helper cells in human mucosal anti-influenza response that can be enhanced by immunological adjuvant CpG-DNA.](https://www.ncbi.nlm.nih.gov/pubmed/27247060)\nAljurayyan, A N; Sharma, R; Upile, N; Beer, H; Vaughan, C; Xie, C; Achar, P; Ahmed, M S; McNamara, P S; Gordon, S B; Zhang, Q\n2016-08-01\nT Follicular helper cells (TFH) are considered critical for B cell antibody response, and recent efforts have focused on promoting TFH in order to enhance vaccine efficacy. We studied the frequency and function of TFH in nasopharynx-associated lymphoid tissues (NALT) from children and adults, and its role in anti-influenza antibody response following stimulation by a live-attenuated influenza vaccine (LAIV) or an inactivated seasonal virus antigen (sH1N1). We further studied whether CpG-DNA promotes TFH and by which enhances anti-influenza response. We showed NALT from children aged 1.5-10 years contained abundant TFH, suggesting efficient priming of TFH during early childhood. Stimulation by LAIV induced a marked increase in TFH that correlated with a strong production of anti-hemagglutinin (HA) IgA/IgG/IgM antibodies in tonsillar cells. Stimulation by the inactivated sH1N1 antigen induced a small increase in TFH which was markedly enhanced by CpG-DNA, accompanied by enhanced anti-HA antibody responses. In B cell co-culture experiment, anti-HA responses were only seen in the presence of TFH, and addition of plasmacytoid dendritic cell to TFH-B cell co-culture enhanced the TFH-mediated antibody production following CpG-DNA and sH1N1 antigen stimulation. Induction of TFH differentiation from na\u00efve T cells was also shown following the stimulation. Our results support a critical role of TFH in human mucosal anti-influenza antibody response. Use of an adjuvant such as CpG-DNA that has the capacity to promote TFH by which to enhance antigen-induced antibody responses in NALT tissue may have important implications for future vaccination strategies against respiratory pathogens. Copyright \u00a9 2016 Elsevier B.V. All rights reserved.\n[Immunogenicity and safety of an inactivated hepatitis A vaccine when coadministered with Diphtheria-tetanus-acellular pertussis and haemophilus influenzae type B vaccines in children 15 months of age.](https://www.ncbi.nlm.nih.gov/pubmed/21494175)\nTrofa, Andrew F; Klein, Nicola P; Paul, Ian M; Michaels, Marian G; Goessler, Mary; Chandrasekaran, Vijayalakshmi; Blatter, Mark\n2011-09-01\nThis study (NCT00197236) evaluated the safety and immunogenicity of a hepatitis A virus (HAV) vaccine when coadministered with diphtheria-tetanus-acellular pertussis (DTaP) and Haemophilus influenzae type b (Hib) vaccines in children 15 months of age. This was an open-labeled, multicenter study with healthy subjects enrolled and randomized (1:1:1) into 3 treatment groups. A total of 394 subjects received the first study vaccinations at 15 months of age. Group HAV (N = 135) received 2 doses of HAV vaccine 6 to 9 months apart. Group HAV+DTaP+Hib (N = 127) received HAV vaccine coadministered with DTaP and Hib vaccines and the second dose of HAV vaccine, 6 to 9 months later. Group DTaP+Hib\u2192HAV (N = 132) received the DTaP and Hib vaccines at 15 months of age, followed by HAV vaccine 30 days later and the second dose of HAV vaccine 7 to 10 months after the DTaP+Hib vaccines. Immune responses were evaluated before the first study vaccination and 30 days after each vaccine dose. Solicited, unsolicited, and serious adverse events were collected. After 2 doses of the HAV vaccine, all subjects in the 3 groups were seropositive. The geometric mean concentration of anti-HAV antibodies ranged between 1625.1 and 1904.4 mIU/mL. Coadministration of the 3 vaccines did not impact immunogenicity of the HAV, DTaP, or Hib vaccines. Vaccines were well tolerated in all groups. A 2-dose schedule of HAV vaccine was well tolerated and immunogenic when administered to children starting at 15 months of age. Immune responses to the DTaP or Hib vaccines were similar whether they were administered alone or were coadministered with the HAV vaccine.\n[Long-term trends in invasive Haemophilus influenzae type B disease among indigenous Australian children following use of PRP-OMP and PRP-T vaccines.](https://www.ncbi.nlm.nih.gov/pubmed/25973940)\nMenzies, Robert Ian; Bremner, Kyla Margaret; Wang, Han; Beard, Frank Hudson; McIntyre, Peter Bruce\n2015-06-01\nAmong indigenous populations with high incidence and early onset of invasive Haemophilus influenzae type b (Hib) disease, PRP-OMP vaccines are used in the United States and PRP-T vaccines in Canada. In Australia, PRP-OMP vaccines were exclusively used in indigenous children from 1993 until they were replaced by PRP-T between late 2005 and 2009. Analytic descriptive study of 20 years of enhanced surveillance data (1993-2013) for invasive Hib disease in Australian children PRP-OMP period (1993-1996) to 6.2 (95% CI: 4.0, 9.2) and 4.7 (95% CI: 1.7, 10.3) in the later PRP-OMP (1996-2009) and PRP-T periods (2009-2013), respectively. The indigenous:nonindigenous incidence rate ratio increased to 43 (95% CI: 16, 145) and 58 (95% CI: 7, 2660) in the later PRP-OMP and PRP-T periods, respectively, more than 10-fold higher than in lesser-incidence Australian regions. We found no change in Hib incidence among indigenous Australian children living in high-incidence regions in the first 4 years following a change to PRP-T-containing combination vaccines. This may be of relevance to North American indigenous populations characterized by suboptimal living conditions and young age of onset for whom PRP-OMP continues to be recommended, such as Alaska Natives.\n[Prescripci\u00f3n de vacunas no incluidas en el calendario vacunal en la Comunitat Valenciana durante el per\u00edodo 2004-2009](http://www.redalyc.org/articulo.oa?id=17020115007) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nAna Ruiz Palacio\n2011-01-01\nFull Text Available Fundamentos, En el marco de las pol\u00edticas de uso racional del medicamento, y al objeto de conseguir una gesti\u00f3n eficiente de los programas de vacunaciones, el objetivo de este trabajo es conocer el n\u00famero de envases de las vacunas prescritas no incluidas en los programas de vacunaci\u00f3n en la Comunitat Valenciana y en sus departamentos de salud, as\u00ed como el gasto que produjeron en 2009, y analizar la evoluci\u00f3n desde 2004, centrando el an\u00e1lisis en la vacuna heptavalente conjugada frente al Streptococcus pneumoniae en menores de dos a\u00f1os. M\u00e9todo, Estudio descriptivo retrospectivo de las vacunas prescritas mediante receta en la Comunitat Valenciana durante el a\u00f1o 2009 y su evoluci\u00f3n desde 2004. Variables, n\u00famero de envases, tipo de beneficiario (activo/pensionista, departamento y gasto generado. Fuentes, Gestor de Prestaci\u00f3n Farmac\u00e9utica (GAIA y Sistema Informaci\u00f3n Poblacional (SIP. Resultados: En 2009 la prescripci\u00f3n mediante receta de vacunas no incluidas en los programas de vacunaci\u00f3n gener\u00f3 un gasto de 683.445,71 ] correspondiente a 17.353 envases, lo que supuso el 87! del total del gasto en vacunas recetadas. La vacuna frente al S. pneumoniae gener\u00f3 el 72! del gasto total de las vacunas no incluidas en el calendario. La evoluci\u00f3n 2004-2009 muestra un aumento del gasto de 735.334 ] (24,66! en 2005 a partir del cual se produjo un descenso acusado y paulatino que alcanz\u00f3 los 1.562.650,67 ] (-228.64!. El gasto por departamentos para la vacuna del neumococo conjugada heptavalente por mil ni\u00f1os/as menores de dos a\u00f1os oscil\u00f3 entre 17.377 y 324 ]. Conclusiones: La tendencia descendente del gasto en recetas prescritas se mantuvo durante 2009, fundamentalmente de vacunas conjugadas frente a neumococo. No obstante, se observ\u00f3 gran variabilidad interdepartamental en las tasas de prescripci\u00f3n que debe ser corregida.\n[Australian Aboriginal Children with Otitis Media Have Reduced Antibody Titers to Specific Nontypeable Haemophilus influenzae Vaccine Antigens](https://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=5382827)\nKirkham, Lea-Ann S.; Corscadden, Karli J.; Wiertsema, Selma P.; Fuery, Angela; Jones, B. Jan; Coates, Harvey L.; Vijayasekaran, Shyan; Zhang, Guicheng; Keil, Anthony; Richmond, Peter C.\n2017-01-01\nABSTRACT Indigenous populations experience high rates of otitis media (OM), with increased chronicity and severity, compared to those experienced by their nonindigenous counterparts. Data on immune responses to otopathogenic bacteria in these high-risk populations are lacking. Nontypeable Haemophilus influenzae (NTHi) is the predominant otopathogen in Australia. No vaccines are currently licensed to target NTHi; however, protein D (PD) from NTHi is included as a carrier protein in the 10-valent pneumococcal polysaccharide conjugate vaccine (PHiD10-CV), and other promising protein vaccine candidates exist, including outer membrane protein 4 (P4) and protein 6 (P6). We measured the levels of serum and salivary IgA and IgG against PD, P4, and P6 in Aboriginal and non-Aboriginal children with chronic OM who were undergoing surgery and compared the levels with those in healthy non-Aboriginal children (controls). We found that Aboriginal cases had lower serum IgG titers to all NTHi proteins assessed, particularly PD. In contrast, serum IgA and salivary IgA and IgG titers to each of these 3 proteins were equivalent to or higher than those in both non-Aboriginal cases and healthy controls. While serum antibody levels increased with age in healthy controls, no changes in titers were observed with age in non-Aboriginal cases, and a trend toward decreasing titers with age was observed in Aboriginal cases. This suggests that decreased serum IgG responses to NTHi outer membrane proteins may contribute to the development of chronic and severe OM in Australian Aboriginal children and other indigenous populations. These data are important for understanding the potential benefits of PHiD10-CV implementation and the development of NTHi protein-based vaccines for indigenous populations. PMID:28151410\n[Bioactivity-guided fractionation and analysis of compounds with anti-influenza virus activity from Gardenia jasminoides Ellis.](https://www.ncbi.nlm.nih.gov/pubmed/22297738)\nYang, Quanjun; Wu, Bin; Shi, Yujing; Du, Xiaowei; Fan, Mingsong; Sun, Zhaolin; Cui, Xiaolan; Huang, Chenggang\n2012-01-01\nBioassay-guided fractionation of extracts from Fructus Gardeniae led to analysis of its bioactive natural products. After infection by influenza virus strain A/FM/1/47-MA in vivo, antiviral activity of the extracts were investigated. The target fraction was orally administered to rats and blood was collected. High-performance liquid chromatography coupled with photo diode array detector and electrospray ion trap multiple-stage tandem mass spectrometry was applied to screen the compounds absorbed into the blood. A structural characterization based on the retention time, ultraviolet spectra, parent ions and fragmentation ions was performed. Thirteen compounds were confirmed or tentatively identified. This provides an accurate profile of the composition of bioactive compounds responsible for the anti-influenza properties.\n[A double-blind trial of a new inactivated, trivalent, intra-nasal anti-influenza vaccine in general practice: relationship between immunogenicity and respiratory morbidity over the winter of 1997-98.](https://www.ncbi.nlm.nih.gov/pubmed/11166665)\nKiderman, A; Furst, A; Stewart, B; Greenbaum, E; Morag, A; Zakay-Rones, Z\n2001-02-01\nInfluenza is responsible for considerable morbidity not only among older people but in younger age groups as well. However, most large-scale anti-influenza vaccination campaigns are still aimed principally at the elderly using injectable vaccines. Until now there has been much less emphasis on targeting younger populations or using intra-nasal vaccines in mass anti-influenza immunisation programmes. To assess the immunogenicity of a new inactivated intra-nasal anti-influenza vaccine and to measure its effect on respiratory morbidity in a volunteer general practice population. A prospective, double-blind, placebo-controlled trial using the new vaccine was carried out over the winter of 1997-98 on 274 healthy patients aged 12-60 from three Israeli general practices, 182 in the vaccine group and 92 in the placebo group. Following vaccination the changes in the antigen levels and episodes of respiratory illness in the vaccine and placebo groups were measured. Protective antibody levels occurred after a single dose of vaccine [influenza H1N1, 41% immune pre-vaccination to 73% post-vaccination; influenza H3N2, 35-66%; influenza B, 27-64%]. Between January and March 1998, when influenza activity was at a peak in Israel, the average number of respiratory illness events in the vaccine group [14 events/100 subjects per month] was significantly less than in the placebo group [22 events/100 subjects per month]; similarly, the average number of respiratory illness days in the vaccine group over the same period [69 days/100 subjects per month] was significantly less than in the placebo group [117 days/100 subjects per month]. The new vaccine possessed significant immunogenicity and was associated with a significant reduction in respiratory morbidity among a group of healthy older children and adults. Since intra-nasal vaccines are simpler to administer and more acceptable to the public than injections the vaccine's potential for use in routine anti-influenza vaccination\n[Dps promotes survival of nontypeable Haemophilus influenzae in biofilm communities in vitro and resistance to clearance in vivo.](https://www.ncbi.nlm.nih.gov/pubmed/22919649)\nPang, Bing; Hong, Wenzhou; Kock, Nancy D; Swords, W Edward\n2012-01-01\nNontypeable Haemophilus influenzae (NTHi) is a common airway commensal and opportunistic pathogen that persists within surface-attached biofilm communities. In this study, we tested the hypothesis that bacterial stress-responses are activated within biofilms. Transcripts for several factors associated with bacterial resistance to environmental stress were increased in biofilm cultures as compared to planktonic cultures. Among these, a homolog of the DNA-binding protein from starved cells (dps) was chosen for further study. An isogenic NTHi 86-028NP dps mutant was generated and tested for resistance to environmental stress, revealing a significant survival defects in high-iron conditions, which was mediated by oxidative stress and was restored by genetic complementation. As expected, NTHi 86-028NP dps had a general stress-response defect, exhibiting decreased resistance to many types of environmental stress. While no differences were observed in density and structure of NTHi 86-028NP and NTHi 86-028NP dps biofilms, bacterial survival was decreased in NTHi 86-028NP dps biofilms as compared to the parental strain. The role of dps persistence in vivo was tested in animal infection studies. NTHi 86-028NP dps had decreased resistance to clearance after pulmonary infection of elastase-treated mice as compared to NTHi 86-028NP, whereas minimal differences were observed in clearance from mock-treated mice. Similarly, lower numbers of NTHi 86-028NP dps were recovered from middle-ear effusions and bullar homogenates in the chinchilla model for otitis media (OM). Therefore, we conclude that Dps promotes bacterial survival within NTHi biofilm communities both in vitro and in chronic infections in vivo.\n[Dps promotes survival of nontypeable Haemophilus influenzae in biofilm communities in vitro and resistance to clearance in vivo](http://journal.frontiersin.org/Journal/10.3389/fcimb.2012.00058/full) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nBing ePang\n2012-05-01\nFull Text Available Nontypeable Haemophilus influenzae (NTHi is a common airway commensal and opportunistic pathogen that persists within surface-attached biofilm communities. In this study, we tested the hypothesis that bacterial stress-responses are activated within biofilms. Transcripts for several factors associated with bacterial resistance to environmental stress were increased in biofilm cultures as compared to planktonic cultures. Among these, a homolog of the DNA-binding protein from starved cells (dps was chosen for further study. An isogenic NTHi 86-028NP dps mutant was generated and tested for resistance to environmental stress, revealing a significant survival defects in high-iron conditions, which was mediated by oxidative stress and was restored by genetic complementation. As expected, NTHi 86-028NP dps had a general stress-response defect, exhibiting decreased resistance to many types of environmental stress. While no differences were observed in density and structure of NTHi 86-028NP and NTHi 86-028NP dps biofilms, bacterial survival was decreased in NTHi 86-028NP dps biofilms as compared to the parental strain. The role of dps persistence in vivo was tested in animal infection studies. NTHi 86-028NP dps had decreased resistance to clearance after pulmonary infection of elastase-treated mice as compared to NTHi 86-028NP, whereas minimal differences were observed in clearance from mock-treated mice. Similarly, lower numbers of NTHi 86-028NP dps were recovered from middle-ear effusions and bullar homogenates in the chinchilla model for otitis media. Therefore, we conclude that Dps promotes bacterial survival within NTHi biofilm communities both in vitro and in chronic infections in vivo.\n[Haemophilus segnis endocarditis](http://www.forskningsdatabasen.dk/en/catalog/63173082) [DEFF Research Database (Denmark)](http://forskningsbasen.deff.dk/?lang=eng)\nBangsborg, Jette Marie; Tvede, M; Skinh\u00f8j, P\n1988-01-01\nHaemophilus segnis is a rarely recognised commensal in the oropharynx. We wish to report the first published case of endocarditis caused by H. segnis. The patient, a 76-year-old female did not recover until after 2 courses of ampicillin given for a total of 57 days. In the second course of treatm......Haemophilus segnis is a rarely recognised commensal in the oropharynx. We wish to report the first published case of endocarditis caused by H. segnis. The patient, a 76-year-old female did not recover until after 2 courses of ampicillin given for a total of 57 days. In the second course...\n[Influenza virus neutralizing antibodies and IgG isotype profiles after immunization of mice with influenza A subunit vaccine using various adjuvants](https://www.narcis.nl/publication/RecordID/oai%3Apure.rug.nl%3Apublications%2F3bc35d9e-bdb3-4d3e-bd25-90b2258510c5/uquery/influenza/id/10/Language/EN)\nBenne, CA; Harmsen, M; vanderGraaff, W; Verheul, AFM; Snippe, H; Kraaijeveld, CA\nThe influence of various adjuvants on the development of influenza virus neutralizing antibodies and distribution of anti-influenza virus IgG isotypes after immunization of mice with influenza A (H3N2) subunit vaccine was investigated. Serum titres of influenza virus neutralizing antibodies and\n[Vaccine-induced anti-HA2 antibodies promote virus fusion and enhance influenza virus respiratory disease.](https://www.ncbi.nlm.nih.gov/pubmed/23986398)\nKhurana, Surender; Loving, Crystal L; Manischewitz, Jody; King, Lisa R; Gauger, Phillip C; Henningson, Jamie; Vincent, Amy L; Golding, Hana\n2013-08-28\nVaccine-induced disease enhancement has been described in connection with several viral vaccines in animal models and in humans. We investigated a swine model to evaluate mismatched influenza vaccine-associated enhanced respiratory disease (VAERD) after pH1N1 infection. Vaccinating pigs with whole inactivated H1N2 (human-like) virus vaccine (WIV-H1N2) resulted in enhanced pneumonia and disease after pH1N1 infection. WIV-H1N2 immune sera contained high titers of cross-reactive anti-pH1N1 hemagglutinin (HA) antibodies that bound exclusively to the HA2 domain but not to the HA1 globular head. No hemagglutination inhibition titers against pH1N1 (challenge virus) were measured. Epitope mapping using phage display library identified the immunodominant epitope recognized by WIV-H1N2 immune sera as amino acids 32 to 77 of pH1N1-HA2 domain, close to the fusion peptide. These cross-reactive anti-HA2 antibodies enhanced pH1N1 infection of Madin-Darby canine kidney cells by promoting virus membrane fusion activity. The enhanced fusion activity correlated with lung pathology in pigs. This study suggests a role for fusion-enhancing anti-HA2 antibodies in VAERD, in the absence of receptor-blocking virus-neutralizing antibodies. These findings should be considered during the evaluation of universal influenza vaccines designed to elicit HA2 stem-targeting antibodies.\n[IN VITRO STUDY OF ANTI-INFLUENZA ACTIVITY OF PARA-AMINOBENZOIC ACID AND PROSPECTS OF NASAL DRUG DEVELOPMENT](http://www.imiamn.org.ua/journal/2_2017/PDF/5.pdf) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nNefedova L.\n2017-06-01\nFull Text Available is a vitamin-like substance, para-aminobenzoic acid (PABA. The aim of this work is to study antiviral activity of para-aminobenzoic acid, \u03b5-aminocaproic acid, and their mixture against influenza virus, to evaluate their cytotoxic effect and to calculate their selectivity index by in vitro methods. Materials and Methods. For evaluation of cytotoxic concentration (CC50 of the substance tested, we used MDCK cell culture. For determination of anti-influenza activity of PABA, \u03b5-\u0410CA, and their mixture under conditions of in vitro experiment, we used 24-hour passaged MDCK culture cells of dog\u2019s kidney, influenza virus strain \u0410/FM/1/47 (H1N1, infected titer of which in MDCK culture cells of was between 3.0 and 9.0 lgID50. Results. As a result of our studies, we have determined that PABA in the concentration range studied from 10 to 1,000 ug/ml did not have any cytopahtic effect in MDCK culture cells. We calculated selectivity index (SI for PABA, that was equal SI=128205, this fact confirm high level of therapeutic safety of this substance. The result of our experiments demonstrate that anti-influenza activity of PABA solution is almost 100 times higher than that of \u201cACA\u201d, furthermore in our in vitro experiment the mixture of PABA and \u03b5-aminocaproic acid (in ratio 1:100 demonstrates a synergetic effect. In addition, for combination of PABA and \u03b5\u0410\u041a\u041a (1:100 we calculated fractional inhibitory coefficient FIC=0.79, that indicates to moderate synergetic effect of these substances. Conclusions. As a result of our in vitro studies, we have determined a high-level antiviral activity of para-aminobenzoic acid against influenza virus, and in combination with \u03b5-aminocaproic acid it demonstrated a synergetic effect. We have determined that PABA does not exhibit any cytotoxic effect on MDCK culture cells in the concentration range studied and demonstrates high level of therapeutic safety.\nAlejandro Roque Vald\u00e9s\n2004-01-01\nEl presente trabajo es un art\u00edculo de revisi\u00f3n que pretende abordar un tema tan controvertido como actual: la posible asociaci\u00f3n causal que se ha querido establecer entre el autismo y las vacunas infantiles. A partir de la \u00faltima d\u00e9cada del siglo XX se producen una serie de cambios en la clasificaci\u00f3n, nomenclatura y criterios diagn\u00f3sticos del autismo. Los hallazgos de estudios epidemiol\u00f3gicos llevados a cabo bajo estos nuevos ponderados han revelado que las tasas de prevalencia del autismo s...\n[Dot Blot para determinar la identidad antig\u00e9nica en vacunas conjugadas contra Streptococcus pneumoniae serotipo 19F](http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1025-028X2017000100001&lng=es&nrm=iso&tlng=es) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nOsmir Cabrera-Blanco\n2017-04-01\nFull Text Available Las autoridades regulatorias recomiendan el uso de t\u00e9cnicas de Resonancia Magn\u00e9tica Nuclear o t\u00e9cnicas serol\u00f3gicas para la determinaci\u00f3n de la identidad de los ant\u00edgenos presentes en las vacunas conjugadas. Con la aparici\u00f3n de las vacunas conjugadas multivalentes, se ha hecho necesario recurrir a t\u00e9cnicas inmunoqu\u00edmicas con la utilizaci\u00f3n de anticuerpos monoclonales para aumentar la sensibilidad en la determinaci\u00f3n de la identidad de los ant\u00edgenos en dichas vacunas conjugadas. El objetivo del presente trabajo fue establecer las condiciones \u00f3ptimas de trabajo que permitieran utilizar la t\u00e9cnica del Dot Blot para determinar la identidad de los ant\u00edgenos en vacunas conjugadas de Streptococcus pneumoniae serotipo 19F. Para ello se estudiaron los tiempos de incubaci\u00f3n, la influencia del reactivo en la soluci\u00f3n de bloqueo; tambi\u00e9n las concentraciones \u00f3ptimas del anticuerpo monoclonal y de los ingredientes farmac\u00e9uticos activos, as\u00ed como los vol\u00famenes de aplicaci\u00f3n \u00f3ptimos para estos y vacunas. Se utiliz\u00f3 un anticuerpo monoclonal contra el polisac\u00e1rido capsular del serotipo 19F de neumococo. Las muestras empleadas en este trabajo fueron lotes de ingredientes farmac\u00e9uticos activos de conjugados de polisac\u00e1rido capsular 19F y lotes de un candidato vacunal cubano conjugado heptavalente contra neumococos. Los resultados mostraron que para la determinaci\u00f3n de la identidad antig\u00e9nica fueron suficientes 10 \u00b5L de muestras de los principios activos a una concentraci\u00f3n de 125 \u00b5g/mL e igual volumen para las vacunas heptavalentes. Qued\u00f3 demostrado que una concentraci\u00f3n de 1 \u00b5g/mL para el anticuerpo monoclonal y tiempos de incubaci\u00f3n de 30 min a 37 \u00b0C fueron suficientes para la determinaci\u00f3n. Estos resultados permiten concluir que quedaron establecidas las condiciones \u00f3ptimas de trabajo para determinar la identidad antig\u00e9nica por Dot Blot del polisac\u00e1rido capsular de S. pneumoniae serotipo 19F presente en las vacunas\n[Characterization of the Anti-Influenza Activity of the Chinese Herbal Plant Paeonia lactiflora](http://www.mdpi.com/1999-4915/6/4/1861) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nJin-Yuan Ho\n2014-04-01\nFull Text Available Bai Shao (BS, the root of Paeonia lactiflora Pall., a common Chinese herb in many recipes used to treat viral infection and liver diseases, is recognized for its ability to nourish menstruation, its Yin convergence, and as an antiperspirant. However, the mechanism and components for its antiviral function remain to be elucidated. In this study, an ethanolic extract of BS was further partitioned into aqueous and organic parts (EAex for in vitro functional study and in vivo efficacy testing. EAex exhibited an IC50 of 0.016 \u00b1 0.005 mg/mL against influenza virus A/WSN/33 (H1N1, with broad-spectrum inhibitory activity against different strains of human influenza A viruses, including clinical oseltamivir-resistant isolates and an H1N1pdm strain. The synthesis of both viral RNA and protein was profoundly inhibited when the cells were treated with EAex. A time-of-addition assay demonstrated that EAex exerted its antiviral activity at various stages of the virus replication cycle. We addressed its antiviral activity at virus entry and demonstrated that EAex inhibits viral hemagglutination and viral binding to and penetration into host cells. In vivo animal testing showed that 200 mg/kg/d of EAex offered significant protection against viral infection. We conclude that BS possesses antiviral activity and has the potential for development as an anti-influenza agent.\n[MICROBIOLOGICAL CHARACTERISATION OF Haemophilus influenzae STRAINS ISOLATED FROM PATIENTS WITH INVASIVE AND RESPIRATORY DISEASES](http://www.journal-imab-bg.org/statii-10/vol16_b3_p66-69.pdf) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nTomislav Kostyanev\n2010-01-01\nFull Text Available A total of 175 H. influenzae strains were collected between 1994 and 2009 from all aged patient groups. The strains were isolated from patients with invasive and community-acquired respiratory tract infections. All strains were identified according to standard microbiological methods. Serotyping was done by a coagglutination test and by molecular PCR capsular genotyping. Beta-lactamase production was determined by the chromogenic cephalosporin test with nitrocephin as substrate. Most of the isolated H. influenzae strains were from children under 5 years of age (57.7%. Overall, 61 strains belonged to serotype b (34.9% by the means of PCR capsular typing, 1 strain was type f, and 113 isolates (64.6% were non-typeable (non-encapsulated H. influenzae. Among the infants and children with meningitis or other invasive infections, aged 2 month to 5 years, all strains, except one, were serotype b. In respiratory tract infections (pneumonia, otitis media, sinusitis and people with chronic pulmonary diseases - exacerbations of COPD, bronchiectasis, cystic fibrosis the most common - 96.5% were non-typeable strains in both groups children and adults. Overall, the prevalence of beta-lactamase production was 19.4%. But, it was much higher for invasive strains from CSF isolates - 37.7%, 25% in blood samples, and 37.5% in otitis media causative strains. Beta-lactamase production was less frequent in respiratory tract isolates - in sputum 13.3% and in URT samples - 2.3%. The rate of beta-lactamase production in CSF isolates has not changed for the last 10 years.PCR capsular genotyping method has to be performed for all non-b-type strains. The implementation of Hib vaccine in our country will be accompanied by a reduction in invasive diseases caused by H. influenzae type b in children, but it is not useful in preventing infections caused by non-typeable H. influenzae strains.\n[Vacuna per escur\u00e7ar el tractament contra la tuberculosi](https://www.openaire.eu/search/publication?articleId=od______1404::024354d31010002918ddb339dc0408a6)\nCardona, Pere-Joan\n2006-01-01\nUn grup d'investigadors de la Unitat de Tuberculosi Experimental de la Fundaci\u00f3 Institut Germans Trias i Pujol ha creat una vacuna que permet reduir la durada del tractament de la infecci\u00f3 latent que provoca la tuberculosi de nou mesos a nom\u00e9s un.\n[Vacunas para la prevenci\u00f3n de la gripe en personas de edad avanzada](https://www.openaire.eu/search/publication?articleId=dedup_wf_001::9f9342f04c4ecfc6206eb357ddd593ea)\nJefferson, Tom; Di Pietrantonj, Carlo; Al-Ansary, Lubna A.; Ferroni, Eliana; Thorning, Sarah; Thomas, Roger E.\n2010-01-01\nAntecedentes: Durante las \u00faltimas cuatro d\u00e9cadas, las vacunas han sido la principal arma global para disminuir la repercusi\u00f3n de la gripe en las personas de edad avanzada, y a nivel mundial se recomiendan para los individuos de 65 a\u00f1os o m\u00e1s de edad. El objetivo principal de la vacunaci\u00f3n contra la gripe en las personas de edad avanzada es reducir el riesgo de complicaciones en quienes son m\u00e1s vulnerables. Objetivos: Evaluar la efectividad de las vacunas sobre la prevenci\u00f3n de la gripe, la...\n[Chancroid and Haemophilus ducreyi.](https://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=358107)\nMorse, S A\n1989-01-01\nHaemophilus ducreyi is the causative agent of chancroid, one of the genital ulcerative diseases. H. ducreyi is the major cause of genital ulcer disease in Africa and Southeast Asia and is of increasing concern in the United States. Definitive diagnosis of chancroid requires the isolation and identification of H. ducreyi, but isolation of this organism is difficult and the available medium is not optimal for all strains. Fluorescent antibody and serologic tests are of limited value. In general, our knowledge of this organism is rather limited, and indeed, recent studies have questioned the placement of H. ducreyi in the genus Haemophilus. H. ducreyi has relatively few biochemical activities, and epidemiologic studies are limited because there are limited phenotypic markers available for strain typing. Specific virulence factors of H. ducreyi have yet to be identified. Antimicrobial resistance in H. ducreyi is of special concern, as this organism has acquired both gram-negative and gram-positive resistance determinants. In addition, some of these determinants can be mobilized and transferred to other Haemophilus species or to Neisseria gonorrhoeae. Images PMID:2650859\n[\"On-Water\" Facile Synthesis of Novel Pyrazolo[3,4-b]pyridinones Possessing Anti-influenza Virus Activity.](https://www.ncbi.nlm.nih.gov/pubmed/28581706)\nZeng, Li-Yan; Liu, Teng; Yang, Jie; Yang, Yueli; Cai, Chun; Liu, Shuwen\n2017-07-10\nA facile and versatile \"on-water\" protocol for the synthesis of pyrazolo[3,4-b]pyridinones was developed by the unprecedented construction of two rings and five new bonds in one-pot. It was proved that water was an important promoter of the reaction and PEG2000 was found to improve the reaction in terms of yield. 32 Derivatives were newly synthesized and most of them were prepared in an hour. The scope and limitation indicated that electron withdrawing groups substituted on synthons, substituted benzoyl acetonitriles or aryl aldehydes, were helpful to construct the pyrazolo[3,4-b]pyridinones. The reaction media PEG2000/H 2 O was successfully recycled and reused at least 5 times without any obvious decrease in yield. The anti-influenza activities of the derivatives were evaluated and the screening results highlighted two derivatives, which exhibited strong inhibitory activity against H5N1 pseudovirus. These positive bioassay results implied that the library of potential anti-influenza virus agent candidates could be rapidly prepared in an eco-friendly manner, and provided a new insight into drug discovery for medicinal chemists.\n[Eficacia de la vacuna meningoc\u00f3cica de polisac\u00e1rido capsular del grupo C](https://www.openaire.eu/search/publication?articleId=doajarticles::665616b0e79abcde2883f393f494e02c)\nGonz\u00e1lez Enr\u00edquez Jes\u00fas; Garc\u00eda Comas Luis; Alcaide Jim\u00e9nez Juan Francisco; S\u00e1enz Calvo Antonio; Conde Olasagasti Jos\u00e9\n1997-01-01\nFUNDAMENTO: Este trabajo consiste esencialmente en una revisi\u00f3n sistem\u00e1tica de la literatura cient\u00edfica sobre los efectos, intensidad y duraci\u00f3n de la respuesta serol\u00f3gica, as\u00ed como sobre la eficacia, efectividad y seguridad de la vacuna meningoc\u00f3cica de polisac\u00e1rido capsular del grupo C. M\u00c9TODOS: B\u00fasqueda en repertorio MEDLINE en el periodo 1970-1996. B\u00fasqueda espec\u00edfica de ensayos cl\u00ednicos aleatorizados y estudios de intervenci\u00f3n prospectivos en humanos con vacunas de polisac\u00e1ridos capsular...\n[Immunogenicity of Nontypeable Haemophilus influenzae Outer Membrane Vesicles and Protective Ability in the Chinchilla Model of Otitis Media.](https://www.ncbi.nlm.nih.gov/pubmed/28768669)\nWinter, Linda E; Barenkamp, Stephen J\n2017-10-01\nOuter membrane vesicles (OMVs) produced by Gram-negative bacteria are enriched in several outer membrane components, including major and minor outer membrane proteins and lipooligosaccharide. We assessed the functional activity of nontypeable Haemophilus influenzae (NTHi) OMV-specific antisera and the protective ability of NTHi OMVs as vaccine antigens in the chinchilla otitis media model. OMVs were purified from three HMW1/HMW2-expressing NTHi strains, two of which were also engineered to overexpress Hia proteins. OMV-specific antisera raised in guinea pigs were assessed for their ability to mediate killing of representative NTHi in an opsonophagocytic assay. The three OMV-specific antisera mediated killing of 18 of 65, 24 of 65, and 30 of 65 unrelated HMW1/HMW2-expressing NTHi strains. Overall, they mediated killing of 39 of 65 HMW1/HMW2-expressing strains. The two Hia-expressing OMV-specific antisera mediated killing of 17 of 25 and 14 of 25 unrelated Hia-expressing NTHi strains. Overall, they mediated killing of 20 of 25 Hia-expressing strains. OMVs from prototype NTHi strain 12 were used to immunize chinchillas and the course of middle ear infection was monitored following intrabullar challenge with the homologous strain. All control animals developed culture-positive otitis media, as did two of three HMW1/HMW2-immunized animals. All OMV-immunized animals, with or without supplemental HMW1/HMW2 immunization, were completely protected against otitis media. NTHi OMVs are the first immunogens examined in this model that provided complete protection with sterile immunity after NTHi strain 12 challenge. These data suggest that NTHi OMVs hold significant potential as components of protective NTHi vaccines, possibly in combination with HMW1/HMW2 proteins. Copyright \u00a9 2017 American Society for Microbiology.\n[Immunogenicity and safety of the 10-valent pneumococcal nontypeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) co-administered with DTPa vaccine in Japanese children: A randomized, controlled study.](https://www.ncbi.nlm.nih.gov/pubmed/25830489)\nIwata, Satoshi; Kawamura, Naohisa; Kuroki, Haruo; Tokoeda, Yasunobu; Miyazu, Mitsunobu; Iwai, Asayuki; Oishi, Tomohiro; Sato, Tomohide; Suyama, Akari; Fran\u00e7ois, Nancy; Shafi, Fakrudeen; Ruiz-Gui\u00f1az\u00fa, Javier; Borys, Dorota\n2015-01-01\nThis phase III, randomized, open-label, multicenter study (NCT01027845) conducted in Japan assessed the immunogenicity, safety, and reactogenicity of 10-valent pneumococcal nontypeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV, given intramuscularly) co-administered with diphtheria-tetanus-acellular pertussis vaccine (DTPa, given subcutaneously). Infants (N=360 ) were randomized (2:1) to receive either PHiD-CV and DTPa (PHiD-CV group) or DTPa alone (control group) as 3-dose primary vaccination (3-4-5 months of age) and booster vaccination (17-19 months of age). Immune responses were measured before and one month after primary/booster vaccination and adverse events (AEs) were recorded. Post-primary immune responses were non-inferior to those in pivotal/efficacy European or Latin American pneumococcal protein D-conjugate vaccine studies. For each PHiD-CV serotype, at least 92.6% of infants post-primary vaccination and at least 97.7% of children post-booster had pneumococcal antibody concentrations \u22650.2 \u03bcg/ml, and at least 95.4% post-primary and at least 98.1% post-booster had opsonophagocytic activity (OPA) titers \u22658 . Geometric mean antibody concentrations and OPA titers (except OPA titer for 6B) were higher post-booster than post-priming for each serotype. All PHiD-CV-vaccinated children had anti-protein D antibody concentrations \u2265100 EL.U/ml one month post-primary/booster vaccination and all were seroprotected/seropositive against each DTPa antigen. Redness and irritability were the most common solicited AEs in both groups. Incidences of unsolicited AEs were comparable between groups. Serious AEs were reported for 47 children (28 in PHiD-CV group); none were assessed as vaccine-related. In conclusion, PHiD-CV induced robust immune responses and was well tolerated when co-administered with DTPa in a 3-dose priming plus booster regimen to Japanese children.\n[Seguridad, reactogenicidad e inmunogenicidad de una nueva vacuna de polisac\u00e1ridos meningoc\u00f3cicos en adultos j\u00f3venes cubanos](http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1025-028X2017000100003&lng=es&nrm=iso&tlng=es) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nRossana Estruch\u2013de la Guardia\n2017-04-01\nFull Text Available Se realiz\u00f3 un estudio aleatorizado, controlado y a doble ciegas, en 352 adultos j\u00f3venes cubanos entre 18 y 35 a\u00f1os de edad, con el objetivo de evaluar la seguridad, reactogenicidad y la inmunogenicidad de una nueva vacuna de polisac\u00e1ridos de Neisseria meningitidis serogrupos A, C y W135, producida por el Instituto Finlay de Vacunas (La Habana, Cuba, con respecto a su similar comercial Mencevax\u00ae ACW de Glaxo Smith Kline. Se tomaron muestras de suero antes y 28 d\u00edas despu\u00e9s de la vacunaci\u00f3n. La reactogenicidad de ambas vacunas fue similar. Los s\u00edntomas y signos, tanto locales como generales fueron leves y aparecieron principalmente durante las primeras 48 h despu\u00e9s de la vacunaci\u00f3n. Ning\u00fan sujeto present\u00f3 eventos adversos graves durante los 28 d\u00edas del per\u00edodo de vigilancia. La vacuna en estudio mostr\u00f3 ser segura y poco reactog\u00e9nica; sus porcentajes de seroconversi\u00f3n a los 28 d\u00edas posteriores a la vacunaci\u00f3n fueron de: 92,19 % para el serogrupo A, 88,89 % para C y 90,06 % para W135. No se detectaron diferencias con respecto a la seroconversi\u00f3n. La seroprotecci\u00f3n alcanzada con la vacuna en estudio fue de 98,44 %, 91,81 % y 95,32 % para los serogrupos A, C y W135 respectivamente y no fue inferior con respecto a la vacuna control para los tres serogrupos estudiados.\n[Inmunizaci\u00f3n para influenza y neumococo en prevenci\u00f3n cardiovascular](http://www.scielo.org.ar/scielo.php?script=sci_arttext&pid=S0025-76802014000300017&lng=en&tlng=en) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nMar\u00eda In\u00e9s Sosa Liprandi\n2014-06-01\nFull Text Available La relaci\u00f3n entre las infecciones respiratorias producidas por el virus de la influenza y el neumococo y los eventos cardiovasculares motivaron la reuni\u00f3n de un grupo interdisciplinario (cardi\u00f3logos, cl\u00ednicos e infect\u00f3logos, con el objeto de analizar la evidencia entre la asociaci\u00f3n de estos fen\u00f3menos y el rol de las estrategias de inmunizaci\u00f3n en la prevenci\u00f3n de la enfermedad cardiovascular. El presente documento sintetiza las conclusiones del grupo de trabajo. El an\u00e1lisis de revisiones sistem\u00e1ticas sugiere una evidencia consistente entre la infecci\u00f3n por influenza y neumococo como desencadenantes de infarto agudo de miocardio y muerte cardiovascular. Los estudios publicados en los \u00faltimos 15 a\u00f1os sugieren que la vacunaci\u00f3n para influenza y neumococo reducen el riesgo de s\u00edndromes coronarios agudos. Con la evidencia existente y teniendo en cuenta los an\u00e1lisis de costo-efectividad, ahorro de costos y perfil de seguridad de las vacunas, las sociedades cient\u00edficas y agencias gubernamentales de salud, tanto nacionales como internacionales, recomiendan fuertemente la incorporaci\u00f3n de la inmunizaci\u00f3n en el grupo de pacientes con enfermedad cardiovascular cr\u00f3nica.\n[Influence of Media on Seasonal Influenza Epidemic Curves.](https://www.ncbi.nlm.nih.gov/pubmed/27418579)\nSaito, Satoshi; Saito, Norihiro; Itoga, Masamichi; Ozaki, Hiromi; Kimura, Toshiyuki; Okamura, Yuji; Murakami, Hiroshi; Kayaba, Hiroyuki\n2016-09-01\nTheoretical investigations predicting the epidemic curves of seasonal influenza have been demonstrated so far; however, there is little empirical research using ever accumulated epidemic curves. The effects of vaccine coverage and information distribution on influenza epidemics were evaluated. Four indices for epidemics (i.e., onset-peak duration, onset-end duration, ratio of the onset-peak duration to onset-end duration and steepness of epidemic curves) were defined, and the correlations between these indices and anti-flu drug prescription dose, vaccine coverage, the volume of media and search trend on influenza through internet were analyzed. Epidemiological data on seasonal influenza epidemics from 2002/2003 to 2013/2014 excluding 2009/2010 season were collected from National Institute of Infectious Diseases of Japan. The onset-peak duration and its ratio to onset-end duration correlated inversely with the volume of anti-flu drug prescription. Onset-peak duration correlated positively with media information volume on influenza. The steepness of the epidemic curve, and anti-flu drug prescription dose inversely correlated with the volume of media information. Pre-epidemic search trend and media volume on influenza correlated with the vaccine coverage in the season. Vaccine coverage had no strong effect on epidemic curve. Education through media has an effect on the epidemic curve of seasonal influenza. Copyright \u00a9 2016 The Author(s). Published by Elsevier Ltd.. All rights reserved.\n[Immunogenicity, safety and reactogenicity of a booster dose of the 10-valent pneumococcal Nontypeable H. influenzae Protein D conjugate vaccine coadministered with DTPa-IPV-Hib in Dutch children](https://www.narcis.nl/publication/RecordID/oai%3Adspace.library.uu.nl%3A1874%2F344372/uquery/vaccine%20AND%20safety%20AND%20children/id/12/Language/EN)\nVan Den Bergh, Menno R.; Spijkerman, Judith; Fran\u00e7ois, Nancy; Swinnen, Kristien; Borys, Dorota; Schuerman, Lode; Veenhoven, Reinier H.; Sanders, Elisabeth A M\n2016-01-01\nBackground: Immune responses and safety profiles may be affected when vaccines are coadministered. We evaluated the immunogenicity, safety and reactogenicity of a booster dose of the 10-valent pneumococcal nontypeable Haemophilus influenzae protein D-conjugate (PHiD-CV; Synflorix GSK Vaccines) and\n[Influenza-induced tachypnea is prevented in immune cotton rats, but cannot be treated with an anti-inflammatory steroid or a neuraminidase inhibitor](http://dx.doi.org/10.1016/j.virol.2004.01.032) [International Nuclear Information System (INIS) ](http://inis.iaea.org/search/)\nEichelberger, Maryna C.; Prince, Gregory A.; Ottolini, Martin G.\n2004-01-01\nInfluenza viruses are one of the leading causes of morbidity and mortality during winter months. Increased respiratory rate (tachypnea) is a sign of increasing lower respiratory disease during influenza infection and is frequently observed in hospitalized patients. We investigated this clinical sign in influenza virus-infected cotton rats (Sigmodon hispidus) and the efficacy of antiviral and anti-inflammatory therapy in reducing symptomatic disease. Cotton rats infected intranasally with A/Wuhan/359/95 (H3N2) had increased respiratory rates from 1 to 4 days postinfection that correlated with the dose of virus used to inoculate the animal but not the amount of virus recovered from the lung. In addition, evaluation of sequential lung tissue pathology revealed that extensive epithelial cell destruction of small airways correlated with tachypnea. Increased respiratory rate was not observed in immune animals, supporting results that demonstrated a requirement for exposure to, and infection by, large amounts of live virus for induction of tachypnea. A variety of therapeutic approaches proved ineffective in reducing tachypnea, including anti-inflammatory therapy with systemic triamcinolone acetonide, bronchodilatory therapy with levalbuterol, or antiviral therapy with zanamivir. These results, together with the pathologic observations, suggest that early disruption of the lower respiratory tract epithelium is a major component of the pathophysiology of influenza infection. Therapeutic approaches need to be tailored to clear airway obstruction and restore an intact epithelium\n[Estudios de inmunogenicidad, seguridad y eficacia de la Vacuna Q frente a la leishmaniosis canina](https://www.openaire.eu/search/publication?articleId=od_______296::4dfda7f2f3e4339756541268672e7022)\nFern\u00e1ndez Cotrina, Javier\n2016-01-01\nSe analizaron la seguridad, inmunogenicidad y eficacia protectiva de cuatro dosis de la vacuna Q de Leishmania infantum (VQ). Para ello, cincuenta perros beagle (10 por grupo) fueron vacunados con una dosis \u00fanica de 200, 100, 50 y 25 \u00b5g de VQ. A los perros del grupo control se les inyect\u00f3 el diluyente de la vacuna. Los datos muestran que la vacunaci\u00f3n con VQ indujo una respuesta humoral temprana y espec\u00edfica dependiente de la dosis. Adem\u00e1s, durante el per\u00edodo post-vacunaci\u00f3n no se detect\u00f3 rea...\n[Desarrollo de una vacuna profil\u00e1ctica de segunda generaci\u00f3n contra el papilomavirus humano](http://www.scielo.org.ar/scielo.php?script=sci_arttext&pid=S0025-76802011000500015&lng=en&tlng=en) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nAlonso Leonardo\n2011-06-01\nFull Text Available Los papilomavirus humanos (HPV son el agente etiol\u00f3gico del c\u00e1ncer cervical (CC, la segunda causa de muerte por c\u00e1ncer en mujeres. Se estima que medio mill\u00f3n de nuevos c\u00e1nceres se diagnostica cada a\u00f1o, ocurriendo la mayor\u00eda de ellos en pa\u00edses en v\u00edas de desarrollo debido a la ausencia o ineficiencia de los programas masivos de detecci\u00f3n temprana. Recientemente se han introducido en el mercado dos vacunas profil\u00e1cticas contra las principales cepas oncog\u00e9nicas de HPV, la cepa 16 y 18, responsables por el 80% de todos los CC. Estas vacunas se obtienen en forma recombinante y han demostrado ser extremadamente seguras y eficaces. Sin embargo, su impacto inmediato en la incidencia de la infecci\u00f3n por HPV en pa\u00edses en v\u00edas de desarrollo ser\u00e1 m\u00ednimo, debido principalmente al alto costo de las mismas. Existe la necesidad de contar con vacunas de segunda generaci\u00f3n, de bajo costo y de aplicaci\u00f3n masiva que permitan disminuir sensiblemente el n\u00famero de CC en la poblaci\u00f3n. Con este objetivo hemos desarrollado una plataforma de expresi\u00f3n recombinante que permite obtener part\u00edculas tipo virus (VLPs con las cuales es posible formular vacunas efectivas y accesibles contra la infecci\u00f3n por HPV.\nBarik, Sailen\n2012-09-13\nInfluenza has a long history of causing morbidity and mortality in the human population through routine seasonal spread and global pandemics. The high mutation rate of the RNA genome of the influenza virus, combined with assortment of its multiple genomic segments, promote antigenic diversity and new subtypes, allowing the virus to evade vaccines and become resistant to antiviral drugs. There is thus a continuing need for new anti-influenza therapy using novel targets and creative strategies. In this review, we summarize prospective future therapeutic regimens based on recent molecular and genomic discoveries.\n[Comparative supragenomic analyses among the pathogens Staphylococcus aureus, Streptococcus pneumoniae, and Haemophilus influenzae Using a modification of the finite supragenome model](http://www.biomedcentral.com/1471-2164/12/187) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nYu Susan\n2011-04-01\nFull Text Available Abstract Background Staphylococcus aureus is associated with a spectrum of symbiotic relationships with its human host from carriage to sepsis and is frequently associated with nosocomial and community-acquired infections, thus the differential gene content among strains is of interest. Results We sequenced three clinical strains and combined these data with 13 publically available human isolates and one bovine strain for comparative genomic analyses. All genomes were annotated using RAST, and then their gene similarities and differences were delineated. Gene clustering yielded 3,155 orthologous gene clusters, of which 2,266 were core, 755 were distributed, and 134 were unique. Individual genomes contained between 2,524 and 2,648 genes. Gene-content comparisons among all possible S. aureus strain pairs (n = 136 revealed a mean difference of 296 genes and a maximum difference of 476 genes. We developed a revised version of our finite supragenome model to estimate the size of the S. aureus supragenome (3,221 genes, with 2,245 core genes, and compared it with those of Haemophilus influenzae and Streptococcus pneumoniae. There was excellent agreement between RAST's annotations and our CDS clustering procedure providing for high fidelity metabolomic subsystem analyses to extend our comparative genomic characterization of these strains. Conclusions Using a multi-species comparative supragenomic analysis enabled by an improved version of our finite supragenome model we provide data and an interpretation explaining the relatively larger core genome of S. aureus compared to other opportunistic nasopharyngeal pathogens. In addition, we provide independent validation for the efficiency and effectiveness of our orthologous gene clustering algorithm.\n[Evaluaci\u00f3n de la toxicidad por dosis \u00fanica y tolerancia local de la vacuna vax-SPIRAL\u00ae en ratas Sprague Dawley](http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1025-028X2004000200002&lng=es&nrm=iso&tlng=es) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nJuan F. Infante\n2004-04-01\nFull Text Available Las pruebas precl\u00ednicas de toxicidad en dosis \u00fanica y en dosis repetidas brindan una valiosa informaci\u00f3n sobre la seguridad del producto, al incluir el estudio macrosc\u00f3pico e histopatol\u00f3gico de \u00f3rganos importantes, as\u00ed como evaluaciones de las v\u00edas de administraci\u00f3n y el r\u00e9gimen de dosificaci\u00f3n. Cuba desarroll\u00f3 una vacuna polivalente de c\u00e9lulas inactivadas qu\u00edmicamente adyuvadas con hidr\u00f3xido de aluminio, vax-SPIRAL\u00ae. Esta vacuna presenta ventajas en relaci\u00f3n con otras vacunas como la procedente de la antigua URSS. El esquema de vacunaci\u00f3n para humanos consiste en dos dosis de 0,5 mL, separadas por un intervalo \u00f3ptimo de seis semanas. El objetivo de este estudio de toxicidad en ratas Sprague Dawley fue determinar la toxicidad potencial, letalidad, \u00f3rganos y sistemas susceptibles y otros eventos adversos, as\u00ed como la toxicidad en el sitio de inoculaci\u00f3n despu\u00e9s de la administraci\u00f3n de una dosis de la vacuna en estudio. Los resultados indicaron que, bajo las condiciones en estudio y seg\u00fan los criterios establecidos para evaluar los datos obtenidos, la vacuna antileptospir\u00f3sica trivalente no produce efectos t\u00f3xicos en el modelo animal usado. Las \u00fanicas alteraciones encontradas fueron formaciones granulomatosas a nivel del sitio de inoculaci\u00f3n. Estas formaciones han sido reportadas como pertenecientes al adyuvante de dep\u00f3sito (hidr\u00f3xido de aluminio, tambi\u00e9n usado en otras vacunas de aplicaci\u00f3n parenteral.\n[Prophage induction in Haemophilus influenzae and its relationship to mutation by chemical and physical agents](https://inis.iaea.orgsearchsinglerecord.aspx?recordsFor=SingleRecord&RN=16041445) [International Nuclear Information System (INIS) ](http://inis.iaea.org/search/)\nBalganesh, M.; Setlow, J.K.\n1984-01-01\nIt is known that UV, X-rays, MMC and MMS are not mutagenic for H. influenzae, whereas HZ, EMS and MNNG are potent mutagens for this bacterium. All of these agents, however, are known to be both mutagenic and able to induce prophage in E. coli. We report here that all the agents except HZ induce prophage in H. influenzae, and EMS even induces in the recombination-defective recl mutant, which is non-inducible by UV, MMC, MNNG and MMS. MMS did not cause single-strand breaks or gaps in DNA synthesized after treatment of H. influenzae, but EMS and MNNG produced them. EMS caused more breaks in DNA synthesized before treatment than in that synthesized after treatment. On the other hand we did observe such breaks or gaps induced in E. coli in DNA synthesized posttreatment by EMS as well as by MMS and MNNG, at comparable survival levels. (orig.)\n[Prophage induction in Haemophilus influenzae and its relationship to mutation by chemical and physical agents](http://www.etde.org/etdeweb/details.jsp?query_id=1&page=0&osti_id=5555017) [Energy Technology Data Exchange (ETDEWEB)](https://www.etde.org/etdeweb/fieldedsearch.jsp)\nBalganesh, M.; Setlow, J.K. (Brookhaven National Lab., Upton, NY (USA))\n1984-01-01\nIt is known that UV, X-rays, MMC and MMS are not mutagenic for H. influenzae, whereas HZ, EMS and MNNG are potent mutagens for this bacterium. All of these agents, however, are known to be both mutagenic and able to induce prophage in E. coli. We report here that all the agents except HZ induce prophage in H. influenzae, and EMS even induces in the recombination-defective recl mutant, which is non-inducible by UV, MMC, MNNG and MMS. MMS did not cause single-strand breaks or gaps in DNA synthesized after treatment of H. influenzae, but EMS and MNNG produced them. EMS caused more breaks in DNA synthesized before treatment than in that synthesized after treatment. On the other hand we did observe such breaks or gaps induced in E. coli in DNA synthesized posttreatment by EMS as well as by MMS and MNNG, at comparable survival levels.\n[Avalia\u00e7\u00e3o do impacto do programa de vacina\u00e7\u00e3o contra o Haemophilus influenzae tipo b (Hib) no Estado de S\u00e3o Paulo e munic\u00edpio de S\u00e3o Paulo, ap\u00f3s dez anos de introdu\u00e7\u00e3o da vacina](https://www.openaire.eu/search/publication?articleId=od______3056::f05567414de6d21aa40ac29e17e5ac10)\nTelma Regina Marques Pinto Carvalhanas\n2014-01-01\nObjetivos: Avaliar o impacto global, direto, indireto e a tend\u00eancia da dura\u00e7\u00e3o de prote\u00e7\u00e3o da vacina\u00e7\u00e3o contra o Haemophilus influenzae tipo b (Hib), no estado de S\u00e3o Paulo (ESP) e no munic\u00edpio de S\u00e3o Paulo (MSP), na popula\u00e7\u00e3o de 0 - 59 meses, comparando os per\u00edodos pr\u00e9-vacinal (1996 - 1998) e p\u00f3s-vacinal (2001 - 2009). M\u00e9todos: estudo com componente descritivo e de cunho anal\u00edtico, retrospectivo. A popula\u00e7\u00e3o de estudo incluiu os menores de cinco anos residentes no ESP e no MSP. Adotou-se com...\n[La Real Expedici\u00f3n Filantr\u00f3pica de la vacuna (1803 - 1810](http://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S0465-546X2007000400010) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nJorge Veiga de Cabo\n2007-12-01\nFull Text Available La Expedici\u00f3n Filantr\u00f3pica de la vacuna supuso una de las empresas sanitarias realizadas en el Siglo XVIII de mayor envergadura, por su complejidad, dificultad y sobre todo, por constituir una de las misiones de Salud P\u00fablica m\u00e1s importantes realizadas en la Historia. Supone el resultado de un proceso en el que una serie de acontecimientos hist\u00f3ricos, sanitarios y sociales confluyen para generar uno de los primeros programas de intervenci\u00f3n en salud p\u00fablica a escala internacional y de expansi\u00f3n de la vacuna de la viruela. Se crean Centros de producci\u00f3n, almacenamiento y distribuci\u00f3n de la vacuna, y programas de capacitaci\u00f3n t\u00e9cnica enfocados a mantener campa\u00f1as de vacunaci\u00f3n poblacional.One of the most important medical achievements made in the eighteenth century was the Philanthropic Expedition of the Vaccine. Due to its complexity and difficulty it was one of the most important Public Health undertakings in history. It was the outcome of a series of historical, social and health advances that converged in creating one of the earliest international programs for the expansion of the smallpox vaccine, creating centres for the production, storage and distribution of the vaccine together with technical training programs aimed at maintaining population vaccination campaigns.\n[Hydrolysis of N-succinyl-L,L-diaminopimelic acid by the Haemophilus influenzae dapE-encoded desuccinylase: metal activation, solvent isotope effects, and kinetic mechanism.](https://www.ncbi.nlm.nih.gov/pubmed/9671518)\nBorn, T L; Zheng, R; Blanchard, J S\n1998-07-21\nHydrolysis of N-succinyl-L,L-diaminopimelic acid by the dapE-encoded desuccinylase is required for the bacterial synthesis of lysine and meso-diaminopimelic acid. We have investigated the catalytic mechanism of the recombinant enzyme from Haemophilus influenzae. The desuccinylase was overexpressed in Escherichia coli and purified to homogeneity. Steady-state kinetic experiments verified that the enzyme is metal-dependent, with a Km for N-succinyl-L,L-diaminopimelic acid of 1.3 mM and a turnover number of 200 s-1 in the presence of zinc. The maximal velocity was independent of pH above 7 but decreased with a slope of 1 below pH 7. The pH dependence of V/K was bell-shaped with apparent pKs of 6.5 and 8.3. Both L,L- and D,L-diaminopimelic acid were competitive inhibitors of the substrate, but d,d-diaminopimelic acid was not. Solvent kinetic isotope effect studies yielded inverse isotope effects, with values for D2OV/K of 0.62 and D2OV of 0.78. Determination of metal stoichiometry by ICP-AES indicated one tightly bound metal ion, while sequence homologies suggest the presence of two metal binding sites. On the basis of these observations, we propose a chemical mechanism for this metalloenzyme, which has a number of important structurally defined homologues.\n[Influenza A (H1N1) neuraminidase inhibitors from Vitis amurensis](http://www.forskningsdatabasen.dk/en/catalog/79004651) [DEFF Research Database (Denmark)](http://forskningsbasen.deff.dk/?lang=eng)\nNguyen, Ngoc Anh; Dao, Trong Tuan; Tung, Bui Thanh\n2011-01-01\nRecently, a novel H1N1 influenza A virus (H1N1/09 virus) was identified and considered a strong candidate for a novel influenza pandemic. As part of an ongoing anti-influenza screening programme on natural products, eight oligostilbenes were isolated as active principles from the methanol extract...... of Vitis amurensis. This manuscript reports the isolation, structural elucidation, and anti-viral activities of eight compounds on various neuraminidases from influenza A/PR/8/34 (H1N1), novel swine-origin influenza A (H1N1), and oseltamivir-resistant novel H1N1 (H274Y) expressed in 293T cells...\n[Immunogenicity, reactogenicity and consistency of production of a Brazilian combined vaccine against diphtheria, tetanus, pertussis and Haemophilus influenzae type b](http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0074-02762008000700014) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nReinaldo de Menezes Martins\n2008-11-01\nFull Text Available A randomized, double-blinded study evaluating the immunogenicity, safety and consistency of production of a combined diphtheria-tetanus-pertussis-Haemophilus influenzae type b vaccine entirely produced in Brazil by Bio-Manguinhos and Instituto Butantan (DTP/Hib-BM was undertaken. The reference vaccine had the same DTP vaccine but the Hib component was produced using purified materials supplied by GlaxoSmithKline (DTP/Hib-GSK, which is registered and has supplied the Brazilian National Immunization Program for over more than five years. One thousand infants were recruited for the study and received vaccinations at two, four and six months of age. With respect to immunogenicity, the vaccination protocol was followed in 95.6% and 98.4% of infants in the DTP/Hib-BM and DTP/Hib-GSK groups, respectively. For the Hib component of the study, there was 100% seroprotection (>0.15 \u00b5g/mL with all three lots of DTP/Hib-BM and DTP/Hib-GSK. The geometric mean titer (GMT was 9.3 \u00b5g/mL, 10.3 \u00b5g/mL and 10.3 \u00b5g/mL for lots 1, 2 and 3 of DTP/Hib-BM, respectively, and the GMT was 11.3 g/mL for DTP/Hib-GSK. For diphtheria, tetanus and pertussis, seroprotection was 99.7%, 100% and 99.9%, respectively, for DTP/Hib-BM, three lots altogether and 99.2%, 100% and 100% for DTP/Hib-GSK. GMTs were similar across all lots and vaccines. Adverse events rates were comparable among the vaccine groups. The Brazilian DTP/Hib vaccine demonstrated an immunogenicity and reactogenicity profile similar to that of the reference vaccine.\n[Estudio de toxicidad por dosis \u00fanica y tolerancia local de una vacuna antimeningoc\u00f3cica tipo B en ratas Sprague Dawley](http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1025-028X2006000200004&lng=es&nrm=iso&tlng=es) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nJuan F. N\u00fa\u00f1ez\n2006-08-01\nFull Text Available La vacuna antimeningoc\u00f3cica tipo B, objetivo de este estudio, contiene ves\u00edculas purificadas de la membrana externa del meningococo del serogrupo B de la cepa (Cu- 385 - 83 B:4:P1.19,15. El esquema de vacunaci\u00f3n propuesto en humanos consiste en tres dosis de 0,5 mL, separadas por un intervalo \u00f3ptimo de ocho semanas. El objetivo de este estudio de toxicidad en ratas Sprague Dawley (SD fue determinar la toxicidad potencial, letalidad, \u00f3rganos, sistemas susceptibles y otros eventos adversos, as\u00ed como la toxicidad en el sitio de inoculaci\u00f3n despu\u00e9s de la administraci\u00f3n de una dosis de la vacuna en estudio. Los resultados indicaron que, bajo las condiciones del estudio y seg\u00fan los criterios establecidos para evaluar los resultados, la vacuna antimeningoc\u00f3cica tipo B, no produce efectos t\u00f3xicos en el modelo animal usado. Todo lo que se observ\u00f3 fueron formaciones granulomatosas a nivel del punto de inoculaci\u00f3n. Estas formaciones han sido reportadas como pertenecientes a los adyuvantes de dep\u00f3sito, como el hidr\u00f3xido de aluminio, usado en otras vacunas parenterales. Se concluye que la vacuna antimeningoc\u00f3cica tipo B result\u00f3 satisfactoria en las pruebas de toxicidad por dosis\u00fanica y tolerancia local realizadas en la especie rata.\n[Drug Discovery of Host CLK1 Inhibitors for Influenza Treatment](http://www.mdpi.com/1420-3049/20/11/19653) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nMian Zu\n2015-11-01\nFull Text Available The rapid evolution of influenza virus makes antiviral drugs less effective, which is considered to be a major bottleneck in antiviral therapy. The key proteins in the host cells, which are related with the replication cycle of influenza virus, are regarded as potential drug targets due to their distinct advantage of lack of evolution and drug resistance. Cdc2-like kinase 1 (CLK1 in the host cells is responsible for alternative splicing of the M2 gene of influenza virus during influenza infection and replication. In this study, we carried out baculovirus-mediated expression and purification of CLK1 and established a reliable screening assay for CLK1 inhibitors. After a virtual screening of CLK1 inhibitors was performed, the activities of the selected compounds were evaluated. Finally, several compounds with strong inhibitory activity against CLK1 were discovered and their in vitro anti-influenza virus activities were validated using a cytopathic effect (CPE reduction assay. The assay results showed that clypearin, corilagin, and pinosylvine were the most potential anti-influenza virus compounds as CLK1 inhibitors among the compounds tested. These findings will provide important information for new drug design and development in influenza treatment, and CLK1 may be a potent drug target for anti-influenza drug screening and discovery.\n[21 CFR 866.3300 - Haemophilus spp. serological reagents.](https://www.gpo.gov/fdsys/pkg/CFR-2010-title21-vol8/pdf/CFR-2010-title21-vol8-sec866-3300.pdf)\n2010-04-01\n... serological tests to identify Haemophilus spp. directly from clinical specimens or tissue culture isolates derived from clinical specimens. The identification aids in the diagnosis of diseases caused by bacteria belonging to the genus Haemophilus and provides epidemiological information on diseases cause by these...\n[Influenza infection and heart failure-vaccination may change heart failure prognosis?](https://www.ncbi.nlm.nih.gov/pubmed/28508293)\nKadoglou, Nikolaos P E; Bracke, Frank; Simmers, Tim; Tsiodras, Sotirios; Parissis, John\n2017-05-01\nThe interaction of influenza infection with the pathogenesis of acute heart failure (AHF) and the worsening of chronic heart failure (CHF) is rather complex. The deleterious effects of influenza infection on AHF/CHF can be attenuated by specific immunization. Our review aimed to summarize the efficacy, effectiveness, safety, and dosage of anti-influenza vaccination in HF. In this literature review, we searched MEDLINE and EMBASE from January 1st 1966 to December 31st, 2016, for studies examining the association between AHF/CHF, influenza infections, and anti-influenza immunizations. We used broad criteria to increase the sensitivity of the search. HF was a prerequisite for our search. The search fields used included \"heart failure,\" \"vaccination,\" \"influenza,\" \"immunization\" along with variants of these terms. No restrictions on the type of study design were applied. The most common clinical scenario is exacerbation of pre-existing CHF by influenza infection. Scarce evidence supports a potential positive association of influenza infection with AHF. Vaccinated patients with pre-existing CHF have reduced all-cause morbidity and mortality, but effects are not consistently documented. Immunization with higher antigen quantity may confer additional protection, but such aggressive approach has not been generally advocated. Further studies are needed to delineate the role of influenza infection on AHF/CHF pathogenesis and maintenance. Annual anti-influenza vaccination appears to be an effective measure for secondary prevention in HF. Better immunization strategies and more efficacious vaccines are urgently necessary.\n[Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nBarik Sailen\n2012-09-01\nFull Text Available Abstract Influenza has a long history of causing morbidity and mortality in the human population through routine seasonal spread and global pandemics. The high mutation rate of the RNA genome of the influenza virus, combined with assortment of its multiple genomic segments, promote antigenic diversity and new subtypes, allowing the virus to evade vaccines and become resistant to antiviral drugs. There is thus a continuing need for new anti-influenza therapy using novel targets and creative strategies. In this review, we summarize prospective future therapeutic regimens based on recent molecular and genomic discoveries.\n[Evaluaci\u00f3n de la informaci\u00f3n sanitaria disponible en internet sobre la vacuna antigripal](https://www.openaire.eu/search/publication?articleId=doajarticles::10bf287ae0007ca1c04dfbe102687a3b)\nI. Hern\u00e1ndez-Garc\u00eda; R. Gonz\u00e1lez Celador\n2014-01-01\nFundamento: La calidad de la informaci\u00f3n sanitaria en internet preocupa a gobiernos y usuarios. Nuestro objetivo fue determinar en qu\u00e9 medida la informaci\u00f3n sobre la vacuna antigripal se adhiere al gold est\u00e1ndar representado por lo establecido por el Ministerio de Sanidad espa\u00f1ol. Material y m\u00e9todos: Entre junio-julio 2014 se evalu\u00f3 la adhesi\u00f3n al gold est\u00e1ndar de la informaci\u00f3n sobre indicaciones, efectos adversos y contraindicaciones de la vacuna. Dicha informaci\u00f3n se obtuvo a trav\u00e9s de Goo...\n[LA VACUNACI\u00d3N ANTI-NEUMOC\u00d3CICA CON LA VACUNA CONJUGADA 13-VALENTE EN POBLACI\u00d3N INMUNOCOMPETENTE DE 65 A\u00d1OS: ANALISIS DEL IMPACTO PRESUPUESTARIO EN ESPA\u00d1A APLICANDO UN MODELO DE TRANSMISI\u00d3N DIN\u00c1MICA](http://www.redalyc.org/articulo.oa?id=17043728001) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nReyes Lorente Anto\u00f1anzas\n2016-01-01\nFull Text Available Fundamentos: Las infecciones causadas por el Streptococcus pneumoniae en el adulto tienen repercusiones importantes en la salud. El objetivo fue analizar el impacto econ\u00f3mico y sanitario en 5 a\u00f1os de la vacunaci\u00f3n de la cohorte espa\u00f1ola de 65 a\u00f1os inmunocompetente con la vacuna antineumoc\u00f3cica conjugada 13-valente.M\u00e9todos: Mediante un modelo de transmisi\u00f3n din\u00e1mica basado en ecuaciones diferenciales se analiz\u00f3 la carga de la enfermedad neumoc\u00f3cica (EN en sujetos de 65 a\u00f1os en 5 a\u00f1os, siendo vacunada anualmente el 36,5% de la cohorte. Se aplic\u00f3 la eficacia de la vacuna del 52,5% observada en el estudio CAPITA en pacientes de 65 a\u00f1os inmunocompetentes, cobertura de serotipos vacunales del 63,4% (estudio CAPA, incidencia de infecci\u00f3n neumoc\u00f3cica de 162,2/100.000 casos a\u00f1o (CMBD 2010-2013 y proporci\u00f3n de vacunados previamente al arranque del modelo del 0,99%. La perspectiva fue la del Sistema Nacional de Salud (SNS. Costes de casos de EN seg\u00fan CMBD y precio de venta de laboratorio de la vacuna conjugada.Resultados: En 5 a\u00f1os la vacunaci\u00f3n con vacuna conjugada 13-valente espera evitar 10.360 casos de EN (7.411 hospitalizaciones por neumon\u00edas y 699 muertes (14.736 a\u00f1os de vida ganados -AVG-, en una cohorte de 65 a 69 a\u00f1os de edad. El coste de vacunaci\u00f3n esperado de 36,5 millones de euros se compensar\u00eda completamente por la reducci\u00f3n de 41,5 millones de costes m\u00e9dicos evitados, con un ahorro neto acumulado de 3,8 millones de euros a precios constantes (4,9 a precios corrientes.Conclusi\u00f3n: La vacunaci\u00f3n con vacuna conjugada 13-valente en adultos de 65 a\u00f1os inmunocompetentes resulta eficiente para el Sistema Nacional de Salud, reduciendo la carga de enfermedad y evitando un n\u00famero importante de muertes.\n[Dengue, zika, chikungunya y el desarrollo de vacunas](https://www.openaire.eu/search/publication?articleId=od_______617::72f63e3faddc26d37afb5bec15e160d2)\nKantor, Isabel N\n2018-01-01\nDengue (DENV), zika (ZIKV) y chikungunya (CHIKV), tres arbovirosis transmitidas por mosquitos Aedes, se han propagado en las \u00faltimas d\u00e9cadas en zonas tropicales y subtropicales h\u00famedas. El dengue es epid\u00e9mico en \u00e1reas subtropicales de la Argentina. Despu\u00e9s de la infecci\u00f3n por DENV hay inmunidad duradera contra el serotipo infectante, pero aumenta el riesgo de enfermedad grave por los otros tres. La vacuna recombinante tetravalente, Dengvaxia\u00ae previene el dengue grave y la hospitalizaci\u00f3n en s...\n[Multi-Omics Studies towards Novel Modulators of Influenza A Virus\u2013Host Interaction](http://www.mdpi.com/1999-4915/8/10/269) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nSandra S\u00f6derholm\n2016-09-01\nFull Text Available Human influenza A viruses (IAVs cause global pandemics and epidemics. These viruses evolve rapidly, making current treatment options ineffective. To identify novel modulators of IAV\u2013host interactions, we re-analyzed our recent transcriptomics, metabolomics, proteomics, phosphoproteomics, and genomics/virtual ligand screening data. We identified 713 potential modulators targeting 199 cellular and two viral proteins. Anti-influenza activity for 48 of them has been reported previously, whereas the antiviral efficacy of the 665 remains unknown. Studying anti-influenza efficacy and immuno/neuro-modulating properties of these compounds and their combinations as well as potential viral and host resistance to them may lead to the discovery of novel modulators of IAV\u2013host interactions, which might be more effective than the currently available anti-influenza therapeutics.\n[Identification of traditional medicinal plant extracts with novel anti-influenza activity.](http://europepmc.org/articles/PMC3842314?pdf=render) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nDhivya Rajasekaran\nFull Text Available The emergence of drug resistant variants of the influenza virus has led to a need to identify novel and effective antiviral agents. As an alternative to synthetic drugs, the consolidation of empirical knowledge with ethnopharmacological evidence of medicinal plants offers a novel platform for the development of antiviral drugs. The aim of this study was to identify plant extracts with proven activity against the influenza virus. Extracts of fifty medicinal plants, originating from the tropical rainforests of Borneo used as herbal medicines by traditional healers to treat flu-like symptoms, were tested against the H1N1 and H3N1 subtypes of the virus. In the initial phase, in vitro micro-inhibition assays along with cytotoxicity screening were performed on MDCK cells. Most plant extracts were found to be minimally cytotoxic, indicating that the compounds linked to an ethnomedical framework were relatively innocuous, and eleven crude extracts exhibited viral inhibition against both the strains. All extracts inhibited the enzymatic activity of viral neuraminidase and four extracts were also shown to act through the hemagglutination inhibition (HI pathway. Moreover, the samples that acted through both HI and neuraminidase inhibition (NI evidenced more than 90% reduction in virus adsorption and penetration, thereby indicating potent action in the early stages of viral replication. Concurrent studies involving Receptor Destroying Enzyme treatments of HI extracts indicated the presence of sialic acid-like component(s that could be responsible for hemagglutination inhibition. The manifestation of both modes of viral inhibition in a single extract suggests that there may be a synergistic effect implicating more than one active component. Overall, our results provide substantive support for the use of Borneo traditional plants as promising sources of novel anti-influenza drug candidates. Furthermore, the pathways involving inhibition of hemagglutination\n[Inmunoterapia en melanoma: vacunas de c\u00e9lulas dendr\u00edticas](http://www.scielosp.org/scielo.php?script=sci_arttext&pid=S1726-46342015000300021&lng=en&tlng=en) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nIvan Lozada-Requena\nFull Text Available La presente es una revisi\u00f3n narrativa que muestra la informaci\u00f3n accesible a la comunidad cient\u00edfica sobre melanoma e inmunoterapia. Las c\u00e9lulas dendr\u00edticas tienen la capacidad de participar en la inmunidad innata y adaptativa, pero no son ajenas a la evasi\u00f3n inmune de los tumores. Conocer su biolog\u00eda y rol ha llevado a generar in vitro varios prospectos de vacunas celulares aut\u00f3logas contra diversos tipos de c\u00e1ncer en humanos y modelos animales; sin embargo, en vista de la poca eficiencia que han mostrado, se deben implementar estrategias para potenciar su capacidad natural ya sea a trav\u00e9s de la coexpresi\u00f3n de mol\u00e9culas clave para activar o reactivar al sistema inmune, en combinaci\u00f3n con biosimilares o drogas quimioterape\u00faticas y no se debe descartar la acci\u00f3n de productos naturales como alternativa inmunoestimulante o adyuvante. Todos los tipos de inmunoterap\u00eda deber\u00edan medir el impacto de las c\u00e9lulas supresoras de origen mieloide, las que pueden atacar al sistema inmune y ayudar a la progresi\u00f3n tumoral, respectivamente. Esto puede reducir la actividad de las vacunas celulares y/o sus combinaciones pudiendo ser la diferencia entre el \u00e9xito o no de la inmunoterapia. Aunque en melanoma existen biosimilares aprobados por la Food and Drug Administration (FDA no todos tienen el \u00e9xito esperado por lo que es necesario evaluar otras estrategias que incluyan vacunas celulares cargadas con p\u00e9ptidos antig\u00e9nicos tumorales expresados exclusivamente o ant\u00edgenos provenientes de extractos tumorales y sus respectivos adyuvantes.\nAgualimpia Janning, Andr\u00e9s; Fundaci\u00f3n Valle de Lili\n2002-01-01\n\u00bfQu\u00e9 es una vacuna?/\u00bfC\u00f3mo funciona una vacuna?/\u00bfLa vacunaci\u00f3n es exclusiva de los ni\u00f1os?/Esquema de vacunaci\u00f3n de aultos normales/Difteria y tetanos/Rube\u00f3la, sarampion y paperas/Hepatiris A/Hepatitis B/Influenza/Varicela/Neumococo/Fiebre amarilla/Malaria/VIH-SIDA\n[Evolution of Therapeutic Antibodies, Influenza Virus Biology, Influenza, and Influenza Immunotherapy](http://dx.doi.org/10.1155/2018/9747549) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nUrai Chaisri\n2018-01-01\nFull Text Available This narrative review article summarizes past and current technologies for generating antibodies for passive immunization/immunotherapy. Contemporary DNA and protein technologies have facilitated the development of engineered therapeutic monoclonal antibodies in a variety of formats according to the required effector functions. Chimeric, humanized, and human monoclonal antibodies to antigenic/epitopic myriads with less immunogenicity than animal-derived antibodies in human recipients can be produced in vitro. Immunotherapy with ready-to-use antibodies has gained wide acceptance as a powerful treatment against both infectious and noninfectious diseases. Influenza, a highly contagious disease, precipitates annual epidemics and occasional pandemics, resulting in high health and economic burden worldwide. Currently available drugs are becoming less and less effective against this rapidly mutating virus. Alternative treatment strategies are needed, particularly for individuals at high risk for severe morbidity. In a setting where vaccines are not yet protective or available, human antibodies that are broadly effective against various influenza subtypes could be highly efficacious in lowering morbidity and mortality and controlling unprecedented epidemic/pandemic. Prototypes of human single-chain antibodies to several conserved proteins of influenza virus with no Fc portion (hence, no ADE effect in recipients are available. These antibodies have high potential as a novel, safe, and effective anti-influenza agent.\n[Lifescience Database Archive (English)](http://biosciencedbc.jp/dbsearch/index.php?lang=en)\nFull Text Available nce. 50 0.006 2 DD419614 |DD419614.1 GENES OF AN OTITIS MEDIA ISOLATE OF NONTYPEABLE HAEMOPHILUS INFLUENZAE.... 54 0.006 1 DD419394 |DD419394.1 GENES OF AN OTITIS MEDIA ISOLATE OF NONTYPEABLE HAEMOPHILUS INFLUENZAE. 54\n[Meningitis and pneumonia in Guatemalan children: the importance of Haemophilus influenzae type b and Streptococcus pneumoniae Meningitis y neumon\u00eda en ni\u00f1os guatemaltecos: importancia de Haemophilus influenzae tipo b y de Streptococcus pneumoniae](http://www.scielosp.org/scielo.php?script=sci_arttext&pid=S1020-49892003001100002) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nEdwin J. Asturias\n2003-12-01\nFull Text Available OBJECTIVE: To determine the epidemiology of Haemophilus influenzae type b (Hib and Streptococcus pneumoniae invasive infections in hospitalized Guatemalan children. This is an important issue since Hib vaccine has not been incorporated into the routine immunization program in Guatemala and information from hospital records in 1995 indicated a low incidence of Hib and S. pneumoniae as causes of meningitis and invasive infections. METHODS: Children who were hospitalized in Guatemala City with clinical signs compatible with bacterial infections were evaluated for evidence of Hib or S. pneumoniae infection. Normally sterile body fluids were cultured, and antigen detection was performed on cerebrospinal fluid (CSF and pleural fluid. RESULTS: Of 1 203 children 1-59 months of age hospitalized over a 28-month period, 725 of them (60.3% had a primary diagnosis of pneumonia, 357 (29.7% of meningitis, 60 (5.0% of cellulitis, and 61 (5.1% of sepsis and other conditions. Hib was identified in 20.0% of children with meningitis and S. pneumoniae in 12.9%. The average annual incidence of Hib meningitis was 13.8 cases per 100 000 children under 5 years of age, and 32.4% of meningitides caused by Hib and 58.7% of S. pneumoniae meningitides occurred prior to 6 months of age. Case fatality rates were 14.1%, 37.0%, and 18.0%, respectively, for children with Hib, S. pneumoniae, and culture-negative and antigen-negative meningitis. Prior antibiotic therapy was common and was associated with significant reductions in CSF-culture-positive results for children with other evidence of Hib or S. pneumoniae meningitis. CONCLUSIONS: Improvements in case detection, culture methods, and latex agglutination for antigen detection in CSF resulted in identification of Hib and S. pneumoniae as important causes of severe disease in Guatemalan children. Using a cutoff of > 10 white blood cells per cubic millimeter in CSF would improve the sensitivity for detection of bacterial\n[The effect of PDT on H. influenzae biofilm in vivo](http://adsabs.harvard.edu/abs/2010SPIE.7548E..30R)\nRhee, Chung-Ku; Chang, So-Young; Hwang, Dong-Jo; Kim, Young Hoon; Ahn, Jin-Chul\n2010-02-01\nBiofilm formation has been demonstrated for many mucosal pathogens such as Haemophilus influenzae. The presence of mucosal biofilms with chronic otitis media with effusion (COME) suggests that bacteria do not clear by antibiotics. Aim: To test the effect of photodynamic therapy (PDT) on H. influenzae induced biofilm in vivo. Methods: Gerbils were divided into control (C), HI group, Laser (L), PS, PDT A, and PDT B groups. The C group received no treatment. HI group was injected with 20\u03bcl (108CFU/ml) of H. influenzae into the bullae and formation of biofilms in the bullae was obtained by 5 days. For L group, 120 J/cm2 (100 mw \u00d7 20 min) of 632 nm LD laser was irradiated by a fiber inserted into the bullae 5 days after the H. influenzaeinjection. For PS group, photofrin 40\u03bcl (1mg/ml) were injected into the bullae 5 days after the H. influenzae injection. PDT A group received photofrin 1 mg/ml and LD laser 120 J/cm2 that were administered into the bullae 5 days after the H. influenzae injection. PDT B group received photofrin 2 mg/ml and laser 150 J/cm2 5 days after the H. influenzae injection. The mucosal tissues in bullae were examined by H/E staining, and SEM. Results: The C group showed normal mucosa of bullae. The HI, L, and PS groups have shown well formed biofilm. Twenty five percent of the PDT A group and 50 % of the PDT B group have shown completely or partially resolved biofilm. Conclusion: The results of this study demonstrated that PDT appears to be effective to treat experimental H. influenzae induced biofilms in vivo. Clinical implication: PDT may be an alternative to antibiotic treatment on otitis media with biofilm formation.\n[Streptococcus pneumoniae aislados durante 2002-2006: serotipos y resistencia antibi\u00f3tica. Correlaci\u00f3n con las vacunas existentes](http://www.scielo.org.pe/scielo.php?script=sci_arttext&pid=S1025-55832008000100006&lng=en&tlng=en) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nJos\u00e9 Mar\u00eda Guevara-Duncan\n2008-03-01\nFull Text Available Objetivos: Identificar los serotipos de S. pneumoniae aislados, correlacion\u00e1ndolos con los incluidos en las vacunas existentes y su resistencia antimicrobiana. Dise\u00f1o: Estudio descriptivo, observacional y longitudinal. Lugar: Instituto de Medicina Tropical Daniel A. Carri\u00f3n, Facultad de Medicina, UNMSM. Material biol\u00f3gico: Cepas de Streptococcus pneumoniae. Intervenciones: Cuarenta Streptococcus pneumoniae de nuestro cepario, aislados entre el 2002 y 2006, fueron serotipificados en el Instituto de Salud Carlos III en Madrid -Espa\u00f1a; 15 fueron invasivos, 11 aislados de infecciones localizadas, 6 de portadores y 8 eran multiresistentes. Principales medidas de resultados: Protecci\u00f3n de las vacunas existentes en nuestro medio a las infecciones causadas por Streptococcus pneumoniae. Resultados: Hubo 14 serotipos diferentes y los serogrupos m\u00e1s identificados fueron 23, 19 y 6. El 28,6% estaba contenido en la vacuna 7-valente, 42,9% en la 9-valente, 50% en la 11-valente y el 71,4% en la 23-valente; 57,5% fue resistente a la penicilina y 30% a eritromicina. El grupo de Streptococcus invasivo result\u00f3 m\u00e1s sensible a los antibi\u00f3ticos que los otros grupos. Los serotipos asociados a multirresistencia fueron 19F y 23F. Conclusiones: Ninguna de las vacunas protege a todas las infecciones causadas por Streptococcus pneumoniae, en nuestro medio.\n[Desarrollo de una vacuna probi\u00f3tica para el tratamiento del c\u00e1ncer c\u00e9rvico-uterino](https://www.openaire.eu/search/publication?articleId=dedup_wf_001::1ea3de1bdf059dfdef615fb2bb624b84)\nCort\u00e9s P\u00e9rez, Naima Gisela; Berm\u00fadez Humar\u00e1n, Luis Gilberto; Alcocer Gonz\u00e1lez, Juan Manuel; Gruss, Alexandra; Le Loir, Yves; Langella, Phillipe; Luna Leal, Roberto Montes de Oca\n2003-01-01\nDado que el virus del papiloma humano tipo 16 (HPV- 16) es la principal causa del c\u00e1ncer c\u00e9rvicouterino, hay una gran necesidad de desarrollar una vacuna profil\u00e1ctica y/o terap\u00e9utica. La oncoprote\u00edna E7 es constitutivamente producida por neoplasias cervicales y, por tanto, considerada como un blanco potencial para dirigir el desarrollo de una vacuna terap\u00e9utica contra el c\u00e1ncer c\u00e9rvico-uterino. En este trabajo desarrollamos un sistema inducible para expresar la prote\u00edn...\n[Now and future influenza vaccines.](https://www.ncbi.nlm.nih.gov/pubmed/2407775)\nRuben, F L\n1990-03-01\nInfluenza is a modern day plague. In the young, the clinical picture is classical, but in the elderly, the disease may go unsuspected until complications such as pneumonia develop. Influenza A and B viruses are responsible, and these viruses mutate with great regularity. Antibodies to the HA and NA surface antigens of influenza viruses, both naturally and vaccine induced, are protective. The earliest influenza vaccines were crude, toxic, and ineffective. With modern purification techniques, the egg-grown viruses have been turned into safe, immunogenic, and effective killed-virus vaccines--whole virus and split virus. Surveillance permits the correct virus strains to be incorporated into each new vaccine. Those who have been experiencing the worst effects of influenza have been identified. These individuals need to be immunized each year. In the future, live influenza virus vaccines may offer the benefits of ease of administration and longer-lasting protection. Synthetic peptides, genetically engineered antigens, and even nonantigen (anti-idiotype) vaccines are possible, but such vaccines will require adjuvant enhancement. For the present, greater efforts must be made to use existing influenza vaccines.\nCa\u00f1as Giraldo, Camilo Augusto; Fundaci\u00f3n Valle de Lili\n2004-01-01\n\u00bfQu\u00e9 es una vacuna?/Tuberculosis/Difteria/La tosferina/el t\u00e9tanos/Poliomielitis/Hepatitis A/Hepatitis B/La varicela/Fiebre amarilla/Infecciones por neumococo/Infecciones por hemofilias influenza/Infecciones por meningococo/Influenza/Rubeola-sarampi\u00f3n-paperas/Consideraciones generales.\n[IgG responses to Pneumococcal and Haemophilus influenzae protein antigens are not impaired in children with a history of recurrent acute otitis media.](https://www.ncbi.nlm.nih.gov/pubmed/23152850)\nWiertsema, Selma P; Corscadden, Karli J; Mowe, Eva N; Zhang, Guicheng; Vijayasekaran, Shyan; Coates, Harvey L; Mitchell, Timothy J; Thomas, Wayne R; Richmond, Peter C; Kirkham, Lea-Ann S\n2012-01-01\nVaccines including conserved antigens from Streptococcus pneumoniae and nontypeable Haemophilus influenzae (NTHi) have the potential to reduce the burden of acute otitis media. Little is known about the antibody response to such antigens in young children with recurrent acute otitis media, however, it has been suggested antibody production may be impaired in these children. We measured serum IgG levels against 4 pneumococcal (PspA1, PspA 2, CbpA and Ply) and 3 NTHi (P4, P6 and PD) proteins in a cross-sectional study of 172 children under 3 years of age with a history of recurrent acute otitis media (median 7 episodes, requiring ventilation tube insertion) and 63 healthy age-matched controls, using a newly developed multiplex bead assay. Children with a history of recurrent acute otitis media had significantly higher geometric mean serum IgG levels against NTHi proteins P4, P6 and PD compared with healthy controls, whereas there was no difference in antibody levels against pneumococcal protein antigens. In both children with and without a history of acute otitis media, antibody levels increased with age and were significantly higher in children colonised with S. pneumoniae or NTHi compared with children that were not colonised. Proteins from S. pneumoniae and NTHi induce serum IgG in children with a history of acute otitis media. The mechanisms in which proteins induce immunity and potential protection requires further investigation but the dogma of impaired antibody responses in children with recurrent acute otitis media should be reconsidered.\n[IgG responses to Pneumococcal and Haemophilus influenzae protein antigens are not impaired in children with a history of recurrent acute otitis media.](http://europepmc.org/articles/PMC3495775?pdf=render) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nSelma P Wiertsema\nFull Text Available BACKGROUND: Vaccines including conserved antigens from Streptococcus pneumoniae and nontypeable Haemophilus influenzae (NTHi have the potential to reduce the burden of acute otitis media. Little is known about the antibody response to such antigens in young children with recurrent acute otitis media, however, it has been suggested antibody production may be impaired in these children. METHODS: We measured serum IgG levels against 4 pneumococcal (PspA1, PspA 2, CbpA and Ply and 3 NTHi (P4, P6 and PD proteins in a cross-sectional study of 172 children under 3 years of age with a history of recurrent acute otitis media (median 7 episodes, requiring ventilation tube insertion and 63 healthy age-matched controls, using a newly developed multiplex bead assay. RESULTS: Children with a history of recurrent acute otitis media had significantly higher geometric mean serum IgG levels against NTHi proteins P4, P6 and PD compared with healthy controls, whereas there was no difference in antibody levels against pneumococcal protein antigens. In both children with and without a history of acute otitis media, antibody levels increased with age and were significantly higher in children colonised with S. pneumoniae or NTHi compared with children that were not colonised. CONCLUSIONS: Proteins from S. pneumoniae and NTHi induce serum IgG in children with a history of acute otitis media. The mechanisms in which proteins induce immunity and potential protection requires further investigation but the dogma of impaired antibody responses in children with recurrent acute otitis media should be reconsidered.\n[Avances en el desarrollo de vacunas contra la neosporosis bovina Advances in the development of vaccines for bovine neosporosis](http://www.scielo.org.ar/scielo.php?script=sci_arttext&pid=S0325-75412012000300014) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nYanina P. Hecker\n2012-09-01\nFull Text Available La neosporosis es una enfermedad que ocasiona abortos en bovinos y est\u00e1 causada por un protozoo intracelular obligado denominado Neospora caninum. Las graves p\u00e9rdidas econ\u00f3micas que provoca en los sistemas de producci\u00f3n de bovinos justifica la necesidad de avanzar en el desarrollo de vacunas. La resistencia a par\u00e1sitos Apicomplexa est\u00e1 asociada a una respuesta inmune T helper 1 mediada por linfocitos T CD4 citot\u00f3xicos y a la producci\u00f3n de interfer\u00f3n-gamma, interleuquina-12, factor de necrosis tumoral e inmunoglobulina G2. La disminuci\u00f3n de la transmisi\u00f3n vertical en las sucesivas pre\u00f1eces y el bajo nivel de repetici\u00f3n de abortos en animales infectados sugieren la existencia de mecanismos inmunitarios de protecci\u00f3n. Hasta el momento se conoce que la inoculaci\u00f3n pre-servicio con taquizo\u00edtos vivos protege contra la infecci\u00f3n y el aborto. Los antecedentes de desarrollo de vacunas vivas contra otros protozoos estimulan a los investigadores a continuar en la b\u00fasqueda de una vacuna de este tipo contra N. caninum de buena eficacia. Por otra parte, una vacuna inactivada, aun con una baja eficacia, es \u00fatil en la prevenci\u00f3n del aborto en aquellos establecimientos donde la enfermedad es epizo\u00f3tica. Una vacuna contra la neosporosis deber\u00eda evitar el aborto, la transmisi\u00f3n transplacental y la persistencia de la infecci\u00f3n. Este trabajo menciona los diversos tipos de vacunas que han sido evaluados hasta el momento, incluyendo inmun\u00f3genos inactivos, taquizo\u00edtos vivos, ant\u00edgenos recombinantes y vacunas en vectores.Neosporosis, a disease caused by the obligate intracellular protozoan Neospora caninum, produces abortions in cattle. The severe economic losses in cattle industry justify the need to develop control measures for preventing bovine abortion. Apicomplexan parasitic resistance is associated with T helper 1 immune response mediated by CD4 cytotoxic T lymphocytes, the production of interferon-gamma, interleukin-12, tumor necrosis\n[VARIABILIDAD EN LA NOTIFICACI\u00d3N DE REACCIONES ADVERSAS A LAS VACUNAS DE LA GRIPE PAND\u00c9MICA Y ESTACIONAL. TEMPORADAS 2009-2010 Y 2010-2011, COMUNITAT VALENCIANA](https://www.openaire.eu/search/publication?articleId=doajarticles::6f322a77ce0bd5fd88c95f861a1a0782)\nAna Mar\u00eda Alguacil Ramos; Jos\u00e9 Antonio Lluch Rodrigo; Antonio Portero Alonso; Rosa Mart\u00edn Ivorra; Eliseo Pastor Villalba\n2012-01-01\nFundamentos: La p\u00e9rdida de confianza en la seguridad de las vacunas derivada de situaciones de alarma, como en el caso de la gripe pand\u00e9mica, puede afectar tanto a las coberturas vacunales como a la sensibilidad frente a la notificaci\u00f3n de las sospechas de reacciones adversas asociadas a vacunas (SRAAV). El objetivo del trabajo es describir los efectos adversos a la vacuna frente a la gripe pand\u00e9mica notificados en la temporada 2009-2010 y comparar si existen diferencias con los descritos con...\n[Process development of a New Haemophilus influenzae type b conjugate vaccine and the use of mathematical modeling to identify process optimization possibilities.](https://www.ncbi.nlm.nih.gov/pubmed/26821825)\nHamidi, Ahd; Kreeftenberg, Hans; V D Pol, Leo; Ghimire, Saroj; V D Wielen, Luuk A M; Ottens, Marcel\n2016-05-01\nVaccination is one of the most successful public health interventions being a cost-effective tool in preventing deaths among young children. The earliest vaccines were developed following empirical methods, creating vaccines by trial and error. New process development tools, for example mathematical modeling, as well as new regulatory initiatives requiring better understanding of both the product and the process are being applied to well-characterized biopharmaceuticals (for example recombinant proteins). The vaccine industry is still running behind in comparison to these industries. A production process for a new Haemophilus influenzae type b (Hib) conjugate vaccine, including related quality control (QC) tests, was developed and transferred to a number of emerging vaccine manufacturers. This contributed to a sustainable global supply of affordable Hib conjugate vaccines, as illustrated by the market launch of the first Hib vaccine based on this technology in 2007 and concomitant price reduction of Hib vaccines. This paper describes the development approach followed for this Hib conjugate vaccine as well as the mathematical modeling tool applied recently in order to indicate options for further improvements of the initial Hib process. The strategy followed during the process development of this Hib conjugate vaccine was a targeted and integrated approach based on prior knowledge and experience with similar products using multi-disciplinary expertise. Mathematical modeling was used to develop a predictive model for the initial Hib process (the 'baseline' model) as well as an 'optimized' model, by proposing a number of process changes which could lead to further reduction in price. \u00a9 2016 American Institute of Chemical Engineers Biotechnol. Prog., 32:568-580, 2016. \u00a9 2016 American Institute of Chemical Engineers.\n[Perspectivas para el desarrollo de vacunas e inmunoterapia contra c\u00e1ncer cervicouterino](http://www.scielosp.org/scielo.php?script=sci_arttext&pid=S0036-36341998000100006) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nGUZM\u00c1N-ROJAS LILIANA\n1998-01-01\nFull Text Available El c\u00e1ncer cervicouterino representa un grave problema de salud p\u00fablica, debido a la asociaci\u00f3n de la neoplasia con el virus del papiloma humano; actualmente se realizan estudios usando estrategias dirigidas a combatir este pat\u00f3geno, mediante vacunas, que podr\u00edan ser de gran utilidad para el control de la progresi\u00f3n de la enfermedad. El estudio tanto de la inmunolog\u00eda humoral como celular ha servido para el desarrollo de vacunas. As\u00ed, la utilizaci\u00f3n de part\u00edculas virales sint\u00e9ticas para el estudio de anticuerpos neutralizantes y el uso de prote\u00ednas tempranas virales, entre otras, para la inducci\u00f3n de inmunidad mediada por c\u00e9lulas, han sido la pauta para realizar estudios que dirijan la respuesta inmune para prevenir la infecci\u00f3n celular tanto hacia c\u00e9lulas infectadas no transformadas como hacia c\u00e9lulas transformadas viralmente con resultados favorables.\n[Comparison of two recombinant hepatitis B vaccines and their interchangeability in Argentine infants Comparaci\u00f3n de dos vacunas recombinantes contra la hepatitis B y su intercambiabilidad en lactantes argentinos](http://www.scielosp.org/scielo.php?script=sci_arttext&pid=S1020-49892004000100006) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nMiguel Tregnaghi\n2004-01-01\n-B.OBJETIVO: Comparar dos vacunas pedi\u00e1tricas recombinantes contra la hepatitis B -Euvax-B y la vacuna de referencia Engerix-B- en cuanto a su inmunogenicidad y reactogenicidad, e investigar su intercambiabilidad, es decir, si el esquema de vacunaci\u00f3n contra la hepatitis B de tres dosis comenzado con una primera dosis de Engerix-B puede completarse con dos dosis de Euvax-B. M\u00c9TODOS: Este estudio se llev\u00f3 a cabo en la ciudad de C\u00f3rdoba, Argentina, entre marzo de 1999 y febrero de 2000. Se vacun\u00f3 contra la hepatitis B a tres grupos de 100 lactantes argentinos a los 0, 1 y 6 meses de edad. El grupo A recibi\u00f3 tres dosis de Euvax-B; el grupo B, tres dosis de Engerix-B; y el grupo C, una dosis de Engerix-B seguida de dos dosis de Euvax-B. Para evaluar la reactogenicidad se utiliz\u00f3 la informaci\u00f3n brindada por los padres acerca de determinados fen\u00f3menos locales o sist\u00e9micos solicitados por los investigadores que hubieran ocurrido durante los siete d\u00edas posteriores a la vacunaci\u00f3n. Para establecer si eran id\u00e9nticas cl\u00ednicamente las vacunas Euvax-B y Engerix-B se utilizaron las tasas de seroprotecci\u00f3n -es decir, t\u00edtulos de anticuerpos contra el ant\u00edgeno de superficie de hepatitis B (anti-HBsAg > 10 miliunidades internacionales por mililitro (mUI/mL- alcanzados dos meses despu\u00e9s de la tercera dosis. RESULTADOS: La reactogenicidad fue baja en los tres grupos de estudio. A los 5 meses de la segunda dosis (es decir, inmediatamente antes de la tercera dosis, las tasas de seroprotecci\u00f3n fueron 95,9%, 94,7% y 90,2% en los grupos A, B y C, respectivamente. Dos meses despu\u00e9s de la tercera dosis, todos los lactantes se encontraban protegidos, con concentraciones medias geom\u00e9tricas de anti-HBsAg de 2 468,1 mUI/mL en el grupo A, de 1 714,8 mUI/mL en el grupo B y de 2 075,3 mUI/mL en el grupo C. CONCLUSIONES: Las dos vacunas recombinantes contra la hepatitis B estudiadas fueron bien toleradas y altamente inmunog\u00e9nicas. La vacuna Euvax-B fue cl\u00ednicamente id\u00e9ntica (no inferior a la\n[La evidencia acerca de la controversia de las vacunas que contienen timerosal y su asociaci\u00f3n con el autismo](http://www.scielosp.org/scielo.php?script=sci_arttext&pid=S1726-46342013000200018&lng=en&tlng=en) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nLisset Garc\u00eda-Fern\u00e1ndez\n2013-06-01\nFull Text Available La vacunaci\u00f3n es una de las medidas de mayor impacto en la salud p\u00fablica para la reducci\u00f3n de la morbimortalidad infantil. El timerosal es un compuesto org\u00e1nico del mercurio utilizado como preservante de los frascos multidosis. Eventualmente, en el Per\u00fa, surgen olas de controversia acerca de la seguridad de estas vacunas, asoci\u00e1ndolas especialmente con el autismo. Como resultado de estas controversias, se han propuesto, incluso, leyes que proh\u00edben este tipo de vacunas, lo que tendr\u00eda un importante impacto en los costos y en los aspectos log\u00edsticos de la estrategia nacional de vacunaci\u00f3n. En este art\u00edculo se revisa la literatura sobre las principales controversias acerca de las vacunas que contienen timerosal y su supuesta asociaci\u00f3n con el autismo. Se realiza una aproximaci\u00f3n hist\u00f3rica sobre estas controversias, se hace una actualizaci\u00f3n de la evidencia cient\u00edfica disponible al momento, y se revisa la posici\u00f3n de los organismos internacionales m\u00e1s importantes con respecto a este tema. Se concluye que la evidencia cient\u00edfica no apoya la noci\u00f3n que exista una asociaci\u00f3n entre el uso del timerosal en las vacunas con los trastornos del espectro autista en ni\u00f1os.\n[[THE NATIONAL NUTRIENT MEDIUM FOR DIAGNOSTIC OF PURULENT BACTERIAL MENINGITIS].](https://www.ncbi.nlm.nih.gov/pubmed/26470444)\nPodkopaev, Ya V; Domotenko, L V; Morozova, T P; Khramov, M K; Shepelin, A P\n2015-05-01\nThe national growth mediums were developed for isolating and cultivating of main agents of purulent bacterial meningitis--haemophilus agar, chocolate agar, PBM-agar. The growing and selective characteristics of developed growth mediums are examined. The haemophilus agar ensures growth of Haemophilus influenzae. The chocolate agar, PBM-agar ensure growth of Neisseria meningitidis, Streptococcus pneumoniae and Haemophilus influenzae. By growing characteristics, the national growth mediums match foreign analogues. Under application of growth mediums with selective additions it is possible to achieve selective isolation of main agents of purulent bacterial meningitis with inhibition of growth of microbes-associates.\n[Caracter\u00edsticas de los v\u00eddeos en espa\u00f1ol publicados en YouTube sobre la vacuna contra el virus del papiloma humano](http://www.redalyc.org/articulo.oa?id=17033372012) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nJos\u00e9 Tuells\n2015-01-01\nFull Text Available Fundamentos: Internet constituye un recurso de b\u00fasqueda de informaci\u00f3n relacionada con la salud. El objetivo de este trabajo fue conocer las caracter\u00edsticas de los v\u00eddeos en idioma espa\u00f1ol de YouTube relacionados con la vacuna contra el virus del papiloma humano (VPH. M\u00e9todos: Se realiz\u00f3 un estudio observacional a partir de una b\u00fasqueda en YouTube el 26 de julio de 2013, con las palabras claves: \u201cvacuna virus papiloma humano\u201d, \u201cvacuna VPH\u201d, \u201cvacuna Gardasil\u201d, \u201cvacuna Cervarix\u201d. Se establecieron categor\u00edas por tipo, fuente de publicaci\u00f3n y predisposici\u00f3n favorable o no hacia la vacuna. Se registr\u00f3 el n\u00famero de visitas, tiempo de duraci\u00f3n de los videos y origen de los 20 v\u00eddeos m\u00e1s visitados. Resultados. Se encontraron 1.080 videos registrados, 170 fueron seleccionados y clasificados como: noticias locales (n=39; 37 favorables, 2 desfavorables; 2:06:29; 42972 visitas, noticias nacionales (n=32; 30/2; 1:49:27; 50138 visitas, creados por subscritores de YouTube (n=21; 13/8; 2:50:35; 144655 visitas, entrevistas (n=21; 20/1; 1:44:39; 10991 visitas, anuncios (n=21; 19/2; 0:27:05; 28435 visitas, conferencias (n=17; 15/2; 3:25:39; 27206 visitas, documentales (n=16; 12/4; 2:11:31; 30629 visitas, y noticias internacionales (n=3; 3/0; 0:11:33; 1667 visitas. De los 20 videos m\u00e1s reproducidos predominan los favorables a la vacunaci\u00f3n (n=12; 0:43:43; 161.789 visitas frente a los desfavorables (n=8; 2:44:14; 86.583 visitas. Conclusiones. Predominan los videos que tiene una opini\u00f3n favorable hacia la vacuna contra el VPH, aunque los videos de contenido negativo son los m\u00e1s extensos y reproducidos-\n[The impact of residency and urbanicity on Haemophilus influenzae Type b and pneumococcal immunization in Shanghai Children: a Retrospective Cohort Study.](http://europepmc.org/articles/PMC4020859?pdf=render) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nAbram L Wagner\nFull Text Available BACKGROUND: Haemophilus influenzae type b (Hib vaccine and pneumococcal conjugate vaccine (PCV are relatively expensive, newly introduced vaccines in China. This study evaluates the impact of residency and urbanicity on Hib vaccine and PCV coverage for children aged 2 to 7 years living in Shanghai, China, in August 2012. METHODS: In this exploratory cohort study, a sample of children aged 2 to 7 years, all of whom were eligible to have received the complete series of Hib vaccine and PCV, was obtained from the Shanghai Immunization Program Information System. Three measures of vaccination coverage for Hib vaccine and PCV were examined: dose 1 coverage, series completion, and timeliness of dose 1 vaccination. Multivariable binomial regression was used to estimate the difference in vaccination coverage between locals and the floating population. RESULTS: Dose 1 coverage was 50.9% for Hib vaccine and 11.4% for PCV for the 28,141 abstracted pediatric records. For both vaccines, dose 1 coverage was higher in locals than in the floating population. The disparity in coverage between locals and the floating population was greater in suburban areas than urban areas. Of all children who received dose 1, 79.7% completed the Hib vaccine series, and 91.3% completed the PCV series. Timely dose 1 coverage was 8.2% for Hib vaccine and 0.5% for PCV. CONCLUSION: Low vaccination coverage and extremely low levels of timely dose 1 vaccination indicate that current vaccination efforts are inadequate to reduce the burden of Hib and pneumococcal disease among Chinese children, especially infants. Government funding of the Hib vaccine and PCV through the Expanded Program on Immunization would increase uptake and could also ensure that improvement in the timeliness of administration and series completion is targeted for all demographic groups.\n[Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nSailen Barik\n2010-07-01\nFull Text Available Influenza virus is one of the most prevalent and ancient infections in humans. About a fifth of world's population is infected by influenza virus annually, leading to high morbidity and mortality, particularly in infants, the elderly and the immunocompromised. In the US alone, influenza outbreaks lead to roughly 30,000 deaths each year. Current vaccines and anti-influenza drugs are of limited use due to high mutation rate of the virus and side effects. In recent years, RNA interference, triggered by synthetic short interfering RNA (siRNA, has rapidly evolved as a potent antiviral regimen. Properly designed siRNAs have been shown to function as potent inhibitors of influenza virus replication. The siRNAs outperform traditional small molecule antivirals in a number of areas, such as ease of design, modest cost, and fast turnaround. Although specificity and tissue delivery remain major bottlenecks in the clinical applications of RNAi in general, intranasal application of siRNA against respiratory viruses including, but not limited to influenza virus, has experienced significant success and optimism, which is reviewed here.\nBarik, Sailen\n2010-07-01\nInfluenza virus is one of the most prevalent and ancient infections in humans. About a fifth of world's population is infected by influenza virus annually, leading to high morbidity and mortality, particularly in infants, the elderly and the immunocompromised. In the US alone, influenza outbreaks lead to roughly 30,000 deaths each year. Current vaccines and anti-influenza drugs are of limited use due to high mutation rate of the virus and side effects. In recent years, RNA interference, triggered by synthetic short interfering RNA (siRNA), has rapidly evolved as a potent antiviral regimen. Properly designed siRNAs have been shown to function as potent inhibitors of influenza virus replication. The siRNAs outperform traditional small molecule antivirals in a number of areas, such as ease of design, modest cost, and fast turnaround. Although specificity and tissue delivery remain major bottlenecks in the clinical applications of RNAi in general, intranasal application of siRNA against respiratory viruses including, but not limited to influenza virus, has experienced significant success and optimism, which is reviewed here.\n[Vacunas de ADN: inducci\u00f3n de la respuesta inmunitaria DNA Vaccines: Induction of the immune response](http://www.scielo.org.mx/scielo.php?script=sci_arttext&pid=S0036-36342009000900012) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nJavier Mota-S\u00e1nchez\n2009-01-01\nFull Text Available La efectividad de las vacunas y la inmunizaci\u00f3n en la prevenci\u00f3n de las enfermedades infecciosas es uno de los grandes avances de la medicina. En la actualidad, el acceso a la tecnolog\u00eda de punta en el \u00e1rea de la gen\u00f3mica y la prote\u00f3mica ha hecho posible acelerar el desarrollo de nuevos modelos de vacunas con caracter\u00edsticas mejoradas en aspectos fundamentales, como la inmunogenicidad y la seguridad. A casi dos d\u00e9cadas del primer informe, en el cual se demostr\u00f3 que un gen puede expresarse mediante la inyecci\u00f3n directa de ADN desnudo, las vacunas de ADN han probado ser eficientes para inducir una respuesta inmunitaria protectora contra par\u00e1sitos, virus y bacterias en diversos modelos animales. Esta revisi\u00f3n tiene por objetivo presentar un panorama general de las vacunas de ADN y los mecanismos mediante los cuales la inmunizaci\u00f3n con ant\u00edgenos insertados en vectores de ADN (pl\u00e1smidos inducen una respuesta inmunitaria.The effectiveness of vaccines and immunization in the prevention of infectious diseases is one of the greatest successes in medicine. In recent years, with access to cutting edge genomic and proteomic technology, it is possible to accelerate the development of new and improved vaccines with better immunogenicity and safety characteristics. Since the first report almost two decades ago, where it was demonstrated that gene expression is possible by directed injection of naked DNA, DNA vaccines have been proven to induce protective immune responses against parasites, virus and bacterium in diverse animal disease models. This review aims to present an overview about DNA vaccines and the mechanisms by which immune responses are induced after immunization with plasmid DNA-encoded antigens.\n[Substrate specificity, metal binding properties, and spectroscopic characterization of the DapE-encoded N-succinyl-L,L-diaminopimelic acid desuccinylase from Haemophilus influenzae.](https://www.ncbi.nlm.nih.gov/pubmed/12962500)\nBienvenue, David L; Gilner, Danuta M; Davis, Ryan S; Bennett, Brian; Holz, Richard C\n2003-09-16\nThe catalytic and structural properties of divalent metal ion cofactor binding sites in the dapE-encoded N-succinyl-L,L-diaminopimelic acid desuccinylase (DapE) from Haemophilus influenzae were investigated. Co(II)-substituted DapE enzyme was 25% more active than the Zn(II)-loaded form of the enzyme. Interestingly, Mn(II) can activate DapE, but only to approximately 20% of the Zn(II)-loaded enzyme. The order of the observed k(cat) values are Co(II) > Zn(II) > Cd(II) > Mn(II) >Ni(II) approximately equal Cu(II) approximately equal Mg(II). DapE was shown to only hydrolyze L,L-N-succinyl-diaminopimelic acid (L,L-SDAP) and was inactive toward D,L-, L,D-, and D,D-SDAP. DapE was also inactive toward several acetylated amino acids as well as D,L-succinyl aminopimelate, which differs from the natural substrate, L,L-SDAP, by the absence of the amine group on the amino acid side chain. These data imply that the carboxylate of the succinyl moiety and the amine form important interactions with the active site of DapE. The affinity of DapE for one versus two Zn(II) ions differs by nearly 2.2 x 10(3) times (K(d1) = 0.14 microM vs K(d2) = 300 microM). In addition, an Arrhenius plot was constructed from k(cat) values measured between 16 and 35 degrees C and was linear over this temperature range. The activation energy for [ZnZn(DapE)] was found to be 31 kJ/mol with the remaining thermodynamic parameters calculated at 25 degrees C being DeltaG(++) = 64 kJ/mol, DeltaH(++) = 28.5 kJ/mol, and DeltaS(++) = -119 J mol(-1) K(-1). Electronic absorption and EPR spectra of [Co_(DapE)] and [CoCo(DapE)] indicate that the first Co(II) binding site is five-coordinate, while the second site is octahedral. In addition, any spin-spin interaction between the two Co(II) ions in [CoCo(DapE)] is very weak. The kinetic and spectroscopic data presented herein suggest that the DapE from H. influenzae has similar divalent metal binding properties to the aminopeptidase from Aeromonas proteolytica (AAP), and\n[Laboratory-supported influenza surveillance in Victorian sentinel general practices.](https://www.ncbi.nlm.nih.gov/pubmed/11225381)\nKelly, H; Murphy, A; Leong, W; Leydon, J; Tresise, P; Gerrard, M; Chibo, D; Birch, C; Andrews, R; Catton, M\n2000-12-01\nLaboratory-supported influenza surveillance is important as part of pandemic preparedness, for identifying and isolating candidate vaccine strains, for supporting trials of anti-influenza drugs and for refining the influenza surveillance case definition in practice. This study describes the implementation of laboratory-supported influenza surveillance in Victorian sentinel general practices and provides an estimate of the proportion of patients with an influenza-like illness proven to have influenza. During 1998 and 1999, 25 sentinel general practices contributed clinical surveillance data and 16 metropolitan practices participated in laboratory surveillance. Serological, virus-antigen detection, virus culture and multiplex polymerase chain reaction procedures were used to establish the diagnosis of influenza. Two laboratories at major teaching hospitals in Melbourne provided additional data on influenza virus identification. General practice sentinel surveillance and laboratory identification of influenza provided similar data on the pattern of influenza in the community between May and September. The clinical suspicion of influenza was confirmed in 49 to 54 per cent of cases seen in general practice.\n[Crystal structures of active fully assembled substrate- and product-bound complexes of UDP-N-acetylmuramic acid:L-alanine ligase (MurC) from Haemophilus influenzae.](https://www.ncbi.nlm.nih.gov/pubmed/12837790)\nMol, Clifford D; Brooun, Alexei; Dougan, Douglas R; Hilgers, Mark T; Tari, Leslie W; Wijnands, Robert A; Knuth, Mark W; McRee, Duncan E; Swanson, Ronald V\n2003-07-01\nUDP-N-acetylmuramic acid:L-alanine ligase (MurC) catalyzes the addition of the first amino acid to the cytoplasmic precursor of the bacterial cell wall peptidoglycan. The crystal structures of Haemophilus influenzae MurC in complex with its substrate UDP-N-acetylmuramic acid (UNAM) and Mg(2+) and of a fully assembled MurC complex with its product UDP-N-acetylmuramoyl-L-alanine (UMA), the nonhydrolyzable ATP analogue AMPPNP, and Mn(2+) have been determined to 1.85- and 1.7-A resolution, respectively. These structures reveal a conserved, three-domain architecture with the binding sites for UNAM and ATP formed at the domain interfaces: the N-terminal domain binds the UDP portion of UNAM, and the central and C-terminal domains form the ATP-binding site, while the C-terminal domain also positions the alanine. An active enzyme structure is thus assembled at the common domain interfaces when all three substrates are bound. The MurC active site clearly shows that the gamma-phosphate of AMPPNP is positioned between two bound metal ions, one of which also binds the reactive UNAM carboxylate, and that the alanine is oriented by interactions with the positively charged side chains of two MurC arginine residues and the negatively charged alanine carboxyl group. These results indicate that significant diversity exists in binding of the UDP moiety of the substrate by MurC and the subsequent ligases in the bacterial cell wall biosynthesis pathway and that alterations in the domain packing and tertiary structure allow the Mur ligases to bind sequentially larger UNAM peptide substrates.\n[Evaluaci\u00f3n del impacto de la vacuna contra rotavirus en Colombia usando m\u00e9todos r\u00e1pidos de evaluaci\u00f3n](http://www.scielosp.org/scielo.php?script=sci_arttext&pid=S1020-49892013001000002&lng=en&tlng=en) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nKarol Cotes\n2013-10-01\nFull Text Available OBJETIVO: Estimar la efectividad de la vacuna monovalente antirrotav\u00edrica para prevenir la hospitalizaci\u00f3n por enfermedad diarreica aguda en ni\u00f1os menores de 2 a\u00f1os en cinco ciudades de Colombia. M\u00c9TODOS: Se realiz\u00f3 una encuesta poblacional sobre una muestra probabil\u00edstica de ni\u00f1os mayores de 2 meses y menores de 24 meses de edad en cinco ciudades de Colombia (Barranquilla, Bogot\u00e1, Cali, Cartagena y Riohacha en el per\u00edodo de agosto a octubre de 2010. La vacuna fue introducida en el Programa Ampliado de Inmunizaciones en enero de 2009. Se estimaron las coberturas de vacunaci\u00f3n contra rotavirus por grupos de edad y la incidencia acumulada de hospitalizaci\u00f3n por diarrea severa, y se evalu\u00f3 la magnitud de la asociaci\u00f3n entre la vacunaci\u00f3n con una o dos dosis de vacuna antirrotav\u00edrica y la hospitalizaci\u00f3n por diarrea, utilizando la raz\u00f3n de probabilidades (RP ajustada por edad y otros factores de importancia epidemiol\u00f3gica. La efectividad de la vacunaci\u00f3n se estim\u00f3 usando la expresi\u00f3n 1 - RP. RESULTADOS: La cobertura de vacunaci\u00f3n con una dosis de vacuna fue de 87,3%. En los 12 meses previos a la encuesta 43,2% (1 453 ni\u00f1os de menores de 24 meses presentaron diarrea, y de ellos, 5,2% (174 ni\u00f1os fueron hospitalizados por esta causa. La efectividad de dos dosis de vacuna antirrotav\u00edrica para prevenir la hospitalizaci\u00f3n por diarrea severa fue de 68% (intervalo de confianza de 95%: 55%-77%. CONCLUSIONES: La vacunaci\u00f3n contra rotavirus en Colombia protege contra la hospitalizaci\u00f3n por diarrea por cualquier causa. El uso de encuestas transversales se mostr\u00f3 adecuado para evaluar r\u00e1pidamente la efectividad de un programa de vacunaci\u00f3n con una nueva vacuna.\n[La evidencia acerca de la controversia de las vacunas que contienen timerosal y su asociaci\u00f3n con el autismo](https://www.openaire.eu/search/publication?articleId=doajarticles::9f083d9cb2b9e06dbceeb1cf2c0fabe3)\nLisset Garc\u00eda-Fern\u00e1ndez; Adri\u00e1n V Hern\u00e1ndez; V\u00edctor Su\u00e1rez Moreno; Fabi\u00e1n Fiestas\n2013-01-01\nLa vacunaci\u00f3n es una de las medidas de mayor impacto en la salud p\u00fablica para la reducci\u00f3n de la morbimortalidad infantil. El timerosal es un compuesto org\u00e1nico del mercurio utilizado como preservante de los frascos multidosis. Eventualmente, en el Per\u00fa, surgen olas de controversia acerca de la seguridad de estas vacunas, asoci\u00e1ndolas especialmente con el autismo. Como resultado de estas controversias, se han propuesto, incluso, leyes que proh\u00edben este tipo de vacunas, lo que tendr\u00eda un impor...\n[Chalcones as novel influenza A (H1N1) neuraminidase inhibitors from Glycyrrhiza inflata](http://www.forskningsdatabasen.dk/en/catalog/152071007) [DEFF Research Database (Denmark)](http://forskningsbasen.deff.dk/?lang=eng)\nDao, Trong Tuan; Nguyen, Phi Hung; Lee, Hong Sik\n2011-01-01\nThe emergence of highly pathogenic influenza A virus strains, such as the new H1N1 swine influenza (novel influenza), represents a serious threat to global human health. During our course of an anti-influenza screening program on natural products, one new licochalcone G (1) and seven known (2-8) ...\n[IgA and neutralizing antibodies to influenza a virus in human milk: a randomized trial of antenatal influenza immunization.](https://www.ncbi.nlm.nih.gov/pubmed/23967126)\nSchlaudecker, Elizabeth P; Steinhoff, Mark C; Omer, Saad B; McNeal, Monica M; Roy, Eliza; Arifeen, Shams E; Dodd, Caitlin N; Raqib, Rubhana; Breiman, Robert F; Zaman, K\n2013-01-01\nAntenatal immunization of mothers with influenza vaccine increases serum antibodies and reduces the rates of influenza illness in mothers and their infants. We report the effect of antenatal immunization on the levels of specific anti-influenza IgA levels in human breast milk. (ClinicalTrials.gov identifier NCT00142389; http://clinicaltrials.gov/ct2/show/NCT00142389). The Mother's Gift study was a prospective, blinded, randomized controlled trial that assigned 340 pregnant Bangladeshi mothers to receive either trivalent inactivated influenza vaccine, or 23-valent pneumococcal polysaccharide vaccine during the third trimester. We evaluated breast milk at birth, 6 weeks, 6 months, and 12 months, and serum at 10 weeks and 12 months. Milk and serum specimens from 57 subjects were assayed for specific IgA antibody to influenza A/New Caledonia (H1N1) using an enzyme-linked immunosorbent assay (ELISA) and a virus neutralization assay, and for total IgA using ELISA. Influenza-specific IgA levels in breast milk were significantly higher in influenza vaccinees than in pneumococcal controls for at least 6 months postpartum (p = 0.04). Geometric mean concentrations ranged from 8.0 to 91.1 ELISA units/ml in vaccinees, versus 2.3 to 13.7 ELISA units/mL in controls. Virus neutralization titers in milk were 1.2 to 3 fold greater in vaccinees, and correlated with influenza-specific IgA levels (r = 0.86). Greater exclusivity of breastfeeding in the first 6 months of life significantly decreased the expected number of respiratory illness with fever episodes in infants of influenza-vaccinated mothers (p = 0.0042) but not in infants of pneumococcal-vaccinated mothers (p = 0.4154). The sustained high levels of actively produced anti-influenza IgA in breast milk and the decreased infant episodes of respiratory illness with fever suggest that breastfeeding may provide local mucosal protection for the infant for at least 6 months. Studies are needed to determine the\n[Reclassification of Actinobacillus actinomycetemcomitans, Haemophilus aphrophilus, Haemophilus paraphrophilus and Haemophilus segnis as Aggregatibacter actinomycetemcomitans gen. nvo., comb. nov., Aggregatibacter aphrophilus comb. nov. and Aggregatibacter segnis comb. nov., and emended description of Aggregatibacter aphrophilus to include V factor-dependent and V factor-independent isolates](http://www.forskningsdatabasen.dk/en/catalog/2389196557) [DEFF Research Database (Denmark)](http://forskningsbasen.deff.dk/?lang=eng)\nN\u00f8rskov-Lauritsen, N.; Kilian, Mogens\n2006-01-01\n-independent growth was identified in Haemophilus aphrophilus. The gene encodes a polypeptide of 462 amino acids that shows 74.5 % amino acid sequence identity to the corresponding enzyme from Actinobacillus actinomycetemcomitans. Ten isolates of Haemophilus paraphrophilus all carried a nadV pseudogene. DNA from...... Haemophilus aphrophilus was able to transform Haemophilus paraphrophilus into the NAD-independent phenotype. The transformants carried a full-length nadV inserted in the former locus of the pseudogene. The DNA-DNA relatedness between the type strains of Haemophilus aphrophilus and Haemophilus paraphrophilus...\n[Influenza interaction with cocirculating pathogens and its impact on surveillance, pathogenesis, and epidemic profile: A key role for mathematical modelling.](http://europepmc.org/articles/PMC5814058?pdf=render) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nLulla Opatowski\n2018-02-01\nFull Text Available Evidence is mounting that influenza virus interacts with other pathogens colonising or infecting the human respiratory tract. Taking into account interactions with other pathogens may be critical to determining the real influenza burden and the full impact of public health policies targeting influenza. This is particularly true for mathematical modelling studies, which have become critical in public health decision-making. Yet models usually focus on influenza virus acquisition and infection alone, thereby making broad oversimplifications of pathogen ecology. Herein, we report evidence of influenza virus interactions with bacteria and viruses and systematically review the modelling studies that have incorporated interactions. Despite the many studies examining possible associations between influenza and Streptococcus pneumoniae, Staphylococcus aureus, Haemophilus influenzae, Neisseria meningitidis, respiratory syncytial virus (RSV, human rhinoviruses, human parainfluenza viruses, etc., very few mathematical models have integrated other pathogens alongside influenza. The notable exception is the pneumococcus-influenza interaction, for which several recent modelling studies demonstrate the power of dynamic modelling as an approach to test biological hypotheses on interaction mechanisms and estimate the strength of those interactions. We explore how different interference mechanisms may lead to unexpected incidence trends and possible misinterpretation, and we illustrate the impact of interactions on public health surveillance using simple transmission models. We demonstrate that the development of multipathogen models is essential to assessing the true public health burden of influenza and that it is needed to help improve planning and evaluation of control measures. Finally, we identify the public health, surveillance, modelling, and biological challenges and propose avenues of research for the coming years.\n[Chronic obstructive pulmonary disease and asthma-associated Proteobacteria, but not commensal Prevotella spp., promote Toll-like receptor 2-independent lung inflammation and pathology](http://orbit.dtu.dk/ws/files/128102313/COPD_postprint.pdf) [DEFF Research Database (Denmark)](http://forskningsbasen.deff.dk/?lang=eng)\nLarsen, Jeppe Madura; Musavian, Hanieh Sadat; Butt, Tariq Mahmood\n2015-01-01\nB, non-typeable Haemophilus influenzae and Moraxella catarrhalis). The commensal Prevotella spp. and pathogenic Proteobacteria were found to exhibit intrinsic differences in innate inflammatory capacities on murine lung cells in vitro. In vivo in mice, non-typeable H.influenzae induced severe Toll...... response to three Gram-negative commensal Prevotella strains (Prevotella melaninogenica, Prevotella nanceiensis and Prevotella salivae) and three Gram-negative pathogenic Proteobacteria known to colonize lungs of patients with chronic obstructive pulmonary disease (COPD) and asthma (Haemophilus influenzae...\n[Validaci\u00f3n de un ELISA tipo inhibici\u00f3n para cuantificar polisac\u00e1rido Vi en la vacuna antitifo\u00eddica cubana vax-TyVi](http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1025-028X2006000200002&lng=es&nrm=iso&tlng=es) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nEsther Mar\u00eda Fajardo\n2006-08-01\nFull Text Available Se describe la validaci\u00f3n de un ELISA tipo inhibici\u00f3n, reportado por primera vez en la literatura cient\u00edfica para cuantificar un ant\u00edgeno vacunal: el polisac\u00e1rido Vi de Salmonella Typhi, para ser empleado en el control de la calidad de la vacuna antitifo\u00eddica cubana vax- TyVi\u00e2. El ensayo consta de seis pasos: 1 Recubrimiento de placa de reacci\u00f3n con poli-L-lisina y posteriormente polisac\u00e1rido Vi; 2 Bloqueo con leche descremada; 3 Inhibici\u00f3n o neutralizaci\u00f3n en tubos de suero anti-Vi de conejo, respectivamente, con polisac\u00e1rido Vi de Curva de Calibraci\u00f3n (concentraciones desde 1\u201332 \u03bcg/mL, control positivo y muestras de vacuna (3 diluciones; 4 Neutralizaci\u00f3n de anticuerpos anti-Vi libres, presentes en las mezclas anteriores, por el Polisac\u00e1rido de Recubrimiento; 5 Reconocimiento de anticuerpos anti-Vi unidos a la placa (conjugado anti-IgG de conejo-fosfatasa alcalina y 6 Revelado por reacci\u00f3n enzima-sustrato. Los par\u00e1metros de validaci\u00f3n estudiados y sus resultados fueron: 1 Precisi\u00f3n, expresada como coeficiente de variaci\u00f3n a tres niveles de concentraci\u00f3n de polisac\u00e1rido, comprendidos en el rango de su especificaci\u00f3n (35, 50 y 70 \u03bcg/mL y evaluada en t\u00e9rminos de repetibilidad; precisi\u00f3n intraensayos (cuatro analistas y reproducibilidad (seis analistas: \u00a3 20%; 2 Linealidad (100*R2: 99,68 %; 3 L\u00edmite de detecci\u00f3n: 0,5 \u03bcg/mL; 4 Exactitud (recuperaci\u00f3n para las tres diluciones de la muestra: entre 100 y 118%, y 5 Robustez: no influye 1,5 h de bloqueo (p = 0,52 ni \u00b1 5 min para leer placa (p = 0,56; influye grandemente la calidad del agua (p = 0,026, a favor del agua para inyecci\u00f3n. El ensayo es adecuado para los fines propuestos y es una medida de la inmunogenicidad in vitro del polisac\u00e1rido Vi.\n[Imipenem heteroresistance in nontypeable Haemophilus influenzae is linked to a combination of altered PBP3, slow drug influx and direct efflux regulation.](https://www.ncbi.nlm.nih.gov/pubmed/27756711)\nCherkaoui, A; Diene, S M; Renzoni, A; Emonet, S; Renzi, G; Fran\u00e7ois, P; Schrenzel, J\n2017-02-01\nTo investigate the potential roles of PBPs, efflux pumps and slow drug influx for imipenem heteroresistance in nontypeable Haemophilus influenzae (NTHi). Fifty-nine NTHi clinical isolates examined in this study were collected at Geneva University Hospitals between 2009 and 2014. Alterations in PBPs were investigated by gene sequencing. To evaluate the affinities of the PBPs to imipenem, steady-state concentration-response experiments were carried out using imipenem in a competition assay with Bocillin-FL. The effect of the carbonyl cyanide m-chlorophenylhydrazone (CCCP) on imipenem susceptibility was assessed using broth dilution and viable cell counting. Using whole-genome sequencing, we explored the potential roles of outer membrane protein P2 (OmpP2), LytM proteins and the dcw gene cluster in imipenem heteroresistance. All 46 imipenem-heteroresistant isolates (IMI hR ) harboured amino acid substitutions in the ftsI gene, which encodes PBP3, corresponding to 25 different mutation patterns that varied from the ftsI gene mutation patterns found in imipenem-susceptible isolates. Among all PBPs, the highest affinity to imipenem was documented for PBP3 (IC 50 , 0.004 \u03bcg/mL). Different amino acid substitutions and insertions were noted in OmpP2, suggesting a relationship with imipenem heteroresistance. The IMI hR isolates were affected by CCCP differently and displayed a higher percentage of killing by imipenem in CCCP-treated cells at concentrations ranging between 0.5 and 8 \u03bcg/mL. The present study provides robust evidence indicating that in combination with the altered PBP3, the slowed drug influx and its enhanced efflux due to the loss of regulation led to the development of imipenem heteroresistance in NTHi. Copyright \u00a9 2016 European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd. All rights reserved.\n[Assessing exposure risks for aquatic organisms posed by Tamiflu use under seasonal influenza and pandemic conditions](http://dx.doi.org/10.1016/j.envpol.2013.09.019) [International Nuclear Information System (INIS) ](http://inis.iaea.org/search/)\nChen, Wei-Yu; Lin, Chia-Jung; Liao, Chung-Min\n2014-01-01\nEnvironmental pollution by anti-influenza drugs is increasingly recognized as a threat to aquatic environments. However, little is known about empirical data on risk effects posed by environmentally relevant concentrations of anti-influenza drug based on recently published ecotoxicological researches in Taiwan. Here we linked ecotoxicology models with an epidemiological scheme to assess exposure risks of aquatic organisms and environmental hazards posed by antiviral oseltamivir (Tamiflu) use in Taiwan. Built on published bioassays, we used probabilistic risk assessment model to estimate potential threats of environmentally relevant hazards on algae, daphnid, and zerbrafish. We found that Tamiflu use was unlikely to pose a significant chronic environmental risk to daphnia and zebrafish during seasonal influenza. However, the chronic environmental risk posed by Tamiflu use during pandemic was alarming. We conclude that no significant risk to algal growth was found during seasonal influenza and high pandemic Tamiflu use. -- Highlights: \u2022 Environmentally relevant concentrations of anti-influenza drug have ecotoxicologically important effects. \u2022 Tamiflu is unlikely to pose a significant chronic environmental risk during seasonal influenza. \u2022 Chronic environmental risk posed by Tamiflu during pandemic is alarming. \u2022 Tertiary process in sewage treatment plants is crucial in mitigating Tamiflu exposure risk. -- A probabilistic framework can be used for assessing exposure risks posed by environmentally relevant concentrations of anti-influenza drug in aquatic ecosystems\n[Estudio de tolerancia local de la vacuna vax-TyVi\u00ae en ratas Sprague Dawley](http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1025-028X2005000100003&lng=es&nrm=iso&tlng=es) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nEligio Sosa Roble\n2005-05-01\nFull Text Available La vacuna antitifo\u00eddica vax-TyVi\u00ae consiste en una preparaci\u00f3n de polisac\u00e1rido capsular Vi de Salmonella typhi, el cual es diluido en una soluci\u00f3n buffer isot\u00f3nica soluci\u00f3n amortiguador, a la que se le a\u00f1ade fenol como preservo. Cada dosis de 0,5 mL contiene 25 \u03bcg de polisac\u00e1rido como sustancia activa. En nuestro pa\u00eds el esquema de vacunaci\u00f3n contra la fiebre tifoidea con vax- TyVi\u00ae se aplica a los alumnos de 9-10 a\u00f1os (5to grado, una 2da dosis a la edad de 12-13 a\u00f1os (8vo grado y una 3ra dosis a la edad de 16-17 a\u00f1os (11no grado. Adem\u00e1s, es vacunado el personal de riesgo de Salud P\u00fablica y el personal que manipula alimentos. En el presente trabajo se describe el ensayo de tolerancia local llevado a cabo con la vacuna vax-TyVi\u00ae durante su fase de estudios precl\u00ednicos, actualmente utilizada en la vacunaci\u00f3n contra la fiebre tifoidea en Cuba. Se emple\u00f3 un total de 170 ratas que fueron tratadas con la vacuna, su placebo (todos los componentes, excepto la materia prima activa, o que no recibieron tratamiento alguno (controles. Se realizaron observaciones cl\u00ednicas diarias durante todo el ensayo, se determin\u00f3 el consumo de agua y alimentos y se realizaron investigaciones anatomopatol\u00f3gicas a animales sacrificados 3, 7, 14, 21, 28, 35 y 42 d\u00edas despu\u00e9s de la inoculaci\u00f3n. No se observaron muertes ni s\u00edntomas de toxicidad; no se encontraron diferencias estad\u00edsticamente significativas entre los pesos vivos, el consumo de agua ni el de alimentos entre los grupos del ensayo. Tampoco se observaron lesiones anatomopatol\u00f3gicas que indicaran toxicidad por parte del producto inoculado. Los resultados permitieron concluir que la potencialidad de la vacuna vax-TyVi\u00ae para producir efectos adversos locales es baja.\n[Immunogenicity and safety of a fully liquid aluminum phosphate adjuvanted Haemophilus influenzae type b PRP-CRM197-conjugate vaccine in healthy Japanese children: A phase III, randomized, observer-blind, multicenter, parallel-group study.](https://www.ncbi.nlm.nih.gov/pubmed/27265451)\nTogashi, Takehiro; Mitsuya, Nodoka; Kogawara, Osamu; Sumino, Shuji; Takanami, Yohei; Sugizaki, Kayoko\n2016-08-31\nBroad use of monovalent Haemophilus influenzae type b (Hib) conjugate vaccines based on the capsular polysaccharide polyribosyl-ribitol phosphate (PRP), has significantly reduced invasive Hib disease burden in children worldwide, particularly in children aged vaccine has been widely used since the initiation of public funding programs followed by a routine vaccination designation in 2013. We compared the immunogenicity and safety of PRP conjugated to a non-toxic diphtheria toxin mutant (PRP-CRM197) vaccine with the PRP-T vaccine when administered subcutaneously to healthy Japanese children in a phase III study. Additionally, we evaluated the immunogenicity and safety profiles of a diphtheria-tetanus acellular pertussis (DTaP) combination vaccine when concomitantly administered with either PRP-CRM197 or PRP-T vaccines. The primary endpoint was the \"long-term seroprotection rate\", defined as the group proportion with anti-PRP antibody titers \u2a7e1.0\u03bcg/mL, after the primary series. Long-term seroprotection rates were 99.3% in the PRP-CRM197 group and 95.6% in the PRP-T group. The intergroup difference (PRP-CRM197 group - PRP-T group) was 3.7% (95% confidence interval: 0.099-7.336), demonstrating that PRP-CRM197 vaccine was non-inferior to PRP-T vaccine (pvaccination was higher in the PRP-CRM197 group than in PRP-T. Concomitant administration of PRP-CRM197 vaccine with DTaP vaccine showed no differences in terms of immunogenicity compared with concomitant vaccination with PRP-T vaccine and DTaP vaccine. Although CRM197 vaccine had higher local reactogenicity, overall, both Hib vaccines had acceptable safety and tolerability profiles. The immunogenicity of PRP-CRM197 vaccine administered subcutaneously as a three-dose primary series in children followed by a booster vaccination 1year after the primary series induced protective levels of Hib antibodies with no safety or tolerability concerns. Registered on ClinicalTrials.gov: NCT01379846. Copyright \u00a9 2016 The Authors\n[ESTRUCTURA MOLECULAR Y ANTIG\u00c9NICA DE LA VACUNA](https://revistas.unal.edu.co/index.php/actabiol/article/view/11338) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nV\u00cdCTOR ANDR\u00c9S VANEGAS\n2008-09-01\nFull Text Available La prote\u00edna L1 del Virus del Papiloma Humano (VPH constituye el 80% de la c\u00e1pside viral. Las vacunas profil\u00e1cticas contra el VPH son sintetizadas a partir de la prote\u00edna L1 ensamblada en Part\u00edculas similares al Virus (del ingl\u00e9s VLP, las cuales son altamente inmunog\u00e9nicas generando anticuerpos espec\u00edficos de tipo y en algunos casos pueden presentar reacci\u00f3n cruzada entre tipos de VPH filogen\u00e9ticamente pr\u00f3ximos. La estructura de la prote\u00edna L1 del VPH es importante porque confiere estabilidad a la c\u00e1pside mediante el establecimiento de interacciones intra e intercapsom\u00e9ricas lo que asegura la integridad viral y antig\u00e9nicamente porque contiene los ep\u00edtopes que inducen la respuesta inmune protectora. En estudios en los que se evalu\u00f3 la antigenicidad de la prote\u00edna L1 se determin\u00f3 que los ep\u00edtopes inmunodominantes de la c\u00e1pside viral se encuentran en los bucles B-C, D-E, F-G, H-I y en el extremo C-terminal. Estos bucles son poco conservados entre los diferentes genotipos y se encuentran en segmentos de la prote\u00edna expuestos en la superficie de la c\u00e1pside. Los amino\u00e1cidos situados en los bucles B-C, F-G y H-I son primordiales para el reconocimiento por los anticuerpos neutralizantes. Los diferentes subtipos y variantes presentan cambios en estos amino\u00e1cidos o en residuos que conforman otros ep\u00edtopes. En esta revisi\u00f3n se presentar\u00e1 un estado del arte de la prote\u00edna L1 del VPH genotipo 16, la estructura y su importancia en el desarrollo de vacunas contra la infecci\u00f3n producida por este virus.\n[Structure-based drug discovery for combating influenza virus by targeting the PA-PB1 interaction.](https://www.ncbi.nlm.nih.gov/pubmed/28842649)\nWatanabe, Ken; Ishikawa, Takeshi; Otaki, Hiroki; Mizuta, Satoshi; Hamada, Tsuyoshi; Nakagaki, Takehiro; Ishibashi, Daisuke; Urata, Shuzo; Yasuda, Jiro; Tanaka, Yoshimasa; Nishida, Noriyuki\n2017-08-25\nInfluenza virus infections are serious public health concerns throughout the world. The development of compounds with novel mechanisms of action is urgently required due to the emergence of viruses with resistance to the currently-approved anti-influenza viral drugs. We performed in silico screening using a structure-based drug discovery algorithm called Nagasaki University Docking Engine (NUDE), which is optimised for a GPU-based supercomputer (DEstination for Gpu Intensive MAchine; DEGIMA), by targeting influenza viral PA protein. The compounds selected by NUDE were tested for anti-influenza virus activity using a cell-based assay. The most potent compound, designated as PA-49, is a medium-sized quinolinone derivative bearing a tetrazole moiety, and it inhibited the replication of influenza virus A/WSN/33 at a half maximal inhibitory concentration of 0.47 \u03bcM. PA-49 has the ability to bind PA and its anti-influenza activity was promising against various influenza strains, including a clinical isolate of A(H1N1)pdm09 and type B viruses. The docking simulation suggested that PA-49 interrupts the PA-PB1 interface where important amino acids are mostly conserved in the virus strains tested, suggesting the strain independent utility. Because our NUDE/DEGIMA system is rapid and efficient, it may help effective drug discovery against the influenza virus and other emerging viruses.\n[Vacuna atenuada de Salmonella como vector de ant\u00edgenos heter\u00f3logos](http://www.revistabiomedica.org/index.php/biomedica/article/view/1056) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nOscar G. G\u00f3mez\n2000-06-01\nFull Text Available Salmonella enterica, serotipo Typhi, es el agente etiol\u00f3gico de la fiebre tifoidea de los habitantes de las regiones m\u00e1s pobres del mundo y es, adem\u00e1s. el centro de atenci\u00f3n de muchos investigadores dados sus fascinantes mecanismos de invasi\u00f3n, multiplicaci\u00f3n intracelular y diseminaci\u00f3n intercelular que expresa in vivo e in vitro. Aunque estos mecanismos se asocian directamente con la patogenicidad y la severidad de la enfermedad, las mutaciones definidas en el cromosoma de Salmonella han permitido que estos mecanismos de virulencia se puedan utilizar en beneficio del hospedero. Las mutantes atenuadas de Salmonella son capaces de invadir las c\u00e9lulas M de la mucosa intestinal y de migrar a las c\u00e9lulas linfoides del sistema reticuloendotelial donde, en lugar de causar enfermedad, activan eficazmente las respuestas inmunes humoral y celular no s\u00f3lo contra el microorganismo mismo sino tambi\u00e9n contra aquellos antigenos heter\u00f3logos recombinantes que la bacteria pueda expresar y transportar. En la presente revisi\u00f3n, se discutir\u00e1n los avances m\u00e1s recientes en el campo de las vacunas vivas atenuadas de Salmonella, su evaluaci\u00f3n preclinica y clinica y, tambi\u00e9n, su aplicaci\u00f3n como vector de antigenos. Se dar\u00e1n a conocer las t\u00e9cnicas biomoleculares de clonaci\u00f3n y expresi\u00f3n procari\u00f3tica de las toxinas dift\u00e9rica, tet\u00e1nica y de pertusis. as\u00ed como de los ant\u00edgenos de Helicobacterpylori y de Plasmodium falciparum. Finalmente, se propone el uso de Salmonella atenuada como vector de vacunas de ADN para expresi\u00f3n eucari\u00f3tica de los ant\u00edgenos recombinantes. Los continuos esfuerzos cientificos y tecnol\u00f3gicos en el campo de la vacunaci\u00f3n con vectores vivos atenuados sugieren que Salmonella es una herramienta potencialmente \u00fatil para enfrentar el constante reto de la fiebre tifoidea. Igualmente, los estudios precl\u00ednicos y cl\u00ednicos de fase I demuestran la eficacia de la vacuna de Salmonella viva atenuada como vector de ant\u00edgenos heter\n[Lactoferrin-derived Peptides Active towards Influenza: Identification of Three Potent Tetrapeptide Inhibitors.](https://www.ncbi.nlm.nih.gov/pubmed/28878220)\nScala, Maria Carmina; Sala, Marina; Pietrantoni, Agostina; Spensiero, Antonia; Di Micco, Simone; Agamennone, Mariangela; Bertamino, Alessia; Novellino, Ettore; Bifulco, Giuseppe; Gomez-Monterrey, Isabel M; Superti, Fabiana; Campiglia, Pietro\n2017-09-06\nBovine lactoferrin is a biglobular multifunctional iron binding glycoprotein that plays an important role in innate immunity against infections. We have previously demonstrated that selected peptides from bovine lactoferrin C-lobe are able to prevent both Influenza virus hemagglutination and cell infection. To deeper investigate the ability of lactoferrin derived peptides to inhibit Influenza virus infection, in this study we identified new bovine lactoferrin C-lobe derived sequences and corresponding synthetic peptides were synthesized and assayed to check their ability to prevent viral hemagglutination and infection. We identified three tetrapeptides endowed with broad anti-Influenza activity and able to inhibit viral infection in a concentration range femto- to picomolar. Our data indicate that these peptides may constitute a non-toxic tool for potential applications as anti-Influenza therapeutics.\n[Immunoglobulin gene usage in the human anti-pathogen response.](https://www.ncbi.nlm.nih.gov/pubmed/8548193)\nNewkirk, M M; Rioux, J D\n1995-09-01\nThe human antibody response to foreign pathogens is generated to a relatively small number of target surface proteins and carbohydrates that nonetheless have an extensive array of epitopes. The study of human monoclonal antibodies to different pathogens shows that there are a diversity of mechanisms used to generate a sufficient repertoire of antibodies to combat the invading pathogens. Although many different immunoglobulin gene elements are used to construct the anti-pathogen response, some elements are used more often than would be expected if all elements were used randomly. For example, the immune response to Haemophilus influenzae polysaccharide appears to be quite narrow, being restricted primarily to a specific heavy-chain gene, 3-15, and a lambda light-chain family II member, 4A. In contrast, for the immune response to cytomegalovirus proteins, a wider group of gene elements is needed. It is also surprising that despite an investigator bias for IgG- rather than IgM-secreting immortal B cells (because of their high affinity and neutralizing abilities), 26% of light chains and 13% of heavy chains showed a very low level of somatic mutation, equivalent to an IgM molecule that has not undergone affinity maturation. Although some highly mutated IgG molecules are present in the anti-pathogen response, most of the monoclonal antibodies specific for viruses or bacteria have a level of somatic hypermutation similar to that of the adult IgM repertoire. A number of studies have shown that there are similarities in the antibody responses to pathogens and to self (autoantibodies).(ABSTRACT TRUNCATED AT 250 WORDS)\n[Changes in IgA protease expression are conferred by changes in genomes during persistent infection by nontypeable Haemophilus influenzae in chronic obstructive pulmonary disease.](https://www.ncbi.nlm.nih.gov/pubmed/29760213)\nGallo, Mary C; Kirkham, Charmaine; Eng, Samantha; Bebawee, Remon S; Kong, Yong; Pettigrew, Melinda M; Tettelin, Herv\u00e9; Murphy, Timothy F\n2018-05-14\nNontypeable Haemophilus influenzae (NTHi) is an exclusively human pathobiont that plays a critical role in the course and pathogenesis of chronic obstructive pulmonary disease (COPD). NTHi causes acute exacerbations of COPD and also causes persistent infection of the lower airways. NTHi expresses four IgA protease variants (A1, A2, B1, and B2) that play different roles in virulence. Expression of IgA proteases varies among NTHi strains, but little is known about the frequency and mechanisms by which NTHi modulates IgA protease expression during infection in COPD. To assess expression of IgA protease during natural infection in COPD, we studied IgA protease expression of 101 persistent strains (median duration of persistence 161 days, range 2 to 1422) collected longitudinally from patients enrolled in a 20-year study of COPD upon initial acquisition and immediately before clearance from the host. Upon acquisition, 89 (88%) expressed IgA protease. A total of 16 of 101 (16%) strains of NTHi altered expression of IgA protease during persistence. Indels and slipped-strand mispairing of mononucleotide repeats conferred changes in expression of igaA1, igaA2, and igaB1 Strains with igaB2 underwent frequent changes in expression of IgA protease B2 during persistence, mediated by slipped-strand mispairing of a 7-nucleotide repeat, TCAAAAT, within the open reading frame of igaB2 We conclude that changes in iga gene sequences result in changes in expression of IgA proteases by NTHi during persistent infection in the respiratory tract of patients with COPD. Copyright \u00a9 2018 American Society for Microbiology.\n[The Annexin A1 Receptor FPR2 Regulates the Endosomal Export of Influenza Virus](http://www.mdpi.com/1422-0067/19/5/1400) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nFryad Rahman\n2018-05-01\nFull Text Available The Formyl Peptide Receptor 2 (FPR2 is a novel promising target for the treatment of influenza. During viral infection, FPR2 is activated by annexinA1, which is present in the envelope of influenza viruses; this activation promotes virus replication. Here, we investigated whether blockage of FPR2 would affect the genome trafficking of influenza virus. We found that, upon infection and cell treatment with the specific FPR2 antagonist WRW4 or the anti-FPR2 monoclonal antibody, FN-1D6-AI, influenza viruses were blocked into endosomes. This effect was independent on the strain and was observed for H1N1 and H3N2 viruses. In addition, blocking FPR2signaling in alveolar lung A549 epithelial cells with the monoclonal anti-FPR2 antibody significantly inhibited virus replication. Altogether, these results show that FPR2signaling interferes with the endosomal trafficking of influenza viruses and provides, for the first time, the proof of concept that monoclonal antibodies directed against FPR2 inhibit virus replication. Antibodies-based therapeutics have emerged as attractive reagents in infectious diseases. Thus, this study suggests that the use of anti-FPR2 antibodies against influenza hold great promise for the future.\n[Synergistic effect of interleukin 1 alpha on nontypeable Haemophilus influenzae-induced up-regulation of human beta-defensin 2 in middle ear epithelial cells](http://www.biomedcentral.com/1471-2334/6/12) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nPark Raekil\n2006-01-01\nFull Text Available Abstract Background We recently showed that beta-defensins have antimicrobial activity against nontypeable Haemophilus influenzae (NTHi and that interleukin 1 alpha (IL-1 alpha up-regulates the transcription of beta-defensin 2 (DEFB4 according to new nomenclature of the Human Genome Organization in human middle ear epithelial cells via a Src-dependent Raf-MEK1/2-ERK signaling pathway. Based on these observations, we investigated if human middle ear epithelial cells could release IL-1 alpha upon exposure to a lysate of NTHi and if this cytokine could have a synergistic effect on beta-defensin 2 up-regulation by the bacterial components. Methods The studies described herein were carried out using epithelial cell lines as well as a murine model of acute otitis media (OM. Human cytokine macroarray analysis was performed to detect the released cytokines in response to NTHi exposure. Real time quantitative PCR was done to compare the induction of IL-1 alpha or beta-defensin 2 mRNAs and to identify the signaling pathways involved. Direct activation of the beta-defensin 2 promoter was monitored using a beta-defensin 2 promoter-Luciferase construct. An IL-1 alpha blocking antibody was used to demonstrate the direct involvement of this cytokine on DEFB4 induction. Results Middle ear epithelial cells released IL-1 alpha when stimulated by NTHi components and this cytokine acted in an autocrine/paracrine synergistic manner with NTHi to up-regulate beta-defensin 2. This synergistic effect of IL-1 alpha on NTHi-induced beta-defensin 2 up-regulation appeared to be mediated by the p38 MAP kinase pathway. Conclusion We demonstrate that IL-1 alpha is secreted by middle ear epithelial cells upon exposure to NTHi components and that it can synergistically act with certain of these molecules to up-regulate beta-defensin 2 via the p38 MAP kinase pathway.\n[Lifescience Database Archive (English)](http://biosciencedbc.jp/dbsearch/index.php?lang=en)\nFull Text Available H01330 Brazilian purpuric fever (BPF) Brazilian purpuric fever (BPF), which is cau...on of Haemophilus influenzae biogroup aegyptius (Haemophilus aegyptius) strains associated with Brazil\n[Evaluaci\u00f3n de los programas de vacunaci\u00f3n mediante estudios serol\u00f3gicos y vacunas distribuidas Evaluation of vaccination programs through serological studies and distributed vaccines](http://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S0213-91112005000600006) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nPedro Plans\n2005-12-01\nFull Text Available Antecedentes: El objetivo del estudio fue comparar las coberturas vacunales en escolares para la vacuna triple v\u00edrica (sarampi\u00f3n-rub\u00e9ola-parotiditis, DTP (difteria-t\u00e9tanos-tos ferina y poliomielitis, obtenidas a partir de las vacunas distribuidas a los centros de vacunaci\u00f3n, las vacunaciones declaradas y el an\u00e1lisis serol\u00f3gico de anticuerpos. M\u00e9todos: La cobertura vacunal se obtuvo a partir de los antecedentes de vacunaci\u00f3n recogidos en un cuestionario y mediante el an\u00e1lisis serol\u00f3gico de anticuerpos frente al sarampi\u00f3n para la vacuna triple v\u00edrica, y el t\u00e9tanos para la vacuna DTP en una muestra representativa de escolares en 2001. La cobertura vacunal por registros se obtuvo dividiendo el n\u00famero de individuos que pod\u00edan haber completado la vacunaci\u00f3n por la poblaci\u00f3n objetivo. Se evalu\u00f3 la concordancia entre los antecedentes de vacunaci\u00f3n y los resultados serol\u00f3gicos mediante el \u00edndice kappa. Resultados: En los escolares de 6-8 y 9-11 a\u00f1os de edad se obtuvo una cobertura vacunal por cuestionario del 85,5 y el 87,6% para la vacuna DTP, del 89,9 y el 89,6% para la vacuna triple v\u00edrica, y del 90,4 y el 89,4% para la vacuna poliomiel\u00edtica, respectivamente, mientras la cobertura vacunal por an\u00e1lisis serol\u00f3gico fue del 100 y el 99,6% para la vacuna DTP, y del 85,5 y el 93,3% para la vacuna triple v\u00edrica, respectivamente. La cobertura vacunal por registros fue significativamente mayor que la obtenida mediante estos 2 m\u00e9todos: un 93,5 y un 100% para la vacuna DTP, un 96,3 y un 98,8% para la vacuna triple v\u00edrica, y un 100% para la vacuna poliomiel\u00edtica. La concordancia obtenida entre los antecedentes de vacunaci\u00f3n y los resultados serol\u00f3gicos fue muy baja (\u03ba Background: The objective of this study was to compare vaccination coverage in schoolchildren for the measles-mumps-rubella (MMR and diphtheria-tetanus-pertussis (DTP triple vaccines, and the poliomyelitis vaccine based on: a vaccines distributed to vaccination\n[Desarrollo de vacunas contra el virus de la inmunodeficiencia humana tipo 1: Relevancia de la inmunidad celular contra subtipos](http://www.scielo.org.ar/scielo.php?script=sci_arttext&pid=S0025-76802010000600014&lng=en&tlng=en) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nAna Mar\u00eda Rodr\u00edguez\n2010-12-01\nFull Text Available Han pasado casi 30 a\u00f1os de la detecci\u00f3n de los primeros casos de infecci\u00f3n con HIV-1 y a\u00fan no se ha conseguido desarrollar una vacuna efectiva y segura. A pesar del impacto positivo sobre la pandemia que se ha conseguido gracias a los avances en la terapia antirretroviral (TARV, el HIV/sida sigue constituyendo un grave problema para la salud p\u00fablica, especialmente en los pa\u00edses en desarrollo, donde es dif\u00edcil el acceso al tratamiento. En el mundo, 33 millones de personas viven con el virus del sida, mientras que en la Argentina se calcula que habr\u00eda unos 120 000 infectados. Uno de los desaf\u00edos para lograr una vacuna contra el HIV es la variabilidad viral. El grupo M, responsable de la pandemia, se encuentra dividido en 10 subtipos y varios sub-subtipos, adem\u00e1s de las 48 formas recombinantes circulantes y m\u00e1s de cien formas recombinantes \u00fanicas. La epidemia de HIV en nuestro pa\u00eds es tan compleja como en el resto del mundo, con la co-circulaci\u00f3n principalmente de virus pertenecientes al subtipo B y recombinantes BF (CRF12_BF y derivadas. A pesar de la cantidad de trabajos dedicados a la caracterizaci\u00f3n de la respuesta inmune y al desarrollo de vacunas, no queda claro cu\u00e1l es el impacto de la variabilidad en la elecci\u00f3n del ant\u00edgeno. Trabajos realizados en nuestro laboratorio demuestran el papel que juega la inmunidad celular con respecto a las variantes recombinantes BF, tanto en humanos como en modelos animales. Estos resultados son de importancia en el desarrollo de futuras vacunas para nuestra regi\u00f3n.\n[Evaluaci\u00f3n de la toxicidad por dosis \u00fanica de la vacuna antitet\u00e1nica vax-TET en ratas Sprague Dawley](http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1025-028X2007000300004&lng=es&nrm=iso&tlng=es) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nYulie\u00e9 L\u00f3pez.\n2007-12-01\nFull Text Available La vacuna vax-TET\u00ae est\u00e1 indicada en la prevenci\u00f3n del t\u00e9tanos y es efectiva si se logra un completo y apropiado esquema de inmunizaci\u00f3n. Para investigar el potencial t\u00f3xico de este producto se realiz\u00f3 una prueba toxicol\u00f3gica con una dosis \u00fanica, por v\u00eda intramuscular, en un volumen de 0,2 mL en ratas Sprague Dawley. La composici\u00f3n de la vacuna de ensayo probada fue la misma de la vacuna comercial. Los animales fueron observados diariamente en busca de s\u00edntomas locales y sist\u00e9micos de toxicidad. Se realizaron mediciones del consumo de agua y alimento, as\u00ed como del peso corporal. Dos semanas despu\u00e9s de la inoculaci\u00f3n las ratas fueron sacrificadas por m\u00e9todos de eutanasia sin dolor y sometidas a necropsia. No se observaron muertes ni s\u00edntomas de toxicidad en los animales estudiados. Tampoco se encontraron diferencias de inter\u00e9s toxicol\u00f3gico entre los grupos experimentales en cuanto a las variables medidas. El estudio anatomopatol\u00f3gico revel\u00f3 la presencia de formaciones granulomatosas de tipo macrof\u00e1gico asociadas, fundamentalmente, al hidr\u00f3xido de aluminio. Estos resultados permitieron concluir que, bajo las condiciones del estudio y seg\u00fan los criterios establecidos, esta vacuna no produce efectos adversos en el modelo animal usado, por lo que se considera potencialmente no t\u00f3xica para humanos.\n[Pneumonia Prevention during a Humanitarian Emergency: Cost-effectiveness of Haemophilus Influenzae Type B Conjugate Vaccine and Pneumococcal Conjugate Vaccine in Somalia.](https://www.ncbi.nlm.nih.gov/pubmed/26061190)\nGargano, Lisa M; Hajjeh, Rana; Cookson, Susan T\n2015-08-01\nPneumonia is a leading cause of death among children less than five years old during humanitarian emergencies. Haemophilus influenzae type b (Hib) and Streptococcus pneumoniae are the leading causes of bacterial pneumonia. Vaccines for both of these pathogens are available to prevent pneumonia. Problem This study describes an economic analysis from a publicly funded health care system perspective performed on a birth cohort in Somalia, a country that has experienced a protracted humanitarian emergency. An impact and cost-effectiveness analysis was performed comparing: no vaccine, Hib vaccine only, pneumococcal conjugate vaccine 10 (PCV10) only, and both together administered through supplemental immunization activities (SIAs). The main summary measure was the incremental cost per disability-adjusted life-years (DALYs) averted. One-way sensitivity analysis was conducted for uncertainty in parameter values. Each SIA would avert a substantial number of cases and deaths. Compared with no vaccine, the DALYs averted by two SIAs for two doses of Hib vaccine was US $202.93 (lower and upper limits: $121.80-$623.52), two doses of PCV10 was US $161.51 ($107.24-$227.21), and two doses of both vaccines was US $152.42 ($101.20-$214.42). Variables that influenced the cost-effectiveness for each strategy most substantially were vaccine effectiveness, case fatality rates (CFRs), and disease burden. The World Health Organization (WHO) defines a cost-effective intervention as costing one to three times the per capita gross domestic product (GDP; in 2011, for Somalia=US $112). Based on the presented model, Hib vaccine alone, PCV10 alone, or Hib vaccine and PCV10 given together in SIAs are cost-effective interventions in Somalia. The WHO/Strategic Advisory Group of Experts decision-making factors for vaccine deployment appear to have all been met: the disease burden is large, the vaccine-related risk is low, prevention in this setting is more feasible than treatment, the vaccine\n[Predictors of administration and attitudes about pneumococcal, Haemophilus influenzae type b and rotavirus vaccines among pediatricians in India: a national survey.](https://www.ncbi.nlm.nih.gov/pubmed/22475859)\nGargano, Lisa M; Thacker, Naveen; Choudhury, Panna; Weiss, Paul S; Pazol, Karen; Bahl, Sunil; Jafari, Hamid S; Arora, Manisha; Orenstein, Walter A; Hughes, James M; Omer, Saad B\n2012-05-21\nAccording to the World Health Organization in 2008, pneumonia accounted for 20% of deaths and diarrheal diseases accounted for 13% of deaths among children under 5 in India. Vaccines are available for Streptococcus pneumoniae (pneumococcal conjugate vaccine (PCV)), Haemophilus influenzae type b (Hib vaccine), and rotavirus. Barriers to including these vaccines in routine immunization schedule in India include potential negative impacts on fragile existing immunization programs and cost. Pediatricians who are members of the Indian Academy of Pediatrics (IAP) are important stakeholders for vaccine delivery and maintaining public confidence in vaccines. A random sample of 785 pediatricians belonging to IAP was selected for the survey conducted from June 2009 to June 2010. Descriptive analyses using sampling weights were performed to evaluate the distributions of variables assessing vaccine-related attitudes and behaviors among pediatricians. Logistic regression was used to assess factors associated with routine vaccine use. The majority of pediatricians reported administering PCV (85.6%), Hib (95.9%), and rotavirus (80.2%) vaccine selectively or routinely. Pediatricians who had high perceived disease susceptibility were 2.42 times more likely to report routine administration of Hib vaccine (OR 2.42, 95% CI 1.24, 4.74). Pediatricians who had high perceived Hib vaccine efficacy were 4.74 times more likely to administer Hib vaccine routinely (OR 4.74, 95% CI 2.09, 10.74). Perceptions of disease susceptibility and severity or of vaccine safety and efficacy were not associated with routine administration of PCV or rotavirus vaccine. Understanding predictors of routine use of a new vaccine could help focus interventions to improve the routine use of other vaccines. The importance of perceived susceptibility to and severity of diseases caused by S. pneumoniae, Hib, and rotavirus and perceived efficacy and safety of the vaccines by pediatricians presents an opportunity to\n[Xanthones from Polygala karensium inhibit neuraminidases from influenza A viruses](http://www.forskningsdatabasen.dk/en/catalog/226876727) [DEFF Research Database (Denmark)](http://forskningsbasen.deff.dk/?lang=eng)\nDao, Trong Tuan; Dang, Thai Trung; Nguyen, Phi Hung\n2012-01-01\nThe emergence of the H1N1 swine flu pandemic has the possibility to develop the occurrence of disaster- or drug-resistant viruses by additional reassortments in novel influenza A virus. In the course of an anti-influenza screening program for natural products, 10 xanthone derivatives (1-10) were ...\n[Desarrollo de un m\u00e9todo de CLAR-IR para la determinaci\u00f3n de etanol residual en vacuna Development of a HPLC-IR method for determination of residual ethanol in vaccine](http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S0034-75152009000200004) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nMatilde Cuevas Valdespino\n2009-08-01\nFull Text Available Los ingredientes farmac\u00e9uticos activos de la vacuna antimeningoc\u00f3cica cubana VA-MENGOC-BC TM (ves\u00edculas de membrana externa purificadas de Neisseria meningitidis, serogrupo B y polisac\u00e1rido capsular purificado de Neisseria meningitidis, serogrupo C son conservados en etanol, de ah\u00ed que dicha vacuna posea un contenido de etanol residual, cuya concentraci\u00f3n real no se conoc\u00eda hasta el momento. Las regulaciones internacionales plantean que los productos biofarmac\u00e9uticos y sus ingredientes farmac\u00e9uticos activos deben tener bien caracterizadas todas sus impurezas, por lo que el objetivo de este trabajo fue el desarrollo de un m\u00e9todo de determinaci\u00f3n de etanol mediante cromatograf\u00eda l\u00edquida de alta resoluci\u00f3n-\u00edndice de refracci\u00f3n para estos fines y su comparaci\u00f3n con un m\u00e9todo utilizado frecuentemente para cuantificar este solvente, como es la cromatograf\u00eda gaseosa. El m\u00e9todo evaluado result\u00f3 ser \u00fatil y con una buena robustez para la determinaci\u00f3n de este solvente org\u00e1nico en esta vacuna antimenigoc\u00f3cica. No se detectaron diferencias estad\u00edsticamente significativas entre los resultados obtenidos al evaluar las mismas muestras de vacuna mediante ambos m\u00e9todos cromatogr\u00e1ficos (cromatograf\u00eda l\u00edquida de alta resoluci\u00f3n y cromatograf\u00eda gaseosa, lo que indica la posibilidad del uso de la cromatograf\u00eda l\u00edquida de alta resoluci\u00f3n en sustituci\u00f3n de la cromatograf\u00eda gaseosa para esta determinaci\u00f3n.Active pharmaceutical ingredients of Cuban anti-meningococcal vaccine VA-MENGOC-BC TM (vesicles of purified external membranes of Neisseria meningitidis, B serum-group, and purified capsular polysaccharide of Neisseria meningitidis, serum-group C are stored in ethanol, thus that such vaccine has residual ethanol content, of which real concentration is not known just now. International regulations propose that the biopharmaceutical products and its active pharmaceutical ingredients must to have well defined all impurities, thus\n[Investigation of genome sequences within the family Pasteurellaceae](http://www.forskningsdatabasen.dk/en/catalog/2389430098) [DEFF Research Database (Denmark)](http://forskningsbasen.deff.dk/?lang=eng)\nAngen, \u00d8ystein; Ussery, David\nIntroduction The bacterial genome sequences are now available for an increasing number of strains within the family Pasteurellaceae. At present, 24 Pasteurellaceae genomes are publicly available through internet databases, and another 40 genomes are being sequenced. This investigation will describe...... the core genome for both the family Pasteurellaceae and for the species Haemophilus influenzae. Methods Twenty genome sequences from the following species were included: Haemophilus influenzae (11 strains), Haemophilus ducreyi (1 strain), Histophilus somni (2 strains), Haemophilus parasuis (1 strain......), Actinobacillus pleuropneumoniae (2 strains), Actinobacillus succinogenes (1 strain), Mannheimia succiniciproducens (1 strain), and Pasteurella multocida (1 strain). The predicted proteins for each genome were BLASTed against each other, and a set of conserved core gene families was determined as described...\n[Anti-phase synchronization of influenza A/H1N1 and A/H3N2 in Hong Kong and countries in the North Temperate Zone](http://www.sciencedirect.com/science/article/pii/S1201971217302886) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nAlice P.Y. Chiu\n2018-01-01\nConclusions: These results are novel in identifying anti-phase synchronization in influenza A subtypes in Hong Kong and the NTZ. These findings should inform public health preparedness for future epidemics of A/H3N2, which are typically more severe than those of A/H1N1.\n[Antimicrobial activity of innate immune molecules against Streptococcus pneumoniae, Moraxella catarrhalis and nontypeable Haemophilus influenzae](http://www.biomedcentral.com/1471-2334/4/12) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nTeufert Karen\n2004-05-01\nFull Text Available Abstract Background Despite its direct connection to the nasopharynx which harbors otitis media pathogens as part of its normal flora, the middle ear cavity is kept free of these bacteria by as yet unknown mechanisms. Respiratory mucosal epithelia, including those of the middle ear and eustachian tube, secrete antimicrobial effectors including lysozyme, lactoferrin and \u03b2 defensins-1 and -2. To elucidate the role of these innate immune molecules in the normal defense and maintenance of sterility of respiratory mucosa such as that of the middle ear, we assessed their effect on the respiratory pathogens nontypeable Haemophilus influenzae (NTHi 12, Moraxella catarrhalis 035E, and Streptococcus pneumoniae 3, and 6B. Methods Two assay methods, the radial assay and the liquid broth assay, were employed for testing the antimicrobial activity of the molecules. This was done in order to minimize the possibility that the observed effects were artifacts of any single assay system employed. Also, transmission electron microscopy (TEM was employed to evaluate the effect of antimicrobial innate immune molecules on OM pathogens. For the statistical analysis of the data, Student's t-test was performed. Results Results of the radial diffusion assay showed that \u03b2 defensin-2 was active against all four OM pathogens tested, while treatment with \u03b2 defensin-1 appeared to only affect M. catarrhalis. The radial assay results also showed that lysozyme was quite effective against S. pneumoniae 3 and 6B and was partially bacteriostatic/bactericidal against M. catarrhalis. Lysozyme however, appeared not to affect the growth of NTHi. Thus, lysozyme seems to have a more pronounced impact on the growth of the Gram-positive S. pneumoniae as compared to that of Gram-negative pathogens. Lactoferrin on the other hand, enhanced the growth of the bacteria tested. The results of the radial assays were confirmed using liquid broth assays for antimicrobial activity, and showed that\n[Serums and vaccines to fight the 1918-1919 influenza pandemic in Spain](http://asclepio.revistas.csic.es/index.php/asclepio/article/view/266/263) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nPorras Gallo, Mar\u00eda Isabel\n2008-12-01\nFull Text Available Against the background of the renewed interest aroused in recent years by the influenza pandemic of 1918-1919, and the leading role now played by research analysing the process of innovation in medicine, this paper assesses the role played by serums and vaccines \u2014the new resources of the medical science of the time\u2014 in the fight against the influenza outbreak of 1918-1919. The paper highlights the dependence on combined scientific, social, economic and professional factors, and also shows the main consequences arising from the fine-tuning and implementation of these therapeutic and prophylactic resources.\nEn el marco de la renovada actualidad alcanzada por la pandemia de gripe de 1918-1919 en los \u00faltimos a\u00f1os y del protagonismo logrado por los estudios que analizan el proceso de innovaci\u00f3n en Medicina, el presente trabajo analiza el papel representado por sueros y vacunas \u2014los nuevos recursos de la ciencia m\u00e9dica del momento\u2014 en la lucha contra la gripe de 1918-1919. El estudio pone de relieve su dependencia de los factores cient\u00edficos, sociales, econ\u00f3micos y profesionales que concurrieron, y muestra tambi\u00e9n las principales consecuencias derivadas de la puesta a punto y uso de los citados recursos terap\u00e9uticos y profil\u00e1cticos.\n[Budget impact analysis of vaccination against Haemophilus influenzae type b as a part of a Pentavalent vaccine in the childhood immunization schedule of Iran.](https://www.ncbi.nlm.nih.gov/pubmed/28088246)\nTeimouri, Fatemeh; Kebriaeezadeh, Abbas; Zahraei, Seyed Mohsen; Gheiratian, MohammadMahdi; Nikfar, Shekoufeh\n2017-01-14\nHealth decision makers need to know the impact of the development of a new intervention on the public health and health care costs so that they can plan for economic and financial objectives. The aim of this study was to determine the budget impact of adding Haemophilus influenzae type b (Hib) as a part of a Pentavalent vaccine (Hib-HBV-DTP) to the national childhood immunization schedule of Iran. An excel-based model was developed to determine the costs of including the Pentavalent vaccine in the national immunization program (NIP), comparing the present schedule with the previous one (including separate DTP and hepatitis B vaccines). The total annual costs included the cost of vaccination (the vaccine and syringe) and the cost of Hib treatment. The health outcome was the estimated annual cases of the diseases. The net budget impact was the difference in the total annual cost between the two schedules. Uncertainty about the vaccine effectiveness, vaccination coverage, cost of the vaccine, and cost of the diseases were handled through scenario analysis. The total cost of vaccination during 5 years was $18,060,463 in the previous program and $67,774,786 in the present program. Inclusion of the Pentavalent vaccine would increase the vaccination cost about $49 million, but would save approximately $6 million in the healthcare costs due to reduction of disease cases and treatment costs. The introduction of the Pentavalent vaccine resulted in a net increase in the healthcare budget expenditure across all scenarios from $43.4 million to $50.7 million. The results of this study showed that the inclusion of the Pentavalent vaccine in the NIP of Iran had a significant impact on the health care budget and increased the financial burden on the government. Budget impact of including Pentavalent vaccine in the national immunization schedule of Iran\u115f.\n[Memory B cells and CD8\u207a lymphocytes do not control seasonal influenza A virus replication after homologous re-challenge of rhesus macaques.](http://europepmc.org/articles/PMC3126839?pdf=render) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nTimothy D Carroll\nFull Text Available This study sought to define the role of memory lymphocytes in the protection from homologous influenza A virus re-challenge in rhesus macaques. Depleting monoclonal antibodies (mAb were administered to the animals prior to their second experimental inoculation with a human seasonal influenza A virus strain. Treatment with either anti-CD8\u03b1 or anti-CD20 mAbs prior to re-challenge had minimal effect on influenza A virus replication. Thus, in non-human primates with pre-existing anti-influenza A antibodies, memory B cells and CD8\u03b1\u207a T cells do not contribute to the control of virus replication after re-challenge with a homologous strain of influenza A virus.\n[CD206+ Cell Number Differentiates Influenza A (H1N1pdm09 from Seasonal Influenza A Virus in Fatal Cases](http://dx.doi.org/10.1155/2014/921054) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nHeidi G. Rodriguez-Ramirez\n2014-01-01\nFull Text Available In 2009, a new influenza A (H1N1 virus affected many persons around the world. There is an urgent need for finding biomarkers to distinguish between influenza A (H1N1pdm09 and seasonal influenza virus. We investigated these possible biomarkers in the lung of fatal cases of confirmed influenza A (H1N1pdm09. Cytokines (inflammatory and anti-inflammatory and cellular markers (macrophages and lymphocytes subpopulation markers were analyzed in lung tissue from both influenza A (H1N1pdm09 and seasonal influenza virus. High levels of IL-17, IFN-\u03b3, and TNF-\u03b1 positive cells were identical in lung tissue from the influenza A (H1N1pdm09 and seasonal cases when compared with healthy lung tissue (P<0.05. Increased IL-4+ cells, and CD4+ and CD14+ cells were also found in high levels in both influenza A (H1N1pdm09 and seasonal influenza virus (P<0.05. Low levels of CD206+ cells (marker of alternatively activated macrophages marker in lung were found in influenza A (H1N1pdm09 when compared with seasonal influenza virus (P<0.05, and the ratio of CD206/CD14+ cells was 2.5-fold higher in seasonal and noninfluenza group compared with influenza A (H1N1pdm09 (P<0.05. In conclusion, CD206+ cells differentiate between influenza A (H1N1pdm09 and seasonal influenza virus in lung tissue of fatal cases.\n[Virulence phenotypes of low-passage clinical isolates of Nontypeable Haemophilus influenzae assessed using the chinchilla laniger model of otitis media](http://www.biomedcentral.com/1471-2180/7/56) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nHogg Justin\n2007-06-01\nFull Text Available Abstract Background The nontypeable Haemophilus influenzae (NTHi are associated with a spectrum of respiratory mucosal infections including: acute otitis media (AOM; chronic otitis media with effusion (COME; otorrhea; locally invasive diseases such as mastoiditis; as well as a range of systemic disease states, suggesting a wide range of virulence phenotypes. Genomic studies have demonstrated that each clinical strain contains a unique genic distribution from a population-based supragenome, the distributed genome hypothesis. These diverse clinical and genotypic findings suggest that each NTHi strain possesses a unique set of virulence factors that contributes to the course of the disease. Results The local and systemic virulence patterns of ten genomically characterized low-passage clinical NTHi strains (PittAA \u2013 PittJJ obtained from children with COME or otorrhea were stratified using the chinchilla model of otitis media (OM. Each isolate was used to bilaterally inoculate six animals and thereafter clinical assessments were carried out daily for 8 days by blinded observers. There was no statistical difference in the time it took for any of the 10 NTHi strains to induce otologic (local disease with respect to any or all of the other strains, however the differences in time to maximal local disease and the severity of local disease were both significant between the strains. Parameters of systemic disease indicated that the strains were not all equivalent: time to development of the systemic disease, maximal systemic scores and mortality were all statistically different among the strains. PittGG induced 100% mortality while PittBB, PittCC, and PittEE produced no mortality. Overall Pitt GG, PittII, and Pitt FF produced the most rapid and most severe local and systemic disease. A post hoc determination of the clinical origins of the 10 NTHi strains revealed that these three strains were of otorrheic origin, whereas the other 7 were from patients\n[Universal antibodies against the highly conserved influenza fusion peptide cross-neutralize several subtypes of influenza A virus](http://www.etde.org/etdeweb/details.jsp?query_id=1&page=0&osti_id=22204709) [Energy Technology Data Exchange (ETDEWEB)](https://www.etde.org/etdeweb/fieldedsearch.jsp)\nHashem, Anwar M. [Centre for Vaccine Evaluation, Biologics and Genetic Therapies Directorate, HPFB, Health Canada, Ottawa, ON (Canada); Department of Microbiology, Faculty of Medicine, King Abdulaziz University, Jeddah (Saudi Arabia); Department of Biochemistry, Microbiology and Immunology, University of Ottawa, Ottawa, ON (Canada); Van Domselaar, Gary [National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, MB (Canada); Li, Changgui; Wang, Junzhi [National Institute for the Control of Pharmaceutical and Biological Products, Beijing (China); She, Yi-Min; Cyr, Terry D. [Centre for Vaccine Evaluation, Biologics and Genetic Therapies Directorate, HPFB, Health Canada, Ottawa, ON (Canada); Sui, Jianhua [Department of Cancer Immunology and AIDS, Dana-Farber Cancer Institute, Department of Medicine, Harvard Medical School, 44 Binney Street, Boston, MA 02115 (United States); He, Runtao [National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, MB (Canada); Marasco, Wayne A. [Department of Cancer Immunology and AIDS, Dana-Farber Cancer Institute, Department of Medicine, Harvard Medical School, 44 Binney Street, Boston, MA 02115 (United States); Li, Xuguang, E-mail: Sean.Li@hc-sc.gc.ca [Centre for Vaccine Evaluation, Biologics and Genetic Therapies Directorate, HPFB, Health Canada, Ottawa, ON (Canada); Department of Biochemistry, Microbiology and Immunology, University of Ottawa, Ottawa, ON (Canada)\n2010-12-10\nResearch highlights: {yields} The fusion peptide is the only universally conserved epitope in all influenza viral hemagglutinins. {yields} Anti-fusion peptide antibodies are universal antibodies that cross-react with all influenza HA subtypes. {yields} The universal antibodies cross-neutralize different influenza A subtypes. {yields} The universal antibodies inhibit the fusion process between the viruses and the target cells. -- Abstract: The fusion peptide of influenza viral hemagglutinin plays a critical role in virus entry by facilitating membrane fusion between the virus and target cells. As the fusion peptide is the only universally conserved epitope in all influenza A and B viruses, it could be an attractive target for vaccine-induced immune responses. We previously reported that antibodies targeting the first 14 amino acids of the N-terminus of the fusion peptide could bind to virtually all influenza virus strains and quantify hemagglutinins in vaccines produced in embryonated eggs. Here we demonstrate that these universal antibodies bind to the viral hemagglutinins in native conformation presented in infected mammalian cell cultures and neutralize multiple subtypes of virus by inhibiting the pH-dependant fusion of viral and cellular membranes. These results suggest that this unique, highly-conserved linear sequence in viral hemagglutinin is exposed sufficiently to be attacked by the antibodies during the course of infection and merits further investigation because of potential importance in the protection against diverse strains of influenza viruses.\n[Universal antibodies against the highly conserved influenza fusion peptide cross-neutralize several subtypes of influenza A virus](http://dx.doi.org/10.1016/j.bbrc.2010.11.030) [International Nuclear Information System (INIS) ](http://inis.iaea.org/search/)\nHashem, Anwar M.; Van Domselaar, Gary; Li, Changgui; Wang, Junzhi; She, Yi-Min; Cyr, Terry D.; Sui, Jianhua; He, Runtao; Marasco, Wayne A.; Li, Xuguang\n2010-01-01\nResearch highlights: \u2192 The fusion peptide is the only universally conserved epitope in all influenza viral hemagglutinins. \u2192 Anti-fusion peptide antibodies are universal antibodies that cross-react with all influenza HA subtypes. \u2192 The universal antibodies cross-neutralize different influenza A subtypes. \u2192 The universal antibodies inhibit the fusion process between the viruses and the target cells. -- Abstract: The fusion peptide of influenza viral hemagglutinin plays a critical role in virus entry by facilitating membrane fusion between the virus and target cells. As the fusion peptide is the only universally conserved epitope in all influenza A and B viruses, it could be an attractive target for vaccine-induced immune responses. We previously reported that antibodies targeting the first 14 amino acids of the N-terminus of the fusion peptide could bind to virtually all influenza virus strains and quantify hemagglutinins in vaccines produced in embryonated eggs. Here we demonstrate that these universal antibodies bind to the viral hemagglutinins in native conformation presented in infected mammalian cell cultures and neutralize multiple subtypes of virus by inhibiting the pH-dependant fusion of viral and cellular membranes. These results suggest that this unique, highly-conserved linear sequence in viral hemagglutinin is exposed sufficiently to be attacked by the antibodies during the course of infection and merits further investigation because of potential importance in the protection against diverse strains of influenza viruses.\n[INTRODUCCI\u00d3N DE NUEVAS VACUNAS: PROCESOS POL\u00cdTICOS, ADMINISTRATIVOS Y FINANCIEROS EN LA TOMA DE DECISIONES DEL PAI-BRASIL](http://revistamedicina.net/ojsanm/index.php/Revistamedicina/article/view/92) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nCarla Magda A.S. Domingues\n2012-07-01\nFull Text Available Se presentan los antecedentes del PAI en el Brasil remont\u00e1ndose al a\u00f1o de 1804 en que se inicia el programa de vacunaci\u00f3n en Brasil aplicando la vacuna contra la viruela hasta llegar a 1973 cuando se crea el Programa Nacional de Inmunizaciones en Brasil, y a partir de ah\u00ed se mantiene un esquema b\u00e1sico de vacunaci\u00f3n hasta llegar al 2012 cuando se introducen las vacunas VIP y pentavalentes. Muestra las alteraciones sufridas en el Calendario de Vacunaci\u00f3n del 2012, para llegar a la reformulaci\u00f3n de un Nuevo Calendario de Vacunaci\u00f3n a partir del 2012. Se\u00f1ala las estrategias nacionales de vacunaci\u00f3n enmarcadas en acciones de rutina, campa\u00f1as y control de brotes. Hace referencia a los criterios de inclusi\u00f3n de nuevas vacunas referidos a aspectos: epidemiol\u00f3gicos, inmunol\u00f3gicos, tecnol\u00f3gicos, log\u00edstica, socio-econ\u00f3micos, aprobaci\u00f3n por los Comit\u00e9s y presupuesto. Registra las novedades ocurridas en el Sistema de Informaciones del Programa Nacional de Inmunizaciones, relacionadas con la situaci\u00f3n actual, propuesta y Resoluci\u00f3n Ministerial. Por \u00faltimo se\u00f1ala los desaf\u00edos que debe enfrentar el Sistema enmarcados principalmente en la capacidad para mantener altas coberturas de vacunaci\u00f3n.\n[Evolution of the paralogous hap and iga genes in Haemophilus influenzae: evidence for a conserved hap pseudogene associated with microcolony formation in the recently diverged Haemophilus aegyptius and H. influenzae biogroup aegyptius](http://www.forskningsdatabasen.dk/en/catalog/117479482) [DEFF Research Database (Denmark)](http://forskningsbasen.deff.dk/?lang=eng)\nKilian, Mogens; Poulsen, Knud; Lomholt, Hans Bredsted\n2002-01-01\ngenetic polymorphism and pronounced mosaic-like patterns in both genes, but no evidence of intrastrain recombination between the two genes. A conserved hap pseudogene was present in all strains of H. aegyptius and H. influenzae biogroup aegyptius, each of which constituted distinct subpopulations...... on conjunctival cells, previously termed microcolony formation. The fact that individual hap pseudogenes differed from the ancestral sequence by zero to two positions within a 1.5 kb stretch suggests that the silencing event happened approximately 2000-11,000 years ago. Divergence of H. aegyptius and H...\n[Inhibitory Effect and Possible Mechanism of Action of Patchouli Alcohol against Influenza A (H2N2 Virus](http://www.mdpi.com/1420-3049/16/8/6489/) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nXue Wang\n2011-08-01\nFull Text Available In the present study, the anti-influenza A (H2N2 virus activity of patchouli alcohol was studied in vitro, in vivo and in silico. The CC50 of patchouli alcohol was above 20 \u00b5M. Patchouli alcohol could inhibit influenza virus with an IC50 of 4.03 \u00b1 0.23 \u00b5M. MTT assay showed that the inhibition by patchouli alcohol appears strongly after penetration of the virus into the cell. In the influenza mouse model, patchouli alcohol showed obvious protection against the viral infection at a dose of 5 mg/kg/day. Flexible docking and molecular dynamic simulations indicated that patchouli alcohol was bound to the neuraminidase protein of influenza virus, with an interaction energy of \u201340.38 kcal mol\u20131. The invariant key active-site residues Asp151, Arg152, Glu119, Glu276 and Tyr406 played important roles during the binding process. Based on spatial and energetic criteria, patchouli alcohol interfered with the NA functions. Results presented here suggest that patchouli alcohol possesses anti-influenza A (H2N2 virus properties, and therefore is a potential source of anti-influenza agents for the pharmaceutical industry.\n[The immunological potency and therapeutic potential of a prototype dual vaccine against influenza and Alzheimer's disease](http://www.translational-medicine.com/content/9/1/127) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nMartinez-Sobrido Luis\n2011-08-01\nFull Text Available Abstract Background Numerous pre-clinical studies and clinical trials demonstrated that induction of antibodies to the \u03b2-amyloid peptide of 42 residues (A\u03b242 elicits therapeutic effects in Alzheimer's disease (AD. However, an active vaccination strategy based on full length A\u03b242 is currently hampered by elicitation of T cell pathological autoreactivity. We attempt to improve vaccine efficacy by creating a novel chimeric flu vaccine expressing the small immunodominant B cell epitope of A\u03b242. We hypothesized that in elderly people with pre-existing memory Th cells specific to influenza this dual vaccine will simultaneously boost anti-influenza immunity and induce production of therapeutically active anti-A\u03b2 antibodies. Methods Plasmid-based reverse genetics system was used for the rescue of recombinant influenza virus containing immunodominant B cell epitopes of A\u03b242 (A\u03b21-7/10. Results Two chimeric flu viruses expressing either 7 or 10 aa of A\u03b242 (flu-A\u03b21-7 or flu-A\u03b21-10 were generated and tested in mice as conventional inactivated vaccines. We demonstrated that this dual vaccine induced therapeutically potent anti-A\u03b2 antibodies and anti-influenza antibodies in mice. Conclusion We suggest that this strategy might be beneficial for treatment of AD patients as well as for prevention of development of AD pathology in pre-symptomatic individuals while concurrently boosting immunity against influenza.\n[Un caso de osteocondritis costal t\u00edfica tratado con vacunas y antivirus](https://www.openaire.eu/search/publication?articleId=od______1326::8fd162326a4cf806bef07884700a3945)\nLleras Acosta, F.; Rueda H., Alfonso\n2011-01-01\nPor considerala de importancia pr\u00e1ctica, presentamos la historiacl\u00ednica de una enferma afectada de osteocondritis costal de origen Eberthiano, tratada con \u00e9xito completo por las autovacunas y antivirus, Debemos esta interesante observaci\u00f3n al Dr. Juan N. Carpas y al interno de su servicio de mujeres, Sr. Azuero, quienes galantemente nos suministraron los datos cl\u00ednicos y las observaciones relativas a los efectos producidos por las vacunas.\n[Trends in global warming and evolution of matrix protein 2 family from influenza A virus.](https://www.ncbi.nlm.nih.gov/pubmed/20640805)\nYan, Shao-Min; Wu, Guang\n2009-12-01\nThe global warming is an important factor affecting the biological evolution, and the influenza is an important disease that threatens humans with possible epidemics or pandemics. In this study, we attempted to analyze the trends in global warming and evolution of matrix protein 2 family from influenza A virus, because this protein is a target of anti-flu drug, and its mutation would have significant effect on the resistance to anti-flu drugs. The evolution of matrix protein 2 of influenza A virus from 1959 to 2008 was defined using the unpredictable portion of amino-acid pair predictability. Then the trend in this evolution was compared with the trend in the global temperature, the temperature in north and south hemispheres, and the temperature in influenza A virus sampling site, and species carrying influenza A virus. The results showed the similar trends in global warming and in evolution of M2 proteins although we could not correlate them at this stage of study. The study suggested the potential impact of global warming on the evolution of proteins from influenza A virus.\n[VIGILANCIA DE LA GRIPE PAND\u00c9MICA EN LA COMUNIDAD VALENCIANA Y VACUNA ANTIGRIPAL ESTACIONAL](http://www.redalyc.org/articulo.oa?id=17015304012) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nRosa Mar\u00eda Carb\u00f3 Malonda\n2010-01-01\nFull Text Available Fundamento: En la Comunidad Valenciana se ha llevado a cabo la vigilancia de la Gripe pand\u00e9mica. Algunos estudios sobre efectividad de la vacuna estacional para Gripe AnH1N1 han presentado resultados no consistentes. El objetivo del trabajo es describir los resultados de la vigilancia epidemiol\u00f3gica y la efectividad de la vacuna estacional para Gripe pand\u00e9mica en las semanas 28 a 51 de 2009. M\u00e9todos: Se estudiaron los casos en atenci\u00f3n primaria, hospitalizados confirmados, aislamientos virales y prote\u00edna C reactiva (PCR y coberturas vacunales. Se calcul\u00f3 la efectividad vacunal por el m\u00e9todo de screening de Farrington, en tres grupos de edad y dos periodos: vacunados de las temporadas 2008-9 y 2009-10. Resultados: En el primer periodo (semanas 28 a 40 los casos se concentraron en el grupo de 15 a 64 a\u00f1os (7.207 casos, seguido de los menores de 15 a\u00f1os (1.596 casos. En el segundo periodo (semanas 45 a 47 afect\u00f3 m\u00e1s a menores de 15 a\u00f1os (28.218 casos. En ambos periodos las tasas de incidencia en mayores de 65 a\u00f1os fue de 56,3 y 125,1 respectivamente. En el periodo estudiado (semanas 28 a 51 se confirmaron 5.481 casos de los que 1.746 (31,8% fueron hospitalizados. La curva de personas hospitalizadas presentaba un perfil similar al de atenci\u00f3n primaria, y tambi\u00e9n el seguimiento microbiol\u00f3gico del virus. La efectividad vacunal en el segundo periodo fue del 25% en adultos entre 15 y 64 a\u00f1os y del 51% en mayores de 64 a\u00f1os. Conclusiones: Se observ\u00f3 una protecci\u00f3n edad dependiente con efectividad vacunal positiva en los mayores de 64 a\u00f1os, aunque puede estar confundida por exposici\u00f3n natural al virus, vacunas previas y o respuesta inmunitaria.\n[Obtenci\u00f3n y evaluaci\u00f3n preliminar de un virus canarypox recombinante como candidato a vacuna antirr\u00e1bica Development and preliminary assessment of a recombinant canarypox virus as an antirabic vaccine candidate](https://www.openaire.eu/search/publication?articleId=doajarticles::0f1a7e9d964b5b4dd7e2026d0f5f7623)\nFlavia Zanetti; Liliana Rudak; Mat\u00edas Micucci; Daniela Conte Grand; Andrea Luque; Susana Russo; Oscar Taboga; Oscar P\u00e9rez; Gabriela Calamante\n2012-01-01\nEn la Argentina, la rabia est\u00e1 circunscripta a algunas provincias del norte. La disponibilidad de nuevas vacunas que eliminen la manipulaci\u00f3n del virus r\u00e1bico y que permitan el control de la enfermedad es de importancia estrat\u00e9gica nacional y regional. Las vacunas basadas en poxvirus recombinantes se han utilizado con \u00e9xito como vacunas antirr\u00e1bicas a nivel mundial. SI bien estos sistemas no est\u00e1n disponibles comercialmente, la plataforma de obtenci\u00f3n de virus canarypox (CNPV) recombinantes y...\n[Molecular Determinants of Influenza Virus Pathogenesis in Mice](https://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=4618372)\nKatz, Jaqueline M.; York, Ian A.\n2015-01-01\nMice are widely used for studying influenza virus pathogenesis and immunology because of their low cost, the wide availability of mouse-specific reagents, and the large number of mouse strains available, including knockout and transgenic strains. However, mice do not fully recapitulate the signs of influenza infection of humans: transmission of influenza between mice is much less efficient than in humans, and influenza viruses often require adaptation before they are able to efficiently replicate in mice. In the process of mouse adaptation, influenza viruses acquire mutations that enhance their ability to attach to mouse cells, replicate within the cells, and suppress immunity, among other functions. Many such mouse-adaptive mutations have been identified, covering all 8 genomic segments of the virus. Identification and analysis of these mutations have provided insight into the molecular determinants of influenza virulence and pathogenesis, not only in mice but also in humans and other species. In particular, several mouse-adaptive mutations of avian influenza viruses have proved to be general mammalian-adaptive changes that are potential markers of pre-pandemic viruses. As well as evaluating influenza pathogenesis, mice have also been used as models for evaluation of novel vaccines and anti-viral therapies. Mice can be a useful animal model for studying influenza biology as long as differences between human and mice infections are taken into account. PMID:25038937\n[Etiology of bacterial meningitis among children aged 2-59 months in Salvador, Northeast Brazil, before and after routine use of Haemophilus influenzae type b vaccine Etiologia da meningite bacteriana em crian\u00e7as com idade entre 2 e 59 meses em Salvador, Nordeste do Brasil, antes e depois do uso rotineiro da vacina para Haemophilus influenzae tipo b](http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0004-282X2004000200011) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nCristiana M. Nascimento-Carvalho\n2004-06-01\nFull Text Available OBJECTIVE: To describe the frequency of etiologic agents of bacterial meningitis (BM among children aged 2-59 months in a sample of patients in Salvador, Northeast Brazil, with emphasis on the frequency of BM of unknown etiology (BMUE, just before, during and after the implementation of routine immunization of infants with Haemophilus influenzae type b (Hib vaccination. METHOD: Demographic, clinical and cerebrospinal fluid (CSF information was collected from the chart of every patient, aged 2-59 months, whose CSF exam was performed at the CSF Lab - Jos\u00e9 Silveira Foundation, between January 1989 and December 2001. Every CSF exam was completely performed according to standard methods. The etiologic diagnosis was based on either culture and/or latex-agglutination test. When the agent was only seen on Gram stained smear, the diagnosis was descriptive. BMUE was defined as: glucose 100 mg / dl, white blood cell count > 20 cells / mm\u00b3, percentage of neutrophils > 80%. RESULTS: Of 1519 patients, 894 (58.9% had normal exams and BM was diagnosed in 95 (6.2%. Etiologic agents were: Hib (44.2%, meningococcus (13.7%, Gram-negative bacilli (11.6%, Mycobacterium tuberculosis (6.3%, pneumococcus (4.2%, other agents (4.2%; BMUE was diagnosed in 15.8% of cases with BM. By analysing the frequency of BMUE and Hib among all exams performed yearly, the peaks were recorded in 1989 (5.3% and 1990 (16.9%, respectively, decreasing to 0.7% and 0% in 2001. CONCLUSION: It is possible that the implementation of the conjugate Hib vaccine during the 1990's has been decreasing not only the occurrence of Hib meningitis but also of BMUE.OBJETIVO: Descrever a freq\u00fc\u00eancia dos agentes etiol\u00f3gicos de meningite bacteriana (MB em amostra das crian\u00e7as com idade entre 2 e 59 meses, em Salvador, Nordeste do Brasil, com \u00eanfase na freq\u00fc\u00eancia de MB de etiologia indeterminada (MBEI, antes, durante e ap\u00f3s a implementa\u00e7\u00e3o da imuniza\u00e7\u00e3o rotineira de lactentes com vacina para\n[Aproximaci\u00f3n al uso de hongos entomopat\u00f3genos y vacunas para el control sostenible de garrapatas en sistemas ganaderos: revisi\u00f3n](http://www.redalyc.org/articulo.oa?id=83743886006) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nAna Carolina Moncada Gonz\u00e1lez\n2015-01-01\nFull Text Available La resistencia desarrollada por las garrapatas frente a los acaricidas de s\u00edntesis, hace necesario replantear las estrategias utilizadas actualmen - te para su control. Los programas de manejo integrado de par\u00e1sitos se presentan como una alternativa que, al promover estrategias de con - trol basadas en la ecolog\u00eda y la epidemiolog\u00eda de cada especie de par\u00e1sito, reducen el riesgo de desarrollo de resistencia. Dichas estrategias incluyen la aplicaci\u00f3n de vacunas antigarrapata y hongos entomopat\u00f3genos que afectan la viabi - lidad y la reproducci\u00f3n en las garrapatas. Sin embargo, la informaci\u00f3n obtenida entre estudios sobre hongos y vacunas ha sido inconsistente, por lo que hoy en d\u00eda ambas representan \u00e1reas de investigaci\u00f3n bastante activas. El prop\u00f3sito de este trabajo consisti\u00f3 en realizar una revisi\u00f3n descriptiva sobre los mecanismos de acci\u00f3n de la vacuna antigarrapata y los hongos entomopat\u00f3genos, en la b\u00fasqueda de una po - sible complementariedad que permita el dise\u00f1o de planes de aplicaci\u00f3n conjunta, con miras a mejorar los resultados de control en sistemas ganaderos. En la primera parte del documento se revisa la actual problem\u00e1tica asociada al uso y abuso de los acaricidas de s\u00edntesis, haciendo un \u00e9nfasis particular en el tema de resistencia; posteriormente, se describen los mecanismos de acci\u00f3n de hongos y vacunas que afectan la re - producci\u00f3n y supervivencia en garrapatas, y se incluye informaci\u00f3n relevante sobre su eficacia. Se espera que la informaci\u00f3n aqu\u00ed recolectada, sirva como base para elaborar estudios que permitan identificar la utilidad de los hongos entomopat\u00f3genos y las vacunas antigarrapata al interior de los programas de manejo integrado de par\u00e1sitos en ganader\u00eda.\n[Anti-Hemagglutinin Antibody Derived Lead Peptides for Inhibitors of Influenza Virus Binding.](http://europepmc.org/articles/PMC4944999?pdf=render) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nHenry Memczak\nFull Text Available Antibodies against spike proteins of influenza are used as a tool for characterization of viruses and therapeutic approaches. However, development, production and quality control of antibodies is expensive and time consuming. To circumvent these difficulties, three peptides were derived from complementarity determining regions of an antibody heavy chain against influenza A spike glycoprotein. Their binding properties were studied experimentally, and by molecular dynamics simulations. Two peptide candidates showed binding to influenza A/Aichi/2/68 H3N2. One of them, termed PeB, with the highest affinity prevented binding to and infection of target cells in the micromolar region without any cytotoxic effect. PeB matches best the conserved receptor binding site of hemagglutinin. PeB bound also to other medical relevant influenza strains, such as human-pathogenic A/California/7/2009 H1N1, and avian-pathogenic A/Mute Swan/Rostock/R901/2006 H7N1. Strategies to improve the affinity and to adapt specificity are discussed and exemplified by a double amino acid substituted peptide, obtained by substitutional analysis. The peptides and their derivatives are of great potential for drug development as well as biosensing.\n[Efficacy of 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine against acute otitis media and nasopharyngeal carriage in Panamanian children \u2013 A randomized controlled trial](https://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=5489287)\nS\u00e1ez-Llorens, Xavier; Rowley, Stella; Wong, Digna; Rodr\u00edguez, Mirna; Calvo, Arlene; Troiti\u00f1o, Marisol; Salas, Albino; Vega, Vielka; Castrej\u00f3n, Maria Mercedes; Lommel, Patricia; Pascal, Thierry G.; Hausdorff, William P.; Borys, Dorota; Ruiz-Gui\u00f1az\u00fa, Javier; Ortega-Barr\u00eda, Eduardo; Yarzabal, Juan Pablo; Schuerman, Lode\n2017-01-01\nABSTRACT We previously reported 10-valent pneumococcal non-typeable Haemophilus influenzae (NTHi) protein D conjugate vaccine (PHiD-CV) efficacy in a double-blind randomized trial (ClinicalTrials.gov: NCT00466947) against various diseases, including acute otitis media (AOM). Here, we provide further analyses. In the Panamanian subset, 7,359 children were randomized (1:1) to receive PHiD-CV or control vaccine at age 2/4/6 and 15\u201318 months. Of these, 2,000 had nasopharyngeal swabs collected. AOM cases were captured when parents sought medical attention for children with AOM symptoms; surveillance was enhanced approximately 2 y into the study through regular telephone calls or home visits by study personnel, who advised parents to visit the clinic if their child had AOM symptoms. Mean follow-up was 31.4 months. Clinical AOM (C-AOM) cases were assessed by physicians and confirmed by otorhinolaryngologists. Middle ear fluid samples, taken from children with C-AOM after specific informed consent, and nasopharyngeal samples were cultured for pathogen identification. For 7,359 children, 2,574 suspected AOM cases were assessed by a primary healthcare physician; 649 cases were C-AOM cases as per protocol definition. From the 503 MEF samples collected, 158 resulted in a positive culture. In the intent-to-treat cohort (7,214 children), PHiD-CV showed VE against first C-AOM (24.0% [95% CI: 8.7, 36.7]) and bacterial (B-AOM) episodes (48.0% [20.3, 66.1]) in children children younger than 24 months, and reduced vaccine-serotype NPC. PMID:28368738\n[Mortalidad en M\u00e9xico por influenza y neumon\u00eda (1990-2005 Mortality due to influenza and pneumonia in Mexico between 1990 and 2005](http://www.scielo.org.mx/scielo.php?script=sci_arttext&pid=S0036-36342006000500004) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nPablo Kuri-Morales\n2006-10-01\nFull Text Available OBJETIVO: Estimar el impacto de la vacuna contra la influenza en personas menores de dos a\u00f1os y mayores de 65, a trav\u00e9s del an\u00e1lisis de la mortalidad por influenza y neumon\u00eda en la Rep\u00fablica mexicana entre 1990 y 2005, y determinar el patr\u00f3n estacional de comportamiento de la mortalidad, la tendencia de mortalidad por volumen de defunciones por periodo estacional y la velocidad de mortalidad. MATERIAL Y M\u00c9TODOS: Los datos se tomaron del Sistema Epidemiol\u00f3gico y Estad\u00edstico de Defunciones (SEED-SSA. RESULTADOS: El an\u00e1lisis mostr\u00f3 una tendencia de defunciones a la baja con una rapidez respectiva de 509 y 29 defunciones menos por a\u00f1o, as\u00ed como una interrupci\u00f3n de la tendencia ascendente de la mortalidad por la vacunaci\u00f3n. CONCLUSIONES: La intervenci\u00f3n por vacunaci\u00f3n tiene costos positivos, tanto econ\u00f3micos como de calidad de vida, por lo que su implementaci\u00f3n debe considerarse en un contexto que refleje una menor incidencia de hospitalizaciones y muertes.OBJECTIVE: To estimate the impact of influenza vaccine in infants less than two years of age and in elders more than sixty-five years of age, through the analysis of mortality due to influenza and pneumonia in Mexico, between 1990 and 2005. To determine the seasonal pattern of mortality, the tendency of mortality by volume of deaths per seasonal period, and the speed rate of mortality. MATERIAL AND METHODS: Data were taken from the Epidemiological and Statistical Mortality System (SEED-SSA per its abbreviation in Spanish. RESULTS AND CONCLUSIONS: The analysis showed there is a tendency of deaths decrease at a rate of 509 deaths less per year in the infants group and 29 deaths less in the elders group. Also, the ascending tendency of mortality was interrupted by vaccination. The vaccination intervention has a positive economic effect and also helps improve the quality of life. Therefore, its implementation is expected to lower hospital admissions and deaths.\n[Un caso de Osteocondritis costal t\u00edfica tratado con vacunas y antivirus](https://revistas.unal.edu.co/index.php/revfacmed/article/view/22140) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nF. Lleras Acosta\n1932-05-01\nFull Text Available Por considerala de importancia pr\u00e1ctica, presentamos la historia cl\u00ednica de una enferma afectada de osteocondritis costal de origen Eberthiano, tratada con \u00e9xito completo por las autovacunas y antivirus, Debemos esta interesante observaci\u00f3n al Dr. Juan N. Carpas y al interno de su servicio de mujeres, Sr. Azuero, quienes galantemente nos suministraron los datos cl\u00ednicos y las observaciones relativas a los efectos producidos por las vacunas.\n[Genetic Reassortment Among the Influenza Viruses (Avian Influenza, Human Influenza and Swine Influenza in Pigs](http://medpub.litbang.pertanian.go.id/index.php/wartazoa/article/view/964/973) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nDyah Ayu Hewajuli\n2012-12-01\nFull Text Available Influenza A virus is a hazardous virus and harm to respiratory tract. The virus infect birds, pigs, horses, dogs, mammals and humans. Pigs are important hosts in ecology of the influenza virus because they have two receptors, namely NeuAc 2,3Gal and NeuAc 2,6Gal which make the pigs are sensitive to infection of influenza virus from birds and humans and genetic reassortment can be occurred. Classical swine influenza H1N1 viruses had been circulated in pigs in North America and other countries for 80 years. In 1998, triple reassortant H3N2 swine influenza viruses that contains genes of human influenza A virus (H3N2, swine influenza virus (H1N1 and avian influenza are reported as cause an outbreaks in pigs in North America. Furthermore, the circulation of triple reassortant H3N2 swine influenza virus resulting reassortant H1N1 swine influenza and reassortant H1N2 swine influenza viruses cause infection in humans. Humans who were infected by triple reassortant swine influenza A virus (H1N1 usually made direct contact with pigs. Although without any clinical symptoms, pigs that are infected by triple reassortant swine influenza A (H1N1 can transmit infection to the humans around them. In June 2009, WHO declared that pandemic influenza of reassortant H1N1 influenza A virus (novel H1N1 has reached phase 6. In Indonesia until 2009, there were 1005 people were infected by H1N1 influenza A and 5 of them died. Novel H1N1 and H5N1 viruses have been circulated in humans and pigs in Indonesia. H5N1 reassortant and H1N1 viruses or the seasonal flu may could arise because of genetic reassortment between avian influenza and humans influenza viruses that infect pigs together.\n[Vacunaci\u00f3n contra influenza para adultos mayores en M\u00e9xico: consideraciones econ\u00f3micas Influenza vaccination in the elderly population in Mexico: economic considerations](http://www.scielo.org.mx/scielo.php?script=sci_arttext&pid=S0036-36342005000300007) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nJuan Pablo Guti\u00e9rrez\n2005-06-01\nFull Text Available OBJETIVO: Presentar una estimaci\u00f3n de los costos y resultados de salud que podr\u00edan obtenerse en M\u00e9xico con la introducci\u00f3n de un programa de vacunaci\u00f3n contra influenza en los adultos de 65 a\u00f1os de edad y m\u00e1s. MATERIAL Y M\u00c9TODOS: Entre junio y octubre de 2004, en Cuernavaca, Morelos, M\u00e9xico, se elabor\u00f3 un modelo para estimar el n\u00famero de a\u00f1os de vida que se pierden por problemas de salud ocasionados por la influenza y el porcentaje de los que podr\u00edan salvarse mediante la vacunaci\u00f3n por influenza en adultos de 65 a\u00f1os de edad y m\u00e1s, as\u00ed como el costo asociado a la atenci\u00f3n de casos de influenza y el costo potencial de la vacunaci\u00f3n, para obtener el costo neto por a\u00f1o de vida salvado. RESULTADOS: Utilizando dos escenarios de efectividad de la vacuna, se estim\u00f3 un total de entre 7 454 y 11 169 a\u00f1os de vida que podr\u00edan salvarse mediante la vacunaci\u00f3n de todos los adultos mayores en M\u00e9xico a un costo de entre 13 301 y 21 037 pesos por a\u00f1o. DISCUSI\u00d3N: Si bien no se compar\u00f3 con otros usos alternativos de los recursos, la intervenci\u00f3n evaluada tiene un costo por a\u00f1o de vida ganado significativamente menor al producto interno bruto per c\u00e1pita de M\u00e9xico, lo que sugiere que es costo efectivo llevar a cabo la vacunaci\u00f3n contra influenza en adultos de 65 a\u00f1os de edad en M\u00e9xico.OBJECTIVE: To estimate costs and health outcomes that could be attained by an influenza vaccination program in adults 65 years of age and older in Mexico. MATERIAL AND METHODS: Between June and October 2004, a model was constructed to estimate the number of life years lost due to influenza and the fraction that could be prevented by vaccination among adults 65 years of age and older. The model also allowed the estimation of the net cost of a vaccination program, including both the cost of delivering the vaccine and savings from prevented infections and their treatment costs. RESULTS: Using two scenarios of vaccine effectiveness, between 7 454 and 11\n[Vacunas para la prevenci\u00f3n de la gripe en personas de edad avanzada](http://www.sciencedirect.com/science/article/pii/S0716864010706088) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nTom Jefferson\n2010-09-01\nConclusiones de los autores: Las pruebas disponibles son de calidad deficiente y no proporcionan orientaci\u00f3n con respecto a la seguridad, la eficacia o la efectividad de las vacunas contra la gripe en las personas de 65 a\u00f1os de edad o m\u00e1s. Para resolver la incertidumbre se debe realizar un ensayo aleatorio controlado con placebo, con financiamiento p\u00fablico y con poder estad\u00edstico adecuado, durante varias estaciones.\n[Using Complementary and Alternative Medicines to Target the Host Response during Severe Influenza](http://dx.doi.org/10.1093/ecam/nep152) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nLisa M. Alleva\n2010-01-01\nFull Text Available It is now accepted that an overwhelming inflammatory response is the cause of human deaths from avian H5N1 influenza infection. With this in mind we sought to examine the literature for examples of complementary and alternative medicines that reduce inflammation, and to place the results of this search in the context of our own work in a mouse model of influenza disease, using a pharmaceutical agent with anti-inflammatory properties. Two Chinese herbs, Angelica sinensis (Dang Gui and Salvia miltiorrhiza (Danshen, have been recently shown to protect mice during lethal experimental sepsis via inhibition of the novel inflammatory cytokine High Mobility Group Box 1 protein (HMGB1. Biochanin A, a ligand of the peroxisome proliferator activated receptors (PPAR alpha and gamma and the active isoflavone in Trifolium pratense (red clover, has anti-inflammatory properties, and thus could be used as an influenza treatment. This is of great interest since we have recently shown that gemfibrozil, a drug used to treat hyperlipidemia in humans and a synthetic ligand of PPAR alpha, significantly reduces the mortality associated with influenza infections in mice. The inflammation-modulating abilities of these natural agents should be considered in light of what is now known about the mechanisms of fatal influenza, and tested as potential candidates for influenza treatments in their own right, or as adjunct treatments to antivirals.\n[Reactogenicidad e inmunogenicidad de una nueva vacuna de toxoide tet\u00e1nico y dift\u00e9rico con concentraci\u00f3n reducida en adolescentes cubanos](http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1025-028X2006000200003&lng=es&nrm=iso&tlng=es) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nRolando Felipe Ochoa.\n2006-08-01\nFull Text Available Se realiz\u00f3 un estudio aleatorizado, controlado y a doble ciegas en 225 adolescentes cubanos entre 13 y 16 a\u00f1os de edad, con el objetivo de evaluar la reactogenicidad y la inmunogenicidad de una nueva vacuna de toxoide tet\u00e1nico y toxoide dift\u00e9rico con concentraci\u00f3n reducida, producida en el Instituto Finlay, con respecto a su similar comercial IMOVAX dT adult de Aventis Pasteur. Se tomaron muestras de suero antes y 21 d\u00edas despu\u00e9s de la vacunaci\u00f3n. La reactogenicidad de ambas vacunas fue similar. Los s\u00edntomas y signos, tanto locales como generales fueron moderados y aparecieron principalmente durante las primeras 72 h despu\u00e9s de la vacunaci\u00f3n. Todos los voluntarios vacunados alcanzaron niveles protectores (\u00b30,1 UI/mL de antitoxina contra el t\u00e9tanos y la difteria. El 99,25% de los inmunizados con la vacuna experimental y el 98,36% de los voluntarios del grupo control presentaron niveles de antitoxina tet\u00e1nica correspondientes a una protecci\u00f3n de larga duraci\u00f3n (\u00b31,0 UI/mL; para la antitoxina dift\u00e9rica se alcanzaron estos niveles en el 81,20% y 80,33% de los voluntarios en cada grupo. Los t\u00edtulos medios geom\u00e9tricos de antitoxina tet\u00e1nica (21,73 UI/mL y antitoxina dift\u00e9rica (2,55 UI/mL inducidos por la nueva vacuna fueron superiores (p<0,05 a los del grupo control: 15,55 UI/mL y 1,84 UI/Ml respectivamente(p<0.05.\n[Antiviral Activities of Several Oral Traditional Chinese Medicines against Influenza Viruses.](https://www.ncbi.nlm.nih.gov/pubmed/26557857)\nMa, Lin-Lin; Ge, Miao; Wang, Hui-Qiang; Yin, Jin-Qiu; Jiang, Jian-Dong; Li, Yu-Huan\n2015-01-01\nInfluenza is still a serious threat to human health with significant morbidity and mortality. The emergence of drug-resistant influenza viruses poses a great challenge to existing antiviral drugs. Traditional Chinese medicines (TCMs) may be an alternative to overcome the challenge. Here, 10 oral proprietary Chinese medicines were selected to evaluate their anti-influenza activities. These drugs exhibit potent inhibitory effects against influenza A H1N1, influenza A H3N2, and influenza B virus. Importantly, they demonstrate potent antiviral activities against drug-resistant strains. In the study of mechanisms, we found that Xiaoqinglong mixture could increase antiviral interferon production by activating p38 MAPK, JNK/SAPK pathway, and relative nuclear transcription factors. Lastly, our studies also indicate that some of these medicines show inhibitory activities against EV71 and CVB strains. In conclusion, the 10 traditional Chinese medicines, as kind of compound combination medicines, show broad-spectrum antiviral activities, possibly also including inhibitory activities against strains resistant to available antiviral drugs.\n[Highly sensitive detection of influenza virus in saliva by real-time PCR method using sugar chain-immobilized gold nanoparticles; application to clinical studies](http://www.sciencedirect.com/science/article/pii/S2215017X15000314) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nYasuo Suda\n2015-09-01\nFull Text Available A highly sensitive and convenient method for detecting influenza virus was developed using modified end-point melt curve analysis of a RT-qPCR SYBR Green method and influenza virus-binding sugar chain-immobilized gold-nanoparticles (SGNP. Because SGNPs capture influenza viruses, the virus-SGNP complex was separated easily by centrifugation. Viral RNA was detected at very low concentrations, suggesting that SGNP increased sensitivity compared with standard methods. This method was applied to clinical studies. Influenza viruses were detected in saliva of patients or inpatients who had been considered influenza-free by a rapid diagnostic assay of nasal swabs. Furthermore, the method was applied to a human trial of prophylactic anti-influenza properties of yogurt containing Lactobacillus acidophilus L-92. The incidence of influenza viruses in saliva of the L-92 group was found to be significantly lower compared to the control group. Thus, this method was useful for monitoring the course of anti-influenza treatment or preventive measures against nosocomial infection.\n[A-equi-2 influenza in horses in the Republic of South Africa.](https://www.ncbi.nlm.nih.gov/pubmed/2839681)\nRogers, A L\n1988-06-01\nIn early December 1986 A-equi-2 influenza virus was isolated for the first time in the Republic of South Africa. All horses were susceptible to the highly contagious aerosol-borne orthomyxovirus resulting in widespread outbreaks of equine influenza with typical primary respiratory symptoms. Treatment consisted of rest, anti-inflammatory drugs, antibiotics and good nursing. Future protection can be obtained by vaccination.\n[Diesel exhaust alters the response of cultured primary bronchial epithelial cells from patients with chronic obstructive pulmonary disease (COPD) to non-typeable Haemophilus influenzae.](https://www.ncbi.nlm.nih.gov/pubmed/28129777)\nZarcone, Maria C; van Schadewijk, Annemarie; Duistermaat, Evert; Hiemstra, Pieter S; Kooter, Ingeborg M\n2017-01-28\nExacerbations constitute a major cause of morbidity and mortality in patients suffering from chronic obstructive pulmonary disease (COPD). Both bacterial infections, such as those with non-typeable Haemophilus influenzae (NTHi), and exposures to diesel engine emissions are known to contribute to exacerbations in COPD patients. However, the effect of diesel exhaust (DE) exposure on the epithelial response to microbial stimulation is incompletely understood, and possible differences in the response to DE of epithelial cells from COPD patients and controls have not been studied. Primary bronchial epithelial cells (PBEC) were obtained from age-matched COPD patients (n = 7) and controls (n = 5). PBEC were cultured at the air-liquid interface (ALI) to achieve mucociliary differentiation. ALI-PBECs were apically exposed for 1 h to a stream of freshly generated whole DE or air. Exposure was followed by 3 h incubation in presence or absence of UV-inactivated NTHi before analysis of epithelial gene expression. DE alone induced an increase in markers of oxidative stress (HMOX1, 50-100-fold) and of the integrated stress response (CHOP, 1.5-2-fold and GADD34, 1.5-fold) in cells from both COPD patients and controls. Exposure of COPD cultures to DE followed by NTHi caused an additive increase in GADD34 expression (up to 3-fold). Importantly, DE caused an inhibition of the NTHi-induced expression of the antimicrobial peptide S100A7, and of the chaperone protein HSP5A/BiP. Our findings show that DE exposure of differentiated primary airway epithelial cells causes activation of the gene expression of HMOX1 and markers of integrated stress response to a similar extent in cells from COPD donors and controls. Furthermore, DE further increased the NTHi-induced expression of GADD34, indicating a possible enhancement of the integrated stress response. DE reduced the NTHi-induced expression of S100A7. These data suggest that DE exposure may cause adverse health effects in part by\n[Vigilancia epidemiol\u00f3gica centinela de Haemophilus influenzae y Streptococcus pneumoniae en menores de 5 a\u00f1os en el Per\u00fa](http://www.scielo.org.pe/scielo.php?script=sci_arttext&pid=S1726-46342003000300007&lng=en&tlng=en) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\n2003-07-01\nFull Text Available Objetivo: Determinar la frecuencia, serotipos y perfil de resistencia antimicrobiana de Haemophilus influenzae (Hi y Streptococcus pneumoniae (Spn en casos de neumon\u00eda y meningitis en ni\u00f1os menores de 5 a\u00f1os en el Per\u00fa. Materiales y m\u00e9todos: Entre octubre de 2000 y diciembre de 2001, se implement\u00f3 la vigilancia centinela de Hi y Spn en dos hospitales de Lima y tres hospitales de otros departamentos (Cusco, Arequipa y Puno. La identificaci\u00f3n de serotipos y el estudio de la resistencia antimicrobiana se realizaron en el Instituto Nacional de Salud de Lima, Per\u00fa. La susceptibilidad antimicrobiana por la concentraci\u00f3n inhibitoria m\u00ednima (CIM se realiz\u00f3 por el m\u00e9todo de microdiluci\u00f3n en placa, siguiendo las pautas del Comit\u00e9 Nacional de Est\u00e1ndares de Laboratorios Cl\u00ednicos (NCCLS. Resultados: Ingresaron 1 283 casos. Se aislaron 59 cepas (31 de Hi y 28 de Spn, de ellos, 2,3% de las neumon\u00edas y 42,5% de las meningitis tuvieron aislamiento bacteriol\u00f3gico. En 10/1210 (0,8% pacientes con neumon\u00eda se aisl\u00f3 Hi y Spn en 18/1210 (1,5%. En 21/73 (28,8% de los casos de meningitis se aislaron Hi y Spn en 10/73 (13,7%. Se identificaron los serotipos de Spn: 1, 5, 6A, 11, 14, 19, 19F y 20. Los cepas aislados de Hi fueron del serotipo B. Se identificaron cepas de Spn con resistencia alta a penicilina (3/13, cotrimoxazol (3/13, eritromicina (1/13, cloranfenicol (1/13 y ceftriaxona (1/13; y cepas de Hi altamente resistentes a cotrimoxazol (4/20 y ampicilina (1/20. Conclusiones: Las tasas de aislamiento de Spn y Hi en menores de 5 a\u00f1os fueron bastante bajas. Se hallaron serotipos ya encontrados en Latinoam\u00e9rica, y se identificaron algunas cepas de Spn y Hi con resistencia a los antibi\u00f3ticos utilizados en los esquemas de tratamiento para neumon\u00eda y meningitis. Recomendamos continuar con este sistema de vigilancia, basado en hospitales centinela.\n[La construcci\u00f3 de fets cient\u00edfics : La vacuna SPf66](https://www.openaire.eu/search/publication?articleId=dedup_wf_001::69504224a67a1db5cf7f4eafc85160f1)\nNaspleda Pardo, Joan\n2015-01-01\nEn aquest treball, a partir de la teoria de l'actor-xarxa i la Sociologia del Coneixement Cient\u00edfic (SCC), analitzem la creaci\u00f3 i evoluci\u00f3 de la vacuna contra la mal\u00e0ria de l'equip del Dr. Manuel Elkin Patarroyo, durant els anys 80 i 90 del passat segle, per mostrar com les interaccions socials participen de manera decisiva en l'acceptaci\u00f3 o rebuig d'una proposta cient\u00edfica. En este trabajo, a partir de la teor\u00eda del actor-red y la Sociolog\u00eda del Conocimiento Cient\u00edfico (SCC), analizamos l...\n[La segunda expedici\u00f3n de Balmis, revoluci\u00f3n y vacuna](https://www.openaire.eu/search/publication?articleId=od_______935::d513a40dc09e50440853f4ad3258003a)\nTuells Hern\u00e1ndez, Jos\u00e9; Duro Torrijos, Jos\u00e9 Luis\n2013-01-01\nCuatro a\u00f1os despu\u00e9s de concluir la Real Expedici\u00f3n Filantr\u00f3pica de la Vacuna (REFV) (1803-1806) en calidad de director, Francisco Xavier Balmis emprendi\u00f3 una nueva comisi\u00f3n con destino a M\u00e9xico que le mantuvo all\u00ed desde 1810 a 1813. El objetivo inicial para el que fue comisionado pasaba por verificar si la estrategia de vacunaci\u00f3n implantada a trav\u00e9s de las Juntas era eficaz y, asimismo, encontrar una fuente de fluido vacuno aut\u00f3ctona que permitiera continuar la acci\u00f3n vacunadora. Balmis ejer...\n[Rheumatoid arthritis and the incidence of influenza and influenza-related complications: a retrospective cohort study](http://www.biomedcentral.com/1471-2474/13/158) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nBlumentals William A\n2012-08-01\nFull Text Available Abstract Background Patients with rheumatoid arthritis (RA are known to be at increased risk of infection, particularly if they are taking drugs with immunomodulatory effects. There is a need for more information on the risk of influenza in patients with RA. Methods A retrospective cohort study was carried out using data gathered from a large US commercial health insurance database (Thomson Reuters Medstat MarketScan from 1 January 2000 to 31 December 2007. Patients were \u226518 years of age, with at least two RA claims diagnoses. The database was scanned for incidence of seasonal influenza and its complications on or up to 30 days after an influenza diagnosis in RA patients and matched controls. Other factors accounted for included medical conditions, use of disease-modifying anti-rheumatic drugs (DMARDs, use of biological agents, influenza vaccination and high- or low-dose corticosteroids. Incidence rate ratios (IRRs were calculated for influenza and its complications in patients with RA. Results 46,030 patients with RA and a matching number of controls had a median age of 57 years. The incidence of influenza was higher in RA patients than in controls (409.33 vs 306.12 cases per 100,000 patient-years, and there was a 2.75-fold increase in incidence of complications in RA. Presence or absence of DMARDs or biologics had no significant effect. The adjusted IRR of influenza was statistically significant in patients aged 60\u201369 years, and especially among men. A significantly increased rate of influenza complications was observed in women and in both genders combined (but not in men only when all age groups were combined. In general, the risk of influenza complications was similar in RA patients not receiving DMARDs or biologics to that in all RA patients. Pneumonia rates were significantly higher in women with RA. Rates of stroke/myocardial infarction (MI were higher in men, although statistical significance was borderline. Conclusions RA is\n[The impact of administration of conjugate vaccines containing cross reacting material on Haemophilus influenzae type b antibody responses in infants: A systematic review and meta-analysis of randomised controlled trials.](https://www.ncbi.nlm.nih.gov/pubmed/27349840)\nVoysey, Merryn; Sadarangani, Manish; Clutterbuck, Elizabeth; Bolgiano, Barbara; Pollard, Andrew J\n2016-07-25\nProtein-polysaccharide conjugate vaccines such as Haemophilus influenzae type b (Hib), meningococcal, and pneumococcal vaccine, induce immunological memory and longer lasting protection than plain polysaccharide vaccines. The most common proteins used as carriers are tetanus toxoid (TT) and cross reacting material-197 (CRM), a mutant form of diphtheria toxoid. CRM conjugate vaccines have been reported to suppress antibody responses to co-administered Hib-TT vaccine. We conducted a systematic review and meta-analysis of randomised controlled trials in which infants were randomised to receive meningococcal or pneumococcal conjugate vaccines along with Hib-TT. Trials of licensed vaccines with different carrier proteins were included for group C meningococcal (MenC), quadrivalent ACWY meningococcal (MenACWY), and pneumococcal vaccines. Twenty-three trials were included in the meta-analyses. Overall, administration of MenC-CRM in a 2 or 3 dose schedule resulted in a 45% reduction in Hib antibody concentrations (GMR 0.55, 95% CI 0.49-0.62). MenACWY-CRM boosted Hib antibody responses by 22% (GMR 1.22, 95% CI 1.06-1.41) whilst pneumococcal CRM conjugate vaccines had no impact on Hib antibody responses (GMR 0.91, 95% CI 0.68-1.22). The effect of CRM protein-polysaccharide conjugate vaccines on Hib antibody responses varies greatly between vaccines. Co-administration of a CRM conjugate vaccine can produce either positive or negative effects on Hib antibody responses. These inconsistencies suggest that CRM itself may not be the main driver of variability in Hib responses, and challenge current perspectives on this issue. Copyright \u00a9 2016 Elsevier Ltd. All rights reserved.\n[A humanized anti-M2 scFv shows protective in vitro activity against influenza](http://www.etde.org/etdeweb/details.jsp?query_id=1&page=0&osti_id=960849) [Energy Technology Data Exchange (ETDEWEB)](https://www.etde.org/etdeweb/fieldedsearch.jsp)\nBradbury, Andrew M [Los Alamos National Laboratory; Velappan, Nileena [Los Alamos National Laboratory; Schmidt, Jurgen G [Los Alamos National Laboratory\n2008-01-01\nM2 is one of the most conserved influenza proteins, and has been widely prospected as a potential universal vaccine target, with protection predominantly mediated by antibodies. In this paper we describe the creation of a humanized single chain Fv from 14C2, a potent monoclonal antibody against M2. We show that the humanized scFv demonstrates similar activity to the parental mAb: it is able to recognize M2 in its native context on cell surfaces and is able to show protective in vitro activity against influenza, and so represents a potential lead antibody candidate for universal prophylactic or therapeutic intervention in influenza.\n[Que hay en el horizonte sobre el virus del papiloma humano, vacunas y el control del c\u00e1ncer](http://www.scielo.org.pe/scielo.php?script=sci_arttext&pid=S1726-46342007000300011&lng=en&tlng=en) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nPatricia J. Garc\u00eda\n2007-07-01\nFull Text Available Esta revisi\u00f3n provee una visi\u00f3n general sobre las infecciones genitales producidas por el virus del papiloma humano (VPH y de las neoplasias relacionadas con \u00e9ste y la informaci\u00f3n sobre las expectativas crecientes de la vacunaci\u00f3n como medio de prevenci\u00f3n. Se explora como se han desarrollado las vacunas contra el VPH y que aspectos hay que tener en cuenta para una posible implementaci\u00f3n de un programa de vacunaci\u00f3n para prevenir el c\u00e1ncer cervical, como los costos, el p\u00fablico objetivo (varones, mujeres o ambos, grupos de riesgo, a que edad vacunarlos, consideraciones que debemos tener en cuenta en la promoci\u00f3n de la vacuna, que pasar\u00eda con los programas de detecci\u00f3n precoz de c\u00e1ncer cervical y cuales son los potenciales problemas que tendr\u00eda en pa\u00edses en desarrollo.\n[Efic\u00e1cia e seguran\u00e7a da vacina brasileira contra hepatite B em rec\u00e9m-nascidos Eficiencia y seguridad de la vacuna brasilera contra hepatitis B en reci\u00e9n-nacidos Efficacy and safety of the Brazilian vaccine against Hepatitis B in newborns](http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0034-89102009000600013) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nExpedito Jos\u00e9 de Albuquerque Luna\n2009-12-01\nFull Text Available OBJETIVO: Analisar a efic\u00e1cia e seguran\u00e7a de vacina recombinante contra hepatite B em rec\u00e9m-nascidos. M\u00c9TODOS: O estudo foi conduzido em hospital geral do munic\u00edpio de Guarulhos, SP, entre 2002 e 2005. A vacina recombinante contra hepatite B do Instituto Butantan (VrHB-IB foi analisada em dois ensaios cl\u00ednicos. Em ambos os ensaios, os rec\u00e9m-nascidos foram alocados aleatoriamente ao grupo experimental ou controle (vacina de refer\u00eancia. Os rec\u00e9m-nascidos receberam tr\u00eas doses das vacinas, uma em at\u00e9 24 h ap\u00f3s o nascimento e as subseq\u00fcentes 30 e 180 dias ap\u00f3s. No primeiro ensaio 538 rec\u00e9m-nascidos completaram o protocolo e no segundo ensaio, 486. Considerou-se crit\u00e9rio de equival\u00eancia a diferen\u00e7a na soroprote\u00e7\u00e3o inferior a 5%. RESULTADOS: A soroprote\u00e7\u00e3o no primeiro ensaio (anti HBs > 10mUI/ml foi de 92,5% (247/267 no grupo experimental, comparada a 98,5% (267/271 no grupo controle (p = 0,001. Com este resultado, a VrHB-IB n\u00e3o atingiu o crit\u00e9rio de equival\u00eancia estabelecido. Ap\u00f3s o aumento da concentra\u00e7\u00e3o de ant\u00edgeno na vacina para 25\u00bcg, a soroprote\u00e7\u00e3o no segundo ensaio foi de 100% no grupo experimental e 99,2% no grupo controle. Nenhum evento adverso grave foi registrado. CONCLUS\u00d5ES: A vacina VrHB-IB modificada foi considerada equivalente \u00e0 vacina de refer\u00eancia e seu uso recomendado \u00e0 vacina\u00e7\u00e3o de rec\u00e9m-nascidos.OBJETIVO: Analizar la eficiencia y seguridad de vacuna recombinante contra hepatitis B en reci\u00e9n-nacidos. M\u00c9TODOS: El estudio fue conducido en hospital general del municipio de Guarulhos, Sureste de Brasil, entre 2002 y 2005. La vacuna recombinante contra hepatitis B del Instituto Butantan (VrHB-IB fue analizada en dos ensayos cl\u00ednicos. En ambos ensayos, los reci\u00e9n-nacidos fueron distribuidos aleatoriamente en el grupo experimental o control (vacuna de referencia. Los reci\u00e9n-nacidos recibieron tres dosis de las vacunas, una en m\u00e1ximo 24 h posterior al nacimiento y las subsecuentes 30 y 180 d\n[Activities of two novel macrolides, GW 773546 and GW 708408, compared with those of telithromycin, erythromycin, azithromycin, and clarithromycin against Haemophilus influenzae.](https://www.ncbi.nlm.nih.gov/pubmed/15504829)\nKosowska, Klaudia; Credito, Kim; Pankuch, Glenn A; Hoellman, Dianne; Lin, Gengrong; Clark, Catherine; Dewasse, Bonifacio; McGhee, Pamela; Jacobs, Michael R; Appelbaum, Peter C\n2004-11-01\nThe MIC at which 50% of strains are inhibited (MIC(50)) and the MIC(90) of GW 773546, a novel macrolide, were 1.0 and 2.0 microg/ml, respectively, for 223 beta-lactamase-positive, beta-lactamase-negative, and beta-lactamase-negative ampicillin-resistant Haemophilus influenzae strains. The MIC(50)s and MIC(90)s of GW 708408, a second novel macrolide, and telithromycin, an established ketolide, were 2.0 and 4.0 microg/ml, respectively, while the MIC(50) and MIC(90) of azithromycin were 1.0 and 2.0 microg/ml, respectively. The MIC(50) and MIC(90) of erythromycin were 4.0 and 8.0 microg/ml, respectively; and those of clarithromycin were 4.0 and 16.0 microg/ml, respectively. All compounds except telithromycin were bactericidal (99.9% killing) against nine strains at two times the MIC after 24 h. Telithromycin was bactericidal against eight of the nine strains. In addition, both novel macrolides and telithromycin at two times the MIC showed 99% killing of all nine strains after 12 h and 90% killing of all strains after 6 h. After 24 h, all drugs were bactericidal against four to seven strains when they were tested at the MIC. Ten of 11 strains tested by multistep selection analysis yielded resistant clones after 14 to 43 passages with erythromycin. Azithromycin gave resistant clones of all strains after 20 to 50 passages, and clarithromycin gave resistant clones of 9 of 11 strains after 14 to 41 passages. By comparison, GW 708408 gave resistant clones of 9 of 11 strains after 14 to 44 passages, and GW 773546 gave resistant clones of 10 of 11 strains after 14 to 45 passages. Telithromycin gave resistant clones of 7 of 11 strains after 18 to 45 passages. Mutations mostly in the L22 and L4 ribosomal proteins and 23S rRNA were detected in resistant strains selected with all compounds, with alterations in the L22 protein predominating. Single-step resistance selection studies at the MIC yielded spontaneous resistant mutants at frequencies of 1.5 x 10(-9) to 2.2 x 10(-6) with\n[Vacunaci\u00f3n de la poblaci\u00f3n de 65 a\u00f1os en Castilla-La Mancha con la vacuna antineumoc\u00f3cica conjugada 13valente (VNC13](http://www.revista-socampar.com/images/articulos/ArticulosSeparadosNum6/Articulo%20especial.pdf) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nSOCAMPAR\n2018-03-01\nFull Text Available La estrategia de vacunaci\u00f3n antineumoc\u00f3cica en adultos a partir de los 65 a\u00f1os de edad ha ido modific\u00e1ndose, tras la aprobaci\u00f3n de la vacuna 13valente conjugada (VNC13 para adultos y la recomendaci\u00f3n de los Centros de Control y Prevenci\u00f3n de enfermedad de EEUU (CDC en el a\u00f1o 2014 de incluir la vacuna VNC13 a la poblaci\u00f3n a partir de 65 a\u00f1os de edad, a partir de los resultados del estudio CAPiTA. Diversos pa\u00edses, y en Espa\u00f1a varias Comunidades Auto- n\u00f3micas, ya han incluido la vacuna VNC13 en los calendarios vacunales de adultos a partir de los 65 a\u00f1os. En este documento, las sociedades: Sociedad de M\u00e9dicos Generales y de Familia de Castilla-La Mancha, Sociedad Castellano Manchega de Patolog\u00eda Respiratoria, Sociedad Castellano Manchega de M\u00e9dicos Preventivistas, Sociedad Castellano Manchega de Geriatr\u00eda, Sociedad Castellano Manchega de M\u00e9dicos Internistas (Secci\u00f3n Infecciosas, Socie- dad Castellano Manchega de Farmacia Familiar y Comunitaria presentamos a la Direcci\u00f3n General de Salud P\u00fablica de la Junta de Comunidades de Castilla-La Mancha nuestra propuesta y justificaci\u00f3n para la inclusi\u00f3n de la vacuna VNC13 en cohorte de 65 a\u00f1os de edad de Castilla-La Mancha\n[A randomised trial to evaluate the immunogenicity, reactogenicity, and safety of the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) co-administered with routine childhood vaccines in Singapore and Malaysia.](https://www.ncbi.nlm.nih.gov/pubmed/25278086)\nLim, Fong Seng; Koh, Mia Tuang; Tan, Kah Kee; Chan, Poh Chong; Chong, Chia Yin; Shung Yehudi, Yeo Wee; Teoh, Yee Leong; Shafi, Fakrudeen; Hezareh, Marjan; Swinnen, Kristien; Borys, Dorota\n2014-10-02\nThe immunogenicity, reactogenicity, and safety of the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) co-administered with routine childhood vaccines were evaluated among infants from Singapore and Malaysia, where PHiD-CV has been licensed. In the primary vaccination phase, 298 infants from Singapore and 168 infants from Malaysia were randomised to receive the Phase III Clinical (Clin) or the Commercial (Com) lot of PHiD-CV at 2, 3, and 5 months of age. In the booster vaccination phase, 238 toddlers from Singapore received one dose of the PHiD-CV Commercial lot at 18-21 months of age. Immune responses to pneumococcal polysaccharides were measured using 22F-inhibition enzyme-linked immunosorbent assay (ELISA) and functional opsonophagocytic activity (OPA) assay and to protein D, using ELISA. Immune responses induced by primary vaccination with the PHiD-CV Commercial lot were non-inferior to the Phase III Clinical lot in terms of adjusted antibody geometric mean concentration (GMC) ratios for each vaccine pneumococcal serotype and protein D. For each vaccine pneumococcal serotype, \u226593.6% and \u226588.5% of infants from Malaysia and Singapore had post-primary vaccination antibody concentrations \u22650.2 \u03bcg/mL and OPA titres \u22658, in the Clin and Com groups, respectively. For each vaccine pneumococcal serotype, \u226560.8% and \u226598.2% of toddlers from Singapore had pre- and post-booster antibody concentrations \u22650.2 \u03bcg/mL, in the Clin and Com groups, respectively. All children, except one, had measurable anti-protein D antibodies and the primary and booster doses of the co-administered vaccines were immunogenic. The incidence of each grade 3 solicited symptom was \u226411.1% in both study phases. No serious adverse events considered causally related to vaccination were reported throughout the study. PHiD-CV given as three-dose primary vaccination to infants in Singapore and Malaysia and booster vaccination to toddlers in\n[Streptococcus pneumoniae aislados de infecciones invasivas: serotipos y resistencia antimicrobiana Streptococcus pneumoniae isolated from invasive infections: serotypes and antimicrobial resistance](http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S0864-21252007000100011) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nGladys Antonia Cueto Montoya\n2007-03-01\nFull Text Available Las meningoencefalitis bacterianas constituyen una enfermedad invasiva importante, quiz\u00e1s no tanto por su frecuencia, como por la gravedad de su cuadro. Los cambios en la epidemiolog\u00eda de los s\u00edndromes neurol\u00f3gicos infecciosos en Cuba a partir de la vacunaci\u00f3n contra meningococo BC y Haemophilus influenzae b han hecho que el Streptococcus pneumoniae constituya el agente causal m\u00e1s frecuente. Debido al incremento de la resistencia de este microorganismo a los antibi\u00f3ticos habituales, se realizaron modificaciones al r\u00e9gimen terap\u00e9utico convencional, fundamentalmente en las meningitis pedi\u00e1tricas. Es necesario lograr el aislamiento en cultivo de este agente para conocer los serotipos m\u00e1s frecuentes en el pa\u00eds, y lograr una vacuna neumoc\u00f3cica conjugada, as\u00ed como para la vigilancia de las cepas frente a los antimicrobianos.The bacterial meningoencephalitis is an important invasive disease, not only because of its frequency, but also because of the severity of its picture. The changes in the epidemiology of the neurological infectious syndromes in Cuba starting from the vaccination against meningococcus BC and Haemophilus infuenzae b have made that Streptococcus pneumoniae be the most frequent causal agent. Due to the increase of the resistance of this microorganism to habitual antibiotics, modifications were made in the conventional therapeutic regimen, mainly in the pediatric meningitis. It is necessary to achieve the isolation in culture of this agent to know the most common serotypes in the country, to attain a conjugated pneumococcal vaccine, and to keep the surveillance of the strains against the antimicrobials.\n[Vacunas y autoinmunidad: una rara asociaci\u00f3n bajo debate Vaccines and autoimmunity: a strange association under debate](http://www.scielosp.org/scielo.php?script=sci_arttext&pid=S1726-46342012000200017) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nAlexander Batista-Duharte\n2012-06-01\nFull Text Available La posible asociaci\u00f3n entre vacunas y enfermedades autoinmunes es un tema controversial. Existen elementos a favor de esta relaci\u00f3n basados en modelos te\u00f3ricos, ensayos de laboratorio y varios casos cl\u00ednicos publicados. En cambio, los estudios epidemiol\u00f3gicos no han confirmado esta asociaci\u00f3n y, de ellos, puede inferirse que las vacunas no constituyen una causa demostrada de enfermedades autoinmunes. En este trabajo se analizan las evidencias a favor y en contra de esta controversial asociaci\u00f3n, adem\u00e1s, se aborda un nuevo s\u00edndrome asociado con la administraci\u00f3n continuada de adyuvantes vacunales. Se concluye que debido al gran impacto en beneficio de la salud logrado con las vacunas, es necesario continuar desarrollando esta tecnolog\u00eda, pero tambi\u00e9n se debe seguir perfeccionando los dise\u00f1os de las nuevas formulaciones y profundizando estudios b\u00e1sicos, precl\u00ednicos, ensayos cl\u00ednicos y farmacovigilancia de los nuevos candidatos vacunales para establecer el riesgo real de desarrollo de un evento autoinmune posvacunaci\u00f3n.The occurrence and significance of autoimmune manifestations after administration of vaccines remain controversial. Evidence for immunization triggered autoimmunity come from several sources including theoretical models, animal studies, single and multiple case reports. In contrast, several epidemiological studies don\u2019t report this association, which is reassuring and at least indicates that vaccines are not a major cause of autoimmune diseases. We analyzed current scientific data concluded that vaccines bring a positive impact on public health, so it is necessary to continue developing this technology. Evaluation methods should be improved to avoid or anticipate the possible autoimmune side effects that can be presented.\n[The susceptibility of circulating human influenza viruses to tizoxanide, the active metabolite of nitazoxanide.](https://www.ncbi.nlm.nih.gov/pubmed/28986103)\nTilmanis, Danielle; van Baalen, Carel; Oh, Ding Yuan; Rossignol, Jean-Francois; Hurt, Aeron C\n2017-11-01\nNitazoxanide is a thiazolide compound that was originally developed as an anti-parasitic agent, but has recently been repurposed for the treatment of influenza virus infections. Thought to exert its anti-influenza activity via the inhibition of hemagglutinin maturation and intracellular trafficking in infected cells, the effectiveness of nitazoxanide in treating patients with non-complicated influenza is currently being assessed in phase III clinical trials. Here, we describe the susceptibility of 210 seasonal influenza viruses to tizoxanide, the active circulating metabolite of nitazoxanide. An optimised cell culture-based focus reduction assay was used to determine the susceptibility of A(H1N1)pdm09, A(H3N2), and influenza B viruses circulating in the southern hemisphere from the period March 2014 to August 2016. Tizoxanide showed potent in vitro antiviral activity against all influenza viruses tested, including neuraminidase inhibitor-resistant viruses, allowing the establishment of a baseline level of susceptibility for each subtype. Median EC 50 values (\u00b1IQR) of 0.48 \u03bcM (0.33-0.71), 0.62 \u03bcM (0.56-0.75), 0.66 \u03bcM (0.62-0.69), and 0.60 \u03bcM (0.51-0.67) were obtained for A(H1N1)pdm09, A(H3N2), B(Victoria lineage), and B(Yamagata lineage) influenza viruses respectively. There was no significant difference in the median baseline tizoxanide susceptibility for each influenza subtype tested. This is the first report on the susceptibility of circulating viruses to tizoxanide. The focus reduction assay format described is sensitive, robust, and less laborious than traditional cell based antiviral assays, making it highly suitable for the surveillance of tizoxanide susceptibility in circulating seasonal influenza viruses. Copyright \u00a9 2017 The Authors. Published by Elsevier B.V. All rights reserved.\n[Modulating the innate immune response to influenza A virus: potential therapeutic use of anti-inflammatory drugs](http://journal.frontiersin.org/Journal/10.3389/fimmu.2015.00361/full) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nIrene eRamos\n2015-07-01\nFull Text Available Infection by influenza A viruses (IAV is frequently characterized by robust inflammation that is usually more pronounced in the case of avian influenza. It is becoming clearer that the morbidity and pathogenesis caused by IAV is a consequence of this inflammatory response, with several components of the innate immune system acting as the main players. It has been postulated that using a therapeutic approach to limit the innate immune response in combination with antiviral drugs has the potential to diminish symptoms and tissue damage caused by IAV infection. Indeed, some anti-inflammatory agents have been shown to be effective in animal models at reducing IAV pathology as a proof of principle. The main challenge in developing such therapies is to selectively modulate signaling pathways that contribute to lung injury while maintaining the ability of the host cells to mount an antiviral response to control virus replication. However, the dissection of those pathways is very complex given the numerous components regulated by the same factors (i.e. NF kappa B transcription factors and the large number of players involved in this regulation, some of which may be undescribed or unknown. This article provides a comprehensive review of the current knowledge regarding the innate immune responses associated with tissue damage by IAV infection, the understanding of which is essential for the development of effective immunomodulatory drugs. Furthermore, we summarize the recent advances on the development and evaluation of such drugs as well as the lessons learned from those studies.\n[Influenza neuraminidase: a druggable target for natural products.](https://www.ncbi.nlm.nih.gov/pubmed/22025274)\nGrienke, Ulrike; Schmidtke, Michaela; von Grafenstein, Susanne; Kirchmair, Johannes; Liedl, Klaus R; Rollinger, Judith M\n2012-01-01\nThe imminent threat of influenza pandemics and repeatedly reported emergence of new drug-resistant influenza virus strains demonstrate the urgent need for developing innovative and effective antiviral agents for prevention and treatment. At present, influenza neuraminidase (NA), a key enzyme in viral replication, spread, and pathogenesis, is considered to be one of the most promising targets for combating influenza. Despite the substantial medical potential of NA inhibitors (NAIs), only three of these drugs are currently on the market (zanamivir, oseltamivir, and peramivir). Moreover, sudden changes in NAI susceptibility revealed the urgent need in the discovery/identification of novel inhibitors. Nature offers an abundance of biosynthesized compounds comprising chemical scaffolds of high diversity, which present an infinite pool of chemical entities for target-oriented drug discovery in the battle against this highly contagious pathogen. This review illuminates the increasing research efforts of the past decade (2000-2011), focusing on the structure, function and druggability of influenza NA, as well as its inhibition by natural products. Following a critical discussion of publications describing some 150 secondary plant metabolites tested for their inhibitory potential against influenza NA, the impact of three different strategies to identify and develop novel NAIs is presented: (i) bioactivity screening of herbal extracts, (ii) exploitation of empirical knowledge, and (iii) computational approaches. This work addresses the latest developments in theoretical and experimental research on properties of NA that are and will be driving anti-influenza drug development now and in the near future.\n[IMPLICACIONES \u00c9TICAS Y SOCIALES DE LA INTRODUCCI\u00d3N DE LA VACUNA CONTRA EL VIRUS DEL PAPILOMA HUMANO EN M\u00c9XICO: REFLEXIONES SOBRE UNA PROPUESTA DE INTERVENCI\u00d3N](https://www.openaire.eu/search/publication?articleId=od______3056::d4191acb1173d7dbea934cb8c961809f)\nPrieto de la Rosa,Alejandra; Guti\u00e9rrez Delgado,Cristina; Feinholz Klip,Dafna; Morales Gonz\u00e1lez,Gisela; Witlen,Renee\n2008-01-01\nEl objetivo de este trabajo es identificar aspectos \u00e9ticos y sociales relacionados con la introducci\u00f3n de la vacuna contra el virus del papiloma humano (VPH) en M\u00e9xico para una decisi\u00f3n informada y justa que considere no s\u00f3lo los aspectos financieros. De acuerdo con la informaci\u00f3n sobre eficiencia y costo de la vacuna, su introducci\u00f3n al sistema p\u00fablico mexicano puede acarrear consecuencias no previstas para las participantes y para toda la sociedad, por lo que debe examinarse en el contexto ...", "language": null, "image": null, "pagetype": null, "links": ["#", "//worldwidescience.org/index.html", "//worldwidescience.org/about.html", "//worldwidescience.org/news.html", "//worldwidescience.org/wws", "//worldwidescience.org/contact.html", "//worldwidescience.org/sitemap.html", "//worldwidescience.org/help.html", "#", "#", "#", "#", "#", "#", "http://www.scielosp.org/scielo.php?script=sci_arttext&pid=S1020-49892008000900002", "https://doaj.org/search#.V6PA8bgrK70", "https://www.openaire.eu/search/publication?articleId=dedup_wf_001::0594a940d911cdbd3278b867bfb39dec", "https://www.openaire.eu/search/advanced/publications", "http://www.anfamed.edu.uy/index.php/rev/article/view/185", "https://doaj.org/search#.V6PA8bgrK70", "http://www.redalyc.org/articulo.oa?id=17076304", "https://doaj.org/search#.V6PA8bgrK70", "http://www.scielosp.org/scielo.php?script=sci_arttext&pid=S1135-57272002000300004", "https://doaj.org/search#.V6PA8bgrK70", "http://www.scielosp.org/scielo.php?script=sci_arttext&pid=S1020-49892006000100005", "https://doaj.org/search#.V6PA8bgrK70", "https://kidshealth.org/en/teens/hib.html", "https://www.science.gov/", "http://www.scielo.org.ar/scielo.php?script=sci_arttext&pid=S0325-75412005000400007", "https://doaj.org/search#.V6PA8bgrK70", "https://www.ncbi.nlm.nih.gov/pubmed/9353749", "https://www.science.gov/", "http://acta.tums.ac.ir/index.php/acta/article/view/4428", "https://doaj.org/search#.V6PA8bgrK70", "http://www.forskningsdatabasen.dk/en/catalog/2389196035", "http://forskningsbasen.deff.dk/?lang=eng", "https://www.openaire.eu/search/publication?articleId=dedup_wf_001::e53e6396d7036924ac4edb136005a9b2", "https://www.openaire.eu/search/advanced/publications", "https://www.ncbi.nlm.nih.gov/pubmed/22301020", "https://www.science.gov/", "http://www.forskningsdatabasen.dk/en/catalog/163541806", "http://forskningsbasen.deff.dk/?lang=eng", "http://www.revistabiomedica.org/index.php/biomedica/article/view/1211", "https://doaj.org/search#.V6PA8bgrK70", "http://www.iatreia.udea.edu.co/index.php/iatreia/article/view/664", "https://doaj.org/search#.V6PA8bgrK70", "https://www.ncbi.nlm.nih.gov/pubmed/23177564", "https://www.science.gov/", "http://www.forskningsdatabasen.dk/en/catalog/2389207629", "http://forskningsbasen.deff.dk/?lang=eng", "http://www.scielo.org.ar/scielo.php?script=sci_arttext&pid=S0325-75412013000400004&lng=en&tlng=en", "https://doaj.org/search#.V6PA8bgrK70", "https://www.ncbi.nlm.nih.gov/pubmed/25753676", "https://www.science.gov/", "#", "#", "#", "#", "#", "#", "#", "#", "#", "#", "#", "#", "https://catalog.data.gov/dataset/nndss-table-ii-giardiasis-to-haemophilus-influenza-ad506", "http://www.data.gov/", "https://catalog.data.gov/dataset/nndss-table-ii-giardiasis-to-haemophilus-influenza-718ed", "http://www.data.gov/", "https://catalog.data.gov/dataset/nndss-table-ii-giardiasis-to-haemophilus-influenza-5cf59", "http://www.data.gov/", "https://catalog.data.gov/dataset/nndss-table-ii-giardiasis-to-haemophilus-influenza", "http://www.data.gov/", "http://www.revistabiomedica.org/index.php/biomedica/article/view/44", "https://doaj.org/search#.V6PA8bgrK70", "https://catalog.data.gov/dataset/nndss-table-ii-giardiasis-to-haemophilus-influenza-73c8e", "http://www.data.gov/", "http://www.scielosp.org/scielo.php?script=sci_arttext&pid=S1020-49892000000800005&lng=en&tlng=en", "https://doaj.org/search#.V6PA8bgrK70", "http://www.scielosp.org/scielo.php?script=sci_arttext&pid=S1020-49892000000800005", "https://doaj.org/search#.V6PA8bgrK70", "https://www2c.cdc.gov/podcasts/player.asp?f=8639125", "http://www2c.cdc.gov/podcasts/search.asp", "https://www.ncbi.nlm.nih.gov/pubmed/28628438", "https://www.science.gov/", "https://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=1769841", "https://www.science.gov/", "https://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=4214300", "https://www.science.gov/", "https://www.ajol.info/index.php/ejhg/article/view/77700", "http://www.ajol.info/index.php", "http://journal.frontiersin.org/Journal/10.3389/fcimb.2012.00100/full", "https://doaj.org/search#.V6PA8bgrK70", "http://www.forskningsdatabasen.dk/en/catalog/2434078580", "http://forskningsbasen.deff.dk/?lang=eng", "https://inis.iaea.orgsearchsinglerecord.aspx?recordsFor=SingleRecord&RN=17068041", "http://inis.iaea.org/search/", "http://www.forskningsdatabasen.dk/en/catalog/241237321", "http://forskningsbasen.deff.dk/?lang=eng", "http://www.forskningsdatabasen.dk/en/catalog/2398336027", "http://forskningsbasen.deff.dk/?lang=eng", "http://www.forskningsdatabasen.dk/en/catalog/2397929331", "http://forskningsbasen.deff.dk/?lang=eng", "https://tools.cdc.gov/medialibrary/index.aspx#/media/id/302614", "http://www2c.cdc.gov/podcasts/search.asp", "#", "#", "#", "#", "#", "#", "#", "#", "#", "#", "#", "#", "https://www.ncbi.nlm.nih.gov/pubmed/27292570", "https://www.science.gov/", "http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S0034-75312014000200012&lng=en&tlng=en", "https://doaj.org/search#.V6PA8bgrK70", "http://www.scielo.org.ar/scielo.php?script=sci_arttext&pid=S0325-75412004000100004", "https://doaj.org/search#.V6PA8bgrK70", "http://www.anfamed.edu.uy/index.php/rev/article/view/123", "https://doaj.org/search#.V6PA8bgrK70", "http://www.dovepress.com/lower-airway-colonization-and-inflammatory-response-in-copd-a-focus-on-peer-reviewed-article-COPD", "https://doaj.org/search#.V6PA8bgrK70", "https://www.ajol.info/index.php/samj/article/view/134279", "http://www.ajol.info/index.php", "http://www.scielosp.org/scielo.php?script=sci_arttext&pid=S1020-49892006000900005", "https://doaj.org/search#.V6PA8bgrK70", "http://www.forskningsdatabasen.dk/en/catalog/2434078496", "http://forskningsbasen.deff.dk/?lang=eng", "http://www.scielosp.org/scielo.php?script=sci_arttext&pid=S1020-49892006000300006", "https://doaj.org/search#.V6PA8bgrK70", "https://www.ncbi.nlm.nih.gov/pubmed/22919689", "https://www.science.gov/", "https://www.narcis.nl/publication/RecordID/oai%3Apure.amc.nl%3Apublications%2F065c92c6-0b76-450f-a36c-5d01eab161b8/uquery/presence%20AND%20capsule%20AND%20bacteria/id/6/Language/EN", "http://www.narcis.nl", "http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0041-87812004000500003", "https://doaj.org/search#.V6PA8bgrK70", "https://pneumonia.org.au/index.php/pneumonia/article/view/520/626", "https://doaj.org/search#.V6PA8bgrK70", "http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0034-89102004000500008", "https://doaj.org/search#.V6PA8bgrK70", "https://www.ncbi.nlm.nih.gov/pubmed/28242259", "https://www.science.gov/", "http://www.forskningsdatabasen.dk/en/catalog/2389066466", "http://forskningsbasen.deff.dk/?lang=eng", "https://www2c.cdc.gov/podcasts/player.asp?f=1135366", "http://www2c.cdc.gov/podcasts/search.asp", "https://www.narcis.nl/publication/RecordID/oai%3Apure.amc.nl%3Apublications%2F657d9a36-232a-4f16-882f-b4644bb978c2/uquery/immunological%20AND%20response/id/18/Language/EN", "http://www.narcis.nl", "http://dx.doi.org/10.1155/2015/706376", "https://doaj.org/search#.V6PA8bgrK70", "http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0074-02762001000400022", "https://doaj.org/search#.V6PA8bgrK70", "#", "#", "#", "#", "#", "#", "#", "#", "#", "#", "#", "#", "http://www.scielo.org.ar/scielo.php?script=sci_arttext&pid=S0025-76802007000400005", "https://doaj.org/search#.V6PA8bgrK70", "https://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=5661755", "https://www.science.gov/", "https://www.ncbi.nlm.nih.gov/pubmed/19535530", "https://www.science.gov/", "https://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=2725679", "https://www.science.gov/", "http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0021-75572006000400013", "https://doaj.org/search#.V6PA8bgrK70", "https://medlineplus.gov/ency/article/000612.htm", "https://www.science.gov/", "http://www.scielo.org.ar/scielo.php?script=sci_arttext&pid=S0025-76802011000200009&lng=en&tlng=en", "https://doaj.org/search#.V6PA8bgrK70", "https://www.ncbi.nlm.nih.gov/pubmed/28324295", "https://www.science.gov/", "https://www.ncbi.nlm.nih.gov/pubmed/26139207", "https://www.science.gov/", "http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1517-83822014000400040&lng=en&tlng=en", "https://doaj.org/search#.V6PA8bgrK70", "http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1025-028X2006000200005&lng=es&nrm=iso&tlng=es", "https://doaj.org/search#.V6PA8bgrK70", "https://www.ncbi.nlm.nih.gov/pubmed/19446978", "https://www.science.gov/", "http://www.forskningsdatabasen.dk/en/catalog/2398113216", "http://forskningsbasen.deff.dk/?lang=eng", "http://www.scielo.org.pe/scielo.php?script=sci_arttext&pid=S1726-46342006000100007&lng=en&tlng=en", "https://doaj.org/search#.V6PA8bgrK70", "http://www.forskningsdatabasen.dk/en/catalog/2264317803", "http://forskningsbasen.deff.dk/?lang=eng", "http://aums.abzums.ac.ir/browse.php?a_code=A-10-1-103&slc_lang=en&sid=1", "https://doaj.org/search#.V6PA8bgrK70", "http://www.forskningsdatabasen.dk/en/catalog/2379269297", "http://forskningsbasen.deff.dk/?lang=eng", "http://www.forskningsdatabasen.dk/en/catalog/38019662", "http://forskningsbasen.deff.dk/?lang=eng", "http://www.forskningsdatabasen.dk/en/catalog/2389199692", "http://forskningsbasen.deff.dk/?lang=eng", "http://oaji.net/articles/2016/3556-1469437061.pdf", "https://doaj.org/search#.V6PA8bgrK70", "#", "#", "#", "#", "#", "#", "#", "#", "#", "#", "#", "#", "http://www.scielosp.org/scielo.php?script=sci_arttext&pid=S1020-49892001000900004", "https://doaj.org/search#.V6PA8bgrK70", "https://www.ncbi.nlm.nih.gov/pubmed/25883794", "https://www.science.gov/", "http://journals.mui.ac.ir/jrms/article/view/903", "https://doaj.org/search#.V6PA8bgrK70", "https://www.ncbi.nlm.nih.gov/pubmed/16107294", "https://www.science.gov/", "https://www.narcis.nl/publication/RecordID/oai%3Apure.amc.nl%3Apublications%2F8549a934-cda3-4b3e-bd69-1627081f32f6/uquery/endogenous%20AND%20exogenous/id/18/Language/EN", "http://www.narcis.nl", "https://www.narcis.nl/publication/RecordID/oai%3Apure.amc.nl%3Apublications%2F501e04c0-6937-4667-b806-571e5904d625/uquery/Human%2C%20AND%20H/id/14/Language/EN", "http://www.narcis.nl", "https://www.ncbi.nlm.nih.gov/pubmed/26378279", "https://www.science.gov/", "https://www.narcis.nl/publication/RecordID/oai%3Apure.amc.nl%3Apublications%2Faf573f94-7642-4280-9dce-64d4ee26c938/uquery/fingerprints%20AND%20identical/id/1/Language/EN", "http://www.narcis.nl", "https://www.ncbi.nlm.nih.gov/pubmed/22470516", "https://www.science.gov/", "http://europepmc.org/articles/PMC3314702?pdf=render", "https://doaj.org/search#.V6PA8bgrK70", "http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S0034-75312003000400006", "https://doaj.org/search#.V6PA8bgrK70", "http://www.scielo.org.pe/scielo.php?script=sci_arttext&pid=S1025-55832011000300003&lng=en&tlng=en", "https://doaj.org/search#.V6PA8bgrK70", "http://www.forskningsdatabasen.dk/en/catalog/2389066514", "http://forskningsbasen.deff.dk/?lang=eng", "https://inis.iaea.orgsearchsinglerecord.aspx?recordsFor=SingleRecord&RN=9349844", "http://inis.iaea.org/search/", "http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0021-75572001000500009", "https://doaj.org/search#.V6PA8bgrK70", "https://www.ncbi.nlm.nih.gov/pubmed/27377430", "https://www.science.gov/", "https://www.narcis.nl/publication/RecordID/oai%3Apure.amc.nl%3Apublications%2Fb7ecd503-9a86-4bd2-b4b3-b5034921455b/uquery/chronic%20AND%20obstructive%20AND%20pulmonary%20AND%20disease%20and%20copd/id/16/Language/EN", "http://www.narcis.nl", "http://www.revistabiomedica.org/index.php/biomedica/article/view/1213", "https://doaj.org/search#.V6PA8bgrK70", "https://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=500174", "https://www.science.gov/", "https://www.ncbi.nlm.nih.gov/pubmed/28637909", "https://www.science.gov/", "#", "#", "#", "#", "#", "#", "#", "#", "#", "#", "#", "#", "http://journal.frontiersin.org/Journal/10.3389/fcimb.2012.00097/full", "https://doaj.org/search#.V6PA8bgrK70", "https://www.ncbi.nlm.nih.gov/pubmed/22919686", "https://www.science.gov/", "http://www.forskningsdatabasen.dk/en/catalog/2270513896", "http://forskningsbasen.deff.dk/?lang=eng", "http://dx.doi.org/10.1023/A:1011264300726", "http://inis.iaea.org/search/", "http://www.etde.org/etdeweb/details.jsp?query_id=1&page=0&osti_id=21099618", "https://www.etde.org/etdeweb/fieldedsearch.jsp", "http://www.forskningsdatabasen.dk/en/catalog/112791499", "http://forskningsbasen.deff.dk/?lang=eng", "https://www.ncbi.nlm.nih.gov/pubmed/27656134", "https://www.science.gov/", "https://www.narcis.nl/publication/RecordID/oai%3Atudelft.nl%3Auuid%3A734f1261-0065-4572-b414-cdaa0b923689/uquery/cogs/id/16/Language/EN", "http://www.narcis.nl", "http://journal.frontiersin.org/Journal/10.3389/fmicb.2014.00069/full", "https://doaj.org/search#.V6PA8bgrK70", "https://www.narcis.nl/publication/RecordID/oai%3Apure.rug.nl%3Apublications%2F50dc1830-d899-4e6d-af1d-d02ebe79446f/uquery/jesus%20AND%20campos%20AND%20garc%C3%ADa/id/1/Language/EN", "http://www.narcis.nl", "http://www.scielosp.org/scielo.php?script=sci_arttext&pid=S1020-49892000000500007", "https://doaj.org/search#.V6PA8bgrK70", "https://www.ncbi.nlm.nih.gov/pubmed/28621044", "https://www.science.gov/", "https://www.ncbi.nlm.nih.gov/pubmed/10722428", "https://www.science.gov/", "https://www.ncbi.nlm.nih.gov/pubmed/18086853", "https://www.science.gov/", "https://inis.iaea.orgsearchsinglerecord.aspx?recordsFor=SingleRecord&RN=21067336", "http://inis.iaea.org/search/", "https://www.osti.gov/servlets/purl/1034171", "https://www.science.gov/", "http://www.etde.org/etdeweb/details.jsp?query_id=1&page=0&osti_id=6745089", "https://www.etde.org/etdeweb/fieldedsearch.jsp", "https://inis.iaea.orgsearchsinglerecord.aspx?recordsFor=SingleRecord&RN=20015433", "http://inis.iaea.org/search/", "https://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=2772505", "https://www.science.gov/", "http://www.forskningsdatabasen.dk/en/catalog/2389066515", "http://forskningsbasen.deff.dk/?lang=eng", "#", "#", "#", "#", "#", "#", "#", "#", "#", "#", "#", "#", "https://www.ncbi.nlm.nih.gov/pubmed/15174745", "https://www.science.gov/", "https://inis.iaea.orgsearchsinglerecord.aspx?recordsFor=SingleRecord&RN=12613223", "http://inis.iaea.org/search/", "http://www.iatreia.udea.edu.co/index.php/iatreia/article/view/284", "https://doaj.org/search#.V6PA8bgrK70", "https://www.ncbi.nlm.nih.gov/pubmed/9770539", "https://www.science.gov/", "https://www.narcis.nl/publication/RecordID/oai%3Apure.amc.nl%3Apublications%2F585b8f9a-5784-4831-af53-5e40899d6a72/uquery/H%20Anton/id/4/Language/EN", "http://www.narcis.nl", "https://www.narcis.nl/publication/RecordID/oai%3Apure.rug.nl%3Apublications%2F2d1e8efd-5bce-4195-a3d7-b4def9bbd272/uquery/R.w.%20AND%20Davies/id/8/Language/EN", "http://www.narcis.nl", "https://inis.iaea.orgsearchsinglerecord.aspx?recordsFor=SingleRecord&RN=13692082", "http://inis.iaea.org/search/", "https://inis.iaea.orgsearchsinglerecord.aspx?recordsFor=SingleRecord&RN=17072304", "http://inis.iaea.org/search/", "http://www.revistabiomedica.org/index.php/biomedica/article/view/2011", "https://doaj.org/search#.V6PA8bgrK70", "http://dx.doi.org/10.1155/2015/163812", "https://doaj.org/search#.V6PA8bgrK70", "http://www.forskningsdatabasen.dk/en/catalog/194413653", "http://forskningsbasen.deff.dk/?lang=eng", "http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0102-311X2007000700021", "https://doaj.org/search#.V6PA8bgrK70", "http://www.lenus.ie/hse/handle/10147/296026", "http://www.lenus.ie/hse/", "https://www.ncbi.nlm.nih.gov/pubmed/23017260", "https://www.science.gov/", "https://inis.iaea.orgsearchsinglerecord.aspx?recordsFor=SingleRecord&RN=21027372", "http://inis.iaea.org/search/", "https://www.dovepress.com/ampicillin-resistance-in-haemophilus-influenzae-from-copd-patients-in--peer-reviewed-article-COPD", "https://doaj.org/search#.V6PA8bgrK70", "https://www.narcis.nl/publication/RecordID/oai%3Apure.rug.nl%3Apublications%2Ff18144fd-7d94-4c15-8d6d-28b48195c69a/uquery/costo/id/11/Language/EN", "http://www.narcis.nl", "https://www.ncbi.nlm.nih.gov/pubmed/24687948", "https://www.science.gov/", "http://www.scielo.org.mx/scielo.php?script=sci_arttext&pid=S0036-36342012000600009", "https://doaj.org/search#.V6PA8bgrK70", "https://www.ncbi.nlm.nih.gov/pubmed/23541117", "https://www.science.gov/", "#", "#", "#", "#", "#", "#", "#", "#", "#", "#", "#", "#", "http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1561-31942009000100003", "https://doaj.org/search#.V6PA8bgrK70", "http://oaji.net/articles/2016/3556-1469433557.pdf", "https://doaj.org/search#.V6PA8bgrK70", "https://www.ncbi.nlm.nih.gov/pubmed/9232253", "https://www.science.gov/", "https://www.ncbi.nlm.nih.gov/pubmed/19048199", "https://www.science.gov/", "http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1413-81232013001100030", "https://doaj.org/search#.V6PA8bgrK70", "https://www.openaire.eu/search/publication?articleId=od_______908::25e783a27073de234a1219b7d164ad2b", "https://www.openaire.eu/search/advanced/publications", "http://europepmc.org/articles/PMC4188559?pdf=render", "https://doaj.org/search#.V6PA8bgrK70", "https://www.ncbi.nlm.nih.gov/pubmed/26109443", "https://www.science.gov/", "https://www.openaire.eu/search/publication?articleId=od_______908::2f8826a972d0c02fd2b0670c47a6e126", "https://www.openaire.eu/search/advanced/publications", "https://www.narcis.nl/publication/RecordID/oai%3Apure.amc.nl%3Apublications%2Fe68da8b2-3a31-4720-835a-33b212a423e1/uquery/fingerprints%20AND%20identical/id/3/Language/EN", "http://www.narcis.nl", "https://www.narcis.nl/publication/RecordID/oai%3Apure.rug.nl%3Apublications%2F83496784-5e96-4d21-81d7-3702af53846d/uquery/fingerprints%20AND%20identical/id/2/Language/EN", "http://www.narcis.nl", "https://www.openaire.eu/search/publication?articleId=od_______908::e9861174eb459cdec76f7c971f45dcdd", "https://www.openaire.eu/search/advanced/publications", "https://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=2718449", "https://www.science.gov/", "http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0102-311X2003000500005", "https://doaj.org/search#.V6PA8bgrK70", "https://www.ncbi.nlm.nih.gov/pubmed/22568263", "https://www.science.gov/", "http://dx.doi.org/10.1023/A:1007320124502", "http://inis.iaea.org/search/", "https://www.ncbi.nlm.nih.gov/pubmed/29460728", "https://www.science.gov/", "https://www.ncbi.nlm.nih.gov/pubmed/29728040", "https://www.science.gov/", "https://www.ncbi.nlm.nih.gov/pubmed/28282645", "https://www.science.gov/", "https://www.ncbi.nlm.nih.gov/pubmed/20802829", "https://www.science.gov/", "#", "#", "#", "#", "#", "#", "#", "#", "#", "#", "#", "#", "http://www.scielosp.org/scielo.php?script=sci_arttext&pid=S1020-49892001001000003", "https://doaj.org/search#.V6PA8bgrK70", "http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0037-86822006000500010", "https://doaj.org/search#.V6PA8bgrK70", "http://europepmc.org/articles/PMC3145789?pdf=render", "https://doaj.org/search#.V6PA8bgrK70", "https://www.ncbi.nlm.nih.gov/pubmed/15908377", "https://www.science.gov/", "https://www2c.cdc.gov/podcasts/player.asp?f=4376197", "http://www2c.cdc.gov/podcasts/search.asp", "http://www.forskningsdatabasen.dk/en/catalog/2389184320", "http://forskningsbasen.deff.dk/?lang=eng", "https://www.ncbi.nlm.nih.gov/pubmed/28619239", "https://www.science.gov/", "https://inis.iaea.orgsearchsinglerecord.aspx?recordsFor=SingleRecord&RN=17043623", "http://inis.iaea.org/search/", "http://www.scielosp.org/scielo.php?script=sci_arttext&pid=S1020-49892008000700001", "https://doaj.org/search#.V6PA8bgrK70", "https://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=4262604", "https://www.science.gov/", "http://www.forskningsdatabasen.dk/en/catalog/2389195185", "http://forskningsbasen.deff.dk/?lang=eng", "https://www.ncbi.nlm.nih.gov/pubmed/20715928", "https://www.science.gov/", "http://escholarship.org/uc/item/4313m32x", "https://doaj.org/search#.V6PA8bgrK70", "https://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=3173798", "https://www.science.gov/", "https://www.ncbi.nlm.nih.gov/pubmed/29860297", "https://www.science.gov/", "https://www.ncbi.nlm.nih.gov/pubmed/26014114", "https://www.science.gov/", "https://www.ncbi.nlm.nih.gov/pubmed/23411622", "https://www.science.gov/", "https://www.ncbi.nlm.nih.gov/pubmed/22107351", "https://www.science.gov/", "https://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=3166929", "https://www.science.gov/", "https://www.ncbi.nlm.nih.gov/pubmed/18417667", "https://www.science.gov/", "#", "#", "#", "#", "#", "#", "#", "#", "#", "#", "#", "#", "https://www.ncbi.nlm.nih.gov/pubmed/20956567", "https://www.science.gov/", "https://www.osti.gov/etdeweb/biblio/7319187", "https://www.etde.org/etdeweb/fieldedsearch.jsp", "https://www.ncbi.nlm.nih.gov/pubmed/11120946", "https://www.science.gov/", "http://www.etde.org/etdeweb/details.jsp?query_id=1&page=0&osti_id=913920", "https://www.etde.org/etdeweb/fieldedsearch.jsp", "https://www.openaire.eu/search/publication?articleId=od_______908::3708acad29fc53abc7e0d6b74de3b7d6", "https://www.openaire.eu/search/advanced/publications", "https://inis.iaea.orgsearchsinglerecord.aspx?recordsFor=SingleRecord&RN=45060391", "http://inis.iaea.org/search/", "http://www.sciencedirect.com/science/article/pii/S0716864011703881", "https://doaj.org/search#.V6PA8bgrK70", "http://www.ljkzedo.com.ba/medglasnik/vol71/MGvol71_10.pdf", "https://doaj.org/search#.V6PA8bgrK70", "http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0036-46651998000100002", "https://doaj.org/search#.V6PA8bgrK70", "https://www.openaire.eu/search/publication?articleId=od______1404::4f4db4f9056e1f4cbb5edb2cfbec944e", "https://www.openaire.eu/search/advanced/publications", "http://www.forskningsdatabasen.dk/en/catalog/2389066337", "http://forskningsbasen.deff.dk/?lang=eng", "https://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=2446616", "https://www.science.gov/", "https://www.ncbi.nlm.nih.gov/pubmed/29862370", "https://www.science.gov/", "https://www.ncbi.nlm.nih.gov/pubmed/22457715", "https://www.science.gov/", "http://www.sciencedirect.com/science/article/pii/S2405844018305437", "https://doaj.org/search#.V6PA8bgrK70", "https://www.ncbi.nlm.nih.gov/pubmed/26215614", "https://www.science.gov/", "https://pneumonia.org.au/index.php/pneumonia/article/view/229", "https://doaj.org/search#.V6PA8bgrK70", "http://www.dtic.mil/docs/citations/ADA629393", "https://www.science.gov/", "https://www.openaire.eu/search/publication?articleId=od_______908::aa788c15a0ee42c8e6bf39ba0bc758e5", "https://www.openaire.eu/search/advanced/publications", "https://www.ncbi.nlm.nih.gov/pubmed/24403544", "https://www.science.gov/", "#", "#", "#", "#", "#", "#", "#", "#", "#", "#", "#", "#", "http://www.iatreia.udea.edu.co/index.php/iatreia/article/view/13644/12135", "https://doaj.org/search#.V6PA8bgrK70", "http://www.dovepress.com/nontypeable-haemophilus-influenzae-in-chronic-obstructive-pulmonary-di-a6156", "https://doaj.org/search#.V6PA8bgrK70", "https://www.ncbi.nlm.nih.gov/pubmed/18159010", "https://www.science.gov/", "https://www.osti.gov/etdeweb/biblio/7137387", "https://www.etde.org/etdeweb/fieldedsearch.jsp", "http://www.forskningsdatabasen.dk/en/catalog/18955081", "http://forskningsbasen.deff.dk/?lang=eng", "http://www.scielosp.org/scielo.php?script=sci_arttext&pid=S1020-49891998001000001&lng=en&tlng=en", "https://doaj.org/search#.V6PA8bgrK70", "https://www.ncbi.nlm.nih.gov/pubmed/21129171", "https://www.science.gov/", "http://www.biomedcentral.com/1471-2180/10/310", "https://doaj.org/search#.V6PA8bgrK70", "https://www.ncbi.nlm.nih.gov/pubmed/3264378", "https://www.science.gov/", "http://www.forskningsdatabasen.dk/en/catalog/51196562", "http://forskningsbasen.deff.dk/?lang=eng", "http://europepmc.org/articles/PMC3198447?pdf=render", "https://doaj.org/search#.V6PA8bgrK70", "https://www.ncbi.nlm.nih.gov/pubmed/3485576", "https://www.science.gov/", "http://europepmc.org/articles/PMC4368769?pdf=render", "https://doaj.org/search#.V6PA8bgrK70", "http://www.scielosp.org/scielo.php?script=sci_arttext&pid=S1020-49891998001000006", "https://doaj.org/search#.V6PA8bgrK70", "http://www.forskningsdatabasen.dk/en/catalog/2389066513", "http://forskningsbasen.deff.dk/?lang=eng", "https://www2c.cdc.gov/podcasts/player.asp?f=8630175", "http://www2c.cdc.gov/podcasts/search.asp", "https://www.ncbi.nlm.nih.gov/pubmed/28513815", "https://www.science.gov/", "https://www.ncbi.nlm.nih.gov/pubmed/26337197", "https://www.science.gov/", "https://www.ncbi.nlm.nih.gov/pubmed/26988256", "https://www.science.gov/", "http://www.etde.org/etdeweb/details.jsp?query_id=1&page=0&osti_id=1033769", "https://www.etde.org/etdeweb/fieldedsearch.jsp", "#", "#", "#", "#", "#", "#", "#", "#", "#", "#", "#", "#", "http://childshealth.zaslavsky.com.ua/article/view/88021", "https://doaj.org/search#.V6PA8bgrK70", "https://www.openaire.eu/search/publication?articleId=od______3040::cc271e44d67bb301b8673ae704eb1321", "https://www.openaire.eu/search/advanced/publications", "http://www.etde.org/etdeweb/details.jsp?query_id=1&page=0&osti_id=6007431", "https://www.etde.org/etdeweb/fieldedsearch.jsp", "https://www.ncbi.nlm.nih.gov/pubmed/25762194", "https://www.science.gov/", "http://www.scielosp.org/scielo.php?script=sci_arttext&pid=S1020-49892007000300011", "https://doaj.org/search#.V6PA8bgrK70", "https://www.openaire.eu/search/publication?articleId=od______3272::e04c2a8ca070b76a97f8c299cefc6434", "https://www.openaire.eu/search/advanced/publications", "https://inis.iaea.orgsearchsinglerecord.aspx?recordsFor=SingleRecord&RN=17039577", "http://inis.iaea.org/search/", "https://www.ncbi.nlm.nih.gov/pubmed/27763775", "https://www.science.gov/", "https://www.ncbi.nlm.nih.gov/pubmed/26867396", "https://www.science.gov/", "http://www.scielo.org.mx/scielo.php?script=sci_arttext&pid=S0036-36342006000300009", "https://doaj.org/search#.V6PA8bgrK70", "http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0103-11042016000400009&lng=en&tlng=en", "https://doaj.org/search#.V6PA8bgrK70", "http://www.etde.org/etdeweb/details.jsp?query_id=1&page=0&osti_id=22594271", "https://www.etde.org/etdeweb/fieldedsearch.jsp", "http://dx.doi.org/10.1016/j.bbrc.2016.01.123", "http://inis.iaea.org/search/", "https://www.ncbi.nlm.nih.gov/pubmed/29241769", "https://www.science.gov/", "https://www.ncbi.nlm.nih.gov/pubmed/15135497", "https://www.science.gov/", "https://inis.iaea.orgsearchsinglerecord.aspx?recordsFor=SingleRecord&RN=17068044", "http://inis.iaea.org/search/", "https://www.ncbi.nlm.nih.gov/pubmed/21747321", "https://www.science.gov/", "http://www.scielosp.org/scielo.php?script=sci_arttext&pid=S1020-49892002001000005", "https://doaj.org/search#.V6PA8bgrK70", "http://dx.doi.org/10.1107/S1744309110021688", "http://inis.iaea.org/search/", "https://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=5481322", "https://www.science.gov/", "#", "#", "#", "#", "#", "#", "#", "#", "#", "#", "#", "#", "http://journal.frontiersin.org/article/10.3389/fmicb.2017.01041/full", "https://doaj.org/search#.V6PA8bgrK70", "https://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=4403991", "https://www.science.gov/", "https://www.openaire.eu/search/publication?articleId=od______1472::a09ac4cf255ae73a6b4363b1bbc0a6ad", "https://www.openaire.eu/search/advanced/publications", "https://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=4654113", "https://www.science.gov/", "http://www.scielosp.org/scielo.php?script=sci_arttext&pid=S1020-49891998001000001", "https://doaj.org/search#.V6PA8bgrK70", "https://www.openaire.eu/search/publication?articleId=doajarticles::4639710bd8874709386dd27339826e1d", "https://www.openaire.eu/search/advanced/publications", "http://www.jbiomedsci.com/content/17/1/13", "https://doaj.org/search#.V6PA8bgrK70", "https://www.ncbi.nlm.nih.gov/pubmed/23964690", "https://www.science.gov/", "http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0034-71672007000400015", "https://doaj.org/search#.V6PA8bgrK70", "https://www.ncbi.nlm.nih.gov/pubmed/28737468", "https://www.science.gov/", "https://www.ncbi.nlm.nih.gov/pubmed/28674033", "https://www.science.gov/", "https://www.ncbi.nlm.nih.gov/pubmed/28889986", "https://www.science.gov/", "http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1025-028X2012000300005&lng=es&nrm=iso", "https://doaj.org/search#.V6PA8bgrK70", "https://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=3732867", "https://www.science.gov/", "https://inis.iaea.orgsearchsinglerecord.aspx?recordsFor=SingleRecord&RN=10420857", "http://inis.iaea.org/search/", "https://www.ncbi.nlm.nih.gov/pubmed/21220774", "https://www.science.gov/", "https://www.openaire.eu/search/publication?articleId=od_______908::7b2efba4f4ae1facffa048f5bd49f88c", "https://www.openaire.eu/search/advanced/publications", "https://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=5886403", "https://www.science.gov/", "http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1025-028X2014000200006&lng=es&nrm=iso", "https://doaj.org/search#.V6PA8bgrK70", "https://www.ncbi.nlm.nih.gov/pubmed/29287704", "https://www.science.gov/", "#", "#", "#", "#", "#", "#", "#", "#", "#", "#", "#", "#", "https://inis.iaea.orgsearchsinglerecord.aspx?recordsFor=SingleRecord&RN=23071324", "http://inis.iaea.org/search/", "http://europepmc.org/articles/PMC4792463?pdf=render", "https://doaj.org/search#.V6PA8bgrK70", "https://www.ncbi.nlm.nih.gov/pubmed/18577410", "https://www.science.gov/", "http://revistamedicina.net/ojsanm/index.php/Revistamedicina/article/view/903", "https://doaj.org/search#.V6PA8bgrK70", "http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1025-028X2004000200001&lng=es&nrm=iso&tlng=es", "https://doaj.org/search#.V6PA8bgrK70", "https://www.openaire.eu/search/publication?articleId=od______1404::6574285bd1662fef225103ab5f2fa6f1", "https://www.openaire.eu/search/advanced/publications", "https://www.ncbi.nlm.nih.gov/pubmed/27034600", "https://www.science.gov/", "https://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=2224784", "https://www.science.gov/", "http://www.redalyc.org/articulo.oa?id=17043728006", "https://doaj.org/search#.V6PA8bgrK70", "https://www.ncbi.nlm.nih.gov/pubmed/14640610", "https://www.science.gov/", "http://www.sciencedirect.com/science/article/pii/S0716864017300160", "https://doaj.org/search#.V6PA8bgrK70", "https://www.ncbi.nlm.nih.gov/pubmed/17768499", "https://www.science.gov/", "https://www.ncbi.nlm.nih.gov/pubmed/11383755", "https://www.science.gov/", "https://www.ncbi.nlm.nih.gov/pubmed/23254497", "https://www.science.gov/", "http://vsp.spr-journal.ru:80/jour/article/view/752", "https://doaj.org/search#.V6PA8bgrK70", "https://www.ncbi.nlm.nih.gov/pubmed/18712420", "https://www.science.gov/", "http://europepmc.org/articles/PMC5291439?pdf=render", "https://doaj.org/search#.V6PA8bgrK70", "http://www.scielosp.org/scielo.php?script=sci_arttext&pid=S1135-57271999000400003", "https://doaj.org/search#.V6PA8bgrK70", "https://inis.iaea.orgsearchsinglerecord.aspx?recordsFor=SingleRecord&RN=7248436", "http://inis.iaea.org/search/", "https://www.openaire.eu/search/publication?articleId=od______1404::05502ca26081377cb9ac9b967d7e66d8", "https://www.openaire.eu/search/advanced/publications", "#", "#", "#", "#", "#", "#", "#", "#", "#", "#", "#", "#", "http://www.revistas.usach.cl/ojs/index.php/historiasocial/article/view/319", "https://doaj.org/search#.V6PA8bgrK70", "https://www.ncbi.nlm.nih.gov/pubmed/28571504", "https://www.science.gov/", "https://www.ncbi.nlm.nih.gov/pubmed/20305714", "https://www.science.gov/", "https://www.openaire.eu/search/publication?articleId=dedup_wf_001::61ee14b25b56c72855596bb426219d56", "https://www.openaire.eu/search/advanced/publications", "https://www.ncbi.nlm.nih.gov/pubmed/27630761", "https://www.science.gov/", "https://www.ncbi.nlm.nih.gov/pubmed/10747284", "https://www.science.gov/", "https://www.ncbi.nlm.nih.gov/pubmed/29555745", "https://www.science.gov/", "https://www.ncbi.nlm.nih.gov/pubmed/21923771", "https://www.science.gov/", "http://www.scielosp.org/scielo.php?script=sci_arttext&pid=S1020-49892004000900002", "https://doaj.org/search#.V6PA8bgrK70", "https://www.ncbi.nlm.nih.gov/pubmed/20592763", "https://www.science.gov/", "https://www.narcis.nl/publication/RecordID/oai%3Apure.rug.nl%3Apublications%2Fd539369e-a7ca-4a4a-9d06-ae24e64f05d1/uquery/antibiotics%20AND%20anti-inflammatory/id/12/Language/EN", "http://www.narcis.nl", "http://asclepio.revistas.csic.es/index.php/asclepio/article/view/71/74", "https://doaj.org/search#.V6PA8bgrK70", "http://adsabs.harvard.edu/abs/2016NatSR...619095L", "https://www.science.gov/", "http://www.scielo.org.ar/scielo.php?script=sci_arttext&pid=S0025-76802003000300002", "https://doaj.org/search#.V6PA8bgrK70", "https://www.openaire.eu/search/publication?articleId=dedup_wf_001::9c7220297c636745e06628ec37f2b47e", "https://www.openaire.eu/search/advanced/publications", "https://www.ncbi.nlm.nih.gov/pubmed/10330195", "https://www.science.gov/", "http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1025-028X2010000300001&lng=es&nrm=iso&tlng=es", "https://doaj.org/search#.V6PA8bgrK70", "https://www.ncbi.nlm.nih.gov/pubmed/11581468", "https://www.science.gov/", "https://www.ncbi.nlm.nih.gov/pubmed/29138021", "https://www.science.gov/", "http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1025-028X2006000200001&lng=es&nrm=iso&tlng=es", "https://doaj.org/search#.V6PA8bgrK70", "#", "#", "#", "#", "#", "#", "#", "#", "#", "#", "#", "#", "https://www.ncbi.nlm.nih.gov/pubmed/24486207", "https://www.science.gov/", "https://www.openaire.eu/search/publication?articleId=od______1326::8ba7ba7cedd44552d4d60ca52f50c9aa", "https://www.openaire.eu/search/advanced/publications", "https://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=5809987", "https://www.science.gov/", "http://journal.frontiersin.org/article/10.3389/fpubh.2017.00289/full", "https://doaj.org/search#.V6PA8bgrK70", "http://www.circumpolarhealthjournal.net/index.php/ijch/article/download/20992/pdf_1", "https://doaj.org/search#.V6PA8bgrK70", "https://www.ncbi.nlm.nih.gov/pubmed/16462964", "https://www.science.gov/", "https://www.openaire.eu/search/publication?articleId=od______1325::4966a7cc814137a440382bdf643c90d0", "https://www.openaire.eu/search/advanced/publications", "http://europepmc.org/articles/PMC2892464?pdf=render", "https://doaj.org/search#.V6PA8bgrK70", "http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1025-028X2016000200003&lng=es&nrm=iso&tlng=es", "https://doaj.org/search#.V6PA8bgrK70", "https://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=1913223", "https://www.science.gov/", "http://www.scielo.org.mx/scielo.php?script=sci_arttext&pid=S0036-36342005000200009", "https://doaj.org/search#.V6PA8bgrK70", "https://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=4582044", "https://www.science.gov/", "http://www.sciencedirect.com/science/article/pii/S0716864014700689", "https://doaj.org/search#.V6PA8bgrK70", "https://www.ncbi.nlm.nih.gov/pubmed/26452008", "https://www.science.gov/", "https://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=5512790", "https://www.science.gov/", "https://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=4090067", "https://www.science.gov/", "http://riiad.org/index.php/riiad/article/view/riiad.2017.2.05", "https://doaj.org/search#.V6PA8bgrK70", "http://www.mdpi.com/1999-4915/2/8/1510/", "https://doaj.org/search#.V6PA8bgrK70", "https://www2c.cdc.gov/podcasts/player.asp?f=8630647", "http://www2c.cdc.gov/podcasts/search.asp", "https://www.ncbi.nlm.nih.gov/pubmed/15876546", "https://www.science.gov/", "#", "#", "#", "#", "#", "#", "#", "#", "#", "#", "#", "#", "https://www.ncbi.nlm.nih.gov/pubmed/29898770", "https://www.science.gov/", "http://www.scielosp.org/scielo.php?script=sci_arttext&pid=S1135-57271997000200003", "https://doaj.org/search#.V6PA8bgrK70", "http://adsabs.harvard.edu/abs/2012JOUC...11..205J", "https://www.science.gov/", "http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1025-028X2010000200006&lng=es&nrm=iso", "https://doaj.org/search#.V6PA8bgrK70", "https://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=2493100", "https://www.science.gov/", "http://www.scielo.org.co/scielo.php?script=sci_arttext&pid=S0123-93922015000200004&lng=en&tlng=en", "https://doaj.org/search#.V6PA8bgrK70", "http://www.revistabiomedica.org/index.php/biomedica/article/view/1320", "https://doaj.org/search#.V6PA8bgrK70", "http://dx.doi.org/10.1023/A:1020021109462", "http://inis.iaea.org/search/", "https://www.ncbi.nlm.nih.gov/pubmed/26194164", "https://www.science.gov/", "https://www.openaire.eu/search/publication?articleId=doajarticles::d1c5d56abb3c55f6f0d140a1ec694442", "https://www.openaire.eu/search/advanced/publications", "http://www.scielo.org.ar/scielo.php?script=sci_arttext&pid=S0025-76802010000300002&lng=en&tlng=en", "https://doaj.org/search#.V6PA8bgrK70", "http://europepmc.org/articles/PMC4090067?pdf=render", "https://doaj.org/search#.V6PA8bgrK70", "https://www.openaire.eu/search/publication?articleId=od______1404::4dfcdb9afa501d98d59e07e37c0dec1f", "https://www.openaire.eu/search/advanced/publications", "http://togodb.dbcls.jp/dicty_cdb_contig/show/1698", "http://biosciencedbc.jp/dbsearch/index.php?lang=en", "http://www.scielosp.org/scielo.php?script=sci_arttext&pid=S1020-49891997001200001", "https://doaj.org/search#.V6PA8bgrK70", "http://www.scielosp.org/scielo.php?script=sci_arttext&pid=S1020-49891997001200001&lng=en&tlng=en", "https://doaj.org/search#.V6PA8bgrK70", "http://revistabionatura.com/2017.02.01.7.html", "https://doaj.org/search#.V6PA8bgrK70", "http://www.redalyc.org/articulo.oa?id=17023106004", "https://doaj.org/search#.V6PA8bgrK70", "http://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S0213-91112006000200004", "https://doaj.org/search#.V6PA8bgrK70", "https://www.openaire.eu/search/publication?articleId=od______1325::3699ed70c8821c924c79160abcf4fcaf", "https://www.openaire.eu/search/advanced/publications", "#", "#", "#", "#", "#", "#", "#", "#", "#", "#", "#", "#", "https://www.ncbi.nlm.nih.gov/pubmed/25348637", "https://www.science.gov/", "https://www.ncbi.nlm.nih.gov/pubmed/29135340", "https://www.science.gov/", "https://www.ncbi.nlm.nih.gov/pubmed/25483504", "https://www.science.gov/", "https://www.ncbi.nlm.nih.gov/pubmed/27247060", "https://www.science.gov/", "https://www.ncbi.nlm.nih.gov/pubmed/21494175", "https://www.science.gov/", "https://www.ncbi.nlm.nih.gov/pubmed/25973940", "https://www.science.gov/", "http://www.redalyc.org/articulo.oa?id=17020115007", "https://doaj.org/search#.V6PA8bgrK70", "https://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=5382827", "https://www.science.gov/", "https://www.ncbi.nlm.nih.gov/pubmed/22297738", "https://www.science.gov/", "https://www.ncbi.nlm.nih.gov/pubmed/11166665", "https://www.science.gov/", "https://www.ncbi.nlm.nih.gov/pubmed/22919649", "https://www.science.gov/", "http://journal.frontiersin.org/Journal/10.3389/fcimb.2012.00058/full", "https://doaj.org/search#.V6PA8bgrK70", "http://www.forskningsdatabasen.dk/en/catalog/63173082", "http://forskningsbasen.deff.dk/?lang=eng", "https://www.narcis.nl/publication/RecordID/oai%3Apure.rug.nl%3Apublications%2F3bc35d9e-bdb3-4d3e-bd25-90b2258510c5/uquery/influenza/id/10/Language/EN", "http://www.narcis.nl", "https://www.ncbi.nlm.nih.gov/pubmed/23986398", "https://www.science.gov/", "http://www.imiamn.org.ua/journal/2_2017/PDF/5.pdf", "https://doaj.org/search#.V6PA8bgrK70", "https://www.openaire.eu/search/publication?articleId=doajarticles::136a986051855d4bcd529e7bf176cfb3", "https://www.openaire.eu/search/advanced/publications", "http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1025-028X2017000100001&lng=es&nrm=iso&tlng=es", "https://doaj.org/search#.V6PA8bgrK70", "http://www.mdpi.com/1999-4915/6/4/1861", "https://doaj.org/search#.V6PA8bgrK70", "http://www.journal-imab-bg.org/statii-10/vol16_b3_p66-69.pdf", "https://doaj.org/search#.V6PA8bgrK70", "#", "#", "#", "#", "#", "#", "#", "#", "#", "#", "#", "#", "https://www.openaire.eu/search/publication?articleId=od______1404::024354d31010002918ddb339dc0408a6", "https://www.openaire.eu/search/advanced/publications", "https://www.openaire.eu/search/publication?articleId=dedup_wf_001::9f9342f04c4ecfc6206eb357ddd593ea", "https://www.openaire.eu/search/advanced/publications", "https://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=358107", "https://www.science.gov/", "https://www.ncbi.nlm.nih.gov/pubmed/28581706", "https://www.science.gov/", "https://www.openaire.eu/search/publication?articleId=doajarticles::665616b0e79abcde2883f393f494e02c", "https://www.openaire.eu/search/advanced/publications", "https://www.ncbi.nlm.nih.gov/pubmed/28768669", "https://www.science.gov/", "https://www.ncbi.nlm.nih.gov/pubmed/25830489", "https://www.science.gov/", "http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1025-028X2017000100003&lng=es&nrm=iso&tlng=es", "https://doaj.org/search#.V6PA8bgrK70", "http://www.scielo.org.ar/scielo.php?script=sci_arttext&pid=S0025-76802014000300017&lng=en&tlng=en", "https://doaj.org/search#.V6PA8bgrK70", "https://www.ncbi.nlm.nih.gov/pubmed/27418579", "https://www.science.gov/", "https://www.narcis.nl/publication/RecordID/oai%3Adspace.library.uu.nl%3A1874%2F344372/uquery/vaccine%20AND%20safety%20AND%20children/id/12/Language/EN", "http://www.narcis.nl", "http://dx.doi.org/10.1016/j.virol.2004.01.032", "http://inis.iaea.org/search/", "https://www.openaire.eu/search/publication?articleId=od_______296::4dfda7f2f3e4339756541268672e7022", "https://www.openaire.eu/search/advanced/publications", "http://www.scielo.org.ar/scielo.php?script=sci_arttext&pid=S0025-76802011000500015&lng=en&tlng=en", "https://doaj.org/search#.V6PA8bgrK70", "https://www.ncbi.nlm.nih.gov/pubmed/22973873", "https://www.science.gov/", "http://www.biomedcentral.com/1471-2164/12/187", "https://doaj.org/search#.V6PA8bgrK70", "http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1025-028X2004000200002&lng=es&nrm=iso&tlng=es", "https://doaj.org/search#.V6PA8bgrK70", "https://inis.iaea.orgsearchsinglerecord.aspx?recordsFor=SingleRecord&RN=16041445", "http://inis.iaea.org/search/", "http://www.etde.org/etdeweb/details.jsp?query_id=1&page=0&osti_id=5555017", "https://www.etde.org/etdeweb/fieldedsearch.jsp", "https://www.openaire.eu/search/publication?articleId=od______3056::f05567414de6d21aa40ac29e17e5ac10", "https://www.openaire.eu/search/advanced/publications", "#", "#", "#", "#", "#", "#", "#", "#", "#", "#", "#", "#", "http://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S0465-546X2007000400010", "https://doaj.org/search#.V6PA8bgrK70", "https://www.ncbi.nlm.nih.gov/pubmed/9671518", "https://www.science.gov/", "http://www.forskningsdatabasen.dk/en/catalog/79004651", "http://forskningsbasen.deff.dk/?lang=eng", "http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0074-02762008000700014", "https://doaj.org/search#.V6PA8bgrK70", "http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1025-028X2006000200004&lng=es&nrm=iso&tlng=es", "https://doaj.org/search#.V6PA8bgrK70", "http://www.mdpi.com/1420-3049/20/11/19653", "https://doaj.org/search#.V6PA8bgrK70", "https://www.gpo.gov/fdsys/pkg/CFR-2010-title21-vol8/pdf/CFR-2010-title21-vol8-sec866-3300.pdf", "https://www.science.gov/", "https://www.ncbi.nlm.nih.gov/pubmed/28508293", "https://www.science.gov/", "http://www.biomedcentral.com/1741-7015/10/104", "https://doaj.org/search#.V6PA8bgrK70", "https://www.openaire.eu/search/publication?articleId=doajarticles::10bf287ae0007ca1c04dfbe102687a3b", "https://www.openaire.eu/search/advanced/publications", "http://www.redalyc.org/articulo.oa?id=17043728001", "https://doaj.org/search#.V6PA8bgrK70", "https://www.openaire.eu/search/publication?articleId=od_______617::72f63e3faddc26d37afb5bec15e160d2", "https://www.openaire.eu/search/advanced/publications", "http://www.mdpi.com/1999-4915/8/10/269", "https://doaj.org/search#.V6PA8bgrK70", "http://europepmc.org/articles/PMC3842314?pdf=render", "https://doaj.org/search#.V6PA8bgrK70", "http://www.scielosp.org/scielo.php?script=sci_arttext&pid=S1726-46342015000300021&lng=en&tlng=en", "https://doaj.org/search#.V6PA8bgrK70", "https://www.openaire.eu/search/publication?articleId=od______3056::5aea482dc46dbe9b8757a5c569ccc32c", "https://www.openaire.eu/search/advanced/publications", "http://dx.doi.org/10.1155/2018/9747549", "https://doaj.org/search#.V6PA8bgrK70", "http://togodb.dbcls.jp/dicty_cdb_clone/show/79951", "http://biosciencedbc.jp/dbsearch/index.php?lang=en", "http://www.scielosp.org/scielo.php?script=sci_arttext&pid=S1020-49892003001100002", "https://doaj.org/search#.V6PA8bgrK70", "http://adsabs.harvard.edu/abs/2010SPIE.7548E..30R", "https://www.science.gov/", "#", "#", "#", "#", "#", "#", "#", "#", "#", "#", "#", "#", "http://www.scielo.org.pe/scielo.php?script=sci_arttext&pid=S1025-55832008000100006&lng=en&tlng=en", "https://doaj.org/search#.V6PA8bgrK70", "https://www.openaire.eu/search/publication?articleId=dedup_wf_001::1ea3de1bdf059dfdef615fb2bb624b84", "https://www.openaire.eu/search/advanced/publications", "https://www.ncbi.nlm.nih.gov/pubmed/2407775", "https://www.science.gov/", "https://www.openaire.eu/search/publication?articleId=od______3056::fdf39db7ea85d0b298d8cb69b7ea59bb", "https://www.openaire.eu/search/advanced/publications", "https://www.ncbi.nlm.nih.gov/pubmed/23152850", "https://www.science.gov/", "http://europepmc.org/articles/PMC3495775?pdf=render", "https://doaj.org/search#.V6PA8bgrK70", "http://www.scielo.org.ar/scielo.php?script=sci_arttext&pid=S0325-75412012000300014", "https://doaj.org/search#.V6PA8bgrK70", "https://www.openaire.eu/search/publication?articleId=doajarticles::6f322a77ce0bd5fd88c95f861a1a0782", "https://www.openaire.eu/search/advanced/publications", "https://www.ncbi.nlm.nih.gov/pubmed/26821825", "https://www.science.gov/", "http://www.scielosp.org/scielo.php?script=sci_arttext&pid=S0036-36341998000100006", "https://doaj.org/search#.V6PA8bgrK70", "http://www.scielosp.org/scielo.php?script=sci_arttext&pid=S1020-49892004000100006", "https://doaj.org/search#.V6PA8bgrK70", "http://www.scielosp.org/scielo.php?script=sci_arttext&pid=S1726-46342013000200018&lng=en&tlng=en", "https://doaj.org/search#.V6PA8bgrK70", "https://www.ncbi.nlm.nih.gov/pubmed/26470444", "https://www.science.gov/", "http://www.redalyc.org/articulo.oa?id=17033372012", "https://doaj.org/search#.V6PA8bgrK70", "http://europepmc.org/articles/PMC4020859?pdf=render", "https://doaj.org/search#.V6PA8bgrK70", "http://www.mdpi.com/1999-4915/2/7/1448/", "https://doaj.org/search#.V6PA8bgrK70", "https://www.ncbi.nlm.nih.gov/pubmed/21994689", "https://www.science.gov/", "http://www.scielo.org.mx/scielo.php?script=sci_arttext&pid=S0036-36342009000900012", "https://doaj.org/search#.V6PA8bgrK70", "https://www.ncbi.nlm.nih.gov/pubmed/12962500", "https://www.science.gov/", "https://www.ncbi.nlm.nih.gov/pubmed/11225381", "https://www.science.gov/", "#", "#", "#", "#", "#", "#", "#", "#", "#", "#", "#", "#", "https://www.ncbi.nlm.nih.gov/pubmed/12837790", "https://www.science.gov/", "http://www.scielosp.org/scielo.php?script=sci_arttext&pid=S1020-49892013001000002&lng=en&tlng=en", "https://doaj.org/search#.V6PA8bgrK70", "https://www.openaire.eu/search/publication?articleId=doajarticles::9f083d9cb2b9e06dbceeb1cf2c0fabe3", "https://www.openaire.eu/search/advanced/publications", "http://www.forskningsdatabasen.dk/en/catalog/152071007", "http://forskningsbasen.deff.dk/?lang=eng", "https://www.ncbi.nlm.nih.gov/pubmed/23967126", "https://www.science.gov/", "http://www.forskningsdatabasen.dk/en/catalog/2389196557", "http://forskningsbasen.deff.dk/?lang=eng", "http://europepmc.org/articles/PMC5814058?pdf=render", "https://doaj.org/search#.V6PA8bgrK70", "http://orbit.dtu.dk/ws/files/128102313/COPD_postprint.pdf", "http://forskningsbasen.deff.dk/?lang=eng", "http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1025-028X2006000200002&lng=es&nrm=iso&tlng=es", "https://doaj.org/search#.V6PA8bgrK70", "https://www.ncbi.nlm.nih.gov/pubmed/27756711", "https://www.science.gov/", "http://dx.doi.org/10.1016/j.envpol.2013.09.019", "http://inis.iaea.org/search/", "http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1025-028X2005000100003&lng=es&nrm=iso&tlng=es", "https://doaj.org/search#.V6PA8bgrK70", "https://www.ncbi.nlm.nih.gov/pubmed/27265451", "https://www.science.gov/", "https://revistas.unal.edu.co/index.php/actabiol/article/view/11338", "https://doaj.org/search#.V6PA8bgrK70", "https://www.ncbi.nlm.nih.gov/pubmed/28842649", "https://www.science.gov/", "http://www.revistabiomedica.org/index.php/biomedica/article/view/1056", "https://doaj.org/search#.V6PA8bgrK70", "https://www.ncbi.nlm.nih.gov/pubmed/28878220", "https://www.science.gov/", "https://www.ncbi.nlm.nih.gov/pubmed/8548193", "https://www.science.gov/", "https://www.ncbi.nlm.nih.gov/pubmed/29760213", "https://www.science.gov/", "http://www.mdpi.com/1422-0067/19/5/1400", "https://doaj.org/search#.V6PA8bgrK70", "#", "#", "#", "#", "#", "#", "#", "#", "#", "#", "#", "#", "http://www.biomedcentral.com/1471-2334/6/12", "https://doaj.org/search#.V6PA8bgrK70", "https://togodb.biosciencedbc.jp/kegg_medicus_disease_en/show/H01330", "http://biosciencedbc.jp/dbsearch/index.php?lang=en", "http://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S0213-91112005000600006", "https://doaj.org/search#.V6PA8bgrK70", "http://www.scielo.org.ar/scielo.php?script=sci_arttext&pid=S0025-76802010000600014&lng=en&tlng=en", "https://doaj.org/search#.V6PA8bgrK70", "http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1025-028X2007000300004&lng=es&nrm=iso&tlng=es", "https://doaj.org/search#.V6PA8bgrK70", "https://www.ncbi.nlm.nih.gov/pubmed/26061190", "https://www.science.gov/", "https://www.ncbi.nlm.nih.gov/pubmed/22475859", "https://www.science.gov/", "http://www.forskningsdatabasen.dk/en/catalog/226876727", "http://forskningsbasen.deff.dk/?lang=eng", "http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S0034-75152009000200004", "https://doaj.org/search#.V6PA8bgrK70", "http://www.forskningsdatabasen.dk/en/catalog/2389430098", "http://forskningsbasen.deff.dk/?lang=eng", "http://www.sciencedirect.com/science/article/pii/S1201971217302886", "https://doaj.org/search#.V6PA8bgrK70", "http://www.biomedcentral.com/1471-2334/4/12", "https://doaj.org/search#.V6PA8bgrK70", "http://asclepio.revistas.csic.es/index.php/asclepio/article/view/266/263", "https://doaj.org/search#.V6PA8bgrK70", "https://www.ncbi.nlm.nih.gov/pubmed/28088246", "https://www.science.gov/", "http://europepmc.org/articles/PMC3126839?pdf=render", "https://doaj.org/search#.V6PA8bgrK70", "http://dx.doi.org/10.1155/2014/921054", "https://doaj.org/search#.V6PA8bgrK70", "http://www.biomedcentral.com/1471-2180/7/56", "https://doaj.org/search#.V6PA8bgrK70", "http://www.etde.org/etdeweb/details.jsp?query_id=1&page=0&osti_id=22204709", "https://www.etde.org/etdeweb/fieldedsearch.jsp", "http://dx.doi.org/10.1016/j.bbrc.2010.11.030", "http://inis.iaea.org/search/", "http://revistamedicina.net/ojsanm/index.php/Revistamedicina/article/view/92", "https://doaj.org/search#.V6PA8bgrK70", "#", "#", "#", "#", "#", "#", "#", "#", "#", "#", "#", "#", "http://www.forskningsdatabasen.dk/en/catalog/117479482", "http://forskningsbasen.deff.dk/?lang=eng", "http://www.mdpi.com/1420-3049/16/8/6489/", "https://doaj.org/search#.V6PA8bgrK70", "http://www.translational-medicine.com/content/9/1/127", "https://doaj.org/search#.V6PA8bgrK70", "https://www.openaire.eu/search/publication?articleId=od______1326::8fd162326a4cf806bef07884700a3945", "https://www.openaire.eu/search/advanced/publications", "https://www.ncbi.nlm.nih.gov/pubmed/20640805", "https://www.science.gov/", "http://www.redalyc.org/articulo.oa?id=17015304012", "https://doaj.org/search#.V6PA8bgrK70", "https://www.openaire.eu/search/publication?articleId=doajarticles::0f1a7e9d964b5b4dd7e2026d0f5f7623", "https://www.openaire.eu/search/advanced/publications", "https://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=4618372", "https://www.science.gov/", "http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0004-282X2004000200011", "https://doaj.org/search#.V6PA8bgrK70", "http://www.redalyc.org/articulo.oa?id=83743886006", "https://doaj.org/search#.V6PA8bgrK70", "http://europepmc.org/articles/PMC4944999?pdf=render", "https://doaj.org/search#.V6PA8bgrK70", "https://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=5489287", "https://www.science.gov/", "http://www.scielo.org.mx/scielo.php?script=sci_arttext&pid=S0036-36342006000500004", "https://doaj.org/search#.V6PA8bgrK70", "https://revistas.unal.edu.co/index.php/revfacmed/article/view/22140", "https://doaj.org/search#.V6PA8bgrK70", "http://medpub.litbang.pertanian.go.id/index.php/wartazoa/article/view/964/973", "https://doaj.org/search#.V6PA8bgrK70", "http://www.scielo.org.mx/scielo.php?script=sci_arttext&pid=S0036-36342005000300007", "https://doaj.org/search#.V6PA8bgrK70", "http://www.sciencedirect.com/science/article/pii/S0716864010706088", "https://doaj.org/search#.V6PA8bgrK70", "http://dx.doi.org/10.1093/ecam/nep152", "https://doaj.org/search#.V6PA8bgrK70", "http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1025-028X2006000200003&lng=es&nrm=iso&tlng=es", "https://doaj.org/search#.V6PA8bgrK70", "https://www.ncbi.nlm.nih.gov/pubmed/26557857", "https://www.science.gov/", "#", "#", "#", "#", "#", "#", "#", "#", "#", "#", "#", "#", "http://www.sciencedirect.com/science/article/pii/S2215017X15000314", "https://doaj.org/search#.V6PA8bgrK70", "https://www.ncbi.nlm.nih.gov/pubmed/2839681", "https://www.science.gov/", "https://www.ncbi.nlm.nih.gov/pubmed/28129777", "https://www.science.gov/", "http://www.scielo.org.pe/scielo.php?script=sci_arttext&pid=S1726-46342003000300007&lng=en&tlng=en", "https://doaj.org/search#.V6PA8bgrK70", "https://www.openaire.eu/search/publication?articleId=dedup_wf_001::69504224a67a1db5cf7f4eafc85160f1", "https://www.openaire.eu/search/advanced/publications", "https://www.openaire.eu/search/publication?articleId=od_______935::d513a40dc09e50440853f4ad3258003a", "https://www.openaire.eu/search/advanced/publications", "http://www.biomedcentral.com/1471-2474/13/158", "https://doaj.org/search#.V6PA8bgrK70", "https://www.ncbi.nlm.nih.gov/pubmed/27349840", "https://www.science.gov/", "http://www.etde.org/etdeweb/details.jsp?query_id=1&page=0&osti_id=960849", "https://www.etde.org/etdeweb/fieldedsearch.jsp", "http://www.scielo.org.pe/scielo.php?script=sci_arttext&pid=S1726-46342007000300011&lng=en&tlng=en", "https://doaj.org/search#.V6PA8bgrK70", "http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0034-89102009000600013", "https://doaj.org/search#.V6PA8bgrK70", "https://www.ncbi.nlm.nih.gov/pubmed/15504829", "https://www.science.gov/", "http://www.revista-socampar.com/images/articulos/ArticulosSeparadosNum6/Articulo%20especial.pdf", "https://doaj.org/search#.V6PA8bgrK70", "https://www.ncbi.nlm.nih.gov/pubmed/25278086", "https://www.science.gov/", "http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S0864-21252007000100011", "https://doaj.org/search#.V6PA8bgrK70", "http://www.scielosp.org/scielo.php?script=sci_arttext&pid=S1726-46342012000200017", "https://doaj.org/search#.V6PA8bgrK70", "https://www.ncbi.nlm.nih.gov/pubmed/28986103", "https://www.science.gov/", "http://journal.frontiersin.org/Journal/10.3389/fimmu.2015.00361/full", "https://doaj.org/search#.V6PA8bgrK70", "https://www.ncbi.nlm.nih.gov/pubmed/22025274", "https://www.science.gov/", "https://www.openaire.eu/search/publication?articleId=od______3056::d4191acb1173d7dbea934cb8c961809f", "https://www.openaire.eu/search/advanced/publications", "#", "#", "#", "#", "#", "#", "http://worldwidescience.org/disclaimer.html", null, "http://www.science.gov", "http://worldwidescience.org"]}